data_1ghu_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1ghu _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 64.5 p-90 . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 117.053 2.242 . . . . 0.0 117.053 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -81.33 121.78 26.64 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 120.696 1.589 . . . . 0.0 110.237 -173.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -124.35 106.42 10.23 Favored 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 104.543 -2.391 . . . . 0.0 104.543 173.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -39.15 -67.57 0.57 Allowed Glycine 0 N--CA 1.487 2.056 0 N-CA-C 119.765 2.666 . . . . 0.0 119.765 -169.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -151.55 91.7 1.69 Allowed 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.46 157.35 62.15 Favored Pre-proline 0 N--CA 1.5 2.066 0 CA-C-O 118.467 -0.778 . . . . 0.0 109.898 177.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -54.68 159.3 9.08 Favored 'Trans proline' 0 C--N 1.371 1.755 0 C-N-CA 123.4 2.733 . . . . 0.0 117.619 178.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 59.6 ttt180 -65.94 -40.02 90.98 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 114.503 1.297 . . . . 0.0 114.503 170.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -66.69 -44.18 82.43 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 173.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -61.02 -38.12 84.97 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 115.45 1.648 . . . . 0.0 115.45 170.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.94 -45.32 94.19 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 115.476 1.658 . . . . 0.0 115.476 169.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -60.95 -42.69 98.72 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 115.199 1.555 . . . . 0.0 115.199 171.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -59.57 -51.27 70.54 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 174.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -63.21 -45.96 89.24 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 115.024 1.491 . . . . 0.0 115.024 177.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 6.5 mp -70.05 -41.12 74.63 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 114.854 1.427 . . . . 0.0 114.854 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 69.8 m -58.76 -35.04 72.13 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 115.839 1.792 . . . . 0.0 115.839 169.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 59.4 mttm -64.29 -38.28 90.49 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 115.287 1.588 . . . . 0.0 115.287 169.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -53.54 137.07 37.39 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 179.313 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 36.0 ptt180 -66.97 -22.85 65.91 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 118.029 2.603 . . . . 0.0 118.029 174.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 67.0 m80 -89.33 138.03 31.8 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-N 119.186 0.903 . . . . 0.0 112.017 -169.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -77.95 124.63 28.24 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.065 169.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.61 11.95 58.75 Favored Glycine 0 CA--C 1.555 2.569 0 CA-C-O 117.839 -1.534 . . . . 0.0 116.866 -169.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -71.34 123.53 22.52 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 120.443 2.122 . . . . 0.0 112.135 -170.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 17.5 p90 -135.7 160.86 37.22 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 116.359 1.985 . . . . 0.0 116.359 -168.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.1 pp -144.14 141.82 30.21 Favored 'General case' 0 CA--C 1.556 1.188 0 CA-C-N 113.786 -1.552 . . . . 0.0 108.277 167.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 52.7 mt -97.62 112.46 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 172.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -105.02 150.42 24.97 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 124.4 1.08 . . . . 0.0 111.905 176.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -89.72 138.28 31.61 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 169.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 68.3 m -64.08 137.18 57.85 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.847 0.859 . . . . 0.0 112.305 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -76.15 109.6 9.96 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.241 1.016 . . . . 0.0 110.28 -169.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . 0.374 16.6 m 103.39 -34.11 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.844 0 CA-C-N 112.286 -2.233 . . . . 0.0 114.665 -172.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -93.15 112.62 57.05 Favored Pre-proline 0 CA--C 1.567 1.61 0 CA-C-N 120.628 1.558 . . . . 0.0 111.685 -176.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -81.48 134.5 8.86 Favored 'Trans proline' 0 C--N 1.371 1.732 0 C-N-CA 123.137 2.558 . . . . 0.0 112.901 -179.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 66.66 33.52 84.66 Favored Glycine 0 CA--C 1.552 2.362 0 N-CA-C 117.012 1.565 . . . . 0.0 117.012 -169.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -126.45 92.0 3.47 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 105.858 -1.904 . . . . 0.0 105.858 -178.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -93.24 163.39 13.64 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-O 122.211 1.005 . . . . 0.0 111.687 -169.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 72.8 m -147.67 120.73 8.83 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 29.9 tp -79.61 103.85 9.81 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 171.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 3.1 m -84.94 108.16 17.44 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 172.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 6.8 p -135.18 126.54 46.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 -173.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -75.72 112.21 11.86 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.645 174.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 12.5 m-30 -117.84 106.82 13.4 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 176.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 85.51 -95.79 2.03 Favored Glycine 0 CA--C 1.54 1.612 0 N-CA-C 111.154 -0.778 . . . . 0.0 111.154 -172.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -127.6 -24.19 3.33 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 114.956 1.465 . . . . 0.0 114.956 169.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -89.24 139.13 30.8 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 119.056 0.844 . . . . 0.0 110.558 -175.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 59.3 t -87.85 110.93 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 N-CA-C 106.66 -1.608 . . . . 0.0 106.66 178.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 69.0 mt-30 -106.95 120.56 42.39 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.177 -169.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 19.8 m-70 -99.65 97.69 8.63 Favored 'General case' 0 CA--C 1.553 1.093 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 -170.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -93.11 125.03 37.51 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 -179.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -75.6 119.84 20.19 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-O 121.32 0.581 . . . . 0.0 112.222 -170.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 90.9 t -93.79 97.86 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 N-CA-C 106.374 -1.713 . . . . 0.0 106.374 178.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 71.0 mt -85.57 154.76 21.51 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.682 0.793 . . . . 0.0 110.951 177.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 65.0 mtp180 -115.87 129.39 56.4 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.505 -0.747 . . . . 0.0 110.798 -177.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -106.23 94.12 4.98 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 123.323 0.649 . . . . 0.0 110.258 176.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 88.96 -112.84 4.01 Favored Glycine 0 CA--C 1.541 1.706 0 N-CA-C 113.918 0.327 . . . . 0.0 113.918 172.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -89.03 -94.25 0.11 Allowed 'General case' 0 N--CA 1.486 1.341 0 CA-C-O 118.228 -0.892 . . . . 0.0 111.35 -169.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -113.73 80.3 0.28 Allowed Glycine 0 N--CA 1.481 1.665 0 CA-C-N 119.335 0.971 . . . . 0.0 110.689 177.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -142.5 146.58 34.87 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -175.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -145.78 108.36 4.48 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 -169.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 21.2 p90 -126.74 117.77 23.36 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.749 0.82 . . . . 0.0 109.602 -175.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -107.95 -42.83 4.58 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 170.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 47.2 t90 -92.03 -74.07 0.53 Allowed 'General case' 0 CA--C 1.558 1.255 0 C-N-CA 124.959 1.304 . . . . 0.0 110.182 -169.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . 0.267 14.8 p -147.24 -64.98 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 C-N-CA 123.612 0.765 . . . . 0.0 109.188 174.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 9.4 m -79.56 142.21 14.29 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.426 0 C-N-CA 124.175 0.99 . . . . 0.0 111.481 -178.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.87 154.65 28.23 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -177.448 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -133.66 116.41 15.79 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 106.471 -1.677 . . . . 0.0 106.471 -171.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -55.68 -50.59 69.86 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 115.884 1.809 . . . . 0.0 115.884 -173.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 69.0 m -106.57 161.58 14.5 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-O 122.025 0.916 . . . . 0.0 111.21 173.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 84.5 mt -67.2 -29.07 68.64 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 168.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -67.07 -39.66 86.87 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-N 119.652 1.114 . . . . 0.0 113.04 169.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -60.47 -41.46 94.23 Favored 'General case' 0 CA--C 1.568 1.67 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 169.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 9.1 tt -56.99 -45.56 82.88 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 114.139 1.163 . . . . 0.0 114.139 169.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 41.3 t -60.01 -61.8 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 C-N-CA 124.308 1.043 . . . . 0.0 112.661 172.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 -63.16 -28.42 70.04 Favored 'General case' 0 CA--C 1.566 1.587 0 N-CA-C 115.879 1.807 . . . . 0.0 115.879 -174.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -63.12 -61.68 2.21 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 119.594 1.088 . . . . 0.0 112.01 169.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . 0.308 49.1 m-70 -70.11 -8.91 53.35 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 118.166 2.654 . . . . 0.0 118.166 177.414 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 59.2 ttm-85 -61.86 -28.81 69.76 Favored 'General case' 0 CA--C 1.579 2.092 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 167.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 71.0 m -110.43 -31.87 7.13 Favored 'General case' 0 CA--C 1.568 1.67 0 C-N-CA 125.199 1.4 . . . . 0.0 114.245 169.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 47.6 m -90.56 149.45 22.15 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-N 120.389 1.449 . . . . 0.0 110.445 175.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 22.8 t -80.96 137.26 36.1 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.741 -1.224 . . . . 0.0 113.242 -179.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 75.5 t -75.08 -58.82 3.99 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.834 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.126 169.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 73.4 m -89.66 114.99 26.7 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.909 0.884 . . . . 0.0 108.724 -177.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 19.3 mmm180 -89.24 81.51 6.69 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 122.33 1.062 . . . . 0.0 112.249 -169.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -160.32 -77.71 0.06 Allowed 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 103.816 -2.661 . . . . 0.0 103.816 173.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -97.08 146.57 24.89 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 169.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 65.5 mt-30 -79.35 112.27 16.42 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.665 -0.647 . . . . 0.0 111.222 -175.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -124.16 127.05 73.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 -178.023 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -119.88 168.33 11.22 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 122.545 1.164 . . . . 0.0 112.447 -169.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 11.0 mp -90.39 115.31 27.47 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 124.318 1.047 . . . . 0.0 110.251 -178.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.21 147.7 42.26 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 124.234 1.013 . . . . 0.0 109.302 178.043 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -74.11 152.17 39.95 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 122.112 0.958 . . . . 0.0 113.456 -176.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 14.3 pt -72.9 164.43 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 CA-C-N 114.903 -1.044 . . . . 0.0 113.583 -178.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 24.4 tp10 . . . . . 0 N--CA 1.485 1.315 0 CA-C-O 122.834 1.302 . . . . 0.0 109.315 172.076 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . 0.259 65.9 p-90 . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -81.82 140.79 33.97 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-N 119.596 1.089 . . . . 0.0 110.826 175.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -116.49 -87.27 0.61 Allowed 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 175.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 138.49 94.15 0.3 Allowed Glycine 0 N--CA 1.48 1.628 0 CA-C-N 119.603 1.092 . . . . 0.0 111.755 177.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . 0.259 20.5 tptm 67.14 73.42 0.34 Allowed 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 124.283 1.033 . . . . 0.0 113.56 173.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 28.4 pt -128.77 151.08 76.62 Favored Pre-proline 0 CA--C 1.576 1.95 0 C-N-CA 123.924 0.89 . . . . 0.0 109.443 176.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -75.42 172.25 16.68 Favored 'Trans proline' 0 CA--C 1.562 1.896 0 C-N-CA 122.997 2.464 . . . . 0.0 114.678 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 53.5 ttt180 -67.03 -41.3 86.8 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 115.771 1.767 . . . . 0.0 115.771 -179.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -66.9 -42.73 84.96 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 115.666 1.728 . . . . 0.0 115.666 177.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -64.94 -36.03 83.08 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 115.028 1.492 . . . . 0.0 115.028 169.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.82 -45.25 90.46 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 115.734 1.753 . . . . 0.0 115.734 170.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -62.43 -38.48 89.9 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 115.246 1.572 . . . . 0.0 115.246 170.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -61.33 -50.43 72.97 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 114.499 1.296 . . . . 0.0 114.499 173.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 39.2 tpp -57.5 -46.53 83.65 Favored 'General case' 0 CA--C 1.564 1.488 0 N-CA-C 115.604 1.705 . . . . 0.0 115.604 172.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 9.2 mp -70.65 -24.9 62.78 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 116.621 2.082 . . . . 0.0 116.621 175.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 71.6 m -57.28 -35.43 69.78 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-N 120.882 1.674 . . . . 0.0 114.908 169.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 56.8 mttp -60.45 -38.5 84.35 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 115.112 1.523 . . . . 0.0 115.112 169.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -68.49 122.29 18.14 Favored 'General case' 0 CA--C 1.556 1.183 0 C-N-CA 124.829 1.251 . . . . 0.0 112.156 178.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 16.4 ptm180 -78.24 -18.05 55.89 Favored 'General case' 0 CA--C 1.569 1.701 0 N-CA-C 118.199 2.666 . . . . 0.0 118.199 175.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 41.7 m80 -89.57 147.39 23.97 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 119.483 1.038 . . . . 0.0 113.722 -168.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -81.77 117.91 22.45 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 169.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 118.22 -32.89 5.08 Favored Glycine 0 CA--C 1.54 1.613 0 CA-C-O 117.704 -1.609 . . . . 0.0 116.35 -169.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -60.91 103.98 0.32 Allowed 'General case' 0 N--CA 1.486 1.339 0 CA-C-N 119.257 1.529 . . . . 0.0 113.9 -169.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 18.4 p90 -120.59 162.48 19.55 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 -168.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.3 pp -135.29 132.16 37.41 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 167.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 70.0 mt -91.82 114.31 28.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 105.611 -1.996 . . . . 0.0 105.611 170.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 46.8 ptt85 -100.45 156.07 17.47 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-N 114.596 -1.183 . . . . 0.0 110.484 170.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -87.67 128.03 35.29 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 168.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 16.4 t -60.36 137.83 58.07 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 113.753 1.02 . . . . 0.0 113.753 -170.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.06 119.86 17.89 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-O 122.907 1.337 . . . . 0.0 111.536 -171.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . 0.33 5.4 t 84.98 -22.21 0.21 Allowed 'General case' 0 N--CA 1.493 1.693 0 CA-C-N 111.569 -2.56 . . . . 0.0 116.075 -169.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -108.55 92.9 10.8 Favored Pre-proline 0 CA--C 1.565 1.533 0 CA-C-N 120.662 1.574 . . . . 0.0 110.213 177.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -73.52 133.15 18.51 Favored 'Trans proline' 0 C--N 1.373 1.821 0 C-N-CA 123.19 2.593 . . . . 0.0 111.429 171.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 98.69 -34.18 5.51 Favored Glycine 0 CA--C 1.553 2.456 0 CA-C-O 119.017 -0.879 . . . . 0.0 114.275 -168.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -79.64 131.84 36.09 Favored 'General case' 0 N--CA 1.484 1.257 0 CA-C-N 118.675 1.238 . . . . 0.0 108.599 169.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -116.63 164.09 15.13 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-O 122.124 0.964 . . . . 0.0 110.58 -178.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 69.0 m -143.54 115.32 8.22 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 -177.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 16.6 tp -83.8 104.93 14.29 Favored 'General case' 0 CA--C 1.561 1.386 0 C-N-CA 124.369 1.068 . . . . 0.0 108.502 174.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.8 m -93.63 108.62 20.32 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 -179.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 24.0 t -116.38 124.5 72.65 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 CA-C-N 119.762 1.164 . . . . 0.0 108.301 -169.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 58.6 tptt -84.06 120.65 26.4 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.211 0.605 . . . . 0.0 109.891 171.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 3.9 m-30 -89.23 -140.03 0.13 Allowed 'General case' 0 CA--C 1.567 1.633 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 173.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -58.13 -71.0 0.82 Allowed Glycine 0 CA--C 1.547 2.053 0 C-N-CA 123.96 0.791 . . . . 0.0 114.242 169.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 31.6 t30 -140.04 58.72 1.59 Allowed 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 117.534 0.667 . . . . 0.0 111.281 169.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -160.0 141.6 12.75 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 124.016 0.926 . . . . 0.0 108.627 176.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 57.2 t -107.35 109.83 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 177.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 18.6 mp0 -101.85 126.76 48.8 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.879 0.871 . . . . 0.0 109.777 179.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 11.9 m-70 -101.78 97.0 7.45 Favored 'General case' 0 CA--C 1.553 1.082 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 -175.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -86.41 128.81 34.99 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 172.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -91.02 118.87 30.73 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 121.208 0.528 . . . . 0.0 110.889 -169.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 91.9 t -85.91 110.21 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 107.224 -1.398 . . . . 0.0 107.224 -177.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 56.8 mt -104.31 134.41 47.58 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 -173.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 37.3 mtm180 -99.52 131.47 45.51 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 118.176 0.444 . . . . 0.0 110.929 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -85.6 -54.47 4.53 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 174.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 179.98 139.44 3.77 Favored Glycine 0 CA--C 1.542 1.732 0 CA-C-N 119.823 1.192 . . . . 0.0 113.77 -178.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . 0.344 . . 78.53 -79.15 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 125.294 1.438 . . . . 0.0 113.3 175.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -157.18 78.13 0.19 Allowed Glycine 0 N--CA 1.478 1.463 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 172.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -143.07 144.1 32.12 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -171.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -138.87 100.6 4.09 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 -172.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -99.89 105.43 17.16 Favored 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 175.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -101.63 -49.94 3.86 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-N 114.327 -1.306 . . . . 0.0 111.239 175.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 79.0 t90 -129.48 101.71 6.07 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 -172.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.405 HG12 ' H ' ' A' ' 123' ' ' VAL 0.509 10.7 p 60.75 -90.68 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 C-N-CA 125.227 1.411 . . . . 0.0 114.188 -179.45 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.405 ' H ' HG12 ' A' ' 122' ' ' VAL . 21.1 m -79.64 158.44 4.54 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.493 0 C-N-CA 124.449 1.1 . . . . 0.0 112.398 -175.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -79.72 152.7 29.73 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 121.876 0.846 . . . . 0.0 112.978 179.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -135.73 109.42 8.04 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 105.9 -1.889 . . . . 0.0 105.9 -171.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 15.1 t30 -57.89 -53.54 57.08 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 115.77 1.767 . . . . 0.0 115.77 -170.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 67.7 m -98.05 149.57 22.34 Favored 'General case' 0 N--CA 1.483 1.225 0 CA-C-O 123.04 1.4 . . . . 0.0 111.337 178.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 8.0 tp -65.96 -31.29 72.12 Favored 'General case' 0 CA--C 1.571 1.764 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 169.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -70.18 -37.85 75.23 Favored 'General case' 0 CA--C 1.57 1.746 0 CA-C-O 117.681 -1.152 . . . . 0.0 113.796 169.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . 0.329 9.1 pt-20 -62.16 -31.14 71.61 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-N 121.139 1.79 . . . . 0.0 115.088 169.319 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 59.6 tp -57.79 -44.13 86.06 Favored 'General case' 0 CA--C 1.574 1.868 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 168.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . 0.333 7.1 p -65.3 -57.61 10.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 CA-C-N 120.17 1.35 . . . . 0.0 113.918 172.644 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -60.32 -23.49 64.25 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 117.391 2.367 . . . . 0.0 117.391 176.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 84.8 t80 -66.25 -61.33 2.08 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-N 119.304 0.956 . . . . 0.0 112.043 169.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 71.4 m-70 -69.83 -9.54 55.13 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 117.734 2.494 . . . . 0.0 117.734 176.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 38.0 ttm180 -59.52 -29.11 67.65 Favored 'General case' 0 CA--C 1.58 2.119 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 167.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 70.7 m -110.2 -30.61 7.66 Favored 'General case' 0 CA--C 1.571 1.771 0 C-N-CA 125.483 1.513 . . . . 0.0 114.037 169.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 56.8 m -90.46 157.36 17.61 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-N 120.546 1.521 . . . . 0.0 111.266 177.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 8.2 t -75.93 129.79 37.47 Favored 'General case' 0 CA--C 1.56 1.363 0 O-C-N 121.491 -0.756 . . . . 0.0 112.8 177.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 14.1 t -69.15 -50.69 50.68 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 C-N-CA 123.807 0.843 . . . . 0.0 111.655 173.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 25.3 t -88.56 145.07 25.92 Favored 'General case' 0 CA--C 1.558 1.259 0 C-N-CA 123.341 0.656 . . . . 0.0 110.211 173.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 84.7 mtt85 -69.95 -50.39 42.43 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 177.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 21.0 m120 -72.84 -55.59 6.44 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 113.445 0.906 . . . . 0.0 113.445 174.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -83.26 146.7 28.41 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-N 118.978 0.808 . . . . 0.0 111.432 -177.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 60.5 mt-30 -86.02 94.78 9.31 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.337 0.589 . . . . 0.0 109.607 176.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 44.1 mm -114.44 133.18 61.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 -174.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -127.56 117.88 22.9 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 -169.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 14.1 tp -80.55 125.57 30.14 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 124.442 1.097 . . . . 0.0 113.952 -168.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 32.5 mmt180 -138.05 160.19 40.02 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 124.085 0.954 . . . . 0.0 110.525 -170.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -73.91 152.98 40.01 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.607 -1.308 . . . . 0.0 112.924 177.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.1 pp -66.55 159.73 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 -179.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 . . . . . 0 N--CA 1.485 1.299 0 CA-C-O 123.981 1.848 . . . . 0.0 108.584 -176.89 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . 0.253 1.6 p90 . . . . . 0 N--CA 1.488 1.448 0 CA-C-O 118.257 -0.878 . . . . 0.0 113.038 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -82.53 141.09 32.91 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 120.598 1.544 . . . . 0.0 112.345 -171.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -118.83 -71.91 0.71 Allowed 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 115.087 -0.96 . . . . 0.0 109.127 174.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 104.22 95.94 2.38 Favored Glycine 0 N--CA 1.481 1.658 0 CA-C-N 119.195 0.907 . . . . 0.0 111.655 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . 0.312 94.9 mttt 63.35 71.03 0.52 Allowed 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 124.615 1.166 . . . . 0.0 114.027 -178.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 26.1 pt -122.8 150.53 58.87 Favored Pre-proline 0 CA--C 1.576 1.948 0 C-N-CA 124.284 1.034 . . . . 0.0 108.646 170.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -72.42 163.97 37.0 Favored 'Trans proline' 0 CA--C 1.562 1.881 0 C-N-CA 122.825 2.35 . . . . 0.0 114.128 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 58.6 ttt180 -63.08 -41.78 99.5 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 115.592 1.701 . . . . 0.0 115.592 179.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.41 -46.31 83.81 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 115.305 1.594 . . . . 0.0 115.305 177.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -63.22 -35.33 79.98 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 115.346 1.61 . . . . 0.0 115.346 169.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.78 -44.72 95.45 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 115.42 1.637 . . . . 0.0 115.42 169.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -61.92 -40.73 96.5 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 115.213 1.56 . . . . 0.0 115.213 170.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -61.48 -50.34 73.12 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 114.895 1.442 . . . . 0.0 114.895 173.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -62.88 -43.98 97.34 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 115.02 1.489 . . . . 0.0 115.02 176.447 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 8.5 mp -65.19 -42.51 93.54 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 114.826 1.417 . . . . 0.0 114.826 172.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 67.5 m -54.98 -36.67 65.65 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 115.87 1.804 . . . . 0.0 115.87 169.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -63.34 -35.49 80.56 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 115.26 1.578 . . . . 0.0 115.26 169.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -63.21 126.86 28.8 Favored 'General case' 0 CA--C 1.557 1.228 0 CA-C-O 122.839 1.304 . . . . 0.0 112.61 172.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 14.5 ptp180 -67.45 -16.53 64.27 Favored 'General case' 0 CA--C 1.567 1.627 0 N-CA-C 119.026 2.973 . . . . 0.0 119.026 175.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 48.2 m80 -89.55 142.33 27.77 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 119.6 1.091 . . . . 0.0 113.281 -168.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -75.94 127.37 32.85 Favored 'General case' 0 N--CA 1.489 1.475 0 CA-C-N 115.014 -0.994 . . . . 0.0 108.632 169.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.45 4.31 66.18 Favored Glycine 0 CA--C 1.555 2.539 0 CA-C-O 117.278 -1.845 . . . . 0.0 117.621 -169.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -70.02 114.88 8.62 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 121.02 2.41 . . . . 0.0 112.73 -169.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 22.4 p90 -127.63 158.54 37.27 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 115.41 1.633 . . . . 0.0 115.41 -168.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.1 pp -134.99 158.21 44.93 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 124.169 0.988 . . . . 0.0 109.535 168.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.8 mp -114.36 113.71 44.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 104.83 -2.285 . . . . 0.0 104.83 169.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 46.6 ptt85 -101.3 140.68 35.26 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 123.783 0.833 . . . . 0.0 109.07 169.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -79.59 138.42 37.44 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.683 -0.636 . . . . 0.0 109.53 170.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 58.2 m -66.79 128.21 35.42 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 123.13 0.572 . . . . 0.0 111.511 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -64.92 -50.92 64.59 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 114.403 1.26 . . . . 0.0 114.403 -171.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.8 t -64.25 -40.31 95.74 Favored 'General case' 0 CA--C 1.564 1.514 0 N-CA-C 115.487 1.662 . . . . 0.0 115.487 170.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -111.8 95.27 27.69 Favored Pre-proline 0 CA--C 1.564 1.493 0 CA-C-N 119.32 0.964 . . . . 0.0 110.819 -177.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.43 129.19 16.49 Favored 'Trans proline' 0 C--N 1.372 1.768 0 C-N-CA 123.054 2.503 . . . . 0.0 111.014 169.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 108.27 -35.43 4.98 Favored Glycine 0 CA--C 1.553 2.434 0 CA-C-O 118.894 -0.948 . . . . 0.0 113.609 -168.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -83.79 131.91 34.87 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-N 118.63 1.215 . . . . 0.0 108.24 169.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -115.77 168.07 10.36 Favored 'General case' 0 CA--C 1.56 1.357 0 CA-C-O 122.083 0.945 . . . . 0.0 110.181 -177.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 72.8 m -145.57 112.8 6.15 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 -177.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 19.9 tp -88.54 104.34 16.74 Favored 'General case' 0 CA--C 1.561 1.393 0 C-N-CA 124.654 1.181 . . . . 0.0 109.429 177.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.8 m -82.56 119.15 23.89 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 124.879 1.272 . . . . 0.0 108.065 173.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 24.0 t -129.36 122.84 56.66 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.193 0 CA-C-N 120.805 1.638 . . . . 0.0 107.782 -175.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 59.4 tttp -80.4 138.62 36.67 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.458 169.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -150.34 105.88 3.39 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 169.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 83.76 -106.75 2.88 Favored Glycine 0 CA--C 1.54 1.61 0 N-CA-C 110.894 -0.882 . . . . 0.0 110.894 -174.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 21.3 m120 -133.9 63.74 1.62 Allowed 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 169.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -160.77 127.67 4.17 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 123.522 0.729 . . . . 0.0 109.481 175.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 99.9 t -103.57 106.39 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 177.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -107.16 131.3 54.3 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.876 0.87 . . . . 0.0 110.82 -176.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 21.8 m-70 -103.33 107.66 18.58 Favored 'General case' 0 CA--C 1.552 1.019 0 C-N-CA 123.649 0.78 . . . . 0.0 109.598 -169.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -91.33 131.55 36.75 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 115.111 -0.95 . . . . 0.0 108.6 175.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 38.3 mtmm -80.52 117.1 20.94 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.239 0.542 . . . . 0.0 109.628 178.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 95.6 t -94.48 98.33 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 N-CA-C 105.994 -1.854 . . . . 0.0 105.994 176.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -97.14 140.26 31.9 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 178.257 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 53.3 mtm180 -100.0 133.35 44.51 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 122.673 0.389 . . . . 0.0 110.88 -176.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . 0.253 4.7 p-10 -80.0 -66.53 0.86 Allowed 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 176.085 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -94.51 -116.83 2.86 Favored Glycine 0 CA--C 1.541 1.661 0 CA-C-N 119.067 0.848 . . . . 0.0 112.211 -177.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -86.62 -83.11 0.19 Allowed 'General case' 0 N--CA 1.487 1.385 0 CA-C-O 118.441 -0.79 . . . . 0.0 110.028 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -109.71 78.91 0.24 Allowed Glycine 0 N--CA 1.479 1.565 0 N-CA-C 109.971 -1.252 . . . . 0.0 109.971 169.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -131.17 78.54 1.84 Allowed 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 -174.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -80.36 119.42 23.06 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 124.114 0.966 . . . . 0.0 111.402 -169.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 10.5 p90 -139.64 123.08 17.18 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 122.49 0.316 . . . . 0.0 110.155 -178.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -112.61 -37.82 4.8 Favored 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 123.61 0.764 . . . . 0.0 112.634 168.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 51.0 t90 -84.04 -86.17 0.12 Allowed 'General case' 0 CA--C 1.56 1.344 0 C-N-CA 124.805 1.242 . . . . 0.0 109.272 -175.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . 0.258 6.1 m -139.88 -61.02 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 C-N-CA 123.833 0.853 . . . . 0.0 109.836 173.356 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.3 p -79.97 140.73 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 CA-C-N 119.094 0.861 . . . . 0.0 111.203 -176.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.97 156.93 24.44 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 -179.264 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -139.45 120.6 14.72 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 -169.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 66.7 m-80 -61.25 -39.91 92.1 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 116.566 2.062 . . . . 0.0 116.566 -173.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 66.6 m -123.75 160.38 27.42 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-O 121.882 0.849 . . . . 0.0 111.898 -176.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 98.1 mt -84.39 86.51 7.26 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 169.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 167.32 -58.56 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 104.087 -2.56 . . . . 0.0 104.087 -168.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -58.75 -44.87 90.66 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 124.379 1.071 . . . . 0.0 113.72 168.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 8.6 tt -57.25 -50.34 73.19 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 114.722 1.379 . . . . 0.0 114.722 169.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 1.7 m -66.01 -49.11 79.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -178.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -67.92 -35.18 78.01 Favored 'General case' 0 CA--C 1.566 1.594 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 -178.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 79.8 t80 -61.11 -55.18 35.52 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-N 119.894 1.225 . . . . 0.0 112.083 169.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . 0.258 76.3 m-70 -68.68 -8.85 46.25 Favored 'General case' 0 CA--C 1.566 1.577 0 N-CA-C 117.797 2.517 . . . . 0.0 117.797 175.352 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 5.9 ttm180 -58.37 -28.1 64.82 Favored 'General case' 0 CA--C 1.579 2.069 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 167.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 70.0 m -114.16 -30.82 6.52 Favored 'General case' 0 CA--C 1.57 1.745 0 C-N-CA 125.341 1.456 . . . . 0.0 113.639 169.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 32.4 m -90.32 152.33 21.07 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-N 120.753 1.615 . . . . 0.0 110.532 176.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 20.5 t -82.04 131.31 35.24 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 120.628 -1.295 . . . . 0.0 112.971 -179.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -66.2 -45.09 91.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 169.548 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 22.0 t -79.67 -32.2 41.46 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 115.584 1.698 . . . . 0.0 115.584 177.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . 0.336 15.9 ttt180 91.88 -66.64 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 124.926 1.29 . . . . 0.0 111.92 179.308 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -69.52 -54.7 12.9 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 172.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -79.87 140.49 36.75 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-N 118.619 0.645 . . . . 0.0 110.358 171.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 3.3 tm0? -87.41 109.41 19.55 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 123.054 0.542 . . . . 0.0 109.564 178.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 5.2 mp -133.3 121.78 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 172.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 21.6 m-30 -115.16 144.73 43.23 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.745 0.783 . . . . 0.0 109.747 173.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 10.1 mp -90.22 121.97 32.72 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 113.372 0.879 . . . . 0.0 113.372 -169.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -119.62 140.47 50.55 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 124.373 1.069 . . . . 0.0 108.388 169.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -70.39 147.21 49.8 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 -176.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 15.4 pt -67.49 154.31 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 N-CA-C 113.658 0.985 . . . . 0.0 113.658 -178.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 . . . . . 0 N--CA 1.484 1.269 0 CA-C-O 122.827 1.298 . . . . 0.0 110.013 -174.999 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 63.7 p-90 . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 115.246 1.573 . . . . 0.0 115.246 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 29.9 t80 -84.25 131.98 34.68 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-N 119.801 1.182 . . . . 0.0 110.884 -175.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -117.38 -58.92 2.0 Allowed 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 114.815 -1.084 . . . . 0.0 109.735 174.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 104.4 87.65 2.01 Favored Glycine 0 N--CA 1.479 1.543 0 CA-C-N 119.043 0.838 . . . . 0.0 111.972 172.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 68.9 tttt 66.85 69.68 0.4 Allowed 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 124.062 0.945 . . . . 0.0 113.24 178.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 25.4 pt -121.14 148.87 50.24 Favored Pre-proline 0 CA--C 1.574 1.892 0 C-N-CA 123.957 0.903 . . . . 0.0 109.024 175.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -70.9 161.48 45.95 Favored 'Trans proline' 0 CA--C 1.559 1.774 0 C-N-CA 122.933 2.422 . . . . 0.0 114.519 -177.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 56.9 ttt180 -65.16 -40.9 94.97 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 115.786 1.773 . . . . 0.0 115.786 -176.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.74 -46.47 82.08 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 115.34 1.607 . . . . 0.0 115.34 179.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 55.5 mtmt -63.55 -34.52 77.98 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 115.037 1.495 . . . . 0.0 115.037 169.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.5 -43.44 90.11 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 115.484 1.661 . . . . 0.0 115.484 170.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -63.64 -42.88 98.08 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 115.09 1.515 . . . . 0.0 115.09 172.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -63.48 -48.13 78.93 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 114.917 1.451 . . . . 0.0 114.917 175.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -65.52 -43.8 88.89 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 114.756 1.391 . . . . 0.0 114.756 176.457 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 85.7 mt -67.35 -40.52 85.83 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 116.228 1.936 . . . . 0.0 116.228 175.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 91.1 p -56.33 -30.47 62.62 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 116.951 2.204 . . . . 0.0 116.951 171.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -66.15 -30.66 71.19 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 116.378 1.992 . . . . 0.0 116.378 170.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -59.64 142.66 52.46 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-O 123.024 1.392 . . . . 0.0 113.577 176.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.28 -15.93 62.96 Favored 'General case' 0 CA--C 1.568 1.659 0 N-CA-C 118.129 2.64 . . . . 0.0 118.129 170.309 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 31.4 m80 -89.43 132.66 34.9 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-N 119.996 1.271 . . . . 0.0 111.137 -169.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -81.29 106.77 13.52 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 169.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 115.82 8.41 13.84 Favored Glycine 0 CA--C 1.557 2.707 0 CA-C-O 116.838 -2.09 . . . . 0.0 116.388 -168.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.44 111.23 3.97 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-N 121.639 2.719 . . . . 0.0 112.331 -170.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 28.5 p90 -118.19 155.92 29.66 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 116.509 2.041 . . . . 0.0 116.509 -168.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.4 pp -148.18 138.68 22.86 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 123.31 0.644 . . . . 0.0 109.972 169.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 81.6 mt -90.17 117.79 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 169.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 4.9 ptm180 -111.23 145.72 38.23 Favored 'General case' 0 N--CA 1.487 1.388 0 CA-C-N 114.102 -1.408 . . . . 0.0 108.708 169.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -79.38 143.93 34.64 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.342 -0.849 . . . . 0.0 109.779 172.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 7.9 t -73.72 8.38 1.95 Allowed 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 119.556 3.169 . . . . 0.0 119.556 -169.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . 0.357 5.9 mp0 74.45 -72.0 0.12 Allowed 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 125.542 1.537 . . . . 0.0 113.654 175.018 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 65.9 m -64.3 -40.71 96.49 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 115.934 1.828 . . . . 0.0 115.934 178.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -111.95 102.41 53.65 Favored Pre-proline 0 CA--C 1.563 1.471 0 CA-C-O 118.077 -0.964 . . . . 0.0 109.49 174.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -58.86 -32.09 96.6 Favored 'Trans proline' 0 C--N 1.37 1.697 0 N-CA-C 119.751 2.943 . . . . 0.0 119.751 174.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -86.76 43.17 3.21 Favored Glycine 0 CA--C 1.554 2.475 0 N-CA-C 115.359 0.903 . . . . 0.0 115.359 169.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -153.83 116.45 4.42 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 105.502 -2.036 . . . . 0.0 105.502 177.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -96.19 172.1 8.18 Favored 'General case' 0 CA--C 1.559 1.323 0 CA-C-O 122.245 1.021 . . . . 0.0 110.746 174.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 71.4 m -146.72 108.33 4.31 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 -176.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 32.5 tp -79.73 117.79 20.95 Favored 'General case' 0 CA--C 1.559 1.312 0 CA-C-O 121.834 0.826 . . . . 0.0 108.925 173.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 18.9 m -104.78 90.46 3.49 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 -172.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 10.0 t -101.09 119.24 48.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 N-CA-C 107.389 -1.338 . . . . 0.0 107.389 -170.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -79.64 134.65 36.44 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.042 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -137.9 109.64 7.1 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 -179.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 78.62 -93.19 1.24 Allowed Glycine 0 N--CA 1.487 2.075 0 N-CA-C 111.838 -0.505 . . . . 0.0 111.838 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 15.7 t30 -149.31 45.38 0.97 Allowed 'General case' 0 CA--C 1.573 1.848 0 C-N-CA 123.295 0.638 . . . . 0.0 110.616 168.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -157.6 134.49 10.04 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 178.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 24.6 t -103.91 121.88 55.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -169.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 66.3 mt-30 -94.06 120.76 34.77 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 175.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 10.2 m-70 -98.86 95.46 7.2 Favored 'General case' 0 CA--C 1.55 0.971 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 -174.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -86.66 125.0 33.56 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-N 114.862 -1.063 . . . . 0.0 108.211 177.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -81.18 125.63 30.51 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-O 121.657 0.742 . . . . 0.0 111.586 -175.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 72.5 t -86.75 106.7 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 173.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.9 pp -114.34 144.67 42.89 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 123.248 0.619 . . . . 0.0 110.903 -176.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -96.99 151.63 19.52 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -169.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . 0.252 4.4 p-10 -100.64 -65.42 0.97 Allowed 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 123.676 0.79 . . . . 0.0 111.62 169.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -94.02 -123.25 3.68 Favored Glycine 0 CA--C 1.543 1.787 0 CA-C-N 119.468 1.031 . . . . 0.0 112.874 -177.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -76.48 -65.49 0.92 Allowed 'General case' 0 N--CA 1.489 1.521 0 CA-C-O 118.833 -0.603 . . . . 0.0 112.041 177.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -135.51 61.61 0.62 Allowed Glycine 0 CA--C 1.542 1.772 0 N-CA-C 111.391 -0.683 . . . . 0.0 111.391 169.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -106.69 92.44 4.1 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 105.75 -1.944 . . . . 0.0 105.75 -179.182 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -82.41 116.7 22.0 Favored 'General case' 0 N--CA 1.484 1.228 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.61 -169.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 15.1 p90 -129.51 125.06 35.48 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-O 121.83 0.824 . . . . 0.0 109.631 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 6.0 tt -104.77 -61.63 1.44 Allowed 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 114.966 -1.016 . . . . 0.0 109.657 176.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 25.6 t90 -83.9 -82.04 0.17 Allowed 'General case' 0 CA--C 1.557 1.218 0 C-N-CA 124.36 1.064 . . . . 0.0 111.41 -169.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . 0.25 7.2 m -136.67 -58.78 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 CA-C-N 118.926 0.785 . . . . 0.0 110.378 176.21 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 13.7 m -79.82 142.02 14.52 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.382 0 C-N-CA 124.085 0.954 . . . . 0.0 111.406 -177.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -79.95 150.35 30.53 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 -176.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -131.77 113.72 13.87 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 -169.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 11.3 p30 -54.97 -42.67 72.67 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 117.297 2.332 . . . . 0.0 117.297 -177.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 98.6 p -117.53 163.61 16.16 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-O 122.266 1.031 . . . . 0.0 111.404 175.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 70.2 mt -66.18 -31.24 71.96 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 114.773 1.397 . . . . 0.0 114.773 169.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -64.14 -43.26 95.78 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-N 119.468 1.031 . . . . 0.0 113.635 169.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -58.74 -40.04 82.65 Favored 'General case' 0 CA--C 1.568 1.637 0 N-CA-C 115.125 1.528 . . . . 0.0 115.125 169.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 8.7 tt -61.24 -51.42 69.01 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 114.62 1.341 . . . . 0.0 114.62 173.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 22.7 m -64.59 -51.23 70.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 N-CA-C 113.461 0.911 . . . . 0.0 113.461 176.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -64.44 -34.34 77.97 Favored 'General case' 0 CA--C 1.564 1.508 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 -176.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -60.7 -52.15 66.35 Favored 'General case' 0 CA--C 1.567 1.61 0 CA-C-N 119.37 0.986 . . . . 0.0 111.471 168.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . 0.255 59.4 m-70 -70.12 -9.25 54.96 Favored 'General case' 0 CA--C 1.565 1.552 0 N-CA-C 118.143 2.646 . . . . 0.0 118.143 176.643 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 90.0 mtt180 -61.53 -30.41 70.62 Favored 'General case' 0 CA--C 1.576 1.97 0 CA-C-N 120.42 1.463 . . . . 0.0 113.025 167.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 70.3 m -102.11 -40.53 6.78 Favored 'General case' 0 CA--C 1.567 1.623 0 C-N-CA 124.934 1.294 . . . . 0.0 113.633 169.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 44.1 m -90.58 156.44 18.15 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-N 120.061 1.3 . . . . 0.0 111.533 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 33.1 t -84.6 134.55 34.39 Favored 'General case' 0 N--CA 1.485 1.312 0 O-C-N 120.654 -1.278 . . . . 0.0 113.904 -175.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -73.16 -43.73 57.17 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.751 0 C-N-CA 123.939 0.896 . . . . 0.0 112.28 168.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 22.8 t -79.48 138.2 37.48 Favored 'General case' 0 CA--C 1.559 1.309 0 CA-C-N 119.367 0.985 . . . . 0.0 111.142 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -70.63 -56.19 7.04 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 -172.014 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -73.51 -66.16 0.73 Allowed 'General case' 0 N--CA 1.489 1.518 0 CA-C-N 119.151 0.887 . . . . 0.0 112.439 -179.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -87.77 141.73 28.37 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.304 0.641 . . . . 0.0 110.73 -178.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -84.13 104.63 14.35 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 122.848 0.459 . . . . 0.0 111.458 -178.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.54 138.91 52.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 178.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -122.35 158.31 29.9 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 121.989 0.899 . . . . 0.0 113.183 -168.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 9.3 mp -87.59 133.91 33.72 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 124.129 0.972 . . . . 0.0 111.925 -175.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 59.5 mmt-85 -129.58 138.21 51.16 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 124.391 1.077 . . . . 0.0 108.517 176.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -74.8 148.42 40.35 Favored 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 121.843 0.83 . . . . 0.0 112.402 -178.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 19.4 pt -69.66 167.6 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 -169.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 . . . . . 0 N--CA 1.486 1.326 0 CA-C-O 123.902 1.811 . . . . 0.0 109.124 173.045 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 65.3 p-90 . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 116.307 1.965 . . . . 0.0 116.307 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -83.33 125.95 32.18 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-N 119.878 1.217 . . . . 0.0 110.625 -173.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -105.6 -73.88 0.67 Allowed 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 171.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 87.32 125.13 2.0 Favored Glycine 0 CA--C 1.541 1.712 0 CA-C-N 119.458 1.026 . . . . 0.0 112.778 176.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . 0.318 20.0 tptm 76.32 -13.15 0.94 Allowed 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 117.313 2.338 . . . . 0.0 117.313 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 20.3 tt -61.92 131.47 93.17 Favored Pre-proline 0 CA--C 1.575 1.93 0 CA-C-N 120.999 1.727 . . . . 0.0 112.231 174.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -53.7 166.52 1.32 Allowed 'Trans proline' 0 CA--C 1.556 1.618 0 C-N-CA 123.597 2.865 . . . . 0.0 117.394 174.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 59.8 ttt180 -64.98 -42.62 94.39 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 169.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -68.01 -42.48 80.61 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 115.673 1.731 . . . . 0.0 115.673 175.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -66.6 -36.05 81.69 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 115.257 1.577 . . . . 0.0 115.257 170.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.9 -46.14 86.19 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 115.201 1.556 . . . . 0.0 115.201 170.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -59.15 -45.28 91.4 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 114.964 1.468 . . . . 0.0 114.964 169.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -61.24 -47.54 85.57 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 115.119 1.526 . . . . 0.0 115.119 176.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -64.87 -36.36 84.1 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 115.909 1.818 . . . . 0.0 115.909 174.154 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.3 mp -90.13 -22.68 21.64 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 116.717 2.117 . . . . 0.0 116.717 -178.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 74.4 m -64.31 -44.02 92.87 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 120.946 1.703 . . . . 0.0 115.481 177.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . 0.26 0.0 OUTLIER -68.96 -21.82 64.15 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 116.763 2.135 . . . . 0.0 116.763 174.216 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -60.92 135.36 57.76 Favored 'General case' 0 N--CA 1.484 1.226 0 CA-C-N 120.268 1.395 . . . . 0.0 112.014 172.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -78.87 -19.08 52.8 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 117.872 2.545 . . . . 0.0 117.872 179.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 41.5 m80 -89.84 115.07 26.89 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 119.472 1.033 . . . . 0.0 111.607 -168.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.05 113.43 6.42 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 123.877 0.871 . . . . 0.0 110.211 179.276 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 114.6 -8.11 22.19 Favored Glycine 0 CA--C 1.546 2.0 0 CA-C-O 116.524 -2.264 . . . . 0.0 117.118 -169.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -75.76 110.88 10.56 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-N 121.789 2.794 . . . . 0.0 109.951 -173.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 16.4 p90 -120.51 163.0 18.61 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 115.164 1.542 . . . . 0.0 115.164 -168.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.2 pp -138.02 134.61 35.02 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-N 114.452 -1.249 . . . . 0.0 108.227 167.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 76.8 mt -91.4 106.79 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 170.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 51.8 ptt85 -88.25 157.39 18.79 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 123.429 0.692 . . . . 0.0 111.723 170.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -86.6 137.59 32.37 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 169.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 18.3 t -77.41 89.32 3.79 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.474 0.71 . . . . 0.0 111.984 -170.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . 0.341 45.4 mt-10 72.65 -89.78 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 125.311 1.444 . . . . 0.0 107.866 -169.357 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 21.5 t -152.55 61.46 0.81 Allowed 'General case' 0 CA--C 1.561 1.402 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 168.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -117.75 99.83 52.28 Favored Pre-proline 0 CA--C 1.56 1.341 0 CA-C-O 117.726 -1.131 . . . . 0.0 108.683 -179.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -71.9 128.81 14.53 Favored 'Trans proline' 0 C--N 1.371 1.736 0 C-N-CA 122.959 2.439 . . . . 0.0 111.761 179.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 104.28 -45.9 1.26 Allowed Glycine 0 CA--C 1.551 2.3 0 CA-C-N 114.964 -1.016 . . . . 0.0 112.575 -168.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -87.17 101.65 13.7 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 172.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -113.28 170.69 8.04 Favored 'General case' 0 CA--C 1.562 1.442 0 CA-C-O 121.887 0.851 . . . . 0.0 110.075 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 74.2 m -134.52 115.6 14.1 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 175.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 19.2 tp -79.87 109.35 14.2 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 124.553 1.141 . . . . 0.0 109.155 176.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 9.8 m -105.05 88.78 2.96 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 115.01 -0.995 . . . . 0.0 108.699 -169.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 13.1 t -103.57 127.59 57.46 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -170.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.14 142.38 41.63 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 173.342 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -152.81 103.98 2.82 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 174.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 84.95 -87.53 1.56 Allowed Glycine 0 CA--C 1.542 1.731 0 N-CA-C 112.043 -0.423 . . . . 0.0 112.043 -175.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -137.29 -27.78 0.95 Allowed 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 169.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -85.8 140.13 30.71 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.919 0.887 . . . . 0.0 110.387 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 51.8 t -103.84 119.3 52.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 -176.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 -97.12 118.71 34.15 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.826 0.85 . . . . 0.0 109.547 -174.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -100.43 108.65 20.7 Favored 'General case' 0 CA--C 1.553 1.067 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 -173.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -109.06 123.45 49.17 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 -173.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 19.7 tptm -78.93 124.55 28.35 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-O 121.794 0.807 . . . . 0.0 111.574 -171.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 40.0 t -97.32 106.67 18.85 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.447 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 178.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 64.7 mt -97.68 175.05 6.33 Favored 'General case' 0 CA--C 1.565 1.545 0 C-N-CA 124.163 0.985 . . . . 0.0 112.198 -175.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 15.4 mmt85 -123.68 136.45 54.48 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 123.794 0.838 . . . . 0.0 112.169 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 25.5 p-10 -136.66 123.8 21.7 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 124.067 0.947 . . . . 0.0 109.036 173.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 95.19 -125.62 8.43 Favored Glycine 0 CA--C 1.542 1.755 0 C-N-CA 123.01 0.338 . . . . 0.0 112.961 177.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -88.72 -78.98 0.32 Allowed 'General case' 0 N--CA 1.488 1.452 0 CA-C-O 118.595 -0.717 . . . . 0.0 110.683 -178.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -137.42 63.04 0.58 Allowed Glycine 0 N--CA 1.482 1.731 0 CA-C-N 118.831 0.741 . . . . 0.0 112.244 169.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -120.72 113.61 20.45 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 106.347 -1.723 . . . . 0.0 106.347 -170.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -89.78 128.35 36.12 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.666 0.786 . . . . 0.0 111.756 -169.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 23.7 p90 -124.48 128.79 49.51 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 175.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 8.3 tt -86.31 -63.96 1.23 Allowed 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 118.788 -0.625 . . . . 0.0 110.147 169.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 17.0 m0 -76.82 -71.34 0.4 Allowed 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 118.754 0.706 . . . . 0.0 111.689 178.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 11.6 p -156.47 -52.41 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 C-N-CA 124.744 1.218 . . . . 0.0 109.898 -170.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 10.9 p -79.13 138.0 20.82 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.427 0 C-N-CA 124.351 1.061 . . . . 0.0 110.431 -176.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -79.76 155.29 27.99 Favored 'General case' 0 CA--C 1.559 1.289 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 -171.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -140.97 104.64 4.71 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 103.955 -2.609 . . . . 0.0 103.955 -174.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . 0.268 8.0 p-10 -47.71 -51.33 22.34 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 118.788 2.884 . . . . 0.0 118.788 -169.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 66.5 m -101.81 163.79 12.07 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-O 122.316 1.055 . . . . 0.0 111.476 176.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 15.4 tp -66.02 -37.89 87.03 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 169.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -65.59 -33.83 76.82 Favored 'General case' 0 CA--C 1.573 1.829 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 168.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -62.15 -42.74 99.55 Favored 'General case' 0 CA--C 1.566 1.591 0 CA-C-N 120.63 1.559 . . . . 0.0 114.943 169.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 7.8 tt -60.37 -45.03 94.96 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 169.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 29.4 t -55.04 -61.33 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 C-N-CA 124.43 1.092 . . . . 0.0 112.63 169.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -58.69 -34.75 71.63 Favored 'General case' 0 CA--C 1.568 1.652 0 N-CA-C 115.701 1.741 . . . . 0.0 115.701 -177.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 90.5 t80 -57.64 -56.12 25.97 Favored 'General case' 0 CA--C 1.564 1.512 0 CA-C-O 118.119 -0.943 . . . . 0.0 112.605 169.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . 0.319 52.3 m-70 -71.81 -9.08 57.79 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 117.875 2.546 . . . . 0.0 117.875 175.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 95.8 mtt-85 -65.39 -32.97 74.88 Favored 'General case' 0 CA--C 1.576 1.951 0 CA-C-N 120.702 1.592 . . . . 0.0 112.396 166.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 68.6 m -95.15 -40.26 9.69 Favored 'General case' 0 CA--C 1.563 1.476 0 N-CA-C 114.586 1.328 . . . . 0.0 114.586 170.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 93.6 m -90.82 149.09 22.1 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 124.747 1.219 . . . . 0.0 111.069 176.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 28.7 p -78.25 134.26 37.58 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.2 -0.938 . . . . 0.0 111.929 174.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 3.4 t -65.73 -52.33 51.47 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 C-N-CA 122.928 0.491 . . . . 0.0 111.091 173.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 74.2 m -98.89 143.08 29.6 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.638 0.732 . . . . 0.0 109.36 169.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 7.9 mpt_? -73.17 -51.73 16.75 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -177.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -68.06 -59.47 3.23 Favored 'General case' 0 N--CA 1.495 1.775 0 CA-C-N 119.199 0.909 . . . . 0.0 113.229 177.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -81.72 113.86 19.98 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 170.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -80.15 101.1 8.59 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 122.753 0.421 . . . . 0.0 111.244 -171.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 11.8 mm -100.14 106.29 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -169.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -112.88 127.4 56.18 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -179.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 9.7 mp -76.24 131.28 39.19 Favored 'General case' 0 CA--C 1.561 1.402 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 -169.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 61.7 ttt-85 -136.24 148.56 48.12 Favored 'General case' 0 CA--C 1.563 1.459 0 C-N-CA 125.258 1.423 . . . . 0.0 108.443 177.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -65.33 164.8 12.87 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 120.526 -1.359 . . . . 0.0 113.211 171.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.3 pp -64.19 162.59 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 -174.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 . . . . . 0 N--CA 1.488 1.444 0 CA-C-O 122.841 1.305 . . . . 0.0 110.488 174.472 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . 0.262 1.6 p90 . . . . . 0 CA--C 1.56 1.341 0 CA-C-O 118.147 -0.93 . . . . 0.0 112.857 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -84.33 137.07 33.63 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 120.409 1.459 . . . . 0.0 111.407 -178.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -99.84 -92.5 0.28 Allowed 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 175.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 146.61 85.29 0.06 OUTLIER Glycine 0 N--CA 1.479 1.554 0 CA-C-N 119.438 1.017 . . . . 0.0 111.605 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 26.1 tptp 64.69 69.97 0.49 Allowed 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 124.168 0.987 . . . . 0.0 113.176 174.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 27.3 pt -125.0 149.29 62.83 Favored Pre-proline 0 CA--C 1.573 1.863 0 C-N-CA 123.793 0.837 . . . . 0.0 109.666 -179.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -75.07 171.34 18.5 Favored 'Trans proline' 0 CA--C 1.558 1.709 0 C-N-CA 122.93 2.42 . . . . 0.0 114.581 -178.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 57.0 ttt180 -65.26 -42.49 93.19 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 114.77 1.396 . . . . 0.0 114.77 176.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.14 -42.63 96.73 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 115.76 1.763 . . . . 0.0 115.76 176.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 14.6 tmtt? -65.37 -38.5 90.24 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 169.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.89 -46.6 84.16 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 115.314 1.598 . . . . 0.0 115.314 172.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -60.62 -40.97 93.84 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 115.16 1.541 . . . . 0.0 115.16 170.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -58.55 -56.46 21.86 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 171.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 45.7 tpp -56.71 -47.67 79.43 Favored 'General case' 0 CA--C 1.564 1.485 0 N-CA-C 115.683 1.735 . . . . 0.0 115.683 178.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 74.8 mt -68.04 -30.94 70.27 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 116.456 2.021 . . . . 0.0 116.456 175.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 21.8 t -62.96 -33.05 74.56 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 115.606 1.706 . . . . 0.0 115.606 169.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -62.46 -37.26 85.23 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 115.748 1.759 . . . . 0.0 115.748 170.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -61.05 139.44 58.07 Favored 'General case' 0 CA--C 1.556 1.18 0 N-CA-C 115.115 1.524 . . . . 0.0 115.115 -175.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 15.7 ptp180 -70.59 -21.0 62.72 Favored 'General case' 0 CA--C 1.568 1.635 0 N-CA-C 118.404 2.742 . . . . 0.0 118.404 174.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 49.5 m80 -89.21 144.97 25.72 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 119.575 1.08 . . . . 0.0 112.667 -168.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -78.09 114.99 17.48 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 123.635 0.774 . . . . 0.0 109.944 175.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 82.57 33.12 25.86 Favored Glycine 0 CA--C 1.548 2.137 0 CA-C-O 118.387 -1.23 . . . . 0.0 115.36 -168.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.99 113.64 6.56 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 118.949 1.374 . . . . 0.0 110.211 178.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 22.2 p90 -123.37 155.52 37.18 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 115.005 1.483 . . . . 0.0 115.005 -168.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.2 pp -142.02 143.84 33.35 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.895 0.878 . . . . 0.0 108.945 168.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.4 mp -94.55 119.6 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 N-CA-C 105.704 -1.962 . . . . 0.0 105.704 169.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 49.4 ptt85 -103.14 158.2 16.47 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 123.503 0.721 . . . . 0.0 111.135 169.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -90.02 126.61 35.82 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 169.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 18.0 t -65.79 139.22 58.31 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 112.878 0.695 . . . . 0.0 112.878 -173.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -70.54 -53.01 17.83 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 -171.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.6 t -62.67 -38.01 88.67 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 115.866 1.802 . . . . 0.0 115.866 172.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -118.69 97.28 50.68 Favored Pre-proline 0 CA--C 1.562 1.439 0 CA-C-N 119.195 0.907 . . . . 0.0 110.015 176.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_exo -57.4 -30.24 87.23 Favored 'Trans proline' 0 C--N 1.37 1.671 0 N-CA-C 119.617 2.891 . . . . 0.0 119.617 172.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -88.28 47.0 3.44 Favored Glycine 0 CA--C 1.552 2.395 0 N-CA-C 114.527 0.571 . . . . 0.0 114.527 168.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -160.09 125.39 4.0 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 105.906 -1.887 . . . . 0.0 105.906 -179.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 11.0 m-30 -95.93 172.26 8.12 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.823 0.821 . . . . 0.0 111.272 175.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 71.5 m -147.85 115.06 6.21 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 -179.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 28.7 tp -79.92 108.59 13.62 Favored 'General case' 0 N--CA 1.487 1.379 0 CA-C-O 122.29 1.043 . . . . 0.0 109.61 174.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 6.2 m -95.54 112.62 24.3 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 34.5 t -121.02 131.1 73.86 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.169 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 -174.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 28.7 tptp -76.98 100.59 5.67 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 123.309 0.644 . . . . 0.0 110.933 175.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -86.13 -169.16 2.51 Favored 'General case' 0 CA--C 1.572 1.817 0 CA-C-O 121.291 0.567 . . . . 0.0 109.586 173.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -68.48 106.58 1.78 Allowed Glycine 0 CA--C 1.544 1.877 0 O-C-N 120.692 -1.255 . . . . 0.0 113.497 179.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . 0.319 10.3 t30 75.23 -18.9 0.42 Allowed 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 118.192 2.664 . . . . 0.0 118.192 -175.299 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -144.33 143.36 30.94 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 120.336 1.426 . . . . 0.0 109.611 -169.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 56.2 t -90.64 113.56 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 178.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -94.76 122.97 37.92 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 121.601 0.715 . . . . 0.0 109.96 178.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 8.7 m-70 -100.19 127.1 46.53 Favored 'General case' 0 CA--C 1.552 1.046 0 CA-C-N 114.985 -1.007 . . . . 0.0 109.251 -175.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -119.21 126.72 52.2 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 -177.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 48.2 mtpt -76.27 116.4 16.93 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-O 121.182 0.515 . . . . 0.0 110.608 -177.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 75.9 t -85.09 98.9 6.63 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.374 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 172.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.8 mt -81.36 137.35 35.73 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.893 -179.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 78.1 mtp180 -113.38 120.68 41.92 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -174.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . 0.286 4.9 p-10 -85.29 -66.13 0.93 Allowed 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -88.92 -110.18 1.16 Allowed Glycine 0 N--CA 1.482 1.737 0 CA-C-N 119.331 0.968 . . . . 0.0 112.395 -176.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -84.6 -84.14 0.15 Allowed 'General case' 0 N--CA 1.487 1.413 0 CA-C-O 118.364 -0.827 . . . . 0.0 109.175 174.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -116.88 63.6 0.37 Allowed Glycine 0 N--CA 1.481 1.68 0 CA-C-N 118.896 0.771 . . . . 0.0 111.535 169.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm -101.79 87.14 3.06 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 106.017 -1.845 . . . . 0.0 106.017 -176.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 47.7 m-85 -82.78 116.85 22.3 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 114.892 -1.049 . . . . 0.0 112.64 -168.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -135.54 114.11 11.75 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.44 0.696 . . . . 0.0 110.144 177.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . 0.276 1.8 pt? -87.09 -45.45 10.7 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-O 118.758 -0.639 . . . . 0.0 112.51 168.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 45.3 m0 -83.57 -84.74 0.13 Allowed 'General case' 0 CA--C 1.564 1.495 0 CA-C-N 118.966 0.803 . . . . 0.0 109.436 173.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 61.0 t -141.02 -55.97 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 C-N-CA 124.32 1.048 . . . . 0.0 109.063 -174.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 13.6 p -79.45 128.83 38.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 C-N-CA 123.663 0.785 . . . . 0.0 110.968 -170.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.44 159.67 18.59 Favored 'General case' 0 N--CA 1.486 1.351 0 CA-C-O 122.53 1.157 . . . . 0.0 113.724 -175.332 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -141.84 121.5 13.41 Favored 'General case' 0 N--CA 1.484 1.242 0 CA-C-N 113.96 -1.473 . . . . 0.0 107.052 -170.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 36.0 m-80 -58.69 -41.4 86.18 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 115.585 1.698 . . . . 0.0 115.585 177.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 26.2 t -114.86 152.74 31.7 Favored 'General case' 0 N--CA 1.484 1.271 0 CA-C-O 122.069 0.937 . . . . 0.0 111.19 178.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 80.6 mt -63.95 -27.26 69.01 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 168.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -59.09 -39.23 81.54 Favored 'General case' 0 CA--C 1.575 1.935 0 CA-C-N 120.105 1.321 . . . . 0.0 113.923 168.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -70.35 -43.52 70.03 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 114.76 1.393 . . . . 0.0 114.76 171.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 9.9 tt -59.1 -46.21 88.89 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 115.361 1.615 . . . . 0.0 115.361 170.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 4.4 p -68.3 -48.41 73.43 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.538 0 N-CA-C 113.742 1.015 . . . . 0.0 113.742 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -56.25 -35.89 67.91 Favored 'General case' 0 CA--C 1.569 1.711 0 N-CA-C 115.182 1.549 . . . . 0.0 115.182 169.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 61.3 t80 -55.6 -55.86 27.12 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 117.26 -1.352 . . . . 0.0 113.102 169.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . 0.381 33.5 m-70 -73.52 -9.22 58.45 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 118.748 2.87 . . . . 0.0 118.748 175.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 91.2 mtt-85 -73.0 -27.06 61.57 Favored 'General case' 0 CA--C 1.581 2.137 0 CA-C-N 120.058 1.299 . . . . 0.0 112.42 166.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 69.6 m -97.85 -42.14 7.7 Favored 'General case' 0 CA--C 1.565 1.543 0 C-N-CA 125.012 1.325 . . . . 0.0 114.24 171.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 92.6 m -85.93 142.58 28.73 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 124.614 1.165 . . . . 0.0 109.717 171.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 33.5 t -72.35 121.09 18.9 Favored 'General case' 0 N--CA 1.485 1.303 0 O-C-N 121.449 -0.782 . . . . 0.0 111.113 173.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 11.4 p -58.33 -35.57 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 N-CA-C 115.525 1.676 . . . . 0.0 115.525 172.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 15.1 t -79.52 -28.11 41.35 Favored 'General case' 0 CA--C 1.564 1.512 0 N-CA-C 116.682 2.104 . . . . 0.0 116.682 179.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . 0.352 98.6 mtt180 86.65 -78.79 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 CA-C-N 120.274 1.397 . . . . 0.0 111.393 -177.287 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 70.1 m-80 -67.5 -52.82 34.56 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -79.7 152.19 30.04 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.166 0.586 . . . . 0.0 110.583 169.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -89.89 88.09 7.2 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 173.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 19.9 mm -113.13 141.39 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -146.63 145.69 30.15 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 121.946 0.879 . . . . 0.0 112.524 -168.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 11.2 mp -83.68 117.2 23.05 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-N 114.761 -1.109 . . . . 0.0 112.279 -169.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 27.2 mmm180 -109.29 137.49 47.09 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 124.304 1.042 . . . . 0.0 109.058 169.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -73.66 142.91 46.43 Favored 'General case' 0 CA--C 1.564 1.487 0 CA-C-O 121.742 0.782 . . . . 0.0 111.713 -178.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 17.9 pt -63.3 156.29 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 114.814 1.413 . . . . 0.0 114.814 -173.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 . . . . . 0 N--CA 1.483 1.213 0 CA-C-O 123.999 1.857 . . . . 0.0 109.11 179.531 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . 0.273 1.8 p90 . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 118.015 -0.993 . . . . 0.0 113.068 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -80.15 135.25 36.26 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-N 120.444 1.475 . . . . 0.0 110.263 172.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -121.3 -80.03 0.62 Allowed 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 179.31 -146.47 7.16 Favored Glycine 0 N--CA 1.48 1.589 0 CA-C-N 119.09 0.859 . . . . 0.0 112.012 176.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -85.03 88.43 7.46 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 121.533 0.682 . . . . 0.0 109.288 -179.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 35.8 pt -118.92 148.29 44.29 Favored Pre-proline 0 CA--C 1.573 1.832 0 C-N-CA 124.126 0.97 . . . . 0.0 109.762 -174.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -71.8 157.77 54.53 Favored 'Trans proline' 0 CA--C 1.559 1.739 0 C-N-CA 122.995 2.463 . . . . 0.0 114.325 -177.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 42.1 ttp85 -66.75 -41.1 88.35 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 115.113 1.523 . . . . 0.0 115.113 -179.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -65.75 -42.75 90.55 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 115.924 1.824 . . . . 0.0 115.924 178.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -67.39 -34.11 76.59 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 169.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.39 -43.75 96.68 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 169.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -60.44 -42.83 96.93 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 115.041 1.497 . . . . 0.0 115.041 169.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -61.7 -51.71 67.3 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 176.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -61.88 -46.51 89.08 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 115.091 1.515 . . . . 0.0 115.091 175.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 8.9 mp -66.22 -36.3 82.68 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 115.822 1.786 . . . . 0.0 115.822 175.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 20.9 t -56.24 -30.17 62.01 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 116.593 2.071 . . . . 0.0 116.593 169.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -60.67 -35.29 75.88 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 115.703 1.742 . . . . 0.0 115.703 169.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -67.93 129.41 39.83 Favored 'General case' 0 CA--C 1.555 1.15 0 CA-C-O 122.935 1.35 . . . . 0.0 112.499 -179.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 14.7 ptp180 -66.52 -17.79 65.0 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 118.912 2.93 . . . . 0.0 118.912 172.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 46.1 m80 -89.46 137.37 32.39 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 119.576 1.08 . . . . 0.0 111.818 -168.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -78.25 105.27 9.37 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 171.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 118.14 -3.65 16.33 Favored Glycine 0 CA--C 1.55 2.251 0 CA-C-O 116.198 -2.446 . . . . 0.0 116.7 -168.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.77 110.15 1.44 Allowed 'General case' 0 N--CA 1.494 1.77 0 CA-C-N 122.017 2.909 . . . . 0.0 112.231 -176.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 18.4 p90 -128.43 161.64 29.02 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 117.263 2.32 . . . . 0.0 117.263 -167.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.2 pp -143.12 151.86 41.18 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 114.233 -1.349 . . . . 0.0 108.446 168.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 3.8 mp -102.44 118.04 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 105.173 -2.158 . . . . 0.0 105.173 169.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 46.8 ptt85 -101.44 141.06 34.87 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.174 0.59 . . . . 0.0 110.083 169.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -79.89 134.96 36.33 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 169.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 53.5 m -72.33 139.21 47.81 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-O 121.491 0.662 . . . . 0.0 111.956 -177.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -69.96 -54.54 12.82 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -173.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 97.2 p -61.91 -41.95 98.52 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 115.994 1.85 . . . . 0.0 115.994 171.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -111.85 96.77 34.95 Favored Pre-proline 0 CA--C 1.562 1.405 0 CA-C-O 117.965 -1.017 . . . . 0.0 109.494 176.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -63.61 -26.59 69.2 Favored 'Trans proline' 0 CA--C 1.559 1.765 0 C-N-CA 122.959 2.439 . . . . 0.0 118.203 174.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -91.5 50.12 2.94 Favored Glycine 0 CA--C 1.553 2.422 0 CA-C-O 119.732 -0.482 . . . . 0.0 113.326 168.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -160.04 120.29 2.96 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 106.026 -1.842 . . . . 0.0 106.026 178.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 12.2 m-30 -98.63 172.2 7.64 Favored 'General case' 0 CA--C 1.565 1.55 0 CA-C-O 122.064 0.935 . . . . 0.0 111.341 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 74.3 m -148.19 112.56 5.27 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 -178.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 27.4 tp -85.21 105.08 15.64 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-O 122.308 1.051 . . . . 0.0 109.638 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.8 m -89.85 111.35 22.36 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 125.177 1.391 . . . . 0.0 107.816 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 22.0 t -127.46 121.19 56.6 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.161 0 CA-C-N 120.031 1.287 . . . . 0.0 107.795 -172.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 7.4 tmtm? -89.47 92.43 9.11 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 122.8 0.44 . . . . 0.0 110.734 177.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 25.3 t80 -125.1 111.18 15.03 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 68.12 71.05 1.01 Allowed Glycine 0 N--CA 1.482 1.739 0 N-CA-C 115.525 0.97 . . . . 0.0 115.525 173.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . 0.294 16.8 m120 70.76 -13.35 0.49 Allowed 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 118.49 2.774 . . . . 0.0 118.49 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -132.65 138.49 47.35 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 120.16 1.345 . . . . 0.0 110.159 -169.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 43.5 t -92.1 111.27 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 N-CA-C 106.045 -1.835 . . . . 0.0 106.045 171.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -104.34 114.8 29.27 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.84 0.856 . . . . 0.0 108.771 -170.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 16.7 m-70 -95.21 97.31 9.79 Favored 'General case' 0 CA--C 1.552 1.023 0 CA-C-N 114.745 -1.116 . . . . 0.0 108.417 -173.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -95.88 122.24 38.47 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 -176.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -76.37 115.85 16.5 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 121.302 0.572 . . . . 0.0 110.715 -171.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 84.7 t -91.45 104.5 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 60.7 mt -92.07 131.45 37.33 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.38 -174.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 78.0 mtp180 -106.64 148.2 28.62 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 122.865 0.466 . . . . 0.0 111.195 -173.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -137.27 129.83 29.96 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 123.029 0.531 . . . . 0.0 110.51 171.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 81.7 -113.58 3.67 Favored Glycine 0 CA--C 1.541 1.693 0 C-N-CA 122.971 0.32 . . . . 0.0 113.462 173.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -82.29 -70.37 0.55 Allowed 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 123.118 0.567 . . . . 0.0 111.102 175.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -159.28 71.76 0.23 Allowed Glycine 0 N--CA 1.477 1.431 0 N-CA-C 111.033 -0.827 . . . . 0.0 111.033 169.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -98.71 96.52 7.98 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 106.468 -1.679 . . . . 0.0 106.468 177.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -86.45 100.27 12.24 Favored 'General case' 0 CA--C 1.558 1.259 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.724 -169.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 46.3 p90 -112.87 122.51 47.86 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 123.608 0.763 . . . . 0.0 109.113 -178.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -134.67 -32.88 0.98 Allowed 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 114.44 1.274 . . . . 0.0 114.44 -171.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 46.2 t90 -114.19 -76.6 0.58 Allowed 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 124.764 1.226 . . . . 0.0 108.089 178.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 96.0 t -130.05 -73.57 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 -178.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.3 p -83.16 145.8 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 C-N-CA 123.514 0.726 . . . . 0.0 111.8 -173.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -79.72 152.51 29.84 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 121.565 0.697 . . . . 0.0 112.329 174.608 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -130.02 121.26 26.13 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -173.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 36.1 t30 -63.64 -50.06 70.8 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 178.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 28.4 t -94.0 148.45 22.15 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-O 122.024 0.916 . . . . 0.0 111.175 173.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 14.1 tp -68.69 -34.93 76.51 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 169.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 -61.44 -40.99 96.48 Favored 'General case' 0 CA--C 1.571 1.771 0 C-N-CA 123.881 0.873 . . . . 0.0 113.331 169.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -58.8 -43.84 90.63 Favored 'General case' 0 CA--C 1.567 1.609 0 N-CA-C 114.956 1.465 . . . . 0.0 114.956 169.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 9.3 tt -54.22 -47.66 71.92 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 114.217 1.191 . . . . 0.0 114.217 169.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 43.7 t -57.86 -60.79 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 C-N-CA 124.361 1.065 . . . . 0.0 112.78 173.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -61.02 -29.15 69.54 Favored 'General case' 0 CA--C 1.568 1.64 0 N-CA-C 116.806 2.15 . . . . 0.0 116.806 -176.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 76.4 t80 -65.4 -58.9 4.74 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-N 119.261 0.937 . . . . 0.0 112.124 169.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 74.2 m-70 -67.95 -9.27 43.9 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 117.832 2.531 . . . . 0.0 117.832 176.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 11.4 ttm180 -60.24 -30.3 69.32 Favored 'General case' 0 CA--C 1.576 1.956 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 167.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 70.5 m -108.93 -31.31 7.71 Favored 'General case' 0 CA--C 1.568 1.643 0 C-N-CA 124.982 1.313 . . . . 0.0 114.252 169.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 59.3 m -91.21 155.68 18.4 Favored 'General case' 0 N--CA 1.498 1.971 0 CA-C-N 120.664 1.575 . . . . 0.0 112.109 176.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.448 ' HG ' ' HA ' ' A' ' 142' ' ' ARG . 38.0 t -70.48 132.63 45.84 Favored 'General case' 0 N--CA 1.485 1.32 0 O-C-N 121.498 -0.751 . . . . 0.0 112.938 175.144 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 15.2 t -68.49 -48.16 73.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 CA-C-O 118.225 -0.893 . . . . 0.0 112.084 171.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 22.7 t -105.94 -113.25 0.26 Allowed 'General case' 0 CA--C 1.559 1.319 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 170.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . 0.448 ' HA ' ' HG ' ' A' ' 139' ' ' SER . 11.7 tpt180 -161.05 -41.67 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 CA-C-N 119.644 1.111 . . . . 0.0 113.275 174.373 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -60.12 -57.02 14.6 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 -176.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -79.76 -16.05 56.31 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 117.587 2.44 . . . . 0.0 117.587 174.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 59.51 77.9 0.29 Allowed 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 125.561 1.545 . . . . 0.0 111.71 -175.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 4.7 mp -84.28 124.23 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 -168.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -127.4 117.33 21.97 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 -176.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 10.8 mp -70.5 137.57 50.33 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 114.778 1.399 . . . . 0.0 114.778 -169.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 19.3 mmt85 -135.56 146.68 48.25 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 124.803 1.241 . . . . 0.0 107.807 179.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -72.28 147.28 46.55 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.702 -1.249 . . . . 0.0 112.924 179.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 29.6 pt -68.52 148.28 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 C-N-CA 124.133 0.973 . . . . 0.0 113.092 -178.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 . . . . . 0 N--CA 1.485 1.301 0 CA-C-O 123.872 1.796 . . . . 0.0 108.84 -174.993 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . 0.274 1.2 p90 . . . . . 0 N--CA 1.489 1.492 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -81.81 134.31 35.41 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 120.657 1.571 . . . . 0.0 111.509 -176.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -101.7 -90.11 0.35 Allowed 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 175.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 154.19 79.49 0.03 OUTLIER Glycine 0 N--CA 1.482 1.718 0 CA-C-N 119.625 1.102 . . . . 0.0 111.941 179.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . 0.384 65.4 pttt 43.16 59.37 2.96 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 117.514 2.413 . . . . 0.0 117.514 -173.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 23.1 pt -85.77 155.07 58.91 Favored Pre-proline 0 CA--C 1.576 1.954 0 CA-C-O 118.385 -0.817 . . . . 0.0 110.509 174.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -71.09 167.98 24.56 Favored 'Trans proline' 0 CA--C 1.561 1.862 0 C-N-CA 122.73 2.287 . . . . 0.0 114.107 177.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 53.9 ttt180 -63.65 -40.6 97.27 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 115.844 1.794 . . . . 0.0 115.844 177.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.4 -41.91 96.39 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 115.574 1.694 . . . . 0.0 115.574 173.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 55.7 tptt -66.86 -34.89 78.79 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 114.869 1.433 . . . . 0.0 114.869 169.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.37 -45.55 87.23 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 115.118 1.525 . . . . 0.0 115.118 171.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -65.79 -33.83 76.76 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 115.754 1.761 . . . . 0.0 115.754 169.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -57.65 -49.42 76.51 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-N 119.99 1.268 . . . . 0.0 114.24 170.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 45.3 tpp -61.36 -47.91 83.7 Favored 'General case' 0 CA--C 1.567 1.624 0 N-CA-C 115.919 1.822 . . . . 0.0 115.919 172.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 83.4 mt -89.35 -43.82 10.65 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 116.735 2.124 . . . . 0.0 116.735 -169.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 49.7 m -61.6 -32.1 72.2 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 115.598 1.703 . . . . 0.0 115.598 171.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -59.64 -43.4 93.86 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 115.706 1.743 . . . . 0.0 115.706 169.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -75.61 134.86 40.55 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-O 122.867 1.318 . . . . 0.0 111.979 177.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -58.95 -13.01 5.24 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 120.199 3.407 . . . . 0.0 120.199 177.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 50.7 m80 -89.07 127.84 35.72 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 120.008 1.276 . . . . 0.0 113.032 -168.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -73.31 130.18 39.63 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 123.932 0.893 . . . . 0.0 109.753 172.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 96.82 -6.58 64.66 Favored Glycine 0 CA--C 1.547 2.07 0 N-CA-C 118.083 1.993 . . . . 0.0 118.083 -169.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.06 114.52 5.28 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-N 120.658 2.229 . . . . 0.0 112.714 -169.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -124.25 156.04 37.54 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 115.093 1.516 . . . . 0.0 115.093 -168.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.9 pp -142.74 139.61 31.13 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-N 114.736 -1.12 . . . . 0.0 108.897 169.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.5 mp -92.84 118.78 39.26 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.436 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 173.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 40.0 ptt85 -108.51 134.73 50.88 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 169.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -79.47 139.72 37.54 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 121.581 0.705 . . . . 0.0 111.087 -177.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 49.1 m -72.2 124.15 24.42 Favored 'General case' 0 N--CA 1.486 1.369 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.719 173.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -75.25 -49.13 20.26 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 177.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 16.2 t -56.96 -35.07 68.68 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 116.369 1.988 . . . . 0.0 116.369 170.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -111.56 92.19 16.16 Favored Pre-proline 0 CA--C 1.564 1.486 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 169.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -72.13 133.05 20.6 Favored 'Trans proline' 0 C--N 1.372 1.803 0 C-N-CA 123.177 2.585 . . . . 0.0 112.324 -176.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 95.22 -35.88 4.07 Favored Glycine 0 CA--C 1.553 2.444 0 CA-C-O 119.08 -0.844 . . . . 0.0 114.297 -168.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -78.86 136.25 37.26 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-N 118.524 1.162 . . . . 0.0 109.467 178.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -106.55 172.22 6.93 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 115.254 -0.884 . . . . 0.0 111.53 -169.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 74.7 m -145.2 116.38 7.92 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 175.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 24.1 tp -79.88 122.58 26.84 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.638 0.775 . . . . 0.0 109.832 174.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 20.7 m -109.51 93.28 4.42 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 106.541 -1.651 . . . . 0.0 106.541 177.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.1 p -108.49 118.55 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 C-N-CA 123.72 0.808 . . . . 0.0 109.891 -171.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -76.71 146.6 37.92 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-N 115.285 -0.87 . . . . 0.0 112.045 172.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -155.03 107.46 2.73 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 171.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 90.61 -75.65 1.64 Allowed Glycine 0 N--CA 1.484 1.856 0 C-N-CA 122.651 0.167 . . . . 0.0 113.294 179.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -136.86 -45.35 0.58 Allowed 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 123.948 0.899 . . . . 0.0 113.147 173.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -92.94 148.29 22.13 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.37 1.068 . . . . 0.0 111.642 -169.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 20.8 t -99.01 120.98 49.06 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 -178.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 24.3 mp0 -98.29 125.01 43.22 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.935 0.894 . . . . 0.0 109.147 178.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 9.8 m-70 -107.44 114.27 28.17 Favored 'General case' 0 CA--C 1.552 1.033 0 CA-C-N 114.79 -1.096 . . . . 0.0 108.361 -169.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -122.56 125.79 46.43 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 -176.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -81.21 123.94 28.88 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-O 121.408 0.623 . . . . 0.0 110.881 -176.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 68.9 t -80.66 104.87 9.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 171.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 59.9 mt -91.13 141.11 29.16 Favored 'General case' 0 N--CA 1.484 1.256 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.826 179.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 53.3 mtp180 -108.35 146.38 33.07 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 123.533 0.733 . . . . 0.0 110.032 179.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 17.7 p-10 -79.58 -42.86 24.11 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 115.783 1.771 . . . . 0.0 115.783 -179.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 179.1 -79.3 0.06 OUTLIER Glycine 0 CA--C 1.537 1.44 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 -172.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -72.41 -64.22 1.0 Allowed 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 175.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 175.73 75.38 0.05 OUTLIER Glycine 0 N--CA 1.479 1.521 0 CA-C-N 119.039 0.836 . . . . 0.0 112.543 173.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp -128.29 111.54 13.49 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 105.018 -2.216 . . . . 0.0 105.018 174.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -91.73 131.72 36.9 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 124.026 0.93 . . . . 0.0 110.728 -169.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -144.08 137.29 27.46 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 123.646 0.778 . . . . 0.0 109.966 -178.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -132.31 -43.16 0.95 Allowed 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 172.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 39.2 t90 -85.74 -77.22 0.3 Allowed 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 124.313 1.045 . . . . 0.0 110.119 -176.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 9.4 p -149.28 -55.87 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 C-N-CA 123.727 0.811 . . . . 0.0 110.465 175.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 13.5 p -79.6 122.8 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 C-N-CA 123.827 0.851 . . . . 0.0 110.53 -175.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 6.5 ttpm? -79.88 146.45 32.17 Favored 'General case' 0 CA--C 1.559 1.299 0 CA-C-O 122.26 1.029 . . . . 0.0 112.919 -176.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -118.58 158.41 25.48 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 114.134 -1.394 . . . . 0.0 109.202 -173.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -76.99 -57.73 3.68 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 118.119 -0.943 . . . . 0.0 112.635 173.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 83.8 p -109.2 162.56 14.17 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-O 122.334 1.064 . . . . 0.0 112.575 -178.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 18.6 tp -64.99 -33.96 77.3 Favored 'General case' 0 CA--C 1.571 1.761 0 N-CA-C 115.036 1.495 . . . . 0.0 115.036 169.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 14.2 m-80 -64.45 -42.74 95.79 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 113.642 0.979 . . . . 0.0 113.642 169.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -58.78 -41.32 86.37 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 115.836 1.791 . . . . 0.0 115.836 169.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 9.7 tt -53.69 -50.25 66.27 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 115.265 1.58 . . . . 0.0 115.265 172.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 25.7 m -67.88 -45.65 83.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 176.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . 0.256 3.7 p30 -65.26 -29.52 70.31 Favored 'General case' 0 CA--C 1.569 1.711 0 N-CA-C 115.408 1.633 . . . . 0.0 115.408 -178.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 77.9 t80 -67.05 -54.2 23.8 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-N 119.256 0.934 . . . . 0.0 111.613 168.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 80.2 m-70 -67.53 -9.2 40.21 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 117.869 2.544 . . . . 0.0 117.869 176.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 52.9 ttm-85 -57.81 -31.46 66.62 Favored 'General case' 0 CA--C 1.577 2.016 0 C-N-CA 124.285 1.034 . . . . 0.0 113.726 167.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 71.0 m -107.73 -34.56 6.94 Favored 'General case' 0 CA--C 1.568 1.654 0 C-N-CA 125.151 1.38 . . . . 0.0 113.955 169.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 90.0 m -90.66 156.56 18.02 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-N 120.504 1.502 . . . . 0.0 111.913 178.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 32.4 t -74.97 121.41 21.91 Favored 'General case' 0 CA--C 1.558 1.279 0 O-C-N 121.342 -0.849 . . . . 0.0 112.034 177.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.5 p -73.14 -34.8 45.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 170.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 20.3 t -85.26 147.24 26.66 Favored 'General case' 0 CA--C 1.558 1.254 0 CA-C-N 119.098 0.863 . . . . 0.0 111.296 174.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 61.1 ttp85 -68.78 -63.37 1.07 Allowed 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 123.162 0.585 . . . . 0.0 112.297 173.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 19.6 t30 -72.42 -52.64 15.05 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 178.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 67.1 mt-30 -79.8 161.62 25.57 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.675 0.75 . . . . 0.0 112.031 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -105.61 94.56 5.27 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 175.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 28.8 mm -113.98 119.14 60.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 -172.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -121.2 126.81 50.59 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 -174.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 11.1 mp -78.5 124.2 27.88 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 -169.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 7.7 mpt_? -120.0 146.88 45.45 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 124.807 1.243 . . . . 0.0 108.242 172.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -75.4 155.56 36.27 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 121.674 0.749 . . . . 0.0 112.564 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 45.7 pt -66.08 156.61 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 N-CA-C 114.542 1.312 . . . . 0.0 114.542 -172.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 . . . . . 0 N--CA 1.483 1.221 0 CA-C-O 123.975 1.845 . . . . 0.0 109.873 -176.43 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 61.9 p-90 . . . . . 0 N--CA 1.493 1.684 0 N-CA-C 117.57 2.434 . . . . 0.0 117.57 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 33.3 t80 -83.2 124.79 30.88 Favored 'General case' 0 N--CA 1.484 1.267 0 CA-C-N 119.559 1.072 . . . . 0.0 109.616 179.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -110.33 -74.19 0.66 Allowed 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 118.483 -0.77 . . . . 0.0 109.046 179.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 177.37 -98.91 0.12 Allowed Glycine 0 N--CA 1.476 1.364 0 CA-C-N 119.263 0.938 . . . . 0.0 111.525 177.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -140.6 94.09 2.69 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 -174.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 36.5 pt -127.98 153.89 78.35 Favored Pre-proline 0 CA--C 1.575 1.922 0 C-N-CA 123.617 0.767 . . . . 0.0 110.484 -175.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -78.2 176.69 9.66 Favored 'Trans proline' 0 CA--C 1.565 2.051 0 C-N-CA 123.037 2.491 . . . . 0.0 114.458 176.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 29.3 ttm180 -61.48 -43.0 99.64 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 115.952 1.834 . . . . 0.0 115.952 172.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.74 -46.84 80.53 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 115.252 1.575 . . . . 0.0 115.252 178.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm -61.95 -35.94 79.93 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 115.559 1.688 . . . . 0.0 115.559 169.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.55 -40.9 89.3 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 115.493 1.664 . . . . 0.0 115.493 171.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -63.75 -39.76 95.06 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 115.313 1.597 . . . . 0.0 115.313 169.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -60.64 -49.2 78.46 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 174.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -62.26 -49.8 74.26 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 114.492 1.293 . . . . 0.0 114.492 173.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 9.9 mp -69.14 -27.8 65.88 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 116.42 2.007 . . . . 0.0 116.42 179.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 23.3 t -59.28 -37.98 79.02 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-N 120.508 1.503 . . . . 0.0 114.683 169.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt -63.84 -31.91 73.25 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 115.64 1.718 . . . . 0.0 115.64 169.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -64.78 120.59 12.76 Favored 'General case' 0 N--CA 1.484 1.27 0 CA-C-N 119.626 1.103 . . . . 0.0 112.196 175.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -69.12 -19.99 64.04 Favored 'General case' 0 CA--C 1.568 1.657 0 N-CA-C 117.935 2.568 . . . . 0.0 117.935 171.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 43.0 m80 -89.59 132.04 35.3 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-N 119.282 0.946 . . . . 0.0 111.136 -169.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -74.52 123.26 24.43 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.445 0.698 . . . . 0.0 109.691 176.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 99.27 2.05 56.8 Favored Glycine 0 CA--C 1.552 2.39 0 N-CA-C 117.86 1.904 . . . . 0.0 117.86 -169.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.62 109.35 4.27 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-N 120.698 2.249 . . . . 0.0 112.026 -172.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -119.52 160.03 23.18 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 116.322 1.971 . . . . 0.0 116.322 -168.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.2 pp -141.61 145.76 35.4 Favored 'General case' 0 CA--C 1.557 1.246 0 CA-C-N 113.826 -1.534 . . . . 0.0 108.989 168.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.8 mp -96.94 115.25 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 N-CA-C 104.112 -2.551 . . . . 0.0 104.112 169.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 50.7 ptt85 -102.83 152.65 21.02 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 123.819 0.847 . . . . 0.0 110.645 169.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -83.18 140.81 32.36 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 168.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 50.2 m -66.86 1.01 2.07 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 120.074 3.361 . . . . 0.0 120.074 -169.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . 0.357 24.9 tt0 79.22 -69.73 0.11 Allowed 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 125.544 1.538 . . . . 0.0 113.467 169.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 66.1 m -64.81 -39.16 93.14 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 115.579 1.696 . . . . 0.0 115.579 171.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -113.53 103.0 55.43 Favored Pre-proline 0 CA--C 1.563 1.45 0 CA-C-N 119.24 0.927 . . . . 0.0 109.875 175.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -58.77 -32.81 97.79 Favored 'Trans proline' 0 C--N 1.37 1.706 0 N-CA-C 119.742 2.939 . . . . 0.0 119.742 173.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -86.79 46.86 3.62 Favored Glycine 0 CA--C 1.552 2.347 0 N-CA-C 114.765 0.666 . . . . 0.0 114.765 169.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -160.08 132.82 6.56 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 176.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -112.43 176.25 5.1 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-O 122.161 0.981 . . . . 0.0 110.645 178.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 58.1 m -151.56 121.4 7.05 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 -179.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 25.7 tp -79.89 114.93 19.18 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 169.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 8.7 m -98.9 97.53 8.7 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 105.913 -1.884 . . . . 0.0 105.913 172.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.8 p -110.1 125.16 67.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 -175.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -76.24 139.9 41.35 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-O 121.54 0.686 . . . . 0.0 111.648 179.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -140.69 170.9 14.9 Favored 'General case' 0 CA--C 1.566 1.578 0 CA-C-O 122.184 0.992 . . . . 0.0 108.383 169.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -60.41 115.91 8.39 Favored Glycine 0 CA--C 1.546 1.978 0 O-C-N 121.108 -0.995 . . . . 0.0 114.339 178.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . 0.377 15.3 m120 83.19 -24.88 0.16 Allowed 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 117.726 2.491 . . . . 0.0 117.726 -174.291 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -147.74 140.37 24.66 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-N 120.264 1.393 . . . . 0.0 111.154 -173.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 69.1 t -94.92 115.76 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 105.196 -2.149 . . . . 0.0 105.196 169.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 62.8 mt-30 -94.3 115.45 27.68 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-O 121.73 0.776 . . . . 0.0 109.686 -175.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 8.2 m-70 -98.52 114.48 26.9 Favored 'General case' 0 CA--C 1.553 1.085 0 CA-C-N 114.844 -1.071 . . . . 0.0 108.419 -175.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -111.46 131.39 55.24 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 -179.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -85.18 119.39 25.51 Favored 'General case' 0 N--CA 1.486 1.375 0 CA-C-O 121.388 0.613 . . . . 0.0 110.283 -176.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 46.9 t -88.54 110.92 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 64.0 mt -93.67 126.11 38.66 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.084 0.554 . . . . 0.0 110.102 -175.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 71.2 mtp180 -96.27 151.89 19.09 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 123.209 0.604 . . . . 0.0 110.756 176.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 25.3 p-10 -79.68 -47.76 14.81 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 115.17 1.545 . . . . 0.0 115.17 174.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 173.57 -73.58 0.09 OUTLIER Glycine 0 CA--C 1.538 1.523 0 N-CA-C 110.841 -0.904 . . . . 0.0 110.841 -169.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -70.5 -64.69 0.85 Allowed 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 175.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 173.81 81.72 0.05 OUTLIER Glycine 0 N--CA 1.478 1.456 0 CA-C-N 118.742 0.701 . . . . 0.0 111.378 174.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -138.23 107.74 6.18 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 105.482 -2.044 . . . . 0.0 105.482 176.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -93.13 119.03 31.9 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.766 0.827 . . . . 0.0 109.383 -169.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -127.2 110.66 13.1 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 4.1 tt -97.98 -54.28 3.14 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 124.29 1.036 . . . . 0.0 111.434 172.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . 0.259 78.1 t90 -93.09 -95.09 0.15 Allowed 'General case' 0 CA--C 1.557 1.213 0 C-N-CA 124.486 1.114 . . . . 0.0 112.275 -167.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 69.7 t -133.2 -60.35 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 -172.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 24.3 m -79.36 128.56 38.47 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.397 0 CA-C-N 119.097 0.862 . . . . 0.0 109.677 178.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -80.04 131.44 35.78 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-O 121.73 0.776 . . . . 0.0 110.666 -175.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -105.15 153.32 21.69 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 114.707 -1.133 . . . . 0.0 109.747 -173.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -74.64 -54.61 7.1 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 172.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 88.0 p -120.72 168.05 11.82 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-O 122.197 0.999 . . . . 0.0 112.346 -175.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 57.5 mt -62.65 -36.47 82.92 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 114.98 1.474 . . . . 0.0 114.98 169.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . 0.281 9.8 p30 -62.22 -38.08 87.83 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 115.496 1.665 . . . . 0.0 115.496 169.53 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -62.28 -45.89 91.22 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 114.896 1.443 . . . . 0.0 114.896 169.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 51.5 tp -55.8 -45.58 78.21 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 115.099 1.518 . . . . 0.0 115.099 169.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 33.2 t -60.08 -61.27 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 C-N-CA 124.309 1.044 . . . . 0.0 112.215 172.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -58.47 -30.03 66.66 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 117.289 2.329 . . . . 0.0 117.289 -175.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -64.95 -55.58 18.3 Favored 'General case' 0 CA--C 1.565 1.544 0 CA-C-N 118.963 0.801 . . . . 0.0 112.619 169.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . 0.303 74.1 m-70 -71.53 -8.99 57.48 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 117.931 2.567 . . . . 0.0 117.931 178.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -48.7 -39.47 24.69 Favored 'General case' 0 N--CA 1.501 2.124 0 CA-C-N 120.59 1.541 . . . . 0.0 114.544 167.48 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 69.7 m -106.47 -29.81 9.46 Favored 'General case' 0 CA--C 1.565 1.532 0 N-CA-C 115.02 1.489 . . . . 0.0 115.02 170.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 39.5 m -89.98 147.19 23.84 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-N 120.733 1.606 . . . . 0.0 110.326 -178.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 23.1 t -77.62 122.87 25.89 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.594 -0.691 . . . . 0.0 111.586 176.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 12.4 p -68.4 -30.73 48.59 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.942 0 N-CA-C 115.3 1.593 . . . . 0.0 115.3 169.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 46.4 m -79.78 -41.26 26.88 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 116.147 1.906 . . . . 0.0 116.147 -176.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . 0.261 4.6 mmp_? 69.04 53.98 0.46 Allowed 'General case' 0 N--CA 1.5 2.027 0 C-N-CA 124.465 1.106 . . . . 0.0 113.24 -169.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -163.96 -81.26 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 177.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 -96.12 163.2 13.21 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 123.794 0.838 . . . . 0.0 109.87 169.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -79.82 98.2 6.97 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.72 -0.613 . . . . 0.0 112.145 -178.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 1.2 mp -102.37 100.74 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 103.757 -2.683 . . . . 0.0 103.757 172.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 20.4 m-30 -110.23 126.44 54.14 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 -178.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 10.8 mp -72.2 121.53 19.5 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 113.148 0.795 . . . . 0.0 113.148 -169.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 22.4 mmt85 -126.85 154.26 44.6 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 125.181 1.393 . . . . 0.0 109.18 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -75.47 147.3 39.96 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.293 -1.505 . . . . 0.0 113.367 -177.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -69.37 158.04 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 113.639 0.977 . . . . 0.0 113.639 179.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 . . . . . 0 N--CA 1.484 1.271 0 CA-C-O 122.851 1.31 . . . . 0.0 109.588 -178.657 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . 0.278 30.0 p-90 . . . . . 0 N--CA 1.489 1.492 0 N-CA-C 115.14 1.533 . . . . 0.0 115.14 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -83.66 134.36 34.78 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 120.771 1.623 . . . . 0.0 110.864 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -111.13 -88.28 0.52 Allowed 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 176.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 153.39 83.33 0.04 OUTLIER Glycine 0 N--CA 1.48 1.622 0 CA-C-N 119.37 0.986 . . . . 0.0 111.088 178.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . 0.257 51.6 mtpt 59.09 61.44 2.11 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 -176.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 17.4 tt -86.06 141.42 35.32 Favored Pre-proline 0 CA--C 1.572 1.811 0 CA-C-O 117.663 -1.16 . . . . 0.0 110.263 179.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -69.1 153.44 71.98 Favored 'Trans proline' 0 CA--C 1.562 1.906 0 CA-C-N 123.575 2.312 . . . . 0.0 113.578 174.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 38.6 ttt85 -58.01 -43.42 86.68 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 116.18 1.918 . . . . 0.0 116.18 -177.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.47 -46.15 84.33 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 115.007 1.484 . . . . 0.0 115.007 175.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 58.7 tttm -59.83 -36.65 77.25 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 115.248 1.573 . . . . 0.0 115.248 169.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.79 -43.29 96.76 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 115.487 1.662 . . . . 0.0 115.487 170.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -63.68 -46.06 87.27 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 114.875 1.435 . . . . 0.0 114.875 172.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -70.77 -39.22 73.35 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 115.212 1.56 . . . . 0.0 115.212 178.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 38.1 mmt -64.99 -45.2 86.61 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-N 119.922 1.237 . . . . 0.0 114.278 172.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 95.3 mt -64.89 -32.1 73.65 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 116.121 1.897 . . . . 0.0 116.121 170.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 18.9 t -57.47 -29.64 64.4 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 116.364 1.987 . . . . 0.0 116.364 169.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -63.55 -34.99 79.02 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 115.775 1.769 . . . . 0.0 115.775 169.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -70.33 131.24 43.84 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-O 122.935 1.35 . . . . 0.0 112.973 -176.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.28 -12.34 61.58 Favored 'General case' 0 CA--C 1.567 1.623 0 N-CA-C 118.947 2.943 . . . . 0.0 118.947 172.114 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 53.5 m80 -89.28 138.03 31.79 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 120.315 1.416 . . . . 0.0 111.936 -169.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -81.47 98.32 8.2 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 107.545 -1.279 . . . . 0.0 107.545 172.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 124.94 -0.1 8.33 Favored Glycine 0 CA--C 1.557 2.668 0 CA-C-O 117.089 -1.951 . . . . 0.0 115.698 -168.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.66 116.27 6.07 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-N 121.161 2.48 . . . . 0.0 112.653 -169.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 20.4 p90 -131.6 155.53 47.36 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 116.273 1.953 . . . . 0.0 116.273 -168.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.0 pp -143.37 138.13 29.21 Favored 'General case' 0 CA--C 1.558 1.25 0 CA-C-N 114.026 -1.443 . . . . 0.0 108.02 169.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.9 mp -83.57 120.09 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 N-CA-C 106.149 -1.797 . . . . 0.0 106.149 174.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 61.8 ttp85 -95.23 125.01 39.58 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-N 114.718 -1.128 . . . . 0.0 109.218 170.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -79.99 132.24 35.98 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 169.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 53.5 m -69.63 138.51 53.13 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.095 0.558 . . . . 0.0 112.32 -175.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -66.24 -59.46 3.71 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -172.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 88.2 p -62.3 -34.37 76.47 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 116.881 2.178 . . . . 0.0 116.881 174.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -121.04 97.28 48.12 Favored Pre-proline 0 CA--C 1.562 1.431 0 CA-C-N 119.112 0.869 . . . . 0.0 109.837 177.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -56.63 -30.95 85.52 Favored 'Trans proline' 0 C--N 1.369 1.641 0 N-CA-C 119.78 2.954 . . . . 0.0 119.78 172.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -88.24 46.12 3.35 Favored Glycine 0 CA--C 1.553 2.458 0 N-CA-C 114.777 0.671 . . . . 0.0 114.777 168.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -156.11 126.81 6.81 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 105.281 -2.118 . . . . 0.0 105.281 178.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -112.79 167.32 10.59 Favored 'General case' 0 CA--C 1.559 1.303 0 CA-C-O 122.416 1.103 . . . . 0.0 110.549 -174.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 71.2 m -146.32 111.89 5.55 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 -179.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 46.2 tp -79.65 107.32 12.33 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-O 122.004 0.906 . . . . 0.0 109.582 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.3 m -90.42 100.45 13.28 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 177.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.3 p -124.81 121.03 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 -172.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -76.37 142.1 41.28 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.535 170.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -150.22 107.44 3.6 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 169.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 88.9 -106.65 3.3 Favored Glycine 0 N--CA 1.481 1.645 0 N-CA-C 110.382 -1.087 . . . . 0.0 110.382 -176.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -135.68 60.1 1.7 Allowed 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 169.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -160.86 129.02 4.45 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.673 0.789 . . . . 0.0 109.386 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 55.8 t -98.91 109.01 23.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 179.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -99.77 120.39 39.66 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.872 0.869 . . . . 0.0 109.465 -176.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -100.58 105.01 16.38 Favored 'General case' 0 CA--C 1.554 1.097 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -175.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -102.34 129.12 48.7 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -177.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -77.07 126.4 30.91 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-O 121.704 0.764 . . . . 0.0 110.525 -178.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 76.9 t -108.93 100.73 11.37 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.347 0 N-CA-C 104.826 -2.287 . . . . 0.0 104.826 178.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -113.27 144.3 42.95 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.788 0.835 . . . . 0.0 110.76 -172.353 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 92.3 mtt180 -88.68 151.75 22.24 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 113.129 0.788 . . . . 0.0 113.129 -175.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -95.83 -63.82 1.12 Allowed 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 123.54 0.736 . . . . 0.0 110.882 169.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -100.01 -104.98 2.65 Favored Glycine 0 CA--C 1.541 1.707 0 CA-C-N 119.223 0.92 . . . . 0.0 111.553 177.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -139.5 122.9 17.15 Favored 'General case' 0 N--CA 1.482 1.17 0 CA-C-O 122.925 1.345 . . . . 0.0 107.566 172.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 61.74 51.71 55.57 Favored Glycine 0 CA--C 1.552 2.35 0 CA-C-N 113.192 -1.822 . . . . 0.0 115.28 -169.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -137.14 77.69 1.65 Allowed 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 105.087 -2.19 . . . . 0.0 105.087 -174.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -85.76 108.89 18.29 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -167.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 21.5 p90 -119.86 135.47 54.86 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.206 0.602 . . . . 0.0 110.571 178.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -94.48 -52.52 4.29 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 123.16 0.584 . . . . 0.0 111.624 169.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 3.2 m-90 -85.07 -76.78 0.3 Allowed 'General case' 0 CA--C 1.564 1.51 0 C-N-CA 123.775 0.83 . . . . 0.0 109.108 177.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 6.2 m -147.38 -46.14 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 C-N-CA 125.352 1.461 . . . . 0.0 110.942 -178.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 12.3 p -79.81 132.22 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 CA-C-N 119.382 0.992 . . . . 0.0 111.355 -173.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 2.2 pptp? -81.65 154.12 26.28 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 113.904 1.076 . . . . 0.0 113.904 -174.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -135.94 114.5 11.83 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 104.617 -2.364 . . . . 0.0 104.617 176.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -53.07 -38.27 62.35 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 118.933 2.938 . . . . 0.0 118.933 -169.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 91.1 p -135.41 160.36 38.68 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-O 122.522 1.153 . . . . 0.0 113.339 -171.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 11.1 mp -77.39 117.88 19.31 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 168.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . 0.356 21.3 t-20 122.88 -53.28 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.017 0 C-N-CA 126.422 1.889 . . . . 0.0 107.535 -168.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -58.84 -49.45 77.69 Favored 'General case' 0 CA--C 1.568 1.646 0 CA-C-N 119.851 1.205 . . . . 0.0 113.777 169.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 31.1 tp -60.59 -40.22 90.96 Favored 'General case' 0 CA--C 1.57 1.74 0 N-CA-C 115.413 1.634 . . . . 0.0 115.413 169.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 40.4 t -59.07 -61.99 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 C-N-CA 124.35 1.06 . . . . 0.0 112.569 173.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -61.88 -30.32 70.79 Favored 'General case' 0 CA--C 1.572 1.814 0 N-CA-C 115.086 1.513 . . . . 0.0 115.086 -178.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 94.0 t80 -59.69 -57.52 12.57 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-N 119.153 0.888 . . . . 0.0 112.245 168.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 74.4 m-70 -70.37 -9.58 56.64 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 117.913 2.56 . . . . 0.0 117.913 175.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 53.1 ttm-85 -61.1 -30.22 70.23 Favored 'General case' 0 CA--C 1.575 1.917 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 167.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 71.0 m -108.6 -30.79 8.05 Favored 'General case' 0 CA--C 1.568 1.64 0 C-N-CA 125.047 1.339 . . . . 0.0 114.081 169.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 99.1 m -90.89 156.33 18.09 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-N 120.371 1.442 . . . . 0.0 111.978 176.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 39.7 t -67.08 137.16 56.18 Favored 'General case' 0 CA--C 1.558 1.267 0 C-N-CA 123.669 0.788 . . . . 0.0 113.076 170.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 19.0 t -71.3 -48.91 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 CA-C-O 118.683 -0.675 . . . . 0.0 111.735 171.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 9.2 t -87.76 172.51 9.61 Favored 'General case' 0 CA--C 1.565 1.541 0 CA-C-N 118.981 0.81 . . . . 0.0 111.754 174.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 40.8 mmt180 -79.93 -57.78 3.48 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.23 -0.919 . . . . 0.0 111.724 169.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -70.1 -59.54 2.84 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 177.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 70.1 mt-30 -79.9 145.08 32.87 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-N 118.869 0.759 . . . . 0.0 111.481 -179.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -102.76 104.56 14.87 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 123.352 0.661 . . . . 0.0 109.533 -177.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 4.3 mp -112.71 127.44 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -125.5 125.38 43.18 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 10.8 mp -74.22 135.33 42.73 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 115.057 1.503 . . . . 0.0 115.057 -168.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 8.9 mmm180 -128.71 139.1 52.39 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 125.486 1.514 . . . . 0.0 108.519 174.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -71.97 146.79 47.5 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.307 -0.87 . . . . 0.0 112.451 177.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 27.1 pt -69.93 158.69 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 N-CA-C 113.564 0.949 . . . . 0.0 113.564 -174.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 . . . . . 0 N--CA 1.484 1.256 0 CA-C-O 122.803 1.287 . . . . 0.0 109.759 179.276 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 55.4 p-90 . . . . . 0 N--CA 1.479 1.017 0 CA-C-O 118.339 -0.839 . . . . 0.0 112.347 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -82.82 127.5 33.53 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-N 119.868 1.213 . . . . 0.0 112.903 -169.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -100.01 -79.67 0.49 Allowed 'General case' 0 N--CA 1.489 1.481 0 CA-C-N 114.937 -1.029 . . . . 0.0 108.765 173.005 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -175.99 -138.05 2.75 Favored Glycine 0 N--CA 1.48 1.569 0 CA-C-N 119.311 0.96 . . . . 0.0 112.28 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 20.9 tptm -103.5 87.13 2.78 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 176.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 32.6 pt -127.09 153.09 76.61 Favored Pre-proline 0 CA--C 1.573 1.828 0 C-N-CA 123.331 0.652 . . . . 0.0 111.086 -169.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -77.24 178.57 7.47 Favored 'Trans proline' 0 CA--C 1.565 2.059 0 C-N-CA 123.043 2.496 . . . . 0.0 113.944 175.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 54.3 ttt180 -65.42 -41.48 93.53 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 115.101 1.519 . . . . 0.0 115.101 175.092 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.2 -41.06 97.23 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 115.96 1.837 . . . . 0.0 115.96 179.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -64.07 -38.46 91.16 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 114.569 1.322 . . . . 0.0 114.569 169.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.59 -41.0 84.77 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 115.951 1.834 . . . . 0.0 115.951 171.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -64.17 -36.81 85.26 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 115.02 1.489 . . . . 0.0 115.02 170.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -63.77 -48.24 77.72 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 114.799 1.407 . . . . 0.0 114.799 172.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 38.8 mmt -61.54 -47.48 85.35 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 174.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 88.3 mt -75.09 -24.52 58.14 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 116.908 2.188 . . . . 0.0 116.908 177.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 97.4 p -61.83 -36.35 80.9 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-N 120.726 1.603 . . . . 0.0 114.631 168.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 59.7 mttm -60.7 -36.58 79.16 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 114.788 1.403 . . . . 0.0 114.788 169.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -64.62 120.47 12.45 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.449 1.1 . . . . 0.0 112.001 170.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 16.5 ptm180 -77.9 -15.99 58.58 Favored 'General case' 0 CA--C 1.569 1.683 0 N-CA-C 118.223 2.675 . . . . 0.0 118.223 176.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 46.0 m80 -89.57 147.85 23.71 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 119.513 1.051 . . . . 0.0 113.557 -168.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -77.6 124.4 27.88 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.789 170.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 105.6 -29.93 10.62 Favored Glycine 0 CA--C 1.546 2.002 0 CA-C-O 117.268 -1.851 . . . . 0.0 116.765 -169.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.11 112.75 1.29 Allowed 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 120.21 2.005 . . . . 0.0 113.386 -170.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.1 p90 -130.32 161.22 31.76 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 -168.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.6 pp -141.99 132.62 25.45 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.695 0.798 . . . . 0.0 108.892 168.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 87.2 mt -86.8 122.09 38.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 169.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 49.1 ptt85 -104.4 153.02 21.6 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.487 169.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -88.85 124.12 33.89 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 105.836 -1.913 . . . . 0.0 105.836 168.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 53.2 m -62.84 121.37 13.31 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.241 0.616 . . . . 0.0 111.871 -172.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -68.1 -47.15 68.99 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 114.496 1.295 . . . . 0.0 114.496 -170.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.1 t -65.66 -31.93 73.22 Favored 'General case' 0 CA--C 1.568 1.659 0 N-CA-C 115.832 1.79 . . . . 0.0 115.832 169.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -118.85 95.31 49.08 Favored Pre-proline 0 CA--C 1.563 1.471 0 CA-C-N 119.863 1.21 . . . . 0.0 110.158 178.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -56.05 -34.65 93.1 Favored 'Trans proline' 0 C--N 1.369 1.658 0 N-CA-C 120.111 3.081 . . . . 0.0 120.111 176.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -87.97 50.09 3.88 Favored Glycine 0 CA--C 1.55 2.281 0 N-CA-C 114.297 0.479 . . . . 0.0 114.297 169.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -159.66 142.04 13.57 Favored 'General case' 0 CA--C 1.556 1.209 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 178.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -116.68 161.19 19.61 Favored 'General case' 0 CA--C 1.564 1.501 0 CA-C-O 122.032 0.92 . . . . 0.0 109.265 171.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 67.4 m -137.4 117.33 13.27 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 178.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 43.0 tp -80.17 110.89 16.01 Favored 'General case' 0 CA--C 1.563 1.452 0 C-N-CA 124.216 1.007 . . . . 0.0 109.429 172.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 3.1 m -97.4 116.04 28.85 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 -178.28 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 41.2 t -126.21 123.2 63.19 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.194 0 CA-C-N 120.798 1.635 . . . . 0.0 108.151 -171.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 59.0 tptt -81.77 121.2 26.12 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 169.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -139.22 99.46 3.76 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 174.116 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 92.01 -98.32 2.4 Favored Glycine 0 CA--C 1.538 1.483 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.984 178.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 12.2 p30 -129.1 19.49 5.93 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 115.629 1.715 . . . . 0.0 115.629 177.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -145.3 141.37 28.5 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 120.117 1.326 . . . . 0.0 109.522 -177.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 60.6 t -96.33 108.37 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 174.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -104.02 127.68 51.58 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 123.917 0.887 . . . . 0.0 110.557 -176.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 12.7 m-70 -102.95 101.31 11.31 Favored 'General case' 0 CA--C 1.551 1.0 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -169.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -84.92 126.22 33.32 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 172.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 32.6 mmmt -82.86 119.51 24.48 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.067 0.46 . . . . 0.0 110.228 -172.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 84.3 t -86.33 103.63 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 177.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 63.3 mt -95.62 147.69 23.31 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.719 -171.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 72.7 mtp180 -116.28 122.52 45.19 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.627 -0.671 . . . . 0.0 110.355 -173.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -101.19 119.7 39.13 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 123.46 0.704 . . . . 0.0 109.75 174.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 82.02 -112.44 3.49 Favored Glycine 0 CA--C 1.541 1.701 0 C-N-CA 122.816 0.246 . . . . 0.0 113.095 177.005 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -86.43 -71.89 0.53 Allowed 'General case' 0 N--CA 1.486 1.368 0 CA-C-O 118.746 -0.645 . . . . 0.0 111.258 177.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -157.01 71.81 0.25 Allowed Glycine 0 N--CA 1.478 1.498 0 CA-C-N 118.681 0.673 . . . . 0.0 112.373 172.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.95 104.58 14.29 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 104.74 -2.318 . . . . 0.0 104.74 172.058 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -84.08 99.67 10.61 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.652 -168.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 32.8 p90 -102.49 114.36 28.5 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.71 0.804 . . . . 0.0 109.107 -178.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -105.66 -52.17 2.87 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.825 176.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 83.1 t90 -135.19 109.19 8.18 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 -169.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . 0.392 22.2 t 69.58 -91.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 C-N-CA 124.278 1.031 . . . . 0.0 111.57 169.615 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 8.1 p -79.97 155.3 4.55 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.609 0 C-N-CA 124.224 1.01 . . . . 0.0 111.408 177.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 25.9 pttm -79.74 148.44 31.5 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-O 121.434 0.635 . . . . 0.0 112.545 173.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -128.07 107.27 9.67 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 106.26 -1.755 . . . . 0.0 106.26 -172.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -50.63 -50.28 54.73 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 117.951 2.574 . . . . 0.0 117.951 -169.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 90.8 p -111.86 160.57 17.25 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 118.897 0.771 . . . . 0.0 111.833 176.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 79.0 mt -66.71 -34.46 77.89 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 115.38 1.622 . . . . 0.0 115.38 170.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -64.21 -45.09 89.8 Favored 'General case' 0 CA--C 1.572 1.825 0 CA-C-N 119.859 1.209 . . . . 0.0 114.002 170.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -59.08 -47.35 85.56 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 114.788 1.403 . . . . 0.0 114.788 169.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 57.4 tp -51.83 -52.48 48.98 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 115.686 1.735 . . . . 0.0 115.686 170.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 9.8 p -67.44 -50.28 63.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 -176.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -63.84 -31.0 72.03 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 114.957 1.466 . . . . 0.0 114.957 174.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -62.43 -54.55 38.55 Favored 'General case' 0 CA--C 1.567 1.618 0 CA-C-N 119.727 1.148 . . . . 0.0 111.702 168.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 36.4 m-70 -73.32 -9.7 58.98 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 118.37 2.73 . . . . 0.0 118.37 179.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 58.0 mtp85 -66.82 -21.46 66.03 Favored 'General case' 0 CA--C 1.579 2.08 0 CA-C-N 120.251 1.387 . . . . 0.0 113.347 167.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 69.3 m -104.38 -43.92 5.07 Favored 'General case' 0 CA--C 1.57 1.73 0 C-N-CA 125.453 1.501 . . . . 0.0 112.509 168.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 57.3 m -90.18 155.42 19.04 Favored 'General case' 0 N--CA 1.499 1.981 0 CA-C-N 120.051 1.296 . . . . 0.0 111.465 -179.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 21.0 t -80.18 130.74 35.44 Favored 'General case' 0 CA--C 1.56 1.352 0 O-C-N 121.293 -0.88 . . . . 0.0 113.053 -178.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 3.2 m -68.88 -42.49 82.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 169.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.8 t -83.49 135.26 34.72 Favored 'General case' 0 CA--C 1.557 1.23 0 CA-C-N 118.967 0.803 . . . . 0.0 110.259 173.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 41.4 ptt180 -69.99 -45.53 67.13 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 115.183 1.549 . . . . 0.0 115.183 174.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 70.9 m-80 -79.1 -55.53 5.04 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 123.451 0.7 . . . . 0.0 112.593 175.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -79.89 154.02 28.63 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 118.782 0.719 . . . . 0.0 111.939 179.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -92.91 96.52 10.17 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 171.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 27.7 mm -117.86 110.86 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 N-CA-C 105.146 -2.168 . . . . 0.0 105.146 -178.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -116.55 127.97 55.0 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.424 -174.168 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 10.7 mp -78.09 126.14 30.37 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.747 0.819 . . . . 0.0 111.905 -169.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 14.1 mmm180 -126.89 162.79 25.1 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-O 122.419 1.104 . . . . 0.0 110.432 178.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -77.36 148.67 35.46 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.984 -1.072 . . . . 0.0 112.68 -176.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 28.1 pt -70.0 159.7 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 113.993 1.108 . . . . 0.0 113.993 -179.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 . . . . . 0 N--CA 1.485 1.287 0 CA-C-O 124.002 1.858 . . . . 0.0 108.541 -177.603 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . 0.387 50.8 p-90 . . . . . 0 N--CA 1.503 2.188 0 N-CA-C 120.703 3.594 . . . . 0.0 120.703 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -128.42 132.99 48.47 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 124.319 1.048 . . . . 0.0 108.268 -169.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -99.71 -75.21 0.57 Allowed 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 118.34 -0.838 . . . . 0.0 109.316 172.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 97.78 113.64 3.2 Favored Glycine 0 N--CA 1.481 1.669 0 CA-C-N 119.371 0.987 . . . . 0.0 112.208 -179.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . 0.307 73.5 mmtt 65.28 25.68 12.19 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 117.425 2.38 . . . . 0.0 117.425 178.3 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 21.1 tt -90.45 129.03 46.61 Favored Pre-proline 0 CA--C 1.569 1.691 0 CA-C-O 117.139 -1.41 . . . . 0.0 107.567 169.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -67.32 170.61 13.06 Favored 'Trans proline' 0 CA--C 1.562 1.882 0 CA-C-N 123.638 2.335 . . . . 0.0 114.19 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 25.6 ttm180 -57.57 -45.59 85.0 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 116.252 1.945 . . . . 0.0 116.252 -177.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -65.98 -46.08 79.34 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 115.457 1.651 . . . . 0.0 115.457 175.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 61.5 mtpt -63.61 -34.91 78.87 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 115.426 1.639 . . . . 0.0 115.426 169.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.48 -42.4 99.46 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 115.278 1.584 . . . . 0.0 115.278 169.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -60.9 -43.45 98.49 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 169.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -64.82 -45.68 85.2 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 115.52 1.674 . . . . 0.0 115.52 175.136 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -59.83 -44.16 94.2 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 114.83 1.418 . . . . 0.0 114.83 172.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 88.6 mt -70.52 -21.75 62.7 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 116.679 2.104 . . . . 0.0 116.679 170.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 12.1 t -53.09 -37.06 61.37 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 117.223 2.305 . . . . 0.0 117.223 178.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? -64.85 -28.9 69.86 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 116.244 1.942 . . . . 0.0 116.244 170.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -71.53 114.4 9.57 Favored 'General case' 0 N--CA 1.485 1.294 0 CA-C-N 119.819 1.19 . . . . 0.0 111.259 178.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.43 -7.35 52.68 Favored 'General case' 0 CA--C 1.57 1.721 0 N-CA-C 118.092 2.627 . . . . 0.0 118.092 172.26 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 35.5 m80 -89.81 139.94 30.08 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 119.667 1.121 . . . . 0.0 111.589 -169.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -75.98 120.12 20.87 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.183 171.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 107.78 -19.77 32.69 Favored Glycine 0 CA--C 1.546 2.022 0 CA-C-O 116.632 -2.204 . . . . 0.0 116.732 -169.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.2 108.72 0.95 Allowed 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 121.26 2.53 . . . . 0.0 112.233 -173.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 23.2 p90 -123.58 158.46 31.38 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 -168.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.9 pp -138.07 128.78 26.72 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 168.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 91.1 mt -88.54 110.76 21.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 172.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.9 ptm180 -89.42 144.61 25.92 Favored 'General case' 0 N--CA 1.484 1.226 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.192 169.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -84.8 126.9 33.84 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 169.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 20.8 t -68.11 123.11 19.76 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 122.909 0.483 . . . . 0.0 111.476 -172.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -91.11 91.17 8.14 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 123.706 1.717 . . . . 0.0 110.411 -173.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 39.7 t 162.54 -41.11 0.0 OUTLIER 'General case' 0 CA--C 1.571 1.768 0 CA-C-N 110.729 -2.941 . . . . 0.0 106.983 -168.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -150.01 113.68 3.37 Favored Pre-proline 0 CA--C 1.563 1.464 0 CA-C-O 117.57 -1.205 . . . . 0.0 108.414 178.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -68.6 -27.22 32.85 Favored 'Trans proline' 0 C--N 1.37 1.699 0 N-CA-C 119.088 2.688 . . . . 0.0 119.088 -178.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -65.3 -21.49 68.43 Favored Glycine 0 CA--C 1.561 2.938 0 N-CA-C 116.492 1.357 . . . . 0.0 116.492 168.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -88.66 137.78 32.01 Favored 'General case' 0 CA--C 1.555 1.171 0 CA-C-N 118.216 1.008 . . . . 0.0 108.839 169.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -122.69 173.16 7.9 Favored 'General case' 0 CA--C 1.567 1.61 0 CA-C-N 114.927 -1.033 . . . . 0.0 108.649 175.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 75.7 m -143.6 115.42 8.24 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 173.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 29.3 tp -79.85 114.47 18.79 Favored 'General case' 0 CA--C 1.561 1.384 0 C-N-CA 124.314 1.046 . . . . 0.0 109.167 175.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.3 m -106.16 88.51 2.81 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 -170.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 16.0 t -101.99 123.02 54.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 -169.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 51.3 tttp -88.26 96.23 10.48 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.474 171.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 20.1 t80 -105.77 112.21 25.18 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.706 -0.849 . . . . 0.0 108.706 179.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 82.78 -106.23 2.73 Favored Glycine 0 CA--C 1.539 1.589 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 -170.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -141.68 59.49 1.49 Allowed 'General case' 0 CA--C 1.565 1.543 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 169.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -155.8 128.57 7.93 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 107.046 -1.465 . . . . 0.0 107.046 177.161 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 50.0 t -95.63 110.72 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 -175.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -104.96 116.08 31.36 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.791 0.836 . . . . 0.0 109.05 -173.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -95.11 108.91 21.02 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 115.036 -0.984 . . . . 0.0 108.828 -175.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -107.07 120.79 43.04 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 -175.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -79.08 112.3 16.14 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 121.906 0.86 . . . . 0.0 110.579 -172.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 75.8 t -85.18 100.94 8.95 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 178.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.9 pp -122.86 133.84 54.41 Favored 'General case' 0 N--CA 1.491 1.575 0 CA-C-O 121.506 0.669 . . . . 0.0 111.099 -169.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -84.7 159.01 20.61 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-O 122.077 0.942 . . . . 0.0 113.042 -176.074 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -85.53 -46.63 10.66 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 114.96 -1.018 . . . . 0.0 113.106 168.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -154.93 -85.5 0.05 OUTLIER Glycine 0 CA--C 1.539 1.556 0 CA-C-N 118.958 0.799 . . . . 0.0 111.258 -177.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -72.95 -70.95 0.33 Allowed 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -175.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -168.75 54.85 0.21 Allowed Glycine 0 N--CA 1.481 1.634 0 CA-C-O 119.333 -0.704 . . . . 0.0 114.276 172.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -109.69 97.83 7.29 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 105.432 -2.062 . . . . 0.0 105.432 173.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -80.32 125.91 30.49 Favored 'General case' 0 CA--C 1.554 1.126 0 CA-C-N 113.922 -1.49 . . . . 0.0 110.775 -169.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 32.2 p90 -128.95 122.83 31.02 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 121.288 0.566 . . . . 0.0 109.884 174.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -102.92 -53.65 2.8 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 124.291 1.036 . . . . 0.0 111.822 169.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 37.4 t90 -84.83 -74.39 0.39 Allowed 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 124.889 1.276 . . . . 0.0 110.029 -178.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 10.5 p -148.59 -56.0 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 C-N-CA 123.872 0.869 . . . . 0.0 110.668 176.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 11.1 p -79.4 135.82 24.88 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.476 0 C-N-CA 123.814 0.845 . . . . 0.0 110.858 -172.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 54.0 mttp -79.94 157.77 26.79 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 122.249 1.023 . . . . 0.0 112.366 -176.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -140.79 114.75 9.07 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 -170.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -58.73 -43.09 90.08 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 116.247 1.943 . . . . 0.0 116.247 177.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 94.8 p -113.37 144.74 42.27 Favored 'General case' 0 N--CA 1.484 1.27 0 CA-C-O 122.018 0.913 . . . . 0.0 111.955 -179.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 19.0 tp -84.53 62.07 7.05 Favored 'General case' 0 CA--C 1.571 1.775 0 CA-C-N 114.625 -1.17 . . . . 0.0 111.195 169.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -156.71 -51.58 0.08 Allowed 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 127.221 2.209 . . . . 0.0 105.445 172.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -61.2 -31.44 71.2 Favored 'General case' 0 CA--C 1.571 1.762 0 CA-C-N 119.537 1.062 . . . . 0.0 113.384 167.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 10.3 tt -51.7 -45.94 63.72 Favored 'General case' 0 N--CA 1.498 1.969 0 CA-C-N 120.158 1.345 . . . . 0.0 114.024 168.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 24.6 t -60.43 -59.32 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 C-N-CA 124.411 1.084 . . . . 0.0 112.162 169.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -58.7 -34.22 71.05 Favored 'General case' 0 CA--C 1.566 1.578 0 N-CA-C 116.269 1.952 . . . . 0.0 116.269 -174.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -61.63 -55.55 29.43 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 119.426 1.012 . . . . 0.0 112.279 169.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . 0.263 48.3 m-70 -69.6 -9.51 54.38 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 117.867 2.543 . . . . 0.0 117.867 177.301 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -62.21 -32.41 73.06 Favored 'General case' 0 CA--C 1.577 1.997 0 CA-C-N 120.266 1.393 . . . . 0.0 112.732 166.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 69.4 m -98.75 -39.64 8.54 Favored 'General case' 0 CA--C 1.565 1.529 0 N-CA-C 114.424 1.268 . . . . 0.0 114.424 169.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 52.1 m -91.07 155.61 18.54 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-N 120.175 1.352 . . . . 0.0 112.052 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 31.3 t -75.27 136.01 40.93 Favored 'General case' 0 CA--C 1.559 1.305 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 177.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 6.5 t -76.82 -50.03 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 CA-C-O 118.552 -0.737 . . . . 0.0 111.47 169.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 67.0 m -87.85 143.22 27.25 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 119.297 0.953 . . . . 0.0 111.338 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 19.3 ptp180 -91.12 64.47 5.31 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 121.993 0.901 . . . . 0.0 111.515 169.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . 0.271 7.2 p-10 -179.66 -70.99 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 125.624 1.57 . . . . 0.0 107.003 -172.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -86.59 149.9 24.61 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.965 0.906 . . . . 0.0 110.558 170.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 16.5 mm100 -93.32 88.45 6.0 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 122.764 0.426 . . . . 0.0 109.935 178.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 14.8 mm -90.57 117.61 34.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 -169.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -125.11 122.01 35.92 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 -177.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 10.6 mp -74.51 142.96 44.76 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 113.839 1.052 . . . . 0.0 113.839 -169.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 4.2 tmt_? -144.75 145.02 31.48 Favored 'General case' 0 CA--C 1.563 1.46 0 N-CA-C 105.798 -1.927 . . . . 0.0 105.798 -174.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -69.23 157.04 37.72 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.29 -1.507 . . . . 0.0 113.459 176.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.1 pp -72.62 159.05 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 179.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 122.88 1.324 . . . . 0.0 110.061 177.955 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . 0.256 69.0 p-90 . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 45.6 t80 -80.71 135.29 35.98 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-N 119.464 1.029 . . . . 0.0 110.967 -177.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -122.77 -76.91 0.59 Allowed 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 177.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 172.92 -112.89 0.45 Allowed Glycine 0 N--CA 1.479 1.542 0 N-CA-C 108.681 -1.768 . . . . 0.0 108.681 173.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 26.9 ttpp -117.83 82.99 1.92 Allowed 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 105.206 -2.146 . . . . 0.0 105.206 169.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -111.49 136.06 21.03 Favored Pre-proline 0 CA--C 1.569 1.695 0 CA-C-O 117.335 -1.317 . . . . 0.0 108.632 -168.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_exo -48.75 153.13 3.81 Favored 'Trans proline' 0 C--N 1.371 1.716 0 C-N-CA 123.736 2.957 . . . . 0.0 119.22 -177.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 59.0 ttt180 -66.5 -37.9 86.07 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 114.817 1.414 . . . . 0.0 114.817 171.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -69.04 -43.33 74.91 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 115.427 1.64 . . . . 0.0 115.427 176.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 54.6 tptt -66.55 -37.31 84.71 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 115.089 1.514 . . . . 0.0 115.089 169.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.27 -45.72 92.0 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 115.612 1.708 . . . . 0.0 115.612 169.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -64.8 -33.95 77.2 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 115.704 1.742 . . . . 0.0 115.704 171.169 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -61.9 -49.53 75.84 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 114.51 1.3 . . . . 0.0 114.51 171.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -62.71 -47.31 84.15 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 114.691 1.367 . . . . 0.0 114.691 173.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.1 mp -68.21 -25.24 65.12 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 116.302 1.964 . . . . 0.0 116.302 175.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 22.9 t -59.1 -36.3 74.9 Favored 'General case' 0 CA--C 1.571 1.759 0 CA-C-N 120.635 1.561 . . . . 0.0 114.078 168.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 27.9 mmtp -61.05 -36.29 79.19 Favored 'General case' 0 CA--C 1.57 1.746 0 N-CA-C 115.054 1.501 . . . . 0.0 115.054 169.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -67.07 119.47 12.07 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.624 1.17 . . . . 0.0 111.769 177.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 14.1 ptp180 -73.93 -17.1 61.06 Favored 'General case' 0 CA--C 1.569 1.685 0 N-CA-C 118.065 2.617 . . . . 0.0 118.065 171.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 46.5 m80 -89.74 141.87 28.21 Favored 'General case' 0 N--CA 1.487 1.418 0 CA-C-N 119.287 0.948 . . . . 0.0 113.188 -168.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.74 119.57 24.5 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 169.62 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 113.61 -28.5 8.52 Favored Glycine 0 CA--C 1.548 2.098 0 CA-C-O 117.685 -1.619 . . . . 0.0 116.347 -169.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.76 109.99 1.6 Allowed 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 120.06 1.93 . . . . 0.0 112.761 -176.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 16.4 p90 -126.63 164.19 21.8 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 115.457 1.651 . . . . 0.0 115.457 -168.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.2 pp -140.69 134.03 29.76 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 167.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 68.1 mt -88.28 117.66 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 106.568 -1.641 . . . . 0.0 106.568 169.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 5.0 ptm180 -110.66 141.9 43.28 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.447 169.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -79.89 139.04 37.28 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 121.533 0.683 . . . . 0.0 109.793 171.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 29.7 t -68.54 128.84 38.07 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.66 -178.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -68.5 -48.14 65.2 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 113.97 1.1 . . . . 0.0 113.97 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.8 t -60.84 -37.72 83.03 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 115.986 1.847 . . . . 0.0 115.986 169.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -119.67 93.11 47.18 Favored Pre-proline 0 CA--C 1.561 1.395 0 CA-C-N 119.577 1.081 . . . . 0.0 109.792 174.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -55.35 -26.36 52.49 Favored 'Trans proline' 0 CA--C 1.557 1.643 0 N-CA-C 119.761 2.947 . . . . 0.0 119.761 171.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -91.31 48.47 2.91 Favored Glycine 0 CA--C 1.552 2.393 0 CA-C-O 119.319 -0.712 . . . . 0.0 113.93 168.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -160.17 126.98 4.36 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 178.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 35.3 m-85 -92.73 165.45 12.94 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 122.213 1.006 . . . . 0.0 111.701 169.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 75.2 m -143.48 112.72 6.78 Favored 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 25.4 tp -79.98 108.65 13.73 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 124.219 1.008 . . . . 0.0 109.447 176.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 12.6 m -99.65 97.25 8.24 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 -173.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 21.7 t -107.6 126.45 63.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 -172.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 58.4 tptt -76.93 109.83 11.07 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 169.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -139.3 90.11 2.39 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -174.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 71.02 74.71 0.68 Allowed Glycine 0 N--CA 1.482 1.765 0 N-CA-C 115.654 1.021 . . . . 0.0 115.654 169.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . 0.286 66.1 m-80 68.97 -11.56 0.44 Allowed 'General case' 0 N--CA 1.501 2.121 0 N-CA-C 118.362 2.727 . . . . 0.0 118.362 -178.488 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -139.47 142.61 37.35 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 119.736 1.153 . . . . 0.0 108.992 -175.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 38.7 t -92.67 114.75 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 177.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 61.6 mt-30 -96.27 118.35 32.65 Favored 'General case' 0 N--CA 1.485 1.301 0 CA-C-O 121.666 0.746 . . . . 0.0 109.848 -178.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 13.9 m-70 -99.25 99.61 10.59 Favored 'General case' 0 CA--C 1.552 1.054 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 -175.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -96.9 121.48 38.82 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 -175.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 65.5 pttt -75.78 116.05 16.09 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.402 0.62 . . . . 0.0 112.59 -169.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 92.0 t -88.12 109.31 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 179.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 57.8 mt -91.91 145.46 24.53 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.378 -174.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 60.9 mtp180 -122.82 124.53 43.5 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.768 -0.583 . . . . 0.0 109.516 -170.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -111.16 99.45 8.29 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 123.263 0.625 . . . . 0.0 110.162 177.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 76.44 89.44 0.27 Allowed Glycine 0 N--CA 1.482 1.761 0 CA-C-O 119.452 -0.638 . . . . 0.0 113.953 174.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . 0.332 . . 75.8 -78.25 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 124.696 1.199 . . . . 0.0 112.675 -175.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -165.48 75.63 0.15 Allowed Glycine 0 CA--C 1.537 1.431 0 CA-C-O 119.782 -0.455 . . . . 0.0 112.077 173.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -105.73 98.31 8.02 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 104.44 -2.43 . . . . 0.0 104.44 169.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -80.05 100.93 8.41 Favored 'General case' 0 N--CA 1.484 1.242 0 CA-C-N 114.617 -1.174 . . . . 0.0 112.286 -167.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -108.91 113.39 26.25 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 64.2 tp -111.12 -49.5 3.01 Favored 'General case' 0 CA--C 1.564 1.504 0 CA-C-N 114.589 -1.187 . . . . 0.0 111.332 176.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . 0.414 ' HZ3' ' HH ' ' A' ' 134' ' ' TYR . 85.9 t90 -129.99 101.98 6.07 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 -175.571 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . 0.519 29.8 m 63.43 -88.02 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 114.895 1.443 . . . . 0.0 114.895 177.146 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 8.6 p -79.99 147.86 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 C-N-CA 124.002 0.921 . . . . 0.0 112.241 -174.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 25.6 pttm -80.04 153.29 28.9 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 121.699 0.762 . . . . 0.0 112.991 173.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -131.24 120.2 22.89 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 -175.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 56.1 m-80 -58.63 -51.66 68.97 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 114.617 1.34 . . . . 0.0 114.617 -178.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 67.2 m -97.14 148.97 22.51 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-O 122.612 1.196 . . . . 0.0 111.664 176.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 15.4 tp -65.63 -37.75 87.46 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 172.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -65.41 -32.92 74.8 Favored 'General case' 0 CA--C 1.572 1.81 0 N-CA-C 114.22 1.193 . . . . 0.0 114.22 168.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -63.19 -41.85 99.24 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-N 120.602 1.547 . . . . 0.0 114.416 169.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 63.5 tp -58.69 -43.44 89.99 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 169.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 25.7 t -58.62 -64.07 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 C-N-CA 124.447 1.099 . . . . 0.0 112.388 171.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -59.66 -30.91 69.08 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 116.116 1.895 . . . . 0.0 116.116 -174.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.414 ' HH ' ' HZ3' ' A' ' 121' ' ' TRP . 85.4 t80 -63.61 -54.07 41.67 Favored 'General case' 0 CA--C 1.567 1.597 0 CA-C-N 118.815 0.734 . . . . 0.0 112.217 168.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . 0.27 62.2 m-70 -69.92 -9.32 54.58 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 117.891 2.552 . . . . 0.0 117.891 177.354 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -51.23 -38.87 54.89 Favored 'General case' 0 N--CA 1.501 2.087 0 CA-C-N 120.726 1.603 . . . . 0.0 113.603 167.154 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 70.0 m -102.91 -34.01 9.12 Favored 'General case' 0 CA--C 1.564 1.505 0 N-CA-C 114.668 1.358 . . . . 0.0 114.668 169.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 30.3 m -90.17 152.43 21.11 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-N 120.681 1.582 . . . . 0.0 111.178 -176.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 29.9 t -74.87 136.58 41.5 Favored 'General case' 0 CA--C 1.56 1.346 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 177.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 88.3 t -71.79 -50.91 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.903 169.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 58.5 m -91.18 154.58 19.22 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-O 122.162 0.982 . . . . 0.0 111.745 -178.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 10.4 mpt_? -71.9 -54.04 11.29 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.709 177.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 24.6 t30 -72.6 -59.56 2.66 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 173.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -79.89 150.62 30.52 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-N 118.793 0.724 . . . . 0.0 112.221 -177.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -101.45 96.97 7.49 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.383 0.673 . . . . 0.0 109.488 -179.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 5.2 mp -109.11 110.71 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 -179.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 19.3 m-30 -108.26 137.34 46.4 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 173.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 9.7 mp -85.47 128.92 34.89 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 123.36 0.664 . . . . 0.0 112.097 -169.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 4.9 mpt_? -129.07 173.77 10.15 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-O 123.409 1.576 . . . . 0.0 109.843 172.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -84.46 157.97 21.18 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-N 114.739 -1.119 . . . . 0.0 113.711 -177.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 29.2 pt -75.36 153.07 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 CA-C-O 121.704 0.764 . . . . 0.0 112.936 178.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 . . . . . 0 N--CA 1.485 1.305 0 CA-C-O 123.977 1.846 . . . . 0.0 108.847 -178.483 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 68.6 p-90 . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 116.109 1.892 . . . . 0.0 116.109 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -84.05 129.26 34.92 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-N 119.464 1.029 . . . . 0.0 110.646 -174.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -135.5 101.87 4.94 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 105.582 -2.006 . . . . 0.0 105.582 171.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -78.81 108.7 2.71 Favored Glycine 0 CA--C 1.541 1.661 0 CA-C-N 115.969 -0.56 . . . . 0.0 113.317 -173.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . 0.27 2.8 tppp? 66.36 80.27 0.22 Allowed 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 124.878 1.271 . . . . 0.0 112.178 -175.573 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.25 130.61 23.71 Favored Pre-proline 0 CA--C 1.572 1.792 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 -175.718 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -63.74 144.75 89.86 Favored 'Trans proline' 0 CA--C 1.559 1.729 0 C-N-CA 122.842 2.361 . . . . 0.0 114.532 -176.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 60.1 ttt180 -59.74 -39.32 84.36 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 116.672 2.101 . . . . 0.0 116.672 -172.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.8 -45.59 85.62 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 115.1 1.519 . . . . 0.0 115.1 174.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -62.92 -36.72 84.34 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 115.038 1.495 . . . . 0.0 115.038 169.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.46 -44.11 97.69 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 115.59 1.7 . . . . 0.0 115.59 169.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -66.07 -38.83 89.29 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 115.26 1.578 . . . . 0.0 115.26 173.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -65.39 -43.88 89.25 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 115.467 1.654 . . . . 0.0 115.467 173.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -66.38 -43.15 86.71 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 114.464 1.283 . . . . 0.0 114.464 174.501 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 94.7 mt -69.8 -31.36 69.23 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 116.179 1.918 . . . . 0.0 116.179 173.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 89.7 p -61.67 -35.78 78.94 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-N 120.245 1.384 . . . . 0.0 114.433 168.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -63.2 -35.22 79.6 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 114.664 1.357 . . . . 0.0 114.664 168.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -63.57 120.88 12.59 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-O 122.23 1.014 . . . . 0.0 111.706 169.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 17.1 ptm180 -70.65 -18.08 62.85 Favored 'General case' 0 CA--C 1.567 1.623 0 N-CA-C 119.061 2.986 . . . . 0.0 119.061 -179.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 51.7 m80 -89.5 146.54 24.55 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-N 119.651 1.114 . . . . 0.0 113.455 -168.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -80.77 110.57 16.41 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.189 -1.411 . . . . 0.0 107.189 169.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 120.1 -17.45 9.88 Favored Glycine 0 CA--C 1.552 2.357 0 CA-C-O 117.347 -1.807 . . . . 0.0 116.043 -168.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.99 113.25 3.36 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-N 120.847 2.323 . . . . 0.0 112.964 -173.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -126.8 168.59 14.22 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 115.167 1.543 . . . . 0.0 115.167 -168.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.5 pp -149.8 134.6 17.75 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 167.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 53.7 mt -85.64 113.25 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 174.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 61.7 ttp85 -95.15 138.86 32.3 Favored 'General case' 0 N--CA 1.483 1.195 0 CA-C-N 114.203 -1.362 . . . . 0.0 110.02 175.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -84.4 125.98 32.81 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 169.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 50.7 m -67.06 128.51 36.62 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.709 0.804 . . . . 0.0 112.411 -169.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -65.76 -49.66 67.57 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 -173.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.4 t -63.96 -40.36 96.25 Favored 'General case' 0 CA--C 1.564 1.51 0 N-CA-C 115.563 1.69 . . . . 0.0 115.563 170.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -112.28 93.53 22.7 Favored Pre-proline 0 CA--C 1.564 1.511 0 CA-C-O 118.02 -0.99 . . . . 0.0 109.779 178.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.58 132.87 21.2 Favored 'Trans proline' 0 C--N 1.371 1.747 0 C-N-CA 123.132 2.555 . . . . 0.0 112.076 177.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 98.91 -34.81 5.08 Favored Glycine 0 CA--C 1.554 2.512 0 CA-C-O 119.055 -0.858 . . . . 0.0 114.464 -168.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -79.24 139.25 37.96 Favored 'General case' 0 N--CA 1.485 1.325 0 CA-C-N 118.529 1.164 . . . . 0.0 109.356 171.026 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -110.0 162.64 14.34 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 122.223 1.011 . . . . 0.0 111.305 -176.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 71.0 m -136.55 117.15 13.88 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 173.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 26.6 tp -79.71 106.62 11.87 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 124.254 1.022 . . . . 0.0 108.731 176.173 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.6 m -95.75 95.69 8.47 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 -170.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 17.6 t -112.08 122.0 65.57 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 -170.196 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -83.29 102.97 12.32 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 169.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -126.14 117.19 22.62 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 107.807 -1.182 . . . . 0.0 107.807 177.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 86.43 -106.35 3.09 Favored Glycine 0 N--CA 1.48 1.621 0 N-CA-C 110.547 -1.021 . . . . 0.0 110.547 -175.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 31.6 t30 -141.88 56.51 1.49 Allowed 'General case' 0 CA--C 1.566 1.574 0 C-N-CA 122.843 0.457 . . . . 0.0 109.999 169.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -158.92 133.2 7.82 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 178.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 56.6 t -91.85 109.94 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 173.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -106.43 115.67 30.62 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.795 0.838 . . . . 0.0 108.786 -169.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 18.4 m-70 -94.88 96.73 9.52 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 114.918 -1.037 . . . . 0.0 108.375 -172.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -94.32 122.13 36.56 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 -174.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -73.79 120.05 18.85 Favored 'General case' 0 N--CA 1.487 1.379 0 CA-C-O 121.445 0.64 . . . . 0.0 111.809 -169.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 76.9 t -97.35 101.4 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 N-CA-C 105.658 -1.979 . . . . 0.0 105.658 175.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -100.13 149.51 23.44 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.284 0.634 . . . . 0.0 110.522 177.588 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 54.7 mtp180 -110.54 128.0 55.45 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 123.164 0.586 . . . . 0.0 110.316 -169.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . 0.277 4.2 p-10 -83.74 -68.64 0.7 Allowed 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 179.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -91.13 -114.56 1.83 Allowed Glycine 0 N--CA 1.482 1.734 0 CA-C-N 119.352 0.978 . . . . 0.0 112.189 -176.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -81.1 -71.65 0.46 Allowed 'General case' 0 N--CA 1.487 1.386 0 CA-C-O 118.357 -0.83 . . . . 0.0 110.607 173.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -134.7 68.1 0.54 Allowed Glycine 0 N--CA 1.48 1.607 0 CA-C-N 118.731 0.696 . . . . 0.0 112.28 169.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 2.3 mppt? -107.28 97.11 6.91 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 105.751 -1.944 . . . . 0.0 105.751 171.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -86.88 110.89 20.29 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 114.309 -1.314 . . . . 0.0 109.343 -169.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -130.56 136.2 48.67 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 121.319 0.58 . . . . 0.0 110.324 -173.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -128.27 -51.51 1.3 Allowed 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 124.067 0.947 . . . . 0.0 111.972 177.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 58.7 t90 -94.46 -79.6 0.42 Allowed 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 124.368 1.067 . . . . 0.0 110.331 -172.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 95.0 t -128.84 -77.77 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 -175.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 10.8 p -80.87 138.86 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 C-N-CA 123.508 0.723 . . . . 0.0 111.362 -172.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.77 147.71 31.74 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 121.648 0.737 . . . . 0.0 112.511 179.309 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -124.26 108.81 12.64 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 -169.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 17.7 p30 -55.79 -30.38 61.24 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 118.195 2.665 . . . . 0.0 118.195 177.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 30.9 t -124.97 146.3 49.46 Favored 'General case' 0 N--CA 1.484 1.237 0 CA-C-O 121.942 0.877 . . . . 0.0 111.436 -177.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 89.6 mt -83.77 103.56 13.16 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 105.356 -2.091 . . . . 0.0 105.356 168.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . 0.273 28.5 t-20 145.98 -57.79 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 104.53 -2.396 . . . . 0.0 104.53 -168.557 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -56.91 -42.44 79.93 Favored 'General case' 0 CA--C 1.574 1.868 0 C-N-CA 124.26 1.024 . . . . 0.0 113.597 168.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 8.4 tt -55.46 -49.44 72.48 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 114.888 1.44 . . . . 0.0 114.888 169.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . 0.276 3.6 m -63.43 -51.47 70.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 CA-C-N 119.224 0.92 . . . . 0.0 113.223 178.188 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -64.67 -33.56 76.24 Favored 'General case' 0 CA--C 1.568 1.664 0 N-CA-C 115.182 1.549 . . . . 0.0 115.182 -176.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 69.2 t80 -62.12 -59.33 5.22 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-N 119.749 1.159 . . . . 0.0 112.826 169.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 60.7 m-70 -68.94 -9.38 51.7 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 117.906 2.558 . . . . 0.0 117.906 178.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 54.5 ttm-85 -53.76 -31.42 48.55 Favored 'General case' 0 CA--C 1.574 1.868 0 N-CA-C 115.074 1.509 . . . . 0.0 115.074 168.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 70.9 m -116.49 -24.32 7.9 Favored 'General case' 0 CA--C 1.57 1.716 0 C-N-CA 125.071 1.348 . . . . 0.0 114.216 169.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 61.0 m -90.13 151.67 21.48 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-N 120.837 1.653 . . . . 0.0 110.577 177.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 32.2 t -68.35 129.09 38.88 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 178.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 35.1 t -71.42 -48.79 51.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 CA-C-O 118.296 -0.859 . . . . 0.0 111.95 172.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 15.7 p -91.08 168.41 11.66 Favored 'General case' 0 N--CA 1.487 1.411 0 CA-C-N 119.235 0.925 . . . . 0.0 112.122 -179.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 30.7 mmt180 -72.11 -58.42 3.44 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 177.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 23.8 t30 -75.64 -61.72 1.82 Allowed 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 65.3 mt-30 -79.95 150.35 30.53 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 118.638 0.654 . . . . 0.0 112.225 -175.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -83.09 121.37 26.95 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 122.843 0.457 . . . . 0.0 110.553 169.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 3.6 mp -123.64 108.82 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 104.248 -2.501 . . . . 0.0 104.248 172.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 18.3 m-30 -113.93 108.19 16.71 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 105.771 -1.937 . . . . 0.0 105.771 179.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . 0.35 1.0 OUTLIER -76.15 170.27 16.62 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 116.381 1.993 . . . . 0.0 116.381 -169.15 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 3.9 tmt_? -160.04 138.22 10.16 Favored 'General case' 0 CA--C 1.56 1.355 0 N-CA-C 104.621 -2.362 . . . . 0.0 104.621 -169.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -67.8 172.39 5.42 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.115 -1.616 . . . . 0.0 114.248 178.353 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 18.3 pt -70.62 156.91 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 O-C-N 120.883 -1.136 . . . . 0.0 113.184 -175.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 . . . . . 0 N--CA 1.489 1.486 0 CA-C-O 122.859 1.314 . . . . 0.0 109.869 176.554 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 62.9 p-90 . . . . . 0 N--CA 1.493 1.678 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 44.6 t80 -82.79 137.82 34.22 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 120.249 1.386 . . . . 0.0 111.799 -173.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -118.64 -73.2 0.65 Allowed 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.43 176.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 108.32 84.85 1.67 Allowed Glycine 0 N--CA 1.481 1.697 0 CA-C-N 118.923 0.783 . . . . 0.0 111.397 -176.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . 0.304 33.0 ttmt 64.98 79.98 0.24 Allowed 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 125.179 1.392 . . . . 0.0 114.109 178.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 17.8 pt -126.14 157.79 68.58 Favored Pre-proline 0 CA--C 1.579 2.083 0 C-N-CA 124.257 1.023 . . . . 0.0 109.396 171.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -75.79 165.07 30.83 Favored 'Trans proline' 0 CA--C 1.564 1.976 0 C-N-CA 122.712 2.274 . . . . 0.0 115.092 -178.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 30.0 ttm180 -63.98 -45.49 88.85 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 115.913 1.82 . . . . 0.0 115.913 176.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.23 -46.42 87.0 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 115.337 1.606 . . . . 0.0 115.337 -179.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm -62.97 -34.71 78.09 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 115.265 1.58 . . . . 0.0 115.265 169.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.88 -42.66 90.04 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 115.442 1.645 . . . . 0.0 115.442 170.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -60.54 -44.91 95.58 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 115.212 1.56 . . . . 0.0 115.212 170.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -58.66 -50.76 72.69 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 114.979 1.474 . . . . 0.0 114.979 175.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -63.96 -49.15 73.68 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 114.708 1.373 . . . . 0.0 114.708 176.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 8.8 mp -71.02 -33.12 70.04 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 116.563 2.06 . . . . 0.0 116.563 -176.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 66.7 m -60.17 -33.09 71.71 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 116.08 1.882 . . . . 0.0 116.08 169.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 57.4 mtmt -64.1 -33.64 76.22 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 115.934 1.827 . . . . 0.0 115.934 169.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -64.5 127.01 29.66 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.62 1.168 . . . . 0.0 113.009 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -62.29 -21.47 65.26 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 119.042 2.978 . . . . 0.0 119.042 177.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 43.4 m80 -89.38 132.71 34.84 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 119.264 0.938 . . . . 0.0 111.09 -169.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -75.55 105.36 6.54 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 171.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 124.78 -7.78 8.25 Favored Glycine 0 CA--C 1.553 2.448 0 CA-C-O 116.91 -2.05 . . . . 0.0 116.523 -169.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.12 111.92 2.77 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 121.229 2.515 . . . . 0.0 111.968 -171.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 20.1 p90 -128.24 161.96 28.11 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 115.427 1.64 . . . . 0.0 115.427 -168.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.1 pp -139.69 136.06 33.84 Favored 'General case' 0 CA--C 1.555 1.14 0 CA-C-N 113.919 -1.491 . . . . 0.0 107.884 168.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 62.7 mt -97.13 106.5 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 169.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 46.7 ptt85 -95.45 157.18 16.01 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 114.45 -1.25 . . . . 0.0 110.324 169.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -85.06 135.87 33.81 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.431 -0.793 . . . . 0.0 109.163 169.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 93.3 p -68.67 121.9 17.41 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-O 121.026 0.441 . . . . 0.0 110.815 172.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -68.66 -39.37 80.69 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 116.684 2.105 . . . . 0.0 116.684 -175.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.5 t -63.1 -22.13 66.65 Favored 'General case' 0 CA--C 1.569 1.697 0 N-CA-C 115.864 1.802 . . . . 0.0 115.864 169.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -135.45 94.78 15.06 Favored Pre-proline 0 CA--C 1.563 1.446 0 CA-C-N 120.011 1.278 . . . . 0.0 109.027 177.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -70.33 134.06 25.93 Favored 'Trans proline' 0 C--N 1.372 1.795 0 C-N-CA 123.038 2.492 . . . . 0.0 111.933 176.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 101.31 -38.05 3.33 Favored Glycine 0 CA--C 1.555 2.574 0 CA-C-O 119.382 -0.676 . . . . 0.0 113.48 -168.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -79.46 130.91 35.86 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 118.182 0.991 . . . . 0.0 109.182 169.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -107.42 169.38 8.61 Favored 'General case' 0 N--CA 1.486 1.374 0 CA-C-O 122.439 1.114 . . . . 0.0 110.861 -178.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 69.4 m -141.65 117.64 10.56 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -179.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 31.2 tp -79.96 113.65 18.28 Favored 'General case' 0 CA--C 1.559 1.314 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 169.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 9.6 m -97.91 104.0 15.99 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 173.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.8 p -124.76 117.63 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 CA-C-N 118.964 0.802 . . . . 0.0 109.0 -171.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -74.62 140.0 44.01 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.931 169.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 15.8 t80 -157.0 95.12 1.48 Allowed 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 171.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 70.04 74.87 0.62 Allowed Glycine 0 CA--C 1.544 1.902 0 CA-C-O 119.421 -0.655 . . . . 0.0 114.64 -177.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . 0.366 9.7 t-20 78.62 -58.14 0.44 Allowed 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 116.664 2.098 . . . . 0.0 116.664 -179.026 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -91.16 142.85 27.3 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 123.898 0.879 . . . . 0.0 112.019 -169.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 41.6 t -102.27 113.21 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 N-CA-C 106.592 -1.632 . . . . 0.0 106.592 -178.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -96.83 117.99 32.29 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.897 0.879 . . . . 0.0 109.334 -176.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 10.5 m-70 -97.98 97.26 8.77 Favored 'General case' 0 CA--C 1.554 1.119 0 CA-C-N 114.991 -1.004 . . . . 0.0 108.443 -174.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -100.86 135.11 42.83 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 124.061 0.945 . . . . 0.0 109.11 -178.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 12.2 mmmm -79.44 125.34 29.42 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.858 -0.526 . . . . 0.0 111.957 -178.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 96.2 t -85.7 112.94 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 106.484 -1.672 . . . . 0.0 106.484 171.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -114.85 145.06 42.57 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.231 0.612 . . . . 0.0 110.528 -175.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -97.11 158.26 15.52 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -175.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -123.1 100.85 7.08 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 169.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 90.73 -112.72 4.14 Favored Glycine 0 CA--C 1.542 1.722 0 CA-C-O 120.082 -0.288 . . . . 0.0 113.417 176.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -84.75 -74.18 0.4 Allowed 'General case' 0 N--CA 1.488 1.462 0 CA-C-O 118.886 -0.578 . . . . 0.0 112.215 -173.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -148.22 74.36 0.28 Allowed Glycine 0 N--CA 1.479 1.518 0 N-CA-C 110.499 -1.04 . . . . 0.0 110.499 173.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -122.38 89.57 3.14 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 -177.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -80.02 115.61 19.69 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.791 -169.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 26.5 p90 -124.86 120.42 31.63 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 174.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -87.86 -59.94 2.1 Favored 'General case' 0 CA--C 1.562 1.424 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.086 169.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 39.3 t90 -80.25 -81.44 0.12 Allowed 'General case' 0 CA--C 1.56 1.343 0 C-N-CA 124.82 1.248 . . . . 0.0 110.383 -175.053 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.1 m -140.44 -53.76 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 C-N-CA 124.012 0.925 . . . . 0.0 110.937 176.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 3.4 m -79.78 140.85 16.14 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.458 0 C-N-CA 124.411 1.084 . . . . 0.0 112.096 -174.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.45 152.34 18.5 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 -171.047 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -146.22 119.91 9.2 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 -171.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -55.91 -40.46 73.09 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 116.575 2.065 . . . . 0.0 116.575 -177.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 27.1 t -102.63 153.07 20.46 Favored 'General case' 0 N--CA 1.485 1.321 0 CA-C-N 119.031 0.832 . . . . 0.0 111.483 174.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 82.9 mt -67.85 -32.64 73.31 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 169.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -64.26 -39.69 94.46 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 119.701 1.137 . . . . 0.0 113.803 170.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -60.56 -44.12 96.5 Favored 'General case' 0 CA--C 1.573 1.854 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 169.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 49.3 tp -55.5 -44.84 76.96 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 115.411 1.634 . . . . 0.0 115.411 169.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . 0.282 10.9 m -63.73 -51.5 69.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 CA-C-N 120.124 1.329 . . . . 0.0 113.232 175.11 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -63.34 -36.05 82.41 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 114.625 1.343 . . . . 0.0 114.625 -175.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 90.3 t80 -60.61 -52.72 63.97 Favored 'General case' 0 CA--C 1.57 1.733 0 CA-C-N 119.404 1.002 . . . . 0.0 112.03 168.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 50.7 m-70 -72.7 -9.13 58.27 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 118.728 2.862 . . . . 0.0 118.728 178.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 88.1 mtt-85 -59.84 -29.04 68.0 Favored 'General case' 0 CA--C 1.575 1.937 0 CA-C-N 120.156 1.344 . . . . 0.0 113.447 167.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 69.7 m -103.01 -39.57 6.85 Favored 'General case' 0 CA--C 1.569 1.696 0 C-N-CA 125.022 1.329 . . . . 0.0 113.094 168.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 34.3 m -90.53 156.38 18.21 Favored 'General case' 0 N--CA 1.498 1.94 0 CA-C-N 120.142 1.337 . . . . 0.0 112.031 -176.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 35.3 t -75.07 132.91 41.62 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 3.3 m -78.88 -38.39 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 114.976 1.472 . . . . 0.0 114.976 169.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 16.8 t -79.82 -40.12 29.25 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 116.61 2.078 . . . . 0.0 116.61 -169.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 15.9 tpt180 84.49 115.88 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 124.777 1.231 . . . . 0.0 108.903 -170.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . 0.351 59.2 m-80 83.62 -58.53 0.14 Allowed 'General case' 0 N--CA 1.499 2.017 0 C-N-CA 124.507 1.123 . . . . 0.0 112.604 -172.496 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 -79.57 126.63 31.13 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 170.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 76.3 mm-40 -90.1 96.03 10.48 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 -175.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 29.6 mm -111.68 109.4 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 105.787 -1.931 . . . . 0.0 105.787 -173.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -111.95 121.93 46.36 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 -173.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 10.5 mp -75.1 136.62 41.12 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 -168.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 81.7 mmt-85 -131.54 153.57 49.71 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 125.368 1.467 . . . . 0.0 108.381 178.468 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -79.31 157.39 27.71 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.822 -1.174 . . . . 0.0 112.798 -177.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 8.5 mt -69.35 146.68 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 C-N-CA 123.934 0.894 . . . . 0.0 109.886 -179.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 123.946 1.832 . . . . 0.0 108.149 178.726 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . 0.418 70.5 p-90 . . . . . 0 N--CA 1.5 2.071 0 N-CA-C 120.732 3.604 . . . . 0.0 120.732 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 44.4 t80 -96.95 131.6 43.59 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.78 0.832 . . . . 0.0 110.153 -169.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -107.73 -65.89 1.08 Allowed 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.352 173.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.04 77.66 1.31 Allowed Glycine 0 N--CA 1.482 1.744 0 CA-C-N 118.952 0.796 . . . . 0.0 112.375 -179.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . 0.298 61.9 tttt 71.24 71.74 0.18 Allowed 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 124.62 1.168 . . . . 0.0 113.936 175.049 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 14.9 pt -118.95 154.74 53.22 Favored Pre-proline 0 CA--C 1.576 1.959 0 C-N-CA 124.056 0.942 . . . . 0.0 109.069 170.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -75.71 172.65 15.91 Favored 'Trans proline' 0 CA--C 1.564 2.015 0 C-N-CA 122.702 2.268 . . . . 0.0 114.34 178.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 28.6 ttm180 -61.63 -43.86 98.07 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 115.915 1.82 . . . . 0.0 115.915 175.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -65.3 -43.38 91.29 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 115.805 1.78 . . . . 0.0 115.805 178.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -67.39 -32.54 73.51 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 115.362 1.615 . . . . 0.0 115.362 169.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.26 -42.14 88.95 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 115.328 1.603 . . . . 0.0 115.328 169.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -62.81 -42.4 99.7 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 114.346 1.239 . . . . 0.0 114.346 169.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -53.41 -48.07 69.03 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 115.395 1.628 . . . . 0.0 115.395 170.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 37.3 mmt -62.37 -48.32 80.31 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 173.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 88.8 mt -76.22 -9.82 58.93 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 117.775 2.509 . . . . 0.0 117.775 178.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 72.4 m -57.69 -38.73 75.71 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 115.875 1.805 . . . . 0.0 115.875 170.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -60.39 -33.27 72.24 Favored 'General case' 0 CA--C 1.571 1.778 0 N-CA-C 116.061 1.875 . . . . 0.0 116.061 169.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -71.7 111.46 6.99 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.165 0.986 . . . . 0.0 112.122 -171.511 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 13.4 ptp180 -74.28 -17.57 60.84 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 117.86 2.541 . . . . 0.0 117.86 173.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 48.4 m80 -89.63 137.29 32.45 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 119.248 0.931 . . . . 0.0 111.338 -168.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -77.56 115.23 17.15 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 122.951 0.5 . . . . 0.0 110.444 176.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 114.63 -23.19 12.27 Favored Glycine 0 CA--C 1.551 2.321 0 CA-C-O 117.269 -1.851 . . . . 0.0 116.246 -169.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.4 113.47 1.99 Allowed 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 120.66 2.23 . . . . 0.0 113.238 -176.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 27.3 p90 -130.18 165.07 23.11 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 115.828 1.788 . . . . 0.0 115.828 -168.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.0 pp -142.16 125.25 16.3 Favored 'General case' 0 CA--C 1.557 1.233 0 N-CA-C 106.803 -1.555 . . . . 0.0 106.803 168.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 59.9 mt -87.07 114.12 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 106.584 -1.636 . . . . 0.0 106.584 173.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 49.3 ptt85 -99.78 159.2 15.24 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-N 114.931 -1.031 . . . . 0.0 111.042 170.028 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -86.58 135.28 33.49 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 168.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 84.1 p -65.32 128.45 35.9 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-O 121.275 0.559 . . . . 0.0 111.733 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -62.46 -45.46 92.94 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 116.017 1.858 . . . . 0.0 116.017 -169.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 68.1 m -69.72 -33.15 72.09 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 116.053 1.871 . . . . 0.0 116.053 171.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -119.18 101.04 50.01 Favored Pre-proline 0 CA--C 1.563 1.469 0 CA-C-N 120.018 1.281 . . . . 0.0 110.939 -175.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -59.46 -32.16 95.92 Favored 'Trans proline' 0 C--N 1.369 1.655 0 N-CA-C 119.934 3.013 . . . . 0.0 119.934 174.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -87.23 44.82 3.33 Favored Glycine 0 CA--C 1.553 2.41 0 N-CA-C 115.247 0.859 . . . . 0.0 115.247 169.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -160.13 130.19 5.37 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 106.187 -1.783 . . . . 0.0 106.187 -178.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 -103.9 174.73 5.74 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 122.106 0.955 . . . . 0.0 111.181 172.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 62.0 m -149.03 120.4 7.88 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 -179.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 36.4 tp -79.93 110.51 15.37 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.803 0.841 . . . . 0.0 109.173 170.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.6 m -96.16 103.1 14.98 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 105.696 -1.964 . . . . 0.0 105.696 174.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.4 p -122.21 121.12 63.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 CA-C-O 121.471 0.653 . . . . 0.0 109.809 -169.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 58.1 tptt -82.68 98.63 9.15 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 124.32 1.048 . . . . 0.0 109.941 177.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -120.08 93.31 4.01 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -175.658 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 69.28 65.18 2.68 Favored Glycine 0 CA--C 1.544 1.845 0 N-CA-C 115.658 1.023 . . . . 0.0 115.658 175.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . 0.269 26.8 t30 54.78 41.83 31.63 Favored 'General case' 0 CA--C 1.574 1.903 0 N-CA-C 116.419 2.007 . . . . 0.0 116.419 -174.207 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -160.77 129.92 4.81 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.541 -0.724 . . . . 0.0 109.738 176.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 41.1 t -94.71 106.04 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 178.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -98.73 119.6 37.75 Favored 'General case' 0 N--CA 1.484 1.27 0 CA-C-O 121.704 0.764 . . . . 0.0 109.37 -177.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 13.0 m-70 -99.19 109.23 21.93 Favored 'General case' 0 CA--C 1.552 1.034 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 -176.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -114.49 127.94 56.07 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -176.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -74.29 132.32 41.98 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-O 121.785 0.802 . . . . 0.0 112.751 -177.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 92.9 t -101.97 103.99 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 N-CA-C 104.859 -2.274 . . . . 0.0 104.859 174.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -104.44 132.35 50.78 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.517 0.727 . . . . 0.0 110.129 -173.5 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -84.96 161.88 19.62 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 121.895 0.855 . . . . 0.0 112.306 -179.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 20.7 p-10 -79.69 -39.41 31.35 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 169.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -178.53 -79.09 0.06 OUTLIER Glycine 0 CA--C 1.539 1.586 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 -173.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -74.83 -69.34 0.47 Allowed 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 177.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -174.18 68.78 0.1 OUTLIER Glycine 0 N--CA 1.479 1.529 0 CA-C-N 118.874 0.761 . . . . 0.0 113.294 175.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -120.38 102.33 8.39 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 105.38 -2.082 . . . . 0.0 105.38 171.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -81.4 121.39 26.17 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.439 1.095 . . . . 0.0 110.488 -169.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 44.0 p90 -130.03 122.0 27.54 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 121.31 0.576 . . . . 0.0 109.616 174.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 5.0 tt -89.36 -65.2 1.04 Allowed 'General case' 0 N--CA 1.488 1.472 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.126 169.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 20.2 t90 -82.32 -61.78 1.8 Allowed 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 124.446 1.098 . . . . 0.0 112.55 -172.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . 0.258 11.2 p -149.76 -67.36 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 CA-C-N 118.849 0.75 . . . . 0.0 110.114 -178.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 3.4 m -79.64 141.91 14.68 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.419 0 C-N-CA 124.291 1.036 . . . . 0.0 112.301 -171.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 10.0 ptpp? -96.64 156.24 16.43 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -173.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -145.14 132.12 20.27 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.248 -169.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 -50.61 -41.73 55.16 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 117.922 2.564 . . . . 0.0 117.922 177.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 90.5 p -122.65 159.33 28.11 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-O 122.688 1.233 . . . . 0.0 111.877 178.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 61.3 mt -62.69 -31.91 72.9 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 115.186 1.551 . . . . 0.0 115.186 169.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -65.36 -36.09 82.96 Favored 'General case' 0 CA--C 1.571 1.755 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 169.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -63.26 -47.83 80.75 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-N 119.86 1.209 . . . . 0.0 113.707 169.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 60.5 tp -59.53 -38.61 81.45 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 115.724 1.75 . . . . 0.0 115.724 169.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . 0.265 0.3 OUTLIER -67.04 -53.9 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 CA-C-N 119.743 1.156 . . . . 0.0 113.251 -179.595 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -57.97 -33.83 69.3 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 115.454 1.65 . . . . 0.0 115.454 172.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -57.28 -55.45 34.62 Favored 'General case' 0 CA--C 1.566 1.579 0 CA-C-N 119.353 0.979 . . . . 0.0 113.021 168.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . 0.265 52.7 m-70 -74.72 -9.47 58.59 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 117.944 2.572 . . . . 0.0 117.944 177.379 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 94.2 mtt-85 -62.15 -33.35 74.33 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-N 120.883 1.674 . . . . 0.0 112.962 167.168 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 70.6 m -97.03 -40.15 8.99 Favored 'General case' 0 CA--C 1.563 1.476 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 170.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 60.7 m -90.8 154.03 19.81 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-N 120.093 1.315 . . . . 0.0 111.527 179.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 33.0 t -75.75 134.66 40.41 Favored 'General case' 0 CA--C 1.559 1.323 0 CA-C-O 121.462 0.648 . . . . 0.0 112.556 177.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 45.5 t -70.24 -48.29 62.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 CA-C-N 115.419 -0.81 . . . . 0.0 112.202 172.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 57.7 m -122.62 154.71 37.64 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-O 122.262 1.03 . . . . 0.0 110.721 -177.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 85.2 mtt85 -77.18 -39.88 47.32 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 115.171 1.545 . . . . 0.0 115.171 -177.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 22.2 m120 -74.58 -66.45 0.74 Allowed 'General case' 0 N--CA 1.495 1.82 0 CA-C-N 119.902 1.228 . . . . 0.0 111.876 174.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 35.7 mm-40 -80.07 126.02 30.53 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 118.909 0.777 . . . . 0.0 109.2 170.08 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 3.2 pm0 -94.43 86.46 4.86 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 123.018 0.527 . . . . 0.0 110.477 -176.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 4.0 mp -85.77 122.04 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -169.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -121.73 117.11 25.81 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 106.428 -1.694 . . . . 0.0 106.428 176.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 11.2 mp -70.85 134.4 47.29 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 -168.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 62.7 mmt-85 -132.28 162.71 30.31 Favored 'General case' 0 CA--C 1.564 1.515 0 C-N-CA 124.963 1.305 . . . . 0.0 109.221 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -76.33 158.89 31.05 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.907 -1.12 . . . . 0.0 113.801 176.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.1 pp -76.65 161.73 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -177.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 . . . . . 0 N--CA 1.484 1.262 0 CA-C-O 124.021 1.867 . . . . 0.0 108.096 177.618 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 1.6 p90 . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 116.248 1.944 . . . . 0.0 116.248 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 72.2 t80 -118.32 124.19 47.17 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 178.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -119.39 66.43 0.79 Allowed 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 121.272 0.558 . . . . 0.0 110.82 -179.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 53.59 -119.42 10.83 Favored Glycine 0 CA--C 1.547 2.065 0 N-CA-C 118.803 2.281 . . . . 0.0 118.803 169.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -141.56 96.53 3.0 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 -171.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.01 149.94 75.19 Favored Pre-proline 0 CA--C 1.572 1.815 0 CA-C-O 118.502 -0.761 . . . . 0.0 109.733 176.255 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -66.49 172.11 9.63 Favored 'Trans proline' 0 CA--C 1.563 1.956 0 C-N-CA 123.005 2.47 . . . . 0.0 114.556 172.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 59.2 ttt-85 -60.32 -41.9 94.48 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 116.08 1.882 . . . . 0.0 116.08 -177.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -66.08 -44.27 84.96 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 115.466 1.654 . . . . 0.0 115.466 176.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -63.24 -33.99 76.68 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 115.674 1.731 . . . . 0.0 115.674 170.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.47 -43.15 95.11 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 115.302 1.593 . . . . 0.0 115.302 169.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -61.22 -43.97 98.02 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 114.943 1.46 . . . . 0.0 114.943 170.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -57.18 -44.0 83.17 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 115.626 1.713 . . . . 0.0 115.626 173.095 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 37.9 mmt -63.04 -48.3 79.33 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 114.528 1.307 . . . . 0.0 114.528 172.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 95.1 mt -73.25 -12.12 60.75 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 117.518 2.414 . . . . 0.0 117.518 175.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 69.6 m -63.0 -37.85 88.82 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-N 120.507 1.503 . . . . 0.0 113.966 168.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt -60.59 -33.78 73.24 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 115.386 1.624 . . . . 0.0 115.386 169.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -71.2 117.04 12.22 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 124.478 1.111 . . . . 0.0 111.225 178.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -79.53 -17.39 54.15 Favored 'General case' 0 CA--C 1.569 1.677 0 N-CA-C 117.531 2.419 . . . . 0.0 117.531 172.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 45.8 m80 -89.53 133.22 34.69 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 119.198 0.908 . . . . 0.0 111.929 -168.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -71.63 123.31 22.22 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 122.953 0.501 . . . . 0.0 110.833 174.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 107.8 -20.22 31.95 Favored Glycine 0 CA--C 1.549 2.179 0 CA-C-O 117.576 -1.68 . . . . 0.0 116.51 -169.257 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.69 123.06 19.07 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-N 120.192 1.996 . . . . 0.0 111.746 -173.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 24.7 p90 -137.36 158.13 45.08 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -168.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.3 pp -137.47 127.99 26.68 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 168.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 74.1 mt -87.64 113.6 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 105.62 -1.993 . . . . 0.0 105.62 175.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 4.1 ptm180 -90.05 149.96 22.29 Favored 'General case' 0 N--CA 1.484 1.27 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.065 170.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -85.87 128.43 34.82 Favored 'General case' 0 CA--C 1.56 1.33 0 N-CA-C 106.795 -1.558 . . . . 0.0 106.795 168.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 50.3 m -65.01 132.61 49.7 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 -169.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -64.67 -50.98 64.92 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 114.666 1.358 . . . . 0.0 114.666 -174.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 95.9 p -65.09 -38.95 92.39 Favored 'General case' 0 CA--C 1.562 1.441 0 N-CA-C 116.083 1.883 . . . . 0.0 116.083 169.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -114.73 95.16 39.98 Favored Pre-proline 0 CA--C 1.563 1.474 0 CA-C-N 119.66 1.118 . . . . 0.0 109.553 -179.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -72.39 135.09 23.84 Favored 'Trans proline' 0 C--N 1.371 1.749 0 C-N-CA 123.068 2.512 . . . . 0.0 112.215 178.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 97.41 -40.49 2.52 Favored Glycine 0 CA--C 1.552 2.383 0 CA-C-O 119.308 -0.718 . . . . 0.0 113.627 -168.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -79.12 131.4 36.22 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 124.076 0.95 . . . . 0.0 109.168 176.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -100.54 168.52 9.67 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 122.102 0.953 . . . . 0.0 111.847 -170.363 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 58.8 m -147.31 123.62 10.93 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 174.106 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 26.8 tp -79.95 108.47 13.55 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.078 0.951 . . . . 0.0 109.635 175.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.2 m -91.38 107.26 19.08 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 106.12 -1.808 . . . . 0.0 106.12 172.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.2 p -131.06 116.11 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 -170.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.19 113.92 20.35 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.334 175.422 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -132.95 116.39 16.38 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 177.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 89.48 -83.33 1.41 Allowed Glycine 0 N--CA 1.481 1.654 0 CA-C-N 116.243 -0.435 . . . . 0.0 112.063 -179.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 10.6 p30 -138.62 -26.4 0.88 Allowed 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 115.533 1.679 . . . . 0.0 115.533 170.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -98.05 142.42 29.77 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 124.051 0.94 . . . . 0.0 110.668 -171.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 47.8 t -85.64 110.01 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 N-CA-C 106.533 -1.654 . . . . 0.0 106.533 172.061 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 61.9 mt-30 -104.42 113.92 27.8 Favored 'General case' 0 N--CA 1.484 1.26 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.002 -169.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 16.8 m-70 -96.26 102.49 14.28 Favored 'General case' 0 CA--C 1.553 1.071 0 CA-C-N 114.766 -1.106 . . . . 0.0 108.262 -174.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -106.78 123.24 47.85 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 -179.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 43.6 mtpt -77.2 122.95 25.76 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 121.687 0.756 . . . . 0.0 112.101 -169.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 98.7 t -92.35 96.94 6.66 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.591 0 N-CA-C 105.026 -2.213 . . . . 0.0 105.026 177.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 62.1 mt -90.52 135.65 33.56 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 -168.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 27.1 mtp-105 -87.42 144.01 26.96 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 122.014 0.912 . . . . 0.0 112.888 176.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -86.57 -53.67 4.84 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-N 114.474 -1.239 . . . . 0.0 114.304 176.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -165.71 -86.08 0.06 OUTLIER Glycine 0 N--CA 1.48 1.628 0 CA-C-N 119.895 1.225 . . . . 0.0 113.287 -173.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -68.29 -63.79 0.99 Allowed 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 114.531 1.308 . . . . 0.0 114.531 -172.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -161.97 13.75 0.13 Allowed Glycine 0 CA--C 1.552 2.398 0 N-CA-C 116.728 1.451 . . . . 0.0 116.728 170.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -91.96 150.58 20.93 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-N 119.204 1.502 . . . . 0.0 109.084 177.494 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -137.98 137.11 37.59 Favored 'General case' 0 N--CA 1.487 1.411 0 CA-C-N 114.944 -1.026 . . . . 0.0 109.517 -174.774 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -123.73 122.55 38.38 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 124.764 1.226 . . . . 0.0 108.693 -172.011 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 60.7 tp -100.6 -56.96 2.21 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.028 169.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 84.6 t90 -133.43 103.66 6.05 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 -174.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . 0.405 22.3 t 78.74 -82.8 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 C-N-CA 124.155 0.982 . . . . 0.0 111.982 171.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 16.9 m -81.37 140.72 16.16 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.399 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -169.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -90.14 138.45 31.51 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.49 0.662 . . . . 0.0 111.106 169.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -172.25 139.5 1.05 Allowed 'General case' 0 N--CA 1.488 1.454 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.623 -169.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -79.47 74.91 6.09 Favored 'General case' 0 N--CA 1.501 2.086 0 CA-C-O 123.76 1.743 . . . . 0.0 109.784 170.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.409 ' CB ' ' HB2' ' A' ' 130' ' ' GLU . 89.3 p -102.94 63.76 0.83 Allowed 'General case' 0 CA--C 1.554 1.122 1 N-CA-C 124.09 4.848 . . . . 0.0 124.09 -166.501 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 75.7 mt -101.52 86.62 3.0 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 104.224 -2.51 . . . . 0.0 104.224 167.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . 0.261 25.0 t-20 133.99 -61.05 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.045 0 C-N-CA 127.39 2.276 . . . . 0.0 105.479 -167.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.409 ' HB2' ' CB ' ' A' ' 127' ' ' SER . 11.8 mm-40 -56.09 -45.58 79.34 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 115.367 1.617 . . . . 0.0 115.367 177.48 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 15.7 tp -66.44 -37.79 85.95 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 177.13 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 44.7 t -58.4 -65.38 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 C-N-CA 124.585 1.154 . . . . 0.0 111.548 174.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -66.73 -35.56 80.4 Favored 'General case' 0 CA--C 1.569 1.677 0 N-CA-C 114.826 1.417 . . . . 0.0 114.826 -173.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -58.59 -59.42 5.42 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 124.419 1.088 . . . . 0.0 113.649 169.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -74.83 -8.56 56.8 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 117.872 2.545 . . . . 0.0 117.872 177.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 46.1 ttm-85 -52.32 -30.83 30.23 Favored 'General case' 0 CA--C 1.577 1.992 0 N-CA-C 114.818 1.414 . . . . 0.0 114.818 168.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 68.0 m -105.05 -40.94 5.72 Favored 'General case' 0 CA--C 1.569 1.673 0 C-N-CA 124.995 1.318 . . . . 0.0 113.037 168.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 53.7 m -90.51 150.58 21.72 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-N 120.199 1.363 . . . . 0.0 111.859 -176.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 21.7 t -80.63 133.68 35.78 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.107 -0.995 . . . . 0.0 112.828 -178.13 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 8.3 m -66.62 -42.65 90.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 115.398 1.629 . . . . 0.0 115.398 170.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 14.3 t -112.65 -45.56 3.22 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 -174.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . 0.302 80.3 mtm180 77.15 71.98 0.06 Allowed 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 125.337 1.455 . . . . 0.0 110.64 -169.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . 0.269 14.4 p-10 -149.58 -65.91 0.22 Allowed 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.996 -1.112 . . . . 0.0 107.996 173.271 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 -96.29 7.42 46.5 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 115.531 1.678 . . . . 0.0 115.531 169.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 83.0 mm-40 56.73 70.31 0.66 Allowed 'General case' 0 N--CA 1.495 1.821 0 C-N-CA 125.196 1.399 . . . . 0.0 111.945 -169.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 5.0 mp -85.68 116.68 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 -169.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -118.64 137.87 52.99 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-N 115.125 -0.943 . . . . 0.0 108.965 -174.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 11.1 mp -83.92 115.84 22.49 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 -168.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -122.97 150.62 42.75 Favored 'General case' 0 CA--C 1.563 1.457 0 C-N-CA 125.437 1.495 . . . . 0.0 109.322 179.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -74.28 156.5 37.12 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.737 -1.227 . . . . 0.0 113.23 178.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.1 pp -72.82 164.51 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 -171.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 . . . . . 0 N--CA 1.485 1.281 0 CA-C-O 123.953 1.835 . . . . 0.0 108.394 179.029 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 1.2 p90 . . . . . 0 N--CA 1.488 1.438 0 N-CA-C 116.167 1.914 . . . . 0.0 116.167 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -80.82 117.82 21.8 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-N 121.466 1.939 . . . . 0.0 109.788 179.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -129.76 94.39 3.73 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 104.942 -2.244 . . . . 0.0 104.942 174.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -77.49 125.45 7.32 Favored Glycine 0 CA--C 1.54 1.609 0 C-N-CA 123.156 0.408 . . . . 0.0 113.577 -170.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . 0.376 64.5 pttt 52.9 63.48 2.22 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 115.335 1.606 . . . . 0.0 115.335 -175.378 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -107.95 127.21 28.08 Favored Pre-proline 0 CA--C 1.574 1.897 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 -173.617 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -68.88 160.91 47.85 Favored 'Trans proline' 0 CA--C 1.56 1.785 0 C-N-CA 123.156 2.571 . . . . 0.0 115.574 -172.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 16.1 ttm180 -73.33 -35.8 66.09 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 117.327 2.343 . . . . 0.0 117.327 -170.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.75 -41.6 97.98 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 115.401 1.63 . . . . 0.0 115.401 169.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -68.27 -40.99 81.7 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 114.497 1.295 . . . . 0.0 114.497 169.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.71 -41.36 98.12 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 115.271 1.582 . . . . 0.0 115.271 172.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -67.13 -44.67 79.27 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 170.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -53.01 -38.88 62.71 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 116.085 1.883 . . . . 0.0 116.085 171.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.51 -62.63 1.56 Allowed 'General case' 0 CA--C 1.566 1.568 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 169.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.1 mp -70.0 -50.71 38.82 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 117.411 2.374 . . . . 0.0 117.411 -168.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 60.2 p -60.3 -34.26 73.52 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 115.921 1.823 . . . . 0.0 115.921 174.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -72.63 -30.54 64.41 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 115.644 1.72 . . . . 0.0 115.644 170.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -50.72 133.23 26.14 Favored 'General case' 0 CA--C 1.556 1.19 0 N-CA-C 114.977 1.473 . . . . 0.0 114.977 176.681 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.12 -23.49 62.17 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 118.613 2.82 . . . . 0.0 118.613 174.159 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 42.9 m80 -89.43 131.51 35.45 Favored 'General case' 0 N--CA 1.484 1.225 0 CA-C-N 119.23 0.923 . . . . 0.0 110.667 -169.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -80.99 102.22 10.03 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 174.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 124.02 4.86 7.7 Favored Glycine 0 CA--C 1.552 2.405 0 CA-C-O 116.652 -2.193 . . . . 0.0 115.991 -168.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.02 116.26 6.95 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-N 121.682 2.741 . . . . 0.0 112.913 -169.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -129.8 161.41 30.8 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 118.135 2.643 . . . . 0.0 118.135 -168.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.8 pp -144.09 154.11 42.86 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 114.126 -1.397 . . . . 0.0 109.422 168.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.0 mp -112.67 124.05 68.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 178.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -90.36 167.49 12.61 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 124.477 1.111 . . . . 0.0 112.199 174.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -129.15 116.11 18.71 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 106.139 -1.801 . . . . 0.0 106.139 169.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 64.7 m -76.85 134.73 38.94 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -170.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -74.62 -56.51 4.74 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-N 115.415 -0.811 . . . . 0.0 112.999 178.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.5 t -61.43 -39.56 91.23 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 116.068 1.877 . . . . 0.0 116.068 177.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -102.92 99.76 14.82 Favored Pre-proline 0 CA--C 1.565 1.523 0 CA-C-O 117.83 -1.081 . . . . 0.0 108.647 170.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -75.22 126.95 10.16 Favored 'Trans proline' 0 C--N 1.371 1.712 0 C-N-CA 123.016 2.477 . . . . 0.0 112.545 -175.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 82.2 6.62 88.63 Favored Glycine 0 CA--C 1.555 2.57 0 N-CA-C 118.189 2.036 . . . . 0.0 118.189 -169.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -98.12 116.54 30.56 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-N 119.813 1.806 . . . . 0.0 107.302 171.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -99.0 151.25 21.13 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.787 -0.819 . . . . 0.0 108.787 -178.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 43.2 m -132.93 112.4 11.84 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.505 -0.747 . . . . 0.0 110.175 -175.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 26.4 tp -79.3 105.77 10.85 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-O 121.967 0.889 . . . . 0.0 108.979 174.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 15.4 m -89.44 93.6 9.57 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 173.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.9 p -112.08 125.95 69.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 -174.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -77.16 129.15 35.59 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 114.813 -1.085 . . . . 0.0 111.049 173.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -137.75 114.65 10.68 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 87.22 -92.37 1.8 Allowed Glycine 0 N--CA 1.481 1.687 0 N-CA-C 112.056 -0.418 . . . . 0.0 112.056 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 10.8 p-10 -130.44 -22.48 2.74 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 115.434 1.642 . . . . 0.0 115.434 169.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -108.49 146.34 33.34 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 124.484 1.114 . . . . 0.0 110.251 -173.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 9.7 p -84.76 123.63 39.28 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.537 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.101 179.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -109.86 122.68 48.09 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 124.093 0.957 . . . . 0.0 108.901 -178.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 12.0 m-70 -103.73 96.37 6.66 Favored 'General case' 0 CA--C 1.555 1.14 0 CA-C-O 121.804 0.812 . . . . 0.0 108.864 -169.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -92.31 141.64 28.34 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 124.431 1.092 . . . . 0.0 110.233 -177.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -96.05 114.73 26.47 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.429 0.633 . . . . 0.0 110.369 -176.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 81.5 t -84.07 124.29 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 174.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 55.0 mt -102.12 136.13 42.49 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.014 -176.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 36.4 mtm180 -108.89 129.87 55.42 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 122.715 0.406 . . . . 0.0 110.368 176.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -97.31 103.32 15.24 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 123.165 0.586 . . . . 0.0 110.555 176.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 90.3 -110.7 3.81 Favored Glycine 0 N--CA 1.481 1.661 0 CA-C-O 120.072 -0.293 . . . . 0.0 113.325 174.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -79.95 -69.49 0.58 Allowed 'General case' 0 N--CA 1.487 1.419 0 CA-C-O 118.762 -0.637 . . . . 0.0 112.53 -176.127 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -159.05 75.03 0.21 Allowed Glycine 0 N--CA 1.477 1.424 0 CA-C-N 118.661 0.664 . . . . 0.0 111.581 171.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -117.63 91.37 3.55 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 -173.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -79.53 115.0 18.89 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 123.82 0.848 . . . . 0.0 111.686 -168.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -131.23 130.62 43.15 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.595 0.758 . . . . 0.0 109.041 177.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 41.8 tp -95.25 -54.76 3.3 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 118.548 -0.739 . . . . 0.0 110.38 169.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 45.2 m0 -74.7 -86.68 0.04 OUTLIER 'General case' 0 CA--C 1.565 1.553 0 CA-C-N 119.359 0.981 . . . . 0.0 110.537 173.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 10.0 m -145.06 -47.53 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 C-N-CA 124.56 1.144 . . . . 0.0 111.107 -175.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 14.0 p -79.54 130.85 35.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 CA-C-N 119.217 0.917 . . . . 0.0 110.212 -175.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.21 161.04 15.9 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-O 122.605 1.193 . . . . 0.0 114.205 -170.615 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -148.31 114.34 5.8 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 105.021 -2.215 . . . . 0.0 105.021 -170.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -57.84 -24.38 57.16 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 119.198 3.036 . . . . 0.0 119.198 -169.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 78.8 p -125.93 165.51 18.62 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-N 120.543 1.52 . . . . 0.0 113.096 179.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 33.0 mt -52.04 -47.69 64.93 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 115.23 1.567 . . . . 0.0 115.23 169.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 18.7 m-80 -63.12 -43.69 97.73 Favored 'General case' 0 CA--C 1.564 1.516 0 N-CA-C 114.071 1.137 . . . . 0.0 114.071 174.048 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -58.94 -50.81 72.66 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 115.388 1.625 . . . . 0.0 115.388 177.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 58.4 tp -61.32 -49.04 78.59 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-N 120.019 1.281 . . . . 0.0 114.237 174.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . 0.311 1.6 p -69.96 -37.5 72.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 -178.125 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -61.55 -34.55 75.76 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-N 119.976 1.262 . . . . 0.0 113.597 168.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 45.8 t80 -58.13 -54.07 51.07 Favored 'General case' 0 CA--C 1.569 1.673 0 CA-C-O 117.546 -1.216 . . . . 0.0 111.984 167.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . 0.347 21.9 m-70 -71.66 -8.99 57.54 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 118.69 2.848 . . . . 0.0 118.69 173.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 55.1 mtp85 -75.94 -22.06 56.37 Favored 'General case' 0 CA--C 1.576 1.958 0 CA-C-N 119.876 1.217 . . . . 0.0 112.926 167.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 70.6 m -100.73 -46.31 5.2 Favored 'General case' 0 CA--C 1.565 1.554 0 C-N-CA 125.005 1.322 . . . . 0.0 112.962 169.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 91.3 m -86.21 154.32 21.38 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 124.948 1.299 . . . . 0.0 110.121 173.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.641 ' HG ' ' HA ' ' A' ' 145' ' ' GLN . 27.4 t -80.48 148.02 30.64 Favored 'General case' 0 N--CA 1.483 1.203 0 O-C-N 121.131 -0.981 . . . . 0.0 113.238 177.376 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 77.1 t -75.17 -54.02 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 168.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 34.2 t -87.77 104.05 16.2 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-N 118.909 0.777 . . . . 0.0 109.071 174.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . 0.273 0.2 OUTLIER -59.95 -40.39 88.85 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 117.711 2.486 . . . . 0.0 117.711 -175.722 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -72.1 -63.5 1.13 Allowed 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 177.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -94.09 104.24 16.28 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 172.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . 0.641 ' HA ' ' HG ' ' A' ' 139' ' ' SER . 64.0 mt-30 -77.45 115.28 17.09 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 -168.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -120.82 133.45 67.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 179.278 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -119.15 153.47 34.83 Favored 'General case' 0 N--CA 1.497 1.875 0 CA-C-O 121.88 0.848 . . . . 0.0 111.337 -170.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 9.5 mp -88.05 143.66 26.95 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 -169.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 29.1 mmm180 -132.87 142.91 49.18 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 124.929 1.292 . . . . 0.0 109.175 -179.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -76.1 143.37 41.31 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.379 -0.826 . . . . 0.0 111.285 176.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 25.0 pt -62.82 146.32 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 -176.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 . . . . . 0 N--CA 1.484 1.261 0 CA-C-O 123.91 1.814 . . . . 0.0 109.435 175.799 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 1.6 p90 . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 118.499 -0.762 . . . . 0.0 111.976 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -82.09 124.76 30.12 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-N 119.931 1.241 . . . . 0.0 110.101 -179.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -128.59 75.14 1.61 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 123.473 0.483 . . . . 0.0 110.253 -175.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 59.05 -114.58 6.26 Favored Glycine 0 N--CA 1.485 1.937 0 C-N-CA 123.873 0.749 . . . . 0.0 114.817 173.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -144.99 111.45 5.69 Favored 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 169.157 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 43.2 pt -122.99 152.2 62.6 Favored Pre-proline 0 CA--C 1.572 1.821 0 CA-C-O 118.525 -0.75 . . . . 0.0 110.476 -179.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -58.78 165.56 7.98 Favored 'Trans proline' 0 CA--C 1.56 1.777 0 C-N-CA 123.4 2.733 . . . . 0.0 116.745 171.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 25.7 ttm180 -62.92 -40.67 98.32 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 114.898 1.444 . . . . 0.0 114.898 169.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -62.56 -41.14 98.72 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 115.728 1.751 . . . . 0.0 115.728 170.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 3.1 tppp? -64.79 -37.63 88.25 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 115.201 1.556 . . . . 0.0 115.201 169.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.91 -41.68 91.12 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 115.682 1.734 . . . . 0.0 115.682 171.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -64.65 -38.78 92.16 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 114.816 1.413 . . . . 0.0 114.816 169.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -60.57 -52.83 63.49 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 114.509 1.3 . . . . 0.0 114.509 172.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 40.4 tpp -61.11 -44.07 97.92 Favored 'General case' 0 CA--C 1.564 1.492 0 N-CA-C 115.793 1.775 . . . . 0.0 115.793 175.386 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 92.6 mt -72.6 -20.72 61.24 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 116.616 2.08 . . . . 0.0 116.616 172.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 22.9 t -60.24 -37.6 80.88 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-N 121.079 1.763 . . . . 0.0 113.497 168.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -59.42 -37.17 77.36 Favored 'General case' 0 CA--C 1.57 1.737 0 N-CA-C 114.525 1.306 . . . . 0.0 114.525 168.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -69.12 114.36 7.32 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 124.322 1.049 . . . . 0.0 110.855 170.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 -76.24 -13.44 60.17 Favored 'General case' 0 CA--C 1.569 1.708 0 N-CA-C 117.816 2.524 . . . . 0.0 117.816 173.326 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 46.3 m80 -89.72 143.82 26.49 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 -168.402 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -71.79 130.84 42.07 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-N 114.448 -1.251 . . . . 0.0 110.818 170.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.92 -18.62 46.57 Favored Glycine 0 CA--C 1.552 2.377 0 N-CA-C 118.239 2.055 . . . . 0.0 118.239 -172.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.13 119.38 10.73 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-N 120.399 2.1 . . . . 0.0 112.345 -176.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 22.2 p90 -128.56 157.51 41.03 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 114.815 1.413 . . . . 0.0 114.815 -168.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.8 pp -138.05 139.33 39.51 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 168.239 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 70.3 mt -98.16 117.86 43.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 106.316 -1.735 . . . . 0.0 106.316 177.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 3.0 ptm180 -97.94 149.2 22.67 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.319 0.648 . . . . 0.0 111.481 170.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -96.35 137.86 34.8 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 168.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 67.4 m -69.9 138.92 52.86 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-O 121.637 0.732 . . . . 0.0 112.694 -176.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -70.69 -53.71 14.63 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 -174.075 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.0 t -62.99 -37.33 86.73 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 115.916 1.821 . . . . 0.0 115.916 172.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -121.01 92.9 48.75 Favored Pre-proline 0 CA--C 1.562 1.441 0 CA-C-N 119.635 1.107 . . . . 0.0 110.102 175.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -62.59 132.53 38.31 Favored 'Trans proline' 0 C--N 1.371 1.742 0 C-N-CA 123.361 2.707 . . . . 0.0 113.25 170.02 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 105.0 -33.73 6.34 Favored Glycine 0 CA--C 1.551 2.302 0 CA-C-O 118.697 -1.057 . . . . 0.0 114.543 -168.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -79.68 108.51 13.28 Favored 'General case' 0 N--CA 1.486 1.348 0 CA-C-N 119.427 1.614 . . . . 0.0 108.484 174.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 5.0 m-30 -93.93 158.65 15.54 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 121.716 0.77 . . . . 0.0 110.451 -174.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 74.6 m -139.81 115.48 10.1 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 176.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 36.4 tp -81.19 107.35 13.91 Favored 'General case' 0 CA--C 1.561 1.368 0 C-N-CA 124.907 1.283 . . . . 0.0 109.687 179.015 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.8 m -95.5 105.53 17.51 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 -174.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 31.9 t -117.57 123.67 72.04 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.171 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 -171.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 12.9 tmtt? -89.24 89.37 7.89 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 123.088 0.555 . . . . 0.0 110.203 178.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -105.49 108.22 19.62 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -177.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 86.95 -98.75 2.39 Favored Glycine 0 N--CA 1.479 1.556 0 N-CA-C 111.435 -0.666 . . . . 0.0 111.435 177.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 12.4 p30 -138.44 44.1 2.12 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 123.178 0.591 . . . . 0.0 112.384 169.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -152.84 134.62 14.63 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 -177.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 57.3 t -95.23 109.85 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 106.298 -1.741 . . . . 0.0 106.298 177.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 60.6 mt-30 -109.11 114.83 28.89 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-O 121.909 0.861 . . . . 0.0 109.306 -169.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -94.15 119.64 33.26 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 114.636 -1.166 . . . . 0.0 109.168 -172.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -118.03 119.33 34.47 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 -174.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -75.5 108.31 8.23 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 -169.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 86.6 t -84.04 117.56 29.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 -178.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 54.5 mt -100.78 137.82 38.66 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.139 -174.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 56.4 mtp180 -109.72 126.37 53.65 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 -179.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . 0.262 3.0 p30 -79.91 -56.94 3.9 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 114.463 1.283 . . . . 0.0 114.463 -179.031 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 179.16 137.86 3.06 Favored Glycine 0 CA--C 1.54 1.632 0 CA-C-N 119.607 1.094 . . . . 0.0 112.759 -176.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . 0.347 . . 80.6 -77.89 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 124.98 1.312 . . . . 0.0 112.497 -178.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -165.96 72.79 0.17 Allowed Glycine 0 N--CA 1.478 1.483 0 N-CA-C 111.696 -0.562 . . . . 0.0 111.696 171.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -126.47 162.22 26.11 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 124.169 0.988 . . . . 0.0 109.93 -178.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -143.99 114.97 7.84 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 -176.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -124.98 123.19 39.35 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 175.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -110.33 -58.79 2.03 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 123.77 0.828 . . . . 0.0 110.621 173.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 8.4 t90 -98.66 -62.97 1.17 Allowed 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 124.076 0.95 . . . . 0.0 112.893 -168.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 30.7 m -129.66 -56.38 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 CA-C-N 119.085 0.857 . . . . 0.0 112.41 -175.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 9.9 p -118.93 161.29 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 CA-C-O 122.278 1.037 . . . . 0.0 111.485 -169.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.52 153.04 29.84 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-O 122.025 0.917 . . . . 0.0 113.121 175.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -142.88 120.69 11.93 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 -175.22 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -59.45 -59.74 4.96 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -175.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 83.6 p -89.58 155.56 19.18 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-O 122.542 1.163 . . . . 0.0 112.378 175.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 10.3 tp -63.01 -33.0 74.49 Favored 'General case' 0 CA--C 1.568 1.661 0 N-CA-C 115.019 1.489 . . . . 0.0 115.019 170.05 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -63.35 -36.77 84.81 Favored 'General case' 0 CA--C 1.569 1.705 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 169.053 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.13 -42.1 94.17 Favored 'General case' 0 N--CA 1.497 1.875 0 CA-C-N 120.622 1.555 . . . . 0.0 114.17 169.758 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 16.8 tp -57.13 -46.89 82.31 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 169.101 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 45.4 t -59.17 -58.2 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 C-N-CA 124.385 1.074 . . . . 0.0 112.878 173.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -60.74 -32.11 71.4 Favored 'General case' 0 CA--C 1.567 1.632 0 N-CA-C 115.655 1.724 . . . . 0.0 115.655 -175.076 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -60.68 -57.8 11.18 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-N 119.665 1.12 . . . . 0.0 112.877 169.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 81.8 m-70 -72.85 -8.91 57.77 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 117.891 2.552 . . . . 0.0 117.891 176.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 50.5 ttm-85 -58.59 -31.71 68.29 Favored 'General case' 0 CA--C 1.576 1.95 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 168.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 69.6 m -104.16 -36.15 7.78 Favored 'General case' 0 CA--C 1.567 1.619 0 C-N-CA 124.978 1.311 . . . . 0.0 113.619 169.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 87.1 m -90.12 150.84 21.87 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-N 119.912 1.233 . . . . 0.0 110.826 -178.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 21.6 t -72.39 123.75 23.72 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.197 -0.939 . . . . 0.0 111.734 175.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.9 p -70.27 -27.78 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 N-CA-C 115.868 1.803 . . . . 0.0 115.868 175.293 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 66.3 m -135.25 136.88 42.03 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-N 119.562 1.073 . . . . 0.0 109.082 173.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? -80.13 93.97 5.91 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.815 0.816 . . . . 0.0 110.637 -178.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . 0.252 13.2 p-10 -165.9 -65.78 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 124.663 1.185 . . . . 0.0 108.044 -178.685 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -113.7 -139.03 0.38 Allowed 'General case' 0 CA--C 1.567 1.625 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 172.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.21 77.83 1.79 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.307 -0.871 . . . . 0.0 109.146 175.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 3.7 mp -86.7 108.48 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 -170.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 19.6 m-30 -114.72 138.4 50.77 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-N 115.331 -0.849 . . . . 0.0 109.523 -172.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 10.7 mp -85.27 108.11 17.62 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.276 -171.075 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 93.5 mtt180 -123.37 168.07 12.99 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 122.369 1.08 . . . . 0.0 109.485 -175.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -81.79 158.75 24.0 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 115.11 1.522 . . . . 0.0 115.11 -170.049 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 36.1 pt -81.29 162.04 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 CA-C-N 114.727 -1.124 . . . . 0.0 112.883 -179.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 . . . . . 0 N--CA 1.485 1.311 0 CA-C-O 122.776 1.274 . . . . 0.0 109.328 -176.765 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . 0.253 66.6 p-90 . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 115.544 1.683 . . . . 0.0 115.544 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -85.78 135.65 33.65 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-N 119.255 0.934 . . . . 0.0 111.403 -173.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -111.68 -88.0 0.53 Allowed 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 175.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 158.12 -150.1 20.77 Favored Glycine 0 N--CA 1.483 1.816 0 CA-C-N 119.634 1.106 . . . . 0.0 112.735 -179.163 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -83.14 89.57 6.96 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 121.566 0.698 . . . . 0.0 111.217 -178.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -124.42 146.62 52.71 Favored Pre-proline 0 CA--C 1.573 1.852 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 169.365 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -50.69 164.79 0.5 Allowed 'Trans proline' 0 C--N 1.37 1.681 0 C-N-CA 123.411 2.74 . . . . 0.0 117.717 175.03 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 60.1 ttt180 -59.06 -41.95 89.17 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 169.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -65.28 -45.45 84.41 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 115.193 1.553 . . . . 0.0 115.193 173.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 48.2 mmtm -61.92 -37.09 83.36 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 115.646 1.721 . . . . 0.0 115.646 171.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.87 -44.85 91.86 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 115.31 1.596 . . . . 0.0 115.31 169.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -61.34 -40.08 92.93 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 115.351 1.611 . . . . 0.0 115.351 170.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -61.54 -46.24 90.76 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 173.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 37.3 mmt -60.12 -46.57 89.17 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 114.898 1.444 . . . . 0.0 114.898 172.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 96.7 mt -72.59 -32.38 65.94 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 115.989 1.848 . . . . 0.0 115.989 177.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 21.1 t -56.02 -35.33 66.72 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 115.662 1.727 . . . . 0.0 115.662 169.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -60.15 -39.47 86.46 Favored 'General case' 0 CA--C 1.568 1.662 0 N-CA-C 115.215 1.561 . . . . 0.0 115.215 169.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -67.88 134.68 51.26 Favored 'General case' 0 CA--C 1.556 1.174 0 CA-C-O 123.5 1.619 . . . . 0.0 113.404 -177.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.43 -10.2 59.34 Favored 'General case' 0 CA--C 1.567 1.597 0 N-CA-C 119.12 3.007 . . . . 0.0 119.12 176.421 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 6.9 m80 -89.62 137.51 32.27 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-N 120.149 1.34 . . . . 0.0 110.836 -169.002 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -80.39 103.54 10.32 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 173.2 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 110.59 11.41 19.5 Favored Glycine 0 CA--C 1.551 2.321 0 CA-C-O 117.56 -1.689 . . . . 0.0 115.758 -168.074 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.66 120.09 14.89 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-N 120.64 2.22 . . . . 0.0 110.244 -175.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 14.6 p90 -132.82 157.32 45.29 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 -169.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.3 pp -140.8 125.58 18.08 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 168.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 84.6 mt -83.78 108.84 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 170.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 48.2 ptt85 -89.88 156.89 18.16 Favored 'General case' 0 CA--C 1.557 1.215 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.192 171.134 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -88.86 134.03 34.08 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 169.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 50.5 m -65.85 132.47 48.74 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 123.107 0.563 . . . . 0.0 111.133 -178.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -55.54 -55.01 36.87 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 116.903 2.186 . . . . 0.0 116.903 -168.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.3 t -72.39 -45.81 58.08 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 174.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -108.77 108.67 60.96 Favored Pre-proline 0 CA--C 1.562 1.422 0 CA-C-O 117.652 -1.166 . . . . 0.0 110.559 -174.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -69.48 -32.24 20.13 Favored 'Trans proline' 0 C--N 1.369 1.609 0 N-CA-C 118.724 2.548 . . . . 0.0 118.724 178.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -65.58 -19.21 66.71 Favored Glycine 0 CA--C 1.559 2.832 0 N-CA-C 117.023 1.569 . . . . 0.0 117.023 168.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -92.16 138.05 31.86 Favored 'General case' 0 N--CA 1.484 1.27 0 CA-C-N 118.337 1.068 . . . . 0.0 108.696 169.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -123.38 170.03 10.74 Favored 'General case' 0 CA--C 1.563 1.472 0 C-N-CA 124.23 1.012 . . . . 0.0 108.907 179.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 73.1 m -143.01 119.79 11.2 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.096 -1.002 . . . . 0.0 108.43 -179.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 43.7 tp -79.88 105.66 11.32 Favored 'General case' 0 N--CA 1.486 1.347 0 CA-C-O 121.844 0.831 . . . . 0.0 109.331 171.176 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.8 m -91.35 109.65 20.93 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 173.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.7 p -137.69 137.49 45.27 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 CA-C-N 119.148 0.885 . . . . 0.0 108.778 -169.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -72.88 118.86 16.34 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.009 0.433 . . . . 0.0 110.996 171.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 4.4 m-30 -107.71 97.69 7.39 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 169.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 81.94 -98.76 1.96 Allowed Glycine 0 CA--C 1.541 1.677 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 -169.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 70.1 m-80 -126.89 -17.6 4.88 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 115.01 1.485 . . . . 0.0 115.01 169.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -85.73 137.88 32.5 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 119.643 1.11 . . . . 0.0 110.081 177.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 64.9 t -89.28 106.43 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 -175.082 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -101.06 124.84 47.39 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-O 121.881 0.848 . . . . 0.0 109.231 -179.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 11.9 m-70 -97.73 131.31 44.38 Favored 'General case' 0 CA--C 1.555 1.159 0 CA-C-N 114.819 -1.082 . . . . 0.0 109.153 -175.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -128.18 125.01 38.2 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 -175.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -80.88 117.49 21.57 Favored 'General case' 0 N--CA 1.485 1.302 0 CA-C-O 121.596 0.712 . . . . 0.0 110.903 -170.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 73.1 t -85.42 102.77 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 171.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.4 pp -121.91 144.13 49.04 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 123.116 0.567 . . . . 0.0 111.346 -174.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.413 HH21 ' HH ' ' A' ' 118' ' ' TYR . 99.7 mtt180 -89.65 155.82 18.98 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 114.009 1.115 . . . . 0.0 114.009 -170.399 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -104.41 -64.3 1.13 Allowed 'General case' 0 N--CA 1.494 1.748 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.951 169.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -97.21 -121.17 4.12 Favored Glycine 0 CA--C 1.542 1.734 0 CA-C-N 119.406 1.003 . . . . 0.0 112.883 -176.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -76.2 -65.24 0.94 Allowed 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 118.786 -0.626 . . . . 0.0 112.337 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -136.08 57.99 0.67 Allowed Glycine 0 CA--C 1.542 1.78 0 CA-C-O 119.559 -0.578 . . . . 0.0 111.928 169.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -106.36 88.85 2.88 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 106.978 -1.489 . . . . 0.0 106.978 -174.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.413 ' HH ' HH21 ' A' ' 112' ' ' ARG . 83.1 m-85 -81.03 122.47 27.35 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 114.852 -1.067 . . . . 0.0 111.1 -169.521 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 21.3 p90 -137.57 124.17 20.96 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 120.941 0.4 . . . . 0.0 110.044 179.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -106.84 -47.78 3.65 Favored 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 123.887 0.875 . . . . 0.0 112.155 169.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 32.2 t90 -89.92 -68.81 0.76 Allowed 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 124.834 1.254 . . . . 0.0 110.91 -171.066 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . 0.264 13.0 p -147.6 -66.89 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 C-N-CA 123.499 0.72 . . . . 0.0 109.704 174.446 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 10.8 p -79.9 138.82 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 C-N-CA 123.941 0.896 . . . . 0.0 111.455 -171.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -83.77 158.86 21.59 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 113.715 1.005 . . . . 0.0 113.715 -178.211 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -140.46 123.13 16.26 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 -171.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 16.9 p30 -57.84 -34.44 69.7 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 117.549 2.425 . . . . 0.0 117.549 176.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 74.2 m -120.88 144.92 48.15 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 119.256 0.935 . . . . 0.0 111.678 -176.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 14.1 tp -86.53 94.27 9.39 Favored 'General case' 0 CA--C 1.563 1.46 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 169.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 12.0 t30 158.19 -60.78 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 103.295 -2.854 . . . . 0.0 103.295 -168.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -54.16 -44.6 71.59 Favored 'General case' 0 CA--C 1.574 1.877 0 C-N-CA 124.699 1.2 . . . . 0.0 114.194 168.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 10.2 tt -53.93 -53.83 47.28 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 115.763 1.764 . . . . 0.0 115.763 170.049 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.2 p -68.32 -50.13 60.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 -177.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -56.31 -32.86 65.03 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 115.516 1.673 . . . . 0.0 115.516 172.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -58.36 -53.64 55.99 Favored 'General case' 0 CA--C 1.566 1.582 0 CA-C-N 119.608 1.094 . . . . 0.0 111.85 168.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . 0.315 40.8 m-70 -71.42 -9.54 58.34 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 118.196 2.665 . . . . 0.0 118.196 176.762 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.62 -32.03 73.38 Favored 'General case' 0 CA--C 1.581 2.142 0 CA-C-N 121.041 1.746 . . . . 0.0 112.171 166.356 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 70.6 m -95.53 -44.84 7.33 Favored 'General case' 0 CA--C 1.564 1.519 0 C-N-CA 124.604 1.162 . . . . 0.0 114.035 169.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 53.8 m -90.2 155.99 18.63 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-N 119.665 1.12 . . . . 0.0 111.04 -178.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 22.7 t -86.3 133.55 33.81 Favored 'General case' 0 CA--C 1.557 1.212 0 O-C-N 121.357 -0.84 . . . . 0.0 113.197 -175.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 96.4 t -69.17 -36.5 73.31 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 CA-C-O 118.534 -0.746 . . . . 0.0 111.752 169.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 22.7 t -79.2 132.86 36.66 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-N 119.639 1.109 . . . . 0.0 109.584 169.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 32.9 ttt85 -75.0 -50.15 17.51 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 -175.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -76.42 -55.67 5.33 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 172.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -80.03 158.77 26.41 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 119.028 0.831 . . . . 0.0 112.225 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 -104.04 89.79 3.39 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 4.0 mm -112.96 141.01 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 176.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -137.3 155.9 48.9 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-O 121.988 0.899 . . . . 0.0 112.497 -169.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 10.0 mp -90.28 124.78 35.17 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 124.046 0.938 . . . . 0.0 112.074 -169.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -118.98 151.73 37.66 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 124.242 1.017 . . . . 0.0 110.091 171.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -81.88 149.5 28.25 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 122.136 0.97 . . . . 0.0 112.656 -177.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.6 pp -76.01 160.32 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 CA-C-N 114.861 -1.063 . . . . 0.0 113.552 -174.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 . . . . . 0 N--CA 1.485 1.294 0 CA-C-O 124.052 1.882 . . . . 0.0 106.332 170.583 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 63.6 p-90 . . . . . 0 N--CA 1.494 1.739 0 N-CA-C 115.3 1.592 . . . . 0.0 115.3 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -81.38 136.3 35.71 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-N 120.449 1.477 . . . . 0.0 112.054 -171.68 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -121.61 -74.83 0.6 Allowed 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 174.279 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 91.91 102.46 1.39 Allowed Glycine 0 CA--C 1.542 1.734 0 CA-C-N 119.376 0.989 . . . . 0.0 111.814 -178.236 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 56.9 mmtt 63.52 69.98 0.54 Allowed 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 124.808 1.243 . . . . 0.0 113.394 -177.265 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 10.6 pt -130.1 151.82 79.01 Favored Pre-proline 0 CA--C 1.574 1.886 0 CA-C-O 118.411 -0.804 . . . . 0.0 109.676 169.876 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_exo -56.45 156.42 21.87 Favored 'Trans proline' 0 C--N 1.369 1.655 0 C-N-CA 123.369 2.713 . . . . 0.0 117.348 177.344 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 61.2 ttt180 -67.52 -36.62 81.39 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 169.489 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.77 -39.84 95.24 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 115.261 1.578 . . . . 0.0 115.261 169.651 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -64.06 -35.27 80.2 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 169.159 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.79 -52.45 63.13 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-N 119.472 1.033 . . . . 0.0 113.19 169.415 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -52.92 -37.71 61.08 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 116.348 1.981 . . . . 0.0 116.348 169.537 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -59.32 -48.65 80.83 Favored 'General case' 0 CA--C 1.566 1.574 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 170.696 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -65.45 -60.46 2.93 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 172.597 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.64 -39.44 91.42 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 117.517 2.414 . . . . 0.0 117.517 -172.576 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 56.3 m -60.61 -41.0 93.92 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 115.368 1.618 . . . . 0.0 115.368 178.719 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -68.45 -26.79 65.68 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 117.024 2.231 . . . . 0.0 117.024 169.986 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -60.52 131.1 49.67 Favored 'General case' 0 CA--C 1.556 1.19 0 CA-C-N 120.248 1.385 . . . . 0.0 113.722 176.555 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 38.9 ptt85 -69.59 -20.03 63.65 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 118.65 2.833 . . . . 0.0 118.65 179.054 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 57.8 m80 -89.51 135.58 33.52 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 119.213 0.915 . . . . 0.0 111.922 -169.141 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -77.59 103.03 7.28 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 169.731 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 124.23 -0.14 8.87 Favored Glycine 0 CA--C 1.555 2.543 0 CA-C-O 117.163 -1.91 . . . . 0.0 115.768 -168.456 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.57 113.19 4.57 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 121.158 2.479 . . . . 0.0 112.173 -169.929 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 17.8 p90 -128.11 155.79 43.86 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 116.334 1.976 . . . . 0.0 116.334 -168.713 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.1 pp -148.75 133.57 17.97 Favored 'General case' 0 N--CA 1.485 1.28 0 CA-C-N 114.33 -1.305 . . . . 0.0 108.454 169.031 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 91.8 mt -91.38 110.59 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 175.897 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 3.5 ptm180 -100.98 140.18 35.64 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 114.614 -1.175 . . . . 0.0 109.329 169.98 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.54 126.57 31.05 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.704 -0.622 . . . . 0.0 109.527 177.72 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 20.5 t -63.25 125.93 25.74 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -170.201 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -63.98 -48.58 75.85 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 175.815 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 95.8 p -59.3 -39.41 82.93 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 116.75 2.13 . . . . 0.0 116.75 171.873 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -115.84 97.7 49.59 Favored Pre-proline 0 CA--C 1.563 1.46 0 CA-C-O 117.967 -1.016 . . . . 0.0 108.997 178.748 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -72.57 135.04 23.36 Favored 'Trans proline' 0 C--N 1.372 1.787 0 C-N-CA 123.157 2.571 . . . . 0.0 112.606 -178.985 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 92.05 -39.36 3.03 Favored Glycine 0 CA--C 1.556 2.622 0 CA-C-N 115.555 -0.748 . . . . 0.0 114.415 -168.595 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -79.76 146.17 32.47 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 124.275 1.03 . . . . 0.0 110.883 175.624 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -106.85 174.16 6.01 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 122.124 0.964 . . . . 0.0 111.859 -171.697 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 57.9 m -146.61 115.81 7.0 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 177.325 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 42.6 tp -79.7 115.42 19.3 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 171.049 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 20.7 m -97.98 83.77 3.19 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 175.998 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.3 p -107.4 119.74 57.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 -171.861 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 15.1 tmtt? -81.37 149.2 28.97 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.768 174.739 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -156.99 107.35 2.29 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 169.948 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 71.38 76.14 0.6 Allowed Glycine 0 N--CA 1.483 1.776 0 N-CA-C 115.186 0.834 . . . . 0.0 115.186 173.097 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . 0.348 15.0 m120 77.06 -38.7 0.31 Allowed 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 118.179 2.659 . . . . 0.0 118.179 -179.898 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -121.43 145.27 48.09 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 124.091 0.956 . . . . 0.0 110.944 -169.688 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 5.3 p -83.02 139.0 18.4 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.54 0 CA-C-N 115.373 -0.831 . . . . 0.0 111.864 178.262 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -125.27 111.53 15.32 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-O 122.103 0.954 . . . . 0.0 108.529 -176.94 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 8.0 m-70 -99.55 128.81 45.67 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-N 114.776 -1.102 . . . . 0.0 109.358 -172.268 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -133.46 133.08 41.82 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 -175.096 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 64.2 pttt -77.74 125.86 29.99 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-O 121.507 0.67 . . . . 0.0 112.05 -179.117 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 80.7 t -94.61 108.22 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 106.287 -1.746 . . . . 0.0 106.287 179.237 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 66.0 mt -95.97 149.99 20.96 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.276 -173.368 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 82.8 mtm180 -109.51 135.95 49.68 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 122.983 0.513 . . . . 0.0 110.304 -177.79 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -108.1 110.19 21.81 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 170.635 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 89.26 -113.58 4.16 Favored Glycine 0 CA--C 1.541 1.683 0 CA-C-N 116.372 -0.376 . . . . 0.0 112.343 -178.763 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -86.4 -68.99 0.7 Allowed 'General case' 0 N--CA 1.488 1.452 0 CA-C-O 118.739 -0.648 . . . . 0.0 111.687 178.792 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -156.39 70.25 0.27 Allowed Glycine 0 N--CA 1.478 1.473 0 CA-C-N 118.602 0.637 . . . . 0.0 112.33 172.58 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -103.88 99.82 9.6 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 105.089 -2.189 . . . . 0.0 105.089 171.702 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -81.19 108.25 14.67 Favored 'General case' 0 N--CA 1.484 1.255 0 CA-C-N 114.741 -1.118 . . . . 0.0 111.756 -168.58 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 33.5 p90 -117.47 121.66 41.63 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 178.788 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 4.7 tt -101.7 -63.07 1.18 Allowed 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 123.429 0.691 . . . . 0.0 109.176 170.648 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . 0.433 ' HZ3' ' HH ' ' A' ' 134' ' ' TYR . 26.9 t90 -82.43 -64.98 1.07 Allowed 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 124.337 1.055 . . . . 0.0 112.17 -169.941 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . 0.276 13.1 p -146.17 -70.33 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 CA-C-N 118.791 0.723 . . . . 0.0 109.427 177.533 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 9.4 p -79.91 143.95 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 C-N-CA 123.879 0.872 . . . . 0.0 111.621 -174.078 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.37 155.52 22.28 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -176.184 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -141.7 114.75 8.67 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 -173.764 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 23.1 t30 -54.1 -41.08 67.88 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 116.696 2.109 . . . . 0.0 116.696 -175.998 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 95.3 p -107.29 155.27 20.14 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-O 122.649 1.214 . . . . 0.0 111.904 170.612 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 60.3 mt -64.31 -29.2 70.29 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 115.282 1.586 . . . . 0.0 115.282 169.714 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -65.33 -38.73 91.05 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-N 119.682 1.128 . . . . 0.0 113.555 169.927 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -61.63 -45.06 95.68 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 169.393 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 53.1 tp -57.02 -44.14 82.55 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 115.09 1.515 . . . . 0.0 115.09 169.68 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 22.2 t -60.32 -63.26 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 C-N-CA 124.581 1.152 . . . . 0.0 112.405 173.525 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -59.56 -28.67 67.32 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 115.984 1.846 . . . . 0.0 115.984 -176.29 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.433 ' HH ' ' HZ3' ' A' ' 121' ' ' TRP . 88.8 t80 -64.35 -56.07 16.92 Favored 'General case' 0 CA--C 1.566 1.586 0 CA-C-N 119.158 0.89 . . . . 0.0 111.849 168.461 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . 0.264 68.0 m-70 -68.85 -9.08 49.4 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 117.874 2.546 . . . . 0.0 117.874 177.795 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -48.48 -39.7 23.97 Favored 'General case' 0 N--CA 1.502 2.174 0 CA-C-N 120.808 1.64 . . . . 0.0 114.47 167.563 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 68.5 m -109.04 -26.38 10.2 Favored 'General case' 0 CA--C 1.565 1.527 0 N-CA-C 114.885 1.439 . . . . 0.0 114.885 169.857 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 40.2 m -90.27 152.34 21.1 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-N 120.825 1.648 . . . . 0.0 111.031 -179.788 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 29.1 t -74.31 133.24 42.57 Favored 'General case' 0 CA--C 1.559 1.31 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 -179.962 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 39.3 t -74.93 -48.09 34.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 C-N-CA 123.593 0.757 . . . . 0.0 111.583 169.861 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 70.8 m -82.85 159.36 22.42 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-O 121.858 0.837 . . . . 0.0 112.049 178.273 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 3.7 tmm_? -70.37 -61.01 1.94 Allowed 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 118.898 -0.572 . . . . 0.0 111.94 174.881 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -74.37 -56.34 4.97 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 178.787 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 51.6 mt-30 -79.86 145.32 32.79 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 118.713 0.688 . . . . 0.0 112.087 -176.81 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -79.2 122.7 26.61 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 122.958 0.503 . . . . 0.0 110.372 169.854 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 8.3 mm -127.43 102.29 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 105.565 -2.013 . . . . 0.0 105.565 179.264 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 20.8 m-30 -113.19 114.38 26.68 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 -174.398 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 10.8 mp -67.67 131.57 45.84 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 114.794 1.405 . . . . 0.0 114.794 -168.975 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 71.4 mmt-85 -127.24 140.88 51.92 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 176.874 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -75.21 141.46 43.57 Favored 'General case' 0 CA--C 1.565 1.521 0 O-C-N 121.183 -0.948 . . . . 0.0 112.209 -175.348 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 16.4 pt -62.89 146.58 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 N-CA-C 113.968 1.099 . . . . 0.0 113.968 -176.446 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 . . . . . 0 N--CA 1.482 1.142 0 CA-C-O 123.931 1.824 . . . . 0.0 109.344 -176.118 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . 0.294 51.2 p-90 . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 113.464 0.913 . . . . 0.0 113.464 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -94.53 133.56 38.02 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 123.63 0.772 . . . . 0.0 109.47 173.692 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -95.6 -77.17 0.48 Allowed 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 118.665 -0.683 . . . . 0.0 109.466 174.772 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -169.96 -159.07 14.92 Favored Glycine 0 CA--C 1.541 1.677 0 CA-C-N 119.077 0.853 . . . . 0.0 112.955 -179.885 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -94.31 91.85 6.91 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 172.101 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -123.71 149.7 59.82 Favored Pre-proline 0 CA--C 1.573 1.852 0 C-N-CA 123.59 0.756 . . . . 0.0 109.194 178.449 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -69.85 177.53 5.56 Favored 'Trans proline' 0 CA--C 1.565 2.029 0 C-N-CA 122.812 2.341 . . . . 0.0 114.285 175.456 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 59.6 ttt180 -61.07 -42.42 98.46 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 115.791 1.774 . . . . 0.0 115.791 179.334 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -67.23 -41.87 84.94 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 115.717 1.747 . . . . 0.0 115.717 175.526 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -64.76 -36.48 84.45 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 169.764 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.62 -40.38 96.75 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 115.799 1.777 . . . . 0.0 115.799 169.929 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -65.52 -40.83 93.43 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 114.85 1.426 . . . . 0.0 114.85 169.926 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -60.11 -48.38 81.98 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 114.957 1.465 . . . . 0.0 114.957 172.463 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 38.1 mmt -66.71 -47.31 72.76 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 176.539 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 7.1 tp -76.27 -17.94 59.22 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 117.119 2.266 . . . . 0.0 117.119 178.802 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 94.1 p -60.76 -31.32 70.66 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-N 120.616 1.553 . . . . 0.0 114.781 168.634 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -59.82 -39.63 85.74 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 169.073 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -65.04 112.83 3.52 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 124.4 1.08 . . . . 0.0 111.533 169.852 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 13.7 ptp180 -80.12 -15.46 57.07 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 117.941 2.571 . . . . 0.0 117.941 177.632 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 50.0 m80 -89.54 147.88 23.71 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 119.417 1.008 . . . . 0.0 112.367 -168.767 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -77.99 120.9 23.49 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.645 178.993 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 100.07 -21.38 44.89 Favored Glycine 0 CA--C 1.545 1.966 0 CA-C-O 117.168 -1.907 . . . . 0.0 117.119 -169.64 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.36 115.45 4.21 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 120.753 2.277 . . . . 0.0 111.128 -177.728 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 27.1 p90 -126.49 156.49 40.65 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 115.361 1.615 . . . . 0.0 115.361 -168.467 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.0 pp -132.33 125.64 31.4 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 168.382 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 71.8 mt -86.99 119.98 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 173.218 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 48.8 ptt85 -92.05 148.9 21.83 Favored 'General case' 0 CA--C 1.558 1.265 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.499 169.547 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -90.09 122.09 32.75 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 106.425 -1.695 . . . . 0.0 106.425 169.089 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 50.7 m -65.51 113.19 3.99 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.549 0.739 . . . . 0.0 111.95 -174.476 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -90.62 92.37 8.81 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-O 123.814 1.769 . . . . 0.0 108.992 178.854 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 51.7 p 163.73 -40.25 0.0 OUTLIER 'General case' 0 CA--C 1.568 1.672 0 CA-C-N 110.764 -2.925 . . . . 0.0 107.434 -168.209 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -131.87 98.61 17.46 Favored Pre-proline 0 CA--C 1.562 1.415 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 172.129 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -62.11 134.67 50.5 Favored 'Trans proline' 0 C--N 1.372 1.772 0 C-N-CA 123.383 2.722 . . . . 0.0 114.842 178.848 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 90.82 -31.7 5.45 Favored Glycine 0 CA--C 1.553 2.437 0 N-CA-C 116.398 1.319 . . . . 0.0 116.398 -169.373 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -80.63 135.5 36.06 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 118.864 1.332 . . . . 0.0 110.062 175.611 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -108.7 172.0 7.1 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 122.317 1.056 . . . . 0.0 111.127 -173.145 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 50.6 m -146.21 124.03 11.95 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 171.939 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 30.3 tp -80.09 114.42 18.98 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.665 0.786 . . . . 0.0 109.996 172.866 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.6 m -98.66 108.91 21.71 Favored 'General case' 0 CA--C 1.562 1.431 0 N-CA-C 105.336 -2.098 . . . . 0.0 105.336 172.353 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.7 p -127.63 118.67 49.89 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -170.455 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -85.19 97.09 9.71 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.236 0.615 . . . . 0.0 110.013 -179.008 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 17.2 t80 -122.0 124.98 45.26 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 -178.94 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 81.81 -111.47 3.33 Favored Glycine 0 N--CA 1.481 1.644 0 N-CA-C 110.319 -1.112 . . . . 0.0 110.319 -173.538 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -137.16 56.97 1.77 Allowed 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 169.023 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -160.04 135.09 7.94 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 -176.592 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 90.2 t -88.44 105.89 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 172.049 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 62.2 mt-30 -102.59 117.84 35.55 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.736 0.814 . . . . 0.0 109.321 -171.282 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 15.4 m-70 -96.98 113.99 25.57 Favored 'General case' 0 CA--C 1.554 1.121 0 CA-C-N 115.194 -0.912 . . . . 0.0 108.958 -173.518 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -115.2 118.52 33.55 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 177.693 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -80.71 125.77 30.46 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.753 -169.897 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 59.1 t -88.54 103.27 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 106.727 -1.582 . . . . 0.0 106.727 175.913 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -104.11 147.76 27.04 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 121.401 0.619 . . . . 0.0 110.988 -179.811 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -96.47 160.95 14.13 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -176.461 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -133.41 86.91 2.34 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.149 169.648 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 76.87 99.1 0.17 Allowed Glycine 0 N--CA 1.482 1.761 0 CA-C-O 119.197 -0.78 . . . . 0.0 114.513 172.337 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . 0.34 . . 82.09 -77.24 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 124.631 1.172 . . . . 0.0 112.72 -179.974 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -170.55 67.64 0.15 Allowed Glycine 0 N--CA 1.479 1.504 0 CA-C-O 119.662 -0.521 . . . . 0.0 113.214 174.682 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -107.6 94.19 4.95 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 105.863 -1.903 . . . . 0.0 105.863 174.078 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -79.43 126.75 31.24 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 124.204 1.002 . . . . 0.0 110.429 -169.706 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 24.0 p90 -147.92 121.22 8.99 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 -179.229 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -104.46 -42.6 5.41 Favored 'General case' 0 N--CA 1.498 1.926 0 C-N-CA 123.35 0.66 . . . . 0.0 112.508 168.853 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 43.4 t90 -89.98 -85.2 0.22 Allowed 'General case' 0 CA--C 1.56 1.336 0 C-N-CA 124.766 1.226 . . . . 0.0 109.942 -173.536 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 96.4 t -139.16 -66.52 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 -173.537 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 12.2 p -79.74 137.53 21.49 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.551 0 C-N-CA 123.772 0.829 . . . . 0.0 111.333 -175.4 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 60.9 pttt -89.36 162.35 15.84 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 -177.953 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 99.7 m-85 -145.78 120.23 9.68 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 -170.196 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 66.2 m-80 -61.12 -43.85 98.25 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 171.479 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 73.3 m -96.51 138.19 34.47 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-O 121.823 0.821 . . . . 0.0 111.272 174.305 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 13.5 tp -65.82 -31.98 73.25 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 169.661 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -59.69 -41.42 90.69 Favored 'General case' 0 CA--C 1.574 1.887 0 N-CA-C 113.92 1.082 . . . . 0.0 113.92 168.992 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -65.69 -38.32 88.93 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 115.49 1.663 . . . . 0.0 115.49 170.684 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 8.5 tt -57.12 -53.51 57.31 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-N 120.094 1.315 . . . . 0.0 114.404 170.313 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 9.9 p -64.59 -50.5 75.51 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.578 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -178.722 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -61.31 -36.79 81.09 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 115.403 1.631 . . . . 0.0 115.403 175.218 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -59.57 -53.4 58.48 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-N 119.957 1.253 . . . . 0.0 112.095 168.862 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . 0.262 69.7 m-70 -71.36 -9.09 57.6 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 118.15 2.648 . . . . 0.0 118.15 178.274 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 89.9 mtt-85 -58.17 -32.0 67.79 Favored 'General case' 0 CA--C 1.576 1.957 0 CA-C-N 120.375 1.443 . . . . 0.0 113.392 167.127 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 69.2 m -99.26 -42.77 6.87 Favored 'General case' 0 CA--C 1.569 1.678 0 C-N-CA 124.714 1.206 . . . . 0.0 112.927 168.688 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 33.7 m -87.97 155.67 19.72 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-N 119.814 1.188 . . . . 0.0 111.41 -175.373 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 25.3 t -79.56 129.13 34.19 Favored 'General case' 0 CA--C 1.56 1.336 0 O-C-N 121.187 -0.946 . . . . 0.0 113.356 -179.578 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 16.0 m -70.33 -36.85 68.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 N-CA-C 114.998 1.481 . . . . 0.0 114.998 169.748 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 22.9 t -87.25 140.1 29.88 Favored 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 123.658 0.783 . . . . 0.0 110.266 174.51 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 66.2 ttt-85 -73.18 -48.86 31.71 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 177.229 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 24.4 t30 -72.52 -57.89 3.8 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 171.962 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 63.4 mt-30 -79.88 154.4 28.38 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 118.763 0.711 . . . . 0.0 112.247 -177.223 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -94.13 104.0 16.04 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 171.928 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 17.2 mm -123.47 102.28 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 -177.802 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 22.4 m-30 -101.32 133.55 45.75 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 115.043 -0.981 . . . . 0.0 109.544 179.203 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 10.9 mp -89.3 121.44 31.58 Favored 'General case' 0 N--CA 1.486 1.338 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.266 -169.462 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 4.0 mpt_? -119.25 168.41 10.93 Favored 'General case' 0 CA--C 1.561 1.377 0 CA-C-O 123.602 1.667 . . . . 0.0 109.086 175.284 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -83.99 158.21 21.59 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-N 114.708 -1.133 . . . . 0.0 112.763 -174.264 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.1 pp -66.97 162.25 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 N-CA-C 114.565 1.321 . . . . 0.0 114.565 -177.463 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 . . . . . 0 N--CA 1.486 1.33 0 CA-C-O 122.815 1.293 . . . . 0.0 108.901 178.235 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 1.2 p90 . . . . . 0 N--CA 1.491 1.622 0 N-CA-C 113.55 0.945 . . . . 0.0 113.55 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -80.81 128.39 33.6 Favored 'General case' 0 N--CA 1.484 1.263 0 CA-C-N 119.885 1.221 . . . . 0.0 110.245 177.551 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -87.49 -73.53 0.47 Allowed 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.225 178.023 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 177.81 -101.39 0.15 Allowed Glycine 0 N--CA 1.476 1.339 0 N-CA-C 109.147 -1.581 . . . . 0.0 109.147 179.618 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -139.26 82.19 1.88 Allowed 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 171.744 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 28.6 pt -107.33 149.68 39.05 Favored Pre-proline 0 CA--C 1.571 1.786 0 C-N-CA 123.564 0.746 . . . . 0.0 109.691 -178.876 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.48 168.97 22.05 Favored 'Trans proline' 0 CA--C 1.56 1.801 0 C-N-CA 122.8 2.333 . . . . 0.0 114.363 179.702 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 58.5 ttt-85 -61.99 -40.19 94.77 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 115.645 1.72 . . . . 0.0 115.645 -179.698 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -65.01 -41.09 95.68 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 115.78 1.77 . . . . 0.0 115.78 173.118 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? -64.3 -36.49 84.27 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 114.979 1.474 . . . . 0.0 114.979 169.637 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.76 -52.5 60.1 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 170.047 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -53.91 -36.15 62.41 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 116.458 2.021 . . . . 0.0 116.458 170.094 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -60.78 -50.06 74.98 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 114.433 1.271 . . . . 0.0 114.433 171.436 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -58.89 -51.32 70.53 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 114.925 1.454 . . . . 0.0 114.925 173.816 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -65.11 -33.46 76.08 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 116.16 1.911 . . . . 0.0 116.16 175.619 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 23.3 t -53.92 -35.46 61.69 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 115.725 1.75 . . . . 0.0 115.725 169.736 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -61.24 -41.12 96.34 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 114.587 1.328 . . . . 0.0 114.587 169.288 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -71.65 122.63 20.91 Favored 'General case' 0 CA--C 1.556 1.179 0 CA-C-O 122.898 1.332 . . . . 0.0 112.474 179.899 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.09 -8.7 55.27 Favored 'General case' 0 CA--C 1.569 1.674 0 N-CA-C 119.056 2.984 . . . . 0.0 119.056 170.972 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 44.6 m80 -89.71 142.66 27.48 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 120.071 1.305 . . . . 0.0 113.104 -168.703 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -78.66 116.75 19.23 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 169.651 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 108.46 -7.0 34.13 Favored Glycine 0 CA--C 1.549 2.202 0 CA-C-O 117.06 -1.967 . . . . 0.0 117.7 -169.398 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.61 117.69 8.45 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 121.14 2.47 . . . . 0.0 112.502 -169.963 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -131.53 155.09 48.06 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 116.281 1.956 . . . . 0.0 116.281 -168.806 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.6 pp -147.48 138.85 23.81 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-N 114.647 -1.16 . . . . 0.0 108.333 168.929 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.7 mp -94.26 120.69 44.05 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.591 0 N-CA-C 106.708 -1.589 . . . . 0.0 106.708 177.229 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 3.4 ptm180 -106.05 146.4 30.17 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 124.092 0.957 . . . . 0.0 109.702 169.679 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -79.82 131.38 35.88 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 169.682 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 22.9 t -63.54 132.42 51.2 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.673 0.789 . . . . 0.0 112.559 -177.189 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -68.18 -52.23 36.79 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 -172.546 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.0 t -64.99 -35.1 80.1 Favored 'General case' 0 CA--C 1.565 1.532 0 N-CA-C 116.256 1.947 . . . . 0.0 116.256 172.059 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -115.53 98.45 50.79 Favored Pre-proline 0 CA--C 1.563 1.466 0 CA-C-N 119.49 1.041 . . . . 0.0 109.99 178.66 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -59.87 -33.46 95.92 Favored 'Trans proline' 0 C--N 1.371 1.718 0 N-CA-C 119.384 2.802 . . . . 0.0 119.384 175.303 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -87.07 47.84 3.75 Favored Glycine 0 CA--C 1.551 2.34 0 N-CA-C 114.633 0.613 . . . . 0.0 114.633 169.239 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -156.19 126.75 6.74 Favored 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 178.881 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 7.5 m-30 -92.91 169.02 10.77 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 122.042 0.925 . . . . 0.0 110.806 169.933 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 69.5 m -149.47 115.69 5.76 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 -178.812 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 33.9 tp -81.02 112.87 18.81 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.896 0.879 . . . . 0.0 109.588 176.902 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.423 ' HG ' ' CE1' ' A' ' 107' ' ' HIS . 9.7 m -94.53 83.17 4.08 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 177.996 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.7 p -107.94 115.69 49.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 -171.412 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 58.0 tttp -77.59 145.59 36.74 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 114.882 -1.054 . . . . 0.0 111.416 171.173 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -148.86 101.34 3.17 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 169.735 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 92.61 -104.12 3.14 Favored Glycine 0 N--CA 1.479 1.534 0 N-CA-C 112.002 -0.439 . . . . 0.0 112.002 179.769 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -113.2 -11.98 13.18 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 117.241 2.311 . . . . 0.0 117.241 178.55 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -116.88 142.01 47.48 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-N 119.558 1.072 . . . . 0.0 110.051 -175.909 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 39.6 t -92.94 110.86 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 175.533 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 55.1 tp60 -102.33 112.22 24.83 Favored 'General case' 0 CA--C 1.552 1.055 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 -172.165 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . 0.423 ' CE1' ' HG ' ' A' ' 98' ' ' SER . 13.8 m-70 -94.96 108.69 20.75 Favored 'General case' 0 CA--C 1.553 1.059 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 -174.68 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -103.13 130.5 50.32 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 176.227 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -77.82 115.5 17.61 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 123.083 0.553 . . . . 0.0 112.254 -175.939 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 97.4 t -85.64 110.35 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 106.83 -1.544 . . . . 0.0 106.83 178.364 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 58.5 mt -90.53 135.63 33.57 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.102 0.561 . . . . 0.0 109.717 -173.349 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 79.1 mtp180 -116.68 119.07 34.34 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 -175.183 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . 0.29 3.9 p-10 -79.91 -66.11 0.92 Allowed 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 -175.561 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -90.85 -107.27 1.39 Allowed Glycine 0 N--CA 1.483 1.826 0 CA-C-N 119.424 1.011 . . . . 0.0 111.801 -179.56 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -79.87 -67.28 0.78 Allowed 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 118.827 -0.606 . . . . 0.0 111.236 172.426 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -149.13 70.68 0.32 Allowed Glycine 0 N--CA 1.477 1.427 0 CA-C-N 118.46 0.573 . . . . 0.0 111.884 169.807 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.17 101.16 11.82 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 105.108 -2.182 . . . . 0.0 105.108 171.664 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -83.84 106.73 15.75 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-N 115.038 -0.983 . . . . 0.0 111.141 -168.509 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -114.38 114.72 26.25 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 107.769 -1.196 . . . . 0.0 107.769 177.505 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 63.0 tp -112.01 -48.9 3.01 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 124.192 0.997 . . . . 0.0 112.191 179.749 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 33.7 t90 -92.5 -74.79 0.51 Allowed 'General case' 0 CA--C 1.557 1.22 0 C-N-CA 124.598 1.159 . . . . 0.0 110.694 -169.727 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . 0.255 10.8 p -146.28 -60.41 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 C-N-CA 123.586 0.754 . . . . 0.0 109.715 177.293 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 15.6 m -79.38 157.15 4.7 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.545 0 C-N-CA 124.251 1.02 . . . . 0.0 111.759 178.892 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -79.88 136.0 36.57 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.526 -178.38 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -124.51 99.5 6.22 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 106.222 -1.77 . . . . 0.0 106.222 177.676 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . 0.272 12.8 p30 -60.45 -41.43 94.05 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 116.874 2.175 . . . . 0.0 116.874 -172.991 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 69.3 m -94.88 152.55 18.28 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-O 122.125 0.964 . . . . 0.0 111.268 172.395 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 12.8 tp -64.77 -34.76 79.11 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 169.66 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -63.68 -35.92 82.14 Favored 'General case' 0 CA--C 1.568 1.641 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 168.81 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -60.19 -48.93 79.66 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-N 120.592 1.542 . . . . 0.0 113.858 169.533 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 53.0 tp -60.82 -50.3 74.01 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 115.355 1.613 . . . . 0.0 115.355 173.752 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 46.3 t -61.38 -60.19 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 C-N-CA 123.957 0.903 . . . . 0.0 112.111 176.445 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -59.3 -31.8 69.47 Favored 'General case' 0 CA--C 1.567 1.634 0 N-CA-C 115.607 1.706 . . . . 0.0 115.607 -176.912 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -62.96 -53.92 46.57 Favored 'General case' 0 CA--C 1.568 1.642 0 CA-C-N 119.833 1.197 . . . . 0.0 112.328 168.78 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . 0.306 76.0 m-70 -71.58 -8.5 54.43 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 118.183 2.661 . . . . 0.0 118.183 178.16 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -47.77 -40.29 20.31 Favored 'General case' 0 N--CA 1.499 2.012 0 CA-C-N 120.693 1.588 . . . . 0.0 114.945 167.916 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 70.0 m -106.38 -32.9 7.93 Favored 'General case' 0 CA--C 1.564 1.493 0 N-CA-C 114.728 1.381 . . . . 0.0 114.728 170.655 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 48.7 m -89.39 147.36 24.09 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-N 120.4 1.455 . . . . 0.0 110.172 -179.706 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.512 ' HB2' ' H ' ' A' ' 146' ' ' ILE . 54.8 p -80.47 141.32 35.33 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 120.97 -1.081 . . . . 0.0 113.346 179.214 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 46.5 t -67.37 -51.54 51.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.916 169.781 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 32.3 t -87.35 132.64 33.89 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.582 0.753 . . . . 0.0 110.715 178.796 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -88.33 70.31 9.11 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 121.629 0.728 . . . . 0.0 110.955 176.37 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . 0.297 5.8 p-10 178.77 -68.58 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 125.218 1.407 . . . . 0.0 107.665 -176.501 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -96.86 138.6 34.16 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.689 0.796 . . . . 0.0 109.413 171.943 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -73.47 117.69 15.53 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 122.696 0.398 . . . . 0.0 111.775 178.809 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.512 ' H ' ' HB2' ' A' ' 139' ' ' SER . 8.4 mm -121.21 92.34 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 176.628 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 21.4 m-30 -100.57 119.82 39.11 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-N 114.249 -1.341 . . . . 0.0 108.109 -176.893 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 10.6 mp -74.04 126.48 30.61 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 123.384 0.674 . . . . 0.0 112.321 -169.748 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 24.1 mmt85 -129.23 143.24 50.78 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 124.551 1.14 . . . . 0.0 108.154 -179.083 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -72.26 146.75 47.03 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 113.645 0.98 . . . . 0.0 113.645 -174.798 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 28.3 pt -69.37 150.15 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 C-N-CA 123.868 0.867 . . . . 0.0 112.726 178.902 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 123.848 1.785 . . . . 0.0 109.55 -177.379 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . 0.38 62.1 p-90 . . . . . 0 N--CA 1.498 1.928 0 N-CA-C 121.583 3.92 . . . . 0.0 121.583 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -139.53 129.26 24.62 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 -169.676 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -140.09 94.86 2.8 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 170.501 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -91.8 164.95 29.21 Favored Glycine 0 CA--C 1.541 1.715 0 CA-C-O 122.924 1.291 . . . . 0.0 116.082 -169.816 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . 0.259 32.3 mmmt 57.38 53.14 7.84 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-N 113.1 -1.55 . . . . 0.0 115.183 -178.364 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 42.3 pt -136.55 152.35 74.53 Favored Pre-proline 0 CA--C 1.573 1.844 0 C-N-CA 123.895 0.878 . . . . 0.0 109.941 -177.751 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -74.08 177.0 8.77 Favored 'Trans proline' 0 CA--C 1.565 2.058 0 C-N-CA 122.919 2.412 . . . . 0.0 114.124 174.847 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 56.3 ttt-85 -63.78 -42.17 97.81 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 115.303 1.594 . . . . 0.0 115.303 176.506 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -66.47 -41.36 89.14 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 115.742 1.756 . . . . 0.0 115.742 176.35 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 29.2 tptp -62.91 -36.65 84.06 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 169.595 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.28 -46.1 81.79 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 115.452 1.649 . . . . 0.0 115.452 171.432 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -62.15 -39.33 92.24 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 115.168 1.544 . . . . 0.0 115.168 170.795 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -60.34 -46.0 91.47 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 114.938 1.459 . . . . 0.0 114.938 172.872 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 34.3 mmt -59.87 -50.36 74.08 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 114.813 1.412 . . . . 0.0 114.813 171.624 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 88.1 mt -75.97 -23.88 55.36 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 117.076 2.25 . . . . 0.0 117.076 -178.985 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 91.7 p -58.8 -35.99 73.75 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 117.082 2.253 . . . . 0.0 117.082 176.574 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 37.9 mtmm -63.07 -31.84 73.08 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 115.719 1.748 . . . . 0.0 115.719 169.656 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -75.51 122.62 24.14 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.533 1.133 . . . . 0.0 111.667 -171.44 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 13.4 ptp180 -63.56 -20.58 65.75 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 119.224 3.046 . . . . 0.0 119.224 -179.826 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 39.2 m80 -89.63 136.9 32.77 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 119.8 1.182 . . . . 0.0 112.718 -168.704 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -77.23 125.31 29.12 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.38 169.674 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 107.43 -21.38 30.81 Favored Glycine 0 CA--C 1.547 2.046 0 CA-C-O 117.036 -1.98 . . . . 0.0 115.879 -168.849 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.23 111.21 2.49 Favored 'General case' 0 N--CA 1.486 1.352 0 CA-C-N 120.823 2.311 . . . . 0.0 111.821 -171.917 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.8 p90 -123.94 158.19 32.58 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 113.826 1.046 . . . . 0.0 113.826 -168.569 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.2 pp -135.67 133.0 37.69 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 168.327 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 74.1 mt -88.95 109.82 20.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 105.661 -1.978 . . . . 0.0 105.661 171.808 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 50.8 ptt85 -91.1 144.06 26.03 Favored 'General case' 0 N--CA 1.486 1.327 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.097 171.657 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -90.24 126.13 35.72 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 169.113 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 53.0 m -67.07 128.78 37.66 Favored 'General case' 0 N--CA 1.487 1.375 0 CA-C-O 121.508 0.671 . . . . 0.0 111.326 -177.937 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -68.64 -47.83 65.58 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 -172.895 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 90.8 p -61.73 -36.89 82.27 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 116.655 2.094 . . . . 0.0 116.655 169.887 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -123.01 96.74 44.51 Favored Pre-proline 0 CA--C 1.563 1.454 0 CA-C-N 119.421 1.01 . . . . 0.0 109.439 177.776 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -58.05 -33.62 97.5 Favored 'Trans proline' 0 C--N 1.371 1.712 0 N-CA-C 120.055 3.059 . . . . 0.0 120.055 178.472 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -87.26 42.65 3.15 Favored Glycine 0 CA--C 1.552 2.389 0 N-CA-C 115.565 0.986 . . . . 0.0 115.565 169.266 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -149.44 110.19 4.29 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 105.03 -2.211 . . . . 0.0 105.03 177.532 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -95.33 168.01 10.99 Favored 'General case' 0 N--CA 1.489 1.475 0 CA-C-O 121.672 0.748 . . . . 0.0 110.105 176.426 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 73.4 m -143.62 114.28 7.61 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 179.327 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 24.9 tp -79.89 107.34 12.6 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 124.442 1.097 . . . . 0.0 109.041 176.257 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 9.4 m -102.79 95.49 6.22 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 -169.956 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 20.0 t -108.62 120.22 59.6 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 CA-C-N 119.113 0.869 . . . . 0.0 109.254 -169.485 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -87.72 96.79 10.57 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.125 0.57 . . . . 0.0 109.526 173.711 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 18.3 t80 -120.53 100.16 6.98 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 179.222 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 68.35 73.0 0.74 Allowed Glycine 0 CA--C 1.542 1.759 0 N-CA-C 115.392 0.917 . . . . 0.0 115.392 175.227 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . 0.321 64.7 m-80 73.67 -22.88 0.23 Allowed 'General case' 0 N--CA 1.5 2.052 0 N-CA-C 118.564 2.802 . . . . 0.0 118.564 -179.821 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -123.91 139.09 54.31 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-N 119.538 1.063 . . . . 0.0 109.935 -169.938 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 39.4 t -100.91 112.39 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 -179.176 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -101.43 115.82 31.37 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.834 0.854 . . . . 0.0 109.208 -174.789 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 -97.12 107.54 20.09 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 115.007 -0.997 . . . . 0.0 108.587 -174.443 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -104.15 119.38 38.81 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 -176.858 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.8 tppp? -75.92 118.5 18.77 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-O 121.98 0.895 . . . . 0.0 110.646 -173.09 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 92.1 t -92.0 101.41 12.52 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.373 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 -179.51 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 68.6 mt -86.37 147.03 26.22 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 123.588 0.755 . . . . 0.0 111.072 178.396 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 73.5 mtp180 -113.0 147.23 37.6 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 123.058 0.543 . . . . 0.0 110.933 -177.776 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -135.41 132.07 37.03 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 123.276 0.63 . . . . 0.0 110.385 173.829 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 81.36 -113.3 3.61 Favored Glycine 0 CA--C 1.541 1.713 0 C-N-CA 122.957 0.313 . . . . 0.0 113.0 175.689 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -83.76 -68.09 0.74 Allowed 'General case' 0 N--CA 1.487 1.401 0 CA-C-O 118.929 -0.558 . . . . 0.0 110.979 172.465 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -162.25 73.04 0.2 Allowed Glycine 0 N--CA 1.477 1.374 0 CA-C-N 118.477 0.581 . . . . 0.0 111.69 169.93 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -99.12 100.93 12.12 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 176.561 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 79.9 m-85 -83.46 112.31 19.84 Favored 'General case' 0 CA--C 1.557 1.227 0 CA-C-N 114.503 -1.226 . . . . 0.0 109.581 -169.585 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -125.13 116.13 21.56 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 123.717 0.807 . . . . 0.0 109.155 -177.115 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -115.7 -38.29 3.75 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 178.773 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 53.2 t90 -99.91 -82.72 0.44 Allowed 'General case' 0 CA--C 1.56 1.336 0 C-N-CA 124.804 1.242 . . . . 0.0 108.679 -179.814 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 99.8 t -137.78 -66.53 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 -175.678 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 10.6 p -79.7 139.05 18.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 C-N-CA 123.69 0.796 . . . . 0.0 110.906 -177.676 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.67 168.11 19.79 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-O 122.256 1.027 . . . . 0.0 113.231 178.631 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -147.23 113.4 5.86 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 -170.104 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 23.3 t30 -59.45 -40.58 87.27 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 115.857 1.799 . . . . 0.0 115.857 -179.49 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 66.0 m -110.65 157.4 19.75 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-O 122.018 0.913 . . . . 0.0 111.203 174.089 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 90.4 mt -66.29 -30.47 70.89 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 114.457 1.28 . . . . 0.0 114.457 169.262 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -63.02 -39.74 95.67 Favored 'General case' 0 CA--C 1.573 1.858 0 CA-C-N 119.89 1.223 . . . . 0.0 113.702 169.287 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -60.8 -43.31 98.31 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 114.217 1.191 . . . . 0.0 114.217 169.282 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 9.5 tt -56.47 -49.84 73.47 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 172.568 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 13.6 m -63.89 -49.11 83.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 N-CA-C 113.831 1.049 . . . . 0.0 113.831 176.973 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -65.8 -33.02 74.89 Favored 'General case' 0 CA--C 1.569 1.68 0 N-CA-C 114.917 1.451 . . . . 0.0 114.917 -175.995 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -61.57 -59.63 4.93 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 119.852 1.205 . . . . 0.0 112.93 169.873 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . 0.261 70.1 m-70 -69.45 -9.23 52.75 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 117.67 2.47 . . . . 0.0 117.67 177.069 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 49.2 ttm-85 -59.03 -32.31 69.62 Favored 'General case' 0 CA--C 1.575 1.925 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 167.573 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 70.1 m -105.11 -35.77 7.5 Favored 'General case' 0 CA--C 1.566 1.581 0 C-N-CA 124.987 1.315 . . . . 0.0 114.045 169.368 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 57.2 m -90.9 155.32 18.83 Favored 'General case' 0 N--CA 1.498 1.959 0 CA-C-N 120.352 1.433 . . . . 0.0 111.983 179.684 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 27.8 t -75.01 135.34 41.3 Favored 'General case' 0 N--CA 1.484 1.263 0 O-C-N 121.545 -0.722 . . . . 0.0 112.73 176.953 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 11.6 t -72.88 -54.32 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 CA-C-O 118.63 -0.7 . . . . 0.0 111.179 170.878 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 39.2 t -101.86 127.57 48.62 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.07 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -62.77 -32.2 73.31 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 116.437 2.014 . . . . 0.0 116.437 -179.49 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 70.9 m-80 -76.37 -62.65 1.55 Allowed 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 119.567 1.076 . . . . 0.0 112.18 169.897 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -91.05 120.78 32.3 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 119.163 0.892 . . . . 0.0 109.258 -178.302 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 58.5 mt-30 -76.37 107.46 8.64 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.794 -0.566 . . . . 0.0 111.505 -174.252 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 14.0 mm -111.72 122.47 66.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 -173.658 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -125.81 129.16 48.88 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 -179.14 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 10.0 mp -78.72 123.09 26.8 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -169.043 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 14.5 tpt180 -111.18 150.72 29.11 Favored 'General case' 0 CA--C 1.56 1.35 0 C-N-CA 125.615 1.566 . . . . 0.0 109.164 172.442 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -76.48 157.41 32.18 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.79 -1.194 . . . . 0.0 112.249 172.262 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -64.31 152.52 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 N-CA-C 114.152 1.167 . . . . 0.0 114.152 -175.305 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 . . . . . 0 N--CA 1.488 1.431 0 CA-C-O 122.843 1.306 . . . . 0.0 108.358 171.952 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.257 0 N-CA-C 111.575 -0.61 . . . . 0.0 111.575 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 71.6 m -82.64 110.15 17.45 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.053 0.541 . . . . 0.0 110.164 -178.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 64.5 p-90 -76.0 -36.21 59.28 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 117.053 2.242 . . . . 0.0 117.053 -175.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -81.33 121.78 26.64 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 120.696 1.589 . . . . 0.0 110.237 -173.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -124.35 106.42 10.23 Favored 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 104.543 -2.391 . . . . 0.0 104.543 173.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -39.15 -67.57 0.57 Allowed Glycine 0 N--CA 1.487 2.056 0 N-CA-C 119.765 2.666 . . . . 0.0 119.765 -169.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -151.55 91.7 1.69 Allowed 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.46 157.35 62.15 Favored Pre-proline 0 N--CA 1.5 2.066 0 CA-C-O 118.467 -0.778 . . . . 0.0 109.898 177.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -54.68 159.3 9.08 Favored 'Trans proline' 0 C--N 1.371 1.755 0 C-N-CA 123.4 2.733 . . . . 0.0 117.619 178.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 59.6 ttt180 -65.94 -40.02 90.98 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 114.503 1.297 . . . . 0.0 114.503 170.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -66.69 -44.18 82.43 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 173.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -61.02 -38.12 84.97 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 115.45 1.648 . . . . 0.0 115.45 170.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.94 -45.32 94.19 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 115.476 1.658 . . . . 0.0 115.476 169.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -60.95 -42.69 98.72 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 115.199 1.555 . . . . 0.0 115.199 171.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -59.57 -51.27 70.54 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 174.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -63.21 -45.96 89.24 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 115.024 1.491 . . . . 0.0 115.024 177.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 6.5 mp -70.05 -41.12 74.63 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 114.854 1.427 . . . . 0.0 114.854 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 69.8 m -58.76 -35.04 72.13 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 115.839 1.792 . . . . 0.0 115.839 169.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 59.4 mttm -64.29 -38.28 90.49 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 115.287 1.588 . . . . 0.0 115.287 169.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -53.54 137.07 37.39 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 179.313 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 36.0 ptt180 -66.97 -22.85 65.91 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 118.029 2.603 . . . . 0.0 118.029 174.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 67.0 m80 -89.33 138.03 31.8 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-N 119.186 0.903 . . . . 0.0 112.017 -169.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -77.95 124.63 28.24 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.065 169.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.61 11.95 58.75 Favored Glycine 0 CA--C 1.555 2.569 0 CA-C-O 117.839 -1.534 . . . . 0.0 116.866 -169.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -71.34 123.53 22.52 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 120.443 2.122 . . . . 0.0 112.135 -170.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 17.5 p90 -135.7 160.86 37.22 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 116.359 1.985 . . . . 0.0 116.359 -168.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.1 pp -144.14 141.82 30.21 Favored 'General case' 0 CA--C 1.556 1.188 0 CA-C-N 113.786 -1.552 . . . . 0.0 108.277 167.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 52.7 mt -97.62 112.46 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 172.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -105.02 150.42 24.97 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 124.4 1.08 . . . . 0.0 111.905 176.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -89.72 138.28 31.61 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 169.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 68.3 m -64.08 137.18 57.85 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.847 0.859 . . . . 0.0 112.305 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -76.15 109.6 9.96 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.241 1.016 . . . . 0.0 110.28 -169.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . 0.374 16.6 m 103.39 -34.11 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.844 0 CA-C-N 112.286 -2.233 . . . . 0.0 114.665 -172.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -93.15 112.62 57.05 Favored Pre-proline 0 CA--C 1.567 1.61 0 CA-C-N 120.628 1.558 . . . . 0.0 111.685 -176.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -81.48 134.5 8.86 Favored 'Trans proline' 0 C--N 1.371 1.732 0 C-N-CA 123.137 2.558 . . . . 0.0 112.901 -179.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 66.66 33.52 84.66 Favored Glycine 0 CA--C 1.552 2.362 0 N-CA-C 117.012 1.565 . . . . 0.0 117.012 -169.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -126.45 92.0 3.47 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 105.858 -1.904 . . . . 0.0 105.858 -178.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -93.24 163.39 13.64 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-O 122.211 1.005 . . . . 0.0 111.687 -169.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 72.8 m -147.67 120.73 8.83 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 29.9 tp -79.61 103.85 9.81 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 171.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 3.1 m -84.94 108.16 17.44 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 172.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 6.8 p -135.18 126.54 46.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 -173.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -75.72 112.21 11.86 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.645 174.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 12.5 m-30 -117.84 106.82 13.4 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 176.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 85.51 -95.79 2.03 Favored Glycine 0 CA--C 1.54 1.612 0 N-CA-C 111.154 -0.778 . . . . 0.0 111.154 -172.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -127.6 -24.19 3.33 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 114.956 1.465 . . . . 0.0 114.956 169.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -89.24 139.13 30.8 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 119.056 0.844 . . . . 0.0 110.558 -175.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 59.3 t -87.85 110.93 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 N-CA-C 106.66 -1.608 . . . . 0.0 106.66 178.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 69.0 mt-30 -106.95 120.56 42.39 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.177 -169.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 19.8 m-70 -99.65 97.69 8.63 Favored 'General case' 0 CA--C 1.553 1.093 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 -170.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -93.11 125.03 37.51 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 -179.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -75.6 119.84 20.19 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-O 121.32 0.581 . . . . 0.0 112.222 -170.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 90.9 t -93.79 97.86 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 N-CA-C 106.374 -1.713 . . . . 0.0 106.374 178.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 71.0 mt -85.57 154.76 21.51 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.682 0.793 . . . . 0.0 110.951 177.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 65.0 mtp180 -115.87 129.39 56.4 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.505 -0.747 . . . . 0.0 110.798 -177.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -106.23 94.12 4.98 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 123.323 0.649 . . . . 0.0 110.258 176.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 88.96 -112.84 4.01 Favored Glycine 0 CA--C 1.541 1.706 0 N-CA-C 113.918 0.327 . . . . 0.0 113.918 172.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -89.03 -94.25 0.11 Allowed 'General case' 0 N--CA 1.486 1.341 0 CA-C-O 118.228 -0.892 . . . . 0.0 111.35 -169.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -113.73 80.3 0.28 Allowed Glycine 0 N--CA 1.481 1.665 0 CA-C-N 119.335 0.971 . . . . 0.0 110.689 177.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -142.5 146.58 34.87 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -175.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -145.78 108.36 4.48 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 -169.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 21.2 p90 -126.74 117.77 23.36 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.749 0.82 . . . . 0.0 109.602 -175.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -107.95 -42.83 4.58 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 170.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 47.2 t90 -92.03 -74.07 0.53 Allowed 'General case' 0 CA--C 1.558 1.255 0 C-N-CA 124.959 1.304 . . . . 0.0 110.182 -169.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . 0.267 14.8 p -147.24 -64.98 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 C-N-CA 123.612 0.765 . . . . 0.0 109.188 174.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 9.4 m -79.56 142.21 14.29 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.426 0 C-N-CA 124.175 0.99 . . . . 0.0 111.481 -178.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.87 154.65 28.23 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -177.448 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -133.66 116.41 15.79 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 106.471 -1.677 . . . . 0.0 106.471 -171.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -55.68 -50.59 69.86 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 115.884 1.809 . . . . 0.0 115.884 -173.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 69.0 m -106.57 161.58 14.5 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-O 122.025 0.916 . . . . 0.0 111.21 173.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 84.5 mt -67.2 -29.07 68.64 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 168.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -67.07 -39.66 86.87 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-N 119.652 1.114 . . . . 0.0 113.04 169.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -60.47 -41.46 94.23 Favored 'General case' 0 CA--C 1.568 1.67 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 169.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 9.1 tt -56.99 -45.56 82.88 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 114.139 1.163 . . . . 0.0 114.139 169.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 41.3 t -60.01 -61.8 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 C-N-CA 124.308 1.043 . . . . 0.0 112.661 172.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 -63.16 -28.42 70.04 Favored 'General case' 0 CA--C 1.566 1.587 0 N-CA-C 115.879 1.807 . . . . 0.0 115.879 -174.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -63.12 -61.68 2.21 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 119.594 1.088 . . . . 0.0 112.01 169.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . 0.308 49.1 m-70 -70.11 -8.91 53.35 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 118.166 2.654 . . . . 0.0 118.166 177.414 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 59.2 ttm-85 -61.86 -28.81 69.76 Favored 'General case' 0 CA--C 1.579 2.092 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 167.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 71.0 m -110.43 -31.87 7.13 Favored 'General case' 0 CA--C 1.568 1.67 0 C-N-CA 125.199 1.4 . . . . 0.0 114.245 169.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 47.6 m -90.56 149.45 22.15 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-N 120.389 1.449 . . . . 0.0 110.445 175.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 22.8 t -80.96 137.26 36.1 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.741 -1.224 . . . . 0.0 113.242 -179.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 75.5 t -75.08 -58.82 3.99 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.834 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.126 169.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 73.4 m -89.66 114.99 26.7 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.909 0.884 . . . . 0.0 108.724 -177.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 19.3 mmm180 -89.24 81.51 6.69 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 122.33 1.062 . . . . 0.0 112.249 -169.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -160.32 -77.71 0.06 Allowed 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 103.816 -2.661 . . . . 0.0 103.816 173.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -97.08 146.57 24.89 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 169.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 65.5 mt-30 -79.35 112.27 16.42 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.665 -0.647 . . . . 0.0 111.222 -175.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -124.16 127.05 73.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 -178.023 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -119.88 168.33 11.22 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 122.545 1.164 . . . . 0.0 112.447 -169.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 11.0 mp -90.39 115.31 27.47 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 124.318 1.047 . . . . 0.0 110.251 -178.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.21 147.7 42.26 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 124.234 1.013 . . . . 0.0 109.302 178.043 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -74.11 152.17 39.95 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 122.112 0.958 . . . . 0.0 113.456 -176.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 14.3 pt -72.9 164.43 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 CA-C-N 114.903 -1.044 . . . . 0.0 113.583 -178.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 24.4 tp10 . . . . . 0 N--CA 1.485 1.315 0 CA-C-O 122.834 1.302 . . . . 0.0 109.315 172.076 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.401 0 N-CA-C 111.356 -0.698 . . . . 0.0 111.356 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 89.1 p -84.23 118.05 23.91 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.059 0.544 . . . . 0.0 111.524 -179.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . 0.259 65.9 p-90 -78.82 -51.78 9.26 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 172.061 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -81.82 140.79 33.97 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-N 119.596 1.089 . . . . 0.0 110.826 175.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -116.49 -87.27 0.61 Allowed 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 175.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 138.49 94.15 0.3 Allowed Glycine 0 N--CA 1.48 1.628 0 CA-C-N 119.603 1.092 . . . . 0.0 111.755 177.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . 0.259 20.5 tptm 67.14 73.42 0.34 Allowed 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 124.283 1.033 . . . . 0.0 113.56 173.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 28.4 pt -128.77 151.08 76.62 Favored Pre-proline 0 CA--C 1.576 1.95 0 C-N-CA 123.924 0.89 . . . . 0.0 109.443 176.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -75.42 172.25 16.68 Favored 'Trans proline' 0 CA--C 1.562 1.896 0 C-N-CA 122.997 2.464 . . . . 0.0 114.678 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 53.5 ttt180 -67.03 -41.3 86.8 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 115.771 1.767 . . . . 0.0 115.771 -179.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -66.9 -42.73 84.96 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 115.666 1.728 . . . . 0.0 115.666 177.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -64.94 -36.03 83.08 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 115.028 1.492 . . . . 0.0 115.028 169.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.82 -45.25 90.46 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 115.734 1.753 . . . . 0.0 115.734 170.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -62.43 -38.48 89.9 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 115.246 1.572 . . . . 0.0 115.246 170.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -61.33 -50.43 72.97 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 114.499 1.296 . . . . 0.0 114.499 173.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 39.2 tpp -57.5 -46.53 83.65 Favored 'General case' 0 CA--C 1.564 1.488 0 N-CA-C 115.604 1.705 . . . . 0.0 115.604 172.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 9.2 mp -70.65 -24.9 62.78 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 116.621 2.082 . . . . 0.0 116.621 175.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 71.6 m -57.28 -35.43 69.78 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-N 120.882 1.674 . . . . 0.0 114.908 169.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 56.8 mttp -60.45 -38.5 84.35 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 115.112 1.523 . . . . 0.0 115.112 169.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -68.49 122.29 18.14 Favored 'General case' 0 CA--C 1.556 1.183 0 C-N-CA 124.829 1.251 . . . . 0.0 112.156 178.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 16.4 ptm180 -78.24 -18.05 55.89 Favored 'General case' 0 CA--C 1.569 1.701 0 N-CA-C 118.199 2.666 . . . . 0.0 118.199 175.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 41.7 m80 -89.57 147.39 23.97 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 119.483 1.038 . . . . 0.0 113.722 -168.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -81.77 117.91 22.45 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 169.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 118.22 -32.89 5.08 Favored Glycine 0 CA--C 1.54 1.613 0 CA-C-O 117.704 -1.609 . . . . 0.0 116.35 -169.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -60.91 103.98 0.32 Allowed 'General case' 0 N--CA 1.486 1.339 0 CA-C-N 119.257 1.529 . . . . 0.0 113.9 -169.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 18.4 p90 -120.59 162.48 19.55 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 -168.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.3 pp -135.29 132.16 37.41 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 167.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 70.0 mt -91.82 114.31 28.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 105.611 -1.996 . . . . 0.0 105.611 170.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 46.8 ptt85 -100.45 156.07 17.47 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-N 114.596 -1.183 . . . . 0.0 110.484 170.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -87.67 128.03 35.29 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 168.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 16.4 t -60.36 137.83 58.07 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 113.753 1.02 . . . . 0.0 113.753 -170.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.06 119.86 17.89 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-O 122.907 1.337 . . . . 0.0 111.536 -171.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . 0.33 5.4 t 84.98 -22.21 0.21 Allowed 'General case' 0 N--CA 1.493 1.693 0 CA-C-N 111.569 -2.56 . . . . 0.0 116.075 -169.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -108.55 92.9 10.8 Favored Pre-proline 0 CA--C 1.565 1.533 0 CA-C-N 120.662 1.574 . . . . 0.0 110.213 177.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -73.52 133.15 18.51 Favored 'Trans proline' 0 C--N 1.373 1.821 0 C-N-CA 123.19 2.593 . . . . 0.0 111.429 171.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 98.69 -34.18 5.51 Favored Glycine 0 CA--C 1.553 2.456 0 CA-C-O 119.017 -0.879 . . . . 0.0 114.275 -168.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -79.64 131.84 36.09 Favored 'General case' 0 N--CA 1.484 1.257 0 CA-C-N 118.675 1.238 . . . . 0.0 108.599 169.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -116.63 164.09 15.13 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-O 122.124 0.964 . . . . 0.0 110.58 -178.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 69.0 m -143.54 115.32 8.22 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 -177.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 16.6 tp -83.8 104.93 14.29 Favored 'General case' 0 CA--C 1.561 1.386 0 C-N-CA 124.369 1.068 . . . . 0.0 108.502 174.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.8 m -93.63 108.62 20.32 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 -179.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 24.0 t -116.38 124.5 72.65 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 CA-C-N 119.762 1.164 . . . . 0.0 108.301 -169.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 58.6 tptt -84.06 120.65 26.4 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.211 0.605 . . . . 0.0 109.891 171.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 3.9 m-30 -89.23 -140.03 0.13 Allowed 'General case' 0 CA--C 1.567 1.633 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 173.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -58.13 -71.0 0.82 Allowed Glycine 0 CA--C 1.547 2.053 0 C-N-CA 123.96 0.791 . . . . 0.0 114.242 169.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 31.6 t30 -140.04 58.72 1.59 Allowed 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 117.534 0.667 . . . . 0.0 111.281 169.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -160.0 141.6 12.75 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 124.016 0.926 . . . . 0.0 108.627 176.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 57.2 t -107.35 109.83 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 177.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 18.6 mp0 -101.85 126.76 48.8 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.879 0.871 . . . . 0.0 109.777 179.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 11.9 m-70 -101.78 97.0 7.45 Favored 'General case' 0 CA--C 1.553 1.082 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 -175.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -86.41 128.81 34.99 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 172.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -91.02 118.87 30.73 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 121.208 0.528 . . . . 0.0 110.889 -169.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 91.9 t -85.91 110.21 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 107.224 -1.398 . . . . 0.0 107.224 -177.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 56.8 mt -104.31 134.41 47.58 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 -173.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 37.3 mtm180 -99.52 131.47 45.51 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 118.176 0.444 . . . . 0.0 110.929 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -85.6 -54.47 4.53 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 174.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 179.98 139.44 3.77 Favored Glycine 0 CA--C 1.542 1.732 0 CA-C-N 119.823 1.192 . . . . 0.0 113.77 -178.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . 0.344 . . 78.53 -79.15 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 125.294 1.438 . . . . 0.0 113.3 175.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -157.18 78.13 0.19 Allowed Glycine 0 N--CA 1.478 1.463 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 172.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -143.07 144.1 32.12 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -171.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -138.87 100.6 4.09 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 -172.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -99.89 105.43 17.16 Favored 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 175.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -101.63 -49.94 3.86 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-N 114.327 -1.306 . . . . 0.0 111.239 175.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 79.0 t90 -129.48 101.71 6.07 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 -172.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.405 HG12 ' H ' ' A' ' 123' ' ' VAL 0.509 10.7 p 60.75 -90.68 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 C-N-CA 125.227 1.411 . . . . 0.0 114.188 -179.45 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.405 ' H ' HG12 ' A' ' 122' ' ' VAL . 21.1 m -79.64 158.44 4.54 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.493 0 C-N-CA 124.449 1.1 . . . . 0.0 112.398 -175.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -79.72 152.7 29.73 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 121.876 0.846 . . . . 0.0 112.978 179.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -135.73 109.42 8.04 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 105.9 -1.889 . . . . 0.0 105.9 -171.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 15.1 t30 -57.89 -53.54 57.08 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 115.77 1.767 . . . . 0.0 115.77 -170.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 67.7 m -98.05 149.57 22.34 Favored 'General case' 0 N--CA 1.483 1.225 0 CA-C-O 123.04 1.4 . . . . 0.0 111.337 178.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 8.0 tp -65.96 -31.29 72.12 Favored 'General case' 0 CA--C 1.571 1.764 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 169.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -70.18 -37.85 75.23 Favored 'General case' 0 CA--C 1.57 1.746 0 CA-C-O 117.681 -1.152 . . . . 0.0 113.796 169.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . 0.329 9.1 pt-20 -62.16 -31.14 71.61 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-N 121.139 1.79 . . . . 0.0 115.088 169.319 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 59.6 tp -57.79 -44.13 86.06 Favored 'General case' 0 CA--C 1.574 1.868 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 168.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . 0.333 7.1 p -65.3 -57.61 10.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 CA-C-N 120.17 1.35 . . . . 0.0 113.918 172.644 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -60.32 -23.49 64.25 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 117.391 2.367 . . . . 0.0 117.391 176.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 84.8 t80 -66.25 -61.33 2.08 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-N 119.304 0.956 . . . . 0.0 112.043 169.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 71.4 m-70 -69.83 -9.54 55.13 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 117.734 2.494 . . . . 0.0 117.734 176.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 38.0 ttm180 -59.52 -29.11 67.65 Favored 'General case' 0 CA--C 1.58 2.119 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 167.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 70.7 m -110.2 -30.61 7.66 Favored 'General case' 0 CA--C 1.571 1.771 0 C-N-CA 125.483 1.513 . . . . 0.0 114.037 169.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 56.8 m -90.46 157.36 17.61 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-N 120.546 1.521 . . . . 0.0 111.266 177.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 8.2 t -75.93 129.79 37.47 Favored 'General case' 0 CA--C 1.56 1.363 0 O-C-N 121.491 -0.756 . . . . 0.0 112.8 177.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 14.1 t -69.15 -50.69 50.68 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 C-N-CA 123.807 0.843 . . . . 0.0 111.655 173.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 25.3 t -88.56 145.07 25.92 Favored 'General case' 0 CA--C 1.558 1.259 0 C-N-CA 123.341 0.656 . . . . 0.0 110.211 173.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 84.7 mtt85 -69.95 -50.39 42.43 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 177.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 21.0 m120 -72.84 -55.59 6.44 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 113.445 0.906 . . . . 0.0 113.445 174.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -83.26 146.7 28.41 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-N 118.978 0.808 . . . . 0.0 111.432 -177.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 60.5 mt-30 -86.02 94.78 9.31 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.337 0.589 . . . . 0.0 109.607 176.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 44.1 mm -114.44 133.18 61.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 -174.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -127.56 117.88 22.9 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 -169.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 14.1 tp -80.55 125.57 30.14 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 124.442 1.097 . . . . 0.0 113.952 -168.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 32.5 mmt180 -138.05 160.19 40.02 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 124.085 0.954 . . . . 0.0 110.525 -170.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -73.91 152.98 40.01 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.607 -1.308 . . . . 0.0 112.924 177.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.1 pp -66.55 159.73 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 -179.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 . . . . . 0 N--CA 1.485 1.299 0 CA-C-O 123.981 1.848 . . . . 0.0 108.584 -176.89 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.354 0 N-CA-C 111.508 -0.637 . . . . 0.0 111.508 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 89.5 p -85.74 120.25 26.95 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 123.038 0.535 . . . . 0.0 111.924 -174.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . 0.253 1.6 p90 -156.59 -44.35 0.07 Allowed 'General case' 0 N--CA 1.488 1.448 0 CA-C-O 118.257 -0.878 . . . . 0.0 113.038 178.465 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -82.53 141.09 32.91 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 120.598 1.544 . . . . 0.0 112.345 -171.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -118.83 -71.91 0.71 Allowed 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 115.087 -0.96 . . . . 0.0 109.127 174.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 104.22 95.94 2.38 Favored Glycine 0 N--CA 1.481 1.658 0 CA-C-N 119.195 0.907 . . . . 0.0 111.655 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . 0.312 94.9 mttt 63.35 71.03 0.52 Allowed 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 124.615 1.166 . . . . 0.0 114.027 -178.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 26.1 pt -122.8 150.53 58.87 Favored Pre-proline 0 CA--C 1.576 1.948 0 C-N-CA 124.284 1.034 . . . . 0.0 108.646 170.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -72.42 163.97 37.0 Favored 'Trans proline' 0 CA--C 1.562 1.881 0 C-N-CA 122.825 2.35 . . . . 0.0 114.128 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 58.6 ttt180 -63.08 -41.78 99.5 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 115.592 1.701 . . . . 0.0 115.592 179.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.41 -46.31 83.81 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 115.305 1.594 . . . . 0.0 115.305 177.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -63.22 -35.33 79.98 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 115.346 1.61 . . . . 0.0 115.346 169.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.78 -44.72 95.45 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 115.42 1.637 . . . . 0.0 115.42 169.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -61.92 -40.73 96.5 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 115.213 1.56 . . . . 0.0 115.213 170.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -61.48 -50.34 73.12 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 114.895 1.442 . . . . 0.0 114.895 173.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -62.88 -43.98 97.34 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 115.02 1.489 . . . . 0.0 115.02 176.447 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 8.5 mp -65.19 -42.51 93.54 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 114.826 1.417 . . . . 0.0 114.826 172.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 67.5 m -54.98 -36.67 65.65 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 115.87 1.804 . . . . 0.0 115.87 169.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -63.34 -35.49 80.56 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 115.26 1.578 . . . . 0.0 115.26 169.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -63.21 126.86 28.8 Favored 'General case' 0 CA--C 1.557 1.228 0 CA-C-O 122.839 1.304 . . . . 0.0 112.61 172.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 14.5 ptp180 -67.45 -16.53 64.27 Favored 'General case' 0 CA--C 1.567 1.627 0 N-CA-C 119.026 2.973 . . . . 0.0 119.026 175.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 48.2 m80 -89.55 142.33 27.77 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 119.6 1.091 . . . . 0.0 113.281 -168.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -75.94 127.37 32.85 Favored 'General case' 0 N--CA 1.489 1.475 0 CA-C-N 115.014 -0.994 . . . . 0.0 108.632 169.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.45 4.31 66.18 Favored Glycine 0 CA--C 1.555 2.539 0 CA-C-O 117.278 -1.845 . . . . 0.0 117.621 -169.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -70.02 114.88 8.62 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 121.02 2.41 . . . . 0.0 112.73 -169.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 22.4 p90 -127.63 158.54 37.27 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 115.41 1.633 . . . . 0.0 115.41 -168.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.1 pp -134.99 158.21 44.93 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 124.169 0.988 . . . . 0.0 109.535 168.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.8 mp -114.36 113.71 44.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 104.83 -2.285 . . . . 0.0 104.83 169.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 46.6 ptt85 -101.3 140.68 35.26 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 123.783 0.833 . . . . 0.0 109.07 169.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -79.59 138.42 37.44 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.683 -0.636 . . . . 0.0 109.53 170.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 58.2 m -66.79 128.21 35.42 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 123.13 0.572 . . . . 0.0 111.511 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -64.92 -50.92 64.59 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 114.403 1.26 . . . . 0.0 114.403 -171.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.8 t -64.25 -40.31 95.74 Favored 'General case' 0 CA--C 1.564 1.514 0 N-CA-C 115.487 1.662 . . . . 0.0 115.487 170.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -111.8 95.27 27.69 Favored Pre-proline 0 CA--C 1.564 1.493 0 CA-C-N 119.32 0.964 . . . . 0.0 110.819 -177.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.43 129.19 16.49 Favored 'Trans proline' 0 C--N 1.372 1.768 0 C-N-CA 123.054 2.503 . . . . 0.0 111.014 169.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 108.27 -35.43 4.98 Favored Glycine 0 CA--C 1.553 2.434 0 CA-C-O 118.894 -0.948 . . . . 0.0 113.609 -168.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -83.79 131.91 34.87 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-N 118.63 1.215 . . . . 0.0 108.24 169.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -115.77 168.07 10.36 Favored 'General case' 0 CA--C 1.56 1.357 0 CA-C-O 122.083 0.945 . . . . 0.0 110.181 -177.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 72.8 m -145.57 112.8 6.15 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 -177.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 19.9 tp -88.54 104.34 16.74 Favored 'General case' 0 CA--C 1.561 1.393 0 C-N-CA 124.654 1.181 . . . . 0.0 109.429 177.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.8 m -82.56 119.15 23.89 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 124.879 1.272 . . . . 0.0 108.065 173.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 24.0 t -129.36 122.84 56.66 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.193 0 CA-C-N 120.805 1.638 . . . . 0.0 107.782 -175.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 59.4 tttp -80.4 138.62 36.67 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.458 169.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -150.34 105.88 3.39 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 169.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 83.76 -106.75 2.88 Favored Glycine 0 CA--C 1.54 1.61 0 N-CA-C 110.894 -0.882 . . . . 0.0 110.894 -174.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 21.3 m120 -133.9 63.74 1.62 Allowed 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 169.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -160.77 127.67 4.17 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 123.522 0.729 . . . . 0.0 109.481 175.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 99.9 t -103.57 106.39 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 177.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -107.16 131.3 54.3 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.876 0.87 . . . . 0.0 110.82 -176.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 21.8 m-70 -103.33 107.66 18.58 Favored 'General case' 0 CA--C 1.552 1.019 0 C-N-CA 123.649 0.78 . . . . 0.0 109.598 -169.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -91.33 131.55 36.75 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 115.111 -0.95 . . . . 0.0 108.6 175.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 38.3 mtmm -80.52 117.1 20.94 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.239 0.542 . . . . 0.0 109.628 178.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 95.6 t -94.48 98.33 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 N-CA-C 105.994 -1.854 . . . . 0.0 105.994 176.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -97.14 140.26 31.9 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 178.257 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 53.3 mtm180 -100.0 133.35 44.51 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 122.673 0.389 . . . . 0.0 110.88 -176.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . 0.253 4.7 p-10 -80.0 -66.53 0.86 Allowed 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 176.085 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -94.51 -116.83 2.86 Favored Glycine 0 CA--C 1.541 1.661 0 CA-C-N 119.067 0.848 . . . . 0.0 112.211 -177.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -86.62 -83.11 0.19 Allowed 'General case' 0 N--CA 1.487 1.385 0 CA-C-O 118.441 -0.79 . . . . 0.0 110.028 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -109.71 78.91 0.24 Allowed Glycine 0 N--CA 1.479 1.565 0 N-CA-C 109.971 -1.252 . . . . 0.0 109.971 169.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -131.17 78.54 1.84 Allowed 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 -174.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -80.36 119.42 23.06 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 124.114 0.966 . . . . 0.0 111.402 -169.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 10.5 p90 -139.64 123.08 17.18 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 122.49 0.316 . . . . 0.0 110.155 -178.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -112.61 -37.82 4.8 Favored 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 123.61 0.764 . . . . 0.0 112.634 168.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 51.0 t90 -84.04 -86.17 0.12 Allowed 'General case' 0 CA--C 1.56 1.344 0 C-N-CA 124.805 1.242 . . . . 0.0 109.272 -175.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . 0.258 6.1 m -139.88 -61.02 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 C-N-CA 123.833 0.853 . . . . 0.0 109.836 173.356 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.3 p -79.97 140.73 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 CA-C-N 119.094 0.861 . . . . 0.0 111.203 -176.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.97 156.93 24.44 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 -179.264 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -139.45 120.6 14.72 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 -169.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 66.7 m-80 -61.25 -39.91 92.1 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 116.566 2.062 . . . . 0.0 116.566 -173.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 66.6 m -123.75 160.38 27.42 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-O 121.882 0.849 . . . . 0.0 111.898 -176.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 98.1 mt -84.39 86.51 7.26 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 169.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 167.32 -58.56 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 104.087 -2.56 . . . . 0.0 104.087 -168.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -58.75 -44.87 90.66 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 124.379 1.071 . . . . 0.0 113.72 168.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 8.6 tt -57.25 -50.34 73.19 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 114.722 1.379 . . . . 0.0 114.722 169.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 1.7 m -66.01 -49.11 79.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -178.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -67.92 -35.18 78.01 Favored 'General case' 0 CA--C 1.566 1.594 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 -178.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 79.8 t80 -61.11 -55.18 35.52 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-N 119.894 1.225 . . . . 0.0 112.083 169.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . 0.258 76.3 m-70 -68.68 -8.85 46.25 Favored 'General case' 0 CA--C 1.566 1.577 0 N-CA-C 117.797 2.517 . . . . 0.0 117.797 175.352 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 5.9 ttm180 -58.37 -28.1 64.82 Favored 'General case' 0 CA--C 1.579 2.069 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 167.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 70.0 m -114.16 -30.82 6.52 Favored 'General case' 0 CA--C 1.57 1.745 0 C-N-CA 125.341 1.456 . . . . 0.0 113.639 169.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 32.4 m -90.32 152.33 21.07 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-N 120.753 1.615 . . . . 0.0 110.532 176.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 20.5 t -82.04 131.31 35.24 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 120.628 -1.295 . . . . 0.0 112.971 -179.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -66.2 -45.09 91.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 169.548 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 22.0 t -79.67 -32.2 41.46 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 115.584 1.698 . . . . 0.0 115.584 177.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . 0.336 15.9 ttt180 91.88 -66.64 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 124.926 1.29 . . . . 0.0 111.92 179.308 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -69.52 -54.7 12.9 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 172.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -79.87 140.49 36.75 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-N 118.619 0.645 . . . . 0.0 110.358 171.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 3.3 tm0? -87.41 109.41 19.55 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 123.054 0.542 . . . . 0.0 109.564 178.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 5.2 mp -133.3 121.78 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 172.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 21.6 m-30 -115.16 144.73 43.23 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.745 0.783 . . . . 0.0 109.747 173.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 10.1 mp -90.22 121.97 32.72 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 113.372 0.879 . . . . 0.0 113.372 -169.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -119.62 140.47 50.55 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 124.373 1.069 . . . . 0.0 108.388 169.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -70.39 147.21 49.8 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 -176.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 15.4 pt -67.49 154.31 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 N-CA-C 113.658 0.985 . . . . 0.0 113.658 -178.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 . . . . . 0 N--CA 1.484 1.269 0 CA-C-O 122.827 1.298 . . . . 0.0 110.013 -174.999 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.373 0 N-CA-C 111.489 -0.645 . . . . 0.0 111.489 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 31.3 t -82.03 105.84 13.46 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-O 121.295 0.569 . . . . 0.0 111.174 -176.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 63.7 p-90 -75.25 -45.94 36.96 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 115.246 1.573 . . . . 0.0 115.246 177.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 29.9 t80 -84.25 131.98 34.68 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-N 119.801 1.182 . . . . 0.0 110.884 -175.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -117.38 -58.92 2.0 Allowed 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 114.815 -1.084 . . . . 0.0 109.735 174.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 104.4 87.65 2.01 Favored Glycine 0 N--CA 1.479 1.543 0 CA-C-N 119.043 0.838 . . . . 0.0 111.972 172.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 68.9 tttt 66.85 69.68 0.4 Allowed 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 124.062 0.945 . . . . 0.0 113.24 178.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 25.4 pt -121.14 148.87 50.24 Favored Pre-proline 0 CA--C 1.574 1.892 0 C-N-CA 123.957 0.903 . . . . 0.0 109.024 175.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -70.9 161.48 45.95 Favored 'Trans proline' 0 CA--C 1.559 1.774 0 C-N-CA 122.933 2.422 . . . . 0.0 114.519 -177.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 56.9 ttt180 -65.16 -40.9 94.97 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 115.786 1.773 . . . . 0.0 115.786 -176.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.74 -46.47 82.08 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 115.34 1.607 . . . . 0.0 115.34 179.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 55.5 mtmt -63.55 -34.52 77.98 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 115.037 1.495 . . . . 0.0 115.037 169.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.5 -43.44 90.11 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 115.484 1.661 . . . . 0.0 115.484 170.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -63.64 -42.88 98.08 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 115.09 1.515 . . . . 0.0 115.09 172.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -63.48 -48.13 78.93 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 114.917 1.451 . . . . 0.0 114.917 175.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -65.52 -43.8 88.89 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 114.756 1.391 . . . . 0.0 114.756 176.457 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 85.7 mt -67.35 -40.52 85.83 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 116.228 1.936 . . . . 0.0 116.228 175.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 91.1 p -56.33 -30.47 62.62 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 116.951 2.204 . . . . 0.0 116.951 171.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -66.15 -30.66 71.19 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 116.378 1.992 . . . . 0.0 116.378 170.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -59.64 142.66 52.46 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-O 123.024 1.392 . . . . 0.0 113.577 176.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.28 -15.93 62.96 Favored 'General case' 0 CA--C 1.568 1.659 0 N-CA-C 118.129 2.64 . . . . 0.0 118.129 170.309 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 31.4 m80 -89.43 132.66 34.9 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-N 119.996 1.271 . . . . 0.0 111.137 -169.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -81.29 106.77 13.52 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 169.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 115.82 8.41 13.84 Favored Glycine 0 CA--C 1.557 2.707 0 CA-C-O 116.838 -2.09 . . . . 0.0 116.388 -168.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.44 111.23 3.97 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-N 121.639 2.719 . . . . 0.0 112.331 -170.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 28.5 p90 -118.19 155.92 29.66 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 116.509 2.041 . . . . 0.0 116.509 -168.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.4 pp -148.18 138.68 22.86 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 123.31 0.644 . . . . 0.0 109.972 169.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 81.6 mt -90.17 117.79 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 169.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 4.9 ptm180 -111.23 145.72 38.23 Favored 'General case' 0 N--CA 1.487 1.388 0 CA-C-N 114.102 -1.408 . . . . 0.0 108.708 169.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -79.38 143.93 34.64 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.342 -0.849 . . . . 0.0 109.779 172.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 7.9 t -73.72 8.38 1.95 Allowed 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 119.556 3.169 . . . . 0.0 119.556 -169.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . 0.357 5.9 mp0 74.45 -72.0 0.12 Allowed 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 125.542 1.537 . . . . 0.0 113.654 175.018 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 65.9 m -64.3 -40.71 96.49 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 115.934 1.828 . . . . 0.0 115.934 178.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -111.95 102.41 53.65 Favored Pre-proline 0 CA--C 1.563 1.471 0 CA-C-O 118.077 -0.964 . . . . 0.0 109.49 174.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -58.86 -32.09 96.6 Favored 'Trans proline' 0 C--N 1.37 1.697 0 N-CA-C 119.751 2.943 . . . . 0.0 119.751 174.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -86.76 43.17 3.21 Favored Glycine 0 CA--C 1.554 2.475 0 N-CA-C 115.359 0.903 . . . . 0.0 115.359 169.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -153.83 116.45 4.42 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 105.502 -2.036 . . . . 0.0 105.502 177.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -96.19 172.1 8.18 Favored 'General case' 0 CA--C 1.559 1.323 0 CA-C-O 122.245 1.021 . . . . 0.0 110.746 174.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 71.4 m -146.72 108.33 4.31 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 -176.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 32.5 tp -79.73 117.79 20.95 Favored 'General case' 0 CA--C 1.559 1.312 0 CA-C-O 121.834 0.826 . . . . 0.0 108.925 173.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 18.9 m -104.78 90.46 3.49 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 -172.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 10.0 t -101.09 119.24 48.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 N-CA-C 107.389 -1.338 . . . . 0.0 107.389 -170.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -79.64 134.65 36.44 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.042 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -137.9 109.64 7.1 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 -179.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 78.62 -93.19 1.24 Allowed Glycine 0 N--CA 1.487 2.075 0 N-CA-C 111.838 -0.505 . . . . 0.0 111.838 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 15.7 t30 -149.31 45.38 0.97 Allowed 'General case' 0 CA--C 1.573 1.848 0 C-N-CA 123.295 0.638 . . . . 0.0 110.616 168.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -157.6 134.49 10.04 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 178.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 24.6 t -103.91 121.88 55.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -169.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 66.3 mt-30 -94.06 120.76 34.77 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 175.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 10.2 m-70 -98.86 95.46 7.2 Favored 'General case' 0 CA--C 1.55 0.971 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 -174.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -86.66 125.0 33.56 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-N 114.862 -1.063 . . . . 0.0 108.211 177.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -81.18 125.63 30.51 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-O 121.657 0.742 . . . . 0.0 111.586 -175.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 72.5 t -86.75 106.7 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 173.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.9 pp -114.34 144.67 42.89 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 123.248 0.619 . . . . 0.0 110.903 -176.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -96.99 151.63 19.52 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -169.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . 0.252 4.4 p-10 -100.64 -65.42 0.97 Allowed 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 123.676 0.79 . . . . 0.0 111.62 169.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -94.02 -123.25 3.68 Favored Glycine 0 CA--C 1.543 1.787 0 CA-C-N 119.468 1.031 . . . . 0.0 112.874 -177.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -76.48 -65.49 0.92 Allowed 'General case' 0 N--CA 1.489 1.521 0 CA-C-O 118.833 -0.603 . . . . 0.0 112.041 177.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -135.51 61.61 0.62 Allowed Glycine 0 CA--C 1.542 1.772 0 N-CA-C 111.391 -0.683 . . . . 0.0 111.391 169.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -106.69 92.44 4.1 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 105.75 -1.944 . . . . 0.0 105.75 -179.182 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -82.41 116.7 22.0 Favored 'General case' 0 N--CA 1.484 1.228 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.61 -169.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 15.1 p90 -129.51 125.06 35.48 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-O 121.83 0.824 . . . . 0.0 109.631 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 6.0 tt -104.77 -61.63 1.44 Allowed 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 114.966 -1.016 . . . . 0.0 109.657 176.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 25.6 t90 -83.9 -82.04 0.17 Allowed 'General case' 0 CA--C 1.557 1.218 0 C-N-CA 124.36 1.064 . . . . 0.0 111.41 -169.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . 0.25 7.2 m -136.67 -58.78 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 CA-C-N 118.926 0.785 . . . . 0.0 110.378 176.21 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 13.7 m -79.82 142.02 14.52 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.382 0 C-N-CA 124.085 0.954 . . . . 0.0 111.406 -177.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -79.95 150.35 30.53 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 -176.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -131.77 113.72 13.87 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 -169.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 11.3 p30 -54.97 -42.67 72.67 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 117.297 2.332 . . . . 0.0 117.297 -177.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 98.6 p -117.53 163.61 16.16 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-O 122.266 1.031 . . . . 0.0 111.404 175.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 70.2 mt -66.18 -31.24 71.96 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 114.773 1.397 . . . . 0.0 114.773 169.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -64.14 -43.26 95.78 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-N 119.468 1.031 . . . . 0.0 113.635 169.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -58.74 -40.04 82.65 Favored 'General case' 0 CA--C 1.568 1.637 0 N-CA-C 115.125 1.528 . . . . 0.0 115.125 169.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 8.7 tt -61.24 -51.42 69.01 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 114.62 1.341 . . . . 0.0 114.62 173.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 22.7 m -64.59 -51.23 70.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 N-CA-C 113.461 0.911 . . . . 0.0 113.461 176.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -64.44 -34.34 77.97 Favored 'General case' 0 CA--C 1.564 1.508 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 -176.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -60.7 -52.15 66.35 Favored 'General case' 0 CA--C 1.567 1.61 0 CA-C-N 119.37 0.986 . . . . 0.0 111.471 168.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . 0.255 59.4 m-70 -70.12 -9.25 54.96 Favored 'General case' 0 CA--C 1.565 1.552 0 N-CA-C 118.143 2.646 . . . . 0.0 118.143 176.643 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 90.0 mtt180 -61.53 -30.41 70.62 Favored 'General case' 0 CA--C 1.576 1.97 0 CA-C-N 120.42 1.463 . . . . 0.0 113.025 167.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 70.3 m -102.11 -40.53 6.78 Favored 'General case' 0 CA--C 1.567 1.623 0 C-N-CA 124.934 1.294 . . . . 0.0 113.633 169.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 44.1 m -90.58 156.44 18.15 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-N 120.061 1.3 . . . . 0.0 111.533 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 33.1 t -84.6 134.55 34.39 Favored 'General case' 0 N--CA 1.485 1.312 0 O-C-N 120.654 -1.278 . . . . 0.0 113.904 -175.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -73.16 -43.73 57.17 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.751 0 C-N-CA 123.939 0.896 . . . . 0.0 112.28 168.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 22.8 t -79.48 138.2 37.48 Favored 'General case' 0 CA--C 1.559 1.309 0 CA-C-N 119.367 0.985 . . . . 0.0 111.142 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -70.63 -56.19 7.04 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 -172.014 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -73.51 -66.16 0.73 Allowed 'General case' 0 N--CA 1.489 1.518 0 CA-C-N 119.151 0.887 . . . . 0.0 112.439 -179.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -87.77 141.73 28.37 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.304 0.641 . . . . 0.0 110.73 -178.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -84.13 104.63 14.35 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 122.848 0.459 . . . . 0.0 111.458 -178.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.54 138.91 52.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 178.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -122.35 158.31 29.9 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 121.989 0.899 . . . . 0.0 113.183 -168.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 9.3 mp -87.59 133.91 33.72 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 124.129 0.972 . . . . 0.0 111.925 -175.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 59.5 mmt-85 -129.58 138.21 51.16 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 124.391 1.077 . . . . 0.0 108.517 176.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -74.8 148.42 40.35 Favored 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 121.843 0.83 . . . . 0.0 112.402 -178.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 19.4 pt -69.66 167.6 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 -169.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 . . . . . 0 N--CA 1.486 1.326 0 CA-C-O 123.902 1.811 . . . . 0.0 109.124 173.045 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.448 0 N-CA-C 111.678 -0.569 . . . . 0.0 111.678 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 23.4 m 75.39 115.27 0.06 Allowed 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 124.675 1.19 . . . . 0.0 112.628 175.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 65.3 p-90 -81.85 -39.72 23.51 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 116.307 1.965 . . . . 0.0 116.307 178.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -83.33 125.95 32.18 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-N 119.878 1.217 . . . . 0.0 110.625 -173.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -105.6 -73.88 0.67 Allowed 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 171.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 87.32 125.13 2.0 Favored Glycine 0 CA--C 1.541 1.712 0 CA-C-N 119.458 1.026 . . . . 0.0 112.778 176.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . 0.318 20.0 tptm 76.32 -13.15 0.94 Allowed 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 117.313 2.338 . . . . 0.0 117.313 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 20.3 tt -61.92 131.47 93.17 Favored Pre-proline 0 CA--C 1.575 1.93 0 CA-C-N 120.999 1.727 . . . . 0.0 112.231 174.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -53.7 166.52 1.32 Allowed 'Trans proline' 0 CA--C 1.556 1.618 0 C-N-CA 123.597 2.865 . . . . 0.0 117.394 174.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 59.8 ttt180 -64.98 -42.62 94.39 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 169.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -68.01 -42.48 80.61 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 115.673 1.731 . . . . 0.0 115.673 175.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -66.6 -36.05 81.69 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 115.257 1.577 . . . . 0.0 115.257 170.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.9 -46.14 86.19 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 115.201 1.556 . . . . 0.0 115.201 170.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -59.15 -45.28 91.4 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 114.964 1.468 . . . . 0.0 114.964 169.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -61.24 -47.54 85.57 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 115.119 1.526 . . . . 0.0 115.119 176.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -64.87 -36.36 84.1 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 115.909 1.818 . . . . 0.0 115.909 174.154 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.3 mp -90.13 -22.68 21.64 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 116.717 2.117 . . . . 0.0 116.717 -178.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 74.4 m -64.31 -44.02 92.87 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 120.946 1.703 . . . . 0.0 115.481 177.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . 0.26 0.0 OUTLIER -68.96 -21.82 64.15 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 116.763 2.135 . . . . 0.0 116.763 174.216 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -60.92 135.36 57.76 Favored 'General case' 0 N--CA 1.484 1.226 0 CA-C-N 120.268 1.395 . . . . 0.0 112.014 172.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -78.87 -19.08 52.8 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 117.872 2.545 . . . . 0.0 117.872 179.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 41.5 m80 -89.84 115.07 26.89 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 119.472 1.033 . . . . 0.0 111.607 -168.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.05 113.43 6.42 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 123.877 0.871 . . . . 0.0 110.211 179.276 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 114.6 -8.11 22.19 Favored Glycine 0 CA--C 1.546 2.0 0 CA-C-O 116.524 -2.264 . . . . 0.0 117.118 -169.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -75.76 110.88 10.56 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-N 121.789 2.794 . . . . 0.0 109.951 -173.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 16.4 p90 -120.51 163.0 18.61 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 115.164 1.542 . . . . 0.0 115.164 -168.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.2 pp -138.02 134.61 35.02 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-N 114.452 -1.249 . . . . 0.0 108.227 167.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 76.8 mt -91.4 106.79 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 170.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 51.8 ptt85 -88.25 157.39 18.79 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 123.429 0.692 . . . . 0.0 111.723 170.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -86.6 137.59 32.37 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 169.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 18.3 t -77.41 89.32 3.79 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.474 0.71 . . . . 0.0 111.984 -170.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . 0.341 45.4 mt-10 72.65 -89.78 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 125.311 1.444 . . . . 0.0 107.866 -169.357 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 21.5 t -152.55 61.46 0.81 Allowed 'General case' 0 CA--C 1.561 1.402 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 168.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -117.75 99.83 52.28 Favored Pre-proline 0 CA--C 1.56 1.341 0 CA-C-O 117.726 -1.131 . . . . 0.0 108.683 -179.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -71.9 128.81 14.53 Favored 'Trans proline' 0 C--N 1.371 1.736 0 C-N-CA 122.959 2.439 . . . . 0.0 111.761 179.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 104.28 -45.9 1.26 Allowed Glycine 0 CA--C 1.551 2.3 0 CA-C-N 114.964 -1.016 . . . . 0.0 112.575 -168.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -87.17 101.65 13.7 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 172.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -113.28 170.69 8.04 Favored 'General case' 0 CA--C 1.562 1.442 0 CA-C-O 121.887 0.851 . . . . 0.0 110.075 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 74.2 m -134.52 115.6 14.1 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 175.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 19.2 tp -79.87 109.35 14.2 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 124.553 1.141 . . . . 0.0 109.155 176.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 9.8 m -105.05 88.78 2.96 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 115.01 -0.995 . . . . 0.0 108.699 -169.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 13.1 t -103.57 127.59 57.46 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -170.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.14 142.38 41.63 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 173.342 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -152.81 103.98 2.82 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 174.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 84.95 -87.53 1.56 Allowed Glycine 0 CA--C 1.542 1.731 0 N-CA-C 112.043 -0.423 . . . . 0.0 112.043 -175.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -137.29 -27.78 0.95 Allowed 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 169.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -85.8 140.13 30.71 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.919 0.887 . . . . 0.0 110.387 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 51.8 t -103.84 119.3 52.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 -176.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 -97.12 118.71 34.15 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.826 0.85 . . . . 0.0 109.547 -174.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -100.43 108.65 20.7 Favored 'General case' 0 CA--C 1.553 1.067 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 -173.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -109.06 123.45 49.17 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 -173.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 19.7 tptm -78.93 124.55 28.35 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-O 121.794 0.807 . . . . 0.0 111.574 -171.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 40.0 t -97.32 106.67 18.85 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.447 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 178.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 64.7 mt -97.68 175.05 6.33 Favored 'General case' 0 CA--C 1.565 1.545 0 C-N-CA 124.163 0.985 . . . . 0.0 112.198 -175.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 15.4 mmt85 -123.68 136.45 54.48 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 123.794 0.838 . . . . 0.0 112.169 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 25.5 p-10 -136.66 123.8 21.7 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 124.067 0.947 . . . . 0.0 109.036 173.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 95.19 -125.62 8.43 Favored Glycine 0 CA--C 1.542 1.755 0 C-N-CA 123.01 0.338 . . . . 0.0 112.961 177.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -88.72 -78.98 0.32 Allowed 'General case' 0 N--CA 1.488 1.452 0 CA-C-O 118.595 -0.717 . . . . 0.0 110.683 -178.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -137.42 63.04 0.58 Allowed Glycine 0 N--CA 1.482 1.731 0 CA-C-N 118.831 0.741 . . . . 0.0 112.244 169.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -120.72 113.61 20.45 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 106.347 -1.723 . . . . 0.0 106.347 -170.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -89.78 128.35 36.12 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.666 0.786 . . . . 0.0 111.756 -169.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 23.7 p90 -124.48 128.79 49.51 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 175.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 8.3 tt -86.31 -63.96 1.23 Allowed 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 118.788 -0.625 . . . . 0.0 110.147 169.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 17.0 m0 -76.82 -71.34 0.4 Allowed 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 118.754 0.706 . . . . 0.0 111.689 178.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 11.6 p -156.47 -52.41 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 C-N-CA 124.744 1.218 . . . . 0.0 109.898 -170.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 10.9 p -79.13 138.0 20.82 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.427 0 C-N-CA 124.351 1.061 . . . . 0.0 110.431 -176.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -79.76 155.29 27.99 Favored 'General case' 0 CA--C 1.559 1.289 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 -171.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -140.97 104.64 4.71 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 103.955 -2.609 . . . . 0.0 103.955 -174.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . 0.268 8.0 p-10 -47.71 -51.33 22.34 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 118.788 2.884 . . . . 0.0 118.788 -169.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 66.5 m -101.81 163.79 12.07 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-O 122.316 1.055 . . . . 0.0 111.476 176.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 15.4 tp -66.02 -37.89 87.03 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 169.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -65.59 -33.83 76.82 Favored 'General case' 0 CA--C 1.573 1.829 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 168.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -62.15 -42.74 99.55 Favored 'General case' 0 CA--C 1.566 1.591 0 CA-C-N 120.63 1.559 . . . . 0.0 114.943 169.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 7.8 tt -60.37 -45.03 94.96 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 169.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 29.4 t -55.04 -61.33 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 C-N-CA 124.43 1.092 . . . . 0.0 112.63 169.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -58.69 -34.75 71.63 Favored 'General case' 0 CA--C 1.568 1.652 0 N-CA-C 115.701 1.741 . . . . 0.0 115.701 -177.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 90.5 t80 -57.64 -56.12 25.97 Favored 'General case' 0 CA--C 1.564 1.512 0 CA-C-O 118.119 -0.943 . . . . 0.0 112.605 169.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . 0.319 52.3 m-70 -71.81 -9.08 57.79 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 117.875 2.546 . . . . 0.0 117.875 175.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 95.8 mtt-85 -65.39 -32.97 74.88 Favored 'General case' 0 CA--C 1.576 1.951 0 CA-C-N 120.702 1.592 . . . . 0.0 112.396 166.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 68.6 m -95.15 -40.26 9.69 Favored 'General case' 0 CA--C 1.563 1.476 0 N-CA-C 114.586 1.328 . . . . 0.0 114.586 170.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 93.6 m -90.82 149.09 22.1 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 124.747 1.219 . . . . 0.0 111.069 176.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 28.7 p -78.25 134.26 37.58 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.2 -0.938 . . . . 0.0 111.929 174.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 3.4 t -65.73 -52.33 51.47 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 C-N-CA 122.928 0.491 . . . . 0.0 111.091 173.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 74.2 m -98.89 143.08 29.6 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.638 0.732 . . . . 0.0 109.36 169.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 7.9 mpt_? -73.17 -51.73 16.75 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -177.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -68.06 -59.47 3.23 Favored 'General case' 0 N--CA 1.495 1.775 0 CA-C-N 119.199 0.909 . . . . 0.0 113.229 177.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -81.72 113.86 19.98 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 170.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -80.15 101.1 8.59 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 122.753 0.421 . . . . 0.0 111.244 -171.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 11.8 mm -100.14 106.29 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -169.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -112.88 127.4 56.18 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -179.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 9.7 mp -76.24 131.28 39.19 Favored 'General case' 0 CA--C 1.561 1.402 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 -169.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 61.7 ttt-85 -136.24 148.56 48.12 Favored 'General case' 0 CA--C 1.563 1.459 0 C-N-CA 125.258 1.423 . . . . 0.0 108.443 177.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -65.33 164.8 12.87 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 120.526 -1.359 . . . . 0.0 113.211 171.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.3 pp -64.19 162.59 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 -174.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 . . . . . 0 N--CA 1.488 1.444 0 CA-C-O 122.841 1.305 . . . . 0.0 110.488 174.472 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.379 0 N-CA-C 111.352 -0.699 . . . . 0.0 111.352 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 32.1 t -88.83 116.68 27.27 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.123 0.569 . . . . 0.0 109.997 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . 0.262 1.6 p90 -130.71 -47.15 1.05 Allowed 'General case' 0 CA--C 1.56 1.341 0 CA-C-O 118.147 -0.93 . . . . 0.0 112.857 -177.046 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -84.33 137.07 33.63 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 120.409 1.459 . . . . 0.0 111.407 -178.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -99.84 -92.5 0.28 Allowed 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 175.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 146.61 85.29 0.06 OUTLIER Glycine 0 N--CA 1.479 1.554 0 CA-C-N 119.438 1.017 . . . . 0.0 111.605 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 26.1 tptp 64.69 69.97 0.49 Allowed 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 124.168 0.987 . . . . 0.0 113.176 174.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 27.3 pt -125.0 149.29 62.83 Favored Pre-proline 0 CA--C 1.573 1.863 0 C-N-CA 123.793 0.837 . . . . 0.0 109.666 -179.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -75.07 171.34 18.5 Favored 'Trans proline' 0 CA--C 1.558 1.709 0 C-N-CA 122.93 2.42 . . . . 0.0 114.581 -178.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 57.0 ttt180 -65.26 -42.49 93.19 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 114.77 1.396 . . . . 0.0 114.77 176.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.14 -42.63 96.73 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 115.76 1.763 . . . . 0.0 115.76 176.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 14.6 tmtt? -65.37 -38.5 90.24 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 169.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.89 -46.6 84.16 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 115.314 1.598 . . . . 0.0 115.314 172.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -60.62 -40.97 93.84 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 115.16 1.541 . . . . 0.0 115.16 170.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -58.55 -56.46 21.86 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 171.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 45.7 tpp -56.71 -47.67 79.43 Favored 'General case' 0 CA--C 1.564 1.485 0 N-CA-C 115.683 1.735 . . . . 0.0 115.683 178.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 74.8 mt -68.04 -30.94 70.27 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 116.456 2.021 . . . . 0.0 116.456 175.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 21.8 t -62.96 -33.05 74.56 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 115.606 1.706 . . . . 0.0 115.606 169.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -62.46 -37.26 85.23 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 115.748 1.759 . . . . 0.0 115.748 170.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -61.05 139.44 58.07 Favored 'General case' 0 CA--C 1.556 1.18 0 N-CA-C 115.115 1.524 . . . . 0.0 115.115 -175.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 15.7 ptp180 -70.59 -21.0 62.72 Favored 'General case' 0 CA--C 1.568 1.635 0 N-CA-C 118.404 2.742 . . . . 0.0 118.404 174.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 49.5 m80 -89.21 144.97 25.72 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 119.575 1.08 . . . . 0.0 112.667 -168.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -78.09 114.99 17.48 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 123.635 0.774 . . . . 0.0 109.944 175.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 82.57 33.12 25.86 Favored Glycine 0 CA--C 1.548 2.137 0 CA-C-O 118.387 -1.23 . . . . 0.0 115.36 -168.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.99 113.64 6.56 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 118.949 1.374 . . . . 0.0 110.211 178.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 22.2 p90 -123.37 155.52 37.18 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 115.005 1.483 . . . . 0.0 115.005 -168.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.2 pp -142.02 143.84 33.35 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.895 0.878 . . . . 0.0 108.945 168.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.4 mp -94.55 119.6 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 N-CA-C 105.704 -1.962 . . . . 0.0 105.704 169.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 49.4 ptt85 -103.14 158.2 16.47 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 123.503 0.721 . . . . 0.0 111.135 169.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -90.02 126.61 35.82 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 169.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 18.0 t -65.79 139.22 58.31 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 112.878 0.695 . . . . 0.0 112.878 -173.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -70.54 -53.01 17.83 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 -171.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.6 t -62.67 -38.01 88.67 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 115.866 1.802 . . . . 0.0 115.866 172.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -118.69 97.28 50.68 Favored Pre-proline 0 CA--C 1.562 1.439 0 CA-C-N 119.195 0.907 . . . . 0.0 110.015 176.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_exo -57.4 -30.24 87.23 Favored 'Trans proline' 0 C--N 1.37 1.671 0 N-CA-C 119.617 2.891 . . . . 0.0 119.617 172.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -88.28 47.0 3.44 Favored Glycine 0 CA--C 1.552 2.395 0 N-CA-C 114.527 0.571 . . . . 0.0 114.527 168.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -160.09 125.39 4.0 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 105.906 -1.887 . . . . 0.0 105.906 -179.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 11.0 m-30 -95.93 172.26 8.12 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.823 0.821 . . . . 0.0 111.272 175.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 71.5 m -147.85 115.06 6.21 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 -179.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 28.7 tp -79.92 108.59 13.62 Favored 'General case' 0 N--CA 1.487 1.379 0 CA-C-O 122.29 1.043 . . . . 0.0 109.61 174.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 6.2 m -95.54 112.62 24.3 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 34.5 t -121.02 131.1 73.86 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.169 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 -174.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 28.7 tptp -76.98 100.59 5.67 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 123.309 0.644 . . . . 0.0 110.933 175.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -86.13 -169.16 2.51 Favored 'General case' 0 CA--C 1.572 1.817 0 CA-C-O 121.291 0.567 . . . . 0.0 109.586 173.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -68.48 106.58 1.78 Allowed Glycine 0 CA--C 1.544 1.877 0 O-C-N 120.692 -1.255 . . . . 0.0 113.497 179.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . 0.319 10.3 t30 75.23 -18.9 0.42 Allowed 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 118.192 2.664 . . . . 0.0 118.192 -175.299 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -144.33 143.36 30.94 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 120.336 1.426 . . . . 0.0 109.611 -169.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 56.2 t -90.64 113.56 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 178.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -94.76 122.97 37.92 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 121.601 0.715 . . . . 0.0 109.96 178.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 8.7 m-70 -100.19 127.1 46.53 Favored 'General case' 0 CA--C 1.552 1.046 0 CA-C-N 114.985 -1.007 . . . . 0.0 109.251 -175.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -119.21 126.72 52.2 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 -177.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 48.2 mtpt -76.27 116.4 16.93 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-O 121.182 0.515 . . . . 0.0 110.608 -177.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 75.9 t -85.09 98.9 6.63 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.374 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 172.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.8 mt -81.36 137.35 35.73 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.893 -179.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 78.1 mtp180 -113.38 120.68 41.92 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -174.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . 0.286 4.9 p-10 -85.29 -66.13 0.93 Allowed 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -88.92 -110.18 1.16 Allowed Glycine 0 N--CA 1.482 1.737 0 CA-C-N 119.331 0.968 . . . . 0.0 112.395 -176.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -84.6 -84.14 0.15 Allowed 'General case' 0 N--CA 1.487 1.413 0 CA-C-O 118.364 -0.827 . . . . 0.0 109.175 174.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -116.88 63.6 0.37 Allowed Glycine 0 N--CA 1.481 1.68 0 CA-C-N 118.896 0.771 . . . . 0.0 111.535 169.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm -101.79 87.14 3.06 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 106.017 -1.845 . . . . 0.0 106.017 -176.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 47.7 m-85 -82.78 116.85 22.3 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 114.892 -1.049 . . . . 0.0 112.64 -168.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -135.54 114.11 11.75 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.44 0.696 . . . . 0.0 110.144 177.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . 0.276 1.8 pt? -87.09 -45.45 10.7 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-O 118.758 -0.639 . . . . 0.0 112.51 168.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 45.3 m0 -83.57 -84.74 0.13 Allowed 'General case' 0 CA--C 1.564 1.495 0 CA-C-N 118.966 0.803 . . . . 0.0 109.436 173.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 61.0 t -141.02 -55.97 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 C-N-CA 124.32 1.048 . . . . 0.0 109.063 -174.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 13.6 p -79.45 128.83 38.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 C-N-CA 123.663 0.785 . . . . 0.0 110.968 -170.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.44 159.67 18.59 Favored 'General case' 0 N--CA 1.486 1.351 0 CA-C-O 122.53 1.157 . . . . 0.0 113.724 -175.332 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -141.84 121.5 13.41 Favored 'General case' 0 N--CA 1.484 1.242 0 CA-C-N 113.96 -1.473 . . . . 0.0 107.052 -170.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 36.0 m-80 -58.69 -41.4 86.18 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 115.585 1.698 . . . . 0.0 115.585 177.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 26.2 t -114.86 152.74 31.7 Favored 'General case' 0 N--CA 1.484 1.271 0 CA-C-O 122.069 0.937 . . . . 0.0 111.19 178.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 80.6 mt -63.95 -27.26 69.01 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 168.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -59.09 -39.23 81.54 Favored 'General case' 0 CA--C 1.575 1.935 0 CA-C-N 120.105 1.321 . . . . 0.0 113.923 168.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -70.35 -43.52 70.03 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 114.76 1.393 . . . . 0.0 114.76 171.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 9.9 tt -59.1 -46.21 88.89 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 115.361 1.615 . . . . 0.0 115.361 170.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 4.4 p -68.3 -48.41 73.43 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.538 0 N-CA-C 113.742 1.015 . . . . 0.0 113.742 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -56.25 -35.89 67.91 Favored 'General case' 0 CA--C 1.569 1.711 0 N-CA-C 115.182 1.549 . . . . 0.0 115.182 169.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 61.3 t80 -55.6 -55.86 27.12 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 117.26 -1.352 . . . . 0.0 113.102 169.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . 0.381 33.5 m-70 -73.52 -9.22 58.45 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 118.748 2.87 . . . . 0.0 118.748 175.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 91.2 mtt-85 -73.0 -27.06 61.57 Favored 'General case' 0 CA--C 1.581 2.137 0 CA-C-N 120.058 1.299 . . . . 0.0 112.42 166.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 69.6 m -97.85 -42.14 7.7 Favored 'General case' 0 CA--C 1.565 1.543 0 C-N-CA 125.012 1.325 . . . . 0.0 114.24 171.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 92.6 m -85.93 142.58 28.73 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 124.614 1.165 . . . . 0.0 109.717 171.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 33.5 t -72.35 121.09 18.9 Favored 'General case' 0 N--CA 1.485 1.303 0 O-C-N 121.449 -0.782 . . . . 0.0 111.113 173.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 11.4 p -58.33 -35.57 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 N-CA-C 115.525 1.676 . . . . 0.0 115.525 172.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 15.1 t -79.52 -28.11 41.35 Favored 'General case' 0 CA--C 1.564 1.512 0 N-CA-C 116.682 2.104 . . . . 0.0 116.682 179.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . 0.352 98.6 mtt180 86.65 -78.79 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 CA-C-N 120.274 1.397 . . . . 0.0 111.393 -177.287 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 70.1 m-80 -67.5 -52.82 34.56 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -79.7 152.19 30.04 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.166 0.586 . . . . 0.0 110.583 169.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -89.89 88.09 7.2 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 173.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 19.9 mm -113.13 141.39 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -146.63 145.69 30.15 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 121.946 0.879 . . . . 0.0 112.524 -168.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 11.2 mp -83.68 117.2 23.05 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-N 114.761 -1.109 . . . . 0.0 112.279 -169.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 27.2 mmm180 -109.29 137.49 47.09 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 124.304 1.042 . . . . 0.0 109.058 169.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -73.66 142.91 46.43 Favored 'General case' 0 CA--C 1.564 1.487 0 CA-C-O 121.742 0.782 . . . . 0.0 111.713 -178.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 17.9 pt -63.3 156.29 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 114.814 1.413 . . . . 0.0 114.814 -173.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 . . . . . 0 N--CA 1.483 1.213 0 CA-C-O 123.999 1.857 . . . . 0.0 109.11 179.531 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.361 0 N-CA-C 111.488 -0.645 . . . . 0.0 111.488 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 30.6 t -88.76 108.79 19.69 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 177.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . 0.273 1.8 p90 -119.19 -47.55 2.47 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-O 118.015 -0.993 . . . . 0.0 113.068 -174.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -80.15 135.25 36.26 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-N 120.444 1.475 . . . . 0.0 110.263 172.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -121.3 -80.03 0.62 Allowed 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 179.31 -146.47 7.16 Favored Glycine 0 N--CA 1.48 1.589 0 CA-C-N 119.09 0.859 . . . . 0.0 112.012 176.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -85.03 88.43 7.46 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 121.533 0.682 . . . . 0.0 109.288 -179.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 35.8 pt -118.92 148.29 44.29 Favored Pre-proline 0 CA--C 1.573 1.832 0 C-N-CA 124.126 0.97 . . . . 0.0 109.762 -174.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -71.8 157.77 54.53 Favored 'Trans proline' 0 CA--C 1.559 1.739 0 C-N-CA 122.995 2.463 . . . . 0.0 114.325 -177.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 42.1 ttp85 -66.75 -41.1 88.35 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 115.113 1.523 . . . . 0.0 115.113 -179.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -65.75 -42.75 90.55 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 115.924 1.824 . . . . 0.0 115.924 178.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -67.39 -34.11 76.59 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 169.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.39 -43.75 96.68 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 169.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -60.44 -42.83 96.93 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 115.041 1.497 . . . . 0.0 115.041 169.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -61.7 -51.71 67.3 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 176.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -61.88 -46.51 89.08 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 115.091 1.515 . . . . 0.0 115.091 175.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 8.9 mp -66.22 -36.3 82.68 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 115.822 1.786 . . . . 0.0 115.822 175.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 20.9 t -56.24 -30.17 62.01 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 116.593 2.071 . . . . 0.0 116.593 169.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -60.67 -35.29 75.88 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 115.703 1.742 . . . . 0.0 115.703 169.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -67.93 129.41 39.83 Favored 'General case' 0 CA--C 1.555 1.15 0 CA-C-O 122.935 1.35 . . . . 0.0 112.499 -179.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 14.7 ptp180 -66.52 -17.79 65.0 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 118.912 2.93 . . . . 0.0 118.912 172.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 46.1 m80 -89.46 137.37 32.39 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 119.576 1.08 . . . . 0.0 111.818 -168.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -78.25 105.27 9.37 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 171.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 118.14 -3.65 16.33 Favored Glycine 0 CA--C 1.55 2.251 0 CA-C-O 116.198 -2.446 . . . . 0.0 116.7 -168.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.77 110.15 1.44 Allowed 'General case' 0 N--CA 1.494 1.77 0 CA-C-N 122.017 2.909 . . . . 0.0 112.231 -176.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 18.4 p90 -128.43 161.64 29.02 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 117.263 2.32 . . . . 0.0 117.263 -167.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.2 pp -143.12 151.86 41.18 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 114.233 -1.349 . . . . 0.0 108.446 168.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 3.8 mp -102.44 118.04 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 105.173 -2.158 . . . . 0.0 105.173 169.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 46.8 ptt85 -101.44 141.06 34.87 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.174 0.59 . . . . 0.0 110.083 169.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -79.89 134.96 36.33 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 169.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 53.5 m -72.33 139.21 47.81 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-O 121.491 0.662 . . . . 0.0 111.956 -177.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -69.96 -54.54 12.82 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -173.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 97.2 p -61.91 -41.95 98.52 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 115.994 1.85 . . . . 0.0 115.994 171.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -111.85 96.77 34.95 Favored Pre-proline 0 CA--C 1.562 1.405 0 CA-C-O 117.965 -1.017 . . . . 0.0 109.494 176.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -63.61 -26.59 69.2 Favored 'Trans proline' 0 CA--C 1.559 1.765 0 C-N-CA 122.959 2.439 . . . . 0.0 118.203 174.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -91.5 50.12 2.94 Favored Glycine 0 CA--C 1.553 2.422 0 CA-C-O 119.732 -0.482 . . . . 0.0 113.326 168.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -160.04 120.29 2.96 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 106.026 -1.842 . . . . 0.0 106.026 178.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 12.2 m-30 -98.63 172.2 7.64 Favored 'General case' 0 CA--C 1.565 1.55 0 CA-C-O 122.064 0.935 . . . . 0.0 111.341 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 74.3 m -148.19 112.56 5.27 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 -178.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 27.4 tp -85.21 105.08 15.64 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-O 122.308 1.051 . . . . 0.0 109.638 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.8 m -89.85 111.35 22.36 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 125.177 1.391 . . . . 0.0 107.816 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 22.0 t -127.46 121.19 56.6 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.161 0 CA-C-N 120.031 1.287 . . . . 0.0 107.795 -172.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 7.4 tmtm? -89.47 92.43 9.11 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 122.8 0.44 . . . . 0.0 110.734 177.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 25.3 t80 -125.1 111.18 15.03 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 68.12 71.05 1.01 Allowed Glycine 0 N--CA 1.482 1.739 0 N-CA-C 115.525 0.97 . . . . 0.0 115.525 173.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . 0.294 16.8 m120 70.76 -13.35 0.49 Allowed 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 118.49 2.774 . . . . 0.0 118.49 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -132.65 138.49 47.35 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 120.16 1.345 . . . . 0.0 110.159 -169.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 43.5 t -92.1 111.27 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 N-CA-C 106.045 -1.835 . . . . 0.0 106.045 171.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -104.34 114.8 29.27 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.84 0.856 . . . . 0.0 108.771 -170.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 16.7 m-70 -95.21 97.31 9.79 Favored 'General case' 0 CA--C 1.552 1.023 0 CA-C-N 114.745 -1.116 . . . . 0.0 108.417 -173.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -95.88 122.24 38.47 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 -176.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -76.37 115.85 16.5 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 121.302 0.572 . . . . 0.0 110.715 -171.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 84.7 t -91.45 104.5 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 60.7 mt -92.07 131.45 37.33 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.38 -174.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 78.0 mtp180 -106.64 148.2 28.62 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 122.865 0.466 . . . . 0.0 111.195 -173.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -137.27 129.83 29.96 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 123.029 0.531 . . . . 0.0 110.51 171.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 81.7 -113.58 3.67 Favored Glycine 0 CA--C 1.541 1.693 0 C-N-CA 122.971 0.32 . . . . 0.0 113.462 173.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -82.29 -70.37 0.55 Allowed 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 123.118 0.567 . . . . 0.0 111.102 175.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -159.28 71.76 0.23 Allowed Glycine 0 N--CA 1.477 1.431 0 N-CA-C 111.033 -0.827 . . . . 0.0 111.033 169.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -98.71 96.52 7.98 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 106.468 -1.679 . . . . 0.0 106.468 177.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -86.45 100.27 12.24 Favored 'General case' 0 CA--C 1.558 1.259 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.724 -169.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 46.3 p90 -112.87 122.51 47.86 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 123.608 0.763 . . . . 0.0 109.113 -178.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -134.67 -32.88 0.98 Allowed 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 114.44 1.274 . . . . 0.0 114.44 -171.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 46.2 t90 -114.19 -76.6 0.58 Allowed 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 124.764 1.226 . . . . 0.0 108.089 178.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 96.0 t -130.05 -73.57 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 -178.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.3 p -83.16 145.8 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 C-N-CA 123.514 0.726 . . . . 0.0 111.8 -173.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -79.72 152.51 29.84 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 121.565 0.697 . . . . 0.0 112.329 174.608 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -130.02 121.26 26.13 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -173.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 36.1 t30 -63.64 -50.06 70.8 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 178.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 28.4 t -94.0 148.45 22.15 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-O 122.024 0.916 . . . . 0.0 111.175 173.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 14.1 tp -68.69 -34.93 76.51 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 169.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 -61.44 -40.99 96.48 Favored 'General case' 0 CA--C 1.571 1.771 0 C-N-CA 123.881 0.873 . . . . 0.0 113.331 169.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -58.8 -43.84 90.63 Favored 'General case' 0 CA--C 1.567 1.609 0 N-CA-C 114.956 1.465 . . . . 0.0 114.956 169.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 9.3 tt -54.22 -47.66 71.92 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 114.217 1.191 . . . . 0.0 114.217 169.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 43.7 t -57.86 -60.79 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 C-N-CA 124.361 1.065 . . . . 0.0 112.78 173.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -61.02 -29.15 69.54 Favored 'General case' 0 CA--C 1.568 1.64 0 N-CA-C 116.806 2.15 . . . . 0.0 116.806 -176.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 76.4 t80 -65.4 -58.9 4.74 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-N 119.261 0.937 . . . . 0.0 112.124 169.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 74.2 m-70 -67.95 -9.27 43.9 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 117.832 2.531 . . . . 0.0 117.832 176.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 11.4 ttm180 -60.24 -30.3 69.32 Favored 'General case' 0 CA--C 1.576 1.956 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 167.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 70.5 m -108.93 -31.31 7.71 Favored 'General case' 0 CA--C 1.568 1.643 0 C-N-CA 124.982 1.313 . . . . 0.0 114.252 169.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 59.3 m -91.21 155.68 18.4 Favored 'General case' 0 N--CA 1.498 1.971 0 CA-C-N 120.664 1.575 . . . . 0.0 112.109 176.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.448 ' HG ' ' HA ' ' A' ' 142' ' ' ARG . 38.0 t -70.48 132.63 45.84 Favored 'General case' 0 N--CA 1.485 1.32 0 O-C-N 121.498 -0.751 . . . . 0.0 112.938 175.144 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 15.2 t -68.49 -48.16 73.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 CA-C-O 118.225 -0.893 . . . . 0.0 112.084 171.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 22.7 t -105.94 -113.25 0.26 Allowed 'General case' 0 CA--C 1.559 1.319 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 170.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . 0.448 ' HA ' ' HG ' ' A' ' 139' ' ' SER . 11.7 tpt180 -161.05 -41.67 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 CA-C-N 119.644 1.111 . . . . 0.0 113.275 174.373 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -60.12 -57.02 14.6 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 -176.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -79.76 -16.05 56.31 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 117.587 2.44 . . . . 0.0 117.587 174.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 59.51 77.9 0.29 Allowed 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 125.561 1.545 . . . . 0.0 111.71 -175.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 4.7 mp -84.28 124.23 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 -168.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -127.4 117.33 21.97 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 -176.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 10.8 mp -70.5 137.57 50.33 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 114.778 1.399 . . . . 0.0 114.778 -169.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 19.3 mmt85 -135.56 146.68 48.25 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 124.803 1.241 . . . . 0.0 107.807 179.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -72.28 147.28 46.55 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.702 -1.249 . . . . 0.0 112.924 179.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 29.6 pt -68.52 148.28 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 C-N-CA 124.133 0.973 . . . . 0.0 113.092 -178.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 . . . . . 0 N--CA 1.485 1.301 0 CA-C-O 123.872 1.796 . . . . 0.0 108.84 -174.993 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.429 0 CA-C-O 119.986 -0.341 . . . . 0.0 112.428 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 90.9 p -79.32 124.68 28.63 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 112.567 0.581 . . . . 0.0 112.567 -173.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . 0.274 1.2 p90 -149.41 -43.13 0.14 Allowed 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 -177.061 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -81.81 134.31 35.41 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 120.657 1.571 . . . . 0.0 111.509 -176.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -101.7 -90.11 0.35 Allowed 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 175.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 154.19 79.49 0.03 OUTLIER Glycine 0 N--CA 1.482 1.718 0 CA-C-N 119.625 1.102 . . . . 0.0 111.941 179.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . 0.384 65.4 pttt 43.16 59.37 2.96 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 117.514 2.413 . . . . 0.0 117.514 -173.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 23.1 pt -85.77 155.07 58.91 Favored Pre-proline 0 CA--C 1.576 1.954 0 CA-C-O 118.385 -0.817 . . . . 0.0 110.509 174.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -71.09 167.98 24.56 Favored 'Trans proline' 0 CA--C 1.561 1.862 0 C-N-CA 122.73 2.287 . . . . 0.0 114.107 177.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 53.9 ttt180 -63.65 -40.6 97.27 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 115.844 1.794 . . . . 0.0 115.844 177.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.4 -41.91 96.39 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 115.574 1.694 . . . . 0.0 115.574 173.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 55.7 tptt -66.86 -34.89 78.79 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 114.869 1.433 . . . . 0.0 114.869 169.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.37 -45.55 87.23 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 115.118 1.525 . . . . 0.0 115.118 171.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -65.79 -33.83 76.76 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 115.754 1.761 . . . . 0.0 115.754 169.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -57.65 -49.42 76.51 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-N 119.99 1.268 . . . . 0.0 114.24 170.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 45.3 tpp -61.36 -47.91 83.7 Favored 'General case' 0 CA--C 1.567 1.624 0 N-CA-C 115.919 1.822 . . . . 0.0 115.919 172.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 83.4 mt -89.35 -43.82 10.65 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 116.735 2.124 . . . . 0.0 116.735 -169.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 49.7 m -61.6 -32.1 72.2 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 115.598 1.703 . . . . 0.0 115.598 171.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -59.64 -43.4 93.86 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 115.706 1.743 . . . . 0.0 115.706 169.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -75.61 134.86 40.55 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-O 122.867 1.318 . . . . 0.0 111.979 177.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -58.95 -13.01 5.24 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 120.199 3.407 . . . . 0.0 120.199 177.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 50.7 m80 -89.07 127.84 35.72 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 120.008 1.276 . . . . 0.0 113.032 -168.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -73.31 130.18 39.63 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 123.932 0.893 . . . . 0.0 109.753 172.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 96.82 -6.58 64.66 Favored Glycine 0 CA--C 1.547 2.07 0 N-CA-C 118.083 1.993 . . . . 0.0 118.083 -169.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.06 114.52 5.28 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-N 120.658 2.229 . . . . 0.0 112.714 -169.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -124.25 156.04 37.54 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 115.093 1.516 . . . . 0.0 115.093 -168.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.9 pp -142.74 139.61 31.13 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-N 114.736 -1.12 . . . . 0.0 108.897 169.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.5 mp -92.84 118.78 39.26 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.436 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 173.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 40.0 ptt85 -108.51 134.73 50.88 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 169.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -79.47 139.72 37.54 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 121.581 0.705 . . . . 0.0 111.087 -177.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 49.1 m -72.2 124.15 24.42 Favored 'General case' 0 N--CA 1.486 1.369 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.719 173.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -75.25 -49.13 20.26 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 177.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 16.2 t -56.96 -35.07 68.68 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 116.369 1.988 . . . . 0.0 116.369 170.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -111.56 92.19 16.16 Favored Pre-proline 0 CA--C 1.564 1.486 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 169.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -72.13 133.05 20.6 Favored 'Trans proline' 0 C--N 1.372 1.803 0 C-N-CA 123.177 2.585 . . . . 0.0 112.324 -176.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 95.22 -35.88 4.07 Favored Glycine 0 CA--C 1.553 2.444 0 CA-C-O 119.08 -0.844 . . . . 0.0 114.297 -168.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -78.86 136.25 37.26 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-N 118.524 1.162 . . . . 0.0 109.467 178.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -106.55 172.22 6.93 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 115.254 -0.884 . . . . 0.0 111.53 -169.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 74.7 m -145.2 116.38 7.92 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 175.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 24.1 tp -79.88 122.58 26.84 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.638 0.775 . . . . 0.0 109.832 174.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 20.7 m -109.51 93.28 4.42 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 106.541 -1.651 . . . . 0.0 106.541 177.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.1 p -108.49 118.55 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 C-N-CA 123.72 0.808 . . . . 0.0 109.891 -171.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -76.71 146.6 37.92 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-N 115.285 -0.87 . . . . 0.0 112.045 172.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -155.03 107.46 2.73 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 171.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 90.61 -75.65 1.64 Allowed Glycine 0 N--CA 1.484 1.856 0 C-N-CA 122.651 0.167 . . . . 0.0 113.294 179.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -136.86 -45.35 0.58 Allowed 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 123.948 0.899 . . . . 0.0 113.147 173.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -92.94 148.29 22.13 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.37 1.068 . . . . 0.0 111.642 -169.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 20.8 t -99.01 120.98 49.06 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 -178.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 24.3 mp0 -98.29 125.01 43.22 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.935 0.894 . . . . 0.0 109.147 178.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 9.8 m-70 -107.44 114.27 28.17 Favored 'General case' 0 CA--C 1.552 1.033 0 CA-C-N 114.79 -1.096 . . . . 0.0 108.361 -169.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -122.56 125.79 46.43 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 -176.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -81.21 123.94 28.88 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-O 121.408 0.623 . . . . 0.0 110.881 -176.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 68.9 t -80.66 104.87 9.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 171.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 59.9 mt -91.13 141.11 29.16 Favored 'General case' 0 N--CA 1.484 1.256 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.826 179.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 53.3 mtp180 -108.35 146.38 33.07 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 123.533 0.733 . . . . 0.0 110.032 179.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 17.7 p-10 -79.58 -42.86 24.11 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 115.783 1.771 . . . . 0.0 115.783 -179.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 179.1 -79.3 0.06 OUTLIER Glycine 0 CA--C 1.537 1.44 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 -172.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -72.41 -64.22 1.0 Allowed 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 175.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 175.73 75.38 0.05 OUTLIER Glycine 0 N--CA 1.479 1.521 0 CA-C-N 119.039 0.836 . . . . 0.0 112.543 173.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp -128.29 111.54 13.49 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 105.018 -2.216 . . . . 0.0 105.018 174.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -91.73 131.72 36.9 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 124.026 0.93 . . . . 0.0 110.728 -169.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -144.08 137.29 27.46 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 123.646 0.778 . . . . 0.0 109.966 -178.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -132.31 -43.16 0.95 Allowed 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 172.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 39.2 t90 -85.74 -77.22 0.3 Allowed 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 124.313 1.045 . . . . 0.0 110.119 -176.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 9.4 p -149.28 -55.87 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 C-N-CA 123.727 0.811 . . . . 0.0 110.465 175.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 13.5 p -79.6 122.8 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 C-N-CA 123.827 0.851 . . . . 0.0 110.53 -175.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 6.5 ttpm? -79.88 146.45 32.17 Favored 'General case' 0 CA--C 1.559 1.299 0 CA-C-O 122.26 1.029 . . . . 0.0 112.919 -176.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -118.58 158.41 25.48 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 114.134 -1.394 . . . . 0.0 109.202 -173.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -76.99 -57.73 3.68 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 118.119 -0.943 . . . . 0.0 112.635 173.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 83.8 p -109.2 162.56 14.17 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-O 122.334 1.064 . . . . 0.0 112.575 -178.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 18.6 tp -64.99 -33.96 77.3 Favored 'General case' 0 CA--C 1.571 1.761 0 N-CA-C 115.036 1.495 . . . . 0.0 115.036 169.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 14.2 m-80 -64.45 -42.74 95.79 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 113.642 0.979 . . . . 0.0 113.642 169.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -58.78 -41.32 86.37 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 115.836 1.791 . . . . 0.0 115.836 169.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 9.7 tt -53.69 -50.25 66.27 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 115.265 1.58 . . . . 0.0 115.265 172.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 25.7 m -67.88 -45.65 83.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 176.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . 0.256 3.7 p30 -65.26 -29.52 70.31 Favored 'General case' 0 CA--C 1.569 1.711 0 N-CA-C 115.408 1.633 . . . . 0.0 115.408 -178.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 77.9 t80 -67.05 -54.2 23.8 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-N 119.256 0.934 . . . . 0.0 111.613 168.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 80.2 m-70 -67.53 -9.2 40.21 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 117.869 2.544 . . . . 0.0 117.869 176.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 52.9 ttm-85 -57.81 -31.46 66.62 Favored 'General case' 0 CA--C 1.577 2.016 0 C-N-CA 124.285 1.034 . . . . 0.0 113.726 167.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 71.0 m -107.73 -34.56 6.94 Favored 'General case' 0 CA--C 1.568 1.654 0 C-N-CA 125.151 1.38 . . . . 0.0 113.955 169.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 90.0 m -90.66 156.56 18.02 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-N 120.504 1.502 . . . . 0.0 111.913 178.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 32.4 t -74.97 121.41 21.91 Favored 'General case' 0 CA--C 1.558 1.279 0 O-C-N 121.342 -0.849 . . . . 0.0 112.034 177.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.5 p -73.14 -34.8 45.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 170.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 20.3 t -85.26 147.24 26.66 Favored 'General case' 0 CA--C 1.558 1.254 0 CA-C-N 119.098 0.863 . . . . 0.0 111.296 174.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 61.1 ttp85 -68.78 -63.37 1.07 Allowed 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 123.162 0.585 . . . . 0.0 112.297 173.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 19.6 t30 -72.42 -52.64 15.05 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 178.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 67.1 mt-30 -79.8 161.62 25.57 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.675 0.75 . . . . 0.0 112.031 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -105.61 94.56 5.27 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 175.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 28.8 mm -113.98 119.14 60.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 -172.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -121.2 126.81 50.59 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 -174.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 11.1 mp -78.5 124.2 27.88 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 -169.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 7.7 mpt_? -120.0 146.88 45.45 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 124.807 1.243 . . . . 0.0 108.242 172.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -75.4 155.56 36.27 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 121.674 0.749 . . . . 0.0 112.564 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 45.7 pt -66.08 156.61 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 N-CA-C 114.542 1.312 . . . . 0.0 114.542 -172.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 . . . . . 0 N--CA 1.483 1.221 0 CA-C-O 123.975 1.845 . . . . 0.0 109.873 -176.43 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.345 0 N-CA-C 111.58 -0.608 . . . . 0.0 111.58 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 32.7 t -84.36 103.88 13.91 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 122.997 0.519 . . . . 0.0 109.922 177.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 61.9 p-90 -61.53 -38.15 86.36 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 117.57 2.434 . . . . 0.0 117.57 -175.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 33.3 t80 -83.2 124.79 30.88 Favored 'General case' 0 N--CA 1.484 1.267 0 CA-C-N 119.559 1.072 . . . . 0.0 109.616 179.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -110.33 -74.19 0.66 Allowed 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 118.483 -0.77 . . . . 0.0 109.046 179.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 177.37 -98.91 0.12 Allowed Glycine 0 N--CA 1.476 1.364 0 CA-C-N 119.263 0.938 . . . . 0.0 111.525 177.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -140.6 94.09 2.69 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 -174.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 36.5 pt -127.98 153.89 78.35 Favored Pre-proline 0 CA--C 1.575 1.922 0 C-N-CA 123.617 0.767 . . . . 0.0 110.484 -175.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -78.2 176.69 9.66 Favored 'Trans proline' 0 CA--C 1.565 2.051 0 C-N-CA 123.037 2.491 . . . . 0.0 114.458 176.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 29.3 ttm180 -61.48 -43.0 99.64 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 115.952 1.834 . . . . 0.0 115.952 172.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.74 -46.84 80.53 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 115.252 1.575 . . . . 0.0 115.252 178.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm -61.95 -35.94 79.93 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 115.559 1.688 . . . . 0.0 115.559 169.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.55 -40.9 89.3 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 115.493 1.664 . . . . 0.0 115.493 171.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -63.75 -39.76 95.06 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 115.313 1.597 . . . . 0.0 115.313 169.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -60.64 -49.2 78.46 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 174.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -62.26 -49.8 74.26 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 114.492 1.293 . . . . 0.0 114.492 173.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 9.9 mp -69.14 -27.8 65.88 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 116.42 2.007 . . . . 0.0 116.42 179.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 23.3 t -59.28 -37.98 79.02 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-N 120.508 1.503 . . . . 0.0 114.683 169.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt -63.84 -31.91 73.25 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 115.64 1.718 . . . . 0.0 115.64 169.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -64.78 120.59 12.76 Favored 'General case' 0 N--CA 1.484 1.27 0 CA-C-N 119.626 1.103 . . . . 0.0 112.196 175.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -69.12 -19.99 64.04 Favored 'General case' 0 CA--C 1.568 1.657 0 N-CA-C 117.935 2.568 . . . . 0.0 117.935 171.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 43.0 m80 -89.59 132.04 35.3 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-N 119.282 0.946 . . . . 0.0 111.136 -169.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -74.52 123.26 24.43 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.445 0.698 . . . . 0.0 109.691 176.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 99.27 2.05 56.8 Favored Glycine 0 CA--C 1.552 2.39 0 N-CA-C 117.86 1.904 . . . . 0.0 117.86 -169.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.62 109.35 4.27 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-N 120.698 2.249 . . . . 0.0 112.026 -172.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -119.52 160.03 23.18 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 116.322 1.971 . . . . 0.0 116.322 -168.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.2 pp -141.61 145.76 35.4 Favored 'General case' 0 CA--C 1.557 1.246 0 CA-C-N 113.826 -1.534 . . . . 0.0 108.989 168.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.8 mp -96.94 115.25 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 N-CA-C 104.112 -2.551 . . . . 0.0 104.112 169.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 50.7 ptt85 -102.83 152.65 21.02 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 123.819 0.847 . . . . 0.0 110.645 169.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -83.18 140.81 32.36 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 168.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 50.2 m -66.86 1.01 2.07 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 120.074 3.361 . . . . 0.0 120.074 -169.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . 0.357 24.9 tt0 79.22 -69.73 0.11 Allowed 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 125.544 1.538 . . . . 0.0 113.467 169.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 66.1 m -64.81 -39.16 93.14 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 115.579 1.696 . . . . 0.0 115.579 171.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -113.53 103.0 55.43 Favored Pre-proline 0 CA--C 1.563 1.45 0 CA-C-N 119.24 0.927 . . . . 0.0 109.875 175.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -58.77 -32.81 97.79 Favored 'Trans proline' 0 C--N 1.37 1.706 0 N-CA-C 119.742 2.939 . . . . 0.0 119.742 173.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -86.79 46.86 3.62 Favored Glycine 0 CA--C 1.552 2.347 0 N-CA-C 114.765 0.666 . . . . 0.0 114.765 169.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -160.08 132.82 6.56 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 176.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -112.43 176.25 5.1 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-O 122.161 0.981 . . . . 0.0 110.645 178.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 58.1 m -151.56 121.4 7.05 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 -179.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 25.7 tp -79.89 114.93 19.18 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 169.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 8.7 m -98.9 97.53 8.7 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 105.913 -1.884 . . . . 0.0 105.913 172.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.8 p -110.1 125.16 67.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 -175.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -76.24 139.9 41.35 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-O 121.54 0.686 . . . . 0.0 111.648 179.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -140.69 170.9 14.9 Favored 'General case' 0 CA--C 1.566 1.578 0 CA-C-O 122.184 0.992 . . . . 0.0 108.383 169.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -60.41 115.91 8.39 Favored Glycine 0 CA--C 1.546 1.978 0 O-C-N 121.108 -0.995 . . . . 0.0 114.339 178.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . 0.377 15.3 m120 83.19 -24.88 0.16 Allowed 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 117.726 2.491 . . . . 0.0 117.726 -174.291 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -147.74 140.37 24.66 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-N 120.264 1.393 . . . . 0.0 111.154 -173.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 69.1 t -94.92 115.76 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 105.196 -2.149 . . . . 0.0 105.196 169.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 62.8 mt-30 -94.3 115.45 27.68 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-O 121.73 0.776 . . . . 0.0 109.686 -175.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 8.2 m-70 -98.52 114.48 26.9 Favored 'General case' 0 CA--C 1.553 1.085 0 CA-C-N 114.844 -1.071 . . . . 0.0 108.419 -175.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -111.46 131.39 55.24 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 -179.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -85.18 119.39 25.51 Favored 'General case' 0 N--CA 1.486 1.375 0 CA-C-O 121.388 0.613 . . . . 0.0 110.283 -176.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 46.9 t -88.54 110.92 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 64.0 mt -93.67 126.11 38.66 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.084 0.554 . . . . 0.0 110.102 -175.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 71.2 mtp180 -96.27 151.89 19.09 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 123.209 0.604 . . . . 0.0 110.756 176.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 25.3 p-10 -79.68 -47.76 14.81 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 115.17 1.545 . . . . 0.0 115.17 174.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 173.57 -73.58 0.09 OUTLIER Glycine 0 CA--C 1.538 1.523 0 N-CA-C 110.841 -0.904 . . . . 0.0 110.841 -169.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -70.5 -64.69 0.85 Allowed 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 175.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 173.81 81.72 0.05 OUTLIER Glycine 0 N--CA 1.478 1.456 0 CA-C-N 118.742 0.701 . . . . 0.0 111.378 174.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -138.23 107.74 6.18 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 105.482 -2.044 . . . . 0.0 105.482 176.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -93.13 119.03 31.9 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.766 0.827 . . . . 0.0 109.383 -169.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -127.2 110.66 13.1 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 4.1 tt -97.98 -54.28 3.14 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 124.29 1.036 . . . . 0.0 111.434 172.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . 0.259 78.1 t90 -93.09 -95.09 0.15 Allowed 'General case' 0 CA--C 1.557 1.213 0 C-N-CA 124.486 1.114 . . . . 0.0 112.275 -167.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 69.7 t -133.2 -60.35 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 -172.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 24.3 m -79.36 128.56 38.47 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.397 0 CA-C-N 119.097 0.862 . . . . 0.0 109.677 178.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -80.04 131.44 35.78 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-O 121.73 0.776 . . . . 0.0 110.666 -175.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -105.15 153.32 21.69 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 114.707 -1.133 . . . . 0.0 109.747 -173.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -74.64 -54.61 7.1 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 172.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 88.0 p -120.72 168.05 11.82 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-O 122.197 0.999 . . . . 0.0 112.346 -175.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 57.5 mt -62.65 -36.47 82.92 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 114.98 1.474 . . . . 0.0 114.98 169.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . 0.281 9.8 p30 -62.22 -38.08 87.83 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 115.496 1.665 . . . . 0.0 115.496 169.53 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -62.28 -45.89 91.22 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 114.896 1.443 . . . . 0.0 114.896 169.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 51.5 tp -55.8 -45.58 78.21 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 115.099 1.518 . . . . 0.0 115.099 169.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 33.2 t -60.08 -61.27 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 C-N-CA 124.309 1.044 . . . . 0.0 112.215 172.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -58.47 -30.03 66.66 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 117.289 2.329 . . . . 0.0 117.289 -175.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -64.95 -55.58 18.3 Favored 'General case' 0 CA--C 1.565 1.544 0 CA-C-N 118.963 0.801 . . . . 0.0 112.619 169.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . 0.303 74.1 m-70 -71.53 -8.99 57.48 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 117.931 2.567 . . . . 0.0 117.931 178.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -48.7 -39.47 24.69 Favored 'General case' 0 N--CA 1.501 2.124 0 CA-C-N 120.59 1.541 . . . . 0.0 114.544 167.48 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 69.7 m -106.47 -29.81 9.46 Favored 'General case' 0 CA--C 1.565 1.532 0 N-CA-C 115.02 1.489 . . . . 0.0 115.02 170.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 39.5 m -89.98 147.19 23.84 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-N 120.733 1.606 . . . . 0.0 110.326 -178.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 23.1 t -77.62 122.87 25.89 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.594 -0.691 . . . . 0.0 111.586 176.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 12.4 p -68.4 -30.73 48.59 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.942 0 N-CA-C 115.3 1.593 . . . . 0.0 115.3 169.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 46.4 m -79.78 -41.26 26.88 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 116.147 1.906 . . . . 0.0 116.147 -176.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . 0.261 4.6 mmp_? 69.04 53.98 0.46 Allowed 'General case' 0 N--CA 1.5 2.027 0 C-N-CA 124.465 1.106 . . . . 0.0 113.24 -169.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -163.96 -81.26 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 177.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 -96.12 163.2 13.21 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 123.794 0.838 . . . . 0.0 109.87 169.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -79.82 98.2 6.97 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.72 -0.613 . . . . 0.0 112.145 -178.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 1.2 mp -102.37 100.74 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 103.757 -2.683 . . . . 0.0 103.757 172.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 20.4 m-30 -110.23 126.44 54.14 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 -178.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 10.8 mp -72.2 121.53 19.5 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 113.148 0.795 . . . . 0.0 113.148 -169.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 22.4 mmt85 -126.85 154.26 44.6 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 125.181 1.393 . . . . 0.0 109.18 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -75.47 147.3 39.96 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.293 -1.505 . . . . 0.0 113.367 -177.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -69.37 158.04 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 113.639 0.977 . . . . 0.0 113.639 179.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 . . . . . 0 N--CA 1.484 1.271 0 CA-C-O 122.851 1.31 . . . . 0.0 109.588 -178.657 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.373 0 N-CA-C 111.8 -0.52 . . . . 0.0 111.8 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 88.6 p -80.25 104.17 10.62 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.19 0.596 . . . . 0.0 111.464 -178.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . 0.278 30.0 p-90 -73.48 -47.51 40.69 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 115.14 1.533 . . . . 0.0 115.14 -179.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -83.66 134.36 34.78 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 120.771 1.623 . . . . 0.0 110.864 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -111.13 -88.28 0.52 Allowed 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 176.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 153.39 83.33 0.04 OUTLIER Glycine 0 N--CA 1.48 1.622 0 CA-C-N 119.37 0.986 . . . . 0.0 111.088 178.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . 0.257 51.6 mtpt 59.09 61.44 2.11 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 -176.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 17.4 tt -86.06 141.42 35.32 Favored Pre-proline 0 CA--C 1.572 1.811 0 CA-C-O 117.663 -1.16 . . . . 0.0 110.263 179.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -69.1 153.44 71.98 Favored 'Trans proline' 0 CA--C 1.562 1.906 0 CA-C-N 123.575 2.312 . . . . 0.0 113.578 174.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 38.6 ttt85 -58.01 -43.42 86.68 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 116.18 1.918 . . . . 0.0 116.18 -177.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.47 -46.15 84.33 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 115.007 1.484 . . . . 0.0 115.007 175.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 58.7 tttm -59.83 -36.65 77.25 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 115.248 1.573 . . . . 0.0 115.248 169.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.79 -43.29 96.76 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 115.487 1.662 . . . . 0.0 115.487 170.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -63.68 -46.06 87.27 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 114.875 1.435 . . . . 0.0 114.875 172.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -70.77 -39.22 73.35 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 115.212 1.56 . . . . 0.0 115.212 178.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 38.1 mmt -64.99 -45.2 86.61 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-N 119.922 1.237 . . . . 0.0 114.278 172.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 95.3 mt -64.89 -32.1 73.65 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 116.121 1.897 . . . . 0.0 116.121 170.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 18.9 t -57.47 -29.64 64.4 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 116.364 1.987 . . . . 0.0 116.364 169.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -63.55 -34.99 79.02 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 115.775 1.769 . . . . 0.0 115.775 169.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -70.33 131.24 43.84 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-O 122.935 1.35 . . . . 0.0 112.973 -176.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.28 -12.34 61.58 Favored 'General case' 0 CA--C 1.567 1.623 0 N-CA-C 118.947 2.943 . . . . 0.0 118.947 172.114 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 53.5 m80 -89.28 138.03 31.79 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 120.315 1.416 . . . . 0.0 111.936 -169.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -81.47 98.32 8.2 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 107.545 -1.279 . . . . 0.0 107.545 172.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 124.94 -0.1 8.33 Favored Glycine 0 CA--C 1.557 2.668 0 CA-C-O 117.089 -1.951 . . . . 0.0 115.698 -168.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.66 116.27 6.07 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-N 121.161 2.48 . . . . 0.0 112.653 -169.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 20.4 p90 -131.6 155.53 47.36 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 116.273 1.953 . . . . 0.0 116.273 -168.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.0 pp -143.37 138.13 29.21 Favored 'General case' 0 CA--C 1.558 1.25 0 CA-C-N 114.026 -1.443 . . . . 0.0 108.02 169.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.9 mp -83.57 120.09 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 N-CA-C 106.149 -1.797 . . . . 0.0 106.149 174.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 61.8 ttp85 -95.23 125.01 39.58 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-N 114.718 -1.128 . . . . 0.0 109.218 170.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -79.99 132.24 35.98 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 169.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 53.5 m -69.63 138.51 53.13 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.095 0.558 . . . . 0.0 112.32 -175.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -66.24 -59.46 3.71 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -172.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 88.2 p -62.3 -34.37 76.47 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 116.881 2.178 . . . . 0.0 116.881 174.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -121.04 97.28 48.12 Favored Pre-proline 0 CA--C 1.562 1.431 0 CA-C-N 119.112 0.869 . . . . 0.0 109.837 177.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -56.63 -30.95 85.52 Favored 'Trans proline' 0 C--N 1.369 1.641 0 N-CA-C 119.78 2.954 . . . . 0.0 119.78 172.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -88.24 46.12 3.35 Favored Glycine 0 CA--C 1.553 2.458 0 N-CA-C 114.777 0.671 . . . . 0.0 114.777 168.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -156.11 126.81 6.81 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 105.281 -2.118 . . . . 0.0 105.281 178.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -112.79 167.32 10.59 Favored 'General case' 0 CA--C 1.559 1.303 0 CA-C-O 122.416 1.103 . . . . 0.0 110.549 -174.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 71.2 m -146.32 111.89 5.55 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 -179.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 46.2 tp -79.65 107.32 12.33 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-O 122.004 0.906 . . . . 0.0 109.582 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.3 m -90.42 100.45 13.28 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 177.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.3 p -124.81 121.03 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 -172.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -76.37 142.1 41.28 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.535 170.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -150.22 107.44 3.6 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 169.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 88.9 -106.65 3.3 Favored Glycine 0 N--CA 1.481 1.645 0 N-CA-C 110.382 -1.087 . . . . 0.0 110.382 -176.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -135.68 60.1 1.7 Allowed 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 169.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -160.86 129.02 4.45 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.673 0.789 . . . . 0.0 109.386 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 55.8 t -98.91 109.01 23.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 179.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -99.77 120.39 39.66 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.872 0.869 . . . . 0.0 109.465 -176.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -100.58 105.01 16.38 Favored 'General case' 0 CA--C 1.554 1.097 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -175.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -102.34 129.12 48.7 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -177.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -77.07 126.4 30.91 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-O 121.704 0.764 . . . . 0.0 110.525 -178.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 76.9 t -108.93 100.73 11.37 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.347 0 N-CA-C 104.826 -2.287 . . . . 0.0 104.826 178.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -113.27 144.3 42.95 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.788 0.835 . . . . 0.0 110.76 -172.353 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 92.3 mtt180 -88.68 151.75 22.24 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 113.129 0.788 . . . . 0.0 113.129 -175.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -95.83 -63.82 1.12 Allowed 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 123.54 0.736 . . . . 0.0 110.882 169.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -100.01 -104.98 2.65 Favored Glycine 0 CA--C 1.541 1.707 0 CA-C-N 119.223 0.92 . . . . 0.0 111.553 177.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -139.5 122.9 17.15 Favored 'General case' 0 N--CA 1.482 1.17 0 CA-C-O 122.925 1.345 . . . . 0.0 107.566 172.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 61.74 51.71 55.57 Favored Glycine 0 CA--C 1.552 2.35 0 CA-C-N 113.192 -1.822 . . . . 0.0 115.28 -169.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -137.14 77.69 1.65 Allowed 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 105.087 -2.19 . . . . 0.0 105.087 -174.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -85.76 108.89 18.29 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -167.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 21.5 p90 -119.86 135.47 54.86 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.206 0.602 . . . . 0.0 110.571 178.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -94.48 -52.52 4.29 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 123.16 0.584 . . . . 0.0 111.624 169.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 3.2 m-90 -85.07 -76.78 0.3 Allowed 'General case' 0 CA--C 1.564 1.51 0 C-N-CA 123.775 0.83 . . . . 0.0 109.108 177.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 6.2 m -147.38 -46.14 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 C-N-CA 125.352 1.461 . . . . 0.0 110.942 -178.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 12.3 p -79.81 132.22 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 CA-C-N 119.382 0.992 . . . . 0.0 111.355 -173.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 2.2 pptp? -81.65 154.12 26.28 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 113.904 1.076 . . . . 0.0 113.904 -174.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -135.94 114.5 11.83 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 104.617 -2.364 . . . . 0.0 104.617 176.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -53.07 -38.27 62.35 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 118.933 2.938 . . . . 0.0 118.933 -169.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 91.1 p -135.41 160.36 38.68 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-O 122.522 1.153 . . . . 0.0 113.339 -171.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 11.1 mp -77.39 117.88 19.31 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 168.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . 0.356 21.3 t-20 122.88 -53.28 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.017 0 C-N-CA 126.422 1.889 . . . . 0.0 107.535 -168.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -58.84 -49.45 77.69 Favored 'General case' 0 CA--C 1.568 1.646 0 CA-C-N 119.851 1.205 . . . . 0.0 113.777 169.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 31.1 tp -60.59 -40.22 90.96 Favored 'General case' 0 CA--C 1.57 1.74 0 N-CA-C 115.413 1.634 . . . . 0.0 115.413 169.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 40.4 t -59.07 -61.99 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 C-N-CA 124.35 1.06 . . . . 0.0 112.569 173.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -61.88 -30.32 70.79 Favored 'General case' 0 CA--C 1.572 1.814 0 N-CA-C 115.086 1.513 . . . . 0.0 115.086 -178.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 94.0 t80 -59.69 -57.52 12.57 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-N 119.153 0.888 . . . . 0.0 112.245 168.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 74.4 m-70 -70.37 -9.58 56.64 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 117.913 2.56 . . . . 0.0 117.913 175.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 53.1 ttm-85 -61.1 -30.22 70.23 Favored 'General case' 0 CA--C 1.575 1.917 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 167.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 71.0 m -108.6 -30.79 8.05 Favored 'General case' 0 CA--C 1.568 1.64 0 C-N-CA 125.047 1.339 . . . . 0.0 114.081 169.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 99.1 m -90.89 156.33 18.09 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-N 120.371 1.442 . . . . 0.0 111.978 176.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 39.7 t -67.08 137.16 56.18 Favored 'General case' 0 CA--C 1.558 1.267 0 C-N-CA 123.669 0.788 . . . . 0.0 113.076 170.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 19.0 t -71.3 -48.91 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 CA-C-O 118.683 -0.675 . . . . 0.0 111.735 171.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 9.2 t -87.76 172.51 9.61 Favored 'General case' 0 CA--C 1.565 1.541 0 CA-C-N 118.981 0.81 . . . . 0.0 111.754 174.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 40.8 mmt180 -79.93 -57.78 3.48 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.23 -0.919 . . . . 0.0 111.724 169.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -70.1 -59.54 2.84 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 177.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 70.1 mt-30 -79.9 145.08 32.87 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-N 118.869 0.759 . . . . 0.0 111.481 -179.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -102.76 104.56 14.87 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 123.352 0.661 . . . . 0.0 109.533 -177.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 4.3 mp -112.71 127.44 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -125.5 125.38 43.18 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 10.8 mp -74.22 135.33 42.73 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 115.057 1.503 . . . . 0.0 115.057 -168.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 8.9 mmm180 -128.71 139.1 52.39 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 125.486 1.514 . . . . 0.0 108.519 174.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -71.97 146.79 47.5 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.307 -0.87 . . . . 0.0 112.451 177.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 27.1 pt -69.93 158.69 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 N-CA-C 113.564 0.949 . . . . 0.0 113.564 -174.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 . . . . . 0 N--CA 1.484 1.256 0 CA-C-O 122.803 1.287 . . . . 0.0 109.759 179.276 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.362 0 N-CA-C 111.471 -0.652 . . . . 0.0 111.471 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 23.7 m 57.88 90.67 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 124.951 1.301 . . . . 0.0 112.463 -176.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 55.4 p-90 -137.65 -61.69 0.62 Allowed 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 114.849 -1.068 . . . . 0.0 112.347 -169.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -82.82 127.5 33.53 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-N 119.868 1.213 . . . . 0.0 112.903 -169.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -100.01 -79.67 0.49 Allowed 'General case' 0 N--CA 1.489 1.481 0 CA-C-N 114.937 -1.029 . . . . 0.0 108.765 173.005 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -175.99 -138.05 2.75 Favored Glycine 0 N--CA 1.48 1.569 0 CA-C-N 119.311 0.96 . . . . 0.0 112.28 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 20.9 tptm -103.5 87.13 2.78 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 176.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 32.6 pt -127.09 153.09 76.61 Favored Pre-proline 0 CA--C 1.573 1.828 0 C-N-CA 123.331 0.652 . . . . 0.0 111.086 -169.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -77.24 178.57 7.47 Favored 'Trans proline' 0 CA--C 1.565 2.059 0 C-N-CA 123.043 2.496 . . . . 0.0 113.944 175.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 54.3 ttt180 -65.42 -41.48 93.53 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 115.101 1.519 . . . . 0.0 115.101 175.092 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.2 -41.06 97.23 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 115.96 1.837 . . . . 0.0 115.96 179.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -64.07 -38.46 91.16 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 114.569 1.322 . . . . 0.0 114.569 169.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.59 -41.0 84.77 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 115.951 1.834 . . . . 0.0 115.951 171.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -64.17 -36.81 85.26 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 115.02 1.489 . . . . 0.0 115.02 170.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -63.77 -48.24 77.72 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 114.799 1.407 . . . . 0.0 114.799 172.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 38.8 mmt -61.54 -47.48 85.35 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 174.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 88.3 mt -75.09 -24.52 58.14 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 116.908 2.188 . . . . 0.0 116.908 177.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 97.4 p -61.83 -36.35 80.9 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-N 120.726 1.603 . . . . 0.0 114.631 168.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 59.7 mttm -60.7 -36.58 79.16 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 114.788 1.403 . . . . 0.0 114.788 169.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -64.62 120.47 12.45 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.449 1.1 . . . . 0.0 112.001 170.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 16.5 ptm180 -77.9 -15.99 58.58 Favored 'General case' 0 CA--C 1.569 1.683 0 N-CA-C 118.223 2.675 . . . . 0.0 118.223 176.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 46.0 m80 -89.57 147.85 23.71 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 119.513 1.051 . . . . 0.0 113.557 -168.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -77.6 124.4 27.88 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.789 170.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 105.6 -29.93 10.62 Favored Glycine 0 CA--C 1.546 2.002 0 CA-C-O 117.268 -1.851 . . . . 0.0 116.765 -169.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.11 112.75 1.29 Allowed 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 120.21 2.005 . . . . 0.0 113.386 -170.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.1 p90 -130.32 161.22 31.76 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 -168.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.6 pp -141.99 132.62 25.45 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.695 0.798 . . . . 0.0 108.892 168.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 87.2 mt -86.8 122.09 38.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 169.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 49.1 ptt85 -104.4 153.02 21.6 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.487 169.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -88.85 124.12 33.89 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 105.836 -1.913 . . . . 0.0 105.836 168.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 53.2 m -62.84 121.37 13.31 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.241 0.616 . . . . 0.0 111.871 -172.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -68.1 -47.15 68.99 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 114.496 1.295 . . . . 0.0 114.496 -170.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.1 t -65.66 -31.93 73.22 Favored 'General case' 0 CA--C 1.568 1.659 0 N-CA-C 115.832 1.79 . . . . 0.0 115.832 169.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -118.85 95.31 49.08 Favored Pre-proline 0 CA--C 1.563 1.471 0 CA-C-N 119.863 1.21 . . . . 0.0 110.158 178.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -56.05 -34.65 93.1 Favored 'Trans proline' 0 C--N 1.369 1.658 0 N-CA-C 120.111 3.081 . . . . 0.0 120.111 176.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -87.97 50.09 3.88 Favored Glycine 0 CA--C 1.55 2.281 0 N-CA-C 114.297 0.479 . . . . 0.0 114.297 169.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -159.66 142.04 13.57 Favored 'General case' 0 CA--C 1.556 1.209 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 178.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -116.68 161.19 19.61 Favored 'General case' 0 CA--C 1.564 1.501 0 CA-C-O 122.032 0.92 . . . . 0.0 109.265 171.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 67.4 m -137.4 117.33 13.27 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 178.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 43.0 tp -80.17 110.89 16.01 Favored 'General case' 0 CA--C 1.563 1.452 0 C-N-CA 124.216 1.007 . . . . 0.0 109.429 172.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 3.1 m -97.4 116.04 28.85 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 -178.28 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 41.2 t -126.21 123.2 63.19 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.194 0 CA-C-N 120.798 1.635 . . . . 0.0 108.151 -171.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 59.0 tptt -81.77 121.2 26.12 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 169.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -139.22 99.46 3.76 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 174.116 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 92.01 -98.32 2.4 Favored Glycine 0 CA--C 1.538 1.483 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.984 178.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 12.2 p30 -129.1 19.49 5.93 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 115.629 1.715 . . . . 0.0 115.629 177.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -145.3 141.37 28.5 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 120.117 1.326 . . . . 0.0 109.522 -177.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 60.6 t -96.33 108.37 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 174.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -104.02 127.68 51.58 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 123.917 0.887 . . . . 0.0 110.557 -176.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 12.7 m-70 -102.95 101.31 11.31 Favored 'General case' 0 CA--C 1.551 1.0 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -169.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -84.92 126.22 33.32 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 172.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 32.6 mmmt -82.86 119.51 24.48 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.067 0.46 . . . . 0.0 110.228 -172.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 84.3 t -86.33 103.63 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 177.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 63.3 mt -95.62 147.69 23.31 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.719 -171.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 72.7 mtp180 -116.28 122.52 45.19 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.627 -0.671 . . . . 0.0 110.355 -173.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -101.19 119.7 39.13 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 123.46 0.704 . . . . 0.0 109.75 174.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 82.02 -112.44 3.49 Favored Glycine 0 CA--C 1.541 1.701 0 C-N-CA 122.816 0.246 . . . . 0.0 113.095 177.005 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -86.43 -71.89 0.53 Allowed 'General case' 0 N--CA 1.486 1.368 0 CA-C-O 118.746 -0.645 . . . . 0.0 111.258 177.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -157.01 71.81 0.25 Allowed Glycine 0 N--CA 1.478 1.498 0 CA-C-N 118.681 0.673 . . . . 0.0 112.373 172.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.95 104.58 14.29 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 104.74 -2.318 . . . . 0.0 104.74 172.058 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -84.08 99.67 10.61 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.652 -168.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 32.8 p90 -102.49 114.36 28.5 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.71 0.804 . . . . 0.0 109.107 -178.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -105.66 -52.17 2.87 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.825 176.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 83.1 t90 -135.19 109.19 8.18 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 -169.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . 0.392 22.2 t 69.58 -91.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 C-N-CA 124.278 1.031 . . . . 0.0 111.57 169.615 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 8.1 p -79.97 155.3 4.55 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.609 0 C-N-CA 124.224 1.01 . . . . 0.0 111.408 177.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 25.9 pttm -79.74 148.44 31.5 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-O 121.434 0.635 . . . . 0.0 112.545 173.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -128.07 107.27 9.67 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 106.26 -1.755 . . . . 0.0 106.26 -172.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -50.63 -50.28 54.73 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 117.951 2.574 . . . . 0.0 117.951 -169.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 90.8 p -111.86 160.57 17.25 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 118.897 0.771 . . . . 0.0 111.833 176.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 79.0 mt -66.71 -34.46 77.89 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 115.38 1.622 . . . . 0.0 115.38 170.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -64.21 -45.09 89.8 Favored 'General case' 0 CA--C 1.572 1.825 0 CA-C-N 119.859 1.209 . . . . 0.0 114.002 170.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -59.08 -47.35 85.56 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 114.788 1.403 . . . . 0.0 114.788 169.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 57.4 tp -51.83 -52.48 48.98 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 115.686 1.735 . . . . 0.0 115.686 170.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 9.8 p -67.44 -50.28 63.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 -176.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -63.84 -31.0 72.03 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 114.957 1.466 . . . . 0.0 114.957 174.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -62.43 -54.55 38.55 Favored 'General case' 0 CA--C 1.567 1.618 0 CA-C-N 119.727 1.148 . . . . 0.0 111.702 168.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 36.4 m-70 -73.32 -9.7 58.98 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 118.37 2.73 . . . . 0.0 118.37 179.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 58.0 mtp85 -66.82 -21.46 66.03 Favored 'General case' 0 CA--C 1.579 2.08 0 CA-C-N 120.251 1.387 . . . . 0.0 113.347 167.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 69.3 m -104.38 -43.92 5.07 Favored 'General case' 0 CA--C 1.57 1.73 0 C-N-CA 125.453 1.501 . . . . 0.0 112.509 168.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 57.3 m -90.18 155.42 19.04 Favored 'General case' 0 N--CA 1.499 1.981 0 CA-C-N 120.051 1.296 . . . . 0.0 111.465 -179.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 21.0 t -80.18 130.74 35.44 Favored 'General case' 0 CA--C 1.56 1.352 0 O-C-N 121.293 -0.88 . . . . 0.0 113.053 -178.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 3.2 m -68.88 -42.49 82.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 169.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.8 t -83.49 135.26 34.72 Favored 'General case' 0 CA--C 1.557 1.23 0 CA-C-N 118.967 0.803 . . . . 0.0 110.259 173.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 41.4 ptt180 -69.99 -45.53 67.13 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 115.183 1.549 . . . . 0.0 115.183 174.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 70.9 m-80 -79.1 -55.53 5.04 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 123.451 0.7 . . . . 0.0 112.593 175.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -79.89 154.02 28.63 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 118.782 0.719 . . . . 0.0 111.939 179.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -92.91 96.52 10.17 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 171.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 27.7 mm -117.86 110.86 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 N-CA-C 105.146 -2.168 . . . . 0.0 105.146 -178.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -116.55 127.97 55.0 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.424 -174.168 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 10.7 mp -78.09 126.14 30.37 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.747 0.819 . . . . 0.0 111.905 -169.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 14.1 mmm180 -126.89 162.79 25.1 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-O 122.419 1.104 . . . . 0.0 110.432 178.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -77.36 148.67 35.46 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.984 -1.072 . . . . 0.0 112.68 -176.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 28.1 pt -70.0 159.7 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 113.993 1.108 . . . . 0.0 113.993 -179.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 . . . . . 0 N--CA 1.485 1.287 0 CA-C-O 124.002 1.858 . . . . 0.0 108.541 -177.603 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.348 0 N-CA-C 111.086 -0.806 . . . . 0.0 111.086 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 14.2 t 67.2 105.3 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 124.747 1.219 . . . . 0.0 111.604 -176.003 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . 0.387 50.8 p-90 51.91 11.05 0.13 Allowed 'General case' 0 N--CA 1.503 2.188 0 N-CA-C 120.703 3.594 . . . . 0.0 120.703 -177.107 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -128.42 132.99 48.47 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 124.319 1.048 . . . . 0.0 108.268 -169.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -99.71 -75.21 0.57 Allowed 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 118.34 -0.838 . . . . 0.0 109.316 172.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 97.78 113.64 3.2 Favored Glycine 0 N--CA 1.481 1.669 0 CA-C-N 119.371 0.987 . . . . 0.0 112.208 -179.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . 0.307 73.5 mmtt 65.28 25.68 12.19 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 117.425 2.38 . . . . 0.0 117.425 178.3 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 21.1 tt -90.45 129.03 46.61 Favored Pre-proline 0 CA--C 1.569 1.691 0 CA-C-O 117.139 -1.41 . . . . 0.0 107.567 169.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -67.32 170.61 13.06 Favored 'Trans proline' 0 CA--C 1.562 1.882 0 CA-C-N 123.638 2.335 . . . . 0.0 114.19 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 25.6 ttm180 -57.57 -45.59 85.0 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 116.252 1.945 . . . . 0.0 116.252 -177.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -65.98 -46.08 79.34 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 115.457 1.651 . . . . 0.0 115.457 175.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 61.5 mtpt -63.61 -34.91 78.87 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 115.426 1.639 . . . . 0.0 115.426 169.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.48 -42.4 99.46 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 115.278 1.584 . . . . 0.0 115.278 169.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -60.9 -43.45 98.49 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 169.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -64.82 -45.68 85.2 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 115.52 1.674 . . . . 0.0 115.52 175.136 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -59.83 -44.16 94.2 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 114.83 1.418 . . . . 0.0 114.83 172.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 88.6 mt -70.52 -21.75 62.7 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 116.679 2.104 . . . . 0.0 116.679 170.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 12.1 t -53.09 -37.06 61.37 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 117.223 2.305 . . . . 0.0 117.223 178.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? -64.85 -28.9 69.86 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 116.244 1.942 . . . . 0.0 116.244 170.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -71.53 114.4 9.57 Favored 'General case' 0 N--CA 1.485 1.294 0 CA-C-N 119.819 1.19 . . . . 0.0 111.259 178.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.43 -7.35 52.68 Favored 'General case' 0 CA--C 1.57 1.721 0 N-CA-C 118.092 2.627 . . . . 0.0 118.092 172.26 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 35.5 m80 -89.81 139.94 30.08 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 119.667 1.121 . . . . 0.0 111.589 -169.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -75.98 120.12 20.87 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.183 171.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 107.78 -19.77 32.69 Favored Glycine 0 CA--C 1.546 2.022 0 CA-C-O 116.632 -2.204 . . . . 0.0 116.732 -169.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.2 108.72 0.95 Allowed 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 121.26 2.53 . . . . 0.0 112.233 -173.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 23.2 p90 -123.58 158.46 31.38 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 -168.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.9 pp -138.07 128.78 26.72 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 168.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 91.1 mt -88.54 110.76 21.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 172.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.9 ptm180 -89.42 144.61 25.92 Favored 'General case' 0 N--CA 1.484 1.226 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.192 169.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -84.8 126.9 33.84 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 169.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 20.8 t -68.11 123.11 19.76 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 122.909 0.483 . . . . 0.0 111.476 -172.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -91.11 91.17 8.14 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 123.706 1.717 . . . . 0.0 110.411 -173.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 39.7 t 162.54 -41.11 0.0 OUTLIER 'General case' 0 CA--C 1.571 1.768 0 CA-C-N 110.729 -2.941 . . . . 0.0 106.983 -168.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -150.01 113.68 3.37 Favored Pre-proline 0 CA--C 1.563 1.464 0 CA-C-O 117.57 -1.205 . . . . 0.0 108.414 178.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -68.6 -27.22 32.85 Favored 'Trans proline' 0 C--N 1.37 1.699 0 N-CA-C 119.088 2.688 . . . . 0.0 119.088 -178.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -65.3 -21.49 68.43 Favored Glycine 0 CA--C 1.561 2.938 0 N-CA-C 116.492 1.357 . . . . 0.0 116.492 168.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -88.66 137.78 32.01 Favored 'General case' 0 CA--C 1.555 1.171 0 CA-C-N 118.216 1.008 . . . . 0.0 108.839 169.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -122.69 173.16 7.9 Favored 'General case' 0 CA--C 1.567 1.61 0 CA-C-N 114.927 -1.033 . . . . 0.0 108.649 175.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 75.7 m -143.6 115.42 8.24 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 173.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 29.3 tp -79.85 114.47 18.79 Favored 'General case' 0 CA--C 1.561 1.384 0 C-N-CA 124.314 1.046 . . . . 0.0 109.167 175.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.3 m -106.16 88.51 2.81 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 -170.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 16.0 t -101.99 123.02 54.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 -169.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 51.3 tttp -88.26 96.23 10.48 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.474 171.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 20.1 t80 -105.77 112.21 25.18 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.706 -0.849 . . . . 0.0 108.706 179.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 82.78 -106.23 2.73 Favored Glycine 0 CA--C 1.539 1.589 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 -170.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -141.68 59.49 1.49 Allowed 'General case' 0 CA--C 1.565 1.543 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 169.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -155.8 128.57 7.93 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 107.046 -1.465 . . . . 0.0 107.046 177.161 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 50.0 t -95.63 110.72 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 -175.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -104.96 116.08 31.36 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.791 0.836 . . . . 0.0 109.05 -173.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -95.11 108.91 21.02 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 115.036 -0.984 . . . . 0.0 108.828 -175.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -107.07 120.79 43.04 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 -175.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -79.08 112.3 16.14 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 121.906 0.86 . . . . 0.0 110.579 -172.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 75.8 t -85.18 100.94 8.95 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 178.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.9 pp -122.86 133.84 54.41 Favored 'General case' 0 N--CA 1.491 1.575 0 CA-C-O 121.506 0.669 . . . . 0.0 111.099 -169.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -84.7 159.01 20.61 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-O 122.077 0.942 . . . . 0.0 113.042 -176.074 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -85.53 -46.63 10.66 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 114.96 -1.018 . . . . 0.0 113.106 168.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -154.93 -85.5 0.05 OUTLIER Glycine 0 CA--C 1.539 1.556 0 CA-C-N 118.958 0.799 . . . . 0.0 111.258 -177.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -72.95 -70.95 0.33 Allowed 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -175.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -168.75 54.85 0.21 Allowed Glycine 0 N--CA 1.481 1.634 0 CA-C-O 119.333 -0.704 . . . . 0.0 114.276 172.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -109.69 97.83 7.29 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 105.432 -2.062 . . . . 0.0 105.432 173.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -80.32 125.91 30.49 Favored 'General case' 0 CA--C 1.554 1.126 0 CA-C-N 113.922 -1.49 . . . . 0.0 110.775 -169.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 32.2 p90 -128.95 122.83 31.02 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 121.288 0.566 . . . . 0.0 109.884 174.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -102.92 -53.65 2.8 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 124.291 1.036 . . . . 0.0 111.822 169.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 37.4 t90 -84.83 -74.39 0.39 Allowed 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 124.889 1.276 . . . . 0.0 110.029 -178.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 10.5 p -148.59 -56.0 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 C-N-CA 123.872 0.869 . . . . 0.0 110.668 176.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 11.1 p -79.4 135.82 24.88 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.476 0 C-N-CA 123.814 0.845 . . . . 0.0 110.858 -172.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 54.0 mttp -79.94 157.77 26.79 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 122.249 1.023 . . . . 0.0 112.366 -176.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -140.79 114.75 9.07 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 -170.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -58.73 -43.09 90.08 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 116.247 1.943 . . . . 0.0 116.247 177.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 94.8 p -113.37 144.74 42.27 Favored 'General case' 0 N--CA 1.484 1.27 0 CA-C-O 122.018 0.913 . . . . 0.0 111.955 -179.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 19.0 tp -84.53 62.07 7.05 Favored 'General case' 0 CA--C 1.571 1.775 0 CA-C-N 114.625 -1.17 . . . . 0.0 111.195 169.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -156.71 -51.58 0.08 Allowed 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 127.221 2.209 . . . . 0.0 105.445 172.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -61.2 -31.44 71.2 Favored 'General case' 0 CA--C 1.571 1.762 0 CA-C-N 119.537 1.062 . . . . 0.0 113.384 167.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 10.3 tt -51.7 -45.94 63.72 Favored 'General case' 0 N--CA 1.498 1.969 0 CA-C-N 120.158 1.345 . . . . 0.0 114.024 168.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 24.6 t -60.43 -59.32 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 C-N-CA 124.411 1.084 . . . . 0.0 112.162 169.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -58.7 -34.22 71.05 Favored 'General case' 0 CA--C 1.566 1.578 0 N-CA-C 116.269 1.952 . . . . 0.0 116.269 -174.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -61.63 -55.55 29.43 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 119.426 1.012 . . . . 0.0 112.279 169.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . 0.263 48.3 m-70 -69.6 -9.51 54.38 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 117.867 2.543 . . . . 0.0 117.867 177.301 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -62.21 -32.41 73.06 Favored 'General case' 0 CA--C 1.577 1.997 0 CA-C-N 120.266 1.393 . . . . 0.0 112.732 166.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 69.4 m -98.75 -39.64 8.54 Favored 'General case' 0 CA--C 1.565 1.529 0 N-CA-C 114.424 1.268 . . . . 0.0 114.424 169.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 52.1 m -91.07 155.61 18.54 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-N 120.175 1.352 . . . . 0.0 112.052 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 31.3 t -75.27 136.01 40.93 Favored 'General case' 0 CA--C 1.559 1.305 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 177.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 6.5 t -76.82 -50.03 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 CA-C-O 118.552 -0.737 . . . . 0.0 111.47 169.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 67.0 m -87.85 143.22 27.25 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 119.297 0.953 . . . . 0.0 111.338 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 19.3 ptp180 -91.12 64.47 5.31 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 121.993 0.901 . . . . 0.0 111.515 169.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . 0.271 7.2 p-10 -179.66 -70.99 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 125.624 1.57 . . . . 0.0 107.003 -172.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -86.59 149.9 24.61 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.965 0.906 . . . . 0.0 110.558 170.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 16.5 mm100 -93.32 88.45 6.0 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 122.764 0.426 . . . . 0.0 109.935 178.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 14.8 mm -90.57 117.61 34.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 -169.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -125.11 122.01 35.92 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 -177.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 10.6 mp -74.51 142.96 44.76 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 113.839 1.052 . . . . 0.0 113.839 -169.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 4.2 tmt_? -144.75 145.02 31.48 Favored 'General case' 0 CA--C 1.563 1.46 0 N-CA-C 105.798 -1.927 . . . . 0.0 105.798 -174.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -69.23 157.04 37.72 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.29 -1.507 . . . . 0.0 113.459 176.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.1 pp -72.62 159.05 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 179.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 122.88 1.324 . . . . 0.0 110.061 177.955 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.491 0 N-CA-C 111.772 -0.531 . . . . 0.0 111.772 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 32.7 t -92.77 120.84 33.56 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 122.948 0.499 . . . . 0.0 111.576 -171.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . 0.256 69.0 p-90 -88.16 -47.7 8.27 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 169.432 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 45.6 t80 -80.71 135.29 35.98 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-N 119.464 1.029 . . . . 0.0 110.967 -177.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -122.77 -76.91 0.59 Allowed 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 177.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 172.92 -112.89 0.45 Allowed Glycine 0 N--CA 1.479 1.542 0 N-CA-C 108.681 -1.768 . . . . 0.0 108.681 173.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 26.9 ttpp -117.83 82.99 1.92 Allowed 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 105.206 -2.146 . . . . 0.0 105.206 169.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -111.49 136.06 21.03 Favored Pre-proline 0 CA--C 1.569 1.695 0 CA-C-O 117.335 -1.317 . . . . 0.0 108.632 -168.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_exo -48.75 153.13 3.81 Favored 'Trans proline' 0 C--N 1.371 1.716 0 C-N-CA 123.736 2.957 . . . . 0.0 119.22 -177.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 59.0 ttt180 -66.5 -37.9 86.07 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 114.817 1.414 . . . . 0.0 114.817 171.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -69.04 -43.33 74.91 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 115.427 1.64 . . . . 0.0 115.427 176.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 54.6 tptt -66.55 -37.31 84.71 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 115.089 1.514 . . . . 0.0 115.089 169.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.27 -45.72 92.0 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 115.612 1.708 . . . . 0.0 115.612 169.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -64.8 -33.95 77.2 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 115.704 1.742 . . . . 0.0 115.704 171.169 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -61.9 -49.53 75.84 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 114.51 1.3 . . . . 0.0 114.51 171.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -62.71 -47.31 84.15 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 114.691 1.367 . . . . 0.0 114.691 173.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.1 mp -68.21 -25.24 65.12 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 116.302 1.964 . . . . 0.0 116.302 175.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 22.9 t -59.1 -36.3 74.9 Favored 'General case' 0 CA--C 1.571 1.759 0 CA-C-N 120.635 1.561 . . . . 0.0 114.078 168.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 27.9 mmtp -61.05 -36.29 79.19 Favored 'General case' 0 CA--C 1.57 1.746 0 N-CA-C 115.054 1.501 . . . . 0.0 115.054 169.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -67.07 119.47 12.07 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.624 1.17 . . . . 0.0 111.769 177.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 14.1 ptp180 -73.93 -17.1 61.06 Favored 'General case' 0 CA--C 1.569 1.685 0 N-CA-C 118.065 2.617 . . . . 0.0 118.065 171.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 46.5 m80 -89.74 141.87 28.21 Favored 'General case' 0 N--CA 1.487 1.418 0 CA-C-N 119.287 0.948 . . . . 0.0 113.188 -168.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.74 119.57 24.5 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 169.62 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 113.61 -28.5 8.52 Favored Glycine 0 CA--C 1.548 2.098 0 CA-C-O 117.685 -1.619 . . . . 0.0 116.347 -169.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.76 109.99 1.6 Allowed 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 120.06 1.93 . . . . 0.0 112.761 -176.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 16.4 p90 -126.63 164.19 21.8 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 115.457 1.651 . . . . 0.0 115.457 -168.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.2 pp -140.69 134.03 29.76 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 167.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 68.1 mt -88.28 117.66 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 106.568 -1.641 . . . . 0.0 106.568 169.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 5.0 ptm180 -110.66 141.9 43.28 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.447 169.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -79.89 139.04 37.28 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 121.533 0.683 . . . . 0.0 109.793 171.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 29.7 t -68.54 128.84 38.07 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.66 -178.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -68.5 -48.14 65.2 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 113.97 1.1 . . . . 0.0 113.97 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.8 t -60.84 -37.72 83.03 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 115.986 1.847 . . . . 0.0 115.986 169.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -119.67 93.11 47.18 Favored Pre-proline 0 CA--C 1.561 1.395 0 CA-C-N 119.577 1.081 . . . . 0.0 109.792 174.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -55.35 -26.36 52.49 Favored 'Trans proline' 0 CA--C 1.557 1.643 0 N-CA-C 119.761 2.947 . . . . 0.0 119.761 171.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -91.31 48.47 2.91 Favored Glycine 0 CA--C 1.552 2.393 0 CA-C-O 119.319 -0.712 . . . . 0.0 113.93 168.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -160.17 126.98 4.36 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 178.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 35.3 m-85 -92.73 165.45 12.94 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 122.213 1.006 . . . . 0.0 111.701 169.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 75.2 m -143.48 112.72 6.78 Favored 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 25.4 tp -79.98 108.65 13.73 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 124.219 1.008 . . . . 0.0 109.447 176.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 12.6 m -99.65 97.25 8.24 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 -173.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 21.7 t -107.6 126.45 63.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 -172.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 58.4 tptt -76.93 109.83 11.07 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 169.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -139.3 90.11 2.39 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -174.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 71.02 74.71 0.68 Allowed Glycine 0 N--CA 1.482 1.765 0 N-CA-C 115.654 1.021 . . . . 0.0 115.654 169.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . 0.286 66.1 m-80 68.97 -11.56 0.44 Allowed 'General case' 0 N--CA 1.501 2.121 0 N-CA-C 118.362 2.727 . . . . 0.0 118.362 -178.488 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -139.47 142.61 37.35 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 119.736 1.153 . . . . 0.0 108.992 -175.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 38.7 t -92.67 114.75 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 177.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 61.6 mt-30 -96.27 118.35 32.65 Favored 'General case' 0 N--CA 1.485 1.301 0 CA-C-O 121.666 0.746 . . . . 0.0 109.848 -178.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 13.9 m-70 -99.25 99.61 10.59 Favored 'General case' 0 CA--C 1.552 1.054 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 -175.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -96.9 121.48 38.82 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 -175.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 65.5 pttt -75.78 116.05 16.09 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.402 0.62 . . . . 0.0 112.59 -169.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 92.0 t -88.12 109.31 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 179.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 57.8 mt -91.91 145.46 24.53 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.378 -174.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 60.9 mtp180 -122.82 124.53 43.5 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.768 -0.583 . . . . 0.0 109.516 -170.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -111.16 99.45 8.29 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 123.263 0.625 . . . . 0.0 110.162 177.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 76.44 89.44 0.27 Allowed Glycine 0 N--CA 1.482 1.761 0 CA-C-O 119.452 -0.638 . . . . 0.0 113.953 174.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . 0.332 . . 75.8 -78.25 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 124.696 1.199 . . . . 0.0 112.675 -175.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -165.48 75.63 0.15 Allowed Glycine 0 CA--C 1.537 1.431 0 CA-C-O 119.782 -0.455 . . . . 0.0 112.077 173.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -105.73 98.31 8.02 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 104.44 -2.43 . . . . 0.0 104.44 169.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -80.05 100.93 8.41 Favored 'General case' 0 N--CA 1.484 1.242 0 CA-C-N 114.617 -1.174 . . . . 0.0 112.286 -167.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -108.91 113.39 26.25 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 64.2 tp -111.12 -49.5 3.01 Favored 'General case' 0 CA--C 1.564 1.504 0 CA-C-N 114.589 -1.187 . . . . 0.0 111.332 176.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . 0.414 ' HZ3' ' HH ' ' A' ' 134' ' ' TYR . 85.9 t90 -129.99 101.98 6.07 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 -175.571 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . 0.519 29.8 m 63.43 -88.02 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 114.895 1.443 . . . . 0.0 114.895 177.146 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 8.6 p -79.99 147.86 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 C-N-CA 124.002 0.921 . . . . 0.0 112.241 -174.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 25.6 pttm -80.04 153.29 28.9 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 121.699 0.762 . . . . 0.0 112.991 173.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -131.24 120.2 22.89 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 -175.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 56.1 m-80 -58.63 -51.66 68.97 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 114.617 1.34 . . . . 0.0 114.617 -178.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 67.2 m -97.14 148.97 22.51 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-O 122.612 1.196 . . . . 0.0 111.664 176.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 15.4 tp -65.63 -37.75 87.46 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 172.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -65.41 -32.92 74.8 Favored 'General case' 0 CA--C 1.572 1.81 0 N-CA-C 114.22 1.193 . . . . 0.0 114.22 168.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -63.19 -41.85 99.24 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-N 120.602 1.547 . . . . 0.0 114.416 169.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 63.5 tp -58.69 -43.44 89.99 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 169.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 25.7 t -58.62 -64.07 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 C-N-CA 124.447 1.099 . . . . 0.0 112.388 171.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -59.66 -30.91 69.08 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 116.116 1.895 . . . . 0.0 116.116 -174.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.414 ' HH ' ' HZ3' ' A' ' 121' ' ' TRP . 85.4 t80 -63.61 -54.07 41.67 Favored 'General case' 0 CA--C 1.567 1.597 0 CA-C-N 118.815 0.734 . . . . 0.0 112.217 168.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . 0.27 62.2 m-70 -69.92 -9.32 54.58 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 117.891 2.552 . . . . 0.0 117.891 177.354 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -51.23 -38.87 54.89 Favored 'General case' 0 N--CA 1.501 2.087 0 CA-C-N 120.726 1.603 . . . . 0.0 113.603 167.154 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 70.0 m -102.91 -34.01 9.12 Favored 'General case' 0 CA--C 1.564 1.505 0 N-CA-C 114.668 1.358 . . . . 0.0 114.668 169.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 30.3 m -90.17 152.43 21.11 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-N 120.681 1.582 . . . . 0.0 111.178 -176.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 29.9 t -74.87 136.58 41.5 Favored 'General case' 0 CA--C 1.56 1.346 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 177.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 88.3 t -71.79 -50.91 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.903 169.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 58.5 m -91.18 154.58 19.22 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-O 122.162 0.982 . . . . 0.0 111.745 -178.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 10.4 mpt_? -71.9 -54.04 11.29 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.709 177.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 24.6 t30 -72.6 -59.56 2.66 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 173.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -79.89 150.62 30.52 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-N 118.793 0.724 . . . . 0.0 112.221 -177.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -101.45 96.97 7.49 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.383 0.673 . . . . 0.0 109.488 -179.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 5.2 mp -109.11 110.71 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 -179.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 19.3 m-30 -108.26 137.34 46.4 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 173.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 9.7 mp -85.47 128.92 34.89 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 123.36 0.664 . . . . 0.0 112.097 -169.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 4.9 mpt_? -129.07 173.77 10.15 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-O 123.409 1.576 . . . . 0.0 109.843 172.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -84.46 157.97 21.18 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-N 114.739 -1.119 . . . . 0.0 113.711 -177.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 29.2 pt -75.36 153.07 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 CA-C-O 121.704 0.764 . . . . 0.0 112.936 178.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 . . . . . 0 N--CA 1.485 1.305 0 CA-C-O 123.977 1.846 . . . . 0.0 108.847 -178.483 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.452 0 N-CA-C 111.617 -0.593 . . . . 0.0 111.617 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 82.5 p -93.97 100.6 12.71 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.088 0.555 . . . . 0.0 110.841 -176.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 68.6 p-90 -76.58 -39.35 52.91 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 116.109 1.892 . . . . 0.0 116.109 176.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -84.05 129.26 34.92 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-N 119.464 1.029 . . . . 0.0 110.646 -174.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -135.5 101.87 4.94 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 105.582 -2.006 . . . . 0.0 105.582 171.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -78.81 108.7 2.71 Favored Glycine 0 CA--C 1.541 1.661 0 CA-C-N 115.969 -0.56 . . . . 0.0 113.317 -173.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . 0.27 2.8 tppp? 66.36 80.27 0.22 Allowed 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 124.878 1.271 . . . . 0.0 112.178 -175.573 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.25 130.61 23.71 Favored Pre-proline 0 CA--C 1.572 1.792 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 -175.718 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -63.74 144.75 89.86 Favored 'Trans proline' 0 CA--C 1.559 1.729 0 C-N-CA 122.842 2.361 . . . . 0.0 114.532 -176.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 60.1 ttt180 -59.74 -39.32 84.36 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 116.672 2.101 . . . . 0.0 116.672 -172.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.8 -45.59 85.62 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 115.1 1.519 . . . . 0.0 115.1 174.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -62.92 -36.72 84.34 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 115.038 1.495 . . . . 0.0 115.038 169.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.46 -44.11 97.69 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 115.59 1.7 . . . . 0.0 115.59 169.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -66.07 -38.83 89.29 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 115.26 1.578 . . . . 0.0 115.26 173.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -65.39 -43.88 89.25 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 115.467 1.654 . . . . 0.0 115.467 173.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -66.38 -43.15 86.71 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 114.464 1.283 . . . . 0.0 114.464 174.501 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 94.7 mt -69.8 -31.36 69.23 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 116.179 1.918 . . . . 0.0 116.179 173.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 89.7 p -61.67 -35.78 78.94 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-N 120.245 1.384 . . . . 0.0 114.433 168.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -63.2 -35.22 79.6 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 114.664 1.357 . . . . 0.0 114.664 168.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -63.57 120.88 12.59 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-O 122.23 1.014 . . . . 0.0 111.706 169.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 17.1 ptm180 -70.65 -18.08 62.85 Favored 'General case' 0 CA--C 1.567 1.623 0 N-CA-C 119.061 2.986 . . . . 0.0 119.061 -179.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 51.7 m80 -89.5 146.54 24.55 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-N 119.651 1.114 . . . . 0.0 113.455 -168.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -80.77 110.57 16.41 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.189 -1.411 . . . . 0.0 107.189 169.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 120.1 -17.45 9.88 Favored Glycine 0 CA--C 1.552 2.357 0 CA-C-O 117.347 -1.807 . . . . 0.0 116.043 -168.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.99 113.25 3.36 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-N 120.847 2.323 . . . . 0.0 112.964 -173.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -126.8 168.59 14.22 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 115.167 1.543 . . . . 0.0 115.167 -168.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.5 pp -149.8 134.6 17.75 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 167.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 53.7 mt -85.64 113.25 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 174.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 61.7 ttp85 -95.15 138.86 32.3 Favored 'General case' 0 N--CA 1.483 1.195 0 CA-C-N 114.203 -1.362 . . . . 0.0 110.02 175.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -84.4 125.98 32.81 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 169.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 50.7 m -67.06 128.51 36.62 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.709 0.804 . . . . 0.0 112.411 -169.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -65.76 -49.66 67.57 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 -173.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.4 t -63.96 -40.36 96.25 Favored 'General case' 0 CA--C 1.564 1.51 0 N-CA-C 115.563 1.69 . . . . 0.0 115.563 170.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -112.28 93.53 22.7 Favored Pre-proline 0 CA--C 1.564 1.511 0 CA-C-O 118.02 -0.99 . . . . 0.0 109.779 178.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.58 132.87 21.2 Favored 'Trans proline' 0 C--N 1.371 1.747 0 C-N-CA 123.132 2.555 . . . . 0.0 112.076 177.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 98.91 -34.81 5.08 Favored Glycine 0 CA--C 1.554 2.512 0 CA-C-O 119.055 -0.858 . . . . 0.0 114.464 -168.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -79.24 139.25 37.96 Favored 'General case' 0 N--CA 1.485 1.325 0 CA-C-N 118.529 1.164 . . . . 0.0 109.356 171.026 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -110.0 162.64 14.34 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 122.223 1.011 . . . . 0.0 111.305 -176.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 71.0 m -136.55 117.15 13.88 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 173.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 26.6 tp -79.71 106.62 11.87 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 124.254 1.022 . . . . 0.0 108.731 176.173 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.6 m -95.75 95.69 8.47 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 -170.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 17.6 t -112.08 122.0 65.57 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 -170.196 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -83.29 102.97 12.32 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 169.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -126.14 117.19 22.62 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 107.807 -1.182 . . . . 0.0 107.807 177.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 86.43 -106.35 3.09 Favored Glycine 0 N--CA 1.48 1.621 0 N-CA-C 110.547 -1.021 . . . . 0.0 110.547 -175.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 31.6 t30 -141.88 56.51 1.49 Allowed 'General case' 0 CA--C 1.566 1.574 0 C-N-CA 122.843 0.457 . . . . 0.0 109.999 169.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -158.92 133.2 7.82 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 178.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 56.6 t -91.85 109.94 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 173.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -106.43 115.67 30.62 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.795 0.838 . . . . 0.0 108.786 -169.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 18.4 m-70 -94.88 96.73 9.52 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 114.918 -1.037 . . . . 0.0 108.375 -172.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -94.32 122.13 36.56 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 -174.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -73.79 120.05 18.85 Favored 'General case' 0 N--CA 1.487 1.379 0 CA-C-O 121.445 0.64 . . . . 0.0 111.809 -169.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 76.9 t -97.35 101.4 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 N-CA-C 105.658 -1.979 . . . . 0.0 105.658 175.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -100.13 149.51 23.44 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.284 0.634 . . . . 0.0 110.522 177.588 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 54.7 mtp180 -110.54 128.0 55.45 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 123.164 0.586 . . . . 0.0 110.316 -169.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . 0.277 4.2 p-10 -83.74 -68.64 0.7 Allowed 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 179.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -91.13 -114.56 1.83 Allowed Glycine 0 N--CA 1.482 1.734 0 CA-C-N 119.352 0.978 . . . . 0.0 112.189 -176.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -81.1 -71.65 0.46 Allowed 'General case' 0 N--CA 1.487 1.386 0 CA-C-O 118.357 -0.83 . . . . 0.0 110.607 173.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -134.7 68.1 0.54 Allowed Glycine 0 N--CA 1.48 1.607 0 CA-C-N 118.731 0.696 . . . . 0.0 112.28 169.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 2.3 mppt? -107.28 97.11 6.91 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 105.751 -1.944 . . . . 0.0 105.751 171.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -86.88 110.89 20.29 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 114.309 -1.314 . . . . 0.0 109.343 -169.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -130.56 136.2 48.67 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 121.319 0.58 . . . . 0.0 110.324 -173.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -128.27 -51.51 1.3 Allowed 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 124.067 0.947 . . . . 0.0 111.972 177.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 58.7 t90 -94.46 -79.6 0.42 Allowed 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 124.368 1.067 . . . . 0.0 110.331 -172.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 95.0 t -128.84 -77.77 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 -175.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 10.8 p -80.87 138.86 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 C-N-CA 123.508 0.723 . . . . 0.0 111.362 -172.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.77 147.71 31.74 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 121.648 0.737 . . . . 0.0 112.511 179.309 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -124.26 108.81 12.64 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 -169.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 17.7 p30 -55.79 -30.38 61.24 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 118.195 2.665 . . . . 0.0 118.195 177.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 30.9 t -124.97 146.3 49.46 Favored 'General case' 0 N--CA 1.484 1.237 0 CA-C-O 121.942 0.877 . . . . 0.0 111.436 -177.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 89.6 mt -83.77 103.56 13.16 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 105.356 -2.091 . . . . 0.0 105.356 168.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . 0.273 28.5 t-20 145.98 -57.79 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 104.53 -2.396 . . . . 0.0 104.53 -168.557 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -56.91 -42.44 79.93 Favored 'General case' 0 CA--C 1.574 1.868 0 C-N-CA 124.26 1.024 . . . . 0.0 113.597 168.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 8.4 tt -55.46 -49.44 72.48 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 114.888 1.44 . . . . 0.0 114.888 169.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . 0.276 3.6 m -63.43 -51.47 70.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 CA-C-N 119.224 0.92 . . . . 0.0 113.223 178.188 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -64.67 -33.56 76.24 Favored 'General case' 0 CA--C 1.568 1.664 0 N-CA-C 115.182 1.549 . . . . 0.0 115.182 -176.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 69.2 t80 -62.12 -59.33 5.22 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-N 119.749 1.159 . . . . 0.0 112.826 169.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 60.7 m-70 -68.94 -9.38 51.7 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 117.906 2.558 . . . . 0.0 117.906 178.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 54.5 ttm-85 -53.76 -31.42 48.55 Favored 'General case' 0 CA--C 1.574 1.868 0 N-CA-C 115.074 1.509 . . . . 0.0 115.074 168.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 70.9 m -116.49 -24.32 7.9 Favored 'General case' 0 CA--C 1.57 1.716 0 C-N-CA 125.071 1.348 . . . . 0.0 114.216 169.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 61.0 m -90.13 151.67 21.48 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-N 120.837 1.653 . . . . 0.0 110.577 177.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 32.2 t -68.35 129.09 38.88 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 178.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 35.1 t -71.42 -48.79 51.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 CA-C-O 118.296 -0.859 . . . . 0.0 111.95 172.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 15.7 p -91.08 168.41 11.66 Favored 'General case' 0 N--CA 1.487 1.411 0 CA-C-N 119.235 0.925 . . . . 0.0 112.122 -179.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 30.7 mmt180 -72.11 -58.42 3.44 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 177.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 23.8 t30 -75.64 -61.72 1.82 Allowed 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 65.3 mt-30 -79.95 150.35 30.53 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 118.638 0.654 . . . . 0.0 112.225 -175.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -83.09 121.37 26.95 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 122.843 0.457 . . . . 0.0 110.553 169.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 3.6 mp -123.64 108.82 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 104.248 -2.501 . . . . 0.0 104.248 172.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 18.3 m-30 -113.93 108.19 16.71 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 105.771 -1.937 . . . . 0.0 105.771 179.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . 0.35 1.0 OUTLIER -76.15 170.27 16.62 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 116.381 1.993 . . . . 0.0 116.381 -169.15 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 3.9 tmt_? -160.04 138.22 10.16 Favored 'General case' 0 CA--C 1.56 1.355 0 N-CA-C 104.621 -2.362 . . . . 0.0 104.621 -169.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -67.8 172.39 5.42 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.115 -1.616 . . . . 0.0 114.248 178.353 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 18.3 pt -70.62 156.91 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 O-C-N 120.883 -1.136 . . . . 0.0 113.184 -175.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 . . . . . 0 N--CA 1.489 1.486 0 CA-C-O 122.859 1.314 . . . . 0.0 109.869 176.554 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.454 0 N-CA-C 111.558 -0.617 . . . . 0.0 111.558 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 89.6 p -84.67 108.51 17.43 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 123.153 0.581 . . . . 0.0 111.324 -179.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 62.9 p-90 -155.46 -44.14 0.08 Allowed 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 178.066 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 44.6 t80 -82.79 137.82 34.22 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 120.249 1.386 . . . . 0.0 111.799 -173.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -118.64 -73.2 0.65 Allowed 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.43 176.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 108.32 84.85 1.67 Allowed Glycine 0 N--CA 1.481 1.697 0 CA-C-N 118.923 0.783 . . . . 0.0 111.397 -176.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . 0.304 33.0 ttmt 64.98 79.98 0.24 Allowed 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 125.179 1.392 . . . . 0.0 114.109 178.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 17.8 pt -126.14 157.79 68.58 Favored Pre-proline 0 CA--C 1.579 2.083 0 C-N-CA 124.257 1.023 . . . . 0.0 109.396 171.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -75.79 165.07 30.83 Favored 'Trans proline' 0 CA--C 1.564 1.976 0 C-N-CA 122.712 2.274 . . . . 0.0 115.092 -178.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 30.0 ttm180 -63.98 -45.49 88.85 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 115.913 1.82 . . . . 0.0 115.913 176.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.23 -46.42 87.0 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 115.337 1.606 . . . . 0.0 115.337 -179.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm -62.97 -34.71 78.09 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 115.265 1.58 . . . . 0.0 115.265 169.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.88 -42.66 90.04 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 115.442 1.645 . . . . 0.0 115.442 170.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -60.54 -44.91 95.58 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 115.212 1.56 . . . . 0.0 115.212 170.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -58.66 -50.76 72.69 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 114.979 1.474 . . . . 0.0 114.979 175.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -63.96 -49.15 73.68 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 114.708 1.373 . . . . 0.0 114.708 176.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 8.8 mp -71.02 -33.12 70.04 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 116.563 2.06 . . . . 0.0 116.563 -176.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 66.7 m -60.17 -33.09 71.71 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 116.08 1.882 . . . . 0.0 116.08 169.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 57.4 mtmt -64.1 -33.64 76.22 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 115.934 1.827 . . . . 0.0 115.934 169.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -64.5 127.01 29.66 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.62 1.168 . . . . 0.0 113.009 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -62.29 -21.47 65.26 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 119.042 2.978 . . . . 0.0 119.042 177.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 43.4 m80 -89.38 132.71 34.84 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 119.264 0.938 . . . . 0.0 111.09 -169.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -75.55 105.36 6.54 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 171.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 124.78 -7.78 8.25 Favored Glycine 0 CA--C 1.553 2.448 0 CA-C-O 116.91 -2.05 . . . . 0.0 116.523 -169.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.12 111.92 2.77 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 121.229 2.515 . . . . 0.0 111.968 -171.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 20.1 p90 -128.24 161.96 28.11 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 115.427 1.64 . . . . 0.0 115.427 -168.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.1 pp -139.69 136.06 33.84 Favored 'General case' 0 CA--C 1.555 1.14 0 CA-C-N 113.919 -1.491 . . . . 0.0 107.884 168.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 62.7 mt -97.13 106.5 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 169.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 46.7 ptt85 -95.45 157.18 16.01 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 114.45 -1.25 . . . . 0.0 110.324 169.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -85.06 135.87 33.81 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.431 -0.793 . . . . 0.0 109.163 169.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 93.3 p -68.67 121.9 17.41 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-O 121.026 0.441 . . . . 0.0 110.815 172.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -68.66 -39.37 80.69 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 116.684 2.105 . . . . 0.0 116.684 -175.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.5 t -63.1 -22.13 66.65 Favored 'General case' 0 CA--C 1.569 1.697 0 N-CA-C 115.864 1.802 . . . . 0.0 115.864 169.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -135.45 94.78 15.06 Favored Pre-proline 0 CA--C 1.563 1.446 0 CA-C-N 120.011 1.278 . . . . 0.0 109.027 177.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -70.33 134.06 25.93 Favored 'Trans proline' 0 C--N 1.372 1.795 0 C-N-CA 123.038 2.492 . . . . 0.0 111.933 176.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 101.31 -38.05 3.33 Favored Glycine 0 CA--C 1.555 2.574 0 CA-C-O 119.382 -0.676 . . . . 0.0 113.48 -168.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -79.46 130.91 35.86 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 118.182 0.991 . . . . 0.0 109.182 169.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -107.42 169.38 8.61 Favored 'General case' 0 N--CA 1.486 1.374 0 CA-C-O 122.439 1.114 . . . . 0.0 110.861 -178.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 69.4 m -141.65 117.64 10.56 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -179.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 31.2 tp -79.96 113.65 18.28 Favored 'General case' 0 CA--C 1.559 1.314 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 169.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 9.6 m -97.91 104.0 15.99 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 173.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.8 p -124.76 117.63 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 CA-C-N 118.964 0.802 . . . . 0.0 109.0 -171.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -74.62 140.0 44.01 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.931 169.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 15.8 t80 -157.0 95.12 1.48 Allowed 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 171.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 70.04 74.87 0.62 Allowed Glycine 0 CA--C 1.544 1.902 0 CA-C-O 119.421 -0.655 . . . . 0.0 114.64 -177.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . 0.366 9.7 t-20 78.62 -58.14 0.44 Allowed 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 116.664 2.098 . . . . 0.0 116.664 -179.026 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -91.16 142.85 27.3 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 123.898 0.879 . . . . 0.0 112.019 -169.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 41.6 t -102.27 113.21 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 N-CA-C 106.592 -1.632 . . . . 0.0 106.592 -178.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -96.83 117.99 32.29 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.897 0.879 . . . . 0.0 109.334 -176.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 10.5 m-70 -97.98 97.26 8.77 Favored 'General case' 0 CA--C 1.554 1.119 0 CA-C-N 114.991 -1.004 . . . . 0.0 108.443 -174.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -100.86 135.11 42.83 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 124.061 0.945 . . . . 0.0 109.11 -178.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 12.2 mmmm -79.44 125.34 29.42 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.858 -0.526 . . . . 0.0 111.957 -178.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 96.2 t -85.7 112.94 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 106.484 -1.672 . . . . 0.0 106.484 171.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -114.85 145.06 42.57 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.231 0.612 . . . . 0.0 110.528 -175.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -97.11 158.26 15.52 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -175.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -123.1 100.85 7.08 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 169.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 90.73 -112.72 4.14 Favored Glycine 0 CA--C 1.542 1.722 0 CA-C-O 120.082 -0.288 . . . . 0.0 113.417 176.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -84.75 -74.18 0.4 Allowed 'General case' 0 N--CA 1.488 1.462 0 CA-C-O 118.886 -0.578 . . . . 0.0 112.215 -173.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -148.22 74.36 0.28 Allowed Glycine 0 N--CA 1.479 1.518 0 N-CA-C 110.499 -1.04 . . . . 0.0 110.499 173.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -122.38 89.57 3.14 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 -177.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -80.02 115.61 19.69 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.791 -169.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 26.5 p90 -124.86 120.42 31.63 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 174.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -87.86 -59.94 2.1 Favored 'General case' 0 CA--C 1.562 1.424 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.086 169.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 39.3 t90 -80.25 -81.44 0.12 Allowed 'General case' 0 CA--C 1.56 1.343 0 C-N-CA 124.82 1.248 . . . . 0.0 110.383 -175.053 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.1 m -140.44 -53.76 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 C-N-CA 124.012 0.925 . . . . 0.0 110.937 176.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 3.4 m -79.78 140.85 16.14 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.458 0 C-N-CA 124.411 1.084 . . . . 0.0 112.096 -174.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.45 152.34 18.5 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 -171.047 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -146.22 119.91 9.2 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 -171.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -55.91 -40.46 73.09 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 116.575 2.065 . . . . 0.0 116.575 -177.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 27.1 t -102.63 153.07 20.46 Favored 'General case' 0 N--CA 1.485 1.321 0 CA-C-N 119.031 0.832 . . . . 0.0 111.483 174.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 82.9 mt -67.85 -32.64 73.31 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 169.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -64.26 -39.69 94.46 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 119.701 1.137 . . . . 0.0 113.803 170.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -60.56 -44.12 96.5 Favored 'General case' 0 CA--C 1.573 1.854 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 169.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 49.3 tp -55.5 -44.84 76.96 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 115.411 1.634 . . . . 0.0 115.411 169.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . 0.282 10.9 m -63.73 -51.5 69.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 CA-C-N 120.124 1.329 . . . . 0.0 113.232 175.11 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -63.34 -36.05 82.41 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 114.625 1.343 . . . . 0.0 114.625 -175.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 90.3 t80 -60.61 -52.72 63.97 Favored 'General case' 0 CA--C 1.57 1.733 0 CA-C-N 119.404 1.002 . . . . 0.0 112.03 168.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 50.7 m-70 -72.7 -9.13 58.27 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 118.728 2.862 . . . . 0.0 118.728 178.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 88.1 mtt-85 -59.84 -29.04 68.0 Favored 'General case' 0 CA--C 1.575 1.937 0 CA-C-N 120.156 1.344 . . . . 0.0 113.447 167.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 69.7 m -103.01 -39.57 6.85 Favored 'General case' 0 CA--C 1.569 1.696 0 C-N-CA 125.022 1.329 . . . . 0.0 113.094 168.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 34.3 m -90.53 156.38 18.21 Favored 'General case' 0 N--CA 1.498 1.94 0 CA-C-N 120.142 1.337 . . . . 0.0 112.031 -176.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 35.3 t -75.07 132.91 41.62 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 3.3 m -78.88 -38.39 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 114.976 1.472 . . . . 0.0 114.976 169.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 16.8 t -79.82 -40.12 29.25 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 116.61 2.078 . . . . 0.0 116.61 -169.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 15.9 tpt180 84.49 115.88 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 124.777 1.231 . . . . 0.0 108.903 -170.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . 0.351 59.2 m-80 83.62 -58.53 0.14 Allowed 'General case' 0 N--CA 1.499 2.017 0 C-N-CA 124.507 1.123 . . . . 0.0 112.604 -172.496 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 -79.57 126.63 31.13 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 170.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 76.3 mm-40 -90.1 96.03 10.48 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 -175.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 29.6 mm -111.68 109.4 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 105.787 -1.931 . . . . 0.0 105.787 -173.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -111.95 121.93 46.36 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 -173.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 10.5 mp -75.1 136.62 41.12 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 -168.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 81.7 mmt-85 -131.54 153.57 49.71 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 125.368 1.467 . . . . 0.0 108.381 178.468 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -79.31 157.39 27.71 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.822 -1.174 . . . . 0.0 112.798 -177.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 8.5 mt -69.35 146.68 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 C-N-CA 123.934 0.894 . . . . 0.0 109.886 -179.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 123.946 1.832 . . . . 0.0 108.149 178.726 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.33 0 N-CA-C 111.284 -0.727 . . . . 0.0 111.284 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 47.2 m 65.8 95.79 0.05 Allowed 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 124.696 1.198 . . . . 0.0 112.008 -178.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . 0.418 70.5 p-90 58.27 -17.87 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 120.732 3.604 . . . . 0.0 120.732 -174.854 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 44.4 t80 -96.95 131.6 43.59 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.78 0.832 . . . . 0.0 110.153 -169.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -107.73 -65.89 1.08 Allowed 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.352 173.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.04 77.66 1.31 Allowed Glycine 0 N--CA 1.482 1.744 0 CA-C-N 118.952 0.796 . . . . 0.0 112.375 -179.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . 0.298 61.9 tttt 71.24 71.74 0.18 Allowed 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 124.62 1.168 . . . . 0.0 113.936 175.049 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 14.9 pt -118.95 154.74 53.22 Favored Pre-proline 0 CA--C 1.576 1.959 0 C-N-CA 124.056 0.942 . . . . 0.0 109.069 170.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -75.71 172.65 15.91 Favored 'Trans proline' 0 CA--C 1.564 2.015 0 C-N-CA 122.702 2.268 . . . . 0.0 114.34 178.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 28.6 ttm180 -61.63 -43.86 98.07 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 115.915 1.82 . . . . 0.0 115.915 175.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -65.3 -43.38 91.29 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 115.805 1.78 . . . . 0.0 115.805 178.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -67.39 -32.54 73.51 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 115.362 1.615 . . . . 0.0 115.362 169.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.26 -42.14 88.95 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 115.328 1.603 . . . . 0.0 115.328 169.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -62.81 -42.4 99.7 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 114.346 1.239 . . . . 0.0 114.346 169.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -53.41 -48.07 69.03 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 115.395 1.628 . . . . 0.0 115.395 170.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 37.3 mmt -62.37 -48.32 80.31 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 173.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 88.8 mt -76.22 -9.82 58.93 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 117.775 2.509 . . . . 0.0 117.775 178.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 72.4 m -57.69 -38.73 75.71 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 115.875 1.805 . . . . 0.0 115.875 170.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -60.39 -33.27 72.24 Favored 'General case' 0 CA--C 1.571 1.778 0 N-CA-C 116.061 1.875 . . . . 0.0 116.061 169.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -71.7 111.46 6.99 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.165 0.986 . . . . 0.0 112.122 -171.511 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 13.4 ptp180 -74.28 -17.57 60.84 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 117.86 2.541 . . . . 0.0 117.86 173.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 48.4 m80 -89.63 137.29 32.45 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 119.248 0.931 . . . . 0.0 111.338 -168.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -77.56 115.23 17.15 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 122.951 0.5 . . . . 0.0 110.444 176.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 114.63 -23.19 12.27 Favored Glycine 0 CA--C 1.551 2.321 0 CA-C-O 117.269 -1.851 . . . . 0.0 116.246 -169.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.4 113.47 1.99 Allowed 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 120.66 2.23 . . . . 0.0 113.238 -176.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 27.3 p90 -130.18 165.07 23.11 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 115.828 1.788 . . . . 0.0 115.828 -168.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.0 pp -142.16 125.25 16.3 Favored 'General case' 0 CA--C 1.557 1.233 0 N-CA-C 106.803 -1.555 . . . . 0.0 106.803 168.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 59.9 mt -87.07 114.12 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 106.584 -1.636 . . . . 0.0 106.584 173.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 49.3 ptt85 -99.78 159.2 15.24 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-N 114.931 -1.031 . . . . 0.0 111.042 170.028 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -86.58 135.28 33.49 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 168.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 84.1 p -65.32 128.45 35.9 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-O 121.275 0.559 . . . . 0.0 111.733 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -62.46 -45.46 92.94 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 116.017 1.858 . . . . 0.0 116.017 -169.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 68.1 m -69.72 -33.15 72.09 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 116.053 1.871 . . . . 0.0 116.053 171.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -119.18 101.04 50.01 Favored Pre-proline 0 CA--C 1.563 1.469 0 CA-C-N 120.018 1.281 . . . . 0.0 110.939 -175.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -59.46 -32.16 95.92 Favored 'Trans proline' 0 C--N 1.369 1.655 0 N-CA-C 119.934 3.013 . . . . 0.0 119.934 174.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -87.23 44.82 3.33 Favored Glycine 0 CA--C 1.553 2.41 0 N-CA-C 115.247 0.859 . . . . 0.0 115.247 169.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -160.13 130.19 5.37 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 106.187 -1.783 . . . . 0.0 106.187 -178.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 -103.9 174.73 5.74 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 122.106 0.955 . . . . 0.0 111.181 172.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 62.0 m -149.03 120.4 7.88 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 -179.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 36.4 tp -79.93 110.51 15.37 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.803 0.841 . . . . 0.0 109.173 170.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.6 m -96.16 103.1 14.98 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 105.696 -1.964 . . . . 0.0 105.696 174.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.4 p -122.21 121.12 63.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 CA-C-O 121.471 0.653 . . . . 0.0 109.809 -169.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 58.1 tptt -82.68 98.63 9.15 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 124.32 1.048 . . . . 0.0 109.941 177.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -120.08 93.31 4.01 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -175.658 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 69.28 65.18 2.68 Favored Glycine 0 CA--C 1.544 1.845 0 N-CA-C 115.658 1.023 . . . . 0.0 115.658 175.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . 0.269 26.8 t30 54.78 41.83 31.63 Favored 'General case' 0 CA--C 1.574 1.903 0 N-CA-C 116.419 2.007 . . . . 0.0 116.419 -174.207 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -160.77 129.92 4.81 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.541 -0.724 . . . . 0.0 109.738 176.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 41.1 t -94.71 106.04 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 178.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -98.73 119.6 37.75 Favored 'General case' 0 N--CA 1.484 1.27 0 CA-C-O 121.704 0.764 . . . . 0.0 109.37 -177.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 13.0 m-70 -99.19 109.23 21.93 Favored 'General case' 0 CA--C 1.552 1.034 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 -176.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -114.49 127.94 56.07 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -176.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -74.29 132.32 41.98 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-O 121.785 0.802 . . . . 0.0 112.751 -177.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 92.9 t -101.97 103.99 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 N-CA-C 104.859 -2.274 . . . . 0.0 104.859 174.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -104.44 132.35 50.78 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.517 0.727 . . . . 0.0 110.129 -173.5 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -84.96 161.88 19.62 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 121.895 0.855 . . . . 0.0 112.306 -179.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 20.7 p-10 -79.69 -39.41 31.35 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 169.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -178.53 -79.09 0.06 OUTLIER Glycine 0 CA--C 1.539 1.586 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 -173.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -74.83 -69.34 0.47 Allowed 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 177.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -174.18 68.78 0.1 OUTLIER Glycine 0 N--CA 1.479 1.529 0 CA-C-N 118.874 0.761 . . . . 0.0 113.294 175.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -120.38 102.33 8.39 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 105.38 -2.082 . . . . 0.0 105.38 171.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -81.4 121.39 26.17 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.439 1.095 . . . . 0.0 110.488 -169.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 44.0 p90 -130.03 122.0 27.54 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 121.31 0.576 . . . . 0.0 109.616 174.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 5.0 tt -89.36 -65.2 1.04 Allowed 'General case' 0 N--CA 1.488 1.472 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.126 169.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 20.2 t90 -82.32 -61.78 1.8 Allowed 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 124.446 1.098 . . . . 0.0 112.55 -172.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . 0.258 11.2 p -149.76 -67.36 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 CA-C-N 118.849 0.75 . . . . 0.0 110.114 -178.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 3.4 m -79.64 141.91 14.68 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.419 0 C-N-CA 124.291 1.036 . . . . 0.0 112.301 -171.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 10.0 ptpp? -96.64 156.24 16.43 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -173.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -145.14 132.12 20.27 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.248 -169.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 -50.61 -41.73 55.16 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 117.922 2.564 . . . . 0.0 117.922 177.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 90.5 p -122.65 159.33 28.11 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-O 122.688 1.233 . . . . 0.0 111.877 178.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 61.3 mt -62.69 -31.91 72.9 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 115.186 1.551 . . . . 0.0 115.186 169.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -65.36 -36.09 82.96 Favored 'General case' 0 CA--C 1.571 1.755 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 169.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -63.26 -47.83 80.75 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-N 119.86 1.209 . . . . 0.0 113.707 169.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 60.5 tp -59.53 -38.61 81.45 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 115.724 1.75 . . . . 0.0 115.724 169.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . 0.265 0.3 OUTLIER -67.04 -53.9 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 CA-C-N 119.743 1.156 . . . . 0.0 113.251 -179.595 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -57.97 -33.83 69.3 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 115.454 1.65 . . . . 0.0 115.454 172.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -57.28 -55.45 34.62 Favored 'General case' 0 CA--C 1.566 1.579 0 CA-C-N 119.353 0.979 . . . . 0.0 113.021 168.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . 0.265 52.7 m-70 -74.72 -9.47 58.59 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 117.944 2.572 . . . . 0.0 117.944 177.379 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 94.2 mtt-85 -62.15 -33.35 74.33 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-N 120.883 1.674 . . . . 0.0 112.962 167.168 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 70.6 m -97.03 -40.15 8.99 Favored 'General case' 0 CA--C 1.563 1.476 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 170.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 60.7 m -90.8 154.03 19.81 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-N 120.093 1.315 . . . . 0.0 111.527 179.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 33.0 t -75.75 134.66 40.41 Favored 'General case' 0 CA--C 1.559 1.323 0 CA-C-O 121.462 0.648 . . . . 0.0 112.556 177.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 45.5 t -70.24 -48.29 62.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 CA-C-N 115.419 -0.81 . . . . 0.0 112.202 172.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 57.7 m -122.62 154.71 37.64 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-O 122.262 1.03 . . . . 0.0 110.721 -177.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 85.2 mtt85 -77.18 -39.88 47.32 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 115.171 1.545 . . . . 0.0 115.171 -177.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 22.2 m120 -74.58 -66.45 0.74 Allowed 'General case' 0 N--CA 1.495 1.82 0 CA-C-N 119.902 1.228 . . . . 0.0 111.876 174.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 35.7 mm-40 -80.07 126.02 30.53 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 118.909 0.777 . . . . 0.0 109.2 170.08 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 3.2 pm0 -94.43 86.46 4.86 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 123.018 0.527 . . . . 0.0 110.477 -176.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 4.0 mp -85.77 122.04 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -169.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -121.73 117.11 25.81 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 106.428 -1.694 . . . . 0.0 106.428 176.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 11.2 mp -70.85 134.4 47.29 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 -168.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 62.7 mmt-85 -132.28 162.71 30.31 Favored 'General case' 0 CA--C 1.564 1.515 0 C-N-CA 124.963 1.305 . . . . 0.0 109.221 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -76.33 158.89 31.05 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.907 -1.12 . . . . 0.0 113.801 176.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.1 pp -76.65 161.73 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -177.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 . . . . . 0 N--CA 1.484 1.262 0 CA-C-O 124.021 1.867 . . . . 0.0 108.096 177.618 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.35 0 N-CA-C 111.261 -0.736 . . . . 0.0 111.261 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 74.3 m -83.96 105.09 14.57 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 123.099 0.56 . . . . 0.0 109.745 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 1.6 p90 -141.46 -29.81 0.62 Allowed 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 116.248 1.944 . . . . 0.0 116.248 -169.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 72.2 t80 -118.32 124.19 47.17 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 178.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -119.39 66.43 0.79 Allowed 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 121.272 0.558 . . . . 0.0 110.82 -179.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 53.59 -119.42 10.83 Favored Glycine 0 CA--C 1.547 2.065 0 N-CA-C 118.803 2.281 . . . . 0.0 118.803 169.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -141.56 96.53 3.0 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 -171.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.01 149.94 75.19 Favored Pre-proline 0 CA--C 1.572 1.815 0 CA-C-O 118.502 -0.761 . . . . 0.0 109.733 176.255 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -66.49 172.11 9.63 Favored 'Trans proline' 0 CA--C 1.563 1.956 0 C-N-CA 123.005 2.47 . . . . 0.0 114.556 172.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 59.2 ttt-85 -60.32 -41.9 94.48 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 116.08 1.882 . . . . 0.0 116.08 -177.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -66.08 -44.27 84.96 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 115.466 1.654 . . . . 0.0 115.466 176.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -63.24 -33.99 76.68 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 115.674 1.731 . . . . 0.0 115.674 170.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.47 -43.15 95.11 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 115.302 1.593 . . . . 0.0 115.302 169.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -61.22 -43.97 98.02 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 114.943 1.46 . . . . 0.0 114.943 170.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -57.18 -44.0 83.17 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 115.626 1.713 . . . . 0.0 115.626 173.095 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 37.9 mmt -63.04 -48.3 79.33 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 114.528 1.307 . . . . 0.0 114.528 172.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 95.1 mt -73.25 -12.12 60.75 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 117.518 2.414 . . . . 0.0 117.518 175.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 69.6 m -63.0 -37.85 88.82 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-N 120.507 1.503 . . . . 0.0 113.966 168.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt -60.59 -33.78 73.24 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 115.386 1.624 . . . . 0.0 115.386 169.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -71.2 117.04 12.22 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 124.478 1.111 . . . . 0.0 111.225 178.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -79.53 -17.39 54.15 Favored 'General case' 0 CA--C 1.569 1.677 0 N-CA-C 117.531 2.419 . . . . 0.0 117.531 172.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 45.8 m80 -89.53 133.22 34.69 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 119.198 0.908 . . . . 0.0 111.929 -168.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -71.63 123.31 22.22 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 122.953 0.501 . . . . 0.0 110.833 174.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 107.8 -20.22 31.95 Favored Glycine 0 CA--C 1.549 2.179 0 CA-C-O 117.576 -1.68 . . . . 0.0 116.51 -169.257 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.69 123.06 19.07 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-N 120.192 1.996 . . . . 0.0 111.746 -173.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 24.7 p90 -137.36 158.13 45.08 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -168.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.3 pp -137.47 127.99 26.68 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 168.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 74.1 mt -87.64 113.6 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 105.62 -1.993 . . . . 0.0 105.62 175.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 4.1 ptm180 -90.05 149.96 22.29 Favored 'General case' 0 N--CA 1.484 1.27 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.065 170.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -85.87 128.43 34.82 Favored 'General case' 0 CA--C 1.56 1.33 0 N-CA-C 106.795 -1.558 . . . . 0.0 106.795 168.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 50.3 m -65.01 132.61 49.7 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 -169.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -64.67 -50.98 64.92 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 114.666 1.358 . . . . 0.0 114.666 -174.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 95.9 p -65.09 -38.95 92.39 Favored 'General case' 0 CA--C 1.562 1.441 0 N-CA-C 116.083 1.883 . . . . 0.0 116.083 169.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -114.73 95.16 39.98 Favored Pre-proline 0 CA--C 1.563 1.474 0 CA-C-N 119.66 1.118 . . . . 0.0 109.553 -179.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -72.39 135.09 23.84 Favored 'Trans proline' 0 C--N 1.371 1.749 0 C-N-CA 123.068 2.512 . . . . 0.0 112.215 178.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 97.41 -40.49 2.52 Favored Glycine 0 CA--C 1.552 2.383 0 CA-C-O 119.308 -0.718 . . . . 0.0 113.627 -168.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -79.12 131.4 36.22 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 124.076 0.95 . . . . 0.0 109.168 176.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -100.54 168.52 9.67 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 122.102 0.953 . . . . 0.0 111.847 -170.363 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 58.8 m -147.31 123.62 10.93 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 174.106 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 26.8 tp -79.95 108.47 13.55 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.078 0.951 . . . . 0.0 109.635 175.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.2 m -91.38 107.26 19.08 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 106.12 -1.808 . . . . 0.0 106.12 172.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.2 p -131.06 116.11 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 -170.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.19 113.92 20.35 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.334 175.422 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -132.95 116.39 16.38 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 177.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 89.48 -83.33 1.41 Allowed Glycine 0 N--CA 1.481 1.654 0 CA-C-N 116.243 -0.435 . . . . 0.0 112.063 -179.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 10.6 p30 -138.62 -26.4 0.88 Allowed 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 115.533 1.679 . . . . 0.0 115.533 170.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -98.05 142.42 29.77 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 124.051 0.94 . . . . 0.0 110.668 -171.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 47.8 t -85.64 110.01 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 N-CA-C 106.533 -1.654 . . . . 0.0 106.533 172.061 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 61.9 mt-30 -104.42 113.92 27.8 Favored 'General case' 0 N--CA 1.484 1.26 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.002 -169.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 16.8 m-70 -96.26 102.49 14.28 Favored 'General case' 0 CA--C 1.553 1.071 0 CA-C-N 114.766 -1.106 . . . . 0.0 108.262 -174.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -106.78 123.24 47.85 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 -179.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 43.6 mtpt -77.2 122.95 25.76 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 121.687 0.756 . . . . 0.0 112.101 -169.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 98.7 t -92.35 96.94 6.66 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.591 0 N-CA-C 105.026 -2.213 . . . . 0.0 105.026 177.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 62.1 mt -90.52 135.65 33.56 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 -168.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 27.1 mtp-105 -87.42 144.01 26.96 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 122.014 0.912 . . . . 0.0 112.888 176.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -86.57 -53.67 4.84 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-N 114.474 -1.239 . . . . 0.0 114.304 176.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -165.71 -86.08 0.06 OUTLIER Glycine 0 N--CA 1.48 1.628 0 CA-C-N 119.895 1.225 . . . . 0.0 113.287 -173.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -68.29 -63.79 0.99 Allowed 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 114.531 1.308 . . . . 0.0 114.531 -172.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -161.97 13.75 0.13 Allowed Glycine 0 CA--C 1.552 2.398 0 N-CA-C 116.728 1.451 . . . . 0.0 116.728 170.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -91.96 150.58 20.93 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-N 119.204 1.502 . . . . 0.0 109.084 177.494 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -137.98 137.11 37.59 Favored 'General case' 0 N--CA 1.487 1.411 0 CA-C-N 114.944 -1.026 . . . . 0.0 109.517 -174.774 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -123.73 122.55 38.38 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 124.764 1.226 . . . . 0.0 108.693 -172.011 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 60.7 tp -100.6 -56.96 2.21 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.028 169.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 84.6 t90 -133.43 103.66 6.05 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 -174.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . 0.405 22.3 t 78.74 -82.8 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 C-N-CA 124.155 0.982 . . . . 0.0 111.982 171.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 16.9 m -81.37 140.72 16.16 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.399 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -169.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -90.14 138.45 31.51 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.49 0.662 . . . . 0.0 111.106 169.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -172.25 139.5 1.05 Allowed 'General case' 0 N--CA 1.488 1.454 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.623 -169.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -79.47 74.91 6.09 Favored 'General case' 0 N--CA 1.501 2.086 0 CA-C-O 123.76 1.743 . . . . 0.0 109.784 170.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.409 ' CB ' ' HB2' ' A' ' 130' ' ' GLU . 89.3 p -102.94 63.76 0.83 Allowed 'General case' 0 CA--C 1.554 1.122 1 N-CA-C 124.09 4.848 . . . . 0.0 124.09 -166.501 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 75.7 mt -101.52 86.62 3.0 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 104.224 -2.51 . . . . 0.0 104.224 167.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . 0.261 25.0 t-20 133.99 -61.05 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.045 0 C-N-CA 127.39 2.276 . . . . 0.0 105.479 -167.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.409 ' HB2' ' CB ' ' A' ' 127' ' ' SER . 11.8 mm-40 -56.09 -45.58 79.34 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 115.367 1.617 . . . . 0.0 115.367 177.48 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 15.7 tp -66.44 -37.79 85.95 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 177.13 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 44.7 t -58.4 -65.38 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 C-N-CA 124.585 1.154 . . . . 0.0 111.548 174.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -66.73 -35.56 80.4 Favored 'General case' 0 CA--C 1.569 1.677 0 N-CA-C 114.826 1.417 . . . . 0.0 114.826 -173.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -58.59 -59.42 5.42 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 124.419 1.088 . . . . 0.0 113.649 169.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -74.83 -8.56 56.8 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 117.872 2.545 . . . . 0.0 117.872 177.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 46.1 ttm-85 -52.32 -30.83 30.23 Favored 'General case' 0 CA--C 1.577 1.992 0 N-CA-C 114.818 1.414 . . . . 0.0 114.818 168.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 68.0 m -105.05 -40.94 5.72 Favored 'General case' 0 CA--C 1.569 1.673 0 C-N-CA 124.995 1.318 . . . . 0.0 113.037 168.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 53.7 m -90.51 150.58 21.72 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-N 120.199 1.363 . . . . 0.0 111.859 -176.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 21.7 t -80.63 133.68 35.78 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.107 -0.995 . . . . 0.0 112.828 -178.13 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 8.3 m -66.62 -42.65 90.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 115.398 1.629 . . . . 0.0 115.398 170.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 14.3 t -112.65 -45.56 3.22 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 -174.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . 0.302 80.3 mtm180 77.15 71.98 0.06 Allowed 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 125.337 1.455 . . . . 0.0 110.64 -169.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . 0.269 14.4 p-10 -149.58 -65.91 0.22 Allowed 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.996 -1.112 . . . . 0.0 107.996 173.271 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 -96.29 7.42 46.5 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 115.531 1.678 . . . . 0.0 115.531 169.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 83.0 mm-40 56.73 70.31 0.66 Allowed 'General case' 0 N--CA 1.495 1.821 0 C-N-CA 125.196 1.399 . . . . 0.0 111.945 -169.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 5.0 mp -85.68 116.68 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 -169.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -118.64 137.87 52.99 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-N 115.125 -0.943 . . . . 0.0 108.965 -174.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 11.1 mp -83.92 115.84 22.49 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 -168.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -122.97 150.62 42.75 Favored 'General case' 0 CA--C 1.563 1.457 0 C-N-CA 125.437 1.495 . . . . 0.0 109.322 179.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -74.28 156.5 37.12 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.737 -1.227 . . . . 0.0 113.23 178.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.1 pp -72.82 164.51 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 -171.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 . . . . . 0 N--CA 1.485 1.281 0 CA-C-O 123.953 1.835 . . . . 0.0 108.394 179.029 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.358 0 N-CA-C 111.299 -0.72 . . . . 0.0 111.299 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 32.4 t -82.04 112.19 18.88 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 122.983 0.513 . . . . 0.0 109.849 178.087 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 1.2 p90 -136.86 -34.33 0.75 Allowed 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 116.167 1.914 . . . . 0.0 116.167 -169.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -80.82 117.82 21.8 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-N 121.466 1.939 . . . . 0.0 109.788 179.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -129.76 94.39 3.73 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 104.942 -2.244 . . . . 0.0 104.942 174.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -77.49 125.45 7.32 Favored Glycine 0 CA--C 1.54 1.609 0 C-N-CA 123.156 0.408 . . . . 0.0 113.577 -170.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . 0.376 64.5 pttt 52.9 63.48 2.22 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 115.335 1.606 . . . . 0.0 115.335 -175.378 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -107.95 127.21 28.08 Favored Pre-proline 0 CA--C 1.574 1.897 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 -173.617 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -68.88 160.91 47.85 Favored 'Trans proline' 0 CA--C 1.56 1.785 0 C-N-CA 123.156 2.571 . . . . 0.0 115.574 -172.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 16.1 ttm180 -73.33 -35.8 66.09 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 117.327 2.343 . . . . 0.0 117.327 -170.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.75 -41.6 97.98 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 115.401 1.63 . . . . 0.0 115.401 169.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -68.27 -40.99 81.7 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 114.497 1.295 . . . . 0.0 114.497 169.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.71 -41.36 98.12 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 115.271 1.582 . . . . 0.0 115.271 172.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -67.13 -44.67 79.27 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 170.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -53.01 -38.88 62.71 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 116.085 1.883 . . . . 0.0 116.085 171.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.51 -62.63 1.56 Allowed 'General case' 0 CA--C 1.566 1.568 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 169.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.1 mp -70.0 -50.71 38.82 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 117.411 2.374 . . . . 0.0 117.411 -168.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 60.2 p -60.3 -34.26 73.52 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 115.921 1.823 . . . . 0.0 115.921 174.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -72.63 -30.54 64.41 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 115.644 1.72 . . . . 0.0 115.644 170.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -50.72 133.23 26.14 Favored 'General case' 0 CA--C 1.556 1.19 0 N-CA-C 114.977 1.473 . . . . 0.0 114.977 176.681 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.12 -23.49 62.17 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 118.613 2.82 . . . . 0.0 118.613 174.159 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 42.9 m80 -89.43 131.51 35.45 Favored 'General case' 0 N--CA 1.484 1.225 0 CA-C-N 119.23 0.923 . . . . 0.0 110.667 -169.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -80.99 102.22 10.03 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 174.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 124.02 4.86 7.7 Favored Glycine 0 CA--C 1.552 2.405 0 CA-C-O 116.652 -2.193 . . . . 0.0 115.991 -168.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.02 116.26 6.95 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-N 121.682 2.741 . . . . 0.0 112.913 -169.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -129.8 161.41 30.8 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 118.135 2.643 . . . . 0.0 118.135 -168.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.8 pp -144.09 154.11 42.86 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 114.126 -1.397 . . . . 0.0 109.422 168.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.0 mp -112.67 124.05 68.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 178.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -90.36 167.49 12.61 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 124.477 1.111 . . . . 0.0 112.199 174.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -129.15 116.11 18.71 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 106.139 -1.801 . . . . 0.0 106.139 169.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 64.7 m -76.85 134.73 38.94 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -170.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -74.62 -56.51 4.74 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-N 115.415 -0.811 . . . . 0.0 112.999 178.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.5 t -61.43 -39.56 91.23 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 116.068 1.877 . . . . 0.0 116.068 177.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -102.92 99.76 14.82 Favored Pre-proline 0 CA--C 1.565 1.523 0 CA-C-O 117.83 -1.081 . . . . 0.0 108.647 170.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -75.22 126.95 10.16 Favored 'Trans proline' 0 C--N 1.371 1.712 0 C-N-CA 123.016 2.477 . . . . 0.0 112.545 -175.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 82.2 6.62 88.63 Favored Glycine 0 CA--C 1.555 2.57 0 N-CA-C 118.189 2.036 . . . . 0.0 118.189 -169.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -98.12 116.54 30.56 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-N 119.813 1.806 . . . . 0.0 107.302 171.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -99.0 151.25 21.13 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.787 -0.819 . . . . 0.0 108.787 -178.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 43.2 m -132.93 112.4 11.84 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.505 -0.747 . . . . 0.0 110.175 -175.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 26.4 tp -79.3 105.77 10.85 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-O 121.967 0.889 . . . . 0.0 108.979 174.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 15.4 m -89.44 93.6 9.57 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 173.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.9 p -112.08 125.95 69.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 -174.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -77.16 129.15 35.59 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 114.813 -1.085 . . . . 0.0 111.049 173.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -137.75 114.65 10.68 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 87.22 -92.37 1.8 Allowed Glycine 0 N--CA 1.481 1.687 0 N-CA-C 112.056 -0.418 . . . . 0.0 112.056 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 10.8 p-10 -130.44 -22.48 2.74 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 115.434 1.642 . . . . 0.0 115.434 169.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -108.49 146.34 33.34 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 124.484 1.114 . . . . 0.0 110.251 -173.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 9.7 p -84.76 123.63 39.28 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.537 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.101 179.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -109.86 122.68 48.09 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 124.093 0.957 . . . . 0.0 108.901 -178.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 12.0 m-70 -103.73 96.37 6.66 Favored 'General case' 0 CA--C 1.555 1.14 0 CA-C-O 121.804 0.812 . . . . 0.0 108.864 -169.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -92.31 141.64 28.34 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 124.431 1.092 . . . . 0.0 110.233 -177.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -96.05 114.73 26.47 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.429 0.633 . . . . 0.0 110.369 -176.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 81.5 t -84.07 124.29 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 174.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 55.0 mt -102.12 136.13 42.49 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.014 -176.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 36.4 mtm180 -108.89 129.87 55.42 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 122.715 0.406 . . . . 0.0 110.368 176.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -97.31 103.32 15.24 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 123.165 0.586 . . . . 0.0 110.555 176.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 90.3 -110.7 3.81 Favored Glycine 0 N--CA 1.481 1.661 0 CA-C-O 120.072 -0.293 . . . . 0.0 113.325 174.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -79.95 -69.49 0.58 Allowed 'General case' 0 N--CA 1.487 1.419 0 CA-C-O 118.762 -0.637 . . . . 0.0 112.53 -176.127 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -159.05 75.03 0.21 Allowed Glycine 0 N--CA 1.477 1.424 0 CA-C-N 118.661 0.664 . . . . 0.0 111.581 171.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -117.63 91.37 3.55 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 -173.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -79.53 115.0 18.89 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 123.82 0.848 . . . . 0.0 111.686 -168.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -131.23 130.62 43.15 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.595 0.758 . . . . 0.0 109.041 177.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 41.8 tp -95.25 -54.76 3.3 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 118.548 -0.739 . . . . 0.0 110.38 169.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 45.2 m0 -74.7 -86.68 0.04 OUTLIER 'General case' 0 CA--C 1.565 1.553 0 CA-C-N 119.359 0.981 . . . . 0.0 110.537 173.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 10.0 m -145.06 -47.53 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 C-N-CA 124.56 1.144 . . . . 0.0 111.107 -175.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 14.0 p -79.54 130.85 35.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 CA-C-N 119.217 0.917 . . . . 0.0 110.212 -175.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.21 161.04 15.9 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-O 122.605 1.193 . . . . 0.0 114.205 -170.615 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -148.31 114.34 5.8 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 105.021 -2.215 . . . . 0.0 105.021 -170.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -57.84 -24.38 57.16 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 119.198 3.036 . . . . 0.0 119.198 -169.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 78.8 p -125.93 165.51 18.62 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-N 120.543 1.52 . . . . 0.0 113.096 179.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 33.0 mt -52.04 -47.69 64.93 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 115.23 1.567 . . . . 0.0 115.23 169.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 18.7 m-80 -63.12 -43.69 97.73 Favored 'General case' 0 CA--C 1.564 1.516 0 N-CA-C 114.071 1.137 . . . . 0.0 114.071 174.048 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -58.94 -50.81 72.66 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 115.388 1.625 . . . . 0.0 115.388 177.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 58.4 tp -61.32 -49.04 78.59 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-N 120.019 1.281 . . . . 0.0 114.237 174.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . 0.311 1.6 p -69.96 -37.5 72.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 -178.125 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -61.55 -34.55 75.76 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-N 119.976 1.262 . . . . 0.0 113.597 168.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 45.8 t80 -58.13 -54.07 51.07 Favored 'General case' 0 CA--C 1.569 1.673 0 CA-C-O 117.546 -1.216 . . . . 0.0 111.984 167.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . 0.347 21.9 m-70 -71.66 -8.99 57.54 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 118.69 2.848 . . . . 0.0 118.69 173.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 55.1 mtp85 -75.94 -22.06 56.37 Favored 'General case' 0 CA--C 1.576 1.958 0 CA-C-N 119.876 1.217 . . . . 0.0 112.926 167.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 70.6 m -100.73 -46.31 5.2 Favored 'General case' 0 CA--C 1.565 1.554 0 C-N-CA 125.005 1.322 . . . . 0.0 112.962 169.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 91.3 m -86.21 154.32 21.38 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 124.948 1.299 . . . . 0.0 110.121 173.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.641 ' HG ' ' HA ' ' A' ' 145' ' ' GLN . 27.4 t -80.48 148.02 30.64 Favored 'General case' 0 N--CA 1.483 1.203 0 O-C-N 121.131 -0.981 . . . . 0.0 113.238 177.376 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 77.1 t -75.17 -54.02 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 168.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 34.2 t -87.77 104.05 16.2 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-N 118.909 0.777 . . . . 0.0 109.071 174.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . 0.273 0.2 OUTLIER -59.95 -40.39 88.85 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 117.711 2.486 . . . . 0.0 117.711 -175.722 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -72.1 -63.5 1.13 Allowed 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 177.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -94.09 104.24 16.28 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 172.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.641 ' HA ' ' HG ' ' A' ' 139' ' ' SER . 64.0 mt-30 -77.45 115.28 17.09 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 -168.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -120.82 133.45 67.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 179.278 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -119.15 153.47 34.83 Favored 'General case' 0 N--CA 1.497 1.875 0 CA-C-O 121.88 0.848 . . . . 0.0 111.337 -170.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 9.5 mp -88.05 143.66 26.95 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 -169.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 29.1 mmm180 -132.87 142.91 49.18 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 124.929 1.292 . . . . 0.0 109.175 -179.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -76.1 143.37 41.31 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.379 -0.826 . . . . 0.0 111.285 176.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 25.0 pt -62.82 146.32 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 -176.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 . . . . . 0 N--CA 1.484 1.261 0 CA-C-O 123.91 1.814 . . . . 0.0 109.435 175.799 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.31 0 N-CA-C 111.632 -0.587 . . . . 0.0 111.632 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 26.3 t -89.34 95.28 10.22 Favored 'General case' 0 N--CA 1.486 1.331 0 CA-C-O 121.476 0.655 . . . . 0.0 110.605 -174.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 1.6 p90 -144.75 -46.9 0.24 Allowed 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.79 0.836 . . . . 0.0 111.976 -177.047 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -82.09 124.76 30.12 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-N 119.931 1.241 . . . . 0.0 110.101 -179.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -128.59 75.14 1.61 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 123.473 0.483 . . . . 0.0 110.253 -175.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 59.05 -114.58 6.26 Favored Glycine 0 N--CA 1.485 1.937 0 C-N-CA 123.873 0.749 . . . . 0.0 114.817 173.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -144.99 111.45 5.69 Favored 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 169.157 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 43.2 pt -122.99 152.2 62.6 Favored Pre-proline 0 CA--C 1.572 1.821 0 CA-C-O 118.525 -0.75 . . . . 0.0 110.476 -179.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -58.78 165.56 7.98 Favored 'Trans proline' 0 CA--C 1.56 1.777 0 C-N-CA 123.4 2.733 . . . . 0.0 116.745 171.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 25.7 ttm180 -62.92 -40.67 98.32 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 114.898 1.444 . . . . 0.0 114.898 169.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -62.56 -41.14 98.72 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 115.728 1.751 . . . . 0.0 115.728 170.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 3.1 tppp? -64.79 -37.63 88.25 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 115.201 1.556 . . . . 0.0 115.201 169.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.91 -41.68 91.12 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 115.682 1.734 . . . . 0.0 115.682 171.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -64.65 -38.78 92.16 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 114.816 1.413 . . . . 0.0 114.816 169.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -60.57 -52.83 63.49 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 114.509 1.3 . . . . 0.0 114.509 172.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 40.4 tpp -61.11 -44.07 97.92 Favored 'General case' 0 CA--C 1.564 1.492 0 N-CA-C 115.793 1.775 . . . . 0.0 115.793 175.386 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 92.6 mt -72.6 -20.72 61.24 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 116.616 2.08 . . . . 0.0 116.616 172.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 22.9 t -60.24 -37.6 80.88 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-N 121.079 1.763 . . . . 0.0 113.497 168.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -59.42 -37.17 77.36 Favored 'General case' 0 CA--C 1.57 1.737 0 N-CA-C 114.525 1.306 . . . . 0.0 114.525 168.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -69.12 114.36 7.32 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 124.322 1.049 . . . . 0.0 110.855 170.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 -76.24 -13.44 60.17 Favored 'General case' 0 CA--C 1.569 1.708 0 N-CA-C 117.816 2.524 . . . . 0.0 117.816 173.326 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 46.3 m80 -89.72 143.82 26.49 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 -168.402 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -71.79 130.84 42.07 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-N 114.448 -1.251 . . . . 0.0 110.818 170.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.92 -18.62 46.57 Favored Glycine 0 CA--C 1.552 2.377 0 N-CA-C 118.239 2.055 . . . . 0.0 118.239 -172.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.13 119.38 10.73 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-N 120.399 2.1 . . . . 0.0 112.345 -176.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 22.2 p90 -128.56 157.51 41.03 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 114.815 1.413 . . . . 0.0 114.815 -168.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.8 pp -138.05 139.33 39.51 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 168.239 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 70.3 mt -98.16 117.86 43.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 106.316 -1.735 . . . . 0.0 106.316 177.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 3.0 ptm180 -97.94 149.2 22.67 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.319 0.648 . . . . 0.0 111.481 170.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -96.35 137.86 34.8 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 168.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 67.4 m -69.9 138.92 52.86 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-O 121.637 0.732 . . . . 0.0 112.694 -176.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -70.69 -53.71 14.63 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 -174.075 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.0 t -62.99 -37.33 86.73 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 115.916 1.821 . . . . 0.0 115.916 172.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -121.01 92.9 48.75 Favored Pre-proline 0 CA--C 1.562 1.441 0 CA-C-N 119.635 1.107 . . . . 0.0 110.102 175.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -62.59 132.53 38.31 Favored 'Trans proline' 0 C--N 1.371 1.742 0 C-N-CA 123.361 2.707 . . . . 0.0 113.25 170.02 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 105.0 -33.73 6.34 Favored Glycine 0 CA--C 1.551 2.302 0 CA-C-O 118.697 -1.057 . . . . 0.0 114.543 -168.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -79.68 108.51 13.28 Favored 'General case' 0 N--CA 1.486 1.348 0 CA-C-N 119.427 1.614 . . . . 0.0 108.484 174.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 5.0 m-30 -93.93 158.65 15.54 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 121.716 0.77 . . . . 0.0 110.451 -174.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 74.6 m -139.81 115.48 10.1 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 176.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 36.4 tp -81.19 107.35 13.91 Favored 'General case' 0 CA--C 1.561 1.368 0 C-N-CA 124.907 1.283 . . . . 0.0 109.687 179.015 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.8 m -95.5 105.53 17.51 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 -174.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 31.9 t -117.57 123.67 72.04 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.171 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 -171.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 12.9 tmtt? -89.24 89.37 7.89 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 123.088 0.555 . . . . 0.0 110.203 178.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -105.49 108.22 19.62 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -177.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 86.95 -98.75 2.39 Favored Glycine 0 N--CA 1.479 1.556 0 N-CA-C 111.435 -0.666 . . . . 0.0 111.435 177.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 12.4 p30 -138.44 44.1 2.12 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 123.178 0.591 . . . . 0.0 112.384 169.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -152.84 134.62 14.63 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 -177.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 57.3 t -95.23 109.85 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 106.298 -1.741 . . . . 0.0 106.298 177.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 60.6 mt-30 -109.11 114.83 28.89 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-O 121.909 0.861 . . . . 0.0 109.306 -169.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -94.15 119.64 33.26 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 114.636 -1.166 . . . . 0.0 109.168 -172.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -118.03 119.33 34.47 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 -174.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -75.5 108.31 8.23 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 -169.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 86.6 t -84.04 117.56 29.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 -178.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 54.5 mt -100.78 137.82 38.66 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.139 -174.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 56.4 mtp180 -109.72 126.37 53.65 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 -179.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . 0.262 3.0 p30 -79.91 -56.94 3.9 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 114.463 1.283 . . . . 0.0 114.463 -179.031 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 179.16 137.86 3.06 Favored Glycine 0 CA--C 1.54 1.632 0 CA-C-N 119.607 1.094 . . . . 0.0 112.759 -176.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . 0.347 . . 80.6 -77.89 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 124.98 1.312 . . . . 0.0 112.497 -178.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -165.96 72.79 0.17 Allowed Glycine 0 N--CA 1.478 1.483 0 N-CA-C 111.696 -0.562 . . . . 0.0 111.696 171.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -126.47 162.22 26.11 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 124.169 0.988 . . . . 0.0 109.93 -178.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -143.99 114.97 7.84 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 -176.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -124.98 123.19 39.35 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 175.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -110.33 -58.79 2.03 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 123.77 0.828 . . . . 0.0 110.621 173.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 8.4 t90 -98.66 -62.97 1.17 Allowed 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 124.076 0.95 . . . . 0.0 112.893 -168.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 30.7 m -129.66 -56.38 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 CA-C-N 119.085 0.857 . . . . 0.0 112.41 -175.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 9.9 p -118.93 161.29 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 CA-C-O 122.278 1.037 . . . . 0.0 111.485 -169.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.52 153.04 29.84 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-O 122.025 0.917 . . . . 0.0 113.121 175.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -142.88 120.69 11.93 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 -175.22 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -59.45 -59.74 4.96 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -175.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 83.6 p -89.58 155.56 19.18 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-O 122.542 1.163 . . . . 0.0 112.378 175.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 10.3 tp -63.01 -33.0 74.49 Favored 'General case' 0 CA--C 1.568 1.661 0 N-CA-C 115.019 1.489 . . . . 0.0 115.019 170.05 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -63.35 -36.77 84.81 Favored 'General case' 0 CA--C 1.569 1.705 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 169.053 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.13 -42.1 94.17 Favored 'General case' 0 N--CA 1.497 1.875 0 CA-C-N 120.622 1.555 . . . . 0.0 114.17 169.758 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 16.8 tp -57.13 -46.89 82.31 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 169.101 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 45.4 t -59.17 -58.2 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 C-N-CA 124.385 1.074 . . . . 0.0 112.878 173.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -60.74 -32.11 71.4 Favored 'General case' 0 CA--C 1.567 1.632 0 N-CA-C 115.655 1.724 . . . . 0.0 115.655 -175.076 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -60.68 -57.8 11.18 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-N 119.665 1.12 . . . . 0.0 112.877 169.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 81.8 m-70 -72.85 -8.91 57.77 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 117.891 2.552 . . . . 0.0 117.891 176.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 50.5 ttm-85 -58.59 -31.71 68.29 Favored 'General case' 0 CA--C 1.576 1.95 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 168.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 69.6 m -104.16 -36.15 7.78 Favored 'General case' 0 CA--C 1.567 1.619 0 C-N-CA 124.978 1.311 . . . . 0.0 113.619 169.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 87.1 m -90.12 150.84 21.87 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-N 119.912 1.233 . . . . 0.0 110.826 -178.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 21.6 t -72.39 123.75 23.72 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.197 -0.939 . . . . 0.0 111.734 175.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.9 p -70.27 -27.78 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 N-CA-C 115.868 1.803 . . . . 0.0 115.868 175.293 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 66.3 m -135.25 136.88 42.03 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-N 119.562 1.073 . . . . 0.0 109.082 173.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? -80.13 93.97 5.91 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.815 0.816 . . . . 0.0 110.637 -178.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . 0.252 13.2 p-10 -165.9 -65.78 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 124.663 1.185 . . . . 0.0 108.044 -178.685 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -113.7 -139.03 0.38 Allowed 'General case' 0 CA--C 1.567 1.625 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 172.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.21 77.83 1.79 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.307 -0.871 . . . . 0.0 109.146 175.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 3.7 mp -86.7 108.48 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 -170.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 19.6 m-30 -114.72 138.4 50.77 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-N 115.331 -0.849 . . . . 0.0 109.523 -172.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 10.7 mp -85.27 108.11 17.62 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.276 -171.075 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 93.5 mtt180 -123.37 168.07 12.99 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 122.369 1.08 . . . . 0.0 109.485 -175.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -81.79 158.75 24.0 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 115.11 1.522 . . . . 0.0 115.11 -170.049 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 36.1 pt -81.29 162.04 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 CA-C-N 114.727 -1.124 . . . . 0.0 112.883 -179.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 . . . . . 0 N--CA 1.485 1.311 0 CA-C-O 122.776 1.274 . . . . 0.0 109.328 -176.765 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 1.807 0 CA-C-O 121.371 0.428 . . . . 0.0 113.323 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . 0.274 92.5 p 54.42 86.75 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 115.733 1.753 . . . . 0.0 115.733 175.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . 0.253 66.6 p-90 -78.27 -48.8 14.93 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 115.544 1.683 . . . . 0.0 115.544 -178.532 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -85.78 135.65 33.65 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-N 119.255 0.934 . . . . 0.0 111.403 -173.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -111.68 -88.0 0.53 Allowed 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 175.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 158.12 -150.1 20.77 Favored Glycine 0 N--CA 1.483 1.816 0 CA-C-N 119.634 1.106 . . . . 0.0 112.735 -179.163 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -83.14 89.57 6.96 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 121.566 0.698 . . . . 0.0 111.217 -178.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -124.42 146.62 52.71 Favored Pre-proline 0 CA--C 1.573 1.852 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 169.365 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -50.69 164.79 0.5 Allowed 'Trans proline' 0 C--N 1.37 1.681 0 C-N-CA 123.411 2.74 . . . . 0.0 117.717 175.03 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 60.1 ttt180 -59.06 -41.95 89.17 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 169.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -65.28 -45.45 84.41 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 115.193 1.553 . . . . 0.0 115.193 173.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 48.2 mmtm -61.92 -37.09 83.36 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 115.646 1.721 . . . . 0.0 115.646 171.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.87 -44.85 91.86 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 115.31 1.596 . . . . 0.0 115.31 169.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -61.34 -40.08 92.93 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 115.351 1.611 . . . . 0.0 115.351 170.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -61.54 -46.24 90.76 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 173.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 37.3 mmt -60.12 -46.57 89.17 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 114.898 1.444 . . . . 0.0 114.898 172.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 96.7 mt -72.59 -32.38 65.94 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 115.989 1.848 . . . . 0.0 115.989 177.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 21.1 t -56.02 -35.33 66.72 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 115.662 1.727 . . . . 0.0 115.662 169.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -60.15 -39.47 86.46 Favored 'General case' 0 CA--C 1.568 1.662 0 N-CA-C 115.215 1.561 . . . . 0.0 115.215 169.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -67.88 134.68 51.26 Favored 'General case' 0 CA--C 1.556 1.174 0 CA-C-O 123.5 1.619 . . . . 0.0 113.404 -177.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.43 -10.2 59.34 Favored 'General case' 0 CA--C 1.567 1.597 0 N-CA-C 119.12 3.007 . . . . 0.0 119.12 176.421 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 6.9 m80 -89.62 137.51 32.27 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-N 120.149 1.34 . . . . 0.0 110.836 -169.002 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -80.39 103.54 10.32 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 173.2 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 110.59 11.41 19.5 Favored Glycine 0 CA--C 1.551 2.321 0 CA-C-O 117.56 -1.689 . . . . 0.0 115.758 -168.074 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.66 120.09 14.89 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-N 120.64 2.22 . . . . 0.0 110.244 -175.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 14.6 p90 -132.82 157.32 45.29 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 -169.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.3 pp -140.8 125.58 18.08 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 168.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 84.6 mt -83.78 108.84 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 170.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 48.2 ptt85 -89.88 156.89 18.16 Favored 'General case' 0 CA--C 1.557 1.215 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.192 171.134 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -88.86 134.03 34.08 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 169.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 50.5 m -65.85 132.47 48.74 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 123.107 0.563 . . . . 0.0 111.133 -178.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -55.54 -55.01 36.87 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 116.903 2.186 . . . . 0.0 116.903 -168.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.3 t -72.39 -45.81 58.08 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 174.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -108.77 108.67 60.96 Favored Pre-proline 0 CA--C 1.562 1.422 0 CA-C-O 117.652 -1.166 . . . . 0.0 110.559 -174.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -69.48 -32.24 20.13 Favored 'Trans proline' 0 C--N 1.369 1.609 0 N-CA-C 118.724 2.548 . . . . 0.0 118.724 178.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -65.58 -19.21 66.71 Favored Glycine 0 CA--C 1.559 2.832 0 N-CA-C 117.023 1.569 . . . . 0.0 117.023 168.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -92.16 138.05 31.86 Favored 'General case' 0 N--CA 1.484 1.27 0 CA-C-N 118.337 1.068 . . . . 0.0 108.696 169.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -123.38 170.03 10.74 Favored 'General case' 0 CA--C 1.563 1.472 0 C-N-CA 124.23 1.012 . . . . 0.0 108.907 179.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 73.1 m -143.01 119.79 11.2 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.096 -1.002 . . . . 0.0 108.43 -179.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 43.7 tp -79.88 105.66 11.32 Favored 'General case' 0 N--CA 1.486 1.347 0 CA-C-O 121.844 0.831 . . . . 0.0 109.331 171.176 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.8 m -91.35 109.65 20.93 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 173.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.7 p -137.69 137.49 45.27 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 CA-C-N 119.148 0.885 . . . . 0.0 108.778 -169.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -72.88 118.86 16.34 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.009 0.433 . . . . 0.0 110.996 171.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 4.4 m-30 -107.71 97.69 7.39 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 169.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 81.94 -98.76 1.96 Allowed Glycine 0 CA--C 1.541 1.677 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 -169.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 70.1 m-80 -126.89 -17.6 4.88 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 115.01 1.485 . . . . 0.0 115.01 169.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -85.73 137.88 32.5 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 119.643 1.11 . . . . 0.0 110.081 177.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 64.9 t -89.28 106.43 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 -175.082 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -101.06 124.84 47.39 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-O 121.881 0.848 . . . . 0.0 109.231 -179.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 11.9 m-70 -97.73 131.31 44.38 Favored 'General case' 0 CA--C 1.555 1.159 0 CA-C-N 114.819 -1.082 . . . . 0.0 109.153 -175.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -128.18 125.01 38.2 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 -175.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -80.88 117.49 21.57 Favored 'General case' 0 N--CA 1.485 1.302 0 CA-C-O 121.596 0.712 . . . . 0.0 110.903 -170.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 73.1 t -85.42 102.77 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 171.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.4 pp -121.91 144.13 49.04 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 123.116 0.567 . . . . 0.0 111.346 -174.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.413 HH21 ' HH ' ' A' ' 118' ' ' TYR . 99.7 mtt180 -89.65 155.82 18.98 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 114.009 1.115 . . . . 0.0 114.009 -170.399 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -104.41 -64.3 1.13 Allowed 'General case' 0 N--CA 1.494 1.748 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.951 169.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -97.21 -121.17 4.12 Favored Glycine 0 CA--C 1.542 1.734 0 CA-C-N 119.406 1.003 . . . . 0.0 112.883 -176.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -76.2 -65.24 0.94 Allowed 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 118.786 -0.626 . . . . 0.0 112.337 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -136.08 57.99 0.67 Allowed Glycine 0 CA--C 1.542 1.78 0 CA-C-O 119.559 -0.578 . . . . 0.0 111.928 169.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -106.36 88.85 2.88 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 106.978 -1.489 . . . . 0.0 106.978 -174.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.413 ' HH ' HH21 ' A' ' 112' ' ' ARG . 83.1 m-85 -81.03 122.47 27.35 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 114.852 -1.067 . . . . 0.0 111.1 -169.521 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 21.3 p90 -137.57 124.17 20.96 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 120.941 0.4 . . . . 0.0 110.044 179.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -106.84 -47.78 3.65 Favored 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 123.887 0.875 . . . . 0.0 112.155 169.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 32.2 t90 -89.92 -68.81 0.76 Allowed 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 124.834 1.254 . . . . 0.0 110.91 -171.066 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . 0.264 13.0 p -147.6 -66.89 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 C-N-CA 123.499 0.72 . . . . 0.0 109.704 174.446 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 10.8 p -79.9 138.82 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 C-N-CA 123.941 0.896 . . . . 0.0 111.455 -171.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -83.77 158.86 21.59 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 113.715 1.005 . . . . 0.0 113.715 -178.211 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -140.46 123.13 16.26 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 -171.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 16.9 p30 -57.84 -34.44 69.7 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 117.549 2.425 . . . . 0.0 117.549 176.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 74.2 m -120.88 144.92 48.15 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 119.256 0.935 . . . . 0.0 111.678 -176.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 14.1 tp -86.53 94.27 9.39 Favored 'General case' 0 CA--C 1.563 1.46 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 169.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 12.0 t30 158.19 -60.78 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 103.295 -2.854 . . . . 0.0 103.295 -168.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -54.16 -44.6 71.59 Favored 'General case' 0 CA--C 1.574 1.877 0 C-N-CA 124.699 1.2 . . . . 0.0 114.194 168.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 10.2 tt -53.93 -53.83 47.28 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 115.763 1.764 . . . . 0.0 115.763 170.049 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.2 p -68.32 -50.13 60.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 -177.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -56.31 -32.86 65.03 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 115.516 1.673 . . . . 0.0 115.516 172.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -58.36 -53.64 55.99 Favored 'General case' 0 CA--C 1.566 1.582 0 CA-C-N 119.608 1.094 . . . . 0.0 111.85 168.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . 0.315 40.8 m-70 -71.42 -9.54 58.34 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 118.196 2.665 . . . . 0.0 118.196 176.762 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.62 -32.03 73.38 Favored 'General case' 0 CA--C 1.581 2.142 0 CA-C-N 121.041 1.746 . . . . 0.0 112.171 166.356 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 70.6 m -95.53 -44.84 7.33 Favored 'General case' 0 CA--C 1.564 1.519 0 C-N-CA 124.604 1.162 . . . . 0.0 114.035 169.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 53.8 m -90.2 155.99 18.63 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-N 119.665 1.12 . . . . 0.0 111.04 -178.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 22.7 t -86.3 133.55 33.81 Favored 'General case' 0 CA--C 1.557 1.212 0 O-C-N 121.357 -0.84 . . . . 0.0 113.197 -175.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 96.4 t -69.17 -36.5 73.31 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 CA-C-O 118.534 -0.746 . . . . 0.0 111.752 169.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 22.7 t -79.2 132.86 36.66 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-N 119.639 1.109 . . . . 0.0 109.584 169.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 32.9 ttt85 -75.0 -50.15 17.51 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 -175.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -76.42 -55.67 5.33 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 172.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -80.03 158.77 26.41 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 119.028 0.831 . . . . 0.0 112.225 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 -104.04 89.79 3.39 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 4.0 mm -112.96 141.01 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 176.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -137.3 155.9 48.9 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-O 121.988 0.899 . . . . 0.0 112.497 -169.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 10.0 mp -90.28 124.78 35.17 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 124.046 0.938 . . . . 0.0 112.074 -169.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -118.98 151.73 37.66 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 124.242 1.017 . . . . 0.0 110.091 171.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -81.88 149.5 28.25 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 122.136 0.97 . . . . 0.0 112.656 -177.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.6 pp -76.01 160.32 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 CA-C-N 114.861 -1.063 . . . . 0.0 113.552 -174.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 . . . . . 0 N--CA 1.485 1.294 0 CA-C-O 124.052 1.882 . . . . 0.0 106.332 170.583 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.408 0 N-CA-C 111.591 -0.604 . . . . 0.0 111.591 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 89.4 p -86.73 110.59 20.0 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.131 0.573 . . . . 0.0 111.165 -178.772 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 63.6 p-90 -152.55 -36.97 0.11 Allowed 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 115.3 1.592 . . . . 0.0 115.3 -179.941 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -81.38 136.3 35.71 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-N 120.449 1.477 . . . . 0.0 112.054 -171.68 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -121.61 -74.83 0.6 Allowed 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 174.279 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 91.91 102.46 1.39 Allowed Glycine 0 CA--C 1.542 1.734 0 CA-C-N 119.376 0.989 . . . . 0.0 111.814 -178.236 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 56.9 mmtt 63.52 69.98 0.54 Allowed 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 124.808 1.243 . . . . 0.0 113.394 -177.265 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 10.6 pt -130.1 151.82 79.01 Favored Pre-proline 0 CA--C 1.574 1.886 0 CA-C-O 118.411 -0.804 . . . . 0.0 109.676 169.876 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_exo -56.45 156.42 21.87 Favored 'Trans proline' 0 C--N 1.369 1.655 0 C-N-CA 123.369 2.713 . . . . 0.0 117.348 177.344 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 61.2 ttt180 -67.52 -36.62 81.39 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 169.489 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.77 -39.84 95.24 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 115.261 1.578 . . . . 0.0 115.261 169.651 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -64.06 -35.27 80.2 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 169.159 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.79 -52.45 63.13 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-N 119.472 1.033 . . . . 0.0 113.19 169.415 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -52.92 -37.71 61.08 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 116.348 1.981 . . . . 0.0 116.348 169.537 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -59.32 -48.65 80.83 Favored 'General case' 0 CA--C 1.566 1.574 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 170.696 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -65.45 -60.46 2.93 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 172.597 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.64 -39.44 91.42 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 117.517 2.414 . . . . 0.0 117.517 -172.576 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 56.3 m -60.61 -41.0 93.92 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 115.368 1.618 . . . . 0.0 115.368 178.719 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -68.45 -26.79 65.68 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 117.024 2.231 . . . . 0.0 117.024 169.986 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -60.52 131.1 49.67 Favored 'General case' 0 CA--C 1.556 1.19 0 CA-C-N 120.248 1.385 . . . . 0.0 113.722 176.555 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 38.9 ptt85 -69.59 -20.03 63.65 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 118.65 2.833 . . . . 0.0 118.65 179.054 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 57.8 m80 -89.51 135.58 33.52 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 119.213 0.915 . . . . 0.0 111.922 -169.141 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -77.59 103.03 7.28 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 169.731 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 124.23 -0.14 8.87 Favored Glycine 0 CA--C 1.555 2.543 0 CA-C-O 117.163 -1.91 . . . . 0.0 115.768 -168.456 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.57 113.19 4.57 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 121.158 2.479 . . . . 0.0 112.173 -169.929 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 17.8 p90 -128.11 155.79 43.86 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 116.334 1.976 . . . . 0.0 116.334 -168.713 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.1 pp -148.75 133.57 17.97 Favored 'General case' 0 N--CA 1.485 1.28 0 CA-C-N 114.33 -1.305 . . . . 0.0 108.454 169.031 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 91.8 mt -91.38 110.59 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 175.897 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 3.5 ptm180 -100.98 140.18 35.64 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 114.614 -1.175 . . . . 0.0 109.329 169.98 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.54 126.57 31.05 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.704 -0.622 . . . . 0.0 109.527 177.72 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 20.5 t -63.25 125.93 25.74 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -170.201 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -63.98 -48.58 75.85 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 175.815 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 95.8 p -59.3 -39.41 82.93 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 116.75 2.13 . . . . 0.0 116.75 171.873 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -115.84 97.7 49.59 Favored Pre-proline 0 CA--C 1.563 1.46 0 CA-C-O 117.967 -1.016 . . . . 0.0 108.997 178.748 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -72.57 135.04 23.36 Favored 'Trans proline' 0 C--N 1.372 1.787 0 C-N-CA 123.157 2.571 . . . . 0.0 112.606 -178.985 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 92.05 -39.36 3.03 Favored Glycine 0 CA--C 1.556 2.622 0 CA-C-N 115.555 -0.748 . . . . 0.0 114.415 -168.595 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -79.76 146.17 32.47 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 124.275 1.03 . . . . 0.0 110.883 175.624 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -106.85 174.16 6.01 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 122.124 0.964 . . . . 0.0 111.859 -171.697 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 57.9 m -146.61 115.81 7.0 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 177.325 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 42.6 tp -79.7 115.42 19.3 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 171.049 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 20.7 m -97.98 83.77 3.19 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 175.998 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.3 p -107.4 119.74 57.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 -171.861 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 15.1 tmtt? -81.37 149.2 28.97 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.768 174.739 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -156.99 107.35 2.29 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 169.948 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 71.38 76.14 0.6 Allowed Glycine 0 N--CA 1.483 1.776 0 N-CA-C 115.186 0.834 . . . . 0.0 115.186 173.097 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . 0.348 15.0 m120 77.06 -38.7 0.31 Allowed 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 118.179 2.659 . . . . 0.0 118.179 -179.898 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -121.43 145.27 48.09 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 124.091 0.956 . . . . 0.0 110.944 -169.688 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 5.3 p -83.02 139.0 18.4 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.54 0 CA-C-N 115.373 -0.831 . . . . 0.0 111.864 178.262 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -125.27 111.53 15.32 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-O 122.103 0.954 . . . . 0.0 108.529 -176.94 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 8.0 m-70 -99.55 128.81 45.67 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-N 114.776 -1.102 . . . . 0.0 109.358 -172.268 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -133.46 133.08 41.82 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 -175.096 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 64.2 pttt -77.74 125.86 29.99 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-O 121.507 0.67 . . . . 0.0 112.05 -179.117 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 80.7 t -94.61 108.22 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 106.287 -1.746 . . . . 0.0 106.287 179.237 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 66.0 mt -95.97 149.99 20.96 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.276 -173.368 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 82.8 mtm180 -109.51 135.95 49.68 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 122.983 0.513 . . . . 0.0 110.304 -177.79 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -108.1 110.19 21.81 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 170.635 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 89.26 -113.58 4.16 Favored Glycine 0 CA--C 1.541 1.683 0 CA-C-N 116.372 -0.376 . . . . 0.0 112.343 -178.763 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -86.4 -68.99 0.7 Allowed 'General case' 0 N--CA 1.488 1.452 0 CA-C-O 118.739 -0.648 . . . . 0.0 111.687 178.792 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -156.39 70.25 0.27 Allowed Glycine 0 N--CA 1.478 1.473 0 CA-C-N 118.602 0.637 . . . . 0.0 112.33 172.58 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -103.88 99.82 9.6 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 105.089 -2.189 . . . . 0.0 105.089 171.702 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -81.19 108.25 14.67 Favored 'General case' 0 N--CA 1.484 1.255 0 CA-C-N 114.741 -1.118 . . . . 0.0 111.756 -168.58 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 33.5 p90 -117.47 121.66 41.63 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 178.788 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 4.7 tt -101.7 -63.07 1.18 Allowed 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 123.429 0.691 . . . . 0.0 109.176 170.648 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . 0.433 ' HZ3' ' HH ' ' A' ' 134' ' ' TYR . 26.9 t90 -82.43 -64.98 1.07 Allowed 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 124.337 1.055 . . . . 0.0 112.17 -169.941 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . 0.276 13.1 p -146.17 -70.33 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 CA-C-N 118.791 0.723 . . . . 0.0 109.427 177.533 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 9.4 p -79.91 143.95 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 C-N-CA 123.879 0.872 . . . . 0.0 111.621 -174.078 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.37 155.52 22.28 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -176.184 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -141.7 114.75 8.67 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 -173.764 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 23.1 t30 -54.1 -41.08 67.88 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 116.696 2.109 . . . . 0.0 116.696 -175.998 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 95.3 p -107.29 155.27 20.14 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-O 122.649 1.214 . . . . 0.0 111.904 170.612 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 60.3 mt -64.31 -29.2 70.29 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 115.282 1.586 . . . . 0.0 115.282 169.714 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -65.33 -38.73 91.05 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-N 119.682 1.128 . . . . 0.0 113.555 169.927 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -61.63 -45.06 95.68 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 169.393 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 53.1 tp -57.02 -44.14 82.55 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 115.09 1.515 . . . . 0.0 115.09 169.68 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 22.2 t -60.32 -63.26 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 C-N-CA 124.581 1.152 . . . . 0.0 112.405 173.525 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -59.56 -28.67 67.32 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 115.984 1.846 . . . . 0.0 115.984 -176.29 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.433 ' HH ' ' HZ3' ' A' ' 121' ' ' TRP . 88.8 t80 -64.35 -56.07 16.92 Favored 'General case' 0 CA--C 1.566 1.586 0 CA-C-N 119.158 0.89 . . . . 0.0 111.849 168.461 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . 0.264 68.0 m-70 -68.85 -9.08 49.4 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 117.874 2.546 . . . . 0.0 117.874 177.795 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -48.48 -39.7 23.97 Favored 'General case' 0 N--CA 1.502 2.174 0 CA-C-N 120.808 1.64 . . . . 0.0 114.47 167.563 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 68.5 m -109.04 -26.38 10.2 Favored 'General case' 0 CA--C 1.565 1.527 0 N-CA-C 114.885 1.439 . . . . 0.0 114.885 169.857 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 40.2 m -90.27 152.34 21.1 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-N 120.825 1.648 . . . . 0.0 111.031 -179.788 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 29.1 t -74.31 133.24 42.57 Favored 'General case' 0 CA--C 1.559 1.31 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 -179.962 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 39.3 t -74.93 -48.09 34.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 C-N-CA 123.593 0.757 . . . . 0.0 111.583 169.861 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 70.8 m -82.85 159.36 22.42 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-O 121.858 0.837 . . . . 0.0 112.049 178.273 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 3.7 tmm_? -70.37 -61.01 1.94 Allowed 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 118.898 -0.572 . . . . 0.0 111.94 174.881 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -74.37 -56.34 4.97 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 178.787 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 51.6 mt-30 -79.86 145.32 32.79 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 118.713 0.688 . . . . 0.0 112.087 -176.81 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -79.2 122.7 26.61 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 122.958 0.503 . . . . 0.0 110.372 169.854 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 8.3 mm -127.43 102.29 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 105.565 -2.013 . . . . 0.0 105.565 179.264 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 20.8 m-30 -113.19 114.38 26.68 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 -174.398 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 10.8 mp -67.67 131.57 45.84 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 114.794 1.405 . . . . 0.0 114.794 -168.975 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 71.4 mmt-85 -127.24 140.88 51.92 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 176.874 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -75.21 141.46 43.57 Favored 'General case' 0 CA--C 1.565 1.521 0 O-C-N 121.183 -0.948 . . . . 0.0 112.209 -175.348 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 16.4 pt -62.89 146.58 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 N-CA-C 113.968 1.099 . . . . 0.0 113.968 -176.446 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 . . . . . 0 N--CA 1.482 1.142 0 CA-C-O 123.931 1.824 . . . . 0.0 109.344 -176.118 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.31 0 N-CA-C 111.32 -0.712 . . . . 0.0 111.32 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 70.5 m -146.27 112.76 5.92 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -178.882 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . 0.294 51.2 p-90 -80.84 -55.29 4.9 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 113.464 0.913 . . . . 0.0 113.464 170.458 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -94.53 133.56 38.02 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 123.63 0.772 . . . . 0.0 109.47 173.692 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -95.6 -77.17 0.48 Allowed 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 118.665 -0.683 . . . . 0.0 109.466 174.772 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -169.96 -159.07 14.92 Favored Glycine 0 CA--C 1.541 1.677 0 CA-C-N 119.077 0.853 . . . . 0.0 112.955 -179.885 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -94.31 91.85 6.91 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 172.101 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -123.71 149.7 59.82 Favored Pre-proline 0 CA--C 1.573 1.852 0 C-N-CA 123.59 0.756 . . . . 0.0 109.194 178.449 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -69.85 177.53 5.56 Favored 'Trans proline' 0 CA--C 1.565 2.029 0 C-N-CA 122.812 2.341 . . . . 0.0 114.285 175.456 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 59.6 ttt180 -61.07 -42.42 98.46 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 115.791 1.774 . . . . 0.0 115.791 179.334 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -67.23 -41.87 84.94 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 115.717 1.747 . . . . 0.0 115.717 175.526 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -64.76 -36.48 84.45 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 169.764 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.62 -40.38 96.75 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 115.799 1.777 . . . . 0.0 115.799 169.929 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -65.52 -40.83 93.43 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 114.85 1.426 . . . . 0.0 114.85 169.926 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -60.11 -48.38 81.98 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 114.957 1.465 . . . . 0.0 114.957 172.463 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 38.1 mmt -66.71 -47.31 72.76 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 176.539 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 7.1 tp -76.27 -17.94 59.22 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 117.119 2.266 . . . . 0.0 117.119 178.802 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 94.1 p -60.76 -31.32 70.66 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-N 120.616 1.553 . . . . 0.0 114.781 168.634 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -59.82 -39.63 85.74 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 169.073 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -65.04 112.83 3.52 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 124.4 1.08 . . . . 0.0 111.533 169.852 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 13.7 ptp180 -80.12 -15.46 57.07 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 117.941 2.571 . . . . 0.0 117.941 177.632 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 50.0 m80 -89.54 147.88 23.71 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 119.417 1.008 . . . . 0.0 112.367 -168.767 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -77.99 120.9 23.49 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.645 178.993 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 100.07 -21.38 44.89 Favored Glycine 0 CA--C 1.545 1.966 0 CA-C-O 117.168 -1.907 . . . . 0.0 117.119 -169.64 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.36 115.45 4.21 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 120.753 2.277 . . . . 0.0 111.128 -177.728 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 27.1 p90 -126.49 156.49 40.65 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 115.361 1.615 . . . . 0.0 115.361 -168.467 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.0 pp -132.33 125.64 31.4 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 168.382 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 71.8 mt -86.99 119.98 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 173.218 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 48.8 ptt85 -92.05 148.9 21.83 Favored 'General case' 0 CA--C 1.558 1.265 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.499 169.547 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -90.09 122.09 32.75 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 106.425 -1.695 . . . . 0.0 106.425 169.089 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 50.7 m -65.51 113.19 3.99 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.549 0.739 . . . . 0.0 111.95 -174.476 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -90.62 92.37 8.81 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-O 123.814 1.769 . . . . 0.0 108.992 178.854 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 51.7 p 163.73 -40.25 0.0 OUTLIER 'General case' 0 CA--C 1.568 1.672 0 CA-C-N 110.764 -2.925 . . . . 0.0 107.434 -168.209 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -131.87 98.61 17.46 Favored Pre-proline 0 CA--C 1.562 1.415 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 172.129 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -62.11 134.67 50.5 Favored 'Trans proline' 0 C--N 1.372 1.772 0 C-N-CA 123.383 2.722 . . . . 0.0 114.842 178.848 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 90.82 -31.7 5.45 Favored Glycine 0 CA--C 1.553 2.437 0 N-CA-C 116.398 1.319 . . . . 0.0 116.398 -169.373 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -80.63 135.5 36.06 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 118.864 1.332 . . . . 0.0 110.062 175.611 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -108.7 172.0 7.1 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 122.317 1.056 . . . . 0.0 111.127 -173.145 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 50.6 m -146.21 124.03 11.95 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 171.939 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 30.3 tp -80.09 114.42 18.98 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.665 0.786 . . . . 0.0 109.996 172.866 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.6 m -98.66 108.91 21.71 Favored 'General case' 0 CA--C 1.562 1.431 0 N-CA-C 105.336 -2.098 . . . . 0.0 105.336 172.353 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.7 p -127.63 118.67 49.89 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -170.455 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -85.19 97.09 9.71 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.236 0.615 . . . . 0.0 110.013 -179.008 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 17.2 t80 -122.0 124.98 45.26 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 -178.94 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 81.81 -111.47 3.33 Favored Glycine 0 N--CA 1.481 1.644 0 N-CA-C 110.319 -1.112 . . . . 0.0 110.319 -173.538 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -137.16 56.97 1.77 Allowed 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 169.023 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -160.04 135.09 7.94 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 -176.592 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 90.2 t -88.44 105.89 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 172.049 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 62.2 mt-30 -102.59 117.84 35.55 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.736 0.814 . . . . 0.0 109.321 -171.282 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 15.4 m-70 -96.98 113.99 25.57 Favored 'General case' 0 CA--C 1.554 1.121 0 CA-C-N 115.194 -0.912 . . . . 0.0 108.958 -173.518 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -115.2 118.52 33.55 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 177.693 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -80.71 125.77 30.46 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.753 -169.897 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 59.1 t -88.54 103.27 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 106.727 -1.582 . . . . 0.0 106.727 175.913 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -104.11 147.76 27.04 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 121.401 0.619 . . . . 0.0 110.988 -179.811 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -96.47 160.95 14.13 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -176.461 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -133.41 86.91 2.34 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.149 169.648 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 76.87 99.1 0.17 Allowed Glycine 0 N--CA 1.482 1.761 0 CA-C-O 119.197 -0.78 . . . . 0.0 114.513 172.337 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . 0.34 . . 82.09 -77.24 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 124.631 1.172 . . . . 0.0 112.72 -179.974 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -170.55 67.64 0.15 Allowed Glycine 0 N--CA 1.479 1.504 0 CA-C-O 119.662 -0.521 . . . . 0.0 113.214 174.682 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -107.6 94.19 4.95 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 105.863 -1.903 . . . . 0.0 105.863 174.078 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -79.43 126.75 31.24 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 124.204 1.002 . . . . 0.0 110.429 -169.706 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 24.0 p90 -147.92 121.22 8.99 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 -179.229 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -104.46 -42.6 5.41 Favored 'General case' 0 N--CA 1.498 1.926 0 C-N-CA 123.35 0.66 . . . . 0.0 112.508 168.853 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 43.4 t90 -89.98 -85.2 0.22 Allowed 'General case' 0 CA--C 1.56 1.336 0 C-N-CA 124.766 1.226 . . . . 0.0 109.942 -173.536 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 96.4 t -139.16 -66.52 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 -173.537 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 12.2 p -79.74 137.53 21.49 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.551 0 C-N-CA 123.772 0.829 . . . . 0.0 111.333 -175.4 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 60.9 pttt -89.36 162.35 15.84 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 -177.953 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 99.7 m-85 -145.78 120.23 9.68 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 -170.196 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 66.2 m-80 -61.12 -43.85 98.25 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 171.479 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 73.3 m -96.51 138.19 34.47 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-O 121.823 0.821 . . . . 0.0 111.272 174.305 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 13.5 tp -65.82 -31.98 73.25 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 169.661 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -59.69 -41.42 90.69 Favored 'General case' 0 CA--C 1.574 1.887 0 N-CA-C 113.92 1.082 . . . . 0.0 113.92 168.992 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -65.69 -38.32 88.93 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 115.49 1.663 . . . . 0.0 115.49 170.684 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 8.5 tt -57.12 -53.51 57.31 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-N 120.094 1.315 . . . . 0.0 114.404 170.313 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 9.9 p -64.59 -50.5 75.51 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.578 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -178.722 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -61.31 -36.79 81.09 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 115.403 1.631 . . . . 0.0 115.403 175.218 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -59.57 -53.4 58.48 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-N 119.957 1.253 . . . . 0.0 112.095 168.862 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . 0.262 69.7 m-70 -71.36 -9.09 57.6 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 118.15 2.648 . . . . 0.0 118.15 178.274 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 89.9 mtt-85 -58.17 -32.0 67.79 Favored 'General case' 0 CA--C 1.576 1.957 0 CA-C-N 120.375 1.443 . . . . 0.0 113.392 167.127 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 69.2 m -99.26 -42.77 6.87 Favored 'General case' 0 CA--C 1.569 1.678 0 C-N-CA 124.714 1.206 . . . . 0.0 112.927 168.688 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 33.7 m -87.97 155.67 19.72 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-N 119.814 1.188 . . . . 0.0 111.41 -175.373 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 25.3 t -79.56 129.13 34.19 Favored 'General case' 0 CA--C 1.56 1.336 0 O-C-N 121.187 -0.946 . . . . 0.0 113.356 -179.578 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 16.0 m -70.33 -36.85 68.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 N-CA-C 114.998 1.481 . . . . 0.0 114.998 169.748 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 22.9 t -87.25 140.1 29.88 Favored 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 123.658 0.783 . . . . 0.0 110.266 174.51 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 66.2 ttt-85 -73.18 -48.86 31.71 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 177.229 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 24.4 t30 -72.52 -57.89 3.8 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 171.962 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 63.4 mt-30 -79.88 154.4 28.38 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 118.763 0.711 . . . . 0.0 112.247 -177.223 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -94.13 104.0 16.04 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 171.928 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 17.2 mm -123.47 102.28 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 -177.802 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 22.4 m-30 -101.32 133.55 45.75 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 115.043 -0.981 . . . . 0.0 109.544 179.203 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 10.9 mp -89.3 121.44 31.58 Favored 'General case' 0 N--CA 1.486 1.338 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.266 -169.462 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 4.0 mpt_? -119.25 168.41 10.93 Favored 'General case' 0 CA--C 1.561 1.377 0 CA-C-O 123.602 1.667 . . . . 0.0 109.086 175.284 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -83.99 158.21 21.59 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-N 114.708 -1.133 . . . . 0.0 112.763 -174.264 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.1 pp -66.97 162.25 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 N-CA-C 114.565 1.321 . . . . 0.0 114.565 -177.463 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 . . . . . 0 N--CA 1.486 1.33 0 CA-C-O 122.815 1.293 . . . . 0.0 108.901 178.235 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.343 0 N-CA-C 111.664 -0.574 . . . . 0.0 111.664 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 85.5 p -87.37 99.65 12.15 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 121.265 0.555 . . . . 0.0 111.316 -174.607 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 1.2 p90 -157.6 -39.58 0.07 Allowed 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 113.55 0.945 . . . . 0.0 113.55 -174.779 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -80.81 128.39 33.6 Favored 'General case' 0 N--CA 1.484 1.263 0 CA-C-N 119.885 1.221 . . . . 0.0 110.245 177.551 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -87.49 -73.53 0.47 Allowed 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.225 178.023 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 177.81 -101.39 0.15 Allowed Glycine 0 N--CA 1.476 1.339 0 N-CA-C 109.147 -1.581 . . . . 0.0 109.147 179.618 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -139.26 82.19 1.88 Allowed 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 171.744 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 28.6 pt -107.33 149.68 39.05 Favored Pre-proline 0 CA--C 1.571 1.786 0 C-N-CA 123.564 0.746 . . . . 0.0 109.691 -178.876 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.48 168.97 22.05 Favored 'Trans proline' 0 CA--C 1.56 1.801 0 C-N-CA 122.8 2.333 . . . . 0.0 114.363 179.702 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 58.5 ttt-85 -61.99 -40.19 94.77 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 115.645 1.72 . . . . 0.0 115.645 -179.698 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -65.01 -41.09 95.68 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 115.78 1.77 . . . . 0.0 115.78 173.118 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? -64.3 -36.49 84.27 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 114.979 1.474 . . . . 0.0 114.979 169.637 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.76 -52.5 60.1 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 170.047 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -53.91 -36.15 62.41 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 116.458 2.021 . . . . 0.0 116.458 170.094 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -60.78 -50.06 74.98 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 114.433 1.271 . . . . 0.0 114.433 171.436 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -58.89 -51.32 70.53 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 114.925 1.454 . . . . 0.0 114.925 173.816 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -65.11 -33.46 76.08 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 116.16 1.911 . . . . 0.0 116.16 175.619 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 23.3 t -53.92 -35.46 61.69 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 115.725 1.75 . . . . 0.0 115.725 169.736 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -61.24 -41.12 96.34 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 114.587 1.328 . . . . 0.0 114.587 169.288 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -71.65 122.63 20.91 Favored 'General case' 0 CA--C 1.556 1.179 0 CA-C-O 122.898 1.332 . . . . 0.0 112.474 179.899 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.09 -8.7 55.27 Favored 'General case' 0 CA--C 1.569 1.674 0 N-CA-C 119.056 2.984 . . . . 0.0 119.056 170.972 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 44.6 m80 -89.71 142.66 27.48 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 120.071 1.305 . . . . 0.0 113.104 -168.703 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -78.66 116.75 19.23 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 169.651 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 108.46 -7.0 34.13 Favored Glycine 0 CA--C 1.549 2.202 0 CA-C-O 117.06 -1.967 . . . . 0.0 117.7 -169.398 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.61 117.69 8.45 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 121.14 2.47 . . . . 0.0 112.502 -169.963 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -131.53 155.09 48.06 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 116.281 1.956 . . . . 0.0 116.281 -168.806 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.6 pp -147.48 138.85 23.81 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-N 114.647 -1.16 . . . . 0.0 108.333 168.929 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.7 mp -94.26 120.69 44.05 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.591 0 N-CA-C 106.708 -1.589 . . . . 0.0 106.708 177.229 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 3.4 ptm180 -106.05 146.4 30.17 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 124.092 0.957 . . . . 0.0 109.702 169.679 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -79.82 131.38 35.88 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 169.682 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 22.9 t -63.54 132.42 51.2 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.673 0.789 . . . . 0.0 112.559 -177.189 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -68.18 -52.23 36.79 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 -172.546 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.0 t -64.99 -35.1 80.1 Favored 'General case' 0 CA--C 1.565 1.532 0 N-CA-C 116.256 1.947 . . . . 0.0 116.256 172.059 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -115.53 98.45 50.79 Favored Pre-proline 0 CA--C 1.563 1.466 0 CA-C-N 119.49 1.041 . . . . 0.0 109.99 178.66 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -59.87 -33.46 95.92 Favored 'Trans proline' 0 C--N 1.371 1.718 0 N-CA-C 119.384 2.802 . . . . 0.0 119.384 175.303 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -87.07 47.84 3.75 Favored Glycine 0 CA--C 1.551 2.34 0 N-CA-C 114.633 0.613 . . . . 0.0 114.633 169.239 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -156.19 126.75 6.74 Favored 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 178.881 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 7.5 m-30 -92.91 169.02 10.77 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 122.042 0.925 . . . . 0.0 110.806 169.933 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 69.5 m -149.47 115.69 5.76 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 -178.812 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 33.9 tp -81.02 112.87 18.81 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.896 0.879 . . . . 0.0 109.588 176.902 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.423 ' HG ' ' CE1' ' A' ' 107' ' ' HIS . 9.7 m -94.53 83.17 4.08 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 177.996 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.7 p -107.94 115.69 49.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 -171.412 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 58.0 tttp -77.59 145.59 36.74 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 114.882 -1.054 . . . . 0.0 111.416 171.173 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -148.86 101.34 3.17 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 169.735 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 92.61 -104.12 3.14 Favored Glycine 0 N--CA 1.479 1.534 0 N-CA-C 112.002 -0.439 . . . . 0.0 112.002 179.769 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -113.2 -11.98 13.18 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 117.241 2.311 . . . . 0.0 117.241 178.55 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -116.88 142.01 47.48 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-N 119.558 1.072 . . . . 0.0 110.051 -175.909 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 39.6 t -92.94 110.86 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 175.533 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 55.1 tp60 -102.33 112.22 24.83 Favored 'General case' 0 CA--C 1.552 1.055 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 -172.165 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.423 ' CE1' ' HG ' ' A' ' 98' ' ' SER . 13.8 m-70 -94.96 108.69 20.75 Favored 'General case' 0 CA--C 1.553 1.059 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 -174.68 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -103.13 130.5 50.32 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 176.227 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -77.82 115.5 17.61 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 123.083 0.553 . . . . 0.0 112.254 -175.939 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 97.4 t -85.64 110.35 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 106.83 -1.544 . . . . 0.0 106.83 178.364 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 58.5 mt -90.53 135.63 33.57 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.102 0.561 . . . . 0.0 109.717 -173.349 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 79.1 mtp180 -116.68 119.07 34.34 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 -175.183 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . 0.29 3.9 p-10 -79.91 -66.11 0.92 Allowed 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 -175.561 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -90.85 -107.27 1.39 Allowed Glycine 0 N--CA 1.483 1.826 0 CA-C-N 119.424 1.011 . . . . 0.0 111.801 -179.56 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -79.87 -67.28 0.78 Allowed 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 118.827 -0.606 . . . . 0.0 111.236 172.426 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -149.13 70.68 0.32 Allowed Glycine 0 N--CA 1.477 1.427 0 CA-C-N 118.46 0.573 . . . . 0.0 111.884 169.807 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.17 101.16 11.82 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 105.108 -2.182 . . . . 0.0 105.108 171.664 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -83.84 106.73 15.75 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-N 115.038 -0.983 . . . . 0.0 111.141 -168.509 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -114.38 114.72 26.25 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 107.769 -1.196 . . . . 0.0 107.769 177.505 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 63.0 tp -112.01 -48.9 3.01 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 124.192 0.997 . . . . 0.0 112.191 179.749 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 33.7 t90 -92.5 -74.79 0.51 Allowed 'General case' 0 CA--C 1.557 1.22 0 C-N-CA 124.598 1.159 . . . . 0.0 110.694 -169.727 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . 0.255 10.8 p -146.28 -60.41 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 C-N-CA 123.586 0.754 . . . . 0.0 109.715 177.293 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 15.6 m -79.38 157.15 4.7 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.545 0 C-N-CA 124.251 1.02 . . . . 0.0 111.759 178.892 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -79.88 136.0 36.57 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.526 -178.38 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -124.51 99.5 6.22 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 106.222 -1.77 . . . . 0.0 106.222 177.676 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . 0.272 12.8 p30 -60.45 -41.43 94.05 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 116.874 2.175 . . . . 0.0 116.874 -172.991 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 69.3 m -94.88 152.55 18.28 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-O 122.125 0.964 . . . . 0.0 111.268 172.395 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 12.8 tp -64.77 -34.76 79.11 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 169.66 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -63.68 -35.92 82.14 Favored 'General case' 0 CA--C 1.568 1.641 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 168.81 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -60.19 -48.93 79.66 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-N 120.592 1.542 . . . . 0.0 113.858 169.533 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 53.0 tp -60.82 -50.3 74.01 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 115.355 1.613 . . . . 0.0 115.355 173.752 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 46.3 t -61.38 -60.19 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 C-N-CA 123.957 0.903 . . . . 0.0 112.111 176.445 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -59.3 -31.8 69.47 Favored 'General case' 0 CA--C 1.567 1.634 0 N-CA-C 115.607 1.706 . . . . 0.0 115.607 -176.912 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -62.96 -53.92 46.57 Favored 'General case' 0 CA--C 1.568 1.642 0 CA-C-N 119.833 1.197 . . . . 0.0 112.328 168.78 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . 0.306 76.0 m-70 -71.58 -8.5 54.43 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 118.183 2.661 . . . . 0.0 118.183 178.16 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -47.77 -40.29 20.31 Favored 'General case' 0 N--CA 1.499 2.012 0 CA-C-N 120.693 1.588 . . . . 0.0 114.945 167.916 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 70.0 m -106.38 -32.9 7.93 Favored 'General case' 0 CA--C 1.564 1.493 0 N-CA-C 114.728 1.381 . . . . 0.0 114.728 170.655 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 48.7 m -89.39 147.36 24.09 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-N 120.4 1.455 . . . . 0.0 110.172 -179.706 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.512 ' HB2' ' H ' ' A' ' 146' ' ' ILE . 54.8 p -80.47 141.32 35.33 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 120.97 -1.081 . . . . 0.0 113.346 179.214 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 46.5 t -67.37 -51.54 51.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.916 169.781 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 32.3 t -87.35 132.64 33.89 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.582 0.753 . . . . 0.0 110.715 178.796 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -88.33 70.31 9.11 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 121.629 0.728 . . . . 0.0 110.955 176.37 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . 0.297 5.8 p-10 178.77 -68.58 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 125.218 1.407 . . . . 0.0 107.665 -176.501 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -96.86 138.6 34.16 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.689 0.796 . . . . 0.0 109.413 171.943 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -73.47 117.69 15.53 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 122.696 0.398 . . . . 0.0 111.775 178.809 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.512 ' H ' ' HB2' ' A' ' 139' ' ' SER . 8.4 mm -121.21 92.34 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 176.628 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 21.4 m-30 -100.57 119.82 39.11 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-N 114.249 -1.341 . . . . 0.0 108.109 -176.893 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 10.6 mp -74.04 126.48 30.61 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 123.384 0.674 . . . . 0.0 112.321 -169.748 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 24.1 mmt85 -129.23 143.24 50.78 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 124.551 1.14 . . . . 0.0 108.154 -179.083 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -72.26 146.75 47.03 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 113.645 0.98 . . . . 0.0 113.645 -174.798 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 28.3 pt -69.37 150.15 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 C-N-CA 123.868 0.867 . . . . 0.0 112.726 178.902 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 123.848 1.785 . . . . 0.0 109.55 -177.379 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.403 0 N-CA-C 111.748 -0.541 . . . . 0.0 111.748 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 90.7 p -76.86 115.33 16.54 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 122.994 0.517 . . . . 0.0 111.601 -176.59 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . 0.38 62.1 p-90 53.11 4.77 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 121.583 3.92 . . . . 0.0 121.583 -177.431 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -139.53 129.26 24.62 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 -169.676 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -140.09 94.86 2.8 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 170.501 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -91.8 164.95 29.21 Favored Glycine 0 CA--C 1.541 1.715 0 CA-C-O 122.924 1.291 . . . . 0.0 116.082 -169.816 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . 0.259 32.3 mmmt 57.38 53.14 7.84 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-N 113.1 -1.55 . . . . 0.0 115.183 -178.364 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 42.3 pt -136.55 152.35 74.53 Favored Pre-proline 0 CA--C 1.573 1.844 0 C-N-CA 123.895 0.878 . . . . 0.0 109.941 -177.751 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -74.08 177.0 8.77 Favored 'Trans proline' 0 CA--C 1.565 2.058 0 C-N-CA 122.919 2.412 . . . . 0.0 114.124 174.847 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 56.3 ttt-85 -63.78 -42.17 97.81 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 115.303 1.594 . . . . 0.0 115.303 176.506 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -66.47 -41.36 89.14 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 115.742 1.756 . . . . 0.0 115.742 176.35 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 29.2 tptp -62.91 -36.65 84.06 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 169.595 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.28 -46.1 81.79 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 115.452 1.649 . . . . 0.0 115.452 171.432 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -62.15 -39.33 92.24 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 115.168 1.544 . . . . 0.0 115.168 170.795 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -60.34 -46.0 91.47 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 114.938 1.459 . . . . 0.0 114.938 172.872 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 34.3 mmt -59.87 -50.36 74.08 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 114.813 1.412 . . . . 0.0 114.813 171.624 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 88.1 mt -75.97 -23.88 55.36 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 117.076 2.25 . . . . 0.0 117.076 -178.985 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 91.7 p -58.8 -35.99 73.75 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 117.082 2.253 . . . . 0.0 117.082 176.574 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 37.9 mtmm -63.07 -31.84 73.08 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 115.719 1.748 . . . . 0.0 115.719 169.656 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -75.51 122.62 24.14 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.533 1.133 . . . . 0.0 111.667 -171.44 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 13.4 ptp180 -63.56 -20.58 65.75 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 119.224 3.046 . . . . 0.0 119.224 -179.826 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 39.2 m80 -89.63 136.9 32.77 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 119.8 1.182 . . . . 0.0 112.718 -168.704 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -77.23 125.31 29.12 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.38 169.674 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 107.43 -21.38 30.81 Favored Glycine 0 CA--C 1.547 2.046 0 CA-C-O 117.036 -1.98 . . . . 0.0 115.879 -168.849 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.23 111.21 2.49 Favored 'General case' 0 N--CA 1.486 1.352 0 CA-C-N 120.823 2.311 . . . . 0.0 111.821 -171.917 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.8 p90 -123.94 158.19 32.58 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 113.826 1.046 . . . . 0.0 113.826 -168.569 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.2 pp -135.67 133.0 37.69 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 168.327 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 74.1 mt -88.95 109.82 20.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 105.661 -1.978 . . . . 0.0 105.661 171.808 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 50.8 ptt85 -91.1 144.06 26.03 Favored 'General case' 0 N--CA 1.486 1.327 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.097 171.657 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -90.24 126.13 35.72 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 169.113 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 53.0 m -67.07 128.78 37.66 Favored 'General case' 0 N--CA 1.487 1.375 0 CA-C-O 121.508 0.671 . . . . 0.0 111.326 -177.937 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -68.64 -47.83 65.58 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 -172.895 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 90.8 p -61.73 -36.89 82.27 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 116.655 2.094 . . . . 0.0 116.655 169.887 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -123.01 96.74 44.51 Favored Pre-proline 0 CA--C 1.563 1.454 0 CA-C-N 119.421 1.01 . . . . 0.0 109.439 177.776 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -58.05 -33.62 97.5 Favored 'Trans proline' 0 C--N 1.371 1.712 0 N-CA-C 120.055 3.059 . . . . 0.0 120.055 178.472 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -87.26 42.65 3.15 Favored Glycine 0 CA--C 1.552 2.389 0 N-CA-C 115.565 0.986 . . . . 0.0 115.565 169.266 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -149.44 110.19 4.29 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 105.03 -2.211 . . . . 0.0 105.03 177.532 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -95.33 168.01 10.99 Favored 'General case' 0 N--CA 1.489 1.475 0 CA-C-O 121.672 0.748 . . . . 0.0 110.105 176.426 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 73.4 m -143.62 114.28 7.61 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 179.327 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 24.9 tp -79.89 107.34 12.6 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 124.442 1.097 . . . . 0.0 109.041 176.257 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 9.4 m -102.79 95.49 6.22 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 -169.956 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 20.0 t -108.62 120.22 59.6 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 CA-C-N 119.113 0.869 . . . . 0.0 109.254 -169.485 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -87.72 96.79 10.57 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.125 0.57 . . . . 0.0 109.526 173.711 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 18.3 t80 -120.53 100.16 6.98 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 179.222 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 68.35 73.0 0.74 Allowed Glycine 0 CA--C 1.542 1.759 0 N-CA-C 115.392 0.917 . . . . 0.0 115.392 175.227 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . 0.321 64.7 m-80 73.67 -22.88 0.23 Allowed 'General case' 0 N--CA 1.5 2.052 0 N-CA-C 118.564 2.802 . . . . 0.0 118.564 -179.821 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -123.91 139.09 54.31 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-N 119.538 1.063 . . . . 0.0 109.935 -169.938 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 39.4 t -100.91 112.39 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 -179.176 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -101.43 115.82 31.37 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.834 0.854 . . . . 0.0 109.208 -174.789 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 -97.12 107.54 20.09 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 115.007 -0.997 . . . . 0.0 108.587 -174.443 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -104.15 119.38 38.81 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 -176.858 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.8 tppp? -75.92 118.5 18.77 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-O 121.98 0.895 . . . . 0.0 110.646 -173.09 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 92.1 t -92.0 101.41 12.52 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.373 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 -179.51 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 68.6 mt -86.37 147.03 26.22 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 123.588 0.755 . . . . 0.0 111.072 178.396 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 73.5 mtp180 -113.0 147.23 37.6 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 123.058 0.543 . . . . 0.0 110.933 -177.776 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -135.41 132.07 37.03 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 123.276 0.63 . . . . 0.0 110.385 173.829 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 81.36 -113.3 3.61 Favored Glycine 0 CA--C 1.541 1.713 0 C-N-CA 122.957 0.313 . . . . 0.0 113.0 175.689 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -83.76 -68.09 0.74 Allowed 'General case' 0 N--CA 1.487 1.401 0 CA-C-O 118.929 -0.558 . . . . 0.0 110.979 172.465 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -162.25 73.04 0.2 Allowed Glycine 0 N--CA 1.477 1.374 0 CA-C-N 118.477 0.581 . . . . 0.0 111.69 169.93 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -99.12 100.93 12.12 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 176.561 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 79.9 m-85 -83.46 112.31 19.84 Favored 'General case' 0 CA--C 1.557 1.227 0 CA-C-N 114.503 -1.226 . . . . 0.0 109.581 -169.585 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -125.13 116.13 21.56 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 123.717 0.807 . . . . 0.0 109.155 -177.115 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -115.7 -38.29 3.75 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 178.773 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 53.2 t90 -99.91 -82.72 0.44 Allowed 'General case' 0 CA--C 1.56 1.336 0 C-N-CA 124.804 1.242 . . . . 0.0 108.679 -179.814 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 99.8 t -137.78 -66.53 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 -175.678 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 10.6 p -79.7 139.05 18.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 C-N-CA 123.69 0.796 . . . . 0.0 110.906 -177.676 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.67 168.11 19.79 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-O 122.256 1.027 . . . . 0.0 113.231 178.631 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -147.23 113.4 5.86 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 -170.104 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 23.3 t30 -59.45 -40.58 87.27 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 115.857 1.799 . . . . 0.0 115.857 -179.49 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 66.0 m -110.65 157.4 19.75 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-O 122.018 0.913 . . . . 0.0 111.203 174.089 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 90.4 mt -66.29 -30.47 70.89 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 114.457 1.28 . . . . 0.0 114.457 169.262 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -63.02 -39.74 95.67 Favored 'General case' 0 CA--C 1.573 1.858 0 CA-C-N 119.89 1.223 . . . . 0.0 113.702 169.287 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -60.8 -43.31 98.31 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 114.217 1.191 . . . . 0.0 114.217 169.282 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 9.5 tt -56.47 -49.84 73.47 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 172.568 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 13.6 m -63.89 -49.11 83.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 N-CA-C 113.831 1.049 . . . . 0.0 113.831 176.973 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -65.8 -33.02 74.89 Favored 'General case' 0 CA--C 1.569 1.68 0 N-CA-C 114.917 1.451 . . . . 0.0 114.917 -175.995 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -61.57 -59.63 4.93 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 119.852 1.205 . . . . 0.0 112.93 169.873 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . 0.261 70.1 m-70 -69.45 -9.23 52.75 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 117.67 2.47 . . . . 0.0 117.67 177.069 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 49.2 ttm-85 -59.03 -32.31 69.62 Favored 'General case' 0 CA--C 1.575 1.925 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 167.573 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 70.1 m -105.11 -35.77 7.5 Favored 'General case' 0 CA--C 1.566 1.581 0 C-N-CA 124.987 1.315 . . . . 0.0 114.045 169.368 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 57.2 m -90.9 155.32 18.83 Favored 'General case' 0 N--CA 1.498 1.959 0 CA-C-N 120.352 1.433 . . . . 0.0 111.983 179.684 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 27.8 t -75.01 135.34 41.3 Favored 'General case' 0 N--CA 1.484 1.263 0 O-C-N 121.545 -0.722 . . . . 0.0 112.73 176.953 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 11.6 t -72.88 -54.32 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 CA-C-O 118.63 -0.7 . . . . 0.0 111.179 170.878 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 39.2 t -101.86 127.57 48.62 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.07 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -62.77 -32.2 73.31 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 116.437 2.014 . . . . 0.0 116.437 -179.49 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 70.9 m-80 -76.37 -62.65 1.55 Allowed 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 119.567 1.076 . . . . 0.0 112.18 169.897 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -91.05 120.78 32.3 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 119.163 0.892 . . . . 0.0 109.258 -178.302 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 58.5 mt-30 -76.37 107.46 8.64 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.794 -0.566 . . . . 0.0 111.505 -174.252 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 14.0 mm -111.72 122.47 66.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 -173.658 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -125.81 129.16 48.88 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 -179.14 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 10.0 mp -78.72 123.09 26.8 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -169.043 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 14.5 tpt180 -111.18 150.72 29.11 Favored 'General case' 0 CA--C 1.56 1.35 0 C-N-CA 125.615 1.566 . . . . 0.0 109.164 172.442 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -76.48 157.41 32.18 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.79 -1.194 . . . . 0.0 112.249 172.262 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -64.31 152.52 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 N-CA-C 114.152 1.167 . . . . 0.0 114.152 -175.305 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 . . . . . 0 N--CA 1.488 1.431 0 CA-C-O 122.843 1.306 . . . . 0.0 108.358 171.952 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 64.5 p-90 . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 117.053 2.242 . . . . 0.0 117.053 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -81.33 121.78 26.64 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 120.696 1.589 . . . . 0.0 110.237 -173.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -124.35 106.42 10.23 Favored 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 104.543 -2.391 . . . . 0.0 104.543 173.385 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -39.15 -67.57 0.57 Allowed Glycine 0 N--CA 1.487 2.056 0 N-CA-C 119.765 2.666 . . . . 0.0 119.765 -169.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -151.55 91.7 1.69 Allowed 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.46 157.35 62.15 Favored Pre-proline 0 N--CA 1.5 2.066 0 CA-C-O 118.467 -0.778 . . . . 0.0 109.898 177.9 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -54.68 159.3 9.08 Favored 'Trans proline' 0 C--N 1.371 1.755 0 C-N-CA 123.4 2.733 . . . . 0.0 117.619 178.221 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 59.6 ttt180 -65.94 -40.02 90.98 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 114.503 1.297 . . . . 0.0 114.503 170.493 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -66.69 -44.18 82.43 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 173.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -61.02 -38.12 84.97 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 115.45 1.648 . . . . 0.0 115.45 170.034 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.94 -45.32 94.19 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 115.476 1.658 . . . . 0.0 115.476 169.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -60.95 -42.69 98.72 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 115.199 1.555 . . . . 0.0 115.199 171.505 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -59.57 -51.27 70.54 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 174.098 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -63.21 -45.96 89.24 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 115.024 1.491 . . . . 0.0 115.024 177.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 6.5 mp -70.05 -41.12 74.63 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 114.854 1.427 . . . . 0.0 114.854 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 69.8 m -58.76 -35.04 72.13 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 115.839 1.792 . . . . 0.0 115.839 169.67 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 59.4 mttm -64.29 -38.28 90.49 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 115.287 1.588 . . . . 0.0 115.287 169.612 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -53.54 137.07 37.39 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 179.313 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 36.0 ptt180 -66.97 -22.85 65.91 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 118.029 2.603 . . . . 0.0 118.029 174.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 67.0 m80 -89.33 138.03 31.8 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-N 119.186 0.903 . . . . 0.0 112.017 -169.25 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -77.95 124.63 28.24 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.065 169.763 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.61 11.95 58.75 Favored Glycine 0 CA--C 1.555 2.569 0 CA-C-O 117.839 -1.534 . . . . 0.0 116.866 -169.025 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -71.34 123.53 22.52 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 120.443 2.122 . . . . 0.0 112.135 -170.106 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.405 ' HB3' HG23 ' A' ' 99' ' ' VAL . 17.5 p90 -135.7 160.86 37.22 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 116.359 1.985 . . . . 0.0 116.359 -168.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.1 pp -144.14 141.82 30.21 Favored 'General case' 0 CA--C 1.556 1.188 0 CA-C-N 113.786 -1.552 . . . . 0.0 108.277 167.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 52.7 mt -97.62 112.46 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 172.633 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -105.02 150.42 24.97 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 124.4 1.08 . . . . 0.0 111.905 176.444 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -89.72 138.28 31.61 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 169.058 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 68.3 m -64.08 137.18 57.85 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.847 0.859 . . . . 0.0 112.305 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -76.15 109.6 9.96 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.241 1.016 . . . . 0.0 110.28 -169.698 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . 0.374 16.6 m 103.39 -34.11 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.844 0 CA-C-N 112.286 -2.233 . . . . 0.0 114.665 -172.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -93.15 112.62 57.05 Favored Pre-proline 0 CA--C 1.567 1.61 0 CA-C-N 120.628 1.558 . . . . 0.0 111.685 -176.33 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -81.48 134.5 8.86 Favored 'Trans proline' 0 C--N 1.371 1.732 0 C-N-CA 123.137 2.558 . . . . 0.0 112.901 -179.25 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 66.66 33.52 84.66 Favored Glycine 0 CA--C 1.552 2.362 0 N-CA-C 117.012 1.565 . . . . 0.0 117.012 -169.742 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -126.45 92.0 3.47 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 105.858 -1.904 . . . . 0.0 105.858 -178.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -93.24 163.39 13.64 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-O 122.211 1.005 . . . . 0.0 111.687 -169.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 72.8 m -147.67 120.73 8.83 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 29.9 tp -79.61 103.85 9.81 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 171.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 3.1 m -84.94 108.16 17.44 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 172.518 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.405 HG23 ' HB3' ' A' ' 83' ' ' PHE . 6.8 p -135.18 126.54 46.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 -173.245 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -75.72 112.21 11.86 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.645 174.498 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 12.5 m-30 -117.84 106.82 13.4 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 176.736 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 85.51 -95.79 2.03 Favored Glycine 0 CA--C 1.54 1.612 0 N-CA-C 111.154 -0.778 . . . . 0.0 111.154 -172.789 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -127.6 -24.19 3.33 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 114.956 1.465 . . . . 0.0 114.956 169.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -89.24 139.13 30.8 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 119.056 0.844 . . . . 0.0 110.558 -175.518 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 59.3 t -87.85 110.93 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 N-CA-C 106.66 -1.608 . . . . 0.0 106.66 178.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 69.0 mt-30 -106.95 120.56 42.39 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.177 -169.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 19.8 m-70 -99.65 97.69 8.63 Favored 'General case' 0 CA--C 1.553 1.093 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 -170.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -93.11 125.03 37.51 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 -179.271 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -75.6 119.84 20.19 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-O 121.32 0.581 . . . . 0.0 112.222 -170.156 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 90.9 t -93.79 97.86 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 N-CA-C 106.374 -1.713 . . . . 0.0 106.374 178.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 71.0 mt -85.57 154.76 21.51 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.682 0.793 . . . . 0.0 110.951 177.009 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 65.0 mtp180 -115.87 129.39 56.4 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.505 -0.747 . . . . 0.0 110.798 -177.036 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -106.23 94.12 4.98 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 123.323 0.649 . . . . 0.0 110.258 176.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 88.96 -112.84 4.01 Favored Glycine 0 CA--C 1.541 1.706 0 N-CA-C 113.918 0.327 . . . . 0.0 113.918 172.517 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -89.03 -94.25 0.11 Allowed 'General case' 0 N--CA 1.486 1.341 0 CA-C-O 118.228 -0.892 . . . . 0.0 111.35 -169.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -113.73 80.3 0.28 Allowed Glycine 0 N--CA 1.481 1.665 0 CA-C-N 119.335 0.971 . . . . 0.0 110.689 177.7 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -142.5 146.58 34.87 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -175.492 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -145.78 108.36 4.48 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 -169.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 21.2 p90 -126.74 117.77 23.36 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.749 0.82 . . . . 0.0 109.602 -175.604 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -107.95 -42.83 4.58 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 170.379 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 47.2 t90 -92.03 -74.07 0.53 Allowed 'General case' 0 CA--C 1.558 1.255 0 C-N-CA 124.959 1.304 . . . . 0.0 110.182 -169.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . 0.267 14.8 p -147.24 -64.98 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 C-N-CA 123.612 0.765 . . . . 0.0 109.188 174.82 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 9.4 m -79.56 142.21 14.29 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.426 0 C-N-CA 124.175 0.99 . . . . 0.0 111.481 -178.124 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.87 154.65 28.23 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -177.448 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -133.66 116.41 15.79 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 106.471 -1.677 . . . . 0.0 106.471 -171.356 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -55.68 -50.59 69.86 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 115.884 1.809 . . . . 0.0 115.884 -173.144 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 69.0 m -106.57 161.58 14.5 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-O 122.025 0.916 . . . . 0.0 111.21 173.291 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 84.5 mt -67.2 -29.07 68.64 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 168.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -67.07 -39.66 86.87 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-N 119.652 1.114 . . . . 0.0 113.04 169.628 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -60.47 -41.46 94.23 Favored 'General case' 0 CA--C 1.568 1.67 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 169.101 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 9.1 tt -56.99 -45.56 82.88 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 114.139 1.163 . . . . 0.0 114.139 169.477 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 41.3 t -60.01 -61.8 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 C-N-CA 124.308 1.043 . . . . 0.0 112.661 172.472 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 -63.16 -28.42 70.04 Favored 'General case' 0 CA--C 1.566 1.587 0 N-CA-C 115.879 1.807 . . . . 0.0 115.879 -174.564 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -63.12 -61.68 2.21 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 119.594 1.088 . . . . 0.0 112.01 169.488 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . 0.308 49.1 m-70 -70.11 -8.91 53.35 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 118.166 2.654 . . . . 0.0 118.166 177.414 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 59.2 ttm-85 -61.86 -28.81 69.76 Favored 'General case' 0 CA--C 1.579 2.092 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 167.539 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 71.0 m -110.43 -31.87 7.13 Favored 'General case' 0 CA--C 1.568 1.67 0 C-N-CA 125.199 1.4 . . . . 0.0 114.245 169.362 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 47.6 m -90.56 149.45 22.15 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-N 120.389 1.449 . . . . 0.0 110.445 175.778 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 22.8 t -80.96 137.26 36.1 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.741 -1.224 . . . . 0.0 113.242 -179.505 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 75.5 t -75.08 -58.82 3.99 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.834 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.126 169.246 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 73.4 m -89.66 114.99 26.7 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.909 0.884 . . . . 0.0 108.724 -177.279 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 19.3 mmm180 -89.24 81.51 6.69 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 122.33 1.062 . . . . 0.0 112.249 -169.479 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -160.32 -77.71 0.06 Allowed 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 103.816 -2.661 . . . . 0.0 103.816 173.321 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -97.08 146.57 24.89 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 169.005 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 65.5 mt-30 -79.35 112.27 16.42 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.665 -0.647 . . . . 0.0 111.222 -175.728 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -124.16 127.05 73.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 -178.023 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -119.88 168.33 11.22 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 122.545 1.164 . . . . 0.0 112.447 -169.682 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 11.0 mp -90.39 115.31 27.47 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 124.318 1.047 . . . . 0.0 110.251 -178.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.21 147.7 42.26 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 124.234 1.013 . . . . 0.0 109.302 178.043 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -74.11 152.17 39.95 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 122.112 0.958 . . . . 0.0 113.456 -176.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 14.3 pt -72.9 164.43 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 CA-C-N 114.903 -1.044 . . . . 0.0 113.583 -178.274 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 24.4 tp10 . . . . . 0 N--CA 1.485 1.315 0 CA-C-O 122.834 1.302 . . . . 0.0 109.315 172.076 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . 0.259 65.9 p-90 . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -81.82 140.79 33.97 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-N 119.596 1.089 . . . . 0.0 110.826 175.332 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -116.49 -87.27 0.61 Allowed 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 175.423 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 138.49 94.15 0.3 Allowed Glycine 0 N--CA 1.48 1.628 0 CA-C-N 119.603 1.092 . . . . 0.0 111.755 177.158 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . 0.259 20.5 tptm 67.14 73.42 0.34 Allowed 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 124.283 1.033 . . . . 0.0 113.56 173.532 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 28.4 pt -128.77 151.08 76.62 Favored Pre-proline 0 CA--C 1.576 1.95 0 C-N-CA 123.924 0.89 . . . . 0.0 109.443 176.185 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -75.42 172.25 16.68 Favored 'Trans proline' 0 CA--C 1.562 1.896 0 C-N-CA 122.997 2.464 . . . . 0.0 114.678 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 53.5 ttt180 -67.03 -41.3 86.8 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 115.771 1.767 . . . . 0.0 115.771 -179.043 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -66.9 -42.73 84.96 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 115.666 1.728 . . . . 0.0 115.666 177.118 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -64.94 -36.03 83.08 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 115.028 1.492 . . . . 0.0 115.028 169.696 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.82 -45.25 90.46 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 115.734 1.753 . . . . 0.0 115.734 170.309 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -62.43 -38.48 89.9 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 115.246 1.572 . . . . 0.0 115.246 170.501 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -61.33 -50.43 72.97 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 114.499 1.296 . . . . 0.0 114.499 173.823 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 39.2 tpp -57.5 -46.53 83.65 Favored 'General case' 0 CA--C 1.564 1.488 0 N-CA-C 115.604 1.705 . . . . 0.0 115.604 172.23 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 9.2 mp -70.65 -24.9 62.78 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 116.621 2.082 . . . . 0.0 116.621 175.751 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 71.6 m -57.28 -35.43 69.78 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-N 120.882 1.674 . . . . 0.0 114.908 169.153 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 56.8 mttp -60.45 -38.5 84.35 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 115.112 1.523 . . . . 0.0 115.112 169.113 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -68.49 122.29 18.14 Favored 'General case' 0 CA--C 1.556 1.183 0 C-N-CA 124.829 1.251 . . . . 0.0 112.156 178.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 16.4 ptm180 -78.24 -18.05 55.89 Favored 'General case' 0 CA--C 1.569 1.701 0 N-CA-C 118.199 2.666 . . . . 0.0 118.199 175.632 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 41.7 m80 -89.57 147.39 23.97 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 119.483 1.038 . . . . 0.0 113.722 -168.224 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -81.77 117.91 22.45 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 169.657 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 118.22 -32.89 5.08 Favored Glycine 0 CA--C 1.54 1.613 0 CA-C-O 117.704 -1.609 . . . . 0.0 116.35 -169.202 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -60.91 103.98 0.32 Allowed 'General case' 0 N--CA 1.486 1.339 0 CA-C-N 119.257 1.529 . . . . 0.0 113.9 -169.539 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 18.4 p90 -120.59 162.48 19.55 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 -168.688 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.3 pp -135.29 132.16 37.41 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 167.158 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 70.0 mt -91.82 114.31 28.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 105.611 -1.996 . . . . 0.0 105.611 170.058 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 46.8 ptt85 -100.45 156.07 17.47 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-N 114.596 -1.183 . . . . 0.0 110.484 170.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -87.67 128.03 35.29 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 168.703 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 16.4 t -60.36 137.83 58.07 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 113.753 1.02 . . . . 0.0 113.753 -170.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.06 119.86 17.89 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-O 122.907 1.337 . . . . 0.0 111.536 -171.694 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . 0.33 5.4 t 84.98 -22.21 0.21 Allowed 'General case' 0 N--CA 1.493 1.693 0 CA-C-N 111.569 -2.56 . . . . 0.0 116.075 -169.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -108.55 92.9 10.8 Favored Pre-proline 0 CA--C 1.565 1.533 0 CA-C-N 120.662 1.574 . . . . 0.0 110.213 177.164 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -73.52 133.15 18.51 Favored 'Trans proline' 0 C--N 1.373 1.821 0 C-N-CA 123.19 2.593 . . . . 0.0 111.429 171.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 98.69 -34.18 5.51 Favored Glycine 0 CA--C 1.553 2.456 0 CA-C-O 119.017 -0.879 . . . . 0.0 114.275 -168.476 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -79.64 131.84 36.09 Favored 'General case' 0 N--CA 1.484 1.257 0 CA-C-N 118.675 1.238 . . . . 0.0 108.599 169.535 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -116.63 164.09 15.13 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-O 122.124 0.964 . . . . 0.0 110.58 -178.223 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 69.0 m -143.54 115.32 8.22 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 -177.187 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 16.6 tp -83.8 104.93 14.29 Favored 'General case' 0 CA--C 1.561 1.386 0 C-N-CA 124.369 1.068 . . . . 0.0 108.502 174.319 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.8 m -93.63 108.62 20.32 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 -179.098 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 24.0 t -116.38 124.5 72.65 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 CA-C-N 119.762 1.164 . . . . 0.0 108.301 -169.736 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 58.6 tptt -84.06 120.65 26.4 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.211 0.605 . . . . 0.0 109.891 171.741 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 3.9 m-30 -89.23 -140.03 0.13 Allowed 'General case' 0 CA--C 1.567 1.633 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 173.39 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -58.13 -71.0 0.82 Allowed Glycine 0 CA--C 1.547 2.053 0 C-N-CA 123.96 0.791 . . . . 0.0 114.242 169.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 31.6 t30 -140.04 58.72 1.59 Allowed 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 117.534 0.667 . . . . 0.0 111.281 169.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -160.0 141.6 12.75 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 124.016 0.926 . . . . 0.0 108.627 176.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 57.2 t -107.35 109.83 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 177.683 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 18.6 mp0 -101.85 126.76 48.8 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.879 0.871 . . . . 0.0 109.777 179.312 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 21.6 m80 -101.78 97.0 7.45 Favored 'General case' 0 CA--C 1.553 1.082 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 -175.231 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -86.41 128.81 34.99 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 172.318 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -91.02 118.87 30.73 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 121.208 0.528 . . . . 0.0 110.889 -169.752 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 91.9 t -85.91 110.21 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 107.224 -1.398 . . . . 0.0 107.224 -177.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 56.8 mt -104.31 134.41 47.58 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 -173.217 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 37.3 mtm180 -99.52 131.47 45.51 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 118.176 0.444 . . . . 0.0 110.929 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -85.6 -54.47 4.53 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 174.537 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 179.98 139.44 3.77 Favored Glycine 0 CA--C 1.542 1.732 0 CA-C-N 119.823 1.192 . . . . 0.0 113.77 -178.341 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . 0.344 . . 78.53 -79.15 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 125.294 1.438 . . . . 0.0 113.3 175.446 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -157.18 78.13 0.19 Allowed Glycine 0 N--CA 1.478 1.463 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 172.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -143.07 144.1 32.12 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -171.109 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -138.87 100.6 4.09 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 -172.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -99.89 105.43 17.16 Favored 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 175.719 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -101.63 -49.94 3.86 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-N 114.327 -1.306 . . . . 0.0 111.239 175.558 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 79.0 t90 -129.48 101.71 6.07 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 -172.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . 0.509 10.7 p 60.75 -90.68 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 C-N-CA 125.227 1.411 . . . . 0.0 114.188 -179.45 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 21.1 m -79.64 158.44 4.54 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.493 0 C-N-CA 124.449 1.1 . . . . 0.0 112.398 -175.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -79.72 152.7 29.73 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 121.876 0.846 . . . . 0.0 112.978 179.058 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -135.73 109.42 8.04 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 105.9 -1.889 . . . . 0.0 105.9 -171.358 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 15.1 t30 -57.89 -53.54 57.08 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 115.77 1.767 . . . . 0.0 115.77 -170.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 67.7 m -98.05 149.57 22.34 Favored 'General case' 0 N--CA 1.483 1.225 0 CA-C-O 123.04 1.4 . . . . 0.0 111.337 178.252 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 8.0 tp -65.96 -31.29 72.12 Favored 'General case' 0 CA--C 1.571 1.764 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 169.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -70.18 -37.85 75.23 Favored 'General case' 0 CA--C 1.57 1.746 0 CA-C-O 117.681 -1.152 . . . . 0.0 113.796 169.311 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . 0.329 9.1 pt-20 -62.16 -31.14 71.61 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-N 121.139 1.79 . . . . 0.0 115.088 169.319 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 59.6 tp -57.79 -44.13 86.06 Favored 'General case' 0 CA--C 1.574 1.868 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 168.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . 0.333 7.1 p -65.3 -57.61 10.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 CA-C-N 120.17 1.35 . . . . 0.0 113.918 172.644 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -60.32 -23.49 64.25 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 117.391 2.367 . . . . 0.0 117.391 176.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 84.8 t80 -66.25 -61.33 2.08 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-N 119.304 0.956 . . . . 0.0 112.043 169.485 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 71.4 m-70 -69.83 -9.54 55.13 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 117.734 2.494 . . . . 0.0 117.734 176.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 38.0 ttm180 -59.52 -29.11 67.65 Favored 'General case' 0 CA--C 1.58 2.119 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 167.462 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 70.7 m -110.2 -30.61 7.66 Favored 'General case' 0 CA--C 1.571 1.771 0 C-N-CA 125.483 1.513 . . . . 0.0 114.037 169.172 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 56.8 m -90.46 157.36 17.61 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-N 120.546 1.521 . . . . 0.0 111.266 177.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 8.2 t -75.93 129.79 37.47 Favored 'General case' 0 CA--C 1.56 1.363 0 O-C-N 121.491 -0.756 . . . . 0.0 112.8 177.052 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 14.1 t -69.15 -50.69 50.68 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 C-N-CA 123.807 0.843 . . . . 0.0 111.655 173.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 25.3 t -88.56 145.07 25.92 Favored 'General case' 0 CA--C 1.558 1.259 0 C-N-CA 123.341 0.656 . . . . 0.0 110.211 173.062 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 84.7 mtt85 -69.95 -50.39 42.43 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 177.799 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 21.0 m120 -72.84 -55.59 6.44 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 113.445 0.906 . . . . 0.0 113.445 174.031 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -83.26 146.7 28.41 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-N 118.978 0.808 . . . . 0.0 111.432 -177.204 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 60.5 mt-30 -86.02 94.78 9.31 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.337 0.589 . . . . 0.0 109.607 176.007 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 44.1 mm -114.44 133.18 61.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 -174.802 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -127.56 117.88 22.9 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 -169.763 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 14.1 tp -80.55 125.57 30.14 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 124.442 1.097 . . . . 0.0 113.952 -168.79 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 32.5 mmt180 -138.05 160.19 40.02 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 124.085 0.954 . . . . 0.0 110.525 -170.469 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -73.91 152.98 40.01 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.607 -1.308 . . . . 0.0 112.924 177.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.1 pp -66.55 159.73 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 -179.303 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 . . . . . 0 N--CA 1.485 1.299 0 CA-C-O 123.981 1.848 . . . . 0.0 108.584 -176.89 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . 0.253 1.6 p90 . . . . . 0 N--CA 1.488 1.448 0 CA-C-O 118.257 -0.878 . . . . 0.0 113.038 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -82.53 141.09 32.91 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 120.598 1.544 . . . . 0.0 112.345 -171.043 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -118.83 -71.91 0.71 Allowed 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 115.087 -0.96 . . . . 0.0 109.127 174.571 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 104.22 95.94 2.38 Favored Glycine 0 N--CA 1.481 1.658 0 CA-C-N 119.195 0.907 . . . . 0.0 111.655 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . 0.312 94.9 mttt 63.35 71.03 0.52 Allowed 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 124.615 1.166 . . . . 0.0 114.027 -178.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 26.1 pt -122.8 150.53 58.87 Favored Pre-proline 0 CA--C 1.576 1.948 0 C-N-CA 124.284 1.034 . . . . 0.0 108.646 170.01 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -72.42 163.97 37.0 Favored 'Trans proline' 0 CA--C 1.562 1.881 0 C-N-CA 122.825 2.35 . . . . 0.0 114.128 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 58.6 ttt180 -63.08 -41.78 99.5 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 115.592 1.701 . . . . 0.0 115.592 179.051 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.41 -46.31 83.81 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 115.305 1.594 . . . . 0.0 115.305 177.306 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -63.22 -35.33 79.98 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 115.346 1.61 . . . . 0.0 115.346 169.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.78 -44.72 95.45 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 115.42 1.637 . . . . 0.0 115.42 169.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -61.92 -40.73 96.5 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 115.213 1.56 . . . . 0.0 115.213 170.249 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -61.48 -50.34 73.12 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 114.895 1.442 . . . . 0.0 114.895 173.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -62.88 -43.98 97.34 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 115.02 1.489 . . . . 0.0 115.02 176.447 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 8.5 mp -65.19 -42.51 93.54 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 114.826 1.417 . . . . 0.0 114.826 172.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 67.5 m -54.98 -36.67 65.65 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 115.87 1.804 . . . . 0.0 115.87 169.713 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -63.34 -35.49 80.56 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 115.26 1.578 . . . . 0.0 115.26 169.465 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -63.21 126.86 28.8 Favored 'General case' 0 CA--C 1.557 1.228 0 CA-C-O 122.839 1.304 . . . . 0.0 112.61 172.393 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 14.5 ptp180 -67.45 -16.53 64.27 Favored 'General case' 0 CA--C 1.567 1.627 0 N-CA-C 119.026 2.973 . . . . 0.0 119.026 175.283 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 48.2 m80 -89.55 142.33 27.77 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 119.6 1.091 . . . . 0.0 113.281 -168.6 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -75.94 127.37 32.85 Favored 'General case' 0 N--CA 1.489 1.475 0 CA-C-N 115.014 -0.994 . . . . 0.0 108.632 169.642 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.45 4.31 66.18 Favored Glycine 0 CA--C 1.555 2.539 0 CA-C-O 117.278 -1.845 . . . . 0.0 117.621 -169.151 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -70.02 114.88 8.62 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 121.02 2.41 . . . . 0.0 112.73 -169.71 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 22.4 p90 -127.63 158.54 37.27 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 115.41 1.633 . . . . 0.0 115.41 -168.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.1 pp -134.99 158.21 44.93 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 124.169 0.988 . . . . 0.0 109.535 168.185 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.8 mp -114.36 113.71 44.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 104.83 -2.285 . . . . 0.0 104.83 169.535 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 46.6 ptt85 -101.3 140.68 35.26 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 123.783 0.833 . . . . 0.0 109.07 169.586 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -79.59 138.42 37.44 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.683 -0.636 . . . . 0.0 109.53 170.833 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 58.2 m -66.79 128.21 35.42 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 123.13 0.572 . . . . 0.0 111.511 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -64.92 -50.92 64.59 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 114.403 1.26 . . . . 0.0 114.403 -171.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.8 t -64.25 -40.31 95.74 Favored 'General case' 0 CA--C 1.564 1.514 0 N-CA-C 115.487 1.662 . . . . 0.0 115.487 170.518 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -111.8 95.27 27.69 Favored Pre-proline 0 CA--C 1.564 1.493 0 CA-C-N 119.32 0.964 . . . . 0.0 110.819 -177.794 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.43 129.19 16.49 Favored 'Trans proline' 0 C--N 1.372 1.768 0 C-N-CA 123.054 2.503 . . . . 0.0 111.014 169.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 108.27 -35.43 4.98 Favored Glycine 0 CA--C 1.553 2.434 0 CA-C-O 118.894 -0.948 . . . . 0.0 113.609 -168.241 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -83.79 131.91 34.87 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-N 118.63 1.215 . . . . 0.0 108.24 169.203 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -115.77 168.07 10.36 Favored 'General case' 0 CA--C 1.56 1.357 0 CA-C-O 122.083 0.945 . . . . 0.0 110.181 -177.053 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 72.8 m -145.57 112.8 6.15 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 -177.093 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 19.9 tp -88.54 104.34 16.74 Favored 'General case' 0 CA--C 1.561 1.393 0 C-N-CA 124.654 1.181 . . . . 0.0 109.429 177.253 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.8 m -82.56 119.15 23.89 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 124.879 1.272 . . . . 0.0 108.065 173.591 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 24.0 t -129.36 122.84 56.66 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.193 0 CA-C-N 120.805 1.638 . . . . 0.0 107.782 -175.029 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 59.4 tttp -80.4 138.62 36.67 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.458 169.47 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -150.34 105.88 3.39 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 169.719 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 83.76 -106.75 2.88 Favored Glycine 0 CA--C 1.54 1.61 0 N-CA-C 110.894 -0.882 . . . . 0.0 110.894 -174.495 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 21.3 m120 -133.9 63.74 1.62 Allowed 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 169.549 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -160.77 127.67 4.17 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 123.522 0.729 . . . . 0.0 109.481 175.585 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 99.9 t -103.57 106.39 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 177.598 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -107.16 131.3 54.3 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.876 0.87 . . . . 0.0 110.82 -176.546 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 21.8 m-70 -103.33 107.66 18.58 Favored 'General case' 0 CA--C 1.552 1.019 0 C-N-CA 123.649 0.78 . . . . 0.0 109.598 -169.328 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -91.33 131.55 36.75 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 115.111 -0.95 . . . . 0.0 108.6 175.705 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 38.3 mtmm -80.52 117.1 20.94 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.239 0.542 . . . . 0.0 109.628 178.195 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 95.6 t -94.48 98.33 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 N-CA-C 105.994 -1.854 . . . . 0.0 105.994 176.658 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -97.14 140.26 31.9 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 178.257 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 53.3 mtm180 -100.0 133.35 44.51 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 122.673 0.389 . . . . 0.0 110.88 -176.806 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . 0.253 4.7 p-10 -80.0 -66.53 0.86 Allowed 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 176.085 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -94.51 -116.83 2.86 Favored Glycine 0 CA--C 1.541 1.661 0 CA-C-N 119.067 0.848 . . . . 0.0 112.211 -177.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -86.62 -83.11 0.19 Allowed 'General case' 0 N--CA 1.487 1.385 0 CA-C-O 118.441 -0.79 . . . . 0.0 110.028 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -109.71 78.91 0.24 Allowed Glycine 0 N--CA 1.479 1.565 0 N-CA-C 109.971 -1.252 . . . . 0.0 109.971 169.832 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -131.17 78.54 1.84 Allowed 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 -174.269 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -80.36 119.42 23.06 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 124.114 0.966 . . . . 0.0 111.402 -169.216 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 10.5 p90 -139.64 123.08 17.18 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 122.49 0.316 . . . . 0.0 110.155 -178.257 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -112.61 -37.82 4.8 Favored 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 123.61 0.764 . . . . 0.0 112.634 168.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 51.0 t90 -84.04 -86.17 0.12 Allowed 'General case' 0 CA--C 1.56 1.344 0 C-N-CA 124.805 1.242 . . . . 0.0 109.272 -175.77 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . 0.258 6.1 m -139.88 -61.02 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 C-N-CA 123.833 0.853 . . . . 0.0 109.836 173.356 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.3 p -79.97 140.73 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 CA-C-N 119.094 0.861 . . . . 0.0 111.203 -176.122 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.97 156.93 24.44 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 -179.264 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -139.45 120.6 14.72 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 -169.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 66.7 m-80 -61.25 -39.91 92.1 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 116.566 2.062 . . . . 0.0 116.566 -173.228 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 66.6 m -123.75 160.38 27.42 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-O 121.882 0.849 . . . . 0.0 111.898 -176.434 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 98.1 mt -84.39 86.51 7.26 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 169.211 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 167.32 -58.56 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 104.087 -2.56 . . . . 0.0 104.087 -168.713 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -58.75 -44.87 90.66 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 124.379 1.071 . . . . 0.0 113.72 168.674 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 8.6 tt -57.25 -50.34 73.19 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 114.722 1.379 . . . . 0.0 114.722 169.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 1.7 m -66.01 -49.11 79.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -178.109 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -67.92 -35.18 78.01 Favored 'General case' 0 CA--C 1.566 1.594 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 -178.632 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 79.8 t80 -61.11 -55.18 35.52 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-N 119.894 1.225 . . . . 0.0 112.083 169.103 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . 0.258 76.3 m-70 -68.68 -8.85 46.25 Favored 'General case' 0 CA--C 1.566 1.577 0 N-CA-C 117.797 2.517 . . . . 0.0 117.797 175.352 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 5.9 ttm180 -58.37 -28.1 64.82 Favored 'General case' 0 CA--C 1.579 2.069 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 167.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 70.0 m -114.16 -30.82 6.52 Favored 'General case' 0 CA--C 1.57 1.745 0 C-N-CA 125.341 1.456 . . . . 0.0 113.639 169.035 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 32.4 m -90.32 152.33 21.07 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-N 120.753 1.615 . . . . 0.0 110.532 176.37 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 20.5 t -82.04 131.31 35.24 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 120.628 -1.295 . . . . 0.0 112.971 -179.441 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -66.2 -45.09 91.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 169.548 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 22.0 t -79.67 -32.2 41.46 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 115.584 1.698 . . . . 0.0 115.584 177.367 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . 0.336 15.9 ttt180 91.88 -66.64 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 124.926 1.29 . . . . 0.0 111.92 179.308 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -69.52 -54.7 12.9 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 172.888 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -79.87 140.49 36.75 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-N 118.619 0.645 . . . . 0.0 110.358 171.039 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 3.3 tm0? -87.41 109.41 19.55 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 123.054 0.542 . . . . 0.0 109.564 178.387 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 5.2 mp -133.3 121.78 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 172.674 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 21.6 m-30 -115.16 144.73 43.23 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.745 0.783 . . . . 0.0 109.747 173.747 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 10.1 mp -90.22 121.97 32.72 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 113.372 0.879 . . . . 0.0 113.372 -169.29 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -119.62 140.47 50.55 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 124.373 1.069 . . . . 0.0 108.388 169.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -70.39 147.21 49.8 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 -176.036 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 15.4 pt -67.49 154.31 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 N-CA-C 113.658 0.985 . . . . 0.0 113.658 -178.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 . . . . . 0 N--CA 1.484 1.269 0 CA-C-O 122.827 1.298 . . . . 0.0 110.013 -174.999 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 63.7 p-90 . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 115.246 1.573 . . . . 0.0 115.246 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 29.9 t80 -84.25 131.98 34.68 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-N 119.801 1.182 . . . . 0.0 110.884 -175.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -117.38 -58.92 2.0 Allowed 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 114.815 -1.084 . . . . 0.0 109.735 174.17 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 104.4 87.65 2.01 Favored Glycine 0 N--CA 1.479 1.543 0 CA-C-N 119.043 0.838 . . . . 0.0 111.972 172.149 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 68.9 tttt 66.85 69.68 0.4 Allowed 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 124.062 0.945 . . . . 0.0 113.24 178.373 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 25.4 pt -121.14 148.87 50.24 Favored Pre-proline 0 CA--C 1.574 1.892 0 C-N-CA 123.957 0.903 . . . . 0.0 109.024 175.241 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -70.9 161.48 45.95 Favored 'Trans proline' 0 CA--C 1.559 1.774 0 C-N-CA 122.933 2.422 . . . . 0.0 114.519 -177.603 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 56.9 ttt180 -65.16 -40.9 94.97 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 115.786 1.773 . . . . 0.0 115.786 -176.765 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.74 -46.47 82.08 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 115.34 1.607 . . . . 0.0 115.34 179.593 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 55.5 mtmt -63.55 -34.52 77.98 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 115.037 1.495 . . . . 0.0 115.037 169.631 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.5 -43.44 90.11 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 115.484 1.661 . . . . 0.0 115.484 170.326 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -63.64 -42.88 98.08 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 115.09 1.515 . . . . 0.0 115.09 172.467 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -63.48 -48.13 78.93 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 114.917 1.451 . . . . 0.0 114.917 175.257 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -65.52 -43.8 88.89 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 114.756 1.391 . . . . 0.0 114.756 176.457 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 85.7 mt -67.35 -40.52 85.83 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 116.228 1.936 . . . . 0.0 116.228 175.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 91.1 p -56.33 -30.47 62.62 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 116.951 2.204 . . . . 0.0 116.951 171.049 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -66.15 -30.66 71.19 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 116.378 1.992 . . . . 0.0 116.378 170.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -59.64 142.66 52.46 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-O 123.024 1.392 . . . . 0.0 113.577 176.395 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.413 ' HD3' ' H ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -70.28 -15.93 62.96 Favored 'General case' 0 CA--C 1.568 1.659 0 N-CA-C 118.129 2.64 . . . . 0.0 118.129 170.309 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 31.4 m80 -89.43 132.66 34.9 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-N 119.996 1.271 . . . . 0.0 111.137 -169.239 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -81.29 106.77 13.52 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 169.758 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 115.82 8.41 13.84 Favored Glycine 0 CA--C 1.557 2.707 0 CA-C-O 116.838 -2.09 . . . . 0.0 116.388 -168.494 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.44 111.23 3.97 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-N 121.639 2.719 . . . . 0.0 112.331 -170.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 28.5 p90 -118.19 155.92 29.66 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 116.509 2.041 . . . . 0.0 116.509 -168.255 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.4 pp -148.18 138.68 22.86 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 123.31 0.644 . . . . 0.0 109.972 169.266 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 81.6 mt -90.17 117.79 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 169.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 4.9 ptm180 -111.23 145.72 38.23 Favored 'General case' 0 N--CA 1.487 1.388 0 CA-C-N 114.102 -1.408 . . . . 0.0 108.708 169.523 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -79.38 143.93 34.64 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.342 -0.849 . . . . 0.0 109.779 172.163 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 7.9 t -73.72 8.38 1.95 Allowed 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 119.556 3.169 . . . . 0.0 119.556 -169.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . 0.357 5.9 mp0 74.45 -72.0 0.12 Allowed 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 125.542 1.537 . . . . 0.0 113.654 175.018 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 65.9 m -64.3 -40.71 96.49 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 115.934 1.828 . . . . 0.0 115.934 178.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -111.95 102.41 53.65 Favored Pre-proline 0 CA--C 1.563 1.471 0 CA-C-O 118.077 -0.964 . . . . 0.0 109.49 174.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -58.86 -32.09 96.6 Favored 'Trans proline' 0 C--N 1.37 1.697 0 N-CA-C 119.751 2.943 . . . . 0.0 119.751 174.545 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -86.76 43.17 3.21 Favored Glycine 0 CA--C 1.554 2.475 0 N-CA-C 115.359 0.903 . . . . 0.0 115.359 169.245 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -153.83 116.45 4.42 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 105.502 -2.036 . . . . 0.0 105.502 177.006 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -96.19 172.1 8.18 Favored 'General case' 0 CA--C 1.559 1.323 0 CA-C-O 122.245 1.021 . . . . 0.0 110.746 174.558 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 71.4 m -146.72 108.33 4.31 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 -176.626 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 32.5 tp -79.73 117.79 20.95 Favored 'General case' 0 CA--C 1.559 1.312 0 CA-C-O 121.834 0.826 . . . . 0.0 108.925 173.747 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 18.9 m -104.78 90.46 3.49 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 -172.478 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 10.0 t -101.09 119.24 48.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 N-CA-C 107.389 -1.338 . . . . 0.0 107.389 -170.711 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -79.64 134.65 36.44 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.042 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -137.9 109.64 7.1 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 -179.105 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 78.62 -93.19 1.24 Allowed Glycine 0 N--CA 1.487 2.075 0 N-CA-C 111.838 -0.505 . . . . 0.0 111.838 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 15.7 t30 -149.31 45.38 0.97 Allowed 'General case' 0 CA--C 1.573 1.848 0 C-N-CA 123.295 0.638 . . . . 0.0 110.616 168.185 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -157.6 134.49 10.04 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 178.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 24.6 t -103.91 121.88 55.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -169.583 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 66.3 mt-30 -94.06 120.76 34.77 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 175.325 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 10.2 m-70 -98.86 95.46 7.2 Favored 'General case' 0 CA--C 1.55 0.971 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 -174.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -86.66 125.0 33.56 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-N 114.862 -1.063 . . . . 0.0 108.211 177.535 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -81.18 125.63 30.51 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-O 121.657 0.742 . . . . 0.0 111.586 -175.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 72.5 t -86.75 106.7 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 173.487 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.9 pp -114.34 144.67 42.89 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 123.248 0.619 . . . . 0.0 110.903 -176.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -96.99 151.63 19.52 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -169.797 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . 0.252 4.4 p-10 -100.64 -65.42 0.97 Allowed 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 123.676 0.79 . . . . 0.0 111.62 169.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -94.02 -123.25 3.68 Favored Glycine 0 CA--C 1.543 1.787 0 CA-C-N 119.468 1.031 . . . . 0.0 112.874 -177.275 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -76.48 -65.49 0.92 Allowed 'General case' 0 N--CA 1.489 1.521 0 CA-C-O 118.833 -0.603 . . . . 0.0 112.041 177.558 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -135.51 61.61 0.62 Allowed Glycine 0 CA--C 1.542 1.772 0 N-CA-C 111.391 -0.683 . . . . 0.0 111.391 169.328 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -106.69 92.44 4.1 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 105.75 -1.944 . . . . 0.0 105.75 -179.182 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -82.41 116.7 22.0 Favored 'General case' 0 N--CA 1.484 1.228 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.61 -169.345 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 15.1 p90 -129.51 125.06 35.48 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-O 121.83 0.824 . . . . 0.0 109.631 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 6.0 tt -104.77 -61.63 1.44 Allowed 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 114.966 -1.016 . . . . 0.0 109.657 176.235 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 25.6 t90 -83.9 -82.04 0.17 Allowed 'General case' 0 CA--C 1.557 1.218 0 C-N-CA 124.36 1.064 . . . . 0.0 111.41 -169.382 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . 0.25 7.2 m -136.67 -58.78 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 CA-C-N 118.926 0.785 . . . . 0.0 110.378 176.21 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 13.7 m -79.82 142.02 14.52 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.382 0 C-N-CA 124.085 0.954 . . . . 0.0 111.406 -177.197 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -79.95 150.35 30.53 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 -176.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -131.77 113.72 13.87 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 -169.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 11.3 p30 -54.97 -42.67 72.67 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 117.297 2.332 . . . . 0.0 117.297 -177.596 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 98.6 p -117.53 163.61 16.16 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-O 122.266 1.031 . . . . 0.0 111.404 175.316 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 70.2 mt -66.18 -31.24 71.96 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 114.773 1.397 . . . . 0.0 114.773 169.704 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -64.14 -43.26 95.78 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-N 119.468 1.031 . . . . 0.0 113.635 169.291 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -58.74 -40.04 82.65 Favored 'General case' 0 CA--C 1.568 1.637 0 N-CA-C 115.125 1.528 . . . . 0.0 115.125 169.521 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 8.7 tt -61.24 -51.42 69.01 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 114.62 1.341 . . . . 0.0 114.62 173.605 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 22.7 m -64.59 -51.23 70.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 N-CA-C 113.461 0.911 . . . . 0.0 113.461 176.507 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -64.44 -34.34 77.97 Favored 'General case' 0 CA--C 1.564 1.508 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 -176.683 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -60.7 -52.15 66.35 Favored 'General case' 0 CA--C 1.567 1.61 0 CA-C-N 119.37 0.986 . . . . 0.0 111.471 168.195 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . 0.255 59.4 m-70 -70.12 -9.25 54.96 Favored 'General case' 0 CA--C 1.565 1.552 0 N-CA-C 118.143 2.646 . . . . 0.0 118.143 176.643 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 90.0 mtt180 -61.53 -30.41 70.62 Favored 'General case' 0 CA--C 1.576 1.97 0 CA-C-N 120.42 1.463 . . . . 0.0 113.025 167.301 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 70.3 m -102.11 -40.53 6.78 Favored 'General case' 0 CA--C 1.567 1.623 0 C-N-CA 124.934 1.294 . . . . 0.0 113.633 169.149 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 44.1 m -90.58 156.44 18.15 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-N 120.061 1.3 . . . . 0.0 111.533 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 33.1 t -84.6 134.55 34.39 Favored 'General case' 0 N--CA 1.485 1.312 0 O-C-N 120.654 -1.278 . . . . 0.0 113.904 -175.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -73.16 -43.73 57.17 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.751 0 C-N-CA 123.939 0.896 . . . . 0.0 112.28 168.477 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 22.8 t -79.48 138.2 37.48 Favored 'General case' 0 CA--C 1.559 1.309 0 CA-C-N 119.367 0.985 . . . . 0.0 111.142 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -70.63 -56.19 7.04 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 -172.014 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -73.51 -66.16 0.73 Allowed 'General case' 0 N--CA 1.489 1.518 0 CA-C-N 119.151 0.887 . . . . 0.0 112.439 -179.261 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -87.77 141.73 28.37 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.304 0.641 . . . . 0.0 110.73 -178.785 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -84.13 104.63 14.35 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 122.848 0.459 . . . . 0.0 111.458 -178.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.54 138.91 52.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 178.773 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -122.35 158.31 29.9 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 121.989 0.899 . . . . 0.0 113.183 -168.562 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 9.3 mp -87.59 133.91 33.72 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 124.129 0.972 . . . . 0.0 111.925 -175.081 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 59.5 mmt-85 -129.58 138.21 51.16 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 124.391 1.077 . . . . 0.0 108.517 176.089 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -74.8 148.42 40.35 Favored 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 121.843 0.83 . . . . 0.0 112.402 -178.077 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 19.4 pt -69.66 167.6 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 -169.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 . . . . . 0 N--CA 1.486 1.326 0 CA-C-O 123.902 1.811 . . . . 0.0 109.124 173.045 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 65.3 p-90 . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 116.307 1.965 . . . . 0.0 116.307 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -83.33 125.95 32.18 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-N 119.878 1.217 . . . . 0.0 110.625 -173.694 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -105.6 -73.88 0.67 Allowed 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 171.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 87.32 125.13 2.0 Favored Glycine 0 CA--C 1.541 1.712 0 CA-C-N 119.458 1.026 . . . . 0.0 112.778 176.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . 0.318 20.0 tptm 76.32 -13.15 0.94 Allowed 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 117.313 2.338 . . . . 0.0 117.313 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 20.3 tt -61.92 131.47 93.17 Favored Pre-proline 0 CA--C 1.575 1.93 0 CA-C-N 120.999 1.727 . . . . 0.0 112.231 174.129 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -53.7 166.52 1.32 Allowed 'Trans proline' 0 CA--C 1.556 1.618 0 C-N-CA 123.597 2.865 . . . . 0.0 117.394 174.684 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 59.8 ttt180 -64.98 -42.62 94.39 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 169.768 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -68.01 -42.48 80.61 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 115.673 1.731 . . . . 0.0 115.673 175.731 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -66.6 -36.05 81.69 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 115.257 1.577 . . . . 0.0 115.257 170.044 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.9 -46.14 86.19 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 115.201 1.556 . . . . 0.0 115.201 170.238 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -59.15 -45.28 91.4 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 114.964 1.468 . . . . 0.0 114.964 169.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -61.24 -47.54 85.57 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 115.119 1.526 . . . . 0.0 115.119 176.442 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -64.87 -36.36 84.1 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 115.909 1.818 . . . . 0.0 115.909 174.154 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.3 mp -90.13 -22.68 21.64 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 116.717 2.117 . . . . 0.0 116.717 -178.148 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 74.4 m -64.31 -44.02 92.87 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 120.946 1.703 . . . . 0.0 115.481 177.706 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . 0.26 0.0 OUTLIER -68.96 -21.82 64.15 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 116.763 2.135 . . . . 0.0 116.763 174.216 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -60.92 135.36 57.76 Favored 'General case' 0 N--CA 1.484 1.226 0 CA-C-N 120.268 1.395 . . . . 0.0 112.014 172.759 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -78.87 -19.08 52.8 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 117.872 2.545 . . . . 0.0 117.872 179.146 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 41.5 m80 -89.84 115.07 26.89 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 119.472 1.033 . . . . 0.0 111.607 -168.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.05 113.43 6.42 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 123.877 0.871 . . . . 0.0 110.211 179.276 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 114.6 -8.11 22.19 Favored Glycine 0 CA--C 1.546 2.0 0 CA-C-O 116.524 -2.264 . . . . 0.0 117.118 -169.445 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -75.76 110.88 10.56 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-N 121.789 2.794 . . . . 0.0 109.951 -173.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 16.4 p90 -120.51 163.0 18.61 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 115.164 1.542 . . . . 0.0 115.164 -168.387 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.2 pp -138.02 134.61 35.02 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-N 114.452 -1.249 . . . . 0.0 108.227 167.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 76.8 mt -91.4 106.79 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 170.017 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 51.8 ptt85 -88.25 157.39 18.79 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 123.429 0.692 . . . . 0.0 111.723 170.04 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -86.6 137.59 32.37 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 169.684 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 18.3 t -77.41 89.32 3.79 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.474 0.71 . . . . 0.0 111.984 -170.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . 0.341 45.4 mt-10 72.65 -89.78 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 125.311 1.444 . . . . 0.0 107.866 -169.357 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 21.5 t -152.55 61.46 0.81 Allowed 'General case' 0 CA--C 1.561 1.402 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 168.69 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -117.75 99.83 52.28 Favored Pre-proline 0 CA--C 1.56 1.341 0 CA-C-O 117.726 -1.131 . . . . 0.0 108.683 -179.042 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -71.9 128.81 14.53 Favored 'Trans proline' 0 C--N 1.371 1.736 0 C-N-CA 122.959 2.439 . . . . 0.0 111.761 179.445 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 104.28 -45.9 1.26 Allowed Glycine 0 CA--C 1.551 2.3 0 CA-C-N 114.964 -1.016 . . . . 0.0 112.575 -168.009 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -87.17 101.65 13.7 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 172.614 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -113.28 170.69 8.04 Favored 'General case' 0 CA--C 1.562 1.442 0 CA-C-O 121.887 0.851 . . . . 0.0 110.075 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 74.2 m -134.52 115.6 14.1 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 175.421 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 19.2 tp -79.87 109.35 14.2 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 124.553 1.141 . . . . 0.0 109.155 176.741 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 9.8 m -105.05 88.78 2.96 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 115.01 -0.995 . . . . 0.0 108.699 -169.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 13.1 t -103.57 127.59 57.46 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -170.737 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.14 142.38 41.63 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 173.342 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -152.81 103.98 2.82 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 174.604 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 84.95 -87.53 1.56 Allowed Glycine 0 CA--C 1.542 1.731 0 N-CA-C 112.043 -0.423 . . . . 0.0 112.043 -175.553 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -137.29 -27.78 0.95 Allowed 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 169.634 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -85.8 140.13 30.71 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.919 0.887 . . . . 0.0 110.387 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 51.8 t -103.84 119.3 52.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 -176.021 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 -97.12 118.71 34.15 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.826 0.85 . . . . 0.0 109.547 -174.79 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -100.43 108.65 20.7 Favored 'General case' 0 CA--C 1.553 1.067 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 -173.089 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -109.06 123.45 49.17 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 -173.411 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 19.7 tptm -78.93 124.55 28.35 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-O 121.794 0.807 . . . . 0.0 111.574 -171.434 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 40.0 t -97.32 106.67 18.85 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.447 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 178.591 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 64.7 mt -97.68 175.05 6.33 Favored 'General case' 0 CA--C 1.565 1.545 0 C-N-CA 124.163 0.985 . . . . 0.0 112.198 -175.27 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 15.4 mmt85 -123.68 136.45 54.48 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 123.794 0.838 . . . . 0.0 112.169 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 25.5 p-10 -136.66 123.8 21.7 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 124.067 0.947 . . . . 0.0 109.036 173.136 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 95.19 -125.62 8.43 Favored Glycine 0 CA--C 1.542 1.755 0 C-N-CA 123.01 0.338 . . . . 0.0 112.961 177.651 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -88.72 -78.98 0.32 Allowed 'General case' 0 N--CA 1.488 1.452 0 CA-C-O 118.595 -0.717 . . . . 0.0 110.683 -178.496 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -137.42 63.04 0.58 Allowed Glycine 0 N--CA 1.482 1.731 0 CA-C-N 118.831 0.741 . . . . 0.0 112.244 169.726 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -120.72 113.61 20.45 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 106.347 -1.723 . . . . 0.0 106.347 -170.108 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -89.78 128.35 36.12 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.666 0.786 . . . . 0.0 111.756 -169.508 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 23.7 p90 -124.48 128.79 49.51 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 175.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 8.3 tt -86.31 -63.96 1.23 Allowed 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 118.788 -0.625 . . . . 0.0 110.147 169.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 17.0 m0 -76.82 -71.34 0.4 Allowed 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 118.754 0.706 . . . . 0.0 111.689 178.163 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 11.6 p -156.47 -52.41 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 C-N-CA 124.744 1.218 . . . . 0.0 109.898 -170.733 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 10.9 p -79.13 138.0 20.82 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.427 0 C-N-CA 124.351 1.061 . . . . 0.0 110.431 -176.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -79.76 155.29 27.99 Favored 'General case' 0 CA--C 1.559 1.289 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 -171.228 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -140.97 104.64 4.71 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 103.955 -2.609 . . . . 0.0 103.955 -174.281 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . 0.268 8.0 p-10 -47.71 -51.33 22.34 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 118.788 2.884 . . . . 0.0 118.788 -169.579 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 66.5 m -101.81 163.79 12.07 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-O 122.316 1.055 . . . . 0.0 111.476 176.44 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 15.4 tp -66.02 -37.89 87.03 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 169.259 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -65.59 -33.83 76.82 Favored 'General case' 0 CA--C 1.573 1.829 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 168.513 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -62.15 -42.74 99.55 Favored 'General case' 0 CA--C 1.566 1.591 0 CA-C-N 120.63 1.559 . . . . 0.0 114.943 169.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 7.8 tt -60.37 -45.03 94.96 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 169.72 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 29.4 t -55.04 -61.33 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 C-N-CA 124.43 1.092 . . . . 0.0 112.63 169.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -58.69 -34.75 71.63 Favored 'General case' 0 CA--C 1.568 1.652 0 N-CA-C 115.701 1.741 . . . . 0.0 115.701 -177.013 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 90.5 t80 -57.64 -56.12 25.97 Favored 'General case' 0 CA--C 1.564 1.512 0 CA-C-O 118.119 -0.943 . . . . 0.0 112.605 169.033 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . 0.319 52.3 m-70 -71.81 -9.08 57.79 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 117.875 2.546 . . . . 0.0 117.875 175.871 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 95.8 mtt-85 -65.39 -32.97 74.88 Favored 'General case' 0 CA--C 1.576 1.951 0 CA-C-N 120.702 1.592 . . . . 0.0 112.396 166.795 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 68.6 m -95.15 -40.26 9.69 Favored 'General case' 0 CA--C 1.563 1.476 0 N-CA-C 114.586 1.328 . . . . 0.0 114.586 170.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 93.6 m -90.82 149.09 22.1 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 124.747 1.219 . . . . 0.0 111.069 176.794 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 28.7 p -78.25 134.26 37.58 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.2 -0.938 . . . . 0.0 111.929 174.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 3.4 t -65.73 -52.33 51.47 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 C-N-CA 122.928 0.491 . . . . 0.0 111.091 173.288 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 74.2 m -98.89 143.08 29.6 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.638 0.732 . . . . 0.0 109.36 169.863 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 7.9 mpt_? -73.17 -51.73 16.75 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -177.305 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -68.06 -59.47 3.23 Favored 'General case' 0 N--CA 1.495 1.775 0 CA-C-N 119.199 0.909 . . . . 0.0 113.229 177.578 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -81.72 113.86 19.98 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 170.086 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -80.15 101.1 8.59 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 122.753 0.421 . . . . 0.0 111.244 -171.044 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 11.8 mm -100.14 106.29 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -169.369 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -112.88 127.4 56.18 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -179.47 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 9.7 mp -76.24 131.28 39.19 Favored 'General case' 0 CA--C 1.561 1.402 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 -169.072 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 61.7 ttt-85 -136.24 148.56 48.12 Favored 'General case' 0 CA--C 1.563 1.459 0 C-N-CA 125.258 1.423 . . . . 0.0 108.443 177.421 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -65.33 164.8 12.87 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 120.526 -1.359 . . . . 0.0 113.211 171.615 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.3 pp -64.19 162.59 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 -174.153 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 . . . . . 0 N--CA 1.488 1.444 0 CA-C-O 122.841 1.305 . . . . 0.0 110.488 174.472 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . 0.262 1.6 p90 . . . . . 0 CA--C 1.56 1.341 0 CA-C-O 118.147 -0.93 . . . . 0.0 112.857 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -84.33 137.07 33.63 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 120.409 1.459 . . . . 0.0 111.407 -178.677 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -99.84 -92.5 0.28 Allowed 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 175.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 146.61 85.29 0.06 OUTLIER Glycine 0 N--CA 1.479 1.554 0 CA-C-N 119.438 1.017 . . . . 0.0 111.605 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 26.1 tptp 64.69 69.97 0.49 Allowed 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 124.168 0.987 . . . . 0.0 113.176 174.5 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 27.3 pt -125.0 149.29 62.83 Favored Pre-proline 0 CA--C 1.573 1.863 0 C-N-CA 123.793 0.837 . . . . 0.0 109.666 -179.375 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -75.07 171.34 18.5 Favored 'Trans proline' 0 CA--C 1.558 1.709 0 C-N-CA 122.93 2.42 . . . . 0.0 114.581 -178.231 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 57.0 ttt180 -65.26 -42.49 93.19 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 114.77 1.396 . . . . 0.0 114.77 176.296 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.14 -42.63 96.73 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 115.76 1.763 . . . . 0.0 115.76 176.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 14.6 tmtt? -65.37 -38.5 90.24 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 169.528 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.89 -46.6 84.16 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 115.314 1.598 . . . . 0.0 115.314 172.384 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -60.62 -40.97 93.84 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 115.16 1.541 . . . . 0.0 115.16 170.264 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -58.55 -56.46 21.86 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 171.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 45.7 tpp -56.71 -47.67 79.43 Favored 'General case' 0 CA--C 1.564 1.485 0 N-CA-C 115.683 1.735 . . . . 0.0 115.683 178.025 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 74.8 mt -68.04 -30.94 70.27 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 116.456 2.021 . . . . 0.0 116.456 175.057 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 21.8 t -62.96 -33.05 74.56 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 115.606 1.706 . . . . 0.0 115.606 169.537 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -62.46 -37.26 85.23 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 115.748 1.759 . . . . 0.0 115.748 170.151 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -61.05 139.44 58.07 Favored 'General case' 0 CA--C 1.556 1.18 0 N-CA-C 115.115 1.524 . . . . 0.0 115.115 -175.055 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 15.7 ptp180 -70.59 -21.0 62.72 Favored 'General case' 0 CA--C 1.568 1.635 0 N-CA-C 118.404 2.742 . . . . 0.0 118.404 174.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 49.5 m80 -89.21 144.97 25.72 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 119.575 1.08 . . . . 0.0 112.667 -168.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -78.09 114.99 17.48 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 123.635 0.774 . . . . 0.0 109.944 175.503 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 82.57 33.12 25.86 Favored Glycine 0 CA--C 1.548 2.137 0 CA-C-O 118.387 -1.23 . . . . 0.0 115.36 -168.711 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.99 113.64 6.56 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 118.949 1.374 . . . . 0.0 110.211 178.794 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 22.2 p90 -123.37 155.52 37.18 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 115.005 1.483 . . . . 0.0 115.005 -168.437 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.2 pp -142.02 143.84 33.35 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.895 0.878 . . . . 0.0 108.945 168.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.4 mp -94.55 119.6 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 N-CA-C 105.704 -1.962 . . . . 0.0 105.704 169.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 49.4 ptt85 -103.14 158.2 16.47 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 123.503 0.721 . . . . 0.0 111.135 169.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -90.02 126.61 35.82 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 169.025 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 18.0 t -65.79 139.22 58.31 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 112.878 0.695 . . . . 0.0 112.878 -173.295 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -70.54 -53.01 17.83 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 -171.437 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.6 t -62.67 -38.01 88.67 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 115.866 1.802 . . . . 0.0 115.866 172.048 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -118.69 97.28 50.68 Favored Pre-proline 0 CA--C 1.562 1.439 0 CA-C-N 119.195 0.907 . . . . 0.0 110.015 176.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_exo -57.4 -30.24 87.23 Favored 'Trans proline' 0 C--N 1.37 1.671 0 N-CA-C 119.617 2.891 . . . . 0.0 119.617 172.148 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -88.28 47.0 3.44 Favored Glycine 0 CA--C 1.552 2.395 0 N-CA-C 114.527 0.571 . . . . 0.0 114.527 168.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -160.09 125.39 4.0 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 105.906 -1.887 . . . . 0.0 105.906 -179.465 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 11.0 m-30 -95.93 172.26 8.12 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.823 0.821 . . . . 0.0 111.272 175.626 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 71.5 m -147.85 115.06 6.21 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 -179.527 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 28.7 tp -79.92 108.59 13.62 Favored 'General case' 0 N--CA 1.487 1.379 0 CA-C-O 122.29 1.043 . . . . 0.0 109.61 174.159 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 6.2 m -95.54 112.62 24.3 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 34.5 t -121.02 131.1 73.86 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.169 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 -174.666 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 28.7 tptp -76.98 100.59 5.67 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 123.309 0.644 . . . . 0.0 110.933 175.33 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -86.13 -169.16 2.51 Favored 'General case' 0 CA--C 1.572 1.817 0 CA-C-O 121.291 0.567 . . . . 0.0 109.586 173.602 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -68.48 106.58 1.78 Allowed Glycine 0 CA--C 1.544 1.877 0 O-C-N 120.692 -1.255 . . . . 0.0 113.497 179.023 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . 0.319 10.3 t30 75.23 -18.9 0.42 Allowed 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 118.192 2.664 . . . . 0.0 118.192 -175.299 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -144.33 143.36 30.94 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 120.336 1.426 . . . . 0.0 109.611 -169.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 56.2 t -90.64 113.56 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 178.666 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -94.76 122.97 37.92 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 121.601 0.715 . . . . 0.0 109.96 178.09 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 8.7 m-70 -100.19 127.1 46.53 Favored 'General case' 0 CA--C 1.552 1.046 0 CA-C-N 114.985 -1.007 . . . . 0.0 109.251 -175.126 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -119.21 126.72 52.2 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 -177.448 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 48.2 mtpt -76.27 116.4 16.93 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-O 121.182 0.515 . . . . 0.0 110.608 -177.154 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 75.9 t -85.09 98.9 6.63 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.374 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 172.598 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.8 mt -81.36 137.35 35.73 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.893 -179.395 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 78.1 mtp180 -113.38 120.68 41.92 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -174.503 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . 0.286 4.9 p-10 -85.29 -66.13 0.93 Allowed 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -88.92 -110.18 1.16 Allowed Glycine 0 N--CA 1.482 1.737 0 CA-C-N 119.331 0.968 . . . . 0.0 112.395 -176.721 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -84.6 -84.14 0.15 Allowed 'General case' 0 N--CA 1.487 1.413 0 CA-C-O 118.364 -0.827 . . . . 0.0 109.175 174.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -116.88 63.6 0.37 Allowed Glycine 0 N--CA 1.481 1.68 0 CA-C-N 118.896 0.771 . . . . 0.0 111.535 169.341 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm -101.79 87.14 3.06 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 106.017 -1.845 . . . . 0.0 106.017 -176.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 47.7 m-85 -82.78 116.85 22.3 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 114.892 -1.049 . . . . 0.0 112.64 -168.159 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -135.54 114.11 11.75 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.44 0.696 . . . . 0.0 110.144 177.68 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . 0.276 1.8 pt? -87.09 -45.45 10.7 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-O 118.758 -0.639 . . . . 0.0 112.51 168.837 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 45.3 m0 -83.57 -84.74 0.13 Allowed 'General case' 0 CA--C 1.564 1.495 0 CA-C-N 118.966 0.803 . . . . 0.0 109.436 173.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 61.0 t -141.02 -55.97 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 C-N-CA 124.32 1.048 . . . . 0.0 109.063 -174.786 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 13.6 p -79.45 128.83 38.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 C-N-CA 123.663 0.785 . . . . 0.0 110.968 -170.733 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.44 159.67 18.59 Favored 'General case' 0 N--CA 1.486 1.351 0 CA-C-O 122.53 1.157 . . . . 0.0 113.724 -175.332 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -141.84 121.5 13.41 Favored 'General case' 0 N--CA 1.484 1.242 0 CA-C-N 113.96 -1.473 . . . . 0.0 107.052 -170.564 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 36.0 m-80 -58.69 -41.4 86.18 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 115.585 1.698 . . . . 0.0 115.585 177.63 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 26.2 t -114.86 152.74 31.7 Favored 'General case' 0 N--CA 1.484 1.271 0 CA-C-O 122.069 0.937 . . . . 0.0 111.19 178.094 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 80.6 mt -63.95 -27.26 69.01 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 168.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -59.09 -39.23 81.54 Favored 'General case' 0 CA--C 1.575 1.935 0 CA-C-N 120.105 1.321 . . . . 0.0 113.923 168.527 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -70.35 -43.52 70.03 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 114.76 1.393 . . . . 0.0 114.76 171.573 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 9.9 tt -59.1 -46.21 88.89 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 115.361 1.615 . . . . 0.0 115.361 170.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 4.4 p -68.3 -48.41 73.43 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.538 0 N-CA-C 113.742 1.015 . . . . 0.0 113.742 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -56.25 -35.89 67.91 Favored 'General case' 0 CA--C 1.569 1.711 0 N-CA-C 115.182 1.549 . . . . 0.0 115.182 169.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 61.3 t80 -55.6 -55.86 27.12 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 117.26 -1.352 . . . . 0.0 113.102 169.15 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . 0.381 33.5 m-70 -73.52 -9.22 58.45 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 118.748 2.87 . . . . 0.0 118.748 175.757 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 91.2 mtt-85 -73.0 -27.06 61.57 Favored 'General case' 0 CA--C 1.581 2.137 0 CA-C-N 120.058 1.299 . . . . 0.0 112.42 166.703 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 69.6 m -97.85 -42.14 7.7 Favored 'General case' 0 CA--C 1.565 1.543 0 C-N-CA 125.012 1.325 . . . . 0.0 114.24 171.761 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 92.6 m -85.93 142.58 28.73 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 124.614 1.165 . . . . 0.0 109.717 171.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 33.5 t -72.35 121.09 18.9 Favored 'General case' 0 N--CA 1.485 1.303 0 O-C-N 121.449 -0.782 . . . . 0.0 111.113 173.454 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 11.4 p -58.33 -35.57 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 N-CA-C 115.525 1.676 . . . . 0.0 115.525 172.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 15.1 t -79.52 -28.11 41.35 Favored 'General case' 0 CA--C 1.564 1.512 0 N-CA-C 116.682 2.104 . . . . 0.0 116.682 179.233 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . 0.352 98.6 mtt180 86.65 -78.79 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 CA-C-N 120.274 1.397 . . . . 0.0 111.393 -177.287 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 70.1 m-80 -67.5 -52.82 34.56 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -79.7 152.19 30.04 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.166 0.586 . . . . 0.0 110.583 169.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -89.89 88.09 7.2 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 173.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 19.9 mm -113.13 141.39 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -146.63 145.69 30.15 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 121.946 0.879 . . . . 0.0 112.524 -168.793 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 11.2 mp -83.68 117.2 23.05 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-N 114.761 -1.109 . . . . 0.0 112.279 -169.636 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 27.2 mmm180 -109.29 137.49 47.09 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 124.304 1.042 . . . . 0.0 109.058 169.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -73.66 142.91 46.43 Favored 'General case' 0 CA--C 1.564 1.487 0 CA-C-O 121.742 0.782 . . . . 0.0 111.713 -178.332 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 17.9 pt -63.3 156.29 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 114.814 1.413 . . . . 0.0 114.814 -173.074 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 . . . . . 0 N--CA 1.483 1.213 0 CA-C-O 123.999 1.857 . . . . 0.0 109.11 179.531 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . 0.273 1.8 p90 . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 118.015 -0.993 . . . . 0.0 113.068 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -80.15 135.25 36.26 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-N 120.444 1.475 . . . . 0.0 110.263 172.307 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -121.3 -80.03 0.62 Allowed 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 179.31 -146.47 7.16 Favored Glycine 0 N--CA 1.48 1.589 0 CA-C-N 119.09 0.859 . . . . 0.0 112.012 176.761 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -85.03 88.43 7.46 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 121.533 0.682 . . . . 0.0 109.288 -179.432 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 35.8 pt -118.92 148.29 44.29 Favored Pre-proline 0 CA--C 1.573 1.832 0 C-N-CA 124.126 0.97 . . . . 0.0 109.762 -174.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -71.8 157.77 54.53 Favored 'Trans proline' 0 CA--C 1.559 1.739 0 C-N-CA 122.995 2.463 . . . . 0.0 114.325 -177.756 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 42.1 ttp85 -66.75 -41.1 88.35 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 115.113 1.523 . . . . 0.0 115.113 -179.396 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -65.75 -42.75 90.55 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 115.924 1.824 . . . . 0.0 115.924 178.428 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -67.39 -34.11 76.59 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 169.796 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.39 -43.75 96.68 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 169.461 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -60.44 -42.83 96.93 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 115.041 1.497 . . . . 0.0 115.041 169.571 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -61.7 -51.71 67.3 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 176.509 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -61.88 -46.51 89.08 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 115.091 1.515 . . . . 0.0 115.091 175.837 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 8.9 mp -66.22 -36.3 82.68 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 115.822 1.786 . . . . 0.0 115.822 175.658 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 20.9 t -56.24 -30.17 62.01 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 116.593 2.071 . . . . 0.0 116.593 169.782 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -60.67 -35.29 75.88 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 115.703 1.742 . . . . 0.0 115.703 169.77 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -67.93 129.41 39.83 Favored 'General case' 0 CA--C 1.555 1.15 0 CA-C-O 122.935 1.35 . . . . 0.0 112.499 -179.427 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 14.7 ptp180 -66.52 -17.79 65.0 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 118.912 2.93 . . . . 0.0 118.912 172.157 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 46.1 m80 -89.46 137.37 32.39 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 119.576 1.08 . . . . 0.0 111.818 -168.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -78.25 105.27 9.37 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 171.706 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 118.14 -3.65 16.33 Favored Glycine 0 CA--C 1.55 2.251 0 CA-C-O 116.198 -2.446 . . . . 0.0 116.7 -168.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.77 110.15 1.44 Allowed 'General case' 0 N--CA 1.494 1.77 0 CA-C-N 122.017 2.909 . . . . 0.0 112.231 -176.711 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 18.4 p90 -128.43 161.64 29.02 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 117.263 2.32 . . . . 0.0 117.263 -167.51 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.2 pp -143.12 151.86 41.18 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 114.233 -1.349 . . . . 0.0 108.446 168.06 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 3.8 mp -102.44 118.04 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 105.173 -2.158 . . . . 0.0 105.173 169.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 46.8 ptt85 -101.44 141.06 34.87 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.174 0.59 . . . . 0.0 110.083 169.701 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -79.89 134.96 36.33 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 169.635 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 53.5 m -72.33 139.21 47.81 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-O 121.491 0.662 . . . . 0.0 111.956 -177.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -69.96 -54.54 12.82 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -173.513 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 97.2 p -61.91 -41.95 98.52 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 115.994 1.85 . . . . 0.0 115.994 171.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -111.85 96.77 34.95 Favored Pre-proline 0 CA--C 1.562 1.405 0 CA-C-O 117.965 -1.017 . . . . 0.0 109.494 176.795 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -63.61 -26.59 69.2 Favored 'Trans proline' 0 CA--C 1.559 1.765 0 C-N-CA 122.959 2.439 . . . . 0.0 118.203 174.491 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -91.5 50.12 2.94 Favored Glycine 0 CA--C 1.553 2.422 0 CA-C-O 119.732 -0.482 . . . . 0.0 113.326 168.473 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -160.04 120.29 2.96 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 106.026 -1.842 . . . . 0.0 106.026 178.518 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 12.2 m-30 -98.63 172.2 7.64 Favored 'General case' 0 CA--C 1.565 1.55 0 CA-C-O 122.064 0.935 . . . . 0.0 111.341 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 74.3 m -148.19 112.56 5.27 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 -178.065 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 27.4 tp -85.21 105.08 15.64 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-O 122.308 1.051 . . . . 0.0 109.638 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.8 m -89.85 111.35 22.36 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 125.177 1.391 . . . . 0.0 107.816 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 22.0 t -127.46 121.19 56.6 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.161 0 CA-C-N 120.031 1.287 . . . . 0.0 107.795 -172.013 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 7.4 tmtm? -89.47 92.43 9.11 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 122.8 0.44 . . . . 0.0 110.734 177.254 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 25.3 t80 -125.1 111.18 15.03 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 68.12 71.05 1.01 Allowed Glycine 0 N--CA 1.482 1.739 0 N-CA-C 115.525 0.97 . . . . 0.0 115.525 173.139 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . 0.294 16.8 m120 70.76 -13.35 0.49 Allowed 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 118.49 2.774 . . . . 0.0 118.49 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -132.65 138.49 47.35 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 120.16 1.345 . . . . 0.0 110.159 -169.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 43.5 t -92.1 111.27 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 N-CA-C 106.045 -1.835 . . . . 0.0 106.045 171.588 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -104.34 114.8 29.27 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.84 0.856 . . . . 0.0 108.771 -170.238 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 16.7 m-70 -95.21 97.31 9.79 Favored 'General case' 0 CA--C 1.552 1.023 0 CA-C-N 114.745 -1.116 . . . . 0.0 108.417 -173.615 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -95.88 122.24 38.47 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 -176.013 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -76.37 115.85 16.5 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 121.302 0.572 . . . . 0.0 110.715 -171.042 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 84.7 t -91.45 104.5 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 60.7 mt -92.07 131.45 37.33 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.38 -174.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 78.0 mtp180 -106.64 148.2 28.62 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 122.865 0.466 . . . . 0.0 111.195 -173.7 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -137.27 129.83 29.96 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 123.029 0.531 . . . . 0.0 110.51 171.558 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 81.7 -113.58 3.67 Favored Glycine 0 CA--C 1.541 1.693 0 C-N-CA 122.971 0.32 . . . . 0.0 113.462 173.252 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -82.29 -70.37 0.55 Allowed 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 123.118 0.567 . . . . 0.0 111.102 175.669 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -159.28 71.76 0.23 Allowed Glycine 0 N--CA 1.477 1.431 0 N-CA-C 111.033 -0.827 . . . . 0.0 111.033 169.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -98.71 96.52 7.98 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 106.468 -1.679 . . . . 0.0 106.468 177.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -86.45 100.27 12.24 Favored 'General case' 0 CA--C 1.558 1.259 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.724 -169.281 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 46.3 p90 -112.87 122.51 47.86 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 123.608 0.763 . . . . 0.0 109.113 -178.269 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -134.67 -32.88 0.98 Allowed 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 114.44 1.274 . . . . 0.0 114.44 -171.542 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 46.2 t90 -114.19 -76.6 0.58 Allowed 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 124.764 1.226 . . . . 0.0 108.089 178.753 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 96.0 t -130.05 -73.57 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 -178.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.3 p -83.16 145.8 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 C-N-CA 123.514 0.726 . . . . 0.0 111.8 -173.436 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -79.72 152.51 29.84 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 121.565 0.697 . . . . 0.0 112.329 174.608 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -130.02 121.26 26.13 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -173.381 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 36.1 t30 -63.64 -50.06 70.8 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 178.096 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 28.4 t -94.0 148.45 22.15 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-O 122.024 0.916 . . . . 0.0 111.175 173.513 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 14.1 tp -68.69 -34.93 76.51 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 169.617 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 -61.44 -40.99 96.48 Favored 'General case' 0 CA--C 1.571 1.771 0 C-N-CA 123.881 0.873 . . . . 0.0 113.331 169.339 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -58.8 -43.84 90.63 Favored 'General case' 0 CA--C 1.567 1.609 0 N-CA-C 114.956 1.465 . . . . 0.0 114.956 169.483 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 9.3 tt -54.22 -47.66 71.92 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 114.217 1.191 . . . . 0.0 114.217 169.427 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 43.7 t -57.86 -60.79 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 C-N-CA 124.361 1.065 . . . . 0.0 112.78 173.691 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -61.02 -29.15 69.54 Favored 'General case' 0 CA--C 1.568 1.64 0 N-CA-C 116.806 2.15 . . . . 0.0 116.806 -176.371 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 76.4 t80 -65.4 -58.9 4.74 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-N 119.261 0.937 . . . . 0.0 112.124 169.497 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 74.2 m-70 -67.95 -9.27 43.9 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 117.832 2.531 . . . . 0.0 117.832 176.471 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 11.4 ttm180 -60.24 -30.3 69.32 Favored 'General case' 0 CA--C 1.576 1.956 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 167.768 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 70.5 m -108.93 -31.31 7.71 Favored 'General case' 0 CA--C 1.568 1.643 0 C-N-CA 124.982 1.313 . . . . 0.0 114.252 169.433 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 59.3 m -91.21 155.68 18.4 Favored 'General case' 0 N--CA 1.498 1.971 0 CA-C-N 120.664 1.575 . . . . 0.0 112.109 176.796 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 38.0 t -70.48 132.63 45.84 Favored 'General case' 0 N--CA 1.485 1.32 0 O-C-N 121.498 -0.751 . . . . 0.0 112.938 175.144 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 15.2 t -68.49 -48.16 73.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 CA-C-O 118.225 -0.893 . . . . 0.0 112.084 171.263 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 22.7 t -105.94 -113.25 0.26 Allowed 'General case' 0 CA--C 1.559 1.319 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 170.566 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 11.7 tpt180 -161.05 -41.67 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 CA-C-N 119.644 1.111 . . . . 0.0 113.275 174.373 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -60.12 -57.02 14.6 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 -176.778 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -79.76 -16.05 56.31 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 117.587 2.44 . . . . 0.0 117.587 174.191 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 59.51 77.9 0.29 Allowed 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 125.561 1.545 . . . . 0.0 111.71 -175.602 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 4.7 mp -84.28 124.23 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 -168.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -127.4 117.33 21.97 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 -176.045 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 10.8 mp -70.5 137.57 50.33 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 114.778 1.399 . . . . 0.0 114.778 -169.318 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 19.3 mmt85 -135.56 146.68 48.25 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 124.803 1.241 . . . . 0.0 107.807 179.037 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -72.28 147.28 46.55 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.702 -1.249 . . . . 0.0 112.924 179.202 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 29.6 pt -68.52 148.28 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 C-N-CA 124.133 0.973 . . . . 0.0 113.092 -178.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 . . . . . 0 N--CA 1.485 1.301 0 CA-C-O 123.872 1.796 . . . . 0.0 108.84 -174.993 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . 0.274 1.2 p90 . . . . . 0 N--CA 1.489 1.492 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -81.81 134.31 35.41 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 120.657 1.571 . . . . 0.0 111.509 -176.194 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -101.7 -90.11 0.35 Allowed 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 175.159 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 154.19 79.49 0.03 OUTLIER Glycine 0 N--CA 1.482 1.718 0 CA-C-N 119.625 1.102 . . . . 0.0 111.941 179.116 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . 0.384 65.4 pttt 43.16 59.37 2.96 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 117.514 2.413 . . . . 0.0 117.514 -173.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 23.1 pt -85.77 155.07 58.91 Favored Pre-proline 0 CA--C 1.576 1.954 0 CA-C-O 118.385 -0.817 . . . . 0.0 110.509 174.686 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -71.09 167.98 24.56 Favored 'Trans proline' 0 CA--C 1.561 1.862 0 C-N-CA 122.73 2.287 . . . . 0.0 114.107 177.343 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 53.9 ttt180 -63.65 -40.6 97.27 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 115.844 1.794 . . . . 0.0 115.844 177.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.4 -41.91 96.39 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 115.574 1.694 . . . . 0.0 115.574 173.095 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 55.7 tptt -66.86 -34.89 78.79 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 114.869 1.433 . . . . 0.0 114.869 169.493 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.37 -45.55 87.23 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 115.118 1.525 . . . . 0.0 115.118 171.177 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -65.79 -33.83 76.76 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 115.754 1.761 . . . . 0.0 115.754 169.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -57.65 -49.42 76.51 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-N 119.99 1.268 . . . . 0.0 114.24 170.431 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 45.3 tpp -61.36 -47.91 83.7 Favored 'General case' 0 CA--C 1.567 1.624 0 N-CA-C 115.919 1.822 . . . . 0.0 115.919 172.3 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 83.4 mt -89.35 -43.82 10.65 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 116.735 2.124 . . . . 0.0 116.735 -169.262 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 49.7 m -61.6 -32.1 72.2 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 115.598 1.703 . . . . 0.0 115.598 171.121 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -59.64 -43.4 93.86 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 115.706 1.743 . . . . 0.0 115.706 169.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -75.61 134.86 40.55 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-O 122.867 1.318 . . . . 0.0 111.979 177.528 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -58.95 -13.01 5.24 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 120.199 3.407 . . . . 0.0 120.199 177.659 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 50.7 m80 -89.07 127.84 35.72 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 120.008 1.276 . . . . 0.0 113.032 -168.458 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -73.31 130.18 39.63 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 123.932 0.893 . . . . 0.0 109.753 172.639 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 96.82 -6.58 64.66 Favored Glycine 0 CA--C 1.547 2.07 0 N-CA-C 118.083 1.993 . . . . 0.0 118.083 -169.706 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.06 114.52 5.28 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-N 120.658 2.229 . . . . 0.0 112.714 -169.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -124.25 156.04 37.54 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 115.093 1.516 . . . . 0.0 115.093 -168.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.9 pp -142.74 139.61 31.13 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-N 114.736 -1.12 . . . . 0.0 108.897 169.187 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.5 mp -92.84 118.78 39.26 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.436 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 173.25 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 40.0 ptt85 -108.51 134.73 50.88 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 169.662 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -79.47 139.72 37.54 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 121.581 0.705 . . . . 0.0 111.087 -177.362 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 49.1 m -72.2 124.15 24.42 Favored 'General case' 0 N--CA 1.486 1.369 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.719 173.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -75.25 -49.13 20.26 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 177.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 16.2 t -56.96 -35.07 68.68 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 116.369 1.988 . . . . 0.0 116.369 170.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -111.56 92.19 16.16 Favored Pre-proline 0 CA--C 1.564 1.486 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 169.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -72.13 133.05 20.6 Favored 'Trans proline' 0 C--N 1.372 1.803 0 C-N-CA 123.177 2.585 . . . . 0.0 112.324 -176.384 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 95.22 -35.88 4.07 Favored Glycine 0 CA--C 1.553 2.444 0 CA-C-O 119.08 -0.844 . . . . 0.0 114.297 -168.537 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -78.86 136.25 37.26 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-N 118.524 1.162 . . . . 0.0 109.467 178.04 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -106.55 172.22 6.93 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 115.254 -0.884 . . . . 0.0 111.53 -169.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 74.7 m -145.2 116.38 7.92 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 175.765 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 24.1 tp -79.88 122.58 26.84 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.638 0.775 . . . . 0.0 109.832 174.053 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 20.7 m -109.51 93.28 4.42 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 106.541 -1.651 . . . . 0.0 106.541 177.68 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.1 p -108.49 118.55 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 C-N-CA 123.72 0.808 . . . . 0.0 109.891 -171.621 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -76.71 146.6 37.92 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-N 115.285 -0.87 . . . . 0.0 112.045 172.188 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -155.03 107.46 2.73 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 171.365 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 90.61 -75.65 1.64 Allowed Glycine 0 N--CA 1.484 1.856 0 C-N-CA 122.651 0.167 . . . . 0.0 113.294 179.206 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -136.86 -45.35 0.58 Allowed 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 123.948 0.899 . . . . 0.0 113.147 173.134 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -92.94 148.29 22.13 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.37 1.068 . . . . 0.0 111.642 -169.834 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 20.8 t -99.01 120.98 49.06 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 -178.487 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 24.3 mp0 -98.29 125.01 43.22 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.935 0.894 . . . . 0.0 109.147 178.632 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 9.8 m-70 -107.44 114.27 28.17 Favored 'General case' 0 CA--C 1.552 1.033 0 CA-C-N 114.79 -1.096 . . . . 0.0 108.361 -169.801 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -122.56 125.79 46.43 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 -176.322 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -81.21 123.94 28.88 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-O 121.408 0.623 . . . . 0.0 110.881 -176.008 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 68.9 t -80.66 104.87 9.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 171.522 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 59.9 mt -91.13 141.11 29.16 Favored 'General case' 0 N--CA 1.484 1.256 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.826 179.136 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 53.3 mtp180 -108.35 146.38 33.07 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 123.533 0.733 . . . . 0.0 110.032 179.403 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 17.7 p-10 -79.58 -42.86 24.11 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 115.783 1.771 . . . . 0.0 115.783 -179.449 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 179.1 -79.3 0.06 OUTLIER Glycine 0 CA--C 1.537 1.44 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 -172.685 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -72.41 -64.22 1.0 Allowed 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 175.75 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 175.73 75.38 0.05 OUTLIER Glycine 0 N--CA 1.479 1.521 0 CA-C-N 119.039 0.836 . . . . 0.0 112.543 173.098 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp -128.29 111.54 13.49 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 105.018 -2.216 . . . . 0.0 105.018 174.411 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -91.73 131.72 36.9 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 124.026 0.93 . . . . 0.0 110.728 -169.091 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -144.08 137.29 27.46 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 123.646 0.778 . . . . 0.0 109.966 -178.306 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -132.31 -43.16 0.95 Allowed 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 172.215 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 39.2 t90 -85.74 -77.22 0.3 Allowed 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 124.313 1.045 . . . . 0.0 110.119 -176.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 9.4 p -149.28 -55.87 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 C-N-CA 123.727 0.811 . . . . 0.0 110.465 175.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 13.5 p -79.6 122.8 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 C-N-CA 123.827 0.851 . . . . 0.0 110.53 -175.267 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 6.5 ttpm? -79.88 146.45 32.17 Favored 'General case' 0 CA--C 1.559 1.299 0 CA-C-O 122.26 1.029 . . . . 0.0 112.919 -176.436 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -118.58 158.41 25.48 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 114.134 -1.394 . . . . 0.0 109.202 -173.564 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -76.99 -57.73 3.68 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 118.119 -0.943 . . . . 0.0 112.635 173.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 83.8 p -109.2 162.56 14.17 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-O 122.334 1.064 . . . . 0.0 112.575 -178.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 18.6 tp -64.99 -33.96 77.3 Favored 'General case' 0 CA--C 1.571 1.761 0 N-CA-C 115.036 1.495 . . . . 0.0 115.036 169.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 14.2 m-80 -64.45 -42.74 95.79 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 113.642 0.979 . . . . 0.0 113.642 169.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -58.78 -41.32 86.37 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 115.836 1.791 . . . . 0.0 115.836 169.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 9.7 tt -53.69 -50.25 66.27 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 115.265 1.58 . . . . 0.0 115.265 172.697 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 25.7 m -67.88 -45.65 83.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 176.418 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . 0.256 3.7 p30 -65.26 -29.52 70.31 Favored 'General case' 0 CA--C 1.569 1.711 0 N-CA-C 115.408 1.633 . . . . 0.0 115.408 -178.864 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 77.9 t80 -67.05 -54.2 23.8 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-N 119.256 0.934 . . . . 0.0 111.613 168.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 80.2 m-70 -67.53 -9.2 40.21 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 117.869 2.544 . . . . 0.0 117.869 176.116 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 52.9 ttm-85 -57.81 -31.46 66.62 Favored 'General case' 0 CA--C 1.577 2.016 0 C-N-CA 124.285 1.034 . . . . 0.0 113.726 167.518 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 71.0 m -107.73 -34.56 6.94 Favored 'General case' 0 CA--C 1.568 1.654 0 C-N-CA 125.151 1.38 . . . . 0.0 113.955 169.156 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 90.0 m -90.66 156.56 18.02 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-N 120.504 1.502 . . . . 0.0 111.913 178.77 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 32.4 t -74.97 121.41 21.91 Favored 'General case' 0 CA--C 1.558 1.279 0 O-C-N 121.342 -0.849 . . . . 0.0 112.034 177.421 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.5 p -73.14 -34.8 45.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 170.365 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 20.3 t -85.26 147.24 26.66 Favored 'General case' 0 CA--C 1.558 1.254 0 CA-C-N 119.098 0.863 . . . . 0.0 111.296 174.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 61.1 ttp85 -68.78 -63.37 1.07 Allowed 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 123.162 0.585 . . . . 0.0 112.297 173.68 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 19.6 t30 -72.42 -52.64 15.05 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 178.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 67.1 mt-30 -79.8 161.62 25.57 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.675 0.75 . . . . 0.0 112.031 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -105.61 94.56 5.27 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 175.082 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 28.8 mm -113.98 119.14 60.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 -172.744 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -121.2 126.81 50.59 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 -174.413 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 11.1 mp -78.5 124.2 27.88 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 -169.121 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 7.7 mpt_? -120.0 146.88 45.45 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 124.807 1.243 . . . . 0.0 108.242 172.637 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -75.4 155.56 36.27 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 121.674 0.749 . . . . 0.0 112.564 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 45.7 pt -66.08 156.61 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 N-CA-C 114.542 1.312 . . . . 0.0 114.542 -172.393 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 . . . . . 0 N--CA 1.483 1.221 0 CA-C-O 123.975 1.845 . . . . 0.0 109.873 -176.43 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 61.9 p-90 . . . . . 0 N--CA 1.493 1.684 0 N-CA-C 117.57 2.434 . . . . 0.0 117.57 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 33.3 t80 -83.2 124.79 30.88 Favored 'General case' 0 N--CA 1.484 1.267 0 CA-C-N 119.559 1.072 . . . . 0.0 109.616 179.057 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -110.33 -74.19 0.66 Allowed 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 118.483 -0.77 . . . . 0.0 109.046 179.193 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 177.37 -98.91 0.12 Allowed Glycine 0 N--CA 1.476 1.364 0 CA-C-N 119.263 0.938 . . . . 0.0 111.525 177.766 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -140.6 94.09 2.69 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 -174.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 36.5 pt -127.98 153.89 78.35 Favored Pre-proline 0 CA--C 1.575 1.922 0 C-N-CA 123.617 0.767 . . . . 0.0 110.484 -175.766 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -78.2 176.69 9.66 Favored 'Trans proline' 0 CA--C 1.565 2.051 0 C-N-CA 123.037 2.491 . . . . 0.0 114.458 176.797 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 29.3 ttm180 -61.48 -43.0 99.64 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 115.952 1.834 . . . . 0.0 115.952 172.619 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.74 -46.84 80.53 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 115.252 1.575 . . . . 0.0 115.252 178.224 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm -61.95 -35.94 79.93 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 115.559 1.688 . . . . 0.0 115.559 169.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.55 -40.9 89.3 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 115.493 1.664 . . . . 0.0 115.493 171.142 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -63.75 -39.76 95.06 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 115.313 1.597 . . . . 0.0 115.313 169.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -60.64 -49.2 78.46 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 174.381 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -62.26 -49.8 74.26 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 114.492 1.293 . . . . 0.0 114.492 173.769 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 9.9 mp -69.14 -27.8 65.88 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 116.42 2.007 . . . . 0.0 116.42 179.268 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 23.3 t -59.28 -37.98 79.02 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-N 120.508 1.503 . . . . 0.0 114.683 169.376 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt -63.84 -31.91 73.25 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 115.64 1.718 . . . . 0.0 115.64 169.534 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -64.78 120.59 12.76 Favored 'General case' 0 N--CA 1.484 1.27 0 CA-C-N 119.626 1.103 . . . . 0.0 112.196 175.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -69.12 -19.99 64.04 Favored 'General case' 0 CA--C 1.568 1.657 0 N-CA-C 117.935 2.568 . . . . 0.0 117.935 171.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 43.0 m80 -89.59 132.04 35.3 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-N 119.282 0.946 . . . . 0.0 111.136 -169.17 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -74.52 123.26 24.43 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.445 0.698 . . . . 0.0 109.691 176.483 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 99.27 2.05 56.8 Favored Glycine 0 CA--C 1.552 2.39 0 N-CA-C 117.86 1.904 . . . . 0.0 117.86 -169.471 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.62 109.35 4.27 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-N 120.698 2.249 . . . . 0.0 112.026 -172.561 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -119.52 160.03 23.18 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 116.322 1.971 . . . . 0.0 116.322 -168.591 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.2 pp -141.61 145.76 35.4 Favored 'General case' 0 CA--C 1.557 1.246 0 CA-C-N 113.826 -1.534 . . . . 0.0 108.989 168.624 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.8 mp -96.94 115.25 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 N-CA-C 104.112 -2.551 . . . . 0.0 104.112 169.646 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 50.7 ptt85 -102.83 152.65 21.02 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 123.819 0.847 . . . . 0.0 110.645 169.765 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -83.18 140.81 32.36 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 168.833 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 50.2 m -66.86 1.01 2.07 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 120.074 3.361 . . . . 0.0 120.074 -169.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . 0.357 24.9 tt0 79.22 -69.73 0.11 Allowed 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 125.544 1.538 . . . . 0.0 113.467 169.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 66.1 m -64.81 -39.16 93.14 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 115.579 1.696 . . . . 0.0 115.579 171.425 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -113.53 103.0 55.43 Favored Pre-proline 0 CA--C 1.563 1.45 0 CA-C-N 119.24 0.927 . . . . 0.0 109.875 175.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -58.77 -32.81 97.79 Favored 'Trans proline' 0 C--N 1.37 1.706 0 N-CA-C 119.742 2.939 . . . . 0.0 119.742 173.403 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -86.79 46.86 3.62 Favored Glycine 0 CA--C 1.552 2.347 0 N-CA-C 114.765 0.666 . . . . 0.0 114.765 169.109 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -160.08 132.82 6.56 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 176.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -112.43 176.25 5.1 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-O 122.161 0.981 . . . . 0.0 110.645 178.444 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 58.1 m -151.56 121.4 7.05 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 -179.25 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 25.7 tp -79.89 114.93 19.18 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 169.739 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 8.7 m -98.9 97.53 8.7 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 105.913 -1.884 . . . . 0.0 105.913 172.057 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.8 p -110.1 125.16 67.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 -175.674 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -76.24 139.9 41.35 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-O 121.54 0.686 . . . . 0.0 111.648 179.122 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -140.69 170.9 14.9 Favored 'General case' 0 CA--C 1.566 1.578 0 CA-C-O 122.184 0.992 . . . . 0.0 108.383 169.844 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -60.41 115.91 8.39 Favored Glycine 0 CA--C 1.546 1.978 0 O-C-N 121.108 -0.995 . . . . 0.0 114.339 178.26 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . 0.377 15.3 m120 83.19 -24.88 0.16 Allowed 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 117.726 2.491 . . . . 0.0 117.726 -174.291 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -147.74 140.37 24.66 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-N 120.264 1.393 . . . . 0.0 111.154 -173.141 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 69.1 t -94.92 115.76 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 105.196 -2.149 . . . . 0.0 105.196 169.335 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 62.8 mt-30 -94.3 115.45 27.68 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-O 121.73 0.776 . . . . 0.0 109.686 -175.015 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 8.2 m-70 -98.52 114.48 26.9 Favored 'General case' 0 CA--C 1.553 1.085 0 CA-C-N 114.844 -1.071 . . . . 0.0 108.419 -175.811 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -111.46 131.39 55.24 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 -179.382 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -85.18 119.39 25.51 Favored 'General case' 0 N--CA 1.486 1.375 0 CA-C-O 121.388 0.613 . . . . 0.0 110.283 -176.688 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 46.9 t -88.54 110.92 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 64.0 mt -93.67 126.11 38.66 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.084 0.554 . . . . 0.0 110.102 -175.644 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 71.2 mtp180 -96.27 151.89 19.09 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 123.209 0.604 . . . . 0.0 110.756 176.132 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 25.3 p-10 -79.68 -47.76 14.81 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 115.17 1.545 . . . . 0.0 115.17 174.822 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 173.57 -73.58 0.09 OUTLIER Glycine 0 CA--C 1.538 1.523 0 N-CA-C 110.841 -0.904 . . . . 0.0 110.841 -169.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -70.5 -64.69 0.85 Allowed 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 175.307 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 173.81 81.72 0.05 OUTLIER Glycine 0 N--CA 1.478 1.456 0 CA-C-N 118.742 0.701 . . . . 0.0 111.378 174.792 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -138.23 107.74 6.18 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 105.482 -2.044 . . . . 0.0 105.482 176.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -93.13 119.03 31.9 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.766 0.827 . . . . 0.0 109.383 -169.553 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -127.2 110.66 13.1 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.609 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 4.1 tt -97.98 -54.28 3.14 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 124.29 1.036 . . . . 0.0 111.434 172.177 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . 0.259 78.1 t90 -93.09 -95.09 0.15 Allowed 'General case' 0 CA--C 1.557 1.213 0 C-N-CA 124.486 1.114 . . . . 0.0 112.275 -167.711 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 69.7 t -133.2 -60.35 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 -172.014 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 24.3 m -79.36 128.56 38.47 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.397 0 CA-C-N 119.097 0.862 . . . . 0.0 109.677 178.78 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -80.04 131.44 35.78 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-O 121.73 0.776 . . . . 0.0 110.666 -175.445 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -105.15 153.32 21.69 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 114.707 -1.133 . . . . 0.0 109.747 -173.417 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -74.64 -54.61 7.1 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 172.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 88.0 p -120.72 168.05 11.82 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-O 122.197 0.999 . . . . 0.0 112.346 -175.584 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 57.5 mt -62.65 -36.47 82.92 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 114.98 1.474 . . . . 0.0 114.98 169.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . 0.281 9.8 p30 -62.22 -38.08 87.83 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 115.496 1.665 . . . . 0.0 115.496 169.53 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -62.28 -45.89 91.22 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 114.896 1.443 . . . . 0.0 114.896 169.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 51.5 tp -55.8 -45.58 78.21 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 115.099 1.518 . . . . 0.0 115.099 169.454 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 33.2 t -60.08 -61.27 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 C-N-CA 124.309 1.044 . . . . 0.0 112.215 172.162 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -58.47 -30.03 66.66 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 117.289 2.329 . . . . 0.0 117.289 -175.609 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -64.95 -55.58 18.3 Favored 'General case' 0 CA--C 1.565 1.544 0 CA-C-N 118.963 0.801 . . . . 0.0 112.619 169.435 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . 0.303 74.1 m-70 -71.53 -8.99 57.48 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 117.931 2.567 . . . . 0.0 117.931 178.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -48.7 -39.47 24.69 Favored 'General case' 0 N--CA 1.501 2.124 0 CA-C-N 120.59 1.541 . . . . 0.0 114.544 167.48 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 69.7 m -106.47 -29.81 9.46 Favored 'General case' 0 CA--C 1.565 1.532 0 N-CA-C 115.02 1.489 . . . . 0.0 115.02 170.225 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 39.5 m -89.98 147.19 23.84 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-N 120.733 1.606 . . . . 0.0 110.326 -178.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 23.1 t -77.62 122.87 25.89 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.594 -0.691 . . . . 0.0 111.586 176.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 12.4 p -68.4 -30.73 48.59 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.942 0 N-CA-C 115.3 1.593 . . . . 0.0 115.3 169.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 46.4 m -79.78 -41.26 26.88 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 116.147 1.906 . . . . 0.0 116.147 -176.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . 0.261 4.6 mmp_? 69.04 53.98 0.46 Allowed 'General case' 0 N--CA 1.5 2.027 0 C-N-CA 124.465 1.106 . . . . 0.0 113.24 -169.637 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -163.96 -81.26 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 177.736 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 -96.12 163.2 13.21 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 123.794 0.838 . . . . 0.0 109.87 169.669 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -79.82 98.2 6.97 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.72 -0.613 . . . . 0.0 112.145 -178.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 1.2 mp -102.37 100.74 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 103.757 -2.683 . . . . 0.0 103.757 172.494 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 20.4 m-30 -110.23 126.44 54.14 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 -178.179 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 10.8 mp -72.2 121.53 19.5 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 113.148 0.795 . . . . 0.0 113.148 -169.361 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 22.4 mmt85 -126.85 154.26 44.6 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 125.181 1.393 . . . . 0.0 109.18 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -75.47 147.3 39.96 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.293 -1.505 . . . . 0.0 113.367 -177.048 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.442 HD13 ' H ' ' A' ' 151' ' ' ILE . 0.2 OUTLIER -69.37 158.04 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 113.639 0.977 . . . . 0.0 113.639 179.721 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 . . . . . 0 N--CA 1.484 1.271 0 CA-C-O 122.851 1.31 . . . . 0.0 109.588 -178.657 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . 0.278 30.0 p-90 . . . . . 0 N--CA 1.489 1.492 0 N-CA-C 115.14 1.533 . . . . 0.0 115.14 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -83.66 134.36 34.78 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 120.771 1.623 . . . . 0.0 110.864 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -111.13 -88.28 0.52 Allowed 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 176.627 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 153.39 83.33 0.04 OUTLIER Glycine 0 N--CA 1.48 1.622 0 CA-C-N 119.37 0.986 . . . . 0.0 111.088 178.394 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . 0.257 51.6 mtpt 59.09 61.44 2.11 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 -176.509 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 17.4 tt -86.06 141.42 35.32 Favored Pre-proline 0 CA--C 1.572 1.811 0 CA-C-O 117.663 -1.16 . . . . 0.0 110.263 179.158 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -69.1 153.44 71.98 Favored 'Trans proline' 0 CA--C 1.562 1.906 0 CA-C-N 123.575 2.312 . . . . 0.0 113.578 174.399 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 38.6 ttt85 -58.01 -43.42 86.68 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 116.18 1.918 . . . . 0.0 116.18 -177.35 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.47 -46.15 84.33 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 115.007 1.484 . . . . 0.0 115.007 175.383 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 58.7 tttm -59.83 -36.65 77.25 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 115.248 1.573 . . . . 0.0 115.248 169.691 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.79 -43.29 96.76 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 115.487 1.662 . . . . 0.0 115.487 170.038 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -63.68 -46.06 87.27 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 114.875 1.435 . . . . 0.0 114.875 172.592 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -70.77 -39.22 73.35 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 115.212 1.56 . . . . 0.0 115.212 178.331 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 38.1 mmt -64.99 -45.2 86.61 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-N 119.922 1.237 . . . . 0.0 114.278 172.215 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 95.3 mt -64.89 -32.1 73.65 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 116.121 1.897 . . . . 0.0 116.121 170.532 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 18.9 t -57.47 -29.64 64.4 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 116.364 1.987 . . . . 0.0 116.364 169.604 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -63.55 -34.99 79.02 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 115.775 1.769 . . . . 0.0 115.775 169.793 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -70.33 131.24 43.84 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-O 122.935 1.35 . . . . 0.0 112.973 -176.163 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.28 -12.34 61.58 Favored 'General case' 0 CA--C 1.567 1.623 0 N-CA-C 118.947 2.943 . . . . 0.0 118.947 172.114 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 53.5 m80 -89.28 138.03 31.79 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 120.315 1.416 . . . . 0.0 111.936 -169.158 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -81.47 98.32 8.2 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 107.545 -1.279 . . . . 0.0 107.545 172.486 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 124.94 -0.1 8.33 Favored Glycine 0 CA--C 1.557 2.668 0 CA-C-O 117.089 -1.951 . . . . 0.0 115.698 -168.087 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.66 116.27 6.07 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-N 121.161 2.48 . . . . 0.0 112.653 -169.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 20.4 p90 -131.6 155.53 47.36 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 116.273 1.953 . . . . 0.0 116.273 -168.596 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.0 pp -143.37 138.13 29.21 Favored 'General case' 0 CA--C 1.558 1.25 0 CA-C-N 114.026 -1.443 . . . . 0.0 108.02 169.128 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.9 mp -83.57 120.09 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 N-CA-C 106.149 -1.797 . . . . 0.0 106.149 174.373 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 61.8 ttp85 -95.23 125.01 39.58 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-N 114.718 -1.128 . . . . 0.0 109.218 170.706 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -79.99 132.24 35.98 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 169.721 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 53.5 m -69.63 138.51 53.13 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.095 0.558 . . . . 0.0 112.32 -175.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -66.24 -59.46 3.71 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -172.698 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 88.2 p -62.3 -34.37 76.47 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 116.881 2.178 . . . . 0.0 116.881 174.698 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -121.04 97.28 48.12 Favored Pre-proline 0 CA--C 1.562 1.431 0 CA-C-N 119.112 0.869 . . . . 0.0 109.837 177.417 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -56.63 -30.95 85.52 Favored 'Trans proline' 0 C--N 1.369 1.641 0 N-CA-C 119.78 2.954 . . . . 0.0 119.78 172.158 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -88.24 46.12 3.35 Favored Glycine 0 CA--C 1.553 2.458 0 N-CA-C 114.777 0.671 . . . . 0.0 114.777 168.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -156.11 126.81 6.81 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 105.281 -2.118 . . . . 0.0 105.281 178.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -112.79 167.32 10.59 Favored 'General case' 0 CA--C 1.559 1.303 0 CA-C-O 122.416 1.103 . . . . 0.0 110.549 -174.259 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 71.2 m -146.32 111.89 5.55 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 -179.5 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 46.2 tp -79.65 107.32 12.33 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-O 122.004 0.906 . . . . 0.0 109.582 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.3 m -90.42 100.45 13.28 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 177.448 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.3 p -124.81 121.03 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 -172.018 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -76.37 142.1 41.28 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.535 170.395 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -150.22 107.44 3.6 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 169.783 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 88.9 -106.65 3.3 Favored Glycine 0 N--CA 1.481 1.645 0 N-CA-C 110.382 -1.087 . . . . 0.0 110.382 -176.571 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -135.68 60.1 1.7 Allowed 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 169.279 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -160.86 129.02 4.45 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.673 0.789 . . . . 0.0 109.386 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 55.8 t -98.91 109.01 23.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 179.346 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -99.77 120.39 39.66 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.872 0.869 . . . . 0.0 109.465 -176.247 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -100.58 105.01 16.38 Favored 'General case' 0 CA--C 1.554 1.097 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -175.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -102.34 129.12 48.7 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -177.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -77.07 126.4 30.91 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-O 121.704 0.764 . . . . 0.0 110.525 -178.55 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 76.9 t -108.93 100.73 11.37 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.347 0 N-CA-C 104.826 -2.287 . . . . 0.0 104.826 178.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -113.27 144.3 42.95 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.788 0.835 . . . . 0.0 110.76 -172.353 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 92.3 mtt180 -88.68 151.75 22.24 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 113.129 0.788 . . . . 0.0 113.129 -175.605 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -95.83 -63.82 1.12 Allowed 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 123.54 0.736 . . . . 0.0 110.882 169.391 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -100.01 -104.98 2.65 Favored Glycine 0 CA--C 1.541 1.707 0 CA-C-N 119.223 0.92 . . . . 0.0 111.553 177.15 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -139.5 122.9 17.15 Favored 'General case' 0 N--CA 1.482 1.17 0 CA-C-O 122.925 1.345 . . . . 0.0 107.566 172.24 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 61.74 51.71 55.57 Favored Glycine 0 CA--C 1.552 2.35 0 CA-C-N 113.192 -1.822 . . . . 0.0 115.28 -169.345 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -137.14 77.69 1.65 Allowed 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 105.087 -2.19 . . . . 0.0 105.087 -174.126 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -85.76 108.89 18.29 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -167.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 21.5 p90 -119.86 135.47 54.86 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.206 0.602 . . . . 0.0 110.571 178.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -94.48 -52.52 4.29 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 123.16 0.584 . . . . 0.0 111.624 169.207 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 3.2 m-90 -85.07 -76.78 0.3 Allowed 'General case' 0 CA--C 1.564 1.51 0 C-N-CA 123.775 0.83 . . . . 0.0 109.108 177.105 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 6.2 m -147.38 -46.14 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 C-N-CA 125.352 1.461 . . . . 0.0 110.942 -178.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 12.3 p -79.81 132.22 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 CA-C-N 119.382 0.992 . . . . 0.0 111.355 -173.415 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 2.2 pptp? -81.65 154.12 26.28 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 113.904 1.076 . . . . 0.0 113.904 -174.069 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -135.94 114.5 11.83 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 104.617 -2.364 . . . . 0.0 104.617 176.712 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -53.07 -38.27 62.35 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 118.933 2.938 . . . . 0.0 118.933 -169.387 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 91.1 p -135.41 160.36 38.68 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-O 122.522 1.153 . . . . 0.0 113.339 -171.724 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 11.1 mp -77.39 117.88 19.31 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 168.765 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . 0.356 21.3 t-20 122.88 -53.28 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.017 0 C-N-CA 126.422 1.889 . . . . 0.0 107.535 -168.622 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -58.84 -49.45 77.69 Favored 'General case' 0 CA--C 1.568 1.646 0 CA-C-N 119.851 1.205 . . . . 0.0 113.777 169.212 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 31.1 tp -60.59 -40.22 90.96 Favored 'General case' 0 CA--C 1.57 1.74 0 N-CA-C 115.413 1.634 . . . . 0.0 115.413 169.809 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 40.4 t -59.07 -61.99 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 C-N-CA 124.35 1.06 . . . . 0.0 112.569 173.459 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -61.88 -30.32 70.79 Favored 'General case' 0 CA--C 1.572 1.814 0 N-CA-C 115.086 1.513 . . . . 0.0 115.086 -178.597 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 94.0 t80 -59.69 -57.52 12.57 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-N 119.153 0.888 . . . . 0.0 112.245 168.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 74.4 m-70 -70.37 -9.58 56.64 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 117.913 2.56 . . . . 0.0 117.913 175.259 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 53.1 ttm-85 -61.1 -30.22 70.23 Favored 'General case' 0 CA--C 1.575 1.917 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 167.754 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 71.0 m -108.6 -30.79 8.05 Favored 'General case' 0 CA--C 1.568 1.64 0 C-N-CA 125.047 1.339 . . . . 0.0 114.081 169.304 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 99.1 m -90.89 156.33 18.09 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-N 120.371 1.442 . . . . 0.0 111.978 176.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 39.7 t -67.08 137.16 56.18 Favored 'General case' 0 CA--C 1.558 1.267 0 C-N-CA 123.669 0.788 . . . . 0.0 113.076 170.007 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 19.0 t -71.3 -48.91 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 CA-C-O 118.683 -0.675 . . . . 0.0 111.735 171.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 9.2 t -87.76 172.51 9.61 Favored 'General case' 0 CA--C 1.565 1.541 0 CA-C-N 118.981 0.81 . . . . 0.0 111.754 174.326 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 40.8 mmt180 -79.93 -57.78 3.48 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.23 -0.919 . . . . 0.0 111.724 169.599 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -70.1 -59.54 2.84 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 177.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 70.1 mt-30 -79.9 145.08 32.87 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-N 118.869 0.759 . . . . 0.0 111.481 -179.21 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -102.76 104.56 14.87 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 123.352 0.661 . . . . 0.0 109.533 -177.255 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 4.3 mp -112.71 127.44 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -125.5 125.38 43.18 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 10.8 mp -74.22 135.33 42.73 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 115.057 1.503 . . . . 0.0 115.057 -168.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 8.9 mmm180 -128.71 139.1 52.39 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 125.486 1.514 . . . . 0.0 108.519 174.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -71.97 146.79 47.5 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.307 -0.87 . . . . 0.0 112.451 177.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 27.1 pt -69.93 158.69 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 N-CA-C 113.564 0.949 . . . . 0.0 113.564 -174.498 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 . . . . . 0 N--CA 1.484 1.256 0 CA-C-O 122.803 1.287 . . . . 0.0 109.759 179.276 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 55.4 p-90 . . . . . 0 N--CA 1.479 1.017 0 CA-C-O 118.339 -0.839 . . . . 0.0 112.347 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -82.82 127.5 33.53 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-N 119.868 1.213 . . . . 0.0 112.903 -169.246 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -100.01 -79.67 0.49 Allowed 'General case' 0 N--CA 1.489 1.481 0 CA-C-N 114.937 -1.029 . . . . 0.0 108.765 173.005 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -175.99 -138.05 2.75 Favored Glycine 0 N--CA 1.48 1.569 0 CA-C-N 119.311 0.96 . . . . 0.0 112.28 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 20.9 tptm -103.5 87.13 2.78 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 176.587 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 32.6 pt -127.09 153.09 76.61 Favored Pre-proline 0 CA--C 1.573 1.828 0 C-N-CA 123.331 0.652 . . . . 0.0 111.086 -169.606 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -77.24 178.57 7.47 Favored 'Trans proline' 0 CA--C 1.565 2.059 0 C-N-CA 123.043 2.496 . . . . 0.0 113.944 175.846 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 54.3 ttt180 -65.42 -41.48 93.53 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 115.101 1.519 . . . . 0.0 115.101 175.092 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.2 -41.06 97.23 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 115.96 1.837 . . . . 0.0 115.96 179.018 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -64.07 -38.46 91.16 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 114.569 1.322 . . . . 0.0 114.569 169.538 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.59 -41.0 84.77 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 115.951 1.834 . . . . 0.0 115.951 171.824 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -64.17 -36.81 85.26 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 115.02 1.489 . . . . 0.0 115.02 170.0 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -63.77 -48.24 77.72 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 114.799 1.407 . . . . 0.0 114.799 172.42 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 38.8 mmt -61.54 -47.48 85.35 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 174.542 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 88.3 mt -75.09 -24.52 58.14 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 116.908 2.188 . . . . 0.0 116.908 177.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 97.4 p -61.83 -36.35 80.9 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-N 120.726 1.603 . . . . 0.0 114.631 168.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 59.7 mttm -60.7 -36.58 79.16 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 114.788 1.403 . . . . 0.0 114.788 169.203 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -64.62 120.47 12.45 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.449 1.1 . . . . 0.0 112.001 170.509 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 16.5 ptm180 -77.9 -15.99 58.58 Favored 'General case' 0 CA--C 1.569 1.683 0 N-CA-C 118.223 2.675 . . . . 0.0 118.223 176.141 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 46.0 m80 -89.57 147.85 23.71 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 119.513 1.051 . . . . 0.0 113.557 -168.326 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -77.6 124.4 27.88 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.789 170.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 105.6 -29.93 10.62 Favored Glycine 0 CA--C 1.546 2.002 0 CA-C-O 117.268 -1.851 . . . . 0.0 116.765 -169.847 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.11 112.75 1.29 Allowed 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 120.21 2.005 . . . . 0.0 113.386 -170.767 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.1 p90 -130.32 161.22 31.76 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 -168.295 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.6 pp -141.99 132.62 25.45 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.695 0.798 . . . . 0.0 108.892 168.835 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 87.2 mt -86.8 122.09 38.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 169.714 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 49.1 ptt85 -104.4 153.02 21.6 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.487 169.548 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -88.85 124.12 33.89 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 105.836 -1.913 . . . . 0.0 105.836 168.286 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 53.2 m -62.84 121.37 13.31 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.241 0.616 . . . . 0.0 111.871 -172.503 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -68.1 -47.15 68.99 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 114.496 1.295 . . . . 0.0 114.496 -170.574 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.1 t -65.66 -31.93 73.22 Favored 'General case' 0 CA--C 1.568 1.659 0 N-CA-C 115.832 1.79 . . . . 0.0 115.832 169.5 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -118.85 95.31 49.08 Favored Pre-proline 0 CA--C 1.563 1.471 0 CA-C-N 119.863 1.21 . . . . 0.0 110.158 178.195 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -56.05 -34.65 93.1 Favored 'Trans proline' 0 C--N 1.369 1.658 0 N-CA-C 120.111 3.081 . . . . 0.0 120.111 176.705 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -87.97 50.09 3.88 Favored Glycine 0 CA--C 1.55 2.281 0 N-CA-C 114.297 0.479 . . . . 0.0 114.297 169.173 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -159.66 142.04 13.57 Favored 'General case' 0 CA--C 1.556 1.209 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 178.708 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -116.68 161.19 19.61 Favored 'General case' 0 CA--C 1.564 1.501 0 CA-C-O 122.032 0.92 . . . . 0.0 109.265 171.85 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 67.4 m -137.4 117.33 13.27 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 178.241 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 43.0 tp -80.17 110.89 16.01 Favored 'General case' 0 CA--C 1.563 1.452 0 C-N-CA 124.216 1.007 . . . . 0.0 109.429 172.647 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 3.1 m -97.4 116.04 28.85 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 -178.28 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 41.2 t -126.21 123.2 63.19 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.194 0 CA-C-N 120.798 1.635 . . . . 0.0 108.151 -171.547 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 59.0 tptt -81.77 121.2 26.12 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 169.149 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -139.22 99.46 3.76 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 174.116 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 92.01 -98.32 2.4 Favored Glycine 0 CA--C 1.538 1.483 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.984 178.298 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 12.2 p30 -129.1 19.49 5.93 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 115.629 1.715 . . . . 0.0 115.629 177.341 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -145.3 141.37 28.5 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 120.117 1.326 . . . . 0.0 109.522 -177.367 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 60.6 t -96.33 108.37 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 174.636 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -104.02 127.68 51.58 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 123.917 0.887 . . . . 0.0 110.557 -176.629 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 23.0 m80 -102.95 101.31 11.31 Favored 'General case' 0 CA--C 1.551 1.0 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -169.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -84.92 126.22 33.32 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 172.795 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 32.6 mmmt -82.86 119.51 24.48 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.067 0.46 . . . . 0.0 110.228 -172.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 84.3 t -86.33 103.63 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 177.21 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 63.3 mt -95.62 147.69 23.31 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.719 -171.622 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 72.7 mtp180 -116.28 122.52 45.19 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.627 -0.671 . . . . 0.0 110.355 -173.429 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -101.19 119.7 39.13 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 123.46 0.704 . . . . 0.0 109.75 174.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 82.02 -112.44 3.49 Favored Glycine 0 CA--C 1.541 1.701 0 C-N-CA 122.816 0.246 . . . . 0.0 113.095 177.005 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -86.43 -71.89 0.53 Allowed 'General case' 0 N--CA 1.486 1.368 0 CA-C-O 118.746 -0.645 . . . . 0.0 111.258 177.433 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -157.01 71.81 0.25 Allowed Glycine 0 N--CA 1.478 1.498 0 CA-C-N 118.681 0.673 . . . . 0.0 112.373 172.477 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.95 104.58 14.29 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 104.74 -2.318 . . . . 0.0 104.74 172.058 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -84.08 99.67 10.61 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.652 -168.807 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 32.8 p90 -102.49 114.36 28.5 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.71 0.804 . . . . 0.0 109.107 -178.393 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -105.66 -52.17 2.87 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.825 176.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 83.1 t90 -135.19 109.19 8.18 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 -169.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . 0.392 22.2 t 69.58 -91.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 C-N-CA 124.278 1.031 . . . . 0.0 111.57 169.615 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 8.1 p -79.97 155.3 4.55 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.609 0 C-N-CA 124.224 1.01 . . . . 0.0 111.408 177.789 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 25.9 pttm -79.74 148.44 31.5 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-O 121.434 0.635 . . . . 0.0 112.545 173.803 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -128.07 107.27 9.67 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 106.26 -1.755 . . . . 0.0 106.26 -172.822 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -50.63 -50.28 54.73 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 117.951 2.574 . . . . 0.0 117.951 -169.393 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 90.8 p -111.86 160.57 17.25 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 118.897 0.771 . . . . 0.0 111.833 176.565 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 79.0 mt -66.71 -34.46 77.89 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 115.38 1.622 . . . . 0.0 115.38 170.896 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -64.21 -45.09 89.8 Favored 'General case' 0 CA--C 1.572 1.825 0 CA-C-N 119.859 1.209 . . . . 0.0 114.002 170.66 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -59.08 -47.35 85.56 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 114.788 1.403 . . . . 0.0 114.788 169.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 57.4 tp -51.83 -52.48 48.98 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 115.686 1.735 . . . . 0.0 115.686 170.859 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 9.8 p -67.44 -50.28 63.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 -176.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -63.84 -31.0 72.03 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 114.957 1.466 . . . . 0.0 114.957 174.559 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -62.43 -54.55 38.55 Favored 'General case' 0 CA--C 1.567 1.618 0 CA-C-N 119.727 1.148 . . . . 0.0 111.702 168.54 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 36.4 m-70 -73.32 -9.7 58.98 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 118.37 2.73 . . . . 0.0 118.37 179.519 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 58.0 mtp85 -66.82 -21.46 66.03 Favored 'General case' 0 CA--C 1.579 2.08 0 CA-C-N 120.251 1.387 . . . . 0.0 113.347 167.411 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 69.3 m -104.38 -43.92 5.07 Favored 'General case' 0 CA--C 1.57 1.73 0 C-N-CA 125.453 1.501 . . . . 0.0 112.509 168.508 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 57.3 m -90.18 155.42 19.04 Favored 'General case' 0 N--CA 1.499 1.981 0 CA-C-N 120.051 1.296 . . . . 0.0 111.465 -179.142 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 21.0 t -80.18 130.74 35.44 Favored 'General case' 0 CA--C 1.56 1.352 0 O-C-N 121.293 -0.88 . . . . 0.0 113.053 -178.079 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 3.2 m -68.88 -42.49 82.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 169.576 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.8 t -83.49 135.26 34.72 Favored 'General case' 0 CA--C 1.557 1.23 0 CA-C-N 118.967 0.803 . . . . 0.0 110.259 173.79 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 41.4 ptt180 -69.99 -45.53 67.13 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 115.183 1.549 . . . . 0.0 115.183 174.686 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 70.9 m-80 -79.1 -55.53 5.04 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 123.451 0.7 . . . . 0.0 112.593 175.781 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -79.89 154.02 28.63 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 118.782 0.719 . . . . 0.0 111.939 179.107 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -92.91 96.52 10.17 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 171.448 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 27.7 mm -117.86 110.86 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 N-CA-C 105.146 -2.168 . . . . 0.0 105.146 -178.201 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -116.55 127.97 55.0 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.424 -174.168 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 10.7 mp -78.09 126.14 30.37 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.747 0.819 . . . . 0.0 111.905 -169.914 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 14.1 mmm180 -126.89 162.79 25.1 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-O 122.419 1.104 . . . . 0.0 110.432 178.77 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -77.36 148.67 35.46 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.984 -1.072 . . . . 0.0 112.68 -176.546 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 28.1 pt -70.0 159.7 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 113.993 1.108 . . . . 0.0 113.993 -179.595 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 . . . . . 0 N--CA 1.485 1.287 0 CA-C-O 124.002 1.858 . . . . 0.0 108.541 -177.603 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . 0.387 50.8 p-90 . . . . . 0 N--CA 1.503 2.188 0 N-CA-C 120.703 3.594 . . . . 0.0 120.703 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -128.42 132.99 48.47 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 124.319 1.048 . . . . 0.0 108.268 -169.861 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -99.71 -75.21 0.57 Allowed 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 118.34 -0.838 . . . . 0.0 109.316 172.204 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 97.78 113.64 3.2 Favored Glycine 0 N--CA 1.481 1.669 0 CA-C-N 119.371 0.987 . . . . 0.0 112.208 -179.164 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . 0.307 73.5 mmtt 65.28 25.68 12.19 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 117.425 2.38 . . . . 0.0 117.425 178.3 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 21.1 tt -90.45 129.03 46.61 Favored Pre-proline 0 CA--C 1.569 1.691 0 CA-C-O 117.139 -1.41 . . . . 0.0 107.567 169.52 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -67.32 170.61 13.06 Favored 'Trans proline' 0 CA--C 1.562 1.882 0 CA-C-N 123.638 2.335 . . . . 0.0 114.19 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 25.6 ttm180 -57.57 -45.59 85.0 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 116.252 1.945 . . . . 0.0 116.252 -177.443 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -65.98 -46.08 79.34 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 115.457 1.651 . . . . 0.0 115.457 175.371 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 61.5 mtpt -63.61 -34.91 78.87 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 115.426 1.639 . . . . 0.0 115.426 169.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.48 -42.4 99.46 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 115.278 1.584 . . . . 0.0 115.278 169.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -60.9 -43.45 98.49 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 169.721 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -64.82 -45.68 85.2 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 115.52 1.674 . . . . 0.0 115.52 175.136 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -59.83 -44.16 94.2 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 114.83 1.418 . . . . 0.0 114.83 172.823 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 88.6 mt -70.52 -21.75 62.7 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 116.679 2.104 . . . . 0.0 116.679 170.571 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 12.1 t -53.09 -37.06 61.37 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 117.223 2.305 . . . . 0.0 117.223 178.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? -64.85 -28.9 69.86 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 116.244 1.942 . . . . 0.0 116.244 170.759 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -71.53 114.4 9.57 Favored 'General case' 0 N--CA 1.485 1.294 0 CA-C-N 119.819 1.19 . . . . 0.0 111.259 178.391 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.456 ' H ' ' HD3' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -74.43 -7.35 52.68 Favored 'General case' 0 CA--C 1.57 1.721 0 N-CA-C 118.092 2.627 . . . . 0.0 118.092 172.26 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 35.5 m80 -89.81 139.94 30.08 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 119.667 1.121 . . . . 0.0 111.589 -169.053 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -75.98 120.12 20.87 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.183 171.158 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 107.78 -19.77 32.69 Favored Glycine 0 CA--C 1.546 2.022 0 CA-C-O 116.632 -2.204 . . . . 0.0 116.732 -169.366 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.2 108.72 0.95 Allowed 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 121.26 2.53 . . . . 0.0 112.233 -173.531 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 23.2 p90 -123.58 158.46 31.38 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 -168.347 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.9 pp -138.07 128.78 26.72 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 168.292 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 91.1 mt -88.54 110.76 21.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 172.576 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.9 ptm180 -89.42 144.61 25.92 Favored 'General case' 0 N--CA 1.484 1.226 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.192 169.548 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -84.8 126.9 33.84 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 169.768 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 20.8 t -68.11 123.11 19.76 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 122.909 0.483 . . . . 0.0 111.476 -172.772 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -91.11 91.17 8.14 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 123.706 1.717 . . . . 0.0 110.411 -173.632 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 39.7 t 162.54 -41.11 0.0 OUTLIER 'General case' 0 CA--C 1.571 1.768 0 CA-C-N 110.729 -2.941 . . . . 0.0 106.983 -168.535 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -150.01 113.68 3.37 Favored Pre-proline 0 CA--C 1.563 1.464 0 CA-C-O 117.57 -1.205 . . . . 0.0 108.414 178.451 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -68.6 -27.22 32.85 Favored 'Trans proline' 0 C--N 1.37 1.699 0 N-CA-C 119.088 2.688 . . . . 0.0 119.088 -178.256 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -65.3 -21.49 68.43 Favored Glycine 0 CA--C 1.561 2.938 0 N-CA-C 116.492 1.357 . . . . 0.0 116.492 168.375 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -88.66 137.78 32.01 Favored 'General case' 0 CA--C 1.555 1.171 0 CA-C-N 118.216 1.008 . . . . 0.0 108.839 169.684 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -122.69 173.16 7.9 Favored 'General case' 0 CA--C 1.567 1.61 0 CA-C-N 114.927 -1.033 . . . . 0.0 108.649 175.257 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 75.7 m -143.6 115.42 8.24 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 173.907 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 29.3 tp -79.85 114.47 18.79 Favored 'General case' 0 CA--C 1.561 1.384 0 C-N-CA 124.314 1.046 . . . . 0.0 109.167 175.344 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.3 m -106.16 88.51 2.81 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 -170.575 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 16.0 t -101.99 123.02 54.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 -169.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 51.3 tttp -88.26 96.23 10.48 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.474 171.464 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 20.1 t80 -105.77 112.21 25.18 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.706 -0.849 . . . . 0.0 108.706 179.168 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 82.78 -106.23 2.73 Favored Glycine 0 CA--C 1.539 1.589 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 -170.444 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -141.68 59.49 1.49 Allowed 'General case' 0 CA--C 1.565 1.543 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 169.238 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -155.8 128.57 7.93 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 107.046 -1.465 . . . . 0.0 107.046 177.161 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 50.0 t -95.63 110.72 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 -175.406 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -104.96 116.08 31.36 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.791 0.836 . . . . 0.0 109.05 -173.752 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -95.11 108.91 21.02 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 115.036 -0.984 . . . . 0.0 108.828 -175.265 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -107.07 120.79 43.04 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 -175.525 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -79.08 112.3 16.14 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 121.906 0.86 . . . . 0.0 110.579 -172.633 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 75.8 t -85.18 100.94 8.95 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 178.346 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.9 pp -122.86 133.84 54.41 Favored 'General case' 0 N--CA 1.491 1.575 0 CA-C-O 121.506 0.669 . . . . 0.0 111.099 -169.787 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -84.7 159.01 20.61 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-O 122.077 0.942 . . . . 0.0 113.042 -176.074 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -85.53 -46.63 10.66 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 114.96 -1.018 . . . . 0.0 113.106 168.747 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -154.93 -85.5 0.05 OUTLIER Glycine 0 CA--C 1.539 1.556 0 CA-C-N 118.958 0.799 . . . . 0.0 111.258 -177.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -72.95 -70.95 0.33 Allowed 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -175.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -168.75 54.85 0.21 Allowed Glycine 0 N--CA 1.481 1.634 0 CA-C-O 119.333 -0.704 . . . . 0.0 114.276 172.34 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -109.69 97.83 7.29 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 105.432 -2.062 . . . . 0.0 105.432 173.635 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -80.32 125.91 30.49 Favored 'General case' 0 CA--C 1.554 1.126 0 CA-C-N 113.922 -1.49 . . . . 0.0 110.775 -169.814 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 32.2 p90 -128.95 122.83 31.02 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 121.288 0.566 . . . . 0.0 109.884 174.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.484 HD23 ' H ' ' A' ' 120' ' ' LEU . 2.1 pt? -102.92 -53.65 2.8 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 124.291 1.036 . . . . 0.0 111.822 169.847 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 37.4 t90 -84.83 -74.39 0.39 Allowed 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 124.889 1.276 . . . . 0.0 110.029 -178.183 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 10.5 p -148.59 -56.0 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 C-N-CA 123.872 0.869 . . . . 0.0 110.668 176.9 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 11.1 p -79.4 135.82 24.88 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.476 0 C-N-CA 123.814 0.845 . . . . 0.0 110.858 -172.32 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 54.0 mttp -79.94 157.77 26.79 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 122.249 1.023 . . . . 0.0 112.366 -176.47 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -140.79 114.75 9.07 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 -170.589 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -58.73 -43.09 90.08 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 116.247 1.943 . . . . 0.0 116.247 177.115 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 94.8 p -113.37 144.74 42.27 Favored 'General case' 0 N--CA 1.484 1.27 0 CA-C-O 122.018 0.913 . . . . 0.0 111.955 -179.382 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 19.0 tp -84.53 62.07 7.05 Favored 'General case' 0 CA--C 1.571 1.775 0 CA-C-N 114.625 -1.17 . . . . 0.0 111.195 169.668 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -156.71 -51.58 0.08 Allowed 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 127.221 2.209 . . . . 0.0 105.445 172.63 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -61.2 -31.44 71.2 Favored 'General case' 0 CA--C 1.571 1.762 0 CA-C-N 119.537 1.062 . . . . 0.0 113.384 167.775 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 10.3 tt -51.7 -45.94 63.72 Favored 'General case' 0 N--CA 1.498 1.969 0 CA-C-N 120.158 1.345 . . . . 0.0 114.024 168.113 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 24.6 t -60.43 -59.32 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 C-N-CA 124.411 1.084 . . . . 0.0 112.162 169.584 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -58.7 -34.22 71.05 Favored 'General case' 0 CA--C 1.566 1.578 0 N-CA-C 116.269 1.952 . . . . 0.0 116.269 -174.369 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -61.63 -55.55 29.43 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 119.426 1.012 . . . . 0.0 112.279 169.258 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . 0.263 48.3 m-70 -69.6 -9.51 54.38 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 117.867 2.543 . . . . 0.0 117.867 177.301 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -62.21 -32.41 73.06 Favored 'General case' 0 CA--C 1.577 1.997 0 CA-C-N 120.266 1.393 . . . . 0.0 112.732 166.868 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 69.4 m -98.75 -39.64 8.54 Favored 'General case' 0 CA--C 1.565 1.529 0 N-CA-C 114.424 1.268 . . . . 0.0 114.424 169.769 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 52.1 m -91.07 155.61 18.54 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-N 120.175 1.352 . . . . 0.0 112.052 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 31.3 t -75.27 136.01 40.93 Favored 'General case' 0 CA--C 1.559 1.305 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 177.038 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 6.5 t -76.82 -50.03 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 CA-C-O 118.552 -0.737 . . . . 0.0 111.47 169.854 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 67.0 m -87.85 143.22 27.25 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 119.297 0.953 . . . . 0.0 111.338 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 19.3 ptp180 -91.12 64.47 5.31 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 121.993 0.901 . . . . 0.0 111.515 169.69 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . 0.271 7.2 p-10 -179.66 -70.99 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 125.624 1.57 . . . . 0.0 107.003 -172.842 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -86.59 149.9 24.61 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.965 0.906 . . . . 0.0 110.558 170.007 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 16.5 mm100 -93.32 88.45 6.0 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 122.764 0.426 . . . . 0.0 109.935 178.909 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 14.8 mm -90.57 117.61 34.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 -169.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -125.11 122.01 35.92 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 -177.245 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 10.6 mp -74.51 142.96 44.76 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 113.839 1.052 . . . . 0.0 113.839 -169.423 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 4.2 tmt_? -144.75 145.02 31.48 Favored 'General case' 0 CA--C 1.563 1.46 0 N-CA-C 105.798 -1.927 . . . . 0.0 105.798 -174.451 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -69.23 157.04 37.72 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.29 -1.507 . . . . 0.0 113.459 176.733 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.1 pp -72.62 159.05 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 179.198 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 122.88 1.324 . . . . 0.0 110.061 177.955 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . 0.256 69.0 p-90 . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 45.6 t80 -80.71 135.29 35.98 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-N 119.464 1.029 . . . . 0.0 110.967 -177.247 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -122.77 -76.91 0.59 Allowed 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 177.091 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 172.92 -112.89 0.45 Allowed Glycine 0 N--CA 1.479 1.542 0 N-CA-C 108.681 -1.768 . . . . 0.0 108.681 173.894 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 26.9 ttpp -117.83 82.99 1.92 Allowed 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 105.206 -2.146 . . . . 0.0 105.206 169.119 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -111.49 136.06 21.03 Favored Pre-proline 0 CA--C 1.569 1.695 0 CA-C-O 117.335 -1.317 . . . . 0.0 108.632 -168.853 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_exo -48.75 153.13 3.81 Favored 'Trans proline' 0 C--N 1.371 1.716 0 C-N-CA 123.736 2.957 . . . . 0.0 119.22 -177.36 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 59.0 ttt180 -66.5 -37.9 86.07 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 114.817 1.414 . . . . 0.0 114.817 171.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -69.04 -43.33 74.91 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 115.427 1.64 . . . . 0.0 115.427 176.48 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 54.6 tptt -66.55 -37.31 84.71 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 115.089 1.514 . . . . 0.0 115.089 169.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.27 -45.72 92.0 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 115.612 1.708 . . . . 0.0 115.612 169.895 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -64.8 -33.95 77.2 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 115.704 1.742 . . . . 0.0 115.704 171.169 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -61.9 -49.53 75.84 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 114.51 1.3 . . . . 0.0 114.51 171.498 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -62.71 -47.31 84.15 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 114.691 1.367 . . . . 0.0 114.691 173.671 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.1 mp -68.21 -25.24 65.12 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 116.302 1.964 . . . . 0.0 116.302 175.218 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 22.9 t -59.1 -36.3 74.9 Favored 'General case' 0 CA--C 1.571 1.759 0 CA-C-N 120.635 1.561 . . . . 0.0 114.078 168.629 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 27.9 mmtp -61.05 -36.29 79.19 Favored 'General case' 0 CA--C 1.57 1.746 0 N-CA-C 115.054 1.501 . . . . 0.0 115.054 169.304 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -67.07 119.47 12.07 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.624 1.17 . . . . 0.0 111.769 177.469 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 14.1 ptp180 -73.93 -17.1 61.06 Favored 'General case' 0 CA--C 1.569 1.685 0 N-CA-C 118.065 2.617 . . . . 0.0 118.065 171.522 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 46.5 m80 -89.74 141.87 28.21 Favored 'General case' 0 N--CA 1.487 1.418 0 CA-C-N 119.287 0.948 . . . . 0.0 113.188 -168.549 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.74 119.57 24.5 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 169.62 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 113.61 -28.5 8.52 Favored Glycine 0 CA--C 1.548 2.098 0 CA-C-O 117.685 -1.619 . . . . 0.0 116.347 -169.568 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.76 109.99 1.6 Allowed 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 120.06 1.93 . . . . 0.0 112.761 -176.602 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 16.4 p90 -126.63 164.19 21.8 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 115.457 1.651 . . . . 0.0 115.457 -168.612 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.2 pp -140.69 134.03 29.76 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 167.618 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 68.1 mt -88.28 117.66 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 106.568 -1.641 . . . . 0.0 106.568 169.818 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 5.0 ptm180 -110.66 141.9 43.28 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.447 169.658 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -79.89 139.04 37.28 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 121.533 0.683 . . . . 0.0 109.793 171.255 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 29.7 t -68.54 128.84 38.07 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.66 -178.325 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -68.5 -48.14 65.2 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 113.97 1.1 . . . . 0.0 113.97 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.8 t -60.84 -37.72 83.03 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 115.986 1.847 . . . . 0.0 115.986 169.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -119.67 93.11 47.18 Favored Pre-proline 0 CA--C 1.561 1.395 0 CA-C-N 119.577 1.081 . . . . 0.0 109.792 174.426 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -55.35 -26.36 52.49 Favored 'Trans proline' 0 CA--C 1.557 1.643 0 N-CA-C 119.761 2.947 . . . . 0.0 119.761 171.842 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -91.31 48.47 2.91 Favored Glycine 0 CA--C 1.552 2.393 0 CA-C-O 119.319 -0.712 . . . . 0.0 113.93 168.733 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -160.17 126.98 4.36 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 178.74 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 35.3 m-85 -92.73 165.45 12.94 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 122.213 1.006 . . . . 0.0 111.701 169.572 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 75.2 m -143.48 112.72 6.78 Favored 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 25.4 tp -79.98 108.65 13.73 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 124.219 1.008 . . . . 0.0 109.447 176.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 12.6 m -99.65 97.25 8.24 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 -173.436 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 21.7 t -107.6 126.45 63.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 -172.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 58.4 tptt -76.93 109.83 11.07 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 169.664 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -139.3 90.11 2.39 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -174.481 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 71.02 74.71 0.68 Allowed Glycine 0 N--CA 1.482 1.765 0 N-CA-C 115.654 1.021 . . . . 0.0 115.654 169.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . 0.286 66.1 m-80 68.97 -11.56 0.44 Allowed 'General case' 0 N--CA 1.501 2.121 0 N-CA-C 118.362 2.727 . . . . 0.0 118.362 -178.488 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -139.47 142.61 37.35 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 119.736 1.153 . . . . 0.0 108.992 -175.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 38.7 t -92.67 114.75 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 177.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 61.6 mt-30 -96.27 118.35 32.65 Favored 'General case' 0 N--CA 1.485 1.301 0 CA-C-O 121.666 0.746 . . . . 0.0 109.848 -178.123 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 13.9 m-70 -99.25 99.61 10.59 Favored 'General case' 0 CA--C 1.552 1.054 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 -175.432 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -96.9 121.48 38.82 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 -175.891 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 65.5 pttt -75.78 116.05 16.09 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.402 0.62 . . . . 0.0 112.59 -169.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 92.0 t -88.12 109.31 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 179.182 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 57.8 mt -91.91 145.46 24.53 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.378 -174.505 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 60.9 mtp180 -122.82 124.53 43.5 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.768 -0.583 . . . . 0.0 109.516 -170.394 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -111.16 99.45 8.29 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 123.263 0.625 . . . . 0.0 110.162 177.761 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 76.44 89.44 0.27 Allowed Glycine 0 N--CA 1.482 1.761 0 CA-C-O 119.452 -0.638 . . . . 0.0 113.953 174.453 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . 0.332 . . 75.8 -78.25 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 124.696 1.199 . . . . 0.0 112.675 -175.907 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -165.48 75.63 0.15 Allowed Glycine 0 CA--C 1.537 1.431 0 CA-C-O 119.782 -0.455 . . . . 0.0 112.077 173.472 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -105.73 98.31 8.02 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 104.44 -2.43 . . . . 0.0 104.44 169.797 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -80.05 100.93 8.41 Favored 'General case' 0 N--CA 1.484 1.242 0 CA-C-N 114.617 -1.174 . . . . 0.0 112.286 -167.82 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -108.91 113.39 26.25 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.559 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 64.2 tp -111.12 -49.5 3.01 Favored 'General case' 0 CA--C 1.564 1.504 0 CA-C-N 114.589 -1.187 . . . . 0.0 111.332 176.708 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 85.9 t90 -129.99 101.98 6.07 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 -175.571 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . 0.519 29.8 m 63.43 -88.02 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 114.895 1.443 . . . . 0.0 114.895 177.146 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 8.6 p -79.99 147.86 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 C-N-CA 124.002 0.921 . . . . 0.0 112.241 -174.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 25.6 pttm -80.04 153.29 28.9 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 121.699 0.762 . . . . 0.0 112.991 173.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -131.24 120.2 22.89 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 -175.258 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 56.1 m-80 -58.63 -51.66 68.97 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 114.617 1.34 . . . . 0.0 114.617 -178.722 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 67.2 m -97.14 148.97 22.51 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-O 122.612 1.196 . . . . 0.0 111.664 176.484 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 15.4 tp -65.63 -37.75 87.46 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 172.752 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -65.41 -32.92 74.8 Favored 'General case' 0 CA--C 1.572 1.81 0 N-CA-C 114.22 1.193 . . . . 0.0 114.22 168.77 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -63.19 -41.85 99.24 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-N 120.602 1.547 . . . . 0.0 114.416 169.474 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 63.5 tp -58.69 -43.44 89.99 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 169.086 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 25.7 t -58.62 -64.07 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 C-N-CA 124.447 1.099 . . . . 0.0 112.388 171.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -59.66 -30.91 69.08 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 116.116 1.895 . . . . 0.0 116.116 -174.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 85.4 t80 -63.61 -54.07 41.67 Favored 'General case' 0 CA--C 1.567 1.597 0 CA-C-N 118.815 0.734 . . . . 0.0 112.217 168.808 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . 0.27 62.2 m-70 -69.92 -9.32 54.58 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 117.891 2.552 . . . . 0.0 117.891 177.354 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -51.23 -38.87 54.89 Favored 'General case' 0 N--CA 1.501 2.087 0 CA-C-N 120.726 1.603 . . . . 0.0 113.603 167.154 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 70.0 m -102.91 -34.01 9.12 Favored 'General case' 0 CA--C 1.564 1.505 0 N-CA-C 114.668 1.358 . . . . 0.0 114.668 169.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 30.3 m -90.17 152.43 21.11 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-N 120.681 1.582 . . . . 0.0 111.178 -176.403 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 29.9 t -74.87 136.58 41.5 Favored 'General case' 0 CA--C 1.56 1.346 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 177.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 88.3 t -71.79 -50.91 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.903 169.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 58.5 m -91.18 154.58 19.22 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-O 122.162 0.982 . . . . 0.0 111.745 -178.45 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 10.4 mpt_? -71.9 -54.04 11.29 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.709 177.276 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 24.6 t30 -72.6 -59.56 2.66 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 173.285 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -79.89 150.62 30.52 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-N 118.793 0.724 . . . . 0.0 112.221 -177.14 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -101.45 96.97 7.49 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.383 0.673 . . . . 0.0 109.488 -179.462 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 5.2 mp -109.11 110.71 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 -179.421 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 19.3 m-30 -108.26 137.34 46.4 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 173.675 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 9.7 mp -85.47 128.92 34.89 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 123.36 0.664 . . . . 0.0 112.097 -169.711 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 4.9 mpt_? -129.07 173.77 10.15 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-O 123.409 1.576 . . . . 0.0 109.843 172.208 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -84.46 157.97 21.18 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-N 114.739 -1.119 . . . . 0.0 113.711 -177.187 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 29.2 pt -75.36 153.07 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 CA-C-O 121.704 0.764 . . . . 0.0 112.936 178.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 . . . . . 0 N--CA 1.485 1.305 0 CA-C-O 123.977 1.846 . . . . 0.0 108.847 -178.483 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 68.6 p-90 . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 116.109 1.892 . . . . 0.0 116.109 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -84.05 129.26 34.92 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-N 119.464 1.029 . . . . 0.0 110.646 -174.902 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -135.5 101.87 4.94 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 105.582 -2.006 . . . . 0.0 105.582 171.939 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -78.81 108.7 2.71 Favored Glycine 0 CA--C 1.541 1.661 0 CA-C-N 115.969 -0.56 . . . . 0.0 113.317 -173.711 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . 0.27 2.8 tppp? 66.36 80.27 0.22 Allowed 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 124.878 1.271 . . . . 0.0 112.178 -175.573 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.25 130.61 23.71 Favored Pre-proline 0 CA--C 1.572 1.792 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 -175.718 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -63.74 144.75 89.86 Favored 'Trans proline' 0 CA--C 1.559 1.729 0 C-N-CA 122.842 2.361 . . . . 0.0 114.532 -176.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 60.1 ttt180 -59.74 -39.32 84.36 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 116.672 2.101 . . . . 0.0 116.672 -172.725 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.8 -45.59 85.62 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 115.1 1.519 . . . . 0.0 115.1 174.174 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -62.92 -36.72 84.34 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 115.038 1.495 . . . . 0.0 115.038 169.704 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.46 -44.11 97.69 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 115.59 1.7 . . . . 0.0 115.59 169.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -66.07 -38.83 89.29 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 115.26 1.578 . . . . 0.0 115.26 173.156 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -65.39 -43.88 89.25 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 115.467 1.654 . . . . 0.0 115.467 173.192 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -66.38 -43.15 86.71 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 114.464 1.283 . . . . 0.0 114.464 174.501 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 94.7 mt -69.8 -31.36 69.23 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 116.179 1.918 . . . . 0.0 116.179 173.545 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 89.7 p -61.67 -35.78 78.94 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-N 120.245 1.384 . . . . 0.0 114.433 168.828 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -63.2 -35.22 79.6 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 114.664 1.357 . . . . 0.0 114.664 168.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -63.57 120.88 12.59 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-O 122.23 1.014 . . . . 0.0 111.706 169.879 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 17.1 ptm180 -70.65 -18.08 62.85 Favored 'General case' 0 CA--C 1.567 1.623 0 N-CA-C 119.061 2.986 . . . . 0.0 119.061 -179.512 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 51.7 m80 -89.5 146.54 24.55 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-N 119.651 1.114 . . . . 0.0 113.455 -168.469 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -80.77 110.57 16.41 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.189 -1.411 . . . . 0.0 107.189 169.655 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 120.1 -17.45 9.88 Favored Glycine 0 CA--C 1.552 2.357 0 CA-C-O 117.347 -1.807 . . . . 0.0 116.043 -168.854 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.99 113.25 3.36 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-N 120.847 2.323 . . . . 0.0 112.964 -173.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -126.8 168.59 14.22 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 115.167 1.543 . . . . 0.0 115.167 -168.777 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.5 pp -149.8 134.6 17.75 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 167.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 53.7 mt -85.64 113.25 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 174.836 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 61.7 ttp85 -95.15 138.86 32.3 Favored 'General case' 0 N--CA 1.483 1.195 0 CA-C-N 114.203 -1.362 . . . . 0.0 110.02 175.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -84.4 125.98 32.81 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 169.051 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 50.7 m -67.06 128.51 36.62 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.709 0.804 . . . . 0.0 112.411 -169.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -65.76 -49.66 67.57 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 -173.626 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.4 t -63.96 -40.36 96.25 Favored 'General case' 0 CA--C 1.564 1.51 0 N-CA-C 115.563 1.69 . . . . 0.0 115.563 170.447 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -112.28 93.53 22.7 Favored Pre-proline 0 CA--C 1.564 1.511 0 CA-C-O 118.02 -0.99 . . . . 0.0 109.779 178.829 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.58 132.87 21.2 Favored 'Trans proline' 0 C--N 1.371 1.747 0 C-N-CA 123.132 2.555 . . . . 0.0 112.076 177.906 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 98.91 -34.81 5.08 Favored Glycine 0 CA--C 1.554 2.512 0 CA-C-O 119.055 -0.858 . . . . 0.0 114.464 -168.619 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -79.24 139.25 37.96 Favored 'General case' 0 N--CA 1.485 1.325 0 CA-C-N 118.529 1.164 . . . . 0.0 109.356 171.026 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -110.0 162.64 14.34 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 122.223 1.011 . . . . 0.0 111.305 -176.64 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 71.0 m -136.55 117.15 13.88 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 173.862 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 26.6 tp -79.71 106.62 11.87 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 124.254 1.022 . . . . 0.0 108.731 176.173 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.6 m -95.75 95.69 8.47 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 -170.465 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 17.6 t -112.08 122.0 65.57 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 -170.196 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -83.29 102.97 12.32 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 169.851 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -126.14 117.19 22.62 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 107.807 -1.182 . . . . 0.0 107.807 177.3 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 86.43 -106.35 3.09 Favored Glycine 0 N--CA 1.48 1.621 0 N-CA-C 110.547 -1.021 . . . . 0.0 110.547 -175.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 31.6 t30 -141.88 56.51 1.49 Allowed 'General case' 0 CA--C 1.566 1.574 0 C-N-CA 122.843 0.457 . . . . 0.0 109.999 169.3 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -158.92 133.2 7.82 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 178.114 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 56.6 t -91.85 109.94 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 173.43 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -106.43 115.67 30.62 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.795 0.838 . . . . 0.0 108.786 -169.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 18.4 m-70 -94.88 96.73 9.52 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 114.918 -1.037 . . . . 0.0 108.375 -172.814 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -94.32 122.13 36.56 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 -174.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -73.79 120.05 18.85 Favored 'General case' 0 N--CA 1.487 1.379 0 CA-C-O 121.445 0.64 . . . . 0.0 111.809 -169.602 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 76.9 t -97.35 101.4 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 N-CA-C 105.658 -1.979 . . . . 0.0 105.658 175.894 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -100.13 149.51 23.44 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.284 0.634 . . . . 0.0 110.522 177.588 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 54.7 mtp180 -110.54 128.0 55.45 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 123.164 0.586 . . . . 0.0 110.316 -169.779 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . 0.277 4.2 p-10 -83.74 -68.64 0.7 Allowed 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 179.791 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -91.13 -114.56 1.83 Allowed Glycine 0 N--CA 1.482 1.734 0 CA-C-N 119.352 0.978 . . . . 0.0 112.189 -176.181 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -81.1 -71.65 0.46 Allowed 'General case' 0 N--CA 1.487 1.386 0 CA-C-O 118.357 -0.83 . . . . 0.0 110.607 173.3 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -134.7 68.1 0.54 Allowed Glycine 0 N--CA 1.48 1.607 0 CA-C-N 118.731 0.696 . . . . 0.0 112.28 169.891 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 2.3 mppt? -107.28 97.11 6.91 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 105.751 -1.944 . . . . 0.0 105.751 171.072 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -86.88 110.89 20.29 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 114.309 -1.314 . . . . 0.0 109.343 -169.47 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -130.56 136.2 48.67 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 121.319 0.58 . . . . 0.0 110.324 -173.206 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -128.27 -51.51 1.3 Allowed 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 124.067 0.947 . . . . 0.0 111.972 177.472 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 58.7 t90 -94.46 -79.6 0.42 Allowed 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 124.368 1.067 . . . . 0.0 110.331 -172.508 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 95.0 t -128.84 -77.77 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 -175.913 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 10.8 p -80.87 138.86 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 C-N-CA 123.508 0.723 . . . . 0.0 111.362 -172.023 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.77 147.71 31.74 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 121.648 0.737 . . . . 0.0 112.511 179.309 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -124.26 108.81 12.64 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 -169.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 17.7 p30 -55.79 -30.38 61.24 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 118.195 2.665 . . . . 0.0 118.195 177.831 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 30.9 t -124.97 146.3 49.46 Favored 'General case' 0 N--CA 1.484 1.237 0 CA-C-O 121.942 0.877 . . . . 0.0 111.436 -177.375 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 89.6 mt -83.77 103.56 13.16 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 105.356 -2.091 . . . . 0.0 105.356 168.782 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . 0.273 28.5 t-20 145.98 -57.79 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 104.53 -2.396 . . . . 0.0 104.53 -168.557 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -56.91 -42.44 79.93 Favored 'General case' 0 CA--C 1.574 1.868 0 C-N-CA 124.26 1.024 . . . . 0.0 113.597 168.149 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 8.4 tt -55.46 -49.44 72.48 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 114.888 1.44 . . . . 0.0 114.888 169.638 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . 0.276 3.6 m -63.43 -51.47 70.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 CA-C-N 119.224 0.92 . . . . 0.0 113.223 178.188 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -64.67 -33.56 76.24 Favored 'General case' 0 CA--C 1.568 1.664 0 N-CA-C 115.182 1.549 . . . . 0.0 115.182 -176.479 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 69.2 t80 -62.12 -59.33 5.22 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-N 119.749 1.159 . . . . 0.0 112.826 169.722 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 60.7 m-70 -68.94 -9.38 51.7 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 117.906 2.558 . . . . 0.0 117.906 178.389 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 54.5 ttm-85 -53.76 -31.42 48.55 Favored 'General case' 0 CA--C 1.574 1.868 0 N-CA-C 115.074 1.509 . . . . 0.0 115.074 168.811 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 70.9 m -116.49 -24.32 7.9 Favored 'General case' 0 CA--C 1.57 1.716 0 C-N-CA 125.071 1.348 . . . . 0.0 114.216 169.307 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 61.0 m -90.13 151.67 21.48 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-N 120.837 1.653 . . . . 0.0 110.577 177.184 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 32.2 t -68.35 129.09 38.88 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 178.305 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 35.1 t -71.42 -48.79 51.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 CA-C-O 118.296 -0.859 . . . . 0.0 111.95 172.419 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 15.7 p -91.08 168.41 11.66 Favored 'General case' 0 N--CA 1.487 1.411 0 CA-C-N 119.235 0.925 . . . . 0.0 112.122 -179.207 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 30.7 mmt180 -72.11 -58.42 3.44 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 177.53 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 23.8 t30 -75.64 -61.72 1.82 Allowed 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 65.3 mt-30 -79.95 150.35 30.53 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 118.638 0.654 . . . . 0.0 112.225 -175.006 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -83.09 121.37 26.95 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 122.843 0.457 . . . . 0.0 110.553 169.879 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 3.6 mp -123.64 108.82 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 104.248 -2.501 . . . . 0.0 104.248 172.107 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 18.3 m-30 -113.93 108.19 16.71 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 105.771 -1.937 . . . . 0.0 105.771 179.3 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . 0.35 1.0 OUTLIER -76.15 170.27 16.62 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 116.381 1.993 . . . . 0.0 116.381 -169.15 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 3.9 tmt_? -160.04 138.22 10.16 Favored 'General case' 0 CA--C 1.56 1.355 0 N-CA-C 104.621 -2.362 . . . . 0.0 104.621 -169.548 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -67.8 172.39 5.42 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.115 -1.616 . . . . 0.0 114.248 178.353 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 18.3 pt -70.62 156.91 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 O-C-N 120.883 -1.136 . . . . 0.0 113.184 -175.597 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 . . . . . 0 N--CA 1.489 1.486 0 CA-C-O 122.859 1.314 . . . . 0.0 109.869 176.554 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 62.9 p-90 . . . . . 0 N--CA 1.493 1.678 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 44.6 t80 -82.79 137.82 34.22 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 120.249 1.386 . . . . 0.0 111.799 -173.124 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -118.64 -73.2 0.65 Allowed 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.43 176.88 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 108.32 84.85 1.67 Allowed Glycine 0 N--CA 1.481 1.697 0 CA-C-N 118.923 0.783 . . . . 0.0 111.397 -176.253 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.532 ' H ' ' H ' ' A' ' 87' ' ' GLU 0.304 33.0 ttmt 64.98 79.98 0.24 Allowed 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 125.179 1.392 . . . . 0.0 114.109 178.878 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 17.8 pt -126.14 157.79 68.58 Favored Pre-proline 0 CA--C 1.579 2.083 0 C-N-CA 124.257 1.023 . . . . 0.0 109.396 171.462 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -75.79 165.07 30.83 Favored 'Trans proline' 0 CA--C 1.564 1.976 0 C-N-CA 122.712 2.274 . . . . 0.0 115.092 -178.452 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 30.0 ttm180 -63.98 -45.49 88.85 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 115.913 1.82 . . . . 0.0 115.913 176.052 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.23 -46.42 87.0 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 115.337 1.606 . . . . 0.0 115.337 -179.278 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm -62.97 -34.71 78.09 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 115.265 1.58 . . . . 0.0 115.265 169.812 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.88 -42.66 90.04 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 115.442 1.645 . . . . 0.0 115.442 170.398 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -60.54 -44.91 95.58 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 115.212 1.56 . . . . 0.0 115.212 170.682 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -58.66 -50.76 72.69 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 114.979 1.474 . . . . 0.0 114.979 175.739 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -63.96 -49.15 73.68 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 114.708 1.373 . . . . 0.0 114.708 176.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 8.8 mp -71.02 -33.12 70.04 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 116.563 2.06 . . . . 0.0 116.563 -176.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 66.7 m -60.17 -33.09 71.71 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 116.08 1.882 . . . . 0.0 116.08 169.847 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 57.4 mtmt -64.1 -33.64 76.22 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 115.934 1.827 . . . . 0.0 115.934 169.853 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -64.5 127.01 29.66 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.62 1.168 . . . . 0.0 113.009 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -62.29 -21.47 65.26 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 119.042 2.978 . . . . 0.0 119.042 177.582 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 43.4 m80 -89.38 132.71 34.84 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 119.264 0.938 . . . . 0.0 111.09 -169.089 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -75.55 105.36 6.54 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 171.325 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 124.78 -7.78 8.25 Favored Glycine 0 CA--C 1.553 2.448 0 CA-C-O 116.91 -2.05 . . . . 0.0 116.523 -169.029 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.12 111.92 2.77 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 121.229 2.515 . . . . 0.0 111.968 -171.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 20.1 p90 -128.24 161.96 28.11 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 115.427 1.64 . . . . 0.0 115.427 -168.395 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.1 pp -139.69 136.06 33.84 Favored 'General case' 0 CA--C 1.555 1.14 0 CA-C-N 113.919 -1.491 . . . . 0.0 107.884 168.372 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 62.7 mt -97.13 106.5 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 169.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 46.7 ptt85 -95.45 157.18 16.01 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 114.45 -1.25 . . . . 0.0 110.324 169.613 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.532 ' H ' ' H ' ' A' ' 64' ' ' LYS . 28.8 tt0 -85.06 135.87 33.81 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.431 -0.793 . . . . 0.0 109.163 169.484 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 93.3 p -68.67 121.9 17.41 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-O 121.026 0.441 . . . . 0.0 110.815 172.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -68.66 -39.37 80.69 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 116.684 2.105 . . . . 0.0 116.684 -175.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.5 t -63.1 -22.13 66.65 Favored 'General case' 0 CA--C 1.569 1.697 0 N-CA-C 115.864 1.802 . . . . 0.0 115.864 169.2 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -135.45 94.78 15.06 Favored Pre-proline 0 CA--C 1.563 1.446 0 CA-C-N 120.011 1.278 . . . . 0.0 109.027 177.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -70.33 134.06 25.93 Favored 'Trans proline' 0 C--N 1.372 1.795 0 C-N-CA 123.038 2.492 . . . . 0.0 111.933 176.042 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 101.31 -38.05 3.33 Favored Glycine 0 CA--C 1.555 2.574 0 CA-C-O 119.382 -0.676 . . . . 0.0 113.48 -168.241 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -79.46 130.91 35.86 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 118.182 0.991 . . . . 0.0 109.182 169.729 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -107.42 169.38 8.61 Favored 'General case' 0 N--CA 1.486 1.374 0 CA-C-O 122.439 1.114 . . . . 0.0 110.861 -178.259 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 69.4 m -141.65 117.64 10.56 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -179.3 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 31.2 tp -79.96 113.65 18.28 Favored 'General case' 0 CA--C 1.559 1.314 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 169.878 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 9.6 m -97.91 104.0 15.99 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 173.204 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.8 p -124.76 117.63 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 CA-C-N 118.964 0.802 . . . . 0.0 109.0 -171.047 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -74.62 140.0 44.01 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.931 169.698 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 15.8 t80 -157.0 95.12 1.48 Allowed 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 171.558 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 70.04 74.87 0.62 Allowed Glycine 0 CA--C 1.544 1.902 0 CA-C-O 119.421 -0.655 . . . . 0.0 114.64 -177.867 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . 0.366 9.7 t-20 78.62 -58.14 0.44 Allowed 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 116.664 2.098 . . . . 0.0 116.664 -179.026 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -91.16 142.85 27.3 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 123.898 0.879 . . . . 0.0 112.019 -169.32 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 41.6 t -102.27 113.21 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 N-CA-C 106.592 -1.632 . . . . 0.0 106.592 -178.104 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -96.83 117.99 32.29 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.897 0.879 . . . . 0.0 109.334 -176.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 10.5 m-70 -97.98 97.26 8.77 Favored 'General case' 0 CA--C 1.554 1.119 0 CA-C-N 114.991 -1.004 . . . . 0.0 108.443 -174.275 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -100.86 135.11 42.83 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 124.061 0.945 . . . . 0.0 109.11 -178.613 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 12.2 mmmm -79.44 125.34 29.42 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.858 -0.526 . . . . 0.0 111.957 -178.31 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 96.2 t -85.7 112.94 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 106.484 -1.672 . . . . 0.0 106.484 171.017 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -114.85 145.06 42.57 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.231 0.612 . . . . 0.0 110.528 -175.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -97.11 158.26 15.52 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -175.211 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -123.1 100.85 7.08 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 169.452 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 90.73 -112.72 4.14 Favored Glycine 0 CA--C 1.542 1.722 0 CA-C-O 120.082 -0.288 . . . . 0.0 113.417 176.837 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -84.75 -74.18 0.4 Allowed 'General case' 0 N--CA 1.488 1.462 0 CA-C-O 118.886 -0.578 . . . . 0.0 112.215 -173.583 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -148.22 74.36 0.28 Allowed Glycine 0 N--CA 1.479 1.518 0 N-CA-C 110.499 -1.04 . . . . 0.0 110.499 173.498 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -122.38 89.57 3.14 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 -177.106 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -80.02 115.61 19.69 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.791 -169.404 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 26.5 p90 -124.86 120.42 31.63 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 174.704 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -87.86 -59.94 2.1 Favored 'General case' 0 CA--C 1.562 1.424 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.086 169.797 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 39.3 t90 -80.25 -81.44 0.12 Allowed 'General case' 0 CA--C 1.56 1.343 0 C-N-CA 124.82 1.248 . . . . 0.0 110.383 -175.053 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.1 m -140.44 -53.76 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 C-N-CA 124.012 0.925 . . . . 0.0 110.937 176.524 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 3.4 m -79.78 140.85 16.14 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.458 0 C-N-CA 124.411 1.084 . . . . 0.0 112.096 -174.559 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.45 152.34 18.5 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 -171.047 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -146.22 119.91 9.2 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 -171.537 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -55.91 -40.46 73.09 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 116.575 2.065 . . . . 0.0 116.575 -177.471 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 27.1 t -102.63 153.07 20.46 Favored 'General case' 0 N--CA 1.485 1.321 0 CA-C-N 119.031 0.832 . . . . 0.0 111.483 174.86 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 82.9 mt -67.85 -32.64 73.31 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 169.028 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -64.26 -39.69 94.46 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 119.701 1.137 . . . . 0.0 113.803 170.471 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -60.56 -44.12 96.5 Favored 'General case' 0 CA--C 1.573 1.854 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 169.279 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 49.3 tp -55.5 -44.84 76.96 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 115.411 1.634 . . . . 0.0 115.411 169.717 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . 0.282 10.9 m -63.73 -51.5 69.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 CA-C-N 120.124 1.329 . . . . 0.0 113.232 175.11 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -63.34 -36.05 82.41 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 114.625 1.343 . . . . 0.0 114.625 -175.175 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 90.3 t80 -60.61 -52.72 63.97 Favored 'General case' 0 CA--C 1.57 1.733 0 CA-C-N 119.404 1.002 . . . . 0.0 112.03 168.216 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 50.7 m-70 -72.7 -9.13 58.27 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 118.728 2.862 . . . . 0.0 118.728 178.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 88.1 mtt-85 -59.84 -29.04 68.0 Favored 'General case' 0 CA--C 1.575 1.937 0 CA-C-N 120.156 1.344 . . . . 0.0 113.447 167.774 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 69.7 m -103.01 -39.57 6.85 Favored 'General case' 0 CA--C 1.569 1.696 0 C-N-CA 125.022 1.329 . . . . 0.0 113.094 168.608 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 34.3 m -90.53 156.38 18.21 Favored 'General case' 0 N--CA 1.498 1.94 0 CA-C-N 120.142 1.337 . . . . 0.0 112.031 -176.68 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 35.3 t -75.07 132.91 41.62 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 3.3 m -78.88 -38.39 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 114.976 1.472 . . . . 0.0 114.976 169.788 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 16.8 t -79.82 -40.12 29.25 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 116.61 2.078 . . . . 0.0 116.61 -169.647 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 15.9 tpt180 84.49 115.88 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 124.777 1.231 . . . . 0.0 108.903 -170.805 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . 0.351 59.2 m-80 83.62 -58.53 0.14 Allowed 'General case' 0 N--CA 1.499 2.017 0 C-N-CA 124.507 1.123 . . . . 0.0 112.604 -172.496 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 -79.57 126.63 31.13 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 170.463 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 76.3 mm-40 -90.1 96.03 10.48 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 -175.497 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 29.6 mm -111.68 109.4 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 105.787 -1.931 . . . . 0.0 105.787 -173.082 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -111.95 121.93 46.36 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 -173.016 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 10.5 mp -75.1 136.62 41.12 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 -168.681 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 81.7 mmt-85 -131.54 153.57 49.71 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 125.368 1.467 . . . . 0.0 108.381 178.468 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -79.31 157.39 27.71 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.822 -1.174 . . . . 0.0 112.798 -177.689 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 8.5 mt -69.35 146.68 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 C-N-CA 123.934 0.894 . . . . 0.0 109.886 -179.283 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 123.946 1.832 . . . . 0.0 108.149 178.726 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . 0.418 70.5 p-90 . . . . . 0 N--CA 1.5 2.071 0 N-CA-C 120.732 3.604 . . . . 0.0 120.732 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 44.4 t80 -96.95 131.6 43.59 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.78 0.832 . . . . 0.0 110.153 -169.728 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -107.73 -65.89 1.08 Allowed 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.352 173.675 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.04 77.66 1.31 Allowed Glycine 0 N--CA 1.482 1.744 0 CA-C-N 118.952 0.796 . . . . 0.0 112.375 -179.713 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . 0.298 61.9 tttt 71.24 71.74 0.18 Allowed 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 124.62 1.168 . . . . 0.0 113.936 175.049 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 14.9 pt -118.95 154.74 53.22 Favored Pre-proline 0 CA--C 1.576 1.959 0 C-N-CA 124.056 0.942 . . . . 0.0 109.069 170.068 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -75.71 172.65 15.91 Favored 'Trans proline' 0 CA--C 1.564 2.015 0 C-N-CA 122.702 2.268 . . . . 0.0 114.34 178.687 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 28.6 ttm180 -61.63 -43.86 98.07 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 115.915 1.82 . . . . 0.0 115.915 175.407 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -65.3 -43.38 91.29 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 115.805 1.78 . . . . 0.0 115.805 178.349 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -67.39 -32.54 73.51 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 115.362 1.615 . . . . 0.0 115.362 169.875 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.26 -42.14 88.95 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 115.328 1.603 . . . . 0.0 115.328 169.753 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -62.81 -42.4 99.7 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 114.346 1.239 . . . . 0.0 114.346 169.585 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -53.41 -48.07 69.03 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 115.395 1.628 . . . . 0.0 115.395 170.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 37.3 mmt -62.37 -48.32 80.31 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 173.66 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 88.8 mt -76.22 -9.82 58.93 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 117.775 2.509 . . . . 0.0 117.775 178.466 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 72.4 m -57.69 -38.73 75.71 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 115.875 1.805 . . . . 0.0 115.875 170.855 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -60.39 -33.27 72.24 Favored 'General case' 0 CA--C 1.571 1.778 0 N-CA-C 116.061 1.875 . . . . 0.0 116.061 169.739 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -71.7 111.46 6.99 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.165 0.986 . . . . 0.0 112.122 -171.511 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 13.4 ptp180 -74.28 -17.57 60.84 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 117.86 2.541 . . . . 0.0 117.86 173.735 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 48.4 m80 -89.63 137.29 32.45 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 119.248 0.931 . . . . 0.0 111.338 -168.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -77.56 115.23 17.15 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 122.951 0.5 . . . . 0.0 110.444 176.711 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 114.63 -23.19 12.27 Favored Glycine 0 CA--C 1.551 2.321 0 CA-C-O 117.269 -1.851 . . . . 0.0 116.246 -169.291 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.4 113.47 1.99 Allowed 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 120.66 2.23 . . . . 0.0 113.238 -176.779 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 27.3 p90 -130.18 165.07 23.11 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 115.828 1.788 . . . . 0.0 115.828 -168.514 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.0 pp -142.16 125.25 16.3 Favored 'General case' 0 CA--C 1.557 1.233 0 N-CA-C 106.803 -1.555 . . . . 0.0 106.803 168.285 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 59.9 mt -87.07 114.12 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 106.584 -1.636 . . . . 0.0 106.584 173.398 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 49.3 ptt85 -99.78 159.2 15.24 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-N 114.931 -1.031 . . . . 0.0 111.042 170.028 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -86.58 135.28 33.49 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 168.368 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 84.1 p -65.32 128.45 35.9 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-O 121.275 0.559 . . . . 0.0 111.733 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -62.46 -45.46 92.94 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 116.017 1.858 . . . . 0.0 116.017 -169.725 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 68.1 m -69.72 -33.15 72.09 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 116.053 1.871 . . . . 0.0 116.053 171.405 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -119.18 101.04 50.01 Favored Pre-proline 0 CA--C 1.563 1.469 0 CA-C-N 120.018 1.281 . . . . 0.0 110.939 -175.72 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -59.46 -32.16 95.92 Favored 'Trans proline' 0 C--N 1.369 1.655 0 N-CA-C 119.934 3.013 . . . . 0.0 119.934 174.477 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -87.23 44.82 3.33 Favored Glycine 0 CA--C 1.553 2.41 0 N-CA-C 115.247 0.859 . . . . 0.0 115.247 169.374 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -160.13 130.19 5.37 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 106.187 -1.783 . . . . 0.0 106.187 -178.079 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 -103.9 174.73 5.74 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 122.106 0.955 . . . . 0.0 111.181 172.661 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 62.0 m -149.03 120.4 7.88 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 -179.633 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 36.4 tp -79.93 110.51 15.37 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.803 0.841 . . . . 0.0 109.173 170.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.6 m -96.16 103.1 14.98 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 105.696 -1.964 . . . . 0.0 105.696 174.201 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.4 p -122.21 121.12 63.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 CA-C-O 121.471 0.653 . . . . 0.0 109.809 -169.6 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 58.1 tptt -82.68 98.63 9.15 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 124.32 1.048 . . . . 0.0 109.941 177.22 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -120.08 93.31 4.01 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -175.658 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 69.28 65.18 2.68 Favored Glycine 0 CA--C 1.544 1.845 0 N-CA-C 115.658 1.023 . . . . 0.0 115.658 175.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . 0.269 26.8 t30 54.78 41.83 31.63 Favored 'General case' 0 CA--C 1.574 1.903 0 N-CA-C 116.419 2.007 . . . . 0.0 116.419 -174.207 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -160.77 129.92 4.81 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.541 -0.724 . . . . 0.0 109.738 176.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 41.1 t -94.71 106.04 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 178.328 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -98.73 119.6 37.75 Favored 'General case' 0 N--CA 1.484 1.27 0 CA-C-O 121.704 0.764 . . . . 0.0 109.37 -177.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 13.0 m-70 -99.19 109.23 21.93 Favored 'General case' 0 CA--C 1.552 1.034 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 -176.278 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -114.49 127.94 56.07 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -176.491 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -74.29 132.32 41.98 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-O 121.785 0.802 . . . . 0.0 112.751 -177.248 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 92.9 t -101.97 103.99 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 N-CA-C 104.859 -2.274 . . . . 0.0 104.859 174.77 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -104.44 132.35 50.78 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.517 0.727 . . . . 0.0 110.129 -173.5 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -84.96 161.88 19.62 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 121.895 0.855 . . . . 0.0 112.306 -179.261 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 20.7 p-10 -79.69 -39.41 31.35 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 169.685 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -178.53 -79.09 0.06 OUTLIER Glycine 0 CA--C 1.539 1.586 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 -173.361 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -74.83 -69.34 0.47 Allowed 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 177.426 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -174.18 68.78 0.1 OUTLIER Glycine 0 N--CA 1.479 1.529 0 CA-C-N 118.874 0.761 . . . . 0.0 113.294 175.636 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -120.38 102.33 8.39 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 105.38 -2.082 . . . . 0.0 105.38 171.482 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -81.4 121.39 26.17 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.439 1.095 . . . . 0.0 110.488 -169.784 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 44.0 p90 -130.03 122.0 27.54 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 121.31 0.576 . . . . 0.0 109.616 174.226 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 5.0 tt -89.36 -65.2 1.04 Allowed 'General case' 0 N--CA 1.488 1.472 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.126 169.65 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 20.2 t90 -82.32 -61.78 1.8 Allowed 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 124.446 1.098 . . . . 0.0 112.55 -172.553 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . 0.258 11.2 p -149.76 -67.36 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 CA-C-N 118.849 0.75 . . . . 0.0 110.114 -178.858 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 3.4 m -79.64 141.91 14.68 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.419 0 C-N-CA 124.291 1.036 . . . . 0.0 112.301 -171.674 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 10.0 ptpp? -96.64 156.24 16.43 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -173.832 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -145.14 132.12 20.27 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.248 -169.487 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 -50.61 -41.73 55.16 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 117.922 2.564 . . . . 0.0 117.922 177.145 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 90.5 p -122.65 159.33 28.11 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-O 122.688 1.233 . . . . 0.0 111.877 178.079 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 61.3 mt -62.69 -31.91 72.9 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 115.186 1.551 . . . . 0.0 115.186 169.63 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -65.36 -36.09 82.96 Favored 'General case' 0 CA--C 1.571 1.755 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 169.701 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -63.26 -47.83 80.75 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-N 119.86 1.209 . . . . 0.0 113.707 169.585 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 60.5 tp -59.53 -38.61 81.45 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 115.724 1.75 . . . . 0.0 115.724 169.685 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . 0.265 0.3 OUTLIER -67.04 -53.9 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 CA-C-N 119.743 1.156 . . . . 0.0 113.251 -179.595 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -57.97 -33.83 69.3 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 115.454 1.65 . . . . 0.0 115.454 172.282 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -57.28 -55.45 34.62 Favored 'General case' 0 CA--C 1.566 1.579 0 CA-C-N 119.353 0.979 . . . . 0.0 113.021 168.745 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . 0.265 52.7 m-70 -74.72 -9.47 58.59 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 117.944 2.572 . . . . 0.0 117.944 177.379 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 94.2 mtt-85 -62.15 -33.35 74.33 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-N 120.883 1.674 . . . . 0.0 112.962 167.168 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 70.6 m -97.03 -40.15 8.99 Favored 'General case' 0 CA--C 1.563 1.476 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 170.291 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 60.7 m -90.8 154.03 19.81 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-N 120.093 1.315 . . . . 0.0 111.527 179.617 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 33.0 t -75.75 134.66 40.41 Favored 'General case' 0 CA--C 1.559 1.323 0 CA-C-O 121.462 0.648 . . . . 0.0 112.556 177.571 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 45.5 t -70.24 -48.29 62.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 CA-C-N 115.419 -0.81 . . . . 0.0 112.202 172.258 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 57.7 m -122.62 154.71 37.64 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-O 122.262 1.03 . . . . 0.0 110.721 -177.616 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 85.2 mtt85 -77.18 -39.88 47.32 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 115.171 1.545 . . . . 0.0 115.171 -177.918 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 22.2 m120 -74.58 -66.45 0.74 Allowed 'General case' 0 N--CA 1.495 1.82 0 CA-C-N 119.902 1.228 . . . . 0.0 111.876 174.423 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 35.7 mm-40 -80.07 126.02 30.53 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 118.909 0.777 . . . . 0.0 109.2 170.08 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 3.2 pm0 -94.43 86.46 4.86 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 123.018 0.527 . . . . 0.0 110.477 -176.653 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 4.0 mp -85.77 122.04 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -169.526 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -121.73 117.11 25.81 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 106.428 -1.694 . . . . 0.0 106.428 176.671 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 11.2 mp -70.85 134.4 47.29 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 -168.738 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 62.7 mmt-85 -132.28 162.71 30.31 Favored 'General case' 0 CA--C 1.564 1.515 0 C-N-CA 124.963 1.305 . . . . 0.0 109.221 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -76.33 158.89 31.05 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.907 -1.12 . . . . 0.0 113.801 176.398 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.1 pp -76.65 161.73 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -177.463 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 . . . . . 0 N--CA 1.484 1.262 0 CA-C-O 124.021 1.867 . . . . 0.0 108.096 177.618 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 1.6 p90 . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 116.248 1.944 . . . . 0.0 116.248 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 72.2 t80 -118.32 124.19 47.17 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 178.008 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -119.39 66.43 0.79 Allowed 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 121.272 0.558 . . . . 0.0 110.82 -179.052 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 53.59 -119.42 10.83 Favored Glycine 0 CA--C 1.547 2.065 0 N-CA-C 118.803 2.281 . . . . 0.0 118.803 169.433 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -141.56 96.53 3.0 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 -171.834 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.01 149.94 75.19 Favored Pre-proline 0 CA--C 1.572 1.815 0 CA-C-O 118.502 -0.761 . . . . 0.0 109.733 176.255 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -66.49 172.11 9.63 Favored 'Trans proline' 0 CA--C 1.563 1.956 0 C-N-CA 123.005 2.47 . . . . 0.0 114.556 172.342 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 59.2 ttt-85 -60.32 -41.9 94.48 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 116.08 1.882 . . . . 0.0 116.08 -177.71 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -66.08 -44.27 84.96 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 115.466 1.654 . . . . 0.0 115.466 176.077 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -63.24 -33.99 76.68 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 115.674 1.731 . . . . 0.0 115.674 170.14 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.47 -43.15 95.11 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 115.302 1.593 . . . . 0.0 115.302 169.609 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -61.22 -43.97 98.02 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 114.943 1.46 . . . . 0.0 114.943 170.261 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -57.18 -44.0 83.17 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 115.626 1.713 . . . . 0.0 115.626 173.095 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 37.9 mmt -63.04 -48.3 79.33 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 114.528 1.307 . . . . 0.0 114.528 172.456 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 95.1 mt -73.25 -12.12 60.75 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 117.518 2.414 . . . . 0.0 117.518 175.272 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 69.6 m -63.0 -37.85 88.82 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-N 120.507 1.503 . . . . 0.0 113.966 168.909 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt -60.59 -33.78 73.24 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 115.386 1.624 . . . . 0.0 115.386 169.206 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -71.2 117.04 12.22 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 124.478 1.111 . . . . 0.0 111.225 178.165 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -79.53 -17.39 54.15 Favored 'General case' 0 CA--C 1.569 1.677 0 N-CA-C 117.531 2.419 . . . . 0.0 117.531 172.904 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 45.8 m80 -89.53 133.22 34.69 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 119.198 0.908 . . . . 0.0 111.929 -168.683 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -71.63 123.31 22.22 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 122.953 0.501 . . . . 0.0 110.833 174.426 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 107.8 -20.22 31.95 Favored Glycine 0 CA--C 1.549 2.179 0 CA-C-O 117.576 -1.68 . . . . 0.0 116.51 -169.257 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.69 123.06 19.07 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-N 120.192 1.996 . . . . 0.0 111.746 -173.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 24.7 p90 -137.36 158.13 45.08 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -168.798 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.3 pp -137.47 127.99 26.68 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 168.458 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 74.1 mt -87.64 113.6 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 105.62 -1.993 . . . . 0.0 105.62 175.446 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 4.1 ptm180 -90.05 149.96 22.29 Favored 'General case' 0 N--CA 1.484 1.27 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.065 170.377 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -85.87 128.43 34.82 Favored 'General case' 0 CA--C 1.56 1.33 0 N-CA-C 106.795 -1.558 . . . . 0.0 106.795 168.671 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 50.3 m -65.01 132.61 49.7 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 -169.853 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -64.67 -50.98 64.92 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 114.666 1.358 . . . . 0.0 114.666 -174.401 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 95.9 p -65.09 -38.95 92.39 Favored 'General case' 0 CA--C 1.562 1.441 0 N-CA-C 116.083 1.883 . . . . 0.0 116.083 169.888 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -114.73 95.16 39.98 Favored Pre-proline 0 CA--C 1.563 1.474 0 CA-C-N 119.66 1.118 . . . . 0.0 109.553 -179.434 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -72.39 135.09 23.84 Favored 'Trans proline' 0 C--N 1.371 1.749 0 C-N-CA 123.068 2.512 . . . . 0.0 112.215 178.325 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 97.41 -40.49 2.52 Favored Glycine 0 CA--C 1.552 2.383 0 CA-C-O 119.308 -0.718 . . . . 0.0 113.627 -168.52 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -79.12 131.4 36.22 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 124.076 0.95 . . . . 0.0 109.168 176.384 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -100.54 168.52 9.67 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 122.102 0.953 . . . . 0.0 111.847 -170.363 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 58.8 m -147.31 123.62 10.93 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 174.106 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 26.8 tp -79.95 108.47 13.55 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.078 0.951 . . . . 0.0 109.635 175.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.2 m -91.38 107.26 19.08 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 106.12 -1.808 . . . . 0.0 106.12 172.607 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.2 p -131.06 116.11 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 -170.899 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.19 113.92 20.35 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.334 175.422 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -132.95 116.39 16.38 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 177.473 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 89.48 -83.33 1.41 Allowed Glycine 0 N--CA 1.481 1.654 0 CA-C-N 116.243 -0.435 . . . . 0.0 112.063 -179.306 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 10.6 p30 -138.62 -26.4 0.88 Allowed 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 115.533 1.679 . . . . 0.0 115.533 170.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -98.05 142.42 29.77 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 124.051 0.94 . . . . 0.0 110.668 -171.728 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 47.8 t -85.64 110.01 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 N-CA-C 106.533 -1.654 . . . . 0.0 106.533 172.061 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 61.9 mt-30 -104.42 113.92 27.8 Favored 'General case' 0 N--CA 1.484 1.26 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.002 -169.939 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 16.8 m-70 -96.26 102.49 14.28 Favored 'General case' 0 CA--C 1.553 1.071 0 CA-C-N 114.766 -1.106 . . . . 0.0 108.262 -174.192 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -106.78 123.24 47.85 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 -179.233 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 43.6 mtpt -77.2 122.95 25.76 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 121.687 0.756 . . . . 0.0 112.101 -169.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 98.7 t -92.35 96.94 6.66 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.591 0 N-CA-C 105.026 -2.213 . . . . 0.0 105.026 177.43 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 62.1 mt -90.52 135.65 33.56 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 -168.755 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 27.1 mtp-105 -87.42 144.01 26.96 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 122.014 0.912 . . . . 0.0 112.888 176.906 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -86.57 -53.67 4.84 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-N 114.474 -1.239 . . . . 0.0 114.304 176.593 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -165.71 -86.08 0.06 OUTLIER Glycine 0 N--CA 1.48 1.628 0 CA-C-N 119.895 1.225 . . . . 0.0 113.287 -173.08 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -68.29 -63.79 0.99 Allowed 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 114.531 1.308 . . . . 0.0 114.531 -172.394 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -161.97 13.75 0.13 Allowed Glycine 0 CA--C 1.552 2.398 0 N-CA-C 116.728 1.451 . . . . 0.0 116.728 170.823 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -91.96 150.58 20.93 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-N 119.204 1.502 . . . . 0.0 109.084 177.494 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -137.98 137.11 37.59 Favored 'General case' 0 N--CA 1.487 1.411 0 CA-C-N 114.944 -1.026 . . . . 0.0 109.517 -174.774 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -123.73 122.55 38.38 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 124.764 1.226 . . . . 0.0 108.693 -172.011 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 60.7 tp -100.6 -56.96 2.21 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.028 169.454 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 84.6 t90 -133.43 103.66 6.05 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 -174.456 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . 0.405 22.3 t 78.74 -82.8 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 C-N-CA 124.155 0.982 . . . . 0.0 111.982 171.713 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 16.9 m -81.37 140.72 16.16 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.399 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -169.432 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -90.14 138.45 31.51 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.49 0.662 . . . . 0.0 111.106 169.808 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -172.25 139.5 1.05 Allowed 'General case' 0 N--CA 1.488 1.454 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.623 -169.913 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -79.47 74.91 6.09 Favored 'General case' 0 N--CA 1.501 2.086 0 CA-C-O 123.76 1.743 . . . . 0.0 109.784 170.225 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 89.3 p -102.94 63.76 0.83 Allowed 'General case' 0 CA--C 1.554 1.122 1 N-CA-C 124.09 4.848 . . . . 0.0 124.09 -166.501 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 75.7 mt -101.52 86.62 3.0 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 104.224 -2.51 . . . . 0.0 104.224 167.592 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . 0.261 25.0 t-20 133.99 -61.05 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.045 0 C-N-CA 127.39 2.276 . . . . 0.0 105.479 -167.893 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -56.09 -45.58 79.34 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 115.367 1.617 . . . . 0.0 115.367 177.48 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 15.7 tp -66.44 -37.79 85.95 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 177.13 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 44.7 t -58.4 -65.38 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 C-N-CA 124.585 1.154 . . . . 0.0 111.548 174.318 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -66.73 -35.56 80.4 Favored 'General case' 0 CA--C 1.569 1.677 0 N-CA-C 114.826 1.417 . . . . 0.0 114.826 -173.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -58.59 -59.42 5.42 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 124.419 1.088 . . . . 0.0 113.649 169.707 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -74.83 -8.56 56.8 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 117.872 2.545 . . . . 0.0 117.872 177.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 46.1 ttm-85 -52.32 -30.83 30.23 Favored 'General case' 0 CA--C 1.577 1.992 0 N-CA-C 114.818 1.414 . . . . 0.0 114.818 168.23 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 68.0 m -105.05 -40.94 5.72 Favored 'General case' 0 CA--C 1.569 1.673 0 C-N-CA 124.995 1.318 . . . . 0.0 113.037 168.695 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 53.7 m -90.51 150.58 21.72 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-N 120.199 1.363 . . . . 0.0 111.859 -176.773 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 21.7 t -80.63 133.68 35.78 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.107 -0.995 . . . . 0.0 112.828 -178.13 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 8.3 m -66.62 -42.65 90.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 115.398 1.629 . . . . 0.0 115.398 170.649 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 14.3 t -112.65 -45.56 3.22 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 -174.432 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . 0.302 80.3 mtm180 77.15 71.98 0.06 Allowed 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 125.337 1.455 . . . . 0.0 110.64 -169.822 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . 0.269 14.4 p-10 -149.58 -65.91 0.22 Allowed 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.996 -1.112 . . . . 0.0 107.996 173.271 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 -96.29 7.42 46.5 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 115.531 1.678 . . . . 0.0 115.531 169.279 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 83.0 mm-40 56.73 70.31 0.66 Allowed 'General case' 0 N--CA 1.495 1.821 0 C-N-CA 125.196 1.399 . . . . 0.0 111.945 -169.501 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 5.0 mp -85.68 116.68 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 -169.455 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -118.64 137.87 52.99 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-N 115.125 -0.943 . . . . 0.0 108.965 -174.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 11.1 mp -83.92 115.84 22.49 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 -168.909 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -122.97 150.62 42.75 Favored 'General case' 0 CA--C 1.563 1.457 0 C-N-CA 125.437 1.495 . . . . 0.0 109.322 179.425 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -74.28 156.5 37.12 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.737 -1.227 . . . . 0.0 113.23 178.225 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.1 pp -72.82 164.51 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 -171.867 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 . . . . . 0 N--CA 1.485 1.281 0 CA-C-O 123.953 1.835 . . . . 0.0 108.394 179.029 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 1.2 p90 . . . . . 0 N--CA 1.488 1.438 0 N-CA-C 116.167 1.914 . . . . 0.0 116.167 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -80.82 117.82 21.8 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-N 121.466 1.939 . . . . 0.0 109.788 179.409 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -129.76 94.39 3.73 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 104.942 -2.244 . . . . 0.0 104.942 174.66 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -77.49 125.45 7.32 Favored Glycine 0 CA--C 1.54 1.609 0 C-N-CA 123.156 0.408 . . . . 0.0 113.577 -170.481 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.446 ' H ' ' H ' ' A' ' 87' ' ' GLU 0.376 64.5 pttt 52.9 63.48 2.22 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 115.335 1.606 . . . . 0.0 115.335 -175.378 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -107.95 127.21 28.08 Favored Pre-proline 0 CA--C 1.574 1.897 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 -173.617 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -68.88 160.91 47.85 Favored 'Trans proline' 0 CA--C 1.56 1.785 0 C-N-CA 123.156 2.571 . . . . 0.0 115.574 -172.164 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 16.1 ttm180 -73.33 -35.8 66.09 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 117.327 2.343 . . . . 0.0 117.327 -170.024 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.75 -41.6 97.98 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 115.401 1.63 . . . . 0.0 115.401 169.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -68.27 -40.99 81.7 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 114.497 1.295 . . . . 0.0 114.497 169.515 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.71 -41.36 98.12 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 115.271 1.582 . . . . 0.0 115.271 172.817 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -67.13 -44.67 79.27 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 170.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -53.01 -38.88 62.71 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 116.085 1.883 . . . . 0.0 116.085 171.767 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.51 -62.63 1.56 Allowed 'General case' 0 CA--C 1.566 1.568 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 169.915 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.1 mp -70.0 -50.71 38.82 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 117.411 2.374 . . . . 0.0 117.411 -168.674 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 60.2 p -60.3 -34.26 73.52 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 115.921 1.823 . . . . 0.0 115.921 174.631 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -72.63 -30.54 64.41 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 115.644 1.72 . . . . 0.0 115.644 170.58 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -50.72 133.23 26.14 Favored 'General case' 0 CA--C 1.556 1.19 0 N-CA-C 114.977 1.473 . . . . 0.0 114.977 176.681 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.12 -23.49 62.17 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 118.613 2.82 . . . . 0.0 118.613 174.159 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 42.9 m80 -89.43 131.51 35.45 Favored 'General case' 0 N--CA 1.484 1.225 0 CA-C-N 119.23 0.923 . . . . 0.0 110.667 -169.871 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -80.99 102.22 10.03 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 174.712 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 124.02 4.86 7.7 Favored Glycine 0 CA--C 1.552 2.405 0 CA-C-O 116.652 -2.193 . . . . 0.0 115.991 -168.835 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.02 116.26 6.95 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-N 121.682 2.741 . . . . 0.0 112.913 -169.905 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -129.8 161.41 30.8 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 118.135 2.643 . . . . 0.0 118.135 -168.046 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.8 pp -144.09 154.11 42.86 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 114.126 -1.397 . . . . 0.0 109.422 168.666 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.0 mp -112.67 124.05 68.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 178.085 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -90.36 167.49 12.61 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 124.477 1.111 . . . . 0.0 112.199 174.781 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.446 ' H ' ' H ' ' A' ' 64' ' ' LYS . 35.7 tt0 -129.15 116.11 18.71 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 106.139 -1.801 . . . . 0.0 106.139 169.183 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 64.7 m -76.85 134.73 38.94 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -170.295 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -74.62 -56.51 4.74 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-N 115.415 -0.811 . . . . 0.0 112.999 178.125 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.5 t -61.43 -39.56 91.23 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 116.068 1.877 . . . . 0.0 116.068 177.431 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -102.92 99.76 14.82 Favored Pre-proline 0 CA--C 1.565 1.523 0 CA-C-O 117.83 -1.081 . . . . 0.0 108.647 170.359 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -75.22 126.95 10.16 Favored 'Trans proline' 0 C--N 1.371 1.712 0 C-N-CA 123.016 2.477 . . . . 0.0 112.545 -175.152 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 82.2 6.62 88.63 Favored Glycine 0 CA--C 1.555 2.57 0 N-CA-C 118.189 2.036 . . . . 0.0 118.189 -169.683 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -98.12 116.54 30.56 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-N 119.813 1.806 . . . . 0.0 107.302 171.706 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -99.0 151.25 21.13 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.787 -0.819 . . . . 0.0 108.787 -178.178 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 43.2 m -132.93 112.4 11.84 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.505 -0.747 . . . . 0.0 110.175 -175.244 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 26.4 tp -79.3 105.77 10.85 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-O 121.967 0.889 . . . . 0.0 108.979 174.336 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 15.4 m -89.44 93.6 9.57 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 173.028 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.9 p -112.08 125.95 69.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 -174.342 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -77.16 129.15 35.59 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 114.813 -1.085 . . . . 0.0 111.049 173.153 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -137.75 114.65 10.68 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 87.22 -92.37 1.8 Allowed Glycine 0 N--CA 1.481 1.687 0 N-CA-C 112.056 -0.418 . . . . 0.0 112.056 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 10.8 p-10 -130.44 -22.48 2.74 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 115.434 1.642 . . . . 0.0 115.434 169.842 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -108.49 146.34 33.34 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 124.484 1.114 . . . . 0.0 110.251 -173.119 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 9.7 p -84.76 123.63 39.28 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.537 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.101 179.586 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -109.86 122.68 48.09 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 124.093 0.957 . . . . 0.0 108.901 -178.571 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 12.0 m-70 -103.73 96.37 6.66 Favored 'General case' 0 CA--C 1.555 1.14 0 CA-C-O 121.804 0.812 . . . . 0.0 108.864 -169.416 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -92.31 141.64 28.34 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 124.431 1.092 . . . . 0.0 110.233 -177.549 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -96.05 114.73 26.47 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.429 0.633 . . . . 0.0 110.369 -176.542 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 81.5 t -84.07 124.29 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 174.587 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 55.0 mt -102.12 136.13 42.49 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.014 -176.405 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 36.4 mtm180 -108.89 129.87 55.42 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 122.715 0.406 . . . . 0.0 110.368 176.41 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -97.31 103.32 15.24 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 123.165 0.586 . . . . 0.0 110.555 176.674 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 90.3 -110.7 3.81 Favored Glycine 0 N--CA 1.481 1.661 0 CA-C-O 120.072 -0.293 . . . . 0.0 113.325 174.491 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -79.95 -69.49 0.58 Allowed 'General case' 0 N--CA 1.487 1.419 0 CA-C-O 118.762 -0.637 . . . . 0.0 112.53 -176.127 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -159.05 75.03 0.21 Allowed Glycine 0 N--CA 1.477 1.424 0 CA-C-N 118.661 0.664 . . . . 0.0 111.581 171.203 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -117.63 91.37 3.55 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 -173.698 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -79.53 115.0 18.89 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 123.82 0.848 . . . . 0.0 111.686 -168.797 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -131.23 130.62 43.15 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.595 0.758 . . . . 0.0 109.041 177.838 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 41.8 tp -95.25 -54.76 3.3 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 118.548 -0.739 . . . . 0.0 110.38 169.113 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 45.2 m0 -74.7 -86.68 0.04 OUTLIER 'General case' 0 CA--C 1.565 1.553 0 CA-C-N 119.359 0.981 . . . . 0.0 110.537 173.388 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 10.0 m -145.06 -47.53 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 C-N-CA 124.56 1.144 . . . . 0.0 111.107 -175.883 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 14.0 p -79.54 130.85 35.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 CA-C-N 119.217 0.917 . . . . 0.0 110.212 -175.723 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.21 161.04 15.9 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-O 122.605 1.193 . . . . 0.0 114.205 -170.615 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -148.31 114.34 5.8 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 105.021 -2.215 . . . . 0.0 105.021 -170.629 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -57.84 -24.38 57.16 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 119.198 3.036 . . . . 0.0 119.198 -169.449 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 78.8 p -125.93 165.51 18.62 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-N 120.543 1.52 . . . . 0.0 113.096 179.506 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 33.0 mt -52.04 -47.69 64.93 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 115.23 1.567 . . . . 0.0 115.23 169.608 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 18.7 m-80 -63.12 -43.69 97.73 Favored 'General case' 0 CA--C 1.564 1.516 0 N-CA-C 114.071 1.137 . . . . 0.0 114.071 174.048 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -58.94 -50.81 72.66 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 115.388 1.625 . . . . 0.0 115.388 177.819 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 58.4 tp -61.32 -49.04 78.59 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-N 120.019 1.281 . . . . 0.0 114.237 174.566 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . 0.311 1.6 p -69.96 -37.5 72.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 -178.125 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -61.55 -34.55 75.76 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-N 119.976 1.262 . . . . 0.0 113.597 168.73 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 45.8 t80 -58.13 -54.07 51.07 Favored 'General case' 0 CA--C 1.569 1.673 0 CA-C-O 117.546 -1.216 . . . . 0.0 111.984 167.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . 0.347 21.9 m-70 -71.66 -8.99 57.54 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 118.69 2.848 . . . . 0.0 118.69 173.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 55.1 mtp85 -75.94 -22.06 56.37 Favored 'General case' 0 CA--C 1.576 1.958 0 CA-C-N 119.876 1.217 . . . . 0.0 112.926 167.299 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 70.6 m -100.73 -46.31 5.2 Favored 'General case' 0 CA--C 1.565 1.554 0 C-N-CA 125.005 1.322 . . . . 0.0 112.962 169.561 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 91.3 m -86.21 154.32 21.38 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 124.948 1.299 . . . . 0.0 110.121 173.579 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 27.4 t -80.48 148.02 30.64 Favored 'General case' 0 N--CA 1.483 1.203 0 O-C-N 121.131 -0.981 . . . . 0.0 113.238 177.376 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 77.1 t -75.17 -54.02 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 168.636 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 34.2 t -87.77 104.05 16.2 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-N 118.909 0.777 . . . . 0.0 109.071 174.29 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . 0.273 0.2 OUTLIER -59.95 -40.39 88.85 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 117.711 2.486 . . . . 0.0 117.711 -175.722 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -72.1 -63.5 1.13 Allowed 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 177.328 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -94.09 104.24 16.28 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 172.2 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 -77.45 115.28 17.09 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 -168.919 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -120.82 133.45 67.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 179.278 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -119.15 153.47 34.83 Favored 'General case' 0 N--CA 1.497 1.875 0 CA-C-O 121.88 0.848 . . . . 0.0 111.337 -170.923 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 9.5 mp -88.05 143.66 26.95 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 -169.744 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 29.1 mmm180 -132.87 142.91 49.18 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 124.929 1.292 . . . . 0.0 109.175 -179.629 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -76.1 143.37 41.31 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.379 -0.826 . . . . 0.0 111.285 176.298 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 25.0 pt -62.82 146.32 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 -176.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 . . . . . 0 N--CA 1.484 1.261 0 CA-C-O 123.91 1.814 . . . . 0.0 109.435 175.799 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 1.6 p90 . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 118.499 -0.762 . . . . 0.0 111.976 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -82.09 124.76 30.12 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-N 119.931 1.241 . . . . 0.0 110.101 -179.688 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -128.59 75.14 1.61 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 123.473 0.483 . . . . 0.0 110.253 -175.667 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 59.05 -114.58 6.26 Favored Glycine 0 N--CA 1.485 1.937 0 C-N-CA 123.873 0.749 . . . . 0.0 114.817 173.841 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -144.99 111.45 5.69 Favored 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 169.157 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 43.2 pt -122.99 152.2 62.6 Favored Pre-proline 0 CA--C 1.572 1.821 0 CA-C-O 118.525 -0.75 . . . . 0.0 110.476 -179.18 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -58.78 165.56 7.98 Favored 'Trans proline' 0 CA--C 1.56 1.777 0 C-N-CA 123.4 2.733 . . . . 0.0 116.745 171.367 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 25.7 ttm180 -62.92 -40.67 98.32 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 114.898 1.444 . . . . 0.0 114.898 169.679 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -62.56 -41.14 98.72 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 115.728 1.751 . . . . 0.0 115.728 170.783 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 3.1 tppp? -64.79 -37.63 88.25 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 115.201 1.556 . . . . 0.0 115.201 169.739 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.91 -41.68 91.12 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 115.682 1.734 . . . . 0.0 115.682 171.607 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -64.65 -38.78 92.16 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 114.816 1.413 . . . . 0.0 114.816 169.876 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -60.57 -52.83 63.49 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 114.509 1.3 . . . . 0.0 114.509 172.631 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 40.4 tpp -61.11 -44.07 97.92 Favored 'General case' 0 CA--C 1.564 1.492 0 N-CA-C 115.793 1.775 . . . . 0.0 115.793 175.386 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 92.6 mt -72.6 -20.72 61.24 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 116.616 2.08 . . . . 0.0 116.616 172.434 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 22.9 t -60.24 -37.6 80.88 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-N 121.079 1.763 . . . . 0.0 113.497 168.512 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -59.42 -37.17 77.36 Favored 'General case' 0 CA--C 1.57 1.737 0 N-CA-C 114.525 1.306 . . . . 0.0 114.525 168.7 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -69.12 114.36 7.32 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 124.322 1.049 . . . . 0.0 110.855 170.62 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 -76.24 -13.44 60.17 Favored 'General case' 0 CA--C 1.569 1.708 0 N-CA-C 117.816 2.524 . . . . 0.0 117.816 173.326 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 46.3 m80 -89.72 143.82 26.49 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 -168.402 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -71.79 130.84 42.07 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-N 114.448 -1.251 . . . . 0.0 110.818 170.44 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.92 -18.62 46.57 Favored Glycine 0 CA--C 1.552 2.377 0 N-CA-C 118.239 2.055 . . . . 0.0 118.239 -172.454 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.13 119.38 10.73 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-N 120.399 2.1 . . . . 0.0 112.345 -176.227 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 22.2 p90 -128.56 157.51 41.03 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 114.815 1.413 . . . . 0.0 114.815 -168.678 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.8 pp -138.05 139.33 39.51 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 168.239 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 70.3 mt -98.16 117.86 43.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 106.316 -1.735 . . . . 0.0 106.316 177.267 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 3.0 ptm180 -97.94 149.2 22.67 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.319 0.648 . . . . 0.0 111.481 170.547 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -96.35 137.86 34.8 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 168.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 67.4 m -69.9 138.92 52.86 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-O 121.637 0.732 . . . . 0.0 112.694 -176.894 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -70.69 -53.71 14.63 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 -174.075 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.0 t -62.99 -37.33 86.73 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 115.916 1.821 . . . . 0.0 115.916 172.794 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -121.01 92.9 48.75 Favored Pre-proline 0 CA--C 1.562 1.441 0 CA-C-N 119.635 1.107 . . . . 0.0 110.102 175.792 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -62.59 132.53 38.31 Favored 'Trans proline' 0 C--N 1.371 1.742 0 C-N-CA 123.361 2.707 . . . . 0.0 113.25 170.02 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 105.0 -33.73 6.34 Favored Glycine 0 CA--C 1.551 2.302 0 CA-C-O 118.697 -1.057 . . . . 0.0 114.543 -168.859 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -79.68 108.51 13.28 Favored 'General case' 0 N--CA 1.486 1.348 0 CA-C-N 119.427 1.614 . . . . 0.0 108.484 174.398 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 5.0 m-30 -93.93 158.65 15.54 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 121.716 0.77 . . . . 0.0 110.451 -174.826 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 74.6 m -139.81 115.48 10.1 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 176.583 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 36.4 tp -81.19 107.35 13.91 Favored 'General case' 0 CA--C 1.561 1.368 0 C-N-CA 124.907 1.283 . . . . 0.0 109.687 179.015 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.8 m -95.5 105.53 17.51 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 -174.376 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 31.9 t -117.57 123.67 72.04 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.171 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 -171.617 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 12.9 tmtt? -89.24 89.37 7.89 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 123.088 0.555 . . . . 0.0 110.203 178.924 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -105.49 108.22 19.62 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -177.297 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 86.95 -98.75 2.39 Favored Glycine 0 N--CA 1.479 1.556 0 N-CA-C 111.435 -0.666 . . . . 0.0 111.435 177.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 12.4 p30 -138.44 44.1 2.12 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 123.178 0.591 . . . . 0.0 112.384 169.687 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -152.84 134.62 14.63 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 -177.53 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 57.3 t -95.23 109.85 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 106.298 -1.741 . . . . 0.0 106.298 177.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 60.6 mt-30 -109.11 114.83 28.89 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-O 121.909 0.861 . . . . 0.0 109.306 -169.896 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 29.0 m80 -94.15 119.64 33.26 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 114.636 -1.166 . . . . 0.0 109.168 -172.82 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -118.03 119.33 34.47 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 -174.296 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -75.5 108.31 8.23 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 -169.524 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 86.6 t -84.04 117.56 29.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 -178.032 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 54.5 mt -100.78 137.82 38.66 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.139 -174.318 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 56.4 mtp180 -109.72 126.37 53.65 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 -179.522 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . 0.262 3.0 p30 -79.91 -56.94 3.9 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 114.463 1.283 . . . . 0.0 114.463 -179.031 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 179.16 137.86 3.06 Favored Glycine 0 CA--C 1.54 1.632 0 CA-C-N 119.607 1.094 . . . . 0.0 112.759 -176.49 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . 0.347 . . 80.6 -77.89 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 124.98 1.312 . . . . 0.0 112.497 -178.94 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -165.96 72.79 0.17 Allowed Glycine 0 N--CA 1.478 1.483 0 N-CA-C 111.696 -0.562 . . . . 0.0 111.696 171.855 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -126.47 162.22 26.11 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 124.169 0.988 . . . . 0.0 109.93 -178.432 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -143.99 114.97 7.84 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 -176.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -124.98 123.19 39.35 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 175.758 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -110.33 -58.79 2.03 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 123.77 0.828 . . . . 0.0 110.621 173.756 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 8.4 t90 -98.66 -62.97 1.17 Allowed 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 124.076 0.95 . . . . 0.0 112.893 -168.705 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 30.7 m -129.66 -56.38 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 CA-C-N 119.085 0.857 . . . . 0.0 112.41 -175.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 9.9 p -118.93 161.29 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 CA-C-O 122.278 1.037 . . . . 0.0 111.485 -169.541 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.52 153.04 29.84 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-O 122.025 0.917 . . . . 0.0 113.121 175.839 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -142.88 120.69 11.93 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 -175.22 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -59.45 -59.74 4.96 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -175.712 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 83.6 p -89.58 155.56 19.18 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-O 122.542 1.163 . . . . 0.0 112.378 175.372 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 10.3 tp -63.01 -33.0 74.49 Favored 'General case' 0 CA--C 1.568 1.661 0 N-CA-C 115.019 1.489 . . . . 0.0 115.019 170.05 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -63.35 -36.77 84.81 Favored 'General case' 0 CA--C 1.569 1.705 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 169.053 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.13 -42.1 94.17 Favored 'General case' 0 N--CA 1.497 1.875 0 CA-C-N 120.622 1.555 . . . . 0.0 114.17 169.758 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 16.8 tp -57.13 -46.89 82.31 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 169.101 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 45.4 t -59.17 -58.2 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 C-N-CA 124.385 1.074 . . . . 0.0 112.878 173.159 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -60.74 -32.11 71.4 Favored 'General case' 0 CA--C 1.567 1.632 0 N-CA-C 115.655 1.724 . . . . 0.0 115.655 -175.076 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -60.68 -57.8 11.18 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-N 119.665 1.12 . . . . 0.0 112.877 169.381 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 81.8 m-70 -72.85 -8.91 57.77 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 117.891 2.552 . . . . 0.0 117.891 176.688 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 50.5 ttm-85 -58.59 -31.71 68.29 Favored 'General case' 0 CA--C 1.576 1.95 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 168.046 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 69.6 m -104.16 -36.15 7.78 Favored 'General case' 0 CA--C 1.567 1.619 0 C-N-CA 124.978 1.311 . . . . 0.0 113.619 169.123 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 87.1 m -90.12 150.84 21.87 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-N 119.912 1.233 . . . . 0.0 110.826 -178.782 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 21.6 t -72.39 123.75 23.72 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.197 -0.939 . . . . 0.0 111.734 175.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.9 p -70.27 -27.78 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 N-CA-C 115.868 1.803 . . . . 0.0 115.868 175.293 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 66.3 m -135.25 136.88 42.03 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-N 119.562 1.073 . . . . 0.0 109.082 173.433 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? -80.13 93.97 5.91 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.815 0.816 . . . . 0.0 110.637 -178.413 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . 0.252 13.2 p-10 -165.9 -65.78 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 124.663 1.185 . . . . 0.0 108.044 -178.685 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -113.7 -139.03 0.38 Allowed 'General case' 0 CA--C 1.567 1.625 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 172.186 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.21 77.83 1.79 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.307 -0.871 . . . . 0.0 109.146 175.838 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 3.7 mp -86.7 108.48 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 -170.619 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 19.6 m-30 -114.72 138.4 50.77 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-N 115.331 -0.849 . . . . 0.0 109.523 -172.882 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 10.7 mp -85.27 108.11 17.62 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.276 -171.075 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 93.5 mtt180 -123.37 168.07 12.99 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 122.369 1.08 . . . . 0.0 109.485 -175.115 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -81.79 158.75 24.0 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 115.11 1.522 . . . . 0.0 115.11 -170.049 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 36.1 pt -81.29 162.04 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 CA-C-N 114.727 -1.124 . . . . 0.0 112.883 -179.207 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 . . . . . 0 N--CA 1.485 1.311 0 CA-C-O 122.776 1.274 . . . . 0.0 109.328 -176.765 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . 0.253 66.6 p-90 . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 115.544 1.683 . . . . 0.0 115.544 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -85.78 135.65 33.65 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-N 119.255 0.934 . . . . 0.0 111.403 -173.408 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -111.68 -88.0 0.53 Allowed 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 175.486 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 158.12 -150.1 20.77 Favored Glycine 0 N--CA 1.483 1.816 0 CA-C-N 119.634 1.106 . . . . 0.0 112.735 -179.163 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -83.14 89.57 6.96 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 121.566 0.698 . . . . 0.0 111.217 -178.431 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -124.42 146.62 52.71 Favored Pre-proline 0 CA--C 1.573 1.852 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 169.365 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -50.69 164.79 0.5 Allowed 'Trans proline' 0 C--N 1.37 1.681 0 C-N-CA 123.411 2.74 . . . . 0.0 117.717 175.03 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 60.1 ttt180 -59.06 -41.95 89.17 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 169.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -65.28 -45.45 84.41 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 115.193 1.553 . . . . 0.0 115.193 173.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 48.2 mmtm -61.92 -37.09 83.36 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 115.646 1.721 . . . . 0.0 115.646 171.377 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.87 -44.85 91.86 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 115.31 1.596 . . . . 0.0 115.31 169.929 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -61.34 -40.08 92.93 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 115.351 1.611 . . . . 0.0 115.351 170.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -61.54 -46.24 90.76 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 173.532 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 37.3 mmt -60.12 -46.57 89.17 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 114.898 1.444 . . . . 0.0 114.898 172.211 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 96.7 mt -72.59 -32.38 65.94 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 115.989 1.848 . . . . 0.0 115.989 177.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 21.1 t -56.02 -35.33 66.72 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 115.662 1.727 . . . . 0.0 115.662 169.431 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -60.15 -39.47 86.46 Favored 'General case' 0 CA--C 1.568 1.662 0 N-CA-C 115.215 1.561 . . . . 0.0 115.215 169.301 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -67.88 134.68 51.26 Favored 'General case' 0 CA--C 1.556 1.174 0 CA-C-O 123.5 1.619 . . . . 0.0 113.404 -177.963 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.43 -10.2 59.34 Favored 'General case' 0 CA--C 1.567 1.597 0 N-CA-C 119.12 3.007 . . . . 0.0 119.12 176.421 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 6.9 m80 -89.62 137.51 32.27 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-N 120.149 1.34 . . . . 0.0 110.836 -169.002 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -80.39 103.54 10.32 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 173.2 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 110.59 11.41 19.5 Favored Glycine 0 CA--C 1.551 2.321 0 CA-C-O 117.56 -1.689 . . . . 0.0 115.758 -168.074 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.66 120.09 14.89 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-N 120.64 2.22 . . . . 0.0 110.244 -175.339 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 14.6 p90 -132.82 157.32 45.29 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 -169.044 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.3 pp -140.8 125.58 18.08 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 168.662 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 84.6 mt -83.78 108.84 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 170.621 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 48.2 ptt85 -89.88 156.89 18.16 Favored 'General case' 0 CA--C 1.557 1.215 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.192 171.134 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -88.86 134.03 34.08 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 169.483 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 50.5 m -65.85 132.47 48.74 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 123.107 0.563 . . . . 0.0 111.133 -178.821 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -55.54 -55.01 36.87 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 116.903 2.186 . . . . 0.0 116.903 -168.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.3 t -72.39 -45.81 58.08 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 174.367 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -108.77 108.67 60.96 Favored Pre-proline 0 CA--C 1.562 1.422 0 CA-C-O 117.652 -1.166 . . . . 0.0 110.559 -174.161 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -69.48 -32.24 20.13 Favored 'Trans proline' 0 C--N 1.369 1.609 0 N-CA-C 118.724 2.548 . . . . 0.0 118.724 178.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -65.58 -19.21 66.71 Favored Glycine 0 CA--C 1.559 2.832 0 N-CA-C 117.023 1.569 . . . . 0.0 117.023 168.576 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -92.16 138.05 31.86 Favored 'General case' 0 N--CA 1.484 1.27 0 CA-C-N 118.337 1.068 . . . . 0.0 108.696 169.889 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -123.38 170.03 10.74 Favored 'General case' 0 CA--C 1.563 1.472 0 C-N-CA 124.23 1.012 . . . . 0.0 108.907 179.463 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 73.1 m -143.01 119.79 11.2 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.096 -1.002 . . . . 0.0 108.43 -179.299 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 43.7 tp -79.88 105.66 11.32 Favored 'General case' 0 N--CA 1.486 1.347 0 CA-C-O 121.844 0.831 . . . . 0.0 109.331 171.176 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.8 m -91.35 109.65 20.93 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 173.75 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.7 p -137.69 137.49 45.27 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 CA-C-N 119.148 0.885 . . . . 0.0 108.778 -169.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -72.88 118.86 16.34 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.009 0.433 . . . . 0.0 110.996 171.572 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 4.4 m-30 -107.71 97.69 7.39 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 169.874 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 81.94 -98.76 1.96 Allowed Glycine 0 CA--C 1.541 1.677 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 -169.881 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 70.1 m-80 -126.89 -17.6 4.88 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 115.01 1.485 . . . . 0.0 115.01 169.709 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -85.73 137.88 32.5 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 119.643 1.11 . . . . 0.0 110.081 177.863 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 64.9 t -89.28 106.43 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 -175.082 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -101.06 124.84 47.39 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-O 121.881 0.848 . . . . 0.0 109.231 -179.445 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 11.9 m-70 -97.73 131.31 44.38 Favored 'General case' 0 CA--C 1.555 1.159 0 CA-C-N 114.819 -1.082 . . . . 0.0 109.153 -175.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -128.18 125.01 38.2 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 -175.623 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -80.88 117.49 21.57 Favored 'General case' 0 N--CA 1.485 1.302 0 CA-C-O 121.596 0.712 . . . . 0.0 110.903 -170.186 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 73.1 t -85.42 102.77 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 171.764 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.4 pp -121.91 144.13 49.04 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 123.116 0.567 . . . . 0.0 111.346 -174.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -89.65 155.82 18.98 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 114.009 1.115 . . . . 0.0 114.009 -170.399 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -104.41 -64.3 1.13 Allowed 'General case' 0 N--CA 1.494 1.748 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.951 169.479 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -97.21 -121.17 4.12 Favored Glycine 0 CA--C 1.542 1.734 0 CA-C-N 119.406 1.003 . . . . 0.0 112.883 -176.87 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -76.2 -65.24 0.94 Allowed 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 118.786 -0.626 . . . . 0.0 112.337 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -136.08 57.99 0.67 Allowed Glycine 0 CA--C 1.542 1.78 0 CA-C-O 119.559 -0.578 . . . . 0.0 111.928 169.31 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -106.36 88.85 2.88 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 106.978 -1.489 . . . . 0.0 106.978 -174.84 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -81.03 122.47 27.35 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 114.852 -1.067 . . . . 0.0 111.1 -169.521 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 21.3 p90 -137.57 124.17 20.96 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 120.941 0.4 . . . . 0.0 110.044 179.259 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -106.84 -47.78 3.65 Favored 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 123.887 0.875 . . . . 0.0 112.155 169.355 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 32.2 t90 -89.92 -68.81 0.76 Allowed 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 124.834 1.254 . . . . 0.0 110.91 -171.066 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . 0.264 13.0 p -147.6 -66.89 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 C-N-CA 123.499 0.72 . . . . 0.0 109.704 174.446 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 10.8 p -79.9 138.82 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 C-N-CA 123.941 0.896 . . . . 0.0 111.455 -171.86 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -83.77 158.86 21.59 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 113.715 1.005 . . . . 0.0 113.715 -178.211 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -140.46 123.13 16.26 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 -171.48 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 16.9 p30 -57.84 -34.44 69.7 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 117.549 2.425 . . . . 0.0 117.549 176.345 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 74.2 m -120.88 144.92 48.15 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 119.256 0.935 . . . . 0.0 111.678 -176.744 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 14.1 tp -86.53 94.27 9.39 Favored 'General case' 0 CA--C 1.563 1.46 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 169.224 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 12.0 t30 158.19 -60.78 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 103.295 -2.854 . . . . 0.0 103.295 -168.595 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -54.16 -44.6 71.59 Favored 'General case' 0 CA--C 1.574 1.877 0 C-N-CA 124.699 1.2 . . . . 0.0 114.194 168.347 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 10.2 tt -53.93 -53.83 47.28 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 115.763 1.764 . . . . 0.0 115.763 170.049 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.2 p -68.32 -50.13 60.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 -177.803 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -56.31 -32.86 65.03 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 115.516 1.673 . . . . 0.0 115.516 172.41 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -58.36 -53.64 55.99 Favored 'General case' 0 CA--C 1.566 1.582 0 CA-C-N 119.608 1.094 . . . . 0.0 111.85 168.264 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . 0.315 40.8 m-70 -71.42 -9.54 58.34 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 118.196 2.665 . . . . 0.0 118.196 176.762 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.62 -32.03 73.38 Favored 'General case' 0 CA--C 1.581 2.142 0 CA-C-N 121.041 1.746 . . . . 0.0 112.171 166.356 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 70.6 m -95.53 -44.84 7.33 Favored 'General case' 0 CA--C 1.564 1.519 0 C-N-CA 124.604 1.162 . . . . 0.0 114.035 169.773 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 53.8 m -90.2 155.99 18.63 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-N 119.665 1.12 . . . . 0.0 111.04 -178.495 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 22.7 t -86.3 133.55 33.81 Favored 'General case' 0 CA--C 1.557 1.212 0 O-C-N 121.357 -0.84 . . . . 0.0 113.197 -175.585 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 96.4 t -69.17 -36.5 73.31 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 CA-C-O 118.534 -0.746 . . . . 0.0 111.752 169.0 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 22.7 t -79.2 132.86 36.66 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-N 119.639 1.109 . . . . 0.0 109.584 169.929 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 32.9 ttt85 -75.0 -50.15 17.51 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 -175.786 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -76.42 -55.67 5.33 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 172.644 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -80.03 158.77 26.41 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 119.028 0.831 . . . . 0.0 112.225 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 -104.04 89.79 3.39 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 4.0 mm -112.96 141.01 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 176.73 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -137.3 155.9 48.9 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-O 121.988 0.899 . . . . 0.0 112.497 -169.171 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 10.0 mp -90.28 124.78 35.17 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 124.046 0.938 . . . . 0.0 112.074 -169.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -118.98 151.73 37.66 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 124.242 1.017 . . . . 0.0 110.091 171.608 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -81.88 149.5 28.25 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 122.136 0.97 . . . . 0.0 112.656 -177.249 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.6 pp -76.01 160.32 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 CA-C-N 114.861 -1.063 . . . . 0.0 113.552 -174.484 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 . . . . . 0 N--CA 1.485 1.294 0 CA-C-O 124.052 1.882 . . . . 0.0 106.332 170.583 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 63.6 p-90 . . . . . 0 N--CA 1.494 1.739 0 N-CA-C 115.3 1.592 . . . . 0.0 115.3 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -81.38 136.3 35.71 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-N 120.449 1.477 . . . . 0.0 112.054 -171.68 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -121.61 -74.83 0.6 Allowed 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 174.279 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 91.91 102.46 1.39 Allowed Glycine 0 CA--C 1.542 1.734 0 CA-C-N 119.376 0.989 . . . . 0.0 111.814 -178.236 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 56.9 mmtt 63.52 69.98 0.54 Allowed 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 124.808 1.243 . . . . 0.0 113.394 -177.265 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 10.6 pt -130.1 151.82 79.01 Favored Pre-proline 0 CA--C 1.574 1.886 0 CA-C-O 118.411 -0.804 . . . . 0.0 109.676 169.876 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_exo -56.45 156.42 21.87 Favored 'Trans proline' 0 C--N 1.369 1.655 0 C-N-CA 123.369 2.713 . . . . 0.0 117.348 177.344 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 61.2 ttt180 -67.52 -36.62 81.39 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 169.489 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.77 -39.84 95.24 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 115.261 1.578 . . . . 0.0 115.261 169.651 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -64.06 -35.27 80.2 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 169.159 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.79 -52.45 63.13 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-N 119.472 1.033 . . . . 0.0 113.19 169.415 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -52.92 -37.71 61.08 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 116.348 1.981 . . . . 0.0 116.348 169.537 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -59.32 -48.65 80.83 Favored 'General case' 0 CA--C 1.566 1.574 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 170.696 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -65.45 -60.46 2.93 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 172.597 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.64 -39.44 91.42 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 117.517 2.414 . . . . 0.0 117.517 -172.576 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 56.3 m -60.61 -41.0 93.92 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 115.368 1.618 . . . . 0.0 115.368 178.719 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -68.45 -26.79 65.68 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 117.024 2.231 . . . . 0.0 117.024 169.986 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -60.52 131.1 49.67 Favored 'General case' 0 CA--C 1.556 1.19 0 CA-C-N 120.248 1.385 . . . . 0.0 113.722 176.555 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 38.9 ptt85 -69.59 -20.03 63.65 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 118.65 2.833 . . . . 0.0 118.65 179.054 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 57.8 m80 -89.51 135.58 33.52 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 119.213 0.915 . . . . 0.0 111.922 -169.141 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -77.59 103.03 7.28 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 169.731 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 124.23 -0.14 8.87 Favored Glycine 0 CA--C 1.555 2.543 0 CA-C-O 117.163 -1.91 . . . . 0.0 115.768 -168.456 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.57 113.19 4.57 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 121.158 2.479 . . . . 0.0 112.173 -169.929 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 17.8 p90 -128.11 155.79 43.86 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 116.334 1.976 . . . . 0.0 116.334 -168.713 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.1 pp -148.75 133.57 17.97 Favored 'General case' 0 N--CA 1.485 1.28 0 CA-C-N 114.33 -1.305 . . . . 0.0 108.454 169.031 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 91.8 mt -91.38 110.59 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 175.897 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 3.5 ptm180 -100.98 140.18 35.64 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 114.614 -1.175 . . . . 0.0 109.329 169.98 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.54 126.57 31.05 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.704 -0.622 . . . . 0.0 109.527 177.72 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 20.5 t -63.25 125.93 25.74 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -170.201 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -63.98 -48.58 75.85 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 175.815 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 95.8 p -59.3 -39.41 82.93 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 116.75 2.13 . . . . 0.0 116.75 171.873 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -115.84 97.7 49.59 Favored Pre-proline 0 CA--C 1.563 1.46 0 CA-C-O 117.967 -1.016 . . . . 0.0 108.997 178.748 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -72.57 135.04 23.36 Favored 'Trans proline' 0 C--N 1.372 1.787 0 C-N-CA 123.157 2.571 . . . . 0.0 112.606 -178.985 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 92.05 -39.36 3.03 Favored Glycine 0 CA--C 1.556 2.622 0 CA-C-N 115.555 -0.748 . . . . 0.0 114.415 -168.595 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -79.76 146.17 32.47 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 124.275 1.03 . . . . 0.0 110.883 175.624 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -106.85 174.16 6.01 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 122.124 0.964 . . . . 0.0 111.859 -171.697 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 57.9 m -146.61 115.81 7.0 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 177.325 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 42.6 tp -79.7 115.42 19.3 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 171.049 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 20.7 m -97.98 83.77 3.19 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 175.998 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.3 p -107.4 119.74 57.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 -171.861 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 15.1 tmtt? -81.37 149.2 28.97 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.768 174.739 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -156.99 107.35 2.29 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 169.948 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 71.38 76.14 0.6 Allowed Glycine 0 N--CA 1.483 1.776 0 N-CA-C 115.186 0.834 . . . . 0.0 115.186 173.097 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . 0.348 15.0 m120 77.06 -38.7 0.31 Allowed 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 118.179 2.659 . . . . 0.0 118.179 -179.898 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -121.43 145.27 48.09 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 124.091 0.956 . . . . 0.0 110.944 -169.688 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 5.3 p -83.02 139.0 18.4 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.54 0 CA-C-N 115.373 -0.831 . . . . 0.0 111.864 178.262 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -125.27 111.53 15.32 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-O 122.103 0.954 . . . . 0.0 108.529 -176.94 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 8.0 m-70 -99.55 128.81 45.67 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-N 114.776 -1.102 . . . . 0.0 109.358 -172.268 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -133.46 133.08 41.82 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 -175.096 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 64.2 pttt -77.74 125.86 29.99 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-O 121.507 0.67 . . . . 0.0 112.05 -179.117 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 80.7 t -94.61 108.22 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 106.287 -1.746 . . . . 0.0 106.287 179.237 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 66.0 mt -95.97 149.99 20.96 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.276 -173.368 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 82.8 mtm180 -109.51 135.95 49.68 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 122.983 0.513 . . . . 0.0 110.304 -177.79 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -108.1 110.19 21.81 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 170.635 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 89.26 -113.58 4.16 Favored Glycine 0 CA--C 1.541 1.683 0 CA-C-N 116.372 -0.376 . . . . 0.0 112.343 -178.763 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -86.4 -68.99 0.7 Allowed 'General case' 0 N--CA 1.488 1.452 0 CA-C-O 118.739 -0.648 . . . . 0.0 111.687 178.792 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -156.39 70.25 0.27 Allowed Glycine 0 N--CA 1.478 1.473 0 CA-C-N 118.602 0.637 . . . . 0.0 112.33 172.58 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -103.88 99.82 9.6 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 105.089 -2.189 . . . . 0.0 105.089 171.702 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -81.19 108.25 14.67 Favored 'General case' 0 N--CA 1.484 1.255 0 CA-C-N 114.741 -1.118 . . . . 0.0 111.756 -168.58 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 33.5 p90 -117.47 121.66 41.63 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 178.788 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 4.7 tt -101.7 -63.07 1.18 Allowed 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 123.429 0.691 . . . . 0.0 109.176 170.648 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 26.9 t90 -82.43 -64.98 1.07 Allowed 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 124.337 1.055 . . . . 0.0 112.17 -169.941 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . 0.276 13.1 p -146.17 -70.33 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 CA-C-N 118.791 0.723 . . . . 0.0 109.427 177.533 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 9.4 p -79.91 143.95 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 C-N-CA 123.879 0.872 . . . . 0.0 111.621 -174.078 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.37 155.52 22.28 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -176.184 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -141.7 114.75 8.67 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 -173.764 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 23.1 t30 -54.1 -41.08 67.88 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 116.696 2.109 . . . . 0.0 116.696 -175.998 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 95.3 p -107.29 155.27 20.14 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-O 122.649 1.214 . . . . 0.0 111.904 170.612 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 60.3 mt -64.31 -29.2 70.29 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 115.282 1.586 . . . . 0.0 115.282 169.714 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -65.33 -38.73 91.05 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-N 119.682 1.128 . . . . 0.0 113.555 169.927 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -61.63 -45.06 95.68 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 169.393 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 53.1 tp -57.02 -44.14 82.55 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 115.09 1.515 . . . . 0.0 115.09 169.68 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 22.2 t -60.32 -63.26 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 C-N-CA 124.581 1.152 . . . . 0.0 112.405 173.525 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -59.56 -28.67 67.32 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 115.984 1.846 . . . . 0.0 115.984 -176.29 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 88.8 t80 -64.35 -56.07 16.92 Favored 'General case' 0 CA--C 1.566 1.586 0 CA-C-N 119.158 0.89 . . . . 0.0 111.849 168.461 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . 0.264 68.0 m-70 -68.85 -9.08 49.4 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 117.874 2.546 . . . . 0.0 117.874 177.795 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -48.48 -39.7 23.97 Favored 'General case' 0 N--CA 1.502 2.174 0 CA-C-N 120.808 1.64 . . . . 0.0 114.47 167.563 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 68.5 m -109.04 -26.38 10.2 Favored 'General case' 0 CA--C 1.565 1.527 0 N-CA-C 114.885 1.439 . . . . 0.0 114.885 169.857 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 40.2 m -90.27 152.34 21.1 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-N 120.825 1.648 . . . . 0.0 111.031 -179.788 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 29.1 t -74.31 133.24 42.57 Favored 'General case' 0 CA--C 1.559 1.31 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 -179.962 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 39.3 t -74.93 -48.09 34.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 C-N-CA 123.593 0.757 . . . . 0.0 111.583 169.861 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 70.8 m -82.85 159.36 22.42 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-O 121.858 0.837 . . . . 0.0 112.049 178.273 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 3.7 tmm_? -70.37 -61.01 1.94 Allowed 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 118.898 -0.572 . . . . 0.0 111.94 174.881 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -74.37 -56.34 4.97 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 178.787 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 51.6 mt-30 -79.86 145.32 32.79 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 118.713 0.688 . . . . 0.0 112.087 -176.81 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -79.2 122.7 26.61 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 122.958 0.503 . . . . 0.0 110.372 169.854 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 8.3 mm -127.43 102.29 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 105.565 -2.013 . . . . 0.0 105.565 179.264 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 20.8 m-30 -113.19 114.38 26.68 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 -174.398 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 10.8 mp -67.67 131.57 45.84 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 114.794 1.405 . . . . 0.0 114.794 -168.975 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 71.4 mmt-85 -127.24 140.88 51.92 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 176.874 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -75.21 141.46 43.57 Favored 'General case' 0 CA--C 1.565 1.521 0 O-C-N 121.183 -0.948 . . . . 0.0 112.209 -175.348 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 16.4 pt -62.89 146.58 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 N-CA-C 113.968 1.099 . . . . 0.0 113.968 -176.446 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 . . . . . 0 N--CA 1.482 1.142 0 CA-C-O 123.931 1.824 . . . . 0.0 109.344 -176.118 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . 0.294 51.2 p-90 . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 113.464 0.913 . . . . 0.0 113.464 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -94.53 133.56 38.02 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 123.63 0.772 . . . . 0.0 109.47 173.692 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -95.6 -77.17 0.48 Allowed 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 118.665 -0.683 . . . . 0.0 109.466 174.772 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -169.96 -159.07 14.92 Favored Glycine 0 CA--C 1.541 1.677 0 CA-C-N 119.077 0.853 . . . . 0.0 112.955 -179.885 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -94.31 91.85 6.91 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 172.101 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -123.71 149.7 59.82 Favored Pre-proline 0 CA--C 1.573 1.852 0 C-N-CA 123.59 0.756 . . . . 0.0 109.194 178.449 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -69.85 177.53 5.56 Favored 'Trans proline' 0 CA--C 1.565 2.029 0 C-N-CA 122.812 2.341 . . . . 0.0 114.285 175.456 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 59.6 ttt180 -61.07 -42.42 98.46 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 115.791 1.774 . . . . 0.0 115.791 179.334 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -67.23 -41.87 84.94 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 115.717 1.747 . . . . 0.0 115.717 175.526 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -64.76 -36.48 84.45 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 169.764 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.62 -40.38 96.75 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 115.799 1.777 . . . . 0.0 115.799 169.929 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -65.52 -40.83 93.43 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 114.85 1.426 . . . . 0.0 114.85 169.926 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -60.11 -48.38 81.98 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 114.957 1.465 . . . . 0.0 114.957 172.463 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 38.1 mmt -66.71 -47.31 72.76 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 176.539 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 7.1 tp -76.27 -17.94 59.22 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 117.119 2.266 . . . . 0.0 117.119 178.802 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 94.1 p -60.76 -31.32 70.66 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-N 120.616 1.553 . . . . 0.0 114.781 168.634 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -59.82 -39.63 85.74 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 169.073 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -65.04 112.83 3.52 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 124.4 1.08 . . . . 0.0 111.533 169.852 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 13.7 ptp180 -80.12 -15.46 57.07 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 117.941 2.571 . . . . 0.0 117.941 177.632 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 50.0 m80 -89.54 147.88 23.71 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 119.417 1.008 . . . . 0.0 112.367 -168.767 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -77.99 120.9 23.49 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.645 178.993 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 100.07 -21.38 44.89 Favored Glycine 0 CA--C 1.545 1.966 0 CA-C-O 117.168 -1.907 . . . . 0.0 117.119 -169.64 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.36 115.45 4.21 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 120.753 2.277 . . . . 0.0 111.128 -177.728 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 27.1 p90 -126.49 156.49 40.65 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 115.361 1.615 . . . . 0.0 115.361 -168.467 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.0 pp -132.33 125.64 31.4 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 168.382 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 71.8 mt -86.99 119.98 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 173.218 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 48.8 ptt85 -92.05 148.9 21.83 Favored 'General case' 0 CA--C 1.558 1.265 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.499 169.547 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -90.09 122.09 32.75 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 106.425 -1.695 . . . . 0.0 106.425 169.089 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 50.7 m -65.51 113.19 3.99 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.549 0.739 . . . . 0.0 111.95 -174.476 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -90.62 92.37 8.81 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-O 123.814 1.769 . . . . 0.0 108.992 178.854 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 51.7 p 163.73 -40.25 0.0 OUTLIER 'General case' 0 CA--C 1.568 1.672 0 CA-C-N 110.764 -2.925 . . . . 0.0 107.434 -168.209 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -131.87 98.61 17.46 Favored Pre-proline 0 CA--C 1.562 1.415 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 172.129 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -62.11 134.67 50.5 Favored 'Trans proline' 0 C--N 1.372 1.772 0 C-N-CA 123.383 2.722 . . . . 0.0 114.842 178.848 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 90.82 -31.7 5.45 Favored Glycine 0 CA--C 1.553 2.437 0 N-CA-C 116.398 1.319 . . . . 0.0 116.398 -169.373 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -80.63 135.5 36.06 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 118.864 1.332 . . . . 0.0 110.062 175.611 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -108.7 172.0 7.1 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 122.317 1.056 . . . . 0.0 111.127 -173.145 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 50.6 m -146.21 124.03 11.95 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 171.939 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 30.3 tp -80.09 114.42 18.98 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.665 0.786 . . . . 0.0 109.996 172.866 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.6 m -98.66 108.91 21.71 Favored 'General case' 0 CA--C 1.562 1.431 0 N-CA-C 105.336 -2.098 . . . . 0.0 105.336 172.353 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.7 p -127.63 118.67 49.89 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -170.455 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -85.19 97.09 9.71 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.236 0.615 . . . . 0.0 110.013 -179.008 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 17.2 t80 -122.0 124.98 45.26 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 -178.94 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 81.81 -111.47 3.33 Favored Glycine 0 N--CA 1.481 1.644 0 N-CA-C 110.319 -1.112 . . . . 0.0 110.319 -173.538 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -137.16 56.97 1.77 Allowed 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 169.023 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -160.04 135.09 7.94 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 -176.592 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 90.2 t -88.44 105.89 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 172.049 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 62.2 mt-30 -102.59 117.84 35.55 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.736 0.814 . . . . 0.0 109.321 -171.282 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 15.4 m-70 -96.98 113.99 25.57 Favored 'General case' 0 CA--C 1.554 1.121 0 CA-C-N 115.194 -0.912 . . . . 0.0 108.958 -173.518 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -115.2 118.52 33.55 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 177.693 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -80.71 125.77 30.46 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.753 -169.897 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 59.1 t -88.54 103.27 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 106.727 -1.582 . . . . 0.0 106.727 175.913 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -104.11 147.76 27.04 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 121.401 0.619 . . . . 0.0 110.988 -179.811 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -96.47 160.95 14.13 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -176.461 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -133.41 86.91 2.34 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.149 169.648 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 76.87 99.1 0.17 Allowed Glycine 0 N--CA 1.482 1.761 0 CA-C-O 119.197 -0.78 . . . . 0.0 114.513 172.337 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . 0.34 . . 82.09 -77.24 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 124.631 1.172 . . . . 0.0 112.72 -179.974 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -170.55 67.64 0.15 Allowed Glycine 0 N--CA 1.479 1.504 0 CA-C-O 119.662 -0.521 . . . . 0.0 113.214 174.682 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -107.6 94.19 4.95 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 105.863 -1.903 . . . . 0.0 105.863 174.078 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -79.43 126.75 31.24 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 124.204 1.002 . . . . 0.0 110.429 -169.706 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 24.0 p90 -147.92 121.22 8.99 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 -179.229 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -104.46 -42.6 5.41 Favored 'General case' 0 N--CA 1.498 1.926 0 C-N-CA 123.35 0.66 . . . . 0.0 112.508 168.853 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 43.4 t90 -89.98 -85.2 0.22 Allowed 'General case' 0 CA--C 1.56 1.336 0 C-N-CA 124.766 1.226 . . . . 0.0 109.942 -173.536 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 96.4 t -139.16 -66.52 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 -173.537 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 12.2 p -79.74 137.53 21.49 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.551 0 C-N-CA 123.772 0.829 . . . . 0.0 111.333 -175.4 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 60.9 pttt -89.36 162.35 15.84 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 -177.953 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 99.7 m-85 -145.78 120.23 9.68 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 -170.196 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 66.2 m-80 -61.12 -43.85 98.25 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 171.479 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 73.3 m -96.51 138.19 34.47 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-O 121.823 0.821 . . . . 0.0 111.272 174.305 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 13.5 tp -65.82 -31.98 73.25 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 169.661 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -59.69 -41.42 90.69 Favored 'General case' 0 CA--C 1.574 1.887 0 N-CA-C 113.92 1.082 . . . . 0.0 113.92 168.992 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -65.69 -38.32 88.93 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 115.49 1.663 . . . . 0.0 115.49 170.684 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 8.5 tt -57.12 -53.51 57.31 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-N 120.094 1.315 . . . . 0.0 114.404 170.313 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 9.9 p -64.59 -50.5 75.51 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.578 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -178.722 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -61.31 -36.79 81.09 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 115.403 1.631 . . . . 0.0 115.403 175.218 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -59.57 -53.4 58.48 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-N 119.957 1.253 . . . . 0.0 112.095 168.862 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . 0.262 69.7 m-70 -71.36 -9.09 57.6 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 118.15 2.648 . . . . 0.0 118.15 178.274 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 89.9 mtt-85 -58.17 -32.0 67.79 Favored 'General case' 0 CA--C 1.576 1.957 0 CA-C-N 120.375 1.443 . . . . 0.0 113.392 167.127 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 69.2 m -99.26 -42.77 6.87 Favored 'General case' 0 CA--C 1.569 1.678 0 C-N-CA 124.714 1.206 . . . . 0.0 112.927 168.688 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 33.7 m -87.97 155.67 19.72 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-N 119.814 1.188 . . . . 0.0 111.41 -175.373 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 25.3 t -79.56 129.13 34.19 Favored 'General case' 0 CA--C 1.56 1.336 0 O-C-N 121.187 -0.946 . . . . 0.0 113.356 -179.578 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 16.0 m -70.33 -36.85 68.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 N-CA-C 114.998 1.481 . . . . 0.0 114.998 169.748 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 22.9 t -87.25 140.1 29.88 Favored 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 123.658 0.783 . . . . 0.0 110.266 174.51 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 66.2 ttt-85 -73.18 -48.86 31.71 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 177.229 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 24.4 t30 -72.52 -57.89 3.8 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 171.962 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 63.4 mt-30 -79.88 154.4 28.38 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 118.763 0.711 . . . . 0.0 112.247 -177.223 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -94.13 104.0 16.04 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 171.928 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 17.2 mm -123.47 102.28 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 -177.802 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 22.4 m-30 -101.32 133.55 45.75 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 115.043 -0.981 . . . . 0.0 109.544 179.203 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 10.9 mp -89.3 121.44 31.58 Favored 'General case' 0 N--CA 1.486 1.338 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.266 -169.462 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 4.0 mpt_? -119.25 168.41 10.93 Favored 'General case' 0 CA--C 1.561 1.377 0 CA-C-O 123.602 1.667 . . . . 0.0 109.086 175.284 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -83.99 158.21 21.59 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-N 114.708 -1.133 . . . . 0.0 112.763 -174.264 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.1 pp -66.97 162.25 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 N-CA-C 114.565 1.321 . . . . 0.0 114.565 -177.463 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 . . . . . 0 N--CA 1.486 1.33 0 CA-C-O 122.815 1.293 . . . . 0.0 108.901 178.235 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 1.2 p90 . . . . . 0 N--CA 1.491 1.622 0 N-CA-C 113.55 0.945 . . . . 0.0 113.55 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -80.81 128.39 33.6 Favored 'General case' 0 N--CA 1.484 1.263 0 CA-C-N 119.885 1.221 . . . . 0.0 110.245 177.551 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -87.49 -73.53 0.47 Allowed 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.225 178.023 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 177.81 -101.39 0.15 Allowed Glycine 0 N--CA 1.476 1.339 0 N-CA-C 109.147 -1.581 . . . . 0.0 109.147 179.618 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -139.26 82.19 1.88 Allowed 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 171.744 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 28.6 pt -107.33 149.68 39.05 Favored Pre-proline 0 CA--C 1.571 1.786 0 C-N-CA 123.564 0.746 . . . . 0.0 109.691 -178.876 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.48 168.97 22.05 Favored 'Trans proline' 0 CA--C 1.56 1.801 0 C-N-CA 122.8 2.333 . . . . 0.0 114.363 179.702 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 58.5 ttt-85 -61.99 -40.19 94.77 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 115.645 1.72 . . . . 0.0 115.645 -179.698 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -65.01 -41.09 95.68 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 115.78 1.77 . . . . 0.0 115.78 173.118 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? -64.3 -36.49 84.27 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 114.979 1.474 . . . . 0.0 114.979 169.637 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.76 -52.5 60.1 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 170.047 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -53.91 -36.15 62.41 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 116.458 2.021 . . . . 0.0 116.458 170.094 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -60.78 -50.06 74.98 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 114.433 1.271 . . . . 0.0 114.433 171.436 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -58.89 -51.32 70.53 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 114.925 1.454 . . . . 0.0 114.925 173.816 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -65.11 -33.46 76.08 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 116.16 1.911 . . . . 0.0 116.16 175.619 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 23.3 t -53.92 -35.46 61.69 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 115.725 1.75 . . . . 0.0 115.725 169.736 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -61.24 -41.12 96.34 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 114.587 1.328 . . . . 0.0 114.587 169.288 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -71.65 122.63 20.91 Favored 'General case' 0 CA--C 1.556 1.179 0 CA-C-O 122.898 1.332 . . . . 0.0 112.474 179.899 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.449 ' H ' ' HD2' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -71.09 -8.7 55.27 Favored 'General case' 0 CA--C 1.569 1.674 0 N-CA-C 119.056 2.984 . . . . 0.0 119.056 170.972 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 44.6 m80 -89.71 142.66 27.48 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 120.071 1.305 . . . . 0.0 113.104 -168.703 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -78.66 116.75 19.23 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 169.651 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 108.46 -7.0 34.13 Favored Glycine 0 CA--C 1.549 2.202 0 CA-C-O 117.06 -1.967 . . . . 0.0 117.7 -169.398 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.61 117.69 8.45 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 121.14 2.47 . . . . 0.0 112.502 -169.963 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -131.53 155.09 48.06 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 116.281 1.956 . . . . 0.0 116.281 -168.806 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.6 pp -147.48 138.85 23.81 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-N 114.647 -1.16 . . . . 0.0 108.333 168.929 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.7 mp -94.26 120.69 44.05 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.591 0 N-CA-C 106.708 -1.589 . . . . 0.0 106.708 177.229 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 3.4 ptm180 -106.05 146.4 30.17 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 124.092 0.957 . . . . 0.0 109.702 169.679 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -79.82 131.38 35.88 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 169.682 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 22.9 t -63.54 132.42 51.2 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.673 0.789 . . . . 0.0 112.559 -177.189 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -68.18 -52.23 36.79 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 -172.546 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.0 t -64.99 -35.1 80.1 Favored 'General case' 0 CA--C 1.565 1.532 0 N-CA-C 116.256 1.947 . . . . 0.0 116.256 172.059 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -115.53 98.45 50.79 Favored Pre-proline 0 CA--C 1.563 1.466 0 CA-C-N 119.49 1.041 . . . . 0.0 109.99 178.66 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -59.87 -33.46 95.92 Favored 'Trans proline' 0 C--N 1.371 1.718 0 N-CA-C 119.384 2.802 . . . . 0.0 119.384 175.303 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -87.07 47.84 3.75 Favored Glycine 0 CA--C 1.551 2.34 0 N-CA-C 114.633 0.613 . . . . 0.0 114.633 169.239 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -156.19 126.75 6.74 Favored 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 178.881 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 7.5 m-30 -92.91 169.02 10.77 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 122.042 0.925 . . . . 0.0 110.806 169.933 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 69.5 m -149.47 115.69 5.76 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 -178.812 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 33.9 tp -81.02 112.87 18.81 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.896 0.879 . . . . 0.0 109.588 176.902 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 9.7 m -94.53 83.17 4.08 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 177.996 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.7 p -107.94 115.69 49.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 -171.412 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 58.0 tttp -77.59 145.59 36.74 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 114.882 -1.054 . . . . 0.0 111.416 171.173 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -148.86 101.34 3.17 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 169.735 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 92.61 -104.12 3.14 Favored Glycine 0 N--CA 1.479 1.534 0 N-CA-C 112.002 -0.439 . . . . 0.0 112.002 179.769 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -113.2 -11.98 13.18 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 117.241 2.311 . . . . 0.0 117.241 178.55 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -116.88 142.01 47.48 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-N 119.558 1.072 . . . . 0.0 110.051 -175.909 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 39.6 t -92.94 110.86 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 175.533 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 55.1 tp60 -102.33 112.22 24.83 Favored 'General case' 0 CA--C 1.552 1.055 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 -172.165 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -94.96 108.69 20.75 Favored 'General case' 0 CA--C 1.553 1.059 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 -174.68 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -103.13 130.5 50.32 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 176.227 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -77.82 115.5 17.61 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 123.083 0.553 . . . . 0.0 112.254 -175.939 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 97.4 t -85.64 110.35 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 106.83 -1.544 . . . . 0.0 106.83 178.364 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 58.5 mt -90.53 135.63 33.57 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.102 0.561 . . . . 0.0 109.717 -173.349 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 79.1 mtp180 -116.68 119.07 34.34 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 -175.183 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . 0.29 3.9 p-10 -79.91 -66.11 0.92 Allowed 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 -175.561 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -90.85 -107.27 1.39 Allowed Glycine 0 N--CA 1.483 1.826 0 CA-C-N 119.424 1.011 . . . . 0.0 111.801 -179.56 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -79.87 -67.28 0.78 Allowed 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 118.827 -0.606 . . . . 0.0 111.236 172.426 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -149.13 70.68 0.32 Allowed Glycine 0 N--CA 1.477 1.427 0 CA-C-N 118.46 0.573 . . . . 0.0 111.884 169.807 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.17 101.16 11.82 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 105.108 -2.182 . . . . 0.0 105.108 171.664 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -83.84 106.73 15.75 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-N 115.038 -0.983 . . . . 0.0 111.141 -168.509 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -114.38 114.72 26.25 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 107.769 -1.196 . . . . 0.0 107.769 177.505 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 63.0 tp -112.01 -48.9 3.01 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 124.192 0.997 . . . . 0.0 112.191 179.749 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 33.7 t90 -92.5 -74.79 0.51 Allowed 'General case' 0 CA--C 1.557 1.22 0 C-N-CA 124.598 1.159 . . . . 0.0 110.694 -169.727 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . 0.255 10.8 p -146.28 -60.41 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 C-N-CA 123.586 0.754 . . . . 0.0 109.715 177.293 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 15.6 m -79.38 157.15 4.7 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.545 0 C-N-CA 124.251 1.02 . . . . 0.0 111.759 178.892 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -79.88 136.0 36.57 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.526 -178.38 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -124.51 99.5 6.22 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 106.222 -1.77 . . . . 0.0 106.222 177.676 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . 0.272 12.8 p30 -60.45 -41.43 94.05 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 116.874 2.175 . . . . 0.0 116.874 -172.991 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 69.3 m -94.88 152.55 18.28 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-O 122.125 0.964 . . . . 0.0 111.268 172.395 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 12.8 tp -64.77 -34.76 79.11 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 169.66 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -63.68 -35.92 82.14 Favored 'General case' 0 CA--C 1.568 1.641 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 168.81 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -60.19 -48.93 79.66 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-N 120.592 1.542 . . . . 0.0 113.858 169.533 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 53.0 tp -60.82 -50.3 74.01 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 115.355 1.613 . . . . 0.0 115.355 173.752 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 46.3 t -61.38 -60.19 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 C-N-CA 123.957 0.903 . . . . 0.0 112.111 176.445 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -59.3 -31.8 69.47 Favored 'General case' 0 CA--C 1.567 1.634 0 N-CA-C 115.607 1.706 . . . . 0.0 115.607 -176.912 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -62.96 -53.92 46.57 Favored 'General case' 0 CA--C 1.568 1.642 0 CA-C-N 119.833 1.197 . . . . 0.0 112.328 168.78 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . 0.306 76.0 m-70 -71.58 -8.5 54.43 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 118.183 2.661 . . . . 0.0 118.183 178.16 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -47.77 -40.29 20.31 Favored 'General case' 0 N--CA 1.499 2.012 0 CA-C-N 120.693 1.588 . . . . 0.0 114.945 167.916 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 70.0 m -106.38 -32.9 7.93 Favored 'General case' 0 CA--C 1.564 1.493 0 N-CA-C 114.728 1.381 . . . . 0.0 114.728 170.655 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 48.7 m -89.39 147.36 24.09 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-N 120.4 1.455 . . . . 0.0 110.172 -179.706 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.502 ' HB2' ' H ' ' A' ' 146' ' ' ILE . 54.8 p -80.47 141.32 35.33 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 120.97 -1.081 . . . . 0.0 113.346 179.214 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 46.5 t -67.37 -51.54 51.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.916 169.781 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 32.3 t -87.35 132.64 33.89 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.582 0.753 . . . . 0.0 110.715 178.796 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -88.33 70.31 9.11 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 121.629 0.728 . . . . 0.0 110.955 176.37 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . 0.297 5.8 p-10 178.77 -68.58 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 125.218 1.407 . . . . 0.0 107.665 -176.501 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -96.86 138.6 34.16 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.689 0.796 . . . . 0.0 109.413 171.943 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -73.47 117.69 15.53 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 122.696 0.398 . . . . 0.0 111.775 178.809 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.502 ' H ' ' HB2' ' A' ' 139' ' ' SER . 8.4 mm -121.21 92.34 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 176.628 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 21.4 m-30 -100.57 119.82 39.11 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-N 114.249 -1.341 . . . . 0.0 108.109 -176.893 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 10.6 mp -74.04 126.48 30.61 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 123.384 0.674 . . . . 0.0 112.321 -169.748 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 24.1 mmt85 -129.23 143.24 50.78 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 124.551 1.14 . . . . 0.0 108.154 -179.083 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -72.26 146.75 47.03 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 113.645 0.98 . . . . 0.0 113.645 -174.798 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 28.3 pt -69.37 150.15 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 C-N-CA 123.868 0.867 . . . . 0.0 112.726 178.902 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 123.848 1.785 . . . . 0.0 109.55 -177.379 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . 0.38 62.1 p-90 . . . . . 0 N--CA 1.498 1.928 0 N-CA-C 121.583 3.92 . . . . 0.0 121.583 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -139.53 129.26 24.62 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 -169.676 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -140.09 94.86 2.8 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 170.501 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -91.8 164.95 29.21 Favored Glycine 0 CA--C 1.541 1.715 0 CA-C-O 122.924 1.291 . . . . 0.0 116.082 -169.816 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . 0.259 32.3 mmmt 57.38 53.14 7.84 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-N 113.1 -1.55 . . . . 0.0 115.183 -178.364 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 42.3 pt -136.55 152.35 74.53 Favored Pre-proline 0 CA--C 1.573 1.844 0 C-N-CA 123.895 0.878 . . . . 0.0 109.941 -177.751 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -74.08 177.0 8.77 Favored 'Trans proline' 0 CA--C 1.565 2.058 0 C-N-CA 122.919 2.412 . . . . 0.0 114.124 174.847 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 56.3 ttt-85 -63.78 -42.17 97.81 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 115.303 1.594 . . . . 0.0 115.303 176.506 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -66.47 -41.36 89.14 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 115.742 1.756 . . . . 0.0 115.742 176.35 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 29.2 tptp -62.91 -36.65 84.06 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 169.595 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.28 -46.1 81.79 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 115.452 1.649 . . . . 0.0 115.452 171.432 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -62.15 -39.33 92.24 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 115.168 1.544 . . . . 0.0 115.168 170.795 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -60.34 -46.0 91.47 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 114.938 1.459 . . . . 0.0 114.938 172.872 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 34.3 mmt -59.87 -50.36 74.08 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 114.813 1.412 . . . . 0.0 114.813 171.624 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 88.1 mt -75.97 -23.88 55.36 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 117.076 2.25 . . . . 0.0 117.076 -178.985 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 91.7 p -58.8 -35.99 73.75 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 117.082 2.253 . . . . 0.0 117.082 176.574 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 37.9 mtmm -63.07 -31.84 73.08 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 115.719 1.748 . . . . 0.0 115.719 169.656 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -75.51 122.62 24.14 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.533 1.133 . . . . 0.0 111.667 -171.44 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 13.4 ptp180 -63.56 -20.58 65.75 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 119.224 3.046 . . . . 0.0 119.224 -179.826 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 39.2 m80 -89.63 136.9 32.77 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 119.8 1.182 . . . . 0.0 112.718 -168.704 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -77.23 125.31 29.12 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.38 169.674 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 107.43 -21.38 30.81 Favored Glycine 0 CA--C 1.547 2.046 0 CA-C-O 117.036 -1.98 . . . . 0.0 115.879 -168.849 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.23 111.21 2.49 Favored 'General case' 0 N--CA 1.486 1.352 0 CA-C-N 120.823 2.311 . . . . 0.0 111.821 -171.917 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.8 p90 -123.94 158.19 32.58 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 113.826 1.046 . . . . 0.0 113.826 -168.569 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.2 pp -135.67 133.0 37.69 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 168.327 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 74.1 mt -88.95 109.82 20.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 105.661 -1.978 . . . . 0.0 105.661 171.808 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 50.8 ptt85 -91.1 144.06 26.03 Favored 'General case' 0 N--CA 1.486 1.327 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.097 171.657 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -90.24 126.13 35.72 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 169.113 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 53.0 m -67.07 128.78 37.66 Favored 'General case' 0 N--CA 1.487 1.375 0 CA-C-O 121.508 0.671 . . . . 0.0 111.326 -177.937 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -68.64 -47.83 65.58 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 -172.895 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 90.8 p -61.73 -36.89 82.27 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 116.655 2.094 . . . . 0.0 116.655 169.887 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -123.01 96.74 44.51 Favored Pre-proline 0 CA--C 1.563 1.454 0 CA-C-N 119.421 1.01 . . . . 0.0 109.439 177.776 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -58.05 -33.62 97.5 Favored 'Trans proline' 0 C--N 1.371 1.712 0 N-CA-C 120.055 3.059 . . . . 0.0 120.055 178.472 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -87.26 42.65 3.15 Favored Glycine 0 CA--C 1.552 2.389 0 N-CA-C 115.565 0.986 . . . . 0.0 115.565 169.266 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -149.44 110.19 4.29 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 105.03 -2.211 . . . . 0.0 105.03 177.532 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -95.33 168.01 10.99 Favored 'General case' 0 N--CA 1.489 1.475 0 CA-C-O 121.672 0.748 . . . . 0.0 110.105 176.426 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 73.4 m -143.62 114.28 7.61 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 179.327 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 24.9 tp -79.89 107.34 12.6 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 124.442 1.097 . . . . 0.0 109.041 176.257 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 9.4 m -102.79 95.49 6.22 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 -169.956 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 20.0 t -108.62 120.22 59.6 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 CA-C-N 119.113 0.869 . . . . 0.0 109.254 -169.485 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -87.72 96.79 10.57 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.125 0.57 . . . . 0.0 109.526 173.711 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 18.3 t80 -120.53 100.16 6.98 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 179.222 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 68.35 73.0 0.74 Allowed Glycine 0 CA--C 1.542 1.759 0 N-CA-C 115.392 0.917 . . . . 0.0 115.392 175.227 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . 0.321 64.7 m-80 73.67 -22.88 0.23 Allowed 'General case' 0 N--CA 1.5 2.052 0 N-CA-C 118.564 2.802 . . . . 0.0 118.564 -179.821 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -123.91 139.09 54.31 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-N 119.538 1.063 . . . . 0.0 109.935 -169.938 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 39.4 t -100.91 112.39 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 -179.176 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -101.43 115.82 31.37 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.834 0.854 . . . . 0.0 109.208 -174.789 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 -97.12 107.54 20.09 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 115.007 -0.997 . . . . 0.0 108.587 -174.443 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -104.15 119.38 38.81 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 -176.858 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.8 tppp? -75.92 118.5 18.77 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-O 121.98 0.895 . . . . 0.0 110.646 -173.09 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 92.1 t -92.0 101.41 12.52 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.373 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 -179.51 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 68.6 mt -86.37 147.03 26.22 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 123.588 0.755 . . . . 0.0 111.072 178.396 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 73.5 mtp180 -113.0 147.23 37.6 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 123.058 0.543 . . . . 0.0 110.933 -177.776 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -135.41 132.07 37.03 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 123.276 0.63 . . . . 0.0 110.385 173.829 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 81.36 -113.3 3.61 Favored Glycine 0 CA--C 1.541 1.713 0 C-N-CA 122.957 0.313 . . . . 0.0 113.0 175.689 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -83.76 -68.09 0.74 Allowed 'General case' 0 N--CA 1.487 1.401 0 CA-C-O 118.929 -0.558 . . . . 0.0 110.979 172.465 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -162.25 73.04 0.2 Allowed Glycine 0 N--CA 1.477 1.374 0 CA-C-N 118.477 0.581 . . . . 0.0 111.69 169.93 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -99.12 100.93 12.12 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 176.561 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 79.9 m-85 -83.46 112.31 19.84 Favored 'General case' 0 CA--C 1.557 1.227 0 CA-C-N 114.503 -1.226 . . . . 0.0 109.581 -169.585 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -125.13 116.13 21.56 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 123.717 0.807 . . . . 0.0 109.155 -177.115 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -115.7 -38.29 3.75 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 178.773 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 53.2 t90 -99.91 -82.72 0.44 Allowed 'General case' 0 CA--C 1.56 1.336 0 C-N-CA 124.804 1.242 . . . . 0.0 108.679 -179.814 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 99.8 t -137.78 -66.53 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 -175.678 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 10.6 p -79.7 139.05 18.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 C-N-CA 123.69 0.796 . . . . 0.0 110.906 -177.676 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.67 168.11 19.79 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-O 122.256 1.027 . . . . 0.0 113.231 178.631 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -147.23 113.4 5.86 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 -170.104 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 23.3 t30 -59.45 -40.58 87.27 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 115.857 1.799 . . . . 0.0 115.857 -179.49 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 66.0 m -110.65 157.4 19.75 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-O 122.018 0.913 . . . . 0.0 111.203 174.089 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 90.4 mt -66.29 -30.47 70.89 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 114.457 1.28 . . . . 0.0 114.457 169.262 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -63.02 -39.74 95.67 Favored 'General case' 0 CA--C 1.573 1.858 0 CA-C-N 119.89 1.223 . . . . 0.0 113.702 169.287 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -60.8 -43.31 98.31 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 114.217 1.191 . . . . 0.0 114.217 169.282 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 9.5 tt -56.47 -49.84 73.47 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 172.568 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 13.6 m -63.89 -49.11 83.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 N-CA-C 113.831 1.049 . . . . 0.0 113.831 176.973 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -65.8 -33.02 74.89 Favored 'General case' 0 CA--C 1.569 1.68 0 N-CA-C 114.917 1.451 . . . . 0.0 114.917 -175.995 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -61.57 -59.63 4.93 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 119.852 1.205 . . . . 0.0 112.93 169.873 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . 0.261 70.1 m-70 -69.45 -9.23 52.75 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 117.67 2.47 . . . . 0.0 117.67 177.069 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 49.2 ttm-85 -59.03 -32.31 69.62 Favored 'General case' 0 CA--C 1.575 1.925 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 167.573 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 70.1 m -105.11 -35.77 7.5 Favored 'General case' 0 CA--C 1.566 1.581 0 C-N-CA 124.987 1.315 . . . . 0.0 114.045 169.368 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 57.2 m -90.9 155.32 18.83 Favored 'General case' 0 N--CA 1.498 1.959 0 CA-C-N 120.352 1.433 . . . . 0.0 111.983 179.684 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 27.8 t -75.01 135.34 41.3 Favored 'General case' 0 N--CA 1.484 1.263 0 O-C-N 121.545 -0.722 . . . . 0.0 112.73 176.953 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 11.6 t -72.88 -54.32 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 CA-C-O 118.63 -0.7 . . . . 0.0 111.179 170.878 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 39.2 t -101.86 127.57 48.62 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.07 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -62.77 -32.2 73.31 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 116.437 2.014 . . . . 0.0 116.437 -179.49 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 70.9 m-80 -76.37 -62.65 1.55 Allowed 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 119.567 1.076 . . . . 0.0 112.18 169.897 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -91.05 120.78 32.3 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 119.163 0.892 . . . . 0.0 109.258 -178.302 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 58.5 mt-30 -76.37 107.46 8.64 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.794 -0.566 . . . . 0.0 111.505 -174.252 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 14.0 mm -111.72 122.47 66.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 -173.658 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -125.81 129.16 48.88 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 -179.14 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 10.0 mp -78.72 123.09 26.8 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -169.043 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 14.5 tpt180 -111.18 150.72 29.11 Favored 'General case' 0 CA--C 1.56 1.35 0 C-N-CA 125.615 1.566 . . . . 0.0 109.164 172.442 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -76.48 157.41 32.18 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.79 -1.194 . . . . 0.0 112.249 172.262 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -64.31 152.52 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 N-CA-C 114.152 1.167 . . . . 0.0 114.152 -175.305 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 . . . . . 0 N--CA 1.488 1.431 0 CA-C-O 122.843 1.306 . . . . 0.0 108.358 171.952 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.257 0 N-CA-C 111.575 -0.61 . . . . 0.0 111.575 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 71.6 m -82.64 110.15 17.45 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.053 0.541 . . . . 0.0 110.164 -178.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 64.5 p-90 -76.0 -36.21 59.28 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 117.053 2.242 . . . . 0.0 117.053 -175.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -81.33 121.78 26.64 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 120.696 1.589 . . . . 0.0 110.237 -173.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -124.35 106.42 10.23 Favored 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 104.543 -2.391 . . . . 0.0 104.543 173.385 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -39.15 -67.57 0.57 Allowed Glycine 0 N--CA 1.487 2.056 0 N-CA-C 119.765 2.666 . . . . 0.0 119.765 -169.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -151.55 91.7 1.69 Allowed 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.46 157.35 62.15 Favored Pre-proline 0 N--CA 1.5 2.066 0 CA-C-O 118.467 -0.778 . . . . 0.0 109.898 177.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -54.68 159.3 9.08 Favored 'Trans proline' 0 C--N 1.371 1.755 0 C-N-CA 123.4 2.733 . . . . 0.0 117.619 178.221 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 59.6 ttt180 -65.94 -40.02 90.98 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 114.503 1.297 . . . . 0.0 114.503 170.493 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -66.69 -44.18 82.43 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 173.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -61.02 -38.12 84.97 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 115.45 1.648 . . . . 0.0 115.45 170.034 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.94 -45.32 94.19 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 115.476 1.658 . . . . 0.0 115.476 169.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -60.95 -42.69 98.72 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 115.199 1.555 . . . . 0.0 115.199 171.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -59.57 -51.27 70.54 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 174.098 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -63.21 -45.96 89.24 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 115.024 1.491 . . . . 0.0 115.024 177.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 6.5 mp -70.05 -41.12 74.63 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 114.854 1.427 . . . . 0.0 114.854 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 69.8 m -58.76 -35.04 72.13 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 115.839 1.792 . . . . 0.0 115.839 169.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 59.4 mttm -64.29 -38.28 90.49 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 115.287 1.588 . . . . 0.0 115.287 169.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -53.54 137.07 37.39 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 179.313 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 36.0 ptt180 -66.97 -22.85 65.91 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 118.029 2.603 . . . . 0.0 118.029 174.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 67.0 m80 -89.33 138.03 31.8 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-N 119.186 0.903 . . . . 0.0 112.017 -169.25 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -77.95 124.63 28.24 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.065 169.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.61 11.95 58.75 Favored Glycine 0 CA--C 1.555 2.569 0 CA-C-O 117.839 -1.534 . . . . 0.0 116.866 -169.025 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -71.34 123.53 22.52 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 120.443 2.122 . . . . 0.0 112.135 -170.106 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.405 ' HB3' HG23 ' A' ' 99' ' ' VAL . 17.5 p90 -135.7 160.86 37.22 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 116.359 1.985 . . . . 0.0 116.359 -168.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.1 pp -144.14 141.82 30.21 Favored 'General case' 0 CA--C 1.556 1.188 0 CA-C-N 113.786 -1.552 . . . . 0.0 108.277 167.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 52.7 mt -97.62 112.46 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 172.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -105.02 150.42 24.97 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 124.4 1.08 . . . . 0.0 111.905 176.444 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -89.72 138.28 31.61 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 169.058 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 68.3 m -64.08 137.18 57.85 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.847 0.859 . . . . 0.0 112.305 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -76.15 109.6 9.96 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.241 1.016 . . . . 0.0 110.28 -169.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . 0.374 16.6 m 103.39 -34.11 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.844 0 CA-C-N 112.286 -2.233 . . . . 0.0 114.665 -172.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -93.15 112.62 57.05 Favored Pre-proline 0 CA--C 1.567 1.61 0 CA-C-N 120.628 1.558 . . . . 0.0 111.685 -176.33 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -81.48 134.5 8.86 Favored 'Trans proline' 0 C--N 1.371 1.732 0 C-N-CA 123.137 2.558 . . . . 0.0 112.901 -179.25 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 66.66 33.52 84.66 Favored Glycine 0 CA--C 1.552 2.362 0 N-CA-C 117.012 1.565 . . . . 0.0 117.012 -169.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -126.45 92.0 3.47 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 105.858 -1.904 . . . . 0.0 105.858 -178.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -93.24 163.39 13.64 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-O 122.211 1.005 . . . . 0.0 111.687 -169.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 72.8 m -147.67 120.73 8.83 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 29.9 tp -79.61 103.85 9.81 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 171.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 3.1 m -84.94 108.16 17.44 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 172.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.405 HG23 ' HB3' ' A' ' 83' ' ' PHE . 6.8 p -135.18 126.54 46.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 -173.245 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -75.72 112.21 11.86 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.645 174.498 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 12.5 m-30 -117.84 106.82 13.4 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 176.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 85.51 -95.79 2.03 Favored Glycine 0 CA--C 1.54 1.612 0 N-CA-C 111.154 -0.778 . . . . 0.0 111.154 -172.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -127.6 -24.19 3.33 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 114.956 1.465 . . . . 0.0 114.956 169.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -89.24 139.13 30.8 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 119.056 0.844 . . . . 0.0 110.558 -175.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 59.3 t -87.85 110.93 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 N-CA-C 106.66 -1.608 . . . . 0.0 106.66 178.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 69.0 mt-30 -106.95 120.56 42.39 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.177 -169.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 19.8 m-70 -99.65 97.69 8.63 Favored 'General case' 0 CA--C 1.553 1.093 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 -170.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -93.11 125.03 37.51 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 -179.271 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -75.6 119.84 20.19 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-O 121.32 0.581 . . . . 0.0 112.222 -170.156 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 90.9 t -93.79 97.86 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 N-CA-C 106.374 -1.713 . . . . 0.0 106.374 178.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 71.0 mt -85.57 154.76 21.51 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.682 0.793 . . . . 0.0 110.951 177.009 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 65.0 mtp180 -115.87 129.39 56.4 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.505 -0.747 . . . . 0.0 110.798 -177.036 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -106.23 94.12 4.98 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 123.323 0.649 . . . . 0.0 110.258 176.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 88.96 -112.84 4.01 Favored Glycine 0 CA--C 1.541 1.706 0 N-CA-C 113.918 0.327 . . . . 0.0 113.918 172.517 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -89.03 -94.25 0.11 Allowed 'General case' 0 N--CA 1.486 1.341 0 CA-C-O 118.228 -0.892 . . . . 0.0 111.35 -169.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -113.73 80.3 0.28 Allowed Glycine 0 N--CA 1.481 1.665 0 CA-C-N 119.335 0.971 . . . . 0.0 110.689 177.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -142.5 146.58 34.87 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -175.492 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -145.78 108.36 4.48 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 -169.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 21.2 p90 -126.74 117.77 23.36 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.749 0.82 . . . . 0.0 109.602 -175.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -107.95 -42.83 4.58 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 170.379 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 47.2 t90 -92.03 -74.07 0.53 Allowed 'General case' 0 CA--C 1.558 1.255 0 C-N-CA 124.959 1.304 . . . . 0.0 110.182 -169.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . 0.267 14.8 p -147.24 -64.98 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 C-N-CA 123.612 0.765 . . . . 0.0 109.188 174.82 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 9.4 m -79.56 142.21 14.29 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.426 0 C-N-CA 124.175 0.99 . . . . 0.0 111.481 -178.124 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.87 154.65 28.23 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -177.448 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -133.66 116.41 15.79 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 106.471 -1.677 . . . . 0.0 106.471 -171.356 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -55.68 -50.59 69.86 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 115.884 1.809 . . . . 0.0 115.884 -173.144 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 69.0 m -106.57 161.58 14.5 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-O 122.025 0.916 . . . . 0.0 111.21 173.291 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 84.5 mt -67.2 -29.07 68.64 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 168.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -67.07 -39.66 86.87 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-N 119.652 1.114 . . . . 0.0 113.04 169.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -60.47 -41.46 94.23 Favored 'General case' 0 CA--C 1.568 1.67 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 169.101 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 9.1 tt -56.99 -45.56 82.88 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 114.139 1.163 . . . . 0.0 114.139 169.477 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 41.3 t -60.01 -61.8 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 C-N-CA 124.308 1.043 . . . . 0.0 112.661 172.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 -63.16 -28.42 70.04 Favored 'General case' 0 CA--C 1.566 1.587 0 N-CA-C 115.879 1.807 . . . . 0.0 115.879 -174.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -63.12 -61.68 2.21 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 119.594 1.088 . . . . 0.0 112.01 169.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . 0.308 49.1 m-70 -70.11 -8.91 53.35 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 118.166 2.654 . . . . 0.0 118.166 177.414 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 59.2 ttm-85 -61.86 -28.81 69.76 Favored 'General case' 0 CA--C 1.579 2.092 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 167.539 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 71.0 m -110.43 -31.87 7.13 Favored 'General case' 0 CA--C 1.568 1.67 0 C-N-CA 125.199 1.4 . . . . 0.0 114.245 169.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 47.6 m -90.56 149.45 22.15 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-N 120.389 1.449 . . . . 0.0 110.445 175.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 22.8 t -80.96 137.26 36.1 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.741 -1.224 . . . . 0.0 113.242 -179.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 75.5 t -75.08 -58.82 3.99 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.834 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.126 169.246 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 73.4 m -89.66 114.99 26.7 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.909 0.884 . . . . 0.0 108.724 -177.279 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 19.3 mmm180 -89.24 81.51 6.69 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 122.33 1.062 . . . . 0.0 112.249 -169.479 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -160.32 -77.71 0.06 Allowed 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 103.816 -2.661 . . . . 0.0 103.816 173.321 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -97.08 146.57 24.89 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 169.005 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 65.5 mt-30 -79.35 112.27 16.42 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.665 -0.647 . . . . 0.0 111.222 -175.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -124.16 127.05 73.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 -178.023 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -119.88 168.33 11.22 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 122.545 1.164 . . . . 0.0 112.447 -169.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 11.0 mp -90.39 115.31 27.47 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 124.318 1.047 . . . . 0.0 110.251 -178.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.21 147.7 42.26 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 124.234 1.013 . . . . 0.0 109.302 178.043 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -74.11 152.17 39.95 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 122.112 0.958 . . . . 0.0 113.456 -176.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 14.3 pt -72.9 164.43 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 CA-C-N 114.903 -1.044 . . . . 0.0 113.583 -178.274 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 24.4 tp10 . . . . . 0 N--CA 1.485 1.315 0 CA-C-O 122.834 1.302 . . . . 0.0 109.315 172.076 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.401 0 N-CA-C 111.356 -0.698 . . . . 0.0 111.356 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 89.1 p -84.23 118.05 23.91 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.059 0.544 . . . . 0.0 111.524 -179.164 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . 0.259 65.9 p-90 -78.82 -51.78 9.26 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 172.061 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -81.82 140.79 33.97 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-N 119.596 1.089 . . . . 0.0 110.826 175.332 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -116.49 -87.27 0.61 Allowed 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 175.423 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 138.49 94.15 0.3 Allowed Glycine 0 N--CA 1.48 1.628 0 CA-C-N 119.603 1.092 . . . . 0.0 111.755 177.158 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . 0.259 20.5 tptm 67.14 73.42 0.34 Allowed 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 124.283 1.033 . . . . 0.0 113.56 173.532 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 28.4 pt -128.77 151.08 76.62 Favored Pre-proline 0 CA--C 1.576 1.95 0 C-N-CA 123.924 0.89 . . . . 0.0 109.443 176.185 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -75.42 172.25 16.68 Favored 'Trans proline' 0 CA--C 1.562 1.896 0 C-N-CA 122.997 2.464 . . . . 0.0 114.678 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 53.5 ttt180 -67.03 -41.3 86.8 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 115.771 1.767 . . . . 0.0 115.771 -179.043 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -66.9 -42.73 84.96 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 115.666 1.728 . . . . 0.0 115.666 177.118 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -64.94 -36.03 83.08 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 115.028 1.492 . . . . 0.0 115.028 169.696 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.82 -45.25 90.46 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 115.734 1.753 . . . . 0.0 115.734 170.309 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -62.43 -38.48 89.9 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 115.246 1.572 . . . . 0.0 115.246 170.501 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -61.33 -50.43 72.97 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 114.499 1.296 . . . . 0.0 114.499 173.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 39.2 tpp -57.5 -46.53 83.65 Favored 'General case' 0 CA--C 1.564 1.488 0 N-CA-C 115.604 1.705 . . . . 0.0 115.604 172.23 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 9.2 mp -70.65 -24.9 62.78 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 116.621 2.082 . . . . 0.0 116.621 175.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 71.6 m -57.28 -35.43 69.78 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-N 120.882 1.674 . . . . 0.0 114.908 169.153 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 56.8 mttp -60.45 -38.5 84.35 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 115.112 1.523 . . . . 0.0 115.112 169.113 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -68.49 122.29 18.14 Favored 'General case' 0 CA--C 1.556 1.183 0 C-N-CA 124.829 1.251 . . . . 0.0 112.156 178.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 16.4 ptm180 -78.24 -18.05 55.89 Favored 'General case' 0 CA--C 1.569 1.701 0 N-CA-C 118.199 2.666 . . . . 0.0 118.199 175.632 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 41.7 m80 -89.57 147.39 23.97 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 119.483 1.038 . . . . 0.0 113.722 -168.224 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -81.77 117.91 22.45 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 169.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 118.22 -32.89 5.08 Favored Glycine 0 CA--C 1.54 1.613 0 CA-C-O 117.704 -1.609 . . . . 0.0 116.35 -169.202 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -60.91 103.98 0.32 Allowed 'General case' 0 N--CA 1.486 1.339 0 CA-C-N 119.257 1.529 . . . . 0.0 113.9 -169.539 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 18.4 p90 -120.59 162.48 19.55 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 -168.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.3 pp -135.29 132.16 37.41 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 167.158 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 70.0 mt -91.82 114.31 28.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 105.611 -1.996 . . . . 0.0 105.611 170.058 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 46.8 ptt85 -100.45 156.07 17.47 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-N 114.596 -1.183 . . . . 0.0 110.484 170.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -87.67 128.03 35.29 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 168.703 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 16.4 t -60.36 137.83 58.07 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 113.753 1.02 . . . . 0.0 113.753 -170.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.06 119.86 17.89 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-O 122.907 1.337 . . . . 0.0 111.536 -171.694 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . 0.33 5.4 t 84.98 -22.21 0.21 Allowed 'General case' 0 N--CA 1.493 1.693 0 CA-C-N 111.569 -2.56 . . . . 0.0 116.075 -169.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -108.55 92.9 10.8 Favored Pre-proline 0 CA--C 1.565 1.533 0 CA-C-N 120.662 1.574 . . . . 0.0 110.213 177.164 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -73.52 133.15 18.51 Favored 'Trans proline' 0 C--N 1.373 1.821 0 C-N-CA 123.19 2.593 . . . . 0.0 111.429 171.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 98.69 -34.18 5.51 Favored Glycine 0 CA--C 1.553 2.456 0 CA-C-O 119.017 -0.879 . . . . 0.0 114.275 -168.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -79.64 131.84 36.09 Favored 'General case' 0 N--CA 1.484 1.257 0 CA-C-N 118.675 1.238 . . . . 0.0 108.599 169.535 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -116.63 164.09 15.13 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-O 122.124 0.964 . . . . 0.0 110.58 -178.223 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 69.0 m -143.54 115.32 8.22 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 -177.187 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 16.6 tp -83.8 104.93 14.29 Favored 'General case' 0 CA--C 1.561 1.386 0 C-N-CA 124.369 1.068 . . . . 0.0 108.502 174.319 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.8 m -93.63 108.62 20.32 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 -179.098 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 24.0 t -116.38 124.5 72.65 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 CA-C-N 119.762 1.164 . . . . 0.0 108.301 -169.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 58.6 tptt -84.06 120.65 26.4 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.211 0.605 . . . . 0.0 109.891 171.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 3.9 m-30 -89.23 -140.03 0.13 Allowed 'General case' 0 CA--C 1.567 1.633 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 173.39 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -58.13 -71.0 0.82 Allowed Glycine 0 CA--C 1.547 2.053 0 C-N-CA 123.96 0.791 . . . . 0.0 114.242 169.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 31.6 t30 -140.04 58.72 1.59 Allowed 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 117.534 0.667 . . . . 0.0 111.281 169.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -160.0 141.6 12.75 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 124.016 0.926 . . . . 0.0 108.627 176.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 57.2 t -107.35 109.83 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 177.683 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 18.6 mp0 -101.85 126.76 48.8 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.879 0.871 . . . . 0.0 109.777 179.312 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 21.6 m80 -101.78 97.0 7.45 Favored 'General case' 0 CA--C 1.553 1.082 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 -175.231 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -86.41 128.81 34.99 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 172.318 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -91.02 118.87 30.73 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 121.208 0.528 . . . . 0.0 110.889 -169.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 91.9 t -85.91 110.21 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 107.224 -1.398 . . . . 0.0 107.224 -177.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 56.8 mt -104.31 134.41 47.58 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 -173.217 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 37.3 mtm180 -99.52 131.47 45.51 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 118.176 0.444 . . . . 0.0 110.929 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -85.6 -54.47 4.53 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 174.537 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 179.98 139.44 3.77 Favored Glycine 0 CA--C 1.542 1.732 0 CA-C-N 119.823 1.192 . . . . 0.0 113.77 -178.341 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . 0.344 . . 78.53 -79.15 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 125.294 1.438 . . . . 0.0 113.3 175.446 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -157.18 78.13 0.19 Allowed Glycine 0 N--CA 1.478 1.463 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 172.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -143.07 144.1 32.12 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -171.109 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -138.87 100.6 4.09 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 -172.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -99.89 105.43 17.16 Favored 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 175.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -101.63 -49.94 3.86 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-N 114.327 -1.306 . . . . 0.0 111.239 175.558 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 79.0 t90 -129.48 101.71 6.07 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 -172.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . 0.509 10.7 p 60.75 -90.68 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 C-N-CA 125.227 1.411 . . . . 0.0 114.188 -179.45 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 21.1 m -79.64 158.44 4.54 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.493 0 C-N-CA 124.449 1.1 . . . . 0.0 112.398 -175.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -79.72 152.7 29.73 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 121.876 0.846 . . . . 0.0 112.978 179.058 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -135.73 109.42 8.04 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 105.9 -1.889 . . . . 0.0 105.9 -171.358 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 15.1 t30 -57.89 -53.54 57.08 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 115.77 1.767 . . . . 0.0 115.77 -170.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 67.7 m -98.05 149.57 22.34 Favored 'General case' 0 N--CA 1.483 1.225 0 CA-C-O 123.04 1.4 . . . . 0.0 111.337 178.252 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 8.0 tp -65.96 -31.29 72.12 Favored 'General case' 0 CA--C 1.571 1.764 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 169.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -70.18 -37.85 75.23 Favored 'General case' 0 CA--C 1.57 1.746 0 CA-C-O 117.681 -1.152 . . . . 0.0 113.796 169.311 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . 0.329 9.1 pt-20 -62.16 -31.14 71.61 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-N 121.139 1.79 . . . . 0.0 115.088 169.319 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 59.6 tp -57.79 -44.13 86.06 Favored 'General case' 0 CA--C 1.574 1.868 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 168.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . 0.333 7.1 p -65.3 -57.61 10.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 CA-C-N 120.17 1.35 . . . . 0.0 113.918 172.644 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -60.32 -23.49 64.25 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 117.391 2.367 . . . . 0.0 117.391 176.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 84.8 t80 -66.25 -61.33 2.08 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-N 119.304 0.956 . . . . 0.0 112.043 169.485 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 71.4 m-70 -69.83 -9.54 55.13 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 117.734 2.494 . . . . 0.0 117.734 176.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 38.0 ttm180 -59.52 -29.11 67.65 Favored 'General case' 0 CA--C 1.58 2.119 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 167.462 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 70.7 m -110.2 -30.61 7.66 Favored 'General case' 0 CA--C 1.571 1.771 0 C-N-CA 125.483 1.513 . . . . 0.0 114.037 169.172 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 56.8 m -90.46 157.36 17.61 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-N 120.546 1.521 . . . . 0.0 111.266 177.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 8.2 t -75.93 129.79 37.47 Favored 'General case' 0 CA--C 1.56 1.363 0 O-C-N 121.491 -0.756 . . . . 0.0 112.8 177.052 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 14.1 t -69.15 -50.69 50.68 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 C-N-CA 123.807 0.843 . . . . 0.0 111.655 173.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 25.3 t -88.56 145.07 25.92 Favored 'General case' 0 CA--C 1.558 1.259 0 C-N-CA 123.341 0.656 . . . . 0.0 110.211 173.062 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 84.7 mtt85 -69.95 -50.39 42.43 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 177.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 21.0 m120 -72.84 -55.59 6.44 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 113.445 0.906 . . . . 0.0 113.445 174.031 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -83.26 146.7 28.41 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-N 118.978 0.808 . . . . 0.0 111.432 -177.204 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 60.5 mt-30 -86.02 94.78 9.31 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.337 0.589 . . . . 0.0 109.607 176.007 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 44.1 mm -114.44 133.18 61.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 -174.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -127.56 117.88 22.9 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 -169.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 14.1 tp -80.55 125.57 30.14 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 124.442 1.097 . . . . 0.0 113.952 -168.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 32.5 mmt180 -138.05 160.19 40.02 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 124.085 0.954 . . . . 0.0 110.525 -170.469 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -73.91 152.98 40.01 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.607 -1.308 . . . . 0.0 112.924 177.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.1 pp -66.55 159.73 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 -179.303 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 . . . . . 0 N--CA 1.485 1.299 0 CA-C-O 123.981 1.848 . . . . 0.0 108.584 -176.89 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.354 0 N-CA-C 111.508 -0.637 . . . . 0.0 111.508 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 89.5 p -85.74 120.25 26.95 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 123.038 0.535 . . . . 0.0 111.924 -174.356 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . 0.253 1.6 p90 -156.59 -44.35 0.07 Allowed 'General case' 0 N--CA 1.488 1.448 0 CA-C-O 118.257 -0.878 . . . . 0.0 113.038 178.465 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -82.53 141.09 32.91 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 120.598 1.544 . . . . 0.0 112.345 -171.043 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -118.83 -71.91 0.71 Allowed 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 115.087 -0.96 . . . . 0.0 109.127 174.571 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 104.22 95.94 2.38 Favored Glycine 0 N--CA 1.481 1.658 0 CA-C-N 119.195 0.907 . . . . 0.0 111.655 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . 0.312 94.9 mttt 63.35 71.03 0.52 Allowed 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 124.615 1.166 . . . . 0.0 114.027 -178.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 26.1 pt -122.8 150.53 58.87 Favored Pre-proline 0 CA--C 1.576 1.948 0 C-N-CA 124.284 1.034 . . . . 0.0 108.646 170.01 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -72.42 163.97 37.0 Favored 'Trans proline' 0 CA--C 1.562 1.881 0 C-N-CA 122.825 2.35 . . . . 0.0 114.128 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 58.6 ttt180 -63.08 -41.78 99.5 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 115.592 1.701 . . . . 0.0 115.592 179.051 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.41 -46.31 83.81 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 115.305 1.594 . . . . 0.0 115.305 177.306 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -63.22 -35.33 79.98 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 115.346 1.61 . . . . 0.0 115.346 169.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.78 -44.72 95.45 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 115.42 1.637 . . . . 0.0 115.42 169.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -61.92 -40.73 96.5 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 115.213 1.56 . . . . 0.0 115.213 170.249 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -61.48 -50.34 73.12 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 114.895 1.442 . . . . 0.0 114.895 173.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -62.88 -43.98 97.34 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 115.02 1.489 . . . . 0.0 115.02 176.447 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 8.5 mp -65.19 -42.51 93.54 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 114.826 1.417 . . . . 0.0 114.826 172.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 67.5 m -54.98 -36.67 65.65 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 115.87 1.804 . . . . 0.0 115.87 169.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -63.34 -35.49 80.56 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 115.26 1.578 . . . . 0.0 115.26 169.465 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -63.21 126.86 28.8 Favored 'General case' 0 CA--C 1.557 1.228 0 CA-C-O 122.839 1.304 . . . . 0.0 112.61 172.393 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 14.5 ptp180 -67.45 -16.53 64.27 Favored 'General case' 0 CA--C 1.567 1.627 0 N-CA-C 119.026 2.973 . . . . 0.0 119.026 175.283 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 48.2 m80 -89.55 142.33 27.77 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 119.6 1.091 . . . . 0.0 113.281 -168.6 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -75.94 127.37 32.85 Favored 'General case' 0 N--CA 1.489 1.475 0 CA-C-N 115.014 -0.994 . . . . 0.0 108.632 169.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.45 4.31 66.18 Favored Glycine 0 CA--C 1.555 2.539 0 CA-C-O 117.278 -1.845 . . . . 0.0 117.621 -169.151 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -70.02 114.88 8.62 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 121.02 2.41 . . . . 0.0 112.73 -169.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 22.4 p90 -127.63 158.54 37.27 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 115.41 1.633 . . . . 0.0 115.41 -168.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.1 pp -134.99 158.21 44.93 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 124.169 0.988 . . . . 0.0 109.535 168.185 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.8 mp -114.36 113.71 44.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 104.83 -2.285 . . . . 0.0 104.83 169.535 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 46.6 ptt85 -101.3 140.68 35.26 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 123.783 0.833 . . . . 0.0 109.07 169.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -79.59 138.42 37.44 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.683 -0.636 . . . . 0.0 109.53 170.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 58.2 m -66.79 128.21 35.42 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 123.13 0.572 . . . . 0.0 111.511 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -64.92 -50.92 64.59 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 114.403 1.26 . . . . 0.0 114.403 -171.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.8 t -64.25 -40.31 95.74 Favored 'General case' 0 CA--C 1.564 1.514 0 N-CA-C 115.487 1.662 . . . . 0.0 115.487 170.518 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -111.8 95.27 27.69 Favored Pre-proline 0 CA--C 1.564 1.493 0 CA-C-N 119.32 0.964 . . . . 0.0 110.819 -177.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.43 129.19 16.49 Favored 'Trans proline' 0 C--N 1.372 1.768 0 C-N-CA 123.054 2.503 . . . . 0.0 111.014 169.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 108.27 -35.43 4.98 Favored Glycine 0 CA--C 1.553 2.434 0 CA-C-O 118.894 -0.948 . . . . 0.0 113.609 -168.241 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -83.79 131.91 34.87 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-N 118.63 1.215 . . . . 0.0 108.24 169.203 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -115.77 168.07 10.36 Favored 'General case' 0 CA--C 1.56 1.357 0 CA-C-O 122.083 0.945 . . . . 0.0 110.181 -177.053 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 72.8 m -145.57 112.8 6.15 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 -177.093 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 19.9 tp -88.54 104.34 16.74 Favored 'General case' 0 CA--C 1.561 1.393 0 C-N-CA 124.654 1.181 . . . . 0.0 109.429 177.253 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.8 m -82.56 119.15 23.89 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 124.879 1.272 . . . . 0.0 108.065 173.591 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 24.0 t -129.36 122.84 56.66 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.193 0 CA-C-N 120.805 1.638 . . . . 0.0 107.782 -175.029 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 59.4 tttp -80.4 138.62 36.67 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.458 169.47 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -150.34 105.88 3.39 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 169.719 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 83.76 -106.75 2.88 Favored Glycine 0 CA--C 1.54 1.61 0 N-CA-C 110.894 -0.882 . . . . 0.0 110.894 -174.495 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 21.3 m120 -133.9 63.74 1.62 Allowed 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 169.549 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -160.77 127.67 4.17 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 123.522 0.729 . . . . 0.0 109.481 175.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 99.9 t -103.57 106.39 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 177.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -107.16 131.3 54.3 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.876 0.87 . . . . 0.0 110.82 -176.546 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 21.8 m-70 -103.33 107.66 18.58 Favored 'General case' 0 CA--C 1.552 1.019 0 C-N-CA 123.649 0.78 . . . . 0.0 109.598 -169.328 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -91.33 131.55 36.75 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 115.111 -0.95 . . . . 0.0 108.6 175.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 38.3 mtmm -80.52 117.1 20.94 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.239 0.542 . . . . 0.0 109.628 178.195 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 95.6 t -94.48 98.33 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 N-CA-C 105.994 -1.854 . . . . 0.0 105.994 176.658 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -97.14 140.26 31.9 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 178.257 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 53.3 mtm180 -100.0 133.35 44.51 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 122.673 0.389 . . . . 0.0 110.88 -176.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . 0.253 4.7 p-10 -80.0 -66.53 0.86 Allowed 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 176.085 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -94.51 -116.83 2.86 Favored Glycine 0 CA--C 1.541 1.661 0 CA-C-N 119.067 0.848 . . . . 0.0 112.211 -177.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -86.62 -83.11 0.19 Allowed 'General case' 0 N--CA 1.487 1.385 0 CA-C-O 118.441 -0.79 . . . . 0.0 110.028 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -109.71 78.91 0.24 Allowed Glycine 0 N--CA 1.479 1.565 0 N-CA-C 109.971 -1.252 . . . . 0.0 109.971 169.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -131.17 78.54 1.84 Allowed 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 -174.269 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -80.36 119.42 23.06 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 124.114 0.966 . . . . 0.0 111.402 -169.216 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 10.5 p90 -139.64 123.08 17.18 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 122.49 0.316 . . . . 0.0 110.155 -178.257 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -112.61 -37.82 4.8 Favored 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 123.61 0.764 . . . . 0.0 112.634 168.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 51.0 t90 -84.04 -86.17 0.12 Allowed 'General case' 0 CA--C 1.56 1.344 0 C-N-CA 124.805 1.242 . . . . 0.0 109.272 -175.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . 0.258 6.1 m -139.88 -61.02 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 C-N-CA 123.833 0.853 . . . . 0.0 109.836 173.356 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.3 p -79.97 140.73 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 CA-C-N 119.094 0.861 . . . . 0.0 111.203 -176.122 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.97 156.93 24.44 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 -179.264 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -139.45 120.6 14.72 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 -169.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 66.7 m-80 -61.25 -39.91 92.1 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 116.566 2.062 . . . . 0.0 116.566 -173.228 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 66.6 m -123.75 160.38 27.42 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-O 121.882 0.849 . . . . 0.0 111.898 -176.434 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 98.1 mt -84.39 86.51 7.26 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 169.211 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 167.32 -58.56 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 104.087 -2.56 . . . . 0.0 104.087 -168.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -58.75 -44.87 90.66 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 124.379 1.071 . . . . 0.0 113.72 168.674 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 8.6 tt -57.25 -50.34 73.19 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 114.722 1.379 . . . . 0.0 114.722 169.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 1.7 m -66.01 -49.11 79.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -178.109 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -67.92 -35.18 78.01 Favored 'General case' 0 CA--C 1.566 1.594 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 -178.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 79.8 t80 -61.11 -55.18 35.52 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-N 119.894 1.225 . . . . 0.0 112.083 169.103 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . 0.258 76.3 m-70 -68.68 -8.85 46.25 Favored 'General case' 0 CA--C 1.566 1.577 0 N-CA-C 117.797 2.517 . . . . 0.0 117.797 175.352 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 5.9 ttm180 -58.37 -28.1 64.82 Favored 'General case' 0 CA--C 1.579 2.069 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 167.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 70.0 m -114.16 -30.82 6.52 Favored 'General case' 0 CA--C 1.57 1.745 0 C-N-CA 125.341 1.456 . . . . 0.0 113.639 169.035 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 32.4 m -90.32 152.33 21.07 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-N 120.753 1.615 . . . . 0.0 110.532 176.37 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 20.5 t -82.04 131.31 35.24 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 120.628 -1.295 . . . . 0.0 112.971 -179.441 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -66.2 -45.09 91.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 169.548 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 22.0 t -79.67 -32.2 41.46 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 115.584 1.698 . . . . 0.0 115.584 177.367 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . 0.336 15.9 ttt180 91.88 -66.64 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 124.926 1.29 . . . . 0.0 111.92 179.308 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -69.52 -54.7 12.9 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 172.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -79.87 140.49 36.75 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-N 118.619 0.645 . . . . 0.0 110.358 171.039 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 3.3 tm0? -87.41 109.41 19.55 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 123.054 0.542 . . . . 0.0 109.564 178.387 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 5.2 mp -133.3 121.78 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 172.674 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 21.6 m-30 -115.16 144.73 43.23 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.745 0.783 . . . . 0.0 109.747 173.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 10.1 mp -90.22 121.97 32.72 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 113.372 0.879 . . . . 0.0 113.372 -169.29 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -119.62 140.47 50.55 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 124.373 1.069 . . . . 0.0 108.388 169.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -70.39 147.21 49.8 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 -176.036 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 15.4 pt -67.49 154.31 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 N-CA-C 113.658 0.985 . . . . 0.0 113.658 -178.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 . . . . . 0 N--CA 1.484 1.269 0 CA-C-O 122.827 1.298 . . . . 0.0 110.013 -174.999 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.373 0 N-CA-C 111.489 -0.645 . . . . 0.0 111.489 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 31.3 t -82.03 105.84 13.46 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-O 121.295 0.569 . . . . 0.0 111.174 -176.552 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 63.7 p-90 -75.25 -45.94 36.96 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 115.246 1.573 . . . . 0.0 115.246 177.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 29.9 t80 -84.25 131.98 34.68 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-N 119.801 1.182 . . . . 0.0 110.884 -175.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -117.38 -58.92 2.0 Allowed 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 114.815 -1.084 . . . . 0.0 109.735 174.17 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 104.4 87.65 2.01 Favored Glycine 0 N--CA 1.479 1.543 0 CA-C-N 119.043 0.838 . . . . 0.0 111.972 172.149 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 68.9 tttt 66.85 69.68 0.4 Allowed 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 124.062 0.945 . . . . 0.0 113.24 178.373 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 25.4 pt -121.14 148.87 50.24 Favored Pre-proline 0 CA--C 1.574 1.892 0 C-N-CA 123.957 0.903 . . . . 0.0 109.024 175.241 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -70.9 161.48 45.95 Favored 'Trans proline' 0 CA--C 1.559 1.774 0 C-N-CA 122.933 2.422 . . . . 0.0 114.519 -177.603 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 56.9 ttt180 -65.16 -40.9 94.97 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 115.786 1.773 . . . . 0.0 115.786 -176.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.74 -46.47 82.08 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 115.34 1.607 . . . . 0.0 115.34 179.593 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 55.5 mtmt -63.55 -34.52 77.98 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 115.037 1.495 . . . . 0.0 115.037 169.631 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.5 -43.44 90.11 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 115.484 1.661 . . . . 0.0 115.484 170.326 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -63.64 -42.88 98.08 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 115.09 1.515 . . . . 0.0 115.09 172.467 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -63.48 -48.13 78.93 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 114.917 1.451 . . . . 0.0 114.917 175.257 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -65.52 -43.8 88.89 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 114.756 1.391 . . . . 0.0 114.756 176.457 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 85.7 mt -67.35 -40.52 85.83 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 116.228 1.936 . . . . 0.0 116.228 175.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 91.1 p -56.33 -30.47 62.62 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 116.951 2.204 . . . . 0.0 116.951 171.049 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -66.15 -30.66 71.19 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 116.378 1.992 . . . . 0.0 116.378 170.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -59.64 142.66 52.46 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-O 123.024 1.392 . . . . 0.0 113.577 176.395 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.413 ' HD3' ' H ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -70.28 -15.93 62.96 Favored 'General case' 0 CA--C 1.568 1.659 0 N-CA-C 118.129 2.64 . . . . 0.0 118.129 170.309 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 31.4 m80 -89.43 132.66 34.9 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-N 119.996 1.271 . . . . 0.0 111.137 -169.239 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -81.29 106.77 13.52 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 169.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 115.82 8.41 13.84 Favored Glycine 0 CA--C 1.557 2.707 0 CA-C-O 116.838 -2.09 . . . . 0.0 116.388 -168.494 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.44 111.23 3.97 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-N 121.639 2.719 . . . . 0.0 112.331 -170.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 28.5 p90 -118.19 155.92 29.66 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 116.509 2.041 . . . . 0.0 116.509 -168.255 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.4 pp -148.18 138.68 22.86 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 123.31 0.644 . . . . 0.0 109.972 169.266 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 81.6 mt -90.17 117.79 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 169.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 4.9 ptm180 -111.23 145.72 38.23 Favored 'General case' 0 N--CA 1.487 1.388 0 CA-C-N 114.102 -1.408 . . . . 0.0 108.708 169.523 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -79.38 143.93 34.64 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.342 -0.849 . . . . 0.0 109.779 172.163 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 7.9 t -73.72 8.38 1.95 Allowed 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 119.556 3.169 . . . . 0.0 119.556 -169.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . 0.357 5.9 mp0 74.45 -72.0 0.12 Allowed 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 125.542 1.537 . . . . 0.0 113.654 175.018 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 65.9 m -64.3 -40.71 96.49 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 115.934 1.828 . . . . 0.0 115.934 178.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -111.95 102.41 53.65 Favored Pre-proline 0 CA--C 1.563 1.471 0 CA-C-O 118.077 -0.964 . . . . 0.0 109.49 174.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -58.86 -32.09 96.6 Favored 'Trans proline' 0 C--N 1.37 1.697 0 N-CA-C 119.751 2.943 . . . . 0.0 119.751 174.545 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -86.76 43.17 3.21 Favored Glycine 0 CA--C 1.554 2.475 0 N-CA-C 115.359 0.903 . . . . 0.0 115.359 169.245 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -153.83 116.45 4.42 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 105.502 -2.036 . . . . 0.0 105.502 177.006 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -96.19 172.1 8.18 Favored 'General case' 0 CA--C 1.559 1.323 0 CA-C-O 122.245 1.021 . . . . 0.0 110.746 174.558 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 71.4 m -146.72 108.33 4.31 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 -176.626 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 32.5 tp -79.73 117.79 20.95 Favored 'General case' 0 CA--C 1.559 1.312 0 CA-C-O 121.834 0.826 . . . . 0.0 108.925 173.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 18.9 m -104.78 90.46 3.49 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 -172.478 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 10.0 t -101.09 119.24 48.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 N-CA-C 107.389 -1.338 . . . . 0.0 107.389 -170.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -79.64 134.65 36.44 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.042 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -137.9 109.64 7.1 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 -179.105 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 78.62 -93.19 1.24 Allowed Glycine 0 N--CA 1.487 2.075 0 N-CA-C 111.838 -0.505 . . . . 0.0 111.838 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 15.7 t30 -149.31 45.38 0.97 Allowed 'General case' 0 CA--C 1.573 1.848 0 C-N-CA 123.295 0.638 . . . . 0.0 110.616 168.185 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -157.6 134.49 10.04 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 178.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 24.6 t -103.91 121.88 55.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -169.583 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 66.3 mt-30 -94.06 120.76 34.77 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 175.325 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 10.2 m-70 -98.86 95.46 7.2 Favored 'General case' 0 CA--C 1.55 0.971 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 -174.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -86.66 125.0 33.56 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-N 114.862 -1.063 . . . . 0.0 108.211 177.535 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -81.18 125.63 30.51 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-O 121.657 0.742 . . . . 0.0 111.586 -175.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 72.5 t -86.75 106.7 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 173.487 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.9 pp -114.34 144.67 42.89 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 123.248 0.619 . . . . 0.0 110.903 -176.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -96.99 151.63 19.52 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -169.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . 0.252 4.4 p-10 -100.64 -65.42 0.97 Allowed 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 123.676 0.79 . . . . 0.0 111.62 169.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -94.02 -123.25 3.68 Favored Glycine 0 CA--C 1.543 1.787 0 CA-C-N 119.468 1.031 . . . . 0.0 112.874 -177.275 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -76.48 -65.49 0.92 Allowed 'General case' 0 N--CA 1.489 1.521 0 CA-C-O 118.833 -0.603 . . . . 0.0 112.041 177.558 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -135.51 61.61 0.62 Allowed Glycine 0 CA--C 1.542 1.772 0 N-CA-C 111.391 -0.683 . . . . 0.0 111.391 169.328 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -106.69 92.44 4.1 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 105.75 -1.944 . . . . 0.0 105.75 -179.182 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -82.41 116.7 22.0 Favored 'General case' 0 N--CA 1.484 1.228 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.61 -169.345 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 15.1 p90 -129.51 125.06 35.48 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-O 121.83 0.824 . . . . 0.0 109.631 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 6.0 tt -104.77 -61.63 1.44 Allowed 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 114.966 -1.016 . . . . 0.0 109.657 176.235 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 25.6 t90 -83.9 -82.04 0.17 Allowed 'General case' 0 CA--C 1.557 1.218 0 C-N-CA 124.36 1.064 . . . . 0.0 111.41 -169.382 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . 0.25 7.2 m -136.67 -58.78 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 CA-C-N 118.926 0.785 . . . . 0.0 110.378 176.21 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 13.7 m -79.82 142.02 14.52 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.382 0 C-N-CA 124.085 0.954 . . . . 0.0 111.406 -177.197 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -79.95 150.35 30.53 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 -176.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -131.77 113.72 13.87 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 -169.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 11.3 p30 -54.97 -42.67 72.67 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 117.297 2.332 . . . . 0.0 117.297 -177.596 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 98.6 p -117.53 163.61 16.16 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-O 122.266 1.031 . . . . 0.0 111.404 175.316 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 70.2 mt -66.18 -31.24 71.96 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 114.773 1.397 . . . . 0.0 114.773 169.704 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -64.14 -43.26 95.78 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-N 119.468 1.031 . . . . 0.0 113.635 169.291 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -58.74 -40.04 82.65 Favored 'General case' 0 CA--C 1.568 1.637 0 N-CA-C 115.125 1.528 . . . . 0.0 115.125 169.521 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 8.7 tt -61.24 -51.42 69.01 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 114.62 1.341 . . . . 0.0 114.62 173.605 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 22.7 m -64.59 -51.23 70.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 N-CA-C 113.461 0.911 . . . . 0.0 113.461 176.507 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -64.44 -34.34 77.97 Favored 'General case' 0 CA--C 1.564 1.508 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 -176.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -60.7 -52.15 66.35 Favored 'General case' 0 CA--C 1.567 1.61 0 CA-C-N 119.37 0.986 . . . . 0.0 111.471 168.195 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . 0.255 59.4 m-70 -70.12 -9.25 54.96 Favored 'General case' 0 CA--C 1.565 1.552 0 N-CA-C 118.143 2.646 . . . . 0.0 118.143 176.643 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 90.0 mtt180 -61.53 -30.41 70.62 Favored 'General case' 0 CA--C 1.576 1.97 0 CA-C-N 120.42 1.463 . . . . 0.0 113.025 167.301 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 70.3 m -102.11 -40.53 6.78 Favored 'General case' 0 CA--C 1.567 1.623 0 C-N-CA 124.934 1.294 . . . . 0.0 113.633 169.149 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 44.1 m -90.58 156.44 18.15 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-N 120.061 1.3 . . . . 0.0 111.533 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 33.1 t -84.6 134.55 34.39 Favored 'General case' 0 N--CA 1.485 1.312 0 O-C-N 120.654 -1.278 . . . . 0.0 113.904 -175.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -73.16 -43.73 57.17 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.751 0 C-N-CA 123.939 0.896 . . . . 0.0 112.28 168.477 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 22.8 t -79.48 138.2 37.48 Favored 'General case' 0 CA--C 1.559 1.309 0 CA-C-N 119.367 0.985 . . . . 0.0 111.142 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -70.63 -56.19 7.04 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 -172.014 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -73.51 -66.16 0.73 Allowed 'General case' 0 N--CA 1.489 1.518 0 CA-C-N 119.151 0.887 . . . . 0.0 112.439 -179.261 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -87.77 141.73 28.37 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.304 0.641 . . . . 0.0 110.73 -178.785 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -84.13 104.63 14.35 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 122.848 0.459 . . . . 0.0 111.458 -178.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.54 138.91 52.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 178.773 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -122.35 158.31 29.9 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 121.989 0.899 . . . . 0.0 113.183 -168.562 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 9.3 mp -87.59 133.91 33.72 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 124.129 0.972 . . . . 0.0 111.925 -175.081 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 59.5 mmt-85 -129.58 138.21 51.16 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 124.391 1.077 . . . . 0.0 108.517 176.089 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -74.8 148.42 40.35 Favored 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 121.843 0.83 . . . . 0.0 112.402 -178.077 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 19.4 pt -69.66 167.6 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 -169.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 . . . . . 0 N--CA 1.486 1.326 0 CA-C-O 123.902 1.811 . . . . 0.0 109.124 173.045 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.448 0 N-CA-C 111.678 -0.569 . . . . 0.0 111.678 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 23.4 m 75.39 115.27 0.06 Allowed 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 124.675 1.19 . . . . 0.0 112.628 175.552 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 65.3 p-90 -81.85 -39.72 23.51 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 116.307 1.965 . . . . 0.0 116.307 178.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -83.33 125.95 32.18 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-N 119.878 1.217 . . . . 0.0 110.625 -173.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -105.6 -73.88 0.67 Allowed 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 171.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 87.32 125.13 2.0 Favored Glycine 0 CA--C 1.541 1.712 0 CA-C-N 119.458 1.026 . . . . 0.0 112.778 176.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . 0.318 20.0 tptm 76.32 -13.15 0.94 Allowed 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 117.313 2.338 . . . . 0.0 117.313 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 20.3 tt -61.92 131.47 93.17 Favored Pre-proline 0 CA--C 1.575 1.93 0 CA-C-N 120.999 1.727 . . . . 0.0 112.231 174.129 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -53.7 166.52 1.32 Allowed 'Trans proline' 0 CA--C 1.556 1.618 0 C-N-CA 123.597 2.865 . . . . 0.0 117.394 174.684 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 59.8 ttt180 -64.98 -42.62 94.39 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 169.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -68.01 -42.48 80.61 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 115.673 1.731 . . . . 0.0 115.673 175.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -66.6 -36.05 81.69 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 115.257 1.577 . . . . 0.0 115.257 170.044 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.9 -46.14 86.19 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 115.201 1.556 . . . . 0.0 115.201 170.238 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -59.15 -45.28 91.4 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 114.964 1.468 . . . . 0.0 114.964 169.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -61.24 -47.54 85.57 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 115.119 1.526 . . . . 0.0 115.119 176.442 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -64.87 -36.36 84.1 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 115.909 1.818 . . . . 0.0 115.909 174.154 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.3 mp -90.13 -22.68 21.64 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 116.717 2.117 . . . . 0.0 116.717 -178.148 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 74.4 m -64.31 -44.02 92.87 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 120.946 1.703 . . . . 0.0 115.481 177.706 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . 0.26 0.0 OUTLIER -68.96 -21.82 64.15 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 116.763 2.135 . . . . 0.0 116.763 174.216 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -60.92 135.36 57.76 Favored 'General case' 0 N--CA 1.484 1.226 0 CA-C-N 120.268 1.395 . . . . 0.0 112.014 172.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -78.87 -19.08 52.8 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 117.872 2.545 . . . . 0.0 117.872 179.146 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 41.5 m80 -89.84 115.07 26.89 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 119.472 1.033 . . . . 0.0 111.607 -168.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.05 113.43 6.42 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 123.877 0.871 . . . . 0.0 110.211 179.276 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 114.6 -8.11 22.19 Favored Glycine 0 CA--C 1.546 2.0 0 CA-C-O 116.524 -2.264 . . . . 0.0 117.118 -169.445 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -75.76 110.88 10.56 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-N 121.789 2.794 . . . . 0.0 109.951 -173.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 16.4 p90 -120.51 163.0 18.61 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 115.164 1.542 . . . . 0.0 115.164 -168.387 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.2 pp -138.02 134.61 35.02 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-N 114.452 -1.249 . . . . 0.0 108.227 167.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 76.8 mt -91.4 106.79 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 170.017 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 51.8 ptt85 -88.25 157.39 18.79 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 123.429 0.692 . . . . 0.0 111.723 170.04 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -86.6 137.59 32.37 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 169.684 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 18.3 t -77.41 89.32 3.79 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.474 0.71 . . . . 0.0 111.984 -170.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . 0.341 45.4 mt-10 72.65 -89.78 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 125.311 1.444 . . . . 0.0 107.866 -169.357 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 21.5 t -152.55 61.46 0.81 Allowed 'General case' 0 CA--C 1.561 1.402 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 168.69 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -117.75 99.83 52.28 Favored Pre-proline 0 CA--C 1.56 1.341 0 CA-C-O 117.726 -1.131 . . . . 0.0 108.683 -179.042 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -71.9 128.81 14.53 Favored 'Trans proline' 0 C--N 1.371 1.736 0 C-N-CA 122.959 2.439 . . . . 0.0 111.761 179.445 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 104.28 -45.9 1.26 Allowed Glycine 0 CA--C 1.551 2.3 0 CA-C-N 114.964 -1.016 . . . . 0.0 112.575 -168.009 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -87.17 101.65 13.7 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 172.614 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -113.28 170.69 8.04 Favored 'General case' 0 CA--C 1.562 1.442 0 CA-C-O 121.887 0.851 . . . . 0.0 110.075 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 74.2 m -134.52 115.6 14.1 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 175.421 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 19.2 tp -79.87 109.35 14.2 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 124.553 1.141 . . . . 0.0 109.155 176.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 9.8 m -105.05 88.78 2.96 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 115.01 -0.995 . . . . 0.0 108.699 -169.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 13.1 t -103.57 127.59 57.46 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -170.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.14 142.38 41.63 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 173.342 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -152.81 103.98 2.82 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 174.604 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 84.95 -87.53 1.56 Allowed Glycine 0 CA--C 1.542 1.731 0 N-CA-C 112.043 -0.423 . . . . 0.0 112.043 -175.553 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -137.29 -27.78 0.95 Allowed 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 169.634 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -85.8 140.13 30.71 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.919 0.887 . . . . 0.0 110.387 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 51.8 t -103.84 119.3 52.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 -176.021 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 -97.12 118.71 34.15 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.826 0.85 . . . . 0.0 109.547 -174.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -100.43 108.65 20.7 Favored 'General case' 0 CA--C 1.553 1.067 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 -173.089 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -109.06 123.45 49.17 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 -173.411 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 19.7 tptm -78.93 124.55 28.35 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-O 121.794 0.807 . . . . 0.0 111.574 -171.434 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 40.0 t -97.32 106.67 18.85 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.447 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 178.591 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 64.7 mt -97.68 175.05 6.33 Favored 'General case' 0 CA--C 1.565 1.545 0 C-N-CA 124.163 0.985 . . . . 0.0 112.198 -175.27 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 15.4 mmt85 -123.68 136.45 54.48 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 123.794 0.838 . . . . 0.0 112.169 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 25.5 p-10 -136.66 123.8 21.7 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 124.067 0.947 . . . . 0.0 109.036 173.136 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 95.19 -125.62 8.43 Favored Glycine 0 CA--C 1.542 1.755 0 C-N-CA 123.01 0.338 . . . . 0.0 112.961 177.651 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -88.72 -78.98 0.32 Allowed 'General case' 0 N--CA 1.488 1.452 0 CA-C-O 118.595 -0.717 . . . . 0.0 110.683 -178.496 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -137.42 63.04 0.58 Allowed Glycine 0 N--CA 1.482 1.731 0 CA-C-N 118.831 0.741 . . . . 0.0 112.244 169.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -120.72 113.61 20.45 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 106.347 -1.723 . . . . 0.0 106.347 -170.108 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -89.78 128.35 36.12 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.666 0.786 . . . . 0.0 111.756 -169.508 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 23.7 p90 -124.48 128.79 49.51 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 175.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 8.3 tt -86.31 -63.96 1.23 Allowed 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 118.788 -0.625 . . . . 0.0 110.147 169.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 17.0 m0 -76.82 -71.34 0.4 Allowed 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 118.754 0.706 . . . . 0.0 111.689 178.163 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 11.6 p -156.47 -52.41 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 C-N-CA 124.744 1.218 . . . . 0.0 109.898 -170.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 10.9 p -79.13 138.0 20.82 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.427 0 C-N-CA 124.351 1.061 . . . . 0.0 110.431 -176.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -79.76 155.29 27.99 Favored 'General case' 0 CA--C 1.559 1.289 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 -171.228 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -140.97 104.64 4.71 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 103.955 -2.609 . . . . 0.0 103.955 -174.281 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . 0.268 8.0 p-10 -47.71 -51.33 22.34 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 118.788 2.884 . . . . 0.0 118.788 -169.579 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 66.5 m -101.81 163.79 12.07 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-O 122.316 1.055 . . . . 0.0 111.476 176.44 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 15.4 tp -66.02 -37.89 87.03 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 169.259 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -65.59 -33.83 76.82 Favored 'General case' 0 CA--C 1.573 1.829 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 168.513 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -62.15 -42.74 99.55 Favored 'General case' 0 CA--C 1.566 1.591 0 CA-C-N 120.63 1.559 . . . . 0.0 114.943 169.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 7.8 tt -60.37 -45.03 94.96 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 169.72 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 29.4 t -55.04 -61.33 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 C-N-CA 124.43 1.092 . . . . 0.0 112.63 169.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -58.69 -34.75 71.63 Favored 'General case' 0 CA--C 1.568 1.652 0 N-CA-C 115.701 1.741 . . . . 0.0 115.701 -177.013 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 90.5 t80 -57.64 -56.12 25.97 Favored 'General case' 0 CA--C 1.564 1.512 0 CA-C-O 118.119 -0.943 . . . . 0.0 112.605 169.033 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . 0.319 52.3 m-70 -71.81 -9.08 57.79 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 117.875 2.546 . . . . 0.0 117.875 175.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 95.8 mtt-85 -65.39 -32.97 74.88 Favored 'General case' 0 CA--C 1.576 1.951 0 CA-C-N 120.702 1.592 . . . . 0.0 112.396 166.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 68.6 m -95.15 -40.26 9.69 Favored 'General case' 0 CA--C 1.563 1.476 0 N-CA-C 114.586 1.328 . . . . 0.0 114.586 170.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 93.6 m -90.82 149.09 22.1 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 124.747 1.219 . . . . 0.0 111.069 176.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 28.7 p -78.25 134.26 37.58 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.2 -0.938 . . . . 0.0 111.929 174.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 3.4 t -65.73 -52.33 51.47 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 C-N-CA 122.928 0.491 . . . . 0.0 111.091 173.288 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 74.2 m -98.89 143.08 29.6 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.638 0.732 . . . . 0.0 109.36 169.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 7.9 mpt_? -73.17 -51.73 16.75 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -177.305 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -68.06 -59.47 3.23 Favored 'General case' 0 N--CA 1.495 1.775 0 CA-C-N 119.199 0.909 . . . . 0.0 113.229 177.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -81.72 113.86 19.98 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 170.086 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -80.15 101.1 8.59 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 122.753 0.421 . . . . 0.0 111.244 -171.044 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 11.8 mm -100.14 106.29 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -169.369 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -112.88 127.4 56.18 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -179.47 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 9.7 mp -76.24 131.28 39.19 Favored 'General case' 0 CA--C 1.561 1.402 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 -169.072 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 61.7 ttt-85 -136.24 148.56 48.12 Favored 'General case' 0 CA--C 1.563 1.459 0 C-N-CA 125.258 1.423 . . . . 0.0 108.443 177.421 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -65.33 164.8 12.87 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 120.526 -1.359 . . . . 0.0 113.211 171.615 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.3 pp -64.19 162.59 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 -174.153 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 . . . . . 0 N--CA 1.488 1.444 0 CA-C-O 122.841 1.305 . . . . 0.0 110.488 174.472 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.379 0 N-CA-C 111.352 -0.699 . . . . 0.0 111.352 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 32.1 t -88.83 116.68 27.27 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.123 0.569 . . . . 0.0 109.997 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . 0.262 1.6 p90 -130.71 -47.15 1.05 Allowed 'General case' 0 CA--C 1.56 1.341 0 CA-C-O 118.147 -0.93 . . . . 0.0 112.857 -177.046 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -84.33 137.07 33.63 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 120.409 1.459 . . . . 0.0 111.407 -178.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -99.84 -92.5 0.28 Allowed 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 175.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 146.61 85.29 0.06 OUTLIER Glycine 0 N--CA 1.479 1.554 0 CA-C-N 119.438 1.017 . . . . 0.0 111.605 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 26.1 tptp 64.69 69.97 0.49 Allowed 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 124.168 0.987 . . . . 0.0 113.176 174.5 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 27.3 pt -125.0 149.29 62.83 Favored Pre-proline 0 CA--C 1.573 1.863 0 C-N-CA 123.793 0.837 . . . . 0.0 109.666 -179.375 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -75.07 171.34 18.5 Favored 'Trans proline' 0 CA--C 1.558 1.709 0 C-N-CA 122.93 2.42 . . . . 0.0 114.581 -178.231 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 57.0 ttt180 -65.26 -42.49 93.19 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 114.77 1.396 . . . . 0.0 114.77 176.296 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.14 -42.63 96.73 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 115.76 1.763 . . . . 0.0 115.76 176.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 14.6 tmtt? -65.37 -38.5 90.24 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 169.528 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.89 -46.6 84.16 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 115.314 1.598 . . . . 0.0 115.314 172.384 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -60.62 -40.97 93.84 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 115.16 1.541 . . . . 0.0 115.16 170.264 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -58.55 -56.46 21.86 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 171.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 45.7 tpp -56.71 -47.67 79.43 Favored 'General case' 0 CA--C 1.564 1.485 0 N-CA-C 115.683 1.735 . . . . 0.0 115.683 178.025 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 74.8 mt -68.04 -30.94 70.27 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 116.456 2.021 . . . . 0.0 116.456 175.057 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 21.8 t -62.96 -33.05 74.56 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 115.606 1.706 . . . . 0.0 115.606 169.537 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -62.46 -37.26 85.23 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 115.748 1.759 . . . . 0.0 115.748 170.151 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -61.05 139.44 58.07 Favored 'General case' 0 CA--C 1.556 1.18 0 N-CA-C 115.115 1.524 . . . . 0.0 115.115 -175.055 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 15.7 ptp180 -70.59 -21.0 62.72 Favored 'General case' 0 CA--C 1.568 1.635 0 N-CA-C 118.404 2.742 . . . . 0.0 118.404 174.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 49.5 m80 -89.21 144.97 25.72 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 119.575 1.08 . . . . 0.0 112.667 -168.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -78.09 114.99 17.48 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 123.635 0.774 . . . . 0.0 109.944 175.503 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 82.57 33.12 25.86 Favored Glycine 0 CA--C 1.548 2.137 0 CA-C-O 118.387 -1.23 . . . . 0.0 115.36 -168.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.99 113.64 6.56 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 118.949 1.374 . . . . 0.0 110.211 178.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 22.2 p90 -123.37 155.52 37.18 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 115.005 1.483 . . . . 0.0 115.005 -168.437 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.2 pp -142.02 143.84 33.35 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.895 0.878 . . . . 0.0 108.945 168.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.4 mp -94.55 119.6 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 N-CA-C 105.704 -1.962 . . . . 0.0 105.704 169.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 49.4 ptt85 -103.14 158.2 16.47 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 123.503 0.721 . . . . 0.0 111.135 169.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -90.02 126.61 35.82 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 169.025 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 18.0 t -65.79 139.22 58.31 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 112.878 0.695 . . . . 0.0 112.878 -173.295 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -70.54 -53.01 17.83 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 -171.437 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.6 t -62.67 -38.01 88.67 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 115.866 1.802 . . . . 0.0 115.866 172.048 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -118.69 97.28 50.68 Favored Pre-proline 0 CA--C 1.562 1.439 0 CA-C-N 119.195 0.907 . . . . 0.0 110.015 176.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_exo -57.4 -30.24 87.23 Favored 'Trans proline' 0 C--N 1.37 1.671 0 N-CA-C 119.617 2.891 . . . . 0.0 119.617 172.148 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -88.28 47.0 3.44 Favored Glycine 0 CA--C 1.552 2.395 0 N-CA-C 114.527 0.571 . . . . 0.0 114.527 168.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -160.09 125.39 4.0 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 105.906 -1.887 . . . . 0.0 105.906 -179.465 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 11.0 m-30 -95.93 172.26 8.12 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.823 0.821 . . . . 0.0 111.272 175.626 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 71.5 m -147.85 115.06 6.21 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 -179.527 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 28.7 tp -79.92 108.59 13.62 Favored 'General case' 0 N--CA 1.487 1.379 0 CA-C-O 122.29 1.043 . . . . 0.0 109.61 174.159 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 6.2 m -95.54 112.62 24.3 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 34.5 t -121.02 131.1 73.86 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.169 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 -174.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 28.7 tptp -76.98 100.59 5.67 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 123.309 0.644 . . . . 0.0 110.933 175.33 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -86.13 -169.16 2.51 Favored 'General case' 0 CA--C 1.572 1.817 0 CA-C-O 121.291 0.567 . . . . 0.0 109.586 173.602 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -68.48 106.58 1.78 Allowed Glycine 0 CA--C 1.544 1.877 0 O-C-N 120.692 -1.255 . . . . 0.0 113.497 179.023 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . 0.319 10.3 t30 75.23 -18.9 0.42 Allowed 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 118.192 2.664 . . . . 0.0 118.192 -175.299 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -144.33 143.36 30.94 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 120.336 1.426 . . . . 0.0 109.611 -169.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 56.2 t -90.64 113.56 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 178.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -94.76 122.97 37.92 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 121.601 0.715 . . . . 0.0 109.96 178.09 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 8.7 m-70 -100.19 127.1 46.53 Favored 'General case' 0 CA--C 1.552 1.046 0 CA-C-N 114.985 -1.007 . . . . 0.0 109.251 -175.126 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -119.21 126.72 52.2 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 -177.448 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 48.2 mtpt -76.27 116.4 16.93 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-O 121.182 0.515 . . . . 0.0 110.608 -177.154 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 75.9 t -85.09 98.9 6.63 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.374 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 172.598 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.8 mt -81.36 137.35 35.73 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.893 -179.395 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 78.1 mtp180 -113.38 120.68 41.92 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -174.503 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . 0.286 4.9 p-10 -85.29 -66.13 0.93 Allowed 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -88.92 -110.18 1.16 Allowed Glycine 0 N--CA 1.482 1.737 0 CA-C-N 119.331 0.968 . . . . 0.0 112.395 -176.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -84.6 -84.14 0.15 Allowed 'General case' 0 N--CA 1.487 1.413 0 CA-C-O 118.364 -0.827 . . . . 0.0 109.175 174.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -116.88 63.6 0.37 Allowed Glycine 0 N--CA 1.481 1.68 0 CA-C-N 118.896 0.771 . . . . 0.0 111.535 169.341 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm -101.79 87.14 3.06 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 106.017 -1.845 . . . . 0.0 106.017 -176.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 47.7 m-85 -82.78 116.85 22.3 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 114.892 -1.049 . . . . 0.0 112.64 -168.159 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -135.54 114.11 11.75 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.44 0.696 . . . . 0.0 110.144 177.68 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . 0.276 1.8 pt? -87.09 -45.45 10.7 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-O 118.758 -0.639 . . . . 0.0 112.51 168.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 45.3 m0 -83.57 -84.74 0.13 Allowed 'General case' 0 CA--C 1.564 1.495 0 CA-C-N 118.966 0.803 . . . . 0.0 109.436 173.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 61.0 t -141.02 -55.97 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 C-N-CA 124.32 1.048 . . . . 0.0 109.063 -174.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 13.6 p -79.45 128.83 38.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 C-N-CA 123.663 0.785 . . . . 0.0 110.968 -170.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.44 159.67 18.59 Favored 'General case' 0 N--CA 1.486 1.351 0 CA-C-O 122.53 1.157 . . . . 0.0 113.724 -175.332 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -141.84 121.5 13.41 Favored 'General case' 0 N--CA 1.484 1.242 0 CA-C-N 113.96 -1.473 . . . . 0.0 107.052 -170.564 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 36.0 m-80 -58.69 -41.4 86.18 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 115.585 1.698 . . . . 0.0 115.585 177.63 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 26.2 t -114.86 152.74 31.7 Favored 'General case' 0 N--CA 1.484 1.271 0 CA-C-O 122.069 0.937 . . . . 0.0 111.19 178.094 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 80.6 mt -63.95 -27.26 69.01 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 168.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -59.09 -39.23 81.54 Favored 'General case' 0 CA--C 1.575 1.935 0 CA-C-N 120.105 1.321 . . . . 0.0 113.923 168.527 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -70.35 -43.52 70.03 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 114.76 1.393 . . . . 0.0 114.76 171.573 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 9.9 tt -59.1 -46.21 88.89 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 115.361 1.615 . . . . 0.0 115.361 170.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 4.4 p -68.3 -48.41 73.43 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.538 0 N-CA-C 113.742 1.015 . . . . 0.0 113.742 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -56.25 -35.89 67.91 Favored 'General case' 0 CA--C 1.569 1.711 0 N-CA-C 115.182 1.549 . . . . 0.0 115.182 169.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 61.3 t80 -55.6 -55.86 27.12 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 117.26 -1.352 . . . . 0.0 113.102 169.15 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . 0.381 33.5 m-70 -73.52 -9.22 58.45 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 118.748 2.87 . . . . 0.0 118.748 175.757 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 91.2 mtt-85 -73.0 -27.06 61.57 Favored 'General case' 0 CA--C 1.581 2.137 0 CA-C-N 120.058 1.299 . . . . 0.0 112.42 166.703 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 69.6 m -97.85 -42.14 7.7 Favored 'General case' 0 CA--C 1.565 1.543 0 C-N-CA 125.012 1.325 . . . . 0.0 114.24 171.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 92.6 m -85.93 142.58 28.73 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 124.614 1.165 . . . . 0.0 109.717 171.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 33.5 t -72.35 121.09 18.9 Favored 'General case' 0 N--CA 1.485 1.303 0 O-C-N 121.449 -0.782 . . . . 0.0 111.113 173.454 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 11.4 p -58.33 -35.57 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 N-CA-C 115.525 1.676 . . . . 0.0 115.525 172.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 15.1 t -79.52 -28.11 41.35 Favored 'General case' 0 CA--C 1.564 1.512 0 N-CA-C 116.682 2.104 . . . . 0.0 116.682 179.233 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . 0.352 98.6 mtt180 86.65 -78.79 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 CA-C-N 120.274 1.397 . . . . 0.0 111.393 -177.287 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 70.1 m-80 -67.5 -52.82 34.56 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -79.7 152.19 30.04 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.166 0.586 . . . . 0.0 110.583 169.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -89.89 88.09 7.2 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 173.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 19.9 mm -113.13 141.39 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -146.63 145.69 30.15 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 121.946 0.879 . . . . 0.0 112.524 -168.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 11.2 mp -83.68 117.2 23.05 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-N 114.761 -1.109 . . . . 0.0 112.279 -169.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 27.2 mmm180 -109.29 137.49 47.09 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 124.304 1.042 . . . . 0.0 109.058 169.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -73.66 142.91 46.43 Favored 'General case' 0 CA--C 1.564 1.487 0 CA-C-O 121.742 0.782 . . . . 0.0 111.713 -178.332 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 17.9 pt -63.3 156.29 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 114.814 1.413 . . . . 0.0 114.814 -173.074 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 . . . . . 0 N--CA 1.483 1.213 0 CA-C-O 123.999 1.857 . . . . 0.0 109.11 179.531 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.361 0 N-CA-C 111.488 -0.645 . . . . 0.0 111.488 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 30.6 t -88.76 108.79 19.69 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 177.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . 0.273 1.8 p90 -119.19 -47.55 2.47 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-O 118.015 -0.993 . . . . 0.0 113.068 -174.694 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -80.15 135.25 36.26 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-N 120.444 1.475 . . . . 0.0 110.263 172.307 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -121.3 -80.03 0.62 Allowed 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 179.31 -146.47 7.16 Favored Glycine 0 N--CA 1.48 1.589 0 CA-C-N 119.09 0.859 . . . . 0.0 112.012 176.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -85.03 88.43 7.46 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 121.533 0.682 . . . . 0.0 109.288 -179.432 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 35.8 pt -118.92 148.29 44.29 Favored Pre-proline 0 CA--C 1.573 1.832 0 C-N-CA 124.126 0.97 . . . . 0.0 109.762 -174.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -71.8 157.77 54.53 Favored 'Trans proline' 0 CA--C 1.559 1.739 0 C-N-CA 122.995 2.463 . . . . 0.0 114.325 -177.756 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 42.1 ttp85 -66.75 -41.1 88.35 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 115.113 1.523 . . . . 0.0 115.113 -179.396 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -65.75 -42.75 90.55 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 115.924 1.824 . . . . 0.0 115.924 178.428 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -67.39 -34.11 76.59 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 169.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.39 -43.75 96.68 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 169.461 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -60.44 -42.83 96.93 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 115.041 1.497 . . . . 0.0 115.041 169.571 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -61.7 -51.71 67.3 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 176.509 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -61.88 -46.51 89.08 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 115.091 1.515 . . . . 0.0 115.091 175.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 8.9 mp -66.22 -36.3 82.68 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 115.822 1.786 . . . . 0.0 115.822 175.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 20.9 t -56.24 -30.17 62.01 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 116.593 2.071 . . . . 0.0 116.593 169.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -60.67 -35.29 75.88 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 115.703 1.742 . . . . 0.0 115.703 169.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -67.93 129.41 39.83 Favored 'General case' 0 CA--C 1.555 1.15 0 CA-C-O 122.935 1.35 . . . . 0.0 112.499 -179.427 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 14.7 ptp180 -66.52 -17.79 65.0 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 118.912 2.93 . . . . 0.0 118.912 172.157 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 46.1 m80 -89.46 137.37 32.39 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 119.576 1.08 . . . . 0.0 111.818 -168.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -78.25 105.27 9.37 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 171.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 118.14 -3.65 16.33 Favored Glycine 0 CA--C 1.55 2.251 0 CA-C-O 116.198 -2.446 . . . . 0.0 116.7 -168.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.77 110.15 1.44 Allowed 'General case' 0 N--CA 1.494 1.77 0 CA-C-N 122.017 2.909 . . . . 0.0 112.231 -176.711 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 18.4 p90 -128.43 161.64 29.02 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 117.263 2.32 . . . . 0.0 117.263 -167.51 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.2 pp -143.12 151.86 41.18 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 114.233 -1.349 . . . . 0.0 108.446 168.06 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 3.8 mp -102.44 118.04 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 105.173 -2.158 . . . . 0.0 105.173 169.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 46.8 ptt85 -101.44 141.06 34.87 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.174 0.59 . . . . 0.0 110.083 169.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -79.89 134.96 36.33 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 169.635 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 53.5 m -72.33 139.21 47.81 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-O 121.491 0.662 . . . . 0.0 111.956 -177.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -69.96 -54.54 12.82 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -173.513 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 97.2 p -61.91 -41.95 98.52 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 115.994 1.85 . . . . 0.0 115.994 171.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -111.85 96.77 34.95 Favored Pre-proline 0 CA--C 1.562 1.405 0 CA-C-O 117.965 -1.017 . . . . 0.0 109.494 176.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -63.61 -26.59 69.2 Favored 'Trans proline' 0 CA--C 1.559 1.765 0 C-N-CA 122.959 2.439 . . . . 0.0 118.203 174.491 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -91.5 50.12 2.94 Favored Glycine 0 CA--C 1.553 2.422 0 CA-C-O 119.732 -0.482 . . . . 0.0 113.326 168.473 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -160.04 120.29 2.96 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 106.026 -1.842 . . . . 0.0 106.026 178.518 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 12.2 m-30 -98.63 172.2 7.64 Favored 'General case' 0 CA--C 1.565 1.55 0 CA-C-O 122.064 0.935 . . . . 0.0 111.341 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 74.3 m -148.19 112.56 5.27 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 -178.065 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 27.4 tp -85.21 105.08 15.64 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-O 122.308 1.051 . . . . 0.0 109.638 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.8 m -89.85 111.35 22.36 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 125.177 1.391 . . . . 0.0 107.816 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 22.0 t -127.46 121.19 56.6 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.161 0 CA-C-N 120.031 1.287 . . . . 0.0 107.795 -172.013 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 7.4 tmtm? -89.47 92.43 9.11 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 122.8 0.44 . . . . 0.0 110.734 177.254 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 25.3 t80 -125.1 111.18 15.03 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 68.12 71.05 1.01 Allowed Glycine 0 N--CA 1.482 1.739 0 N-CA-C 115.525 0.97 . . . . 0.0 115.525 173.139 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . 0.294 16.8 m120 70.76 -13.35 0.49 Allowed 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 118.49 2.774 . . . . 0.0 118.49 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -132.65 138.49 47.35 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 120.16 1.345 . . . . 0.0 110.159 -169.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 43.5 t -92.1 111.27 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 N-CA-C 106.045 -1.835 . . . . 0.0 106.045 171.588 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -104.34 114.8 29.27 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.84 0.856 . . . . 0.0 108.771 -170.238 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 16.7 m-70 -95.21 97.31 9.79 Favored 'General case' 0 CA--C 1.552 1.023 0 CA-C-N 114.745 -1.116 . . . . 0.0 108.417 -173.615 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -95.88 122.24 38.47 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 -176.013 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -76.37 115.85 16.5 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 121.302 0.572 . . . . 0.0 110.715 -171.042 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 84.7 t -91.45 104.5 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 60.7 mt -92.07 131.45 37.33 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.38 -174.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 78.0 mtp180 -106.64 148.2 28.62 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 122.865 0.466 . . . . 0.0 111.195 -173.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -137.27 129.83 29.96 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 123.029 0.531 . . . . 0.0 110.51 171.558 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 81.7 -113.58 3.67 Favored Glycine 0 CA--C 1.541 1.693 0 C-N-CA 122.971 0.32 . . . . 0.0 113.462 173.252 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -82.29 -70.37 0.55 Allowed 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 123.118 0.567 . . . . 0.0 111.102 175.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -159.28 71.76 0.23 Allowed Glycine 0 N--CA 1.477 1.431 0 N-CA-C 111.033 -0.827 . . . . 0.0 111.033 169.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -98.71 96.52 7.98 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 106.468 -1.679 . . . . 0.0 106.468 177.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -86.45 100.27 12.24 Favored 'General case' 0 CA--C 1.558 1.259 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.724 -169.281 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 46.3 p90 -112.87 122.51 47.86 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 123.608 0.763 . . . . 0.0 109.113 -178.269 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -134.67 -32.88 0.98 Allowed 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 114.44 1.274 . . . . 0.0 114.44 -171.542 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 46.2 t90 -114.19 -76.6 0.58 Allowed 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 124.764 1.226 . . . . 0.0 108.089 178.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 96.0 t -130.05 -73.57 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 -178.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.3 p -83.16 145.8 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 C-N-CA 123.514 0.726 . . . . 0.0 111.8 -173.436 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -79.72 152.51 29.84 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 121.565 0.697 . . . . 0.0 112.329 174.608 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -130.02 121.26 26.13 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -173.381 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 36.1 t30 -63.64 -50.06 70.8 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 178.096 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 28.4 t -94.0 148.45 22.15 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-O 122.024 0.916 . . . . 0.0 111.175 173.513 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 14.1 tp -68.69 -34.93 76.51 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 169.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 -61.44 -40.99 96.48 Favored 'General case' 0 CA--C 1.571 1.771 0 C-N-CA 123.881 0.873 . . . . 0.0 113.331 169.339 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -58.8 -43.84 90.63 Favored 'General case' 0 CA--C 1.567 1.609 0 N-CA-C 114.956 1.465 . . . . 0.0 114.956 169.483 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 9.3 tt -54.22 -47.66 71.92 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 114.217 1.191 . . . . 0.0 114.217 169.427 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 43.7 t -57.86 -60.79 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 C-N-CA 124.361 1.065 . . . . 0.0 112.78 173.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -61.02 -29.15 69.54 Favored 'General case' 0 CA--C 1.568 1.64 0 N-CA-C 116.806 2.15 . . . . 0.0 116.806 -176.371 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 76.4 t80 -65.4 -58.9 4.74 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-N 119.261 0.937 . . . . 0.0 112.124 169.497 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 74.2 m-70 -67.95 -9.27 43.9 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 117.832 2.531 . . . . 0.0 117.832 176.471 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 11.4 ttm180 -60.24 -30.3 69.32 Favored 'General case' 0 CA--C 1.576 1.956 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 167.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 70.5 m -108.93 -31.31 7.71 Favored 'General case' 0 CA--C 1.568 1.643 0 C-N-CA 124.982 1.313 . . . . 0.0 114.252 169.433 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 59.3 m -91.21 155.68 18.4 Favored 'General case' 0 N--CA 1.498 1.971 0 CA-C-N 120.664 1.575 . . . . 0.0 112.109 176.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 38.0 t -70.48 132.63 45.84 Favored 'General case' 0 N--CA 1.485 1.32 0 O-C-N 121.498 -0.751 . . . . 0.0 112.938 175.144 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 15.2 t -68.49 -48.16 73.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 CA-C-O 118.225 -0.893 . . . . 0.0 112.084 171.263 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 22.7 t -105.94 -113.25 0.26 Allowed 'General case' 0 CA--C 1.559 1.319 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 170.566 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 11.7 tpt180 -161.05 -41.67 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 CA-C-N 119.644 1.111 . . . . 0.0 113.275 174.373 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -60.12 -57.02 14.6 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 -176.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -79.76 -16.05 56.31 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 117.587 2.44 . . . . 0.0 117.587 174.191 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 59.51 77.9 0.29 Allowed 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 125.561 1.545 . . . . 0.0 111.71 -175.602 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 4.7 mp -84.28 124.23 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 -168.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -127.4 117.33 21.97 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 -176.045 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 10.8 mp -70.5 137.57 50.33 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 114.778 1.399 . . . . 0.0 114.778 -169.318 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 19.3 mmt85 -135.56 146.68 48.25 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 124.803 1.241 . . . . 0.0 107.807 179.037 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -72.28 147.28 46.55 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.702 -1.249 . . . . 0.0 112.924 179.202 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 29.6 pt -68.52 148.28 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 C-N-CA 124.133 0.973 . . . . 0.0 113.092 -178.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 . . . . . 0 N--CA 1.485 1.301 0 CA-C-O 123.872 1.796 . . . . 0.0 108.84 -174.993 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.429 0 CA-C-O 119.986 -0.341 . . . . 0.0 112.428 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 90.9 p -79.32 124.68 28.63 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 112.567 0.581 . . . . 0.0 112.567 -173.397 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . 0.274 1.2 p90 -149.41 -43.13 0.14 Allowed 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 -177.061 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -81.81 134.31 35.41 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 120.657 1.571 . . . . 0.0 111.509 -176.194 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -101.7 -90.11 0.35 Allowed 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 175.159 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 154.19 79.49 0.03 OUTLIER Glycine 0 N--CA 1.482 1.718 0 CA-C-N 119.625 1.102 . . . . 0.0 111.941 179.116 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . 0.384 65.4 pttt 43.16 59.37 2.96 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 117.514 2.413 . . . . 0.0 117.514 -173.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 23.1 pt -85.77 155.07 58.91 Favored Pre-proline 0 CA--C 1.576 1.954 0 CA-C-O 118.385 -0.817 . . . . 0.0 110.509 174.686 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -71.09 167.98 24.56 Favored 'Trans proline' 0 CA--C 1.561 1.862 0 C-N-CA 122.73 2.287 . . . . 0.0 114.107 177.343 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 53.9 ttt180 -63.65 -40.6 97.27 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 115.844 1.794 . . . . 0.0 115.844 177.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.4 -41.91 96.39 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 115.574 1.694 . . . . 0.0 115.574 173.095 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 55.7 tptt -66.86 -34.89 78.79 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 114.869 1.433 . . . . 0.0 114.869 169.493 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.37 -45.55 87.23 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 115.118 1.525 . . . . 0.0 115.118 171.177 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -65.79 -33.83 76.76 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 115.754 1.761 . . . . 0.0 115.754 169.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -57.65 -49.42 76.51 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-N 119.99 1.268 . . . . 0.0 114.24 170.431 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 45.3 tpp -61.36 -47.91 83.7 Favored 'General case' 0 CA--C 1.567 1.624 0 N-CA-C 115.919 1.822 . . . . 0.0 115.919 172.3 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 83.4 mt -89.35 -43.82 10.65 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 116.735 2.124 . . . . 0.0 116.735 -169.262 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 49.7 m -61.6 -32.1 72.2 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 115.598 1.703 . . . . 0.0 115.598 171.121 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -59.64 -43.4 93.86 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 115.706 1.743 . . . . 0.0 115.706 169.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -75.61 134.86 40.55 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-O 122.867 1.318 . . . . 0.0 111.979 177.528 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -58.95 -13.01 5.24 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 120.199 3.407 . . . . 0.0 120.199 177.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 50.7 m80 -89.07 127.84 35.72 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 120.008 1.276 . . . . 0.0 113.032 -168.458 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -73.31 130.18 39.63 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 123.932 0.893 . . . . 0.0 109.753 172.639 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 96.82 -6.58 64.66 Favored Glycine 0 CA--C 1.547 2.07 0 N-CA-C 118.083 1.993 . . . . 0.0 118.083 -169.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.06 114.52 5.28 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-N 120.658 2.229 . . . . 0.0 112.714 -169.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -124.25 156.04 37.54 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 115.093 1.516 . . . . 0.0 115.093 -168.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.9 pp -142.74 139.61 31.13 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-N 114.736 -1.12 . . . . 0.0 108.897 169.187 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.5 mp -92.84 118.78 39.26 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.436 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 173.25 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 40.0 ptt85 -108.51 134.73 50.88 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 169.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -79.47 139.72 37.54 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 121.581 0.705 . . . . 0.0 111.087 -177.362 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 49.1 m -72.2 124.15 24.42 Favored 'General case' 0 N--CA 1.486 1.369 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.719 173.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -75.25 -49.13 20.26 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 177.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 16.2 t -56.96 -35.07 68.68 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 116.369 1.988 . . . . 0.0 116.369 170.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -111.56 92.19 16.16 Favored Pre-proline 0 CA--C 1.564 1.486 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 169.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -72.13 133.05 20.6 Favored 'Trans proline' 0 C--N 1.372 1.803 0 C-N-CA 123.177 2.585 . . . . 0.0 112.324 -176.384 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 95.22 -35.88 4.07 Favored Glycine 0 CA--C 1.553 2.444 0 CA-C-O 119.08 -0.844 . . . . 0.0 114.297 -168.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -78.86 136.25 37.26 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-N 118.524 1.162 . . . . 0.0 109.467 178.04 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -106.55 172.22 6.93 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 115.254 -0.884 . . . . 0.0 111.53 -169.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 74.7 m -145.2 116.38 7.92 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 175.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 24.1 tp -79.88 122.58 26.84 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.638 0.775 . . . . 0.0 109.832 174.053 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 20.7 m -109.51 93.28 4.42 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 106.541 -1.651 . . . . 0.0 106.541 177.68 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.1 p -108.49 118.55 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 C-N-CA 123.72 0.808 . . . . 0.0 109.891 -171.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -76.71 146.6 37.92 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-N 115.285 -0.87 . . . . 0.0 112.045 172.188 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -155.03 107.46 2.73 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 171.365 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 90.61 -75.65 1.64 Allowed Glycine 0 N--CA 1.484 1.856 0 C-N-CA 122.651 0.167 . . . . 0.0 113.294 179.206 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -136.86 -45.35 0.58 Allowed 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 123.948 0.899 . . . . 0.0 113.147 173.134 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -92.94 148.29 22.13 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.37 1.068 . . . . 0.0 111.642 -169.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 20.8 t -99.01 120.98 49.06 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 -178.487 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 24.3 mp0 -98.29 125.01 43.22 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.935 0.894 . . . . 0.0 109.147 178.632 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 9.8 m-70 -107.44 114.27 28.17 Favored 'General case' 0 CA--C 1.552 1.033 0 CA-C-N 114.79 -1.096 . . . . 0.0 108.361 -169.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -122.56 125.79 46.43 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 -176.322 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -81.21 123.94 28.88 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-O 121.408 0.623 . . . . 0.0 110.881 -176.008 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 68.9 t -80.66 104.87 9.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 171.522 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 59.9 mt -91.13 141.11 29.16 Favored 'General case' 0 N--CA 1.484 1.256 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.826 179.136 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 53.3 mtp180 -108.35 146.38 33.07 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 123.533 0.733 . . . . 0.0 110.032 179.403 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 17.7 p-10 -79.58 -42.86 24.11 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 115.783 1.771 . . . . 0.0 115.783 -179.449 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 179.1 -79.3 0.06 OUTLIER Glycine 0 CA--C 1.537 1.44 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 -172.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -72.41 -64.22 1.0 Allowed 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 175.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 175.73 75.38 0.05 OUTLIER Glycine 0 N--CA 1.479 1.521 0 CA-C-N 119.039 0.836 . . . . 0.0 112.543 173.098 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp -128.29 111.54 13.49 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 105.018 -2.216 . . . . 0.0 105.018 174.411 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -91.73 131.72 36.9 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 124.026 0.93 . . . . 0.0 110.728 -169.091 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -144.08 137.29 27.46 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 123.646 0.778 . . . . 0.0 109.966 -178.306 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -132.31 -43.16 0.95 Allowed 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 172.215 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 39.2 t90 -85.74 -77.22 0.3 Allowed 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 124.313 1.045 . . . . 0.0 110.119 -176.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 9.4 p -149.28 -55.87 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 C-N-CA 123.727 0.811 . . . . 0.0 110.465 175.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 13.5 p -79.6 122.8 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 C-N-CA 123.827 0.851 . . . . 0.0 110.53 -175.267 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 6.5 ttpm? -79.88 146.45 32.17 Favored 'General case' 0 CA--C 1.559 1.299 0 CA-C-O 122.26 1.029 . . . . 0.0 112.919 -176.436 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -118.58 158.41 25.48 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 114.134 -1.394 . . . . 0.0 109.202 -173.564 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -76.99 -57.73 3.68 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 118.119 -0.943 . . . . 0.0 112.635 173.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 83.8 p -109.2 162.56 14.17 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-O 122.334 1.064 . . . . 0.0 112.575 -178.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 18.6 tp -64.99 -33.96 77.3 Favored 'General case' 0 CA--C 1.571 1.761 0 N-CA-C 115.036 1.495 . . . . 0.0 115.036 169.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 14.2 m-80 -64.45 -42.74 95.79 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 113.642 0.979 . . . . 0.0 113.642 169.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -58.78 -41.32 86.37 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 115.836 1.791 . . . . 0.0 115.836 169.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 9.7 tt -53.69 -50.25 66.27 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 115.265 1.58 . . . . 0.0 115.265 172.697 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 25.7 m -67.88 -45.65 83.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 176.418 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . 0.256 3.7 p30 -65.26 -29.52 70.31 Favored 'General case' 0 CA--C 1.569 1.711 0 N-CA-C 115.408 1.633 . . . . 0.0 115.408 -178.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 77.9 t80 -67.05 -54.2 23.8 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-N 119.256 0.934 . . . . 0.0 111.613 168.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 80.2 m-70 -67.53 -9.2 40.21 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 117.869 2.544 . . . . 0.0 117.869 176.116 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 52.9 ttm-85 -57.81 -31.46 66.62 Favored 'General case' 0 CA--C 1.577 2.016 0 C-N-CA 124.285 1.034 . . . . 0.0 113.726 167.518 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 71.0 m -107.73 -34.56 6.94 Favored 'General case' 0 CA--C 1.568 1.654 0 C-N-CA 125.151 1.38 . . . . 0.0 113.955 169.156 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 90.0 m -90.66 156.56 18.02 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-N 120.504 1.502 . . . . 0.0 111.913 178.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 32.4 t -74.97 121.41 21.91 Favored 'General case' 0 CA--C 1.558 1.279 0 O-C-N 121.342 -0.849 . . . . 0.0 112.034 177.421 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.5 p -73.14 -34.8 45.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 170.365 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 20.3 t -85.26 147.24 26.66 Favored 'General case' 0 CA--C 1.558 1.254 0 CA-C-N 119.098 0.863 . . . . 0.0 111.296 174.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 61.1 ttp85 -68.78 -63.37 1.07 Allowed 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 123.162 0.585 . . . . 0.0 112.297 173.68 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 19.6 t30 -72.42 -52.64 15.05 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 178.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 67.1 mt-30 -79.8 161.62 25.57 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.675 0.75 . . . . 0.0 112.031 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -105.61 94.56 5.27 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 175.082 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 28.8 mm -113.98 119.14 60.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 -172.744 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -121.2 126.81 50.59 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 -174.413 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 11.1 mp -78.5 124.2 27.88 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 -169.121 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 7.7 mpt_? -120.0 146.88 45.45 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 124.807 1.243 . . . . 0.0 108.242 172.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -75.4 155.56 36.27 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 121.674 0.749 . . . . 0.0 112.564 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 45.7 pt -66.08 156.61 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 N-CA-C 114.542 1.312 . . . . 0.0 114.542 -172.393 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 . . . . . 0 N--CA 1.483 1.221 0 CA-C-O 123.975 1.845 . . . . 0.0 109.873 -176.43 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.345 0 N-CA-C 111.58 -0.608 . . . . 0.0 111.58 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 32.7 t -84.36 103.88 13.91 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 122.997 0.519 . . . . 0.0 109.922 177.625 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 61.9 p-90 -61.53 -38.15 86.36 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 117.57 2.434 . . . . 0.0 117.57 -175.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 33.3 t80 -83.2 124.79 30.88 Favored 'General case' 0 N--CA 1.484 1.267 0 CA-C-N 119.559 1.072 . . . . 0.0 109.616 179.057 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -110.33 -74.19 0.66 Allowed 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 118.483 -0.77 . . . . 0.0 109.046 179.193 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 177.37 -98.91 0.12 Allowed Glycine 0 N--CA 1.476 1.364 0 CA-C-N 119.263 0.938 . . . . 0.0 111.525 177.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -140.6 94.09 2.69 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 -174.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 36.5 pt -127.98 153.89 78.35 Favored Pre-proline 0 CA--C 1.575 1.922 0 C-N-CA 123.617 0.767 . . . . 0.0 110.484 -175.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -78.2 176.69 9.66 Favored 'Trans proline' 0 CA--C 1.565 2.051 0 C-N-CA 123.037 2.491 . . . . 0.0 114.458 176.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 29.3 ttm180 -61.48 -43.0 99.64 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 115.952 1.834 . . . . 0.0 115.952 172.619 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.74 -46.84 80.53 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 115.252 1.575 . . . . 0.0 115.252 178.224 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm -61.95 -35.94 79.93 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 115.559 1.688 . . . . 0.0 115.559 169.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.55 -40.9 89.3 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 115.493 1.664 . . . . 0.0 115.493 171.142 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -63.75 -39.76 95.06 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 115.313 1.597 . . . . 0.0 115.313 169.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -60.64 -49.2 78.46 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 174.381 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -62.26 -49.8 74.26 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 114.492 1.293 . . . . 0.0 114.492 173.769 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 9.9 mp -69.14 -27.8 65.88 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 116.42 2.007 . . . . 0.0 116.42 179.268 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 23.3 t -59.28 -37.98 79.02 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-N 120.508 1.503 . . . . 0.0 114.683 169.376 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt -63.84 -31.91 73.25 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 115.64 1.718 . . . . 0.0 115.64 169.534 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -64.78 120.59 12.76 Favored 'General case' 0 N--CA 1.484 1.27 0 CA-C-N 119.626 1.103 . . . . 0.0 112.196 175.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -69.12 -19.99 64.04 Favored 'General case' 0 CA--C 1.568 1.657 0 N-CA-C 117.935 2.568 . . . . 0.0 117.935 171.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 43.0 m80 -89.59 132.04 35.3 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-N 119.282 0.946 . . . . 0.0 111.136 -169.17 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -74.52 123.26 24.43 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.445 0.698 . . . . 0.0 109.691 176.483 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 99.27 2.05 56.8 Favored Glycine 0 CA--C 1.552 2.39 0 N-CA-C 117.86 1.904 . . . . 0.0 117.86 -169.471 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.62 109.35 4.27 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-N 120.698 2.249 . . . . 0.0 112.026 -172.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -119.52 160.03 23.18 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 116.322 1.971 . . . . 0.0 116.322 -168.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.2 pp -141.61 145.76 35.4 Favored 'General case' 0 CA--C 1.557 1.246 0 CA-C-N 113.826 -1.534 . . . . 0.0 108.989 168.624 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.8 mp -96.94 115.25 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 N-CA-C 104.112 -2.551 . . . . 0.0 104.112 169.646 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 50.7 ptt85 -102.83 152.65 21.02 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 123.819 0.847 . . . . 0.0 110.645 169.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -83.18 140.81 32.36 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 168.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 50.2 m -66.86 1.01 2.07 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 120.074 3.361 . . . . 0.0 120.074 -169.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . 0.357 24.9 tt0 79.22 -69.73 0.11 Allowed 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 125.544 1.538 . . . . 0.0 113.467 169.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 66.1 m -64.81 -39.16 93.14 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 115.579 1.696 . . . . 0.0 115.579 171.425 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -113.53 103.0 55.43 Favored Pre-proline 0 CA--C 1.563 1.45 0 CA-C-N 119.24 0.927 . . . . 0.0 109.875 175.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -58.77 -32.81 97.79 Favored 'Trans proline' 0 C--N 1.37 1.706 0 N-CA-C 119.742 2.939 . . . . 0.0 119.742 173.403 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -86.79 46.86 3.62 Favored Glycine 0 CA--C 1.552 2.347 0 N-CA-C 114.765 0.666 . . . . 0.0 114.765 169.109 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -160.08 132.82 6.56 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 176.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -112.43 176.25 5.1 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-O 122.161 0.981 . . . . 0.0 110.645 178.444 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 58.1 m -151.56 121.4 7.05 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 -179.25 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 25.7 tp -79.89 114.93 19.18 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 169.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 8.7 m -98.9 97.53 8.7 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 105.913 -1.884 . . . . 0.0 105.913 172.057 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.8 p -110.1 125.16 67.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 -175.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -76.24 139.9 41.35 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-O 121.54 0.686 . . . . 0.0 111.648 179.122 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -140.69 170.9 14.9 Favored 'General case' 0 CA--C 1.566 1.578 0 CA-C-O 122.184 0.992 . . . . 0.0 108.383 169.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -60.41 115.91 8.39 Favored Glycine 0 CA--C 1.546 1.978 0 O-C-N 121.108 -0.995 . . . . 0.0 114.339 178.26 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . 0.377 15.3 m120 83.19 -24.88 0.16 Allowed 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 117.726 2.491 . . . . 0.0 117.726 -174.291 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -147.74 140.37 24.66 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-N 120.264 1.393 . . . . 0.0 111.154 -173.141 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 69.1 t -94.92 115.76 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 105.196 -2.149 . . . . 0.0 105.196 169.335 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 62.8 mt-30 -94.3 115.45 27.68 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-O 121.73 0.776 . . . . 0.0 109.686 -175.015 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 8.2 m-70 -98.52 114.48 26.9 Favored 'General case' 0 CA--C 1.553 1.085 0 CA-C-N 114.844 -1.071 . . . . 0.0 108.419 -175.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -111.46 131.39 55.24 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 -179.382 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -85.18 119.39 25.51 Favored 'General case' 0 N--CA 1.486 1.375 0 CA-C-O 121.388 0.613 . . . . 0.0 110.283 -176.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 46.9 t -88.54 110.92 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 64.0 mt -93.67 126.11 38.66 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.084 0.554 . . . . 0.0 110.102 -175.644 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 71.2 mtp180 -96.27 151.89 19.09 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 123.209 0.604 . . . . 0.0 110.756 176.132 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 25.3 p-10 -79.68 -47.76 14.81 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 115.17 1.545 . . . . 0.0 115.17 174.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 173.57 -73.58 0.09 OUTLIER Glycine 0 CA--C 1.538 1.523 0 N-CA-C 110.841 -0.904 . . . . 0.0 110.841 -169.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -70.5 -64.69 0.85 Allowed 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 175.307 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 173.81 81.72 0.05 OUTLIER Glycine 0 N--CA 1.478 1.456 0 CA-C-N 118.742 0.701 . . . . 0.0 111.378 174.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -138.23 107.74 6.18 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 105.482 -2.044 . . . . 0.0 105.482 176.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -93.13 119.03 31.9 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.766 0.827 . . . . 0.0 109.383 -169.553 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -127.2 110.66 13.1 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 4.1 tt -97.98 -54.28 3.14 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 124.29 1.036 . . . . 0.0 111.434 172.177 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . 0.259 78.1 t90 -93.09 -95.09 0.15 Allowed 'General case' 0 CA--C 1.557 1.213 0 C-N-CA 124.486 1.114 . . . . 0.0 112.275 -167.711 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 69.7 t -133.2 -60.35 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 -172.014 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 24.3 m -79.36 128.56 38.47 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.397 0 CA-C-N 119.097 0.862 . . . . 0.0 109.677 178.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -80.04 131.44 35.78 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-O 121.73 0.776 . . . . 0.0 110.666 -175.445 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -105.15 153.32 21.69 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 114.707 -1.133 . . . . 0.0 109.747 -173.417 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -74.64 -54.61 7.1 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 172.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 88.0 p -120.72 168.05 11.82 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-O 122.197 0.999 . . . . 0.0 112.346 -175.584 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 57.5 mt -62.65 -36.47 82.92 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 114.98 1.474 . . . . 0.0 114.98 169.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . 0.281 9.8 p30 -62.22 -38.08 87.83 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 115.496 1.665 . . . . 0.0 115.496 169.53 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -62.28 -45.89 91.22 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 114.896 1.443 . . . . 0.0 114.896 169.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 51.5 tp -55.8 -45.58 78.21 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 115.099 1.518 . . . . 0.0 115.099 169.454 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 33.2 t -60.08 -61.27 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 C-N-CA 124.309 1.044 . . . . 0.0 112.215 172.162 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -58.47 -30.03 66.66 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 117.289 2.329 . . . . 0.0 117.289 -175.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -64.95 -55.58 18.3 Favored 'General case' 0 CA--C 1.565 1.544 0 CA-C-N 118.963 0.801 . . . . 0.0 112.619 169.435 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . 0.303 74.1 m-70 -71.53 -8.99 57.48 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 117.931 2.567 . . . . 0.0 117.931 178.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -48.7 -39.47 24.69 Favored 'General case' 0 N--CA 1.501 2.124 0 CA-C-N 120.59 1.541 . . . . 0.0 114.544 167.48 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 69.7 m -106.47 -29.81 9.46 Favored 'General case' 0 CA--C 1.565 1.532 0 N-CA-C 115.02 1.489 . . . . 0.0 115.02 170.225 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 39.5 m -89.98 147.19 23.84 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-N 120.733 1.606 . . . . 0.0 110.326 -178.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 23.1 t -77.62 122.87 25.89 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.594 -0.691 . . . . 0.0 111.586 176.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 12.4 p -68.4 -30.73 48.59 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.942 0 N-CA-C 115.3 1.593 . . . . 0.0 115.3 169.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 46.4 m -79.78 -41.26 26.88 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 116.147 1.906 . . . . 0.0 116.147 -176.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . 0.261 4.6 mmp_? 69.04 53.98 0.46 Allowed 'General case' 0 N--CA 1.5 2.027 0 C-N-CA 124.465 1.106 . . . . 0.0 113.24 -169.637 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -163.96 -81.26 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 177.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 -96.12 163.2 13.21 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 123.794 0.838 . . . . 0.0 109.87 169.669 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -79.82 98.2 6.97 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.72 -0.613 . . . . 0.0 112.145 -178.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 1.2 mp -102.37 100.74 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 103.757 -2.683 . . . . 0.0 103.757 172.494 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 20.4 m-30 -110.23 126.44 54.14 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 -178.179 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 10.8 mp -72.2 121.53 19.5 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 113.148 0.795 . . . . 0.0 113.148 -169.361 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 22.4 mmt85 -126.85 154.26 44.6 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 125.181 1.393 . . . . 0.0 109.18 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -75.47 147.3 39.96 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.293 -1.505 . . . . 0.0 113.367 -177.048 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.442 HD13 ' H ' ' A' ' 151' ' ' ILE . 0.2 OUTLIER -69.37 158.04 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 113.639 0.977 . . . . 0.0 113.639 179.721 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 . . . . . 0 N--CA 1.484 1.271 0 CA-C-O 122.851 1.31 . . . . 0.0 109.588 -178.657 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.373 0 N-CA-C 111.8 -0.52 . . . . 0.0 111.8 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 88.6 p -80.25 104.17 10.62 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.19 0.596 . . . . 0.0 111.464 -178.506 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . 0.278 30.0 p-90 -73.48 -47.51 40.69 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 115.14 1.533 . . . . 0.0 115.14 -179.297 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -83.66 134.36 34.78 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 120.771 1.623 . . . . 0.0 110.864 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -111.13 -88.28 0.52 Allowed 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 176.627 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 153.39 83.33 0.04 OUTLIER Glycine 0 N--CA 1.48 1.622 0 CA-C-N 119.37 0.986 . . . . 0.0 111.088 178.394 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . 0.257 51.6 mtpt 59.09 61.44 2.11 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 -176.509 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 17.4 tt -86.06 141.42 35.32 Favored Pre-proline 0 CA--C 1.572 1.811 0 CA-C-O 117.663 -1.16 . . . . 0.0 110.263 179.158 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -69.1 153.44 71.98 Favored 'Trans proline' 0 CA--C 1.562 1.906 0 CA-C-N 123.575 2.312 . . . . 0.0 113.578 174.399 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 38.6 ttt85 -58.01 -43.42 86.68 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 116.18 1.918 . . . . 0.0 116.18 -177.35 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.47 -46.15 84.33 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 115.007 1.484 . . . . 0.0 115.007 175.383 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 58.7 tttm -59.83 -36.65 77.25 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 115.248 1.573 . . . . 0.0 115.248 169.691 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.79 -43.29 96.76 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 115.487 1.662 . . . . 0.0 115.487 170.038 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -63.68 -46.06 87.27 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 114.875 1.435 . . . . 0.0 114.875 172.592 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -70.77 -39.22 73.35 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 115.212 1.56 . . . . 0.0 115.212 178.331 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 38.1 mmt -64.99 -45.2 86.61 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-N 119.922 1.237 . . . . 0.0 114.278 172.215 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 95.3 mt -64.89 -32.1 73.65 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 116.121 1.897 . . . . 0.0 116.121 170.532 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 18.9 t -57.47 -29.64 64.4 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 116.364 1.987 . . . . 0.0 116.364 169.604 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -63.55 -34.99 79.02 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 115.775 1.769 . . . . 0.0 115.775 169.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -70.33 131.24 43.84 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-O 122.935 1.35 . . . . 0.0 112.973 -176.163 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.28 -12.34 61.58 Favored 'General case' 0 CA--C 1.567 1.623 0 N-CA-C 118.947 2.943 . . . . 0.0 118.947 172.114 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 53.5 m80 -89.28 138.03 31.79 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 120.315 1.416 . . . . 0.0 111.936 -169.158 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -81.47 98.32 8.2 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 107.545 -1.279 . . . . 0.0 107.545 172.486 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 124.94 -0.1 8.33 Favored Glycine 0 CA--C 1.557 2.668 0 CA-C-O 117.089 -1.951 . . . . 0.0 115.698 -168.087 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.66 116.27 6.07 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-N 121.161 2.48 . . . . 0.0 112.653 -169.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 20.4 p90 -131.6 155.53 47.36 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 116.273 1.953 . . . . 0.0 116.273 -168.596 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.0 pp -143.37 138.13 29.21 Favored 'General case' 0 CA--C 1.558 1.25 0 CA-C-N 114.026 -1.443 . . . . 0.0 108.02 169.128 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.9 mp -83.57 120.09 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 N-CA-C 106.149 -1.797 . . . . 0.0 106.149 174.373 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 61.8 ttp85 -95.23 125.01 39.58 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-N 114.718 -1.128 . . . . 0.0 109.218 170.706 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -79.99 132.24 35.98 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 169.721 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 53.5 m -69.63 138.51 53.13 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.095 0.558 . . . . 0.0 112.32 -175.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -66.24 -59.46 3.71 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -172.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 88.2 p -62.3 -34.37 76.47 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 116.881 2.178 . . . . 0.0 116.881 174.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -121.04 97.28 48.12 Favored Pre-proline 0 CA--C 1.562 1.431 0 CA-C-N 119.112 0.869 . . . . 0.0 109.837 177.417 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -56.63 -30.95 85.52 Favored 'Trans proline' 0 C--N 1.369 1.641 0 N-CA-C 119.78 2.954 . . . . 0.0 119.78 172.158 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -88.24 46.12 3.35 Favored Glycine 0 CA--C 1.553 2.458 0 N-CA-C 114.777 0.671 . . . . 0.0 114.777 168.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -156.11 126.81 6.81 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 105.281 -2.118 . . . . 0.0 105.281 178.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -112.79 167.32 10.59 Favored 'General case' 0 CA--C 1.559 1.303 0 CA-C-O 122.416 1.103 . . . . 0.0 110.549 -174.259 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 71.2 m -146.32 111.89 5.55 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 -179.5 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 46.2 tp -79.65 107.32 12.33 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-O 122.004 0.906 . . . . 0.0 109.582 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.3 m -90.42 100.45 13.28 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 177.448 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.3 p -124.81 121.03 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 -172.018 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -76.37 142.1 41.28 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.535 170.395 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -150.22 107.44 3.6 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 169.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 88.9 -106.65 3.3 Favored Glycine 0 N--CA 1.481 1.645 0 N-CA-C 110.382 -1.087 . . . . 0.0 110.382 -176.571 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -135.68 60.1 1.7 Allowed 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 169.279 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -160.86 129.02 4.45 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.673 0.789 . . . . 0.0 109.386 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 55.8 t -98.91 109.01 23.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 179.346 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -99.77 120.39 39.66 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.872 0.869 . . . . 0.0 109.465 -176.247 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -100.58 105.01 16.38 Favored 'General case' 0 CA--C 1.554 1.097 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -175.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -102.34 129.12 48.7 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -177.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -77.07 126.4 30.91 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-O 121.704 0.764 . . . . 0.0 110.525 -178.55 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 76.9 t -108.93 100.73 11.37 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.347 0 N-CA-C 104.826 -2.287 . . . . 0.0 104.826 178.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -113.27 144.3 42.95 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.788 0.835 . . . . 0.0 110.76 -172.353 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 92.3 mtt180 -88.68 151.75 22.24 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 113.129 0.788 . . . . 0.0 113.129 -175.605 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -95.83 -63.82 1.12 Allowed 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 123.54 0.736 . . . . 0.0 110.882 169.391 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -100.01 -104.98 2.65 Favored Glycine 0 CA--C 1.541 1.707 0 CA-C-N 119.223 0.92 . . . . 0.0 111.553 177.15 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -139.5 122.9 17.15 Favored 'General case' 0 N--CA 1.482 1.17 0 CA-C-O 122.925 1.345 . . . . 0.0 107.566 172.24 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 61.74 51.71 55.57 Favored Glycine 0 CA--C 1.552 2.35 0 CA-C-N 113.192 -1.822 . . . . 0.0 115.28 -169.345 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -137.14 77.69 1.65 Allowed 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 105.087 -2.19 . . . . 0.0 105.087 -174.126 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -85.76 108.89 18.29 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -167.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 21.5 p90 -119.86 135.47 54.86 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.206 0.602 . . . . 0.0 110.571 178.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -94.48 -52.52 4.29 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 123.16 0.584 . . . . 0.0 111.624 169.207 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 3.2 m-90 -85.07 -76.78 0.3 Allowed 'General case' 0 CA--C 1.564 1.51 0 C-N-CA 123.775 0.83 . . . . 0.0 109.108 177.105 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 6.2 m -147.38 -46.14 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 C-N-CA 125.352 1.461 . . . . 0.0 110.942 -178.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 12.3 p -79.81 132.22 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 CA-C-N 119.382 0.992 . . . . 0.0 111.355 -173.415 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 2.2 pptp? -81.65 154.12 26.28 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 113.904 1.076 . . . . 0.0 113.904 -174.069 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -135.94 114.5 11.83 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 104.617 -2.364 . . . . 0.0 104.617 176.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -53.07 -38.27 62.35 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 118.933 2.938 . . . . 0.0 118.933 -169.387 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 91.1 p -135.41 160.36 38.68 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-O 122.522 1.153 . . . . 0.0 113.339 -171.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 11.1 mp -77.39 117.88 19.31 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 168.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . 0.356 21.3 t-20 122.88 -53.28 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.017 0 C-N-CA 126.422 1.889 . . . . 0.0 107.535 -168.622 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -58.84 -49.45 77.69 Favored 'General case' 0 CA--C 1.568 1.646 0 CA-C-N 119.851 1.205 . . . . 0.0 113.777 169.212 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 31.1 tp -60.59 -40.22 90.96 Favored 'General case' 0 CA--C 1.57 1.74 0 N-CA-C 115.413 1.634 . . . . 0.0 115.413 169.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 40.4 t -59.07 -61.99 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 C-N-CA 124.35 1.06 . . . . 0.0 112.569 173.459 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -61.88 -30.32 70.79 Favored 'General case' 0 CA--C 1.572 1.814 0 N-CA-C 115.086 1.513 . . . . 0.0 115.086 -178.597 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 94.0 t80 -59.69 -57.52 12.57 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-N 119.153 0.888 . . . . 0.0 112.245 168.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 74.4 m-70 -70.37 -9.58 56.64 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 117.913 2.56 . . . . 0.0 117.913 175.259 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 53.1 ttm-85 -61.1 -30.22 70.23 Favored 'General case' 0 CA--C 1.575 1.917 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 167.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 71.0 m -108.6 -30.79 8.05 Favored 'General case' 0 CA--C 1.568 1.64 0 C-N-CA 125.047 1.339 . . . . 0.0 114.081 169.304 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 99.1 m -90.89 156.33 18.09 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-N 120.371 1.442 . . . . 0.0 111.978 176.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 39.7 t -67.08 137.16 56.18 Favored 'General case' 0 CA--C 1.558 1.267 0 C-N-CA 123.669 0.788 . . . . 0.0 113.076 170.007 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 19.0 t -71.3 -48.91 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 CA-C-O 118.683 -0.675 . . . . 0.0 111.735 171.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 9.2 t -87.76 172.51 9.61 Favored 'General case' 0 CA--C 1.565 1.541 0 CA-C-N 118.981 0.81 . . . . 0.0 111.754 174.326 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 40.8 mmt180 -79.93 -57.78 3.48 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.23 -0.919 . . . . 0.0 111.724 169.599 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -70.1 -59.54 2.84 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 177.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 70.1 mt-30 -79.9 145.08 32.87 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-N 118.869 0.759 . . . . 0.0 111.481 -179.21 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -102.76 104.56 14.87 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 123.352 0.661 . . . . 0.0 109.533 -177.255 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 4.3 mp -112.71 127.44 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -125.5 125.38 43.18 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 10.8 mp -74.22 135.33 42.73 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 115.057 1.503 . . . . 0.0 115.057 -168.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 8.9 mmm180 -128.71 139.1 52.39 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 125.486 1.514 . . . . 0.0 108.519 174.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -71.97 146.79 47.5 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.307 -0.87 . . . . 0.0 112.451 177.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 27.1 pt -69.93 158.69 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 N-CA-C 113.564 0.949 . . . . 0.0 113.564 -174.498 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 . . . . . 0 N--CA 1.484 1.256 0 CA-C-O 122.803 1.287 . . . . 0.0 109.759 179.276 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.362 0 N-CA-C 111.471 -0.652 . . . . 0.0 111.471 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 23.7 m 57.88 90.67 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 124.951 1.301 . . . . 0.0 112.463 -176.59 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 55.4 p-90 -137.65 -61.69 0.62 Allowed 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 114.849 -1.068 . . . . 0.0 112.347 -169.364 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -82.82 127.5 33.53 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-N 119.868 1.213 . . . . 0.0 112.903 -169.246 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -100.01 -79.67 0.49 Allowed 'General case' 0 N--CA 1.489 1.481 0 CA-C-N 114.937 -1.029 . . . . 0.0 108.765 173.005 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -175.99 -138.05 2.75 Favored Glycine 0 N--CA 1.48 1.569 0 CA-C-N 119.311 0.96 . . . . 0.0 112.28 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 20.9 tptm -103.5 87.13 2.78 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 176.587 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 32.6 pt -127.09 153.09 76.61 Favored Pre-proline 0 CA--C 1.573 1.828 0 C-N-CA 123.331 0.652 . . . . 0.0 111.086 -169.606 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -77.24 178.57 7.47 Favored 'Trans proline' 0 CA--C 1.565 2.059 0 C-N-CA 123.043 2.496 . . . . 0.0 113.944 175.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 54.3 ttt180 -65.42 -41.48 93.53 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 115.101 1.519 . . . . 0.0 115.101 175.092 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.2 -41.06 97.23 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 115.96 1.837 . . . . 0.0 115.96 179.018 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -64.07 -38.46 91.16 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 114.569 1.322 . . . . 0.0 114.569 169.538 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.59 -41.0 84.77 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 115.951 1.834 . . . . 0.0 115.951 171.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -64.17 -36.81 85.26 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 115.02 1.489 . . . . 0.0 115.02 170.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -63.77 -48.24 77.72 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 114.799 1.407 . . . . 0.0 114.799 172.42 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 38.8 mmt -61.54 -47.48 85.35 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 174.542 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 88.3 mt -75.09 -24.52 58.14 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 116.908 2.188 . . . . 0.0 116.908 177.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 97.4 p -61.83 -36.35 80.9 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-N 120.726 1.603 . . . . 0.0 114.631 168.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 59.7 mttm -60.7 -36.58 79.16 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 114.788 1.403 . . . . 0.0 114.788 169.203 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -64.62 120.47 12.45 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.449 1.1 . . . . 0.0 112.001 170.509 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 16.5 ptm180 -77.9 -15.99 58.58 Favored 'General case' 0 CA--C 1.569 1.683 0 N-CA-C 118.223 2.675 . . . . 0.0 118.223 176.141 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 46.0 m80 -89.57 147.85 23.71 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 119.513 1.051 . . . . 0.0 113.557 -168.326 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -77.6 124.4 27.88 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.789 170.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 105.6 -29.93 10.62 Favored Glycine 0 CA--C 1.546 2.002 0 CA-C-O 117.268 -1.851 . . . . 0.0 116.765 -169.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.11 112.75 1.29 Allowed 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 120.21 2.005 . . . . 0.0 113.386 -170.767 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.1 p90 -130.32 161.22 31.76 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 -168.295 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.6 pp -141.99 132.62 25.45 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.695 0.798 . . . . 0.0 108.892 168.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 87.2 mt -86.8 122.09 38.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 169.714 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 49.1 ptt85 -104.4 153.02 21.6 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.487 169.548 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -88.85 124.12 33.89 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 105.836 -1.913 . . . . 0.0 105.836 168.286 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 53.2 m -62.84 121.37 13.31 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.241 0.616 . . . . 0.0 111.871 -172.503 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -68.1 -47.15 68.99 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 114.496 1.295 . . . . 0.0 114.496 -170.574 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.1 t -65.66 -31.93 73.22 Favored 'General case' 0 CA--C 1.568 1.659 0 N-CA-C 115.832 1.79 . . . . 0.0 115.832 169.5 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -118.85 95.31 49.08 Favored Pre-proline 0 CA--C 1.563 1.471 0 CA-C-N 119.863 1.21 . . . . 0.0 110.158 178.195 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -56.05 -34.65 93.1 Favored 'Trans proline' 0 C--N 1.369 1.658 0 N-CA-C 120.111 3.081 . . . . 0.0 120.111 176.705 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -87.97 50.09 3.88 Favored Glycine 0 CA--C 1.55 2.281 0 N-CA-C 114.297 0.479 . . . . 0.0 114.297 169.173 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -159.66 142.04 13.57 Favored 'General case' 0 CA--C 1.556 1.209 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 178.708 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -116.68 161.19 19.61 Favored 'General case' 0 CA--C 1.564 1.501 0 CA-C-O 122.032 0.92 . . . . 0.0 109.265 171.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 67.4 m -137.4 117.33 13.27 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 178.241 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 43.0 tp -80.17 110.89 16.01 Favored 'General case' 0 CA--C 1.563 1.452 0 C-N-CA 124.216 1.007 . . . . 0.0 109.429 172.647 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 3.1 m -97.4 116.04 28.85 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 -178.28 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 41.2 t -126.21 123.2 63.19 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.194 0 CA-C-N 120.798 1.635 . . . . 0.0 108.151 -171.547 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 59.0 tptt -81.77 121.2 26.12 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 169.149 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -139.22 99.46 3.76 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 174.116 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 92.01 -98.32 2.4 Favored Glycine 0 CA--C 1.538 1.483 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.984 178.298 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 12.2 p30 -129.1 19.49 5.93 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 115.629 1.715 . . . . 0.0 115.629 177.341 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -145.3 141.37 28.5 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 120.117 1.326 . . . . 0.0 109.522 -177.367 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 60.6 t -96.33 108.37 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 174.636 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -104.02 127.68 51.58 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 123.917 0.887 . . . . 0.0 110.557 -176.629 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 23.0 m80 -102.95 101.31 11.31 Favored 'General case' 0 CA--C 1.551 1.0 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -169.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -84.92 126.22 33.32 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 172.795 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 32.6 mmmt -82.86 119.51 24.48 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.067 0.46 . . . . 0.0 110.228 -172.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 84.3 t -86.33 103.63 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 177.21 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 63.3 mt -95.62 147.69 23.31 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.719 -171.622 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 72.7 mtp180 -116.28 122.52 45.19 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.627 -0.671 . . . . 0.0 110.355 -173.429 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -101.19 119.7 39.13 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 123.46 0.704 . . . . 0.0 109.75 174.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 82.02 -112.44 3.49 Favored Glycine 0 CA--C 1.541 1.701 0 C-N-CA 122.816 0.246 . . . . 0.0 113.095 177.005 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -86.43 -71.89 0.53 Allowed 'General case' 0 N--CA 1.486 1.368 0 CA-C-O 118.746 -0.645 . . . . 0.0 111.258 177.433 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -157.01 71.81 0.25 Allowed Glycine 0 N--CA 1.478 1.498 0 CA-C-N 118.681 0.673 . . . . 0.0 112.373 172.477 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.95 104.58 14.29 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 104.74 -2.318 . . . . 0.0 104.74 172.058 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -84.08 99.67 10.61 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.652 -168.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 32.8 p90 -102.49 114.36 28.5 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.71 0.804 . . . . 0.0 109.107 -178.393 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -105.66 -52.17 2.87 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.825 176.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 83.1 t90 -135.19 109.19 8.18 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 -169.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . 0.392 22.2 t 69.58 -91.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 C-N-CA 124.278 1.031 . . . . 0.0 111.57 169.615 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 8.1 p -79.97 155.3 4.55 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.609 0 C-N-CA 124.224 1.01 . . . . 0.0 111.408 177.789 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 25.9 pttm -79.74 148.44 31.5 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-O 121.434 0.635 . . . . 0.0 112.545 173.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -128.07 107.27 9.67 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 106.26 -1.755 . . . . 0.0 106.26 -172.822 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -50.63 -50.28 54.73 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 117.951 2.574 . . . . 0.0 117.951 -169.393 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 90.8 p -111.86 160.57 17.25 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 118.897 0.771 . . . . 0.0 111.833 176.565 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 79.0 mt -66.71 -34.46 77.89 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 115.38 1.622 . . . . 0.0 115.38 170.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -64.21 -45.09 89.8 Favored 'General case' 0 CA--C 1.572 1.825 0 CA-C-N 119.859 1.209 . . . . 0.0 114.002 170.66 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -59.08 -47.35 85.56 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 114.788 1.403 . . . . 0.0 114.788 169.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 57.4 tp -51.83 -52.48 48.98 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 115.686 1.735 . . . . 0.0 115.686 170.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 9.8 p -67.44 -50.28 63.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 -176.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -63.84 -31.0 72.03 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 114.957 1.466 . . . . 0.0 114.957 174.559 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -62.43 -54.55 38.55 Favored 'General case' 0 CA--C 1.567 1.618 0 CA-C-N 119.727 1.148 . . . . 0.0 111.702 168.54 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 36.4 m-70 -73.32 -9.7 58.98 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 118.37 2.73 . . . . 0.0 118.37 179.519 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 58.0 mtp85 -66.82 -21.46 66.03 Favored 'General case' 0 CA--C 1.579 2.08 0 CA-C-N 120.251 1.387 . . . . 0.0 113.347 167.411 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 69.3 m -104.38 -43.92 5.07 Favored 'General case' 0 CA--C 1.57 1.73 0 C-N-CA 125.453 1.501 . . . . 0.0 112.509 168.508 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 57.3 m -90.18 155.42 19.04 Favored 'General case' 0 N--CA 1.499 1.981 0 CA-C-N 120.051 1.296 . . . . 0.0 111.465 -179.142 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 21.0 t -80.18 130.74 35.44 Favored 'General case' 0 CA--C 1.56 1.352 0 O-C-N 121.293 -0.88 . . . . 0.0 113.053 -178.079 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 3.2 m -68.88 -42.49 82.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 169.576 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.8 t -83.49 135.26 34.72 Favored 'General case' 0 CA--C 1.557 1.23 0 CA-C-N 118.967 0.803 . . . . 0.0 110.259 173.79 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 41.4 ptt180 -69.99 -45.53 67.13 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 115.183 1.549 . . . . 0.0 115.183 174.686 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 70.9 m-80 -79.1 -55.53 5.04 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 123.451 0.7 . . . . 0.0 112.593 175.781 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -79.89 154.02 28.63 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 118.782 0.719 . . . . 0.0 111.939 179.107 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -92.91 96.52 10.17 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 171.448 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 27.7 mm -117.86 110.86 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 N-CA-C 105.146 -2.168 . . . . 0.0 105.146 -178.201 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -116.55 127.97 55.0 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.424 -174.168 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 10.7 mp -78.09 126.14 30.37 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.747 0.819 . . . . 0.0 111.905 -169.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 14.1 mmm180 -126.89 162.79 25.1 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-O 122.419 1.104 . . . . 0.0 110.432 178.77 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -77.36 148.67 35.46 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.984 -1.072 . . . . 0.0 112.68 -176.546 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 28.1 pt -70.0 159.7 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 113.993 1.108 . . . . 0.0 113.993 -179.595 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 . . . . . 0 N--CA 1.485 1.287 0 CA-C-O 124.002 1.858 . . . . 0.0 108.541 -177.603 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.348 0 N-CA-C 111.086 -0.806 . . . . 0.0 111.086 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 14.2 t 67.2 105.3 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 124.747 1.219 . . . . 0.0 111.604 -176.003 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . 0.387 50.8 p-90 51.91 11.05 0.13 Allowed 'General case' 0 N--CA 1.503 2.188 0 N-CA-C 120.703 3.594 . . . . 0.0 120.703 -177.107 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -128.42 132.99 48.47 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 124.319 1.048 . . . . 0.0 108.268 -169.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -99.71 -75.21 0.57 Allowed 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 118.34 -0.838 . . . . 0.0 109.316 172.204 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 97.78 113.64 3.2 Favored Glycine 0 N--CA 1.481 1.669 0 CA-C-N 119.371 0.987 . . . . 0.0 112.208 -179.164 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . 0.307 73.5 mmtt 65.28 25.68 12.19 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 117.425 2.38 . . . . 0.0 117.425 178.3 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 21.1 tt -90.45 129.03 46.61 Favored Pre-proline 0 CA--C 1.569 1.691 0 CA-C-O 117.139 -1.41 . . . . 0.0 107.567 169.52 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -67.32 170.61 13.06 Favored 'Trans proline' 0 CA--C 1.562 1.882 0 CA-C-N 123.638 2.335 . . . . 0.0 114.19 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 25.6 ttm180 -57.57 -45.59 85.0 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 116.252 1.945 . . . . 0.0 116.252 -177.443 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -65.98 -46.08 79.34 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 115.457 1.651 . . . . 0.0 115.457 175.371 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 61.5 mtpt -63.61 -34.91 78.87 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 115.426 1.639 . . . . 0.0 115.426 169.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.48 -42.4 99.46 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 115.278 1.584 . . . . 0.0 115.278 169.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -60.9 -43.45 98.49 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 169.721 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -64.82 -45.68 85.2 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 115.52 1.674 . . . . 0.0 115.52 175.136 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -59.83 -44.16 94.2 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 114.83 1.418 . . . . 0.0 114.83 172.823 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 88.6 mt -70.52 -21.75 62.7 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 116.679 2.104 . . . . 0.0 116.679 170.571 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 12.1 t -53.09 -37.06 61.37 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 117.223 2.305 . . . . 0.0 117.223 178.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? -64.85 -28.9 69.86 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 116.244 1.942 . . . . 0.0 116.244 170.759 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -71.53 114.4 9.57 Favored 'General case' 0 N--CA 1.485 1.294 0 CA-C-N 119.819 1.19 . . . . 0.0 111.259 178.391 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.456 ' H ' ' HD3' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -74.43 -7.35 52.68 Favored 'General case' 0 CA--C 1.57 1.721 0 N-CA-C 118.092 2.627 . . . . 0.0 118.092 172.26 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 35.5 m80 -89.81 139.94 30.08 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 119.667 1.121 . . . . 0.0 111.589 -169.053 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -75.98 120.12 20.87 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.183 171.158 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 107.78 -19.77 32.69 Favored Glycine 0 CA--C 1.546 2.022 0 CA-C-O 116.632 -2.204 . . . . 0.0 116.732 -169.366 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.2 108.72 0.95 Allowed 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 121.26 2.53 . . . . 0.0 112.233 -173.531 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 23.2 p90 -123.58 158.46 31.38 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 -168.347 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.9 pp -138.07 128.78 26.72 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 168.292 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 91.1 mt -88.54 110.76 21.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 172.576 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.9 ptm180 -89.42 144.61 25.92 Favored 'General case' 0 N--CA 1.484 1.226 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.192 169.548 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -84.8 126.9 33.84 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 169.768 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 20.8 t -68.11 123.11 19.76 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 122.909 0.483 . . . . 0.0 111.476 -172.772 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -91.11 91.17 8.14 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 123.706 1.717 . . . . 0.0 110.411 -173.632 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 39.7 t 162.54 -41.11 0.0 OUTLIER 'General case' 0 CA--C 1.571 1.768 0 CA-C-N 110.729 -2.941 . . . . 0.0 106.983 -168.535 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -150.01 113.68 3.37 Favored Pre-proline 0 CA--C 1.563 1.464 0 CA-C-O 117.57 -1.205 . . . . 0.0 108.414 178.451 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -68.6 -27.22 32.85 Favored 'Trans proline' 0 C--N 1.37 1.699 0 N-CA-C 119.088 2.688 . . . . 0.0 119.088 -178.256 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -65.3 -21.49 68.43 Favored Glycine 0 CA--C 1.561 2.938 0 N-CA-C 116.492 1.357 . . . . 0.0 116.492 168.375 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -88.66 137.78 32.01 Favored 'General case' 0 CA--C 1.555 1.171 0 CA-C-N 118.216 1.008 . . . . 0.0 108.839 169.684 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -122.69 173.16 7.9 Favored 'General case' 0 CA--C 1.567 1.61 0 CA-C-N 114.927 -1.033 . . . . 0.0 108.649 175.257 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 75.7 m -143.6 115.42 8.24 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 173.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 29.3 tp -79.85 114.47 18.79 Favored 'General case' 0 CA--C 1.561 1.384 0 C-N-CA 124.314 1.046 . . . . 0.0 109.167 175.344 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.3 m -106.16 88.51 2.81 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 -170.575 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 16.0 t -101.99 123.02 54.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 -169.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 51.3 tttp -88.26 96.23 10.48 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.474 171.464 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 20.1 t80 -105.77 112.21 25.18 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.706 -0.849 . . . . 0.0 108.706 179.168 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 82.78 -106.23 2.73 Favored Glycine 0 CA--C 1.539 1.589 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 -170.444 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -141.68 59.49 1.49 Allowed 'General case' 0 CA--C 1.565 1.543 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 169.238 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -155.8 128.57 7.93 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 107.046 -1.465 . . . . 0.0 107.046 177.161 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 50.0 t -95.63 110.72 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 -175.406 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -104.96 116.08 31.36 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.791 0.836 . . . . 0.0 109.05 -173.752 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -95.11 108.91 21.02 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 115.036 -0.984 . . . . 0.0 108.828 -175.265 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -107.07 120.79 43.04 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 -175.525 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -79.08 112.3 16.14 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 121.906 0.86 . . . . 0.0 110.579 -172.633 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 75.8 t -85.18 100.94 8.95 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 178.346 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.9 pp -122.86 133.84 54.41 Favored 'General case' 0 N--CA 1.491 1.575 0 CA-C-O 121.506 0.669 . . . . 0.0 111.099 -169.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -84.7 159.01 20.61 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-O 122.077 0.942 . . . . 0.0 113.042 -176.074 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -85.53 -46.63 10.66 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 114.96 -1.018 . . . . 0.0 113.106 168.747 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -154.93 -85.5 0.05 OUTLIER Glycine 0 CA--C 1.539 1.556 0 CA-C-N 118.958 0.799 . . . . 0.0 111.258 -177.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -72.95 -70.95 0.33 Allowed 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -175.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -168.75 54.85 0.21 Allowed Glycine 0 N--CA 1.481 1.634 0 CA-C-O 119.333 -0.704 . . . . 0.0 114.276 172.34 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -109.69 97.83 7.29 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 105.432 -2.062 . . . . 0.0 105.432 173.635 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -80.32 125.91 30.49 Favored 'General case' 0 CA--C 1.554 1.126 0 CA-C-N 113.922 -1.49 . . . . 0.0 110.775 -169.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 32.2 p90 -128.95 122.83 31.02 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 121.288 0.566 . . . . 0.0 109.884 174.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.484 HD23 ' H ' ' A' ' 120' ' ' LEU . 2.1 pt? -102.92 -53.65 2.8 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 124.291 1.036 . . . . 0.0 111.822 169.847 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 37.4 t90 -84.83 -74.39 0.39 Allowed 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 124.889 1.276 . . . . 0.0 110.029 -178.183 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 10.5 p -148.59 -56.0 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 C-N-CA 123.872 0.869 . . . . 0.0 110.668 176.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 11.1 p -79.4 135.82 24.88 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.476 0 C-N-CA 123.814 0.845 . . . . 0.0 110.858 -172.32 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 54.0 mttp -79.94 157.77 26.79 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 122.249 1.023 . . . . 0.0 112.366 -176.47 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -140.79 114.75 9.07 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 -170.589 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -58.73 -43.09 90.08 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 116.247 1.943 . . . . 0.0 116.247 177.115 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 94.8 p -113.37 144.74 42.27 Favored 'General case' 0 N--CA 1.484 1.27 0 CA-C-O 122.018 0.913 . . . . 0.0 111.955 -179.382 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 19.0 tp -84.53 62.07 7.05 Favored 'General case' 0 CA--C 1.571 1.775 0 CA-C-N 114.625 -1.17 . . . . 0.0 111.195 169.668 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -156.71 -51.58 0.08 Allowed 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 127.221 2.209 . . . . 0.0 105.445 172.63 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -61.2 -31.44 71.2 Favored 'General case' 0 CA--C 1.571 1.762 0 CA-C-N 119.537 1.062 . . . . 0.0 113.384 167.775 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 10.3 tt -51.7 -45.94 63.72 Favored 'General case' 0 N--CA 1.498 1.969 0 CA-C-N 120.158 1.345 . . . . 0.0 114.024 168.113 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 24.6 t -60.43 -59.32 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 C-N-CA 124.411 1.084 . . . . 0.0 112.162 169.584 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -58.7 -34.22 71.05 Favored 'General case' 0 CA--C 1.566 1.578 0 N-CA-C 116.269 1.952 . . . . 0.0 116.269 -174.369 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -61.63 -55.55 29.43 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 119.426 1.012 . . . . 0.0 112.279 169.258 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . 0.263 48.3 m-70 -69.6 -9.51 54.38 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 117.867 2.543 . . . . 0.0 117.867 177.301 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -62.21 -32.41 73.06 Favored 'General case' 0 CA--C 1.577 1.997 0 CA-C-N 120.266 1.393 . . . . 0.0 112.732 166.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 69.4 m -98.75 -39.64 8.54 Favored 'General case' 0 CA--C 1.565 1.529 0 N-CA-C 114.424 1.268 . . . . 0.0 114.424 169.769 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 52.1 m -91.07 155.61 18.54 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-N 120.175 1.352 . . . . 0.0 112.052 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 31.3 t -75.27 136.01 40.93 Favored 'General case' 0 CA--C 1.559 1.305 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 177.038 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 6.5 t -76.82 -50.03 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 CA-C-O 118.552 -0.737 . . . . 0.0 111.47 169.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 67.0 m -87.85 143.22 27.25 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 119.297 0.953 . . . . 0.0 111.338 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 19.3 ptp180 -91.12 64.47 5.31 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 121.993 0.901 . . . . 0.0 111.515 169.69 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . 0.271 7.2 p-10 -179.66 -70.99 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 125.624 1.57 . . . . 0.0 107.003 -172.842 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -86.59 149.9 24.61 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.965 0.906 . . . . 0.0 110.558 170.007 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 16.5 mm100 -93.32 88.45 6.0 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 122.764 0.426 . . . . 0.0 109.935 178.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 14.8 mm -90.57 117.61 34.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 -169.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -125.11 122.01 35.92 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 -177.245 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 10.6 mp -74.51 142.96 44.76 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 113.839 1.052 . . . . 0.0 113.839 -169.423 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 4.2 tmt_? -144.75 145.02 31.48 Favored 'General case' 0 CA--C 1.563 1.46 0 N-CA-C 105.798 -1.927 . . . . 0.0 105.798 -174.451 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -69.23 157.04 37.72 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.29 -1.507 . . . . 0.0 113.459 176.733 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.1 pp -72.62 159.05 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 179.198 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 122.88 1.324 . . . . 0.0 110.061 177.955 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.491 0 N-CA-C 111.772 -0.531 . . . . 0.0 111.772 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 32.7 t -92.77 120.84 33.56 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 122.948 0.499 . . . . 0.0 111.576 -171.662 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . 0.256 69.0 p-90 -88.16 -47.7 8.27 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 169.432 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 45.6 t80 -80.71 135.29 35.98 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-N 119.464 1.029 . . . . 0.0 110.967 -177.247 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -122.77 -76.91 0.59 Allowed 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 177.091 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 172.92 -112.89 0.45 Allowed Glycine 0 N--CA 1.479 1.542 0 N-CA-C 108.681 -1.768 . . . . 0.0 108.681 173.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 26.9 ttpp -117.83 82.99 1.92 Allowed 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 105.206 -2.146 . . . . 0.0 105.206 169.119 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -111.49 136.06 21.03 Favored Pre-proline 0 CA--C 1.569 1.695 0 CA-C-O 117.335 -1.317 . . . . 0.0 108.632 -168.853 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_exo -48.75 153.13 3.81 Favored 'Trans proline' 0 C--N 1.371 1.716 0 C-N-CA 123.736 2.957 . . . . 0.0 119.22 -177.36 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 59.0 ttt180 -66.5 -37.9 86.07 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 114.817 1.414 . . . . 0.0 114.817 171.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -69.04 -43.33 74.91 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 115.427 1.64 . . . . 0.0 115.427 176.48 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 54.6 tptt -66.55 -37.31 84.71 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 115.089 1.514 . . . . 0.0 115.089 169.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.27 -45.72 92.0 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 115.612 1.708 . . . . 0.0 115.612 169.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -64.8 -33.95 77.2 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 115.704 1.742 . . . . 0.0 115.704 171.169 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -61.9 -49.53 75.84 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 114.51 1.3 . . . . 0.0 114.51 171.498 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -62.71 -47.31 84.15 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 114.691 1.367 . . . . 0.0 114.691 173.671 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.1 mp -68.21 -25.24 65.12 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 116.302 1.964 . . . . 0.0 116.302 175.218 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 22.9 t -59.1 -36.3 74.9 Favored 'General case' 0 CA--C 1.571 1.759 0 CA-C-N 120.635 1.561 . . . . 0.0 114.078 168.629 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 27.9 mmtp -61.05 -36.29 79.19 Favored 'General case' 0 CA--C 1.57 1.746 0 N-CA-C 115.054 1.501 . . . . 0.0 115.054 169.304 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -67.07 119.47 12.07 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.624 1.17 . . . . 0.0 111.769 177.469 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 14.1 ptp180 -73.93 -17.1 61.06 Favored 'General case' 0 CA--C 1.569 1.685 0 N-CA-C 118.065 2.617 . . . . 0.0 118.065 171.522 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 46.5 m80 -89.74 141.87 28.21 Favored 'General case' 0 N--CA 1.487 1.418 0 CA-C-N 119.287 0.948 . . . . 0.0 113.188 -168.549 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.74 119.57 24.5 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 169.62 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 113.61 -28.5 8.52 Favored Glycine 0 CA--C 1.548 2.098 0 CA-C-O 117.685 -1.619 . . . . 0.0 116.347 -169.568 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.76 109.99 1.6 Allowed 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 120.06 1.93 . . . . 0.0 112.761 -176.602 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 16.4 p90 -126.63 164.19 21.8 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 115.457 1.651 . . . . 0.0 115.457 -168.612 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.2 pp -140.69 134.03 29.76 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 167.618 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 68.1 mt -88.28 117.66 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 106.568 -1.641 . . . . 0.0 106.568 169.818 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 5.0 ptm180 -110.66 141.9 43.28 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.447 169.658 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -79.89 139.04 37.28 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 121.533 0.683 . . . . 0.0 109.793 171.255 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 29.7 t -68.54 128.84 38.07 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.66 -178.325 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -68.5 -48.14 65.2 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 113.97 1.1 . . . . 0.0 113.97 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.8 t -60.84 -37.72 83.03 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 115.986 1.847 . . . . 0.0 115.986 169.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -119.67 93.11 47.18 Favored Pre-proline 0 CA--C 1.561 1.395 0 CA-C-N 119.577 1.081 . . . . 0.0 109.792 174.426 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -55.35 -26.36 52.49 Favored 'Trans proline' 0 CA--C 1.557 1.643 0 N-CA-C 119.761 2.947 . . . . 0.0 119.761 171.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -91.31 48.47 2.91 Favored Glycine 0 CA--C 1.552 2.393 0 CA-C-O 119.319 -0.712 . . . . 0.0 113.93 168.733 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -160.17 126.98 4.36 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 178.74 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 35.3 m-85 -92.73 165.45 12.94 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 122.213 1.006 . . . . 0.0 111.701 169.572 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 75.2 m -143.48 112.72 6.78 Favored 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 25.4 tp -79.98 108.65 13.73 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 124.219 1.008 . . . . 0.0 109.447 176.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 12.6 m -99.65 97.25 8.24 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 -173.436 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 21.7 t -107.6 126.45 63.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 -172.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 58.4 tptt -76.93 109.83 11.07 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 169.664 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -139.3 90.11 2.39 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -174.481 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 71.02 74.71 0.68 Allowed Glycine 0 N--CA 1.482 1.765 0 N-CA-C 115.654 1.021 . . . . 0.0 115.654 169.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . 0.286 66.1 m-80 68.97 -11.56 0.44 Allowed 'General case' 0 N--CA 1.501 2.121 0 N-CA-C 118.362 2.727 . . . . 0.0 118.362 -178.488 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -139.47 142.61 37.35 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 119.736 1.153 . . . . 0.0 108.992 -175.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 38.7 t -92.67 114.75 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 177.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 61.6 mt-30 -96.27 118.35 32.65 Favored 'General case' 0 N--CA 1.485 1.301 0 CA-C-O 121.666 0.746 . . . . 0.0 109.848 -178.123 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 13.9 m-70 -99.25 99.61 10.59 Favored 'General case' 0 CA--C 1.552 1.054 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 -175.432 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -96.9 121.48 38.82 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 -175.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 65.5 pttt -75.78 116.05 16.09 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.402 0.62 . . . . 0.0 112.59 -169.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 92.0 t -88.12 109.31 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 179.182 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 57.8 mt -91.91 145.46 24.53 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.378 -174.505 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 60.9 mtp180 -122.82 124.53 43.5 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.768 -0.583 . . . . 0.0 109.516 -170.394 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -111.16 99.45 8.29 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 123.263 0.625 . . . . 0.0 110.162 177.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 76.44 89.44 0.27 Allowed Glycine 0 N--CA 1.482 1.761 0 CA-C-O 119.452 -0.638 . . . . 0.0 113.953 174.453 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . 0.332 . . 75.8 -78.25 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 124.696 1.199 . . . . 0.0 112.675 -175.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -165.48 75.63 0.15 Allowed Glycine 0 CA--C 1.537 1.431 0 CA-C-O 119.782 -0.455 . . . . 0.0 112.077 173.472 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -105.73 98.31 8.02 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 104.44 -2.43 . . . . 0.0 104.44 169.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -80.05 100.93 8.41 Favored 'General case' 0 N--CA 1.484 1.242 0 CA-C-N 114.617 -1.174 . . . . 0.0 112.286 -167.82 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -108.91 113.39 26.25 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.559 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 64.2 tp -111.12 -49.5 3.01 Favored 'General case' 0 CA--C 1.564 1.504 0 CA-C-N 114.589 -1.187 . . . . 0.0 111.332 176.708 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 85.9 t90 -129.99 101.98 6.07 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 -175.571 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . 0.519 29.8 m 63.43 -88.02 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 114.895 1.443 . . . . 0.0 114.895 177.146 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 8.6 p -79.99 147.86 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 C-N-CA 124.002 0.921 . . . . 0.0 112.241 -174.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 25.6 pttm -80.04 153.29 28.9 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 121.699 0.762 . . . . 0.0 112.991 173.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -131.24 120.2 22.89 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 -175.258 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 56.1 m-80 -58.63 -51.66 68.97 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 114.617 1.34 . . . . 0.0 114.617 -178.722 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 67.2 m -97.14 148.97 22.51 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-O 122.612 1.196 . . . . 0.0 111.664 176.484 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 15.4 tp -65.63 -37.75 87.46 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 172.752 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -65.41 -32.92 74.8 Favored 'General case' 0 CA--C 1.572 1.81 0 N-CA-C 114.22 1.193 . . . . 0.0 114.22 168.77 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -63.19 -41.85 99.24 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-N 120.602 1.547 . . . . 0.0 114.416 169.474 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 63.5 tp -58.69 -43.44 89.99 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 169.086 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 25.7 t -58.62 -64.07 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 C-N-CA 124.447 1.099 . . . . 0.0 112.388 171.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -59.66 -30.91 69.08 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 116.116 1.895 . . . . 0.0 116.116 -174.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 85.4 t80 -63.61 -54.07 41.67 Favored 'General case' 0 CA--C 1.567 1.597 0 CA-C-N 118.815 0.734 . . . . 0.0 112.217 168.808 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . 0.27 62.2 m-70 -69.92 -9.32 54.58 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 117.891 2.552 . . . . 0.0 117.891 177.354 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -51.23 -38.87 54.89 Favored 'General case' 0 N--CA 1.501 2.087 0 CA-C-N 120.726 1.603 . . . . 0.0 113.603 167.154 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 70.0 m -102.91 -34.01 9.12 Favored 'General case' 0 CA--C 1.564 1.505 0 N-CA-C 114.668 1.358 . . . . 0.0 114.668 169.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 30.3 m -90.17 152.43 21.11 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-N 120.681 1.582 . . . . 0.0 111.178 -176.403 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 29.9 t -74.87 136.58 41.5 Favored 'General case' 0 CA--C 1.56 1.346 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 177.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 88.3 t -71.79 -50.91 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.903 169.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 58.5 m -91.18 154.58 19.22 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-O 122.162 0.982 . . . . 0.0 111.745 -178.45 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 10.4 mpt_? -71.9 -54.04 11.29 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.709 177.276 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 24.6 t30 -72.6 -59.56 2.66 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 173.285 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -79.89 150.62 30.52 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-N 118.793 0.724 . . . . 0.0 112.221 -177.14 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -101.45 96.97 7.49 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.383 0.673 . . . . 0.0 109.488 -179.462 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 5.2 mp -109.11 110.71 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 -179.421 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 19.3 m-30 -108.26 137.34 46.4 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 173.675 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 9.7 mp -85.47 128.92 34.89 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 123.36 0.664 . . . . 0.0 112.097 -169.711 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 4.9 mpt_? -129.07 173.77 10.15 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-O 123.409 1.576 . . . . 0.0 109.843 172.208 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -84.46 157.97 21.18 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-N 114.739 -1.119 . . . . 0.0 113.711 -177.187 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 29.2 pt -75.36 153.07 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 CA-C-O 121.704 0.764 . . . . 0.0 112.936 178.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 . . . . . 0 N--CA 1.485 1.305 0 CA-C-O 123.977 1.846 . . . . 0.0 108.847 -178.483 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.452 0 N-CA-C 111.617 -0.593 . . . . 0.0 111.617 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 82.5 p -93.97 100.6 12.71 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.088 0.555 . . . . 0.0 110.841 -176.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 68.6 p-90 -76.58 -39.35 52.91 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 116.109 1.892 . . . . 0.0 116.109 176.638 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -84.05 129.26 34.92 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-N 119.464 1.029 . . . . 0.0 110.646 -174.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -135.5 101.87 4.94 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 105.582 -2.006 . . . . 0.0 105.582 171.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -78.81 108.7 2.71 Favored Glycine 0 CA--C 1.541 1.661 0 CA-C-N 115.969 -0.56 . . . . 0.0 113.317 -173.711 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . 0.27 2.8 tppp? 66.36 80.27 0.22 Allowed 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 124.878 1.271 . . . . 0.0 112.178 -175.573 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.25 130.61 23.71 Favored Pre-proline 0 CA--C 1.572 1.792 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 -175.718 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -63.74 144.75 89.86 Favored 'Trans proline' 0 CA--C 1.559 1.729 0 C-N-CA 122.842 2.361 . . . . 0.0 114.532 -176.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 60.1 ttt180 -59.74 -39.32 84.36 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 116.672 2.101 . . . . 0.0 116.672 -172.725 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.8 -45.59 85.62 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 115.1 1.519 . . . . 0.0 115.1 174.174 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -62.92 -36.72 84.34 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 115.038 1.495 . . . . 0.0 115.038 169.704 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.46 -44.11 97.69 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 115.59 1.7 . . . . 0.0 115.59 169.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -66.07 -38.83 89.29 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 115.26 1.578 . . . . 0.0 115.26 173.156 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -65.39 -43.88 89.25 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 115.467 1.654 . . . . 0.0 115.467 173.192 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -66.38 -43.15 86.71 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 114.464 1.283 . . . . 0.0 114.464 174.501 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 94.7 mt -69.8 -31.36 69.23 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 116.179 1.918 . . . . 0.0 116.179 173.545 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 89.7 p -61.67 -35.78 78.94 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-N 120.245 1.384 . . . . 0.0 114.433 168.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -63.2 -35.22 79.6 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 114.664 1.357 . . . . 0.0 114.664 168.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -63.57 120.88 12.59 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-O 122.23 1.014 . . . . 0.0 111.706 169.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 17.1 ptm180 -70.65 -18.08 62.85 Favored 'General case' 0 CA--C 1.567 1.623 0 N-CA-C 119.061 2.986 . . . . 0.0 119.061 -179.512 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 51.7 m80 -89.5 146.54 24.55 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-N 119.651 1.114 . . . . 0.0 113.455 -168.469 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -80.77 110.57 16.41 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.189 -1.411 . . . . 0.0 107.189 169.655 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 120.1 -17.45 9.88 Favored Glycine 0 CA--C 1.552 2.357 0 CA-C-O 117.347 -1.807 . . . . 0.0 116.043 -168.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.99 113.25 3.36 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-N 120.847 2.323 . . . . 0.0 112.964 -173.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -126.8 168.59 14.22 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 115.167 1.543 . . . . 0.0 115.167 -168.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.5 pp -149.8 134.6 17.75 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 167.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 53.7 mt -85.64 113.25 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 174.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 61.7 ttp85 -95.15 138.86 32.3 Favored 'General case' 0 N--CA 1.483 1.195 0 CA-C-N 114.203 -1.362 . . . . 0.0 110.02 175.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -84.4 125.98 32.81 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 169.051 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 50.7 m -67.06 128.51 36.62 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.709 0.804 . . . . 0.0 112.411 -169.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -65.76 -49.66 67.57 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 -173.626 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.4 t -63.96 -40.36 96.25 Favored 'General case' 0 CA--C 1.564 1.51 0 N-CA-C 115.563 1.69 . . . . 0.0 115.563 170.447 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -112.28 93.53 22.7 Favored Pre-proline 0 CA--C 1.564 1.511 0 CA-C-O 118.02 -0.99 . . . . 0.0 109.779 178.829 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.58 132.87 21.2 Favored 'Trans proline' 0 C--N 1.371 1.747 0 C-N-CA 123.132 2.555 . . . . 0.0 112.076 177.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 98.91 -34.81 5.08 Favored Glycine 0 CA--C 1.554 2.512 0 CA-C-O 119.055 -0.858 . . . . 0.0 114.464 -168.619 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -79.24 139.25 37.96 Favored 'General case' 0 N--CA 1.485 1.325 0 CA-C-N 118.529 1.164 . . . . 0.0 109.356 171.026 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -110.0 162.64 14.34 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 122.223 1.011 . . . . 0.0 111.305 -176.64 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 71.0 m -136.55 117.15 13.88 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 173.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 26.6 tp -79.71 106.62 11.87 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 124.254 1.022 . . . . 0.0 108.731 176.173 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.6 m -95.75 95.69 8.47 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 -170.465 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 17.6 t -112.08 122.0 65.57 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 -170.196 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -83.29 102.97 12.32 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 169.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -126.14 117.19 22.62 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 107.807 -1.182 . . . . 0.0 107.807 177.3 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 86.43 -106.35 3.09 Favored Glycine 0 N--CA 1.48 1.621 0 N-CA-C 110.547 -1.021 . . . . 0.0 110.547 -175.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 31.6 t30 -141.88 56.51 1.49 Allowed 'General case' 0 CA--C 1.566 1.574 0 C-N-CA 122.843 0.457 . . . . 0.0 109.999 169.3 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -158.92 133.2 7.82 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 178.114 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 56.6 t -91.85 109.94 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 173.43 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -106.43 115.67 30.62 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.795 0.838 . . . . 0.0 108.786 -169.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 18.4 m-70 -94.88 96.73 9.52 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 114.918 -1.037 . . . . 0.0 108.375 -172.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -94.32 122.13 36.56 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 -174.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -73.79 120.05 18.85 Favored 'General case' 0 N--CA 1.487 1.379 0 CA-C-O 121.445 0.64 . . . . 0.0 111.809 -169.602 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 76.9 t -97.35 101.4 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 N-CA-C 105.658 -1.979 . . . . 0.0 105.658 175.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -100.13 149.51 23.44 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.284 0.634 . . . . 0.0 110.522 177.588 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 54.7 mtp180 -110.54 128.0 55.45 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 123.164 0.586 . . . . 0.0 110.316 -169.779 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . 0.277 4.2 p-10 -83.74 -68.64 0.7 Allowed 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 179.791 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -91.13 -114.56 1.83 Allowed Glycine 0 N--CA 1.482 1.734 0 CA-C-N 119.352 0.978 . . . . 0.0 112.189 -176.181 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -81.1 -71.65 0.46 Allowed 'General case' 0 N--CA 1.487 1.386 0 CA-C-O 118.357 -0.83 . . . . 0.0 110.607 173.3 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -134.7 68.1 0.54 Allowed Glycine 0 N--CA 1.48 1.607 0 CA-C-N 118.731 0.696 . . . . 0.0 112.28 169.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 2.3 mppt? -107.28 97.11 6.91 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 105.751 -1.944 . . . . 0.0 105.751 171.072 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -86.88 110.89 20.29 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 114.309 -1.314 . . . . 0.0 109.343 -169.47 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -130.56 136.2 48.67 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 121.319 0.58 . . . . 0.0 110.324 -173.206 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -128.27 -51.51 1.3 Allowed 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 124.067 0.947 . . . . 0.0 111.972 177.472 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 58.7 t90 -94.46 -79.6 0.42 Allowed 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 124.368 1.067 . . . . 0.0 110.331 -172.508 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 95.0 t -128.84 -77.77 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 -175.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 10.8 p -80.87 138.86 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 C-N-CA 123.508 0.723 . . . . 0.0 111.362 -172.023 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.77 147.71 31.74 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 121.648 0.737 . . . . 0.0 112.511 179.309 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -124.26 108.81 12.64 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 -169.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 17.7 p30 -55.79 -30.38 61.24 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 118.195 2.665 . . . . 0.0 118.195 177.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 30.9 t -124.97 146.3 49.46 Favored 'General case' 0 N--CA 1.484 1.237 0 CA-C-O 121.942 0.877 . . . . 0.0 111.436 -177.375 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 89.6 mt -83.77 103.56 13.16 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 105.356 -2.091 . . . . 0.0 105.356 168.782 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . 0.273 28.5 t-20 145.98 -57.79 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 104.53 -2.396 . . . . 0.0 104.53 -168.557 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -56.91 -42.44 79.93 Favored 'General case' 0 CA--C 1.574 1.868 0 C-N-CA 124.26 1.024 . . . . 0.0 113.597 168.149 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 8.4 tt -55.46 -49.44 72.48 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 114.888 1.44 . . . . 0.0 114.888 169.638 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . 0.276 3.6 m -63.43 -51.47 70.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 CA-C-N 119.224 0.92 . . . . 0.0 113.223 178.188 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -64.67 -33.56 76.24 Favored 'General case' 0 CA--C 1.568 1.664 0 N-CA-C 115.182 1.549 . . . . 0.0 115.182 -176.479 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 69.2 t80 -62.12 -59.33 5.22 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-N 119.749 1.159 . . . . 0.0 112.826 169.722 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 60.7 m-70 -68.94 -9.38 51.7 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 117.906 2.558 . . . . 0.0 117.906 178.389 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 54.5 ttm-85 -53.76 -31.42 48.55 Favored 'General case' 0 CA--C 1.574 1.868 0 N-CA-C 115.074 1.509 . . . . 0.0 115.074 168.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 70.9 m -116.49 -24.32 7.9 Favored 'General case' 0 CA--C 1.57 1.716 0 C-N-CA 125.071 1.348 . . . . 0.0 114.216 169.307 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 61.0 m -90.13 151.67 21.48 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-N 120.837 1.653 . . . . 0.0 110.577 177.184 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 32.2 t -68.35 129.09 38.88 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 178.305 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 35.1 t -71.42 -48.79 51.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 CA-C-O 118.296 -0.859 . . . . 0.0 111.95 172.419 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 15.7 p -91.08 168.41 11.66 Favored 'General case' 0 N--CA 1.487 1.411 0 CA-C-N 119.235 0.925 . . . . 0.0 112.122 -179.207 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 30.7 mmt180 -72.11 -58.42 3.44 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 177.53 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 23.8 t30 -75.64 -61.72 1.82 Allowed 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 65.3 mt-30 -79.95 150.35 30.53 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 118.638 0.654 . . . . 0.0 112.225 -175.006 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -83.09 121.37 26.95 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 122.843 0.457 . . . . 0.0 110.553 169.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 3.6 mp -123.64 108.82 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 104.248 -2.501 . . . . 0.0 104.248 172.107 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 18.3 m-30 -113.93 108.19 16.71 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 105.771 -1.937 . . . . 0.0 105.771 179.3 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . 0.35 1.0 OUTLIER -76.15 170.27 16.62 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 116.381 1.993 . . . . 0.0 116.381 -169.15 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 3.9 tmt_? -160.04 138.22 10.16 Favored 'General case' 0 CA--C 1.56 1.355 0 N-CA-C 104.621 -2.362 . . . . 0.0 104.621 -169.548 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -67.8 172.39 5.42 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.115 -1.616 . . . . 0.0 114.248 178.353 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 18.3 pt -70.62 156.91 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 O-C-N 120.883 -1.136 . . . . 0.0 113.184 -175.597 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 . . . . . 0 N--CA 1.489 1.486 0 CA-C-O 122.859 1.314 . . . . 0.0 109.869 176.554 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.454 0 N-CA-C 111.558 -0.617 . . . . 0.0 111.558 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 89.6 p -84.67 108.51 17.43 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 123.153 0.581 . . . . 0.0 111.324 -179.403 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 62.9 p-90 -155.46 -44.14 0.08 Allowed 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 178.066 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 44.6 t80 -82.79 137.82 34.22 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 120.249 1.386 . . . . 0.0 111.799 -173.124 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -118.64 -73.2 0.65 Allowed 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.43 176.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 108.32 84.85 1.67 Allowed Glycine 0 N--CA 1.481 1.697 0 CA-C-N 118.923 0.783 . . . . 0.0 111.397 -176.253 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.532 ' H ' ' H ' ' A' ' 87' ' ' GLU 0.304 33.0 ttmt 64.98 79.98 0.24 Allowed 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 125.179 1.392 . . . . 0.0 114.109 178.878 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 17.8 pt -126.14 157.79 68.58 Favored Pre-proline 0 CA--C 1.579 2.083 0 C-N-CA 124.257 1.023 . . . . 0.0 109.396 171.462 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -75.79 165.07 30.83 Favored 'Trans proline' 0 CA--C 1.564 1.976 0 C-N-CA 122.712 2.274 . . . . 0.0 115.092 -178.452 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 30.0 ttm180 -63.98 -45.49 88.85 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 115.913 1.82 . . . . 0.0 115.913 176.052 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.23 -46.42 87.0 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 115.337 1.606 . . . . 0.0 115.337 -179.278 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm -62.97 -34.71 78.09 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 115.265 1.58 . . . . 0.0 115.265 169.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.88 -42.66 90.04 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 115.442 1.645 . . . . 0.0 115.442 170.398 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -60.54 -44.91 95.58 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 115.212 1.56 . . . . 0.0 115.212 170.682 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -58.66 -50.76 72.69 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 114.979 1.474 . . . . 0.0 114.979 175.739 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -63.96 -49.15 73.68 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 114.708 1.373 . . . . 0.0 114.708 176.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 8.8 mp -71.02 -33.12 70.04 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 116.563 2.06 . . . . 0.0 116.563 -176.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 66.7 m -60.17 -33.09 71.71 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 116.08 1.882 . . . . 0.0 116.08 169.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 57.4 mtmt -64.1 -33.64 76.22 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 115.934 1.827 . . . . 0.0 115.934 169.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -64.5 127.01 29.66 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.62 1.168 . . . . 0.0 113.009 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -62.29 -21.47 65.26 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 119.042 2.978 . . . . 0.0 119.042 177.582 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 43.4 m80 -89.38 132.71 34.84 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 119.264 0.938 . . . . 0.0 111.09 -169.089 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -75.55 105.36 6.54 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 171.325 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 124.78 -7.78 8.25 Favored Glycine 0 CA--C 1.553 2.448 0 CA-C-O 116.91 -2.05 . . . . 0.0 116.523 -169.029 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.12 111.92 2.77 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 121.229 2.515 . . . . 0.0 111.968 -171.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 20.1 p90 -128.24 161.96 28.11 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 115.427 1.64 . . . . 0.0 115.427 -168.395 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.1 pp -139.69 136.06 33.84 Favored 'General case' 0 CA--C 1.555 1.14 0 CA-C-N 113.919 -1.491 . . . . 0.0 107.884 168.372 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 62.7 mt -97.13 106.5 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 169.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 46.7 ptt85 -95.45 157.18 16.01 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 114.45 -1.25 . . . . 0.0 110.324 169.613 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.532 ' H ' ' H ' ' A' ' 64' ' ' LYS . 28.8 tt0 -85.06 135.87 33.81 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.431 -0.793 . . . . 0.0 109.163 169.484 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 93.3 p -68.67 121.9 17.41 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-O 121.026 0.441 . . . . 0.0 110.815 172.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -68.66 -39.37 80.69 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 116.684 2.105 . . . . 0.0 116.684 -175.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.5 t -63.1 -22.13 66.65 Favored 'General case' 0 CA--C 1.569 1.697 0 N-CA-C 115.864 1.802 . . . . 0.0 115.864 169.2 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -135.45 94.78 15.06 Favored Pre-proline 0 CA--C 1.563 1.446 0 CA-C-N 120.011 1.278 . . . . 0.0 109.027 177.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -70.33 134.06 25.93 Favored 'Trans proline' 0 C--N 1.372 1.795 0 C-N-CA 123.038 2.492 . . . . 0.0 111.933 176.042 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 101.31 -38.05 3.33 Favored Glycine 0 CA--C 1.555 2.574 0 CA-C-O 119.382 -0.676 . . . . 0.0 113.48 -168.241 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -79.46 130.91 35.86 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 118.182 0.991 . . . . 0.0 109.182 169.729 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -107.42 169.38 8.61 Favored 'General case' 0 N--CA 1.486 1.374 0 CA-C-O 122.439 1.114 . . . . 0.0 110.861 -178.259 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 69.4 m -141.65 117.64 10.56 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -179.3 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 31.2 tp -79.96 113.65 18.28 Favored 'General case' 0 CA--C 1.559 1.314 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 169.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 9.6 m -97.91 104.0 15.99 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 173.204 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.8 p -124.76 117.63 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 CA-C-N 118.964 0.802 . . . . 0.0 109.0 -171.047 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -74.62 140.0 44.01 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.931 169.698 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 15.8 t80 -157.0 95.12 1.48 Allowed 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 171.558 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 70.04 74.87 0.62 Allowed Glycine 0 CA--C 1.544 1.902 0 CA-C-O 119.421 -0.655 . . . . 0.0 114.64 -177.867 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . 0.366 9.7 t-20 78.62 -58.14 0.44 Allowed 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 116.664 2.098 . . . . 0.0 116.664 -179.026 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -91.16 142.85 27.3 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 123.898 0.879 . . . . 0.0 112.019 -169.32 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 41.6 t -102.27 113.21 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 N-CA-C 106.592 -1.632 . . . . 0.0 106.592 -178.104 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -96.83 117.99 32.29 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.897 0.879 . . . . 0.0 109.334 -176.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 10.5 m-70 -97.98 97.26 8.77 Favored 'General case' 0 CA--C 1.554 1.119 0 CA-C-N 114.991 -1.004 . . . . 0.0 108.443 -174.275 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -100.86 135.11 42.83 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 124.061 0.945 . . . . 0.0 109.11 -178.613 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 12.2 mmmm -79.44 125.34 29.42 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.858 -0.526 . . . . 0.0 111.957 -178.31 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 96.2 t -85.7 112.94 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 106.484 -1.672 . . . . 0.0 106.484 171.017 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -114.85 145.06 42.57 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.231 0.612 . . . . 0.0 110.528 -175.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -97.11 158.26 15.52 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -175.211 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -123.1 100.85 7.08 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 169.452 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 90.73 -112.72 4.14 Favored Glycine 0 CA--C 1.542 1.722 0 CA-C-O 120.082 -0.288 . . . . 0.0 113.417 176.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -84.75 -74.18 0.4 Allowed 'General case' 0 N--CA 1.488 1.462 0 CA-C-O 118.886 -0.578 . . . . 0.0 112.215 -173.583 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -148.22 74.36 0.28 Allowed Glycine 0 N--CA 1.479 1.518 0 N-CA-C 110.499 -1.04 . . . . 0.0 110.499 173.498 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -122.38 89.57 3.14 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 -177.106 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -80.02 115.61 19.69 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.791 -169.404 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 26.5 p90 -124.86 120.42 31.63 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 174.704 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -87.86 -59.94 2.1 Favored 'General case' 0 CA--C 1.562 1.424 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.086 169.797 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 39.3 t90 -80.25 -81.44 0.12 Allowed 'General case' 0 CA--C 1.56 1.343 0 C-N-CA 124.82 1.248 . . . . 0.0 110.383 -175.053 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.1 m -140.44 -53.76 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 C-N-CA 124.012 0.925 . . . . 0.0 110.937 176.524 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 3.4 m -79.78 140.85 16.14 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.458 0 C-N-CA 124.411 1.084 . . . . 0.0 112.096 -174.559 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.45 152.34 18.5 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 -171.047 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -146.22 119.91 9.2 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 -171.537 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -55.91 -40.46 73.09 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 116.575 2.065 . . . . 0.0 116.575 -177.471 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 27.1 t -102.63 153.07 20.46 Favored 'General case' 0 N--CA 1.485 1.321 0 CA-C-N 119.031 0.832 . . . . 0.0 111.483 174.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 82.9 mt -67.85 -32.64 73.31 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 169.028 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -64.26 -39.69 94.46 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 119.701 1.137 . . . . 0.0 113.803 170.471 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -60.56 -44.12 96.5 Favored 'General case' 0 CA--C 1.573 1.854 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 169.279 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 49.3 tp -55.5 -44.84 76.96 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 115.411 1.634 . . . . 0.0 115.411 169.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . 0.282 10.9 m -63.73 -51.5 69.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 CA-C-N 120.124 1.329 . . . . 0.0 113.232 175.11 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -63.34 -36.05 82.41 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 114.625 1.343 . . . . 0.0 114.625 -175.175 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 90.3 t80 -60.61 -52.72 63.97 Favored 'General case' 0 CA--C 1.57 1.733 0 CA-C-N 119.404 1.002 . . . . 0.0 112.03 168.216 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 50.7 m-70 -72.7 -9.13 58.27 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 118.728 2.862 . . . . 0.0 118.728 178.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 88.1 mtt-85 -59.84 -29.04 68.0 Favored 'General case' 0 CA--C 1.575 1.937 0 CA-C-N 120.156 1.344 . . . . 0.0 113.447 167.774 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 69.7 m -103.01 -39.57 6.85 Favored 'General case' 0 CA--C 1.569 1.696 0 C-N-CA 125.022 1.329 . . . . 0.0 113.094 168.608 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 34.3 m -90.53 156.38 18.21 Favored 'General case' 0 N--CA 1.498 1.94 0 CA-C-N 120.142 1.337 . . . . 0.0 112.031 -176.68 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 35.3 t -75.07 132.91 41.62 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 3.3 m -78.88 -38.39 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 114.976 1.472 . . . . 0.0 114.976 169.788 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 16.8 t -79.82 -40.12 29.25 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 116.61 2.078 . . . . 0.0 116.61 -169.647 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 15.9 tpt180 84.49 115.88 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 124.777 1.231 . . . . 0.0 108.903 -170.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . 0.351 59.2 m-80 83.62 -58.53 0.14 Allowed 'General case' 0 N--CA 1.499 2.017 0 C-N-CA 124.507 1.123 . . . . 0.0 112.604 -172.496 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 -79.57 126.63 31.13 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 170.463 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 76.3 mm-40 -90.1 96.03 10.48 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 -175.497 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 29.6 mm -111.68 109.4 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 105.787 -1.931 . . . . 0.0 105.787 -173.082 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -111.95 121.93 46.36 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 -173.016 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 10.5 mp -75.1 136.62 41.12 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 -168.681 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 81.7 mmt-85 -131.54 153.57 49.71 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 125.368 1.467 . . . . 0.0 108.381 178.468 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -79.31 157.39 27.71 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.822 -1.174 . . . . 0.0 112.798 -177.689 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 8.5 mt -69.35 146.68 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 C-N-CA 123.934 0.894 . . . . 0.0 109.886 -179.283 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 123.946 1.832 . . . . 0.0 108.149 178.726 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.33 0 N-CA-C 111.284 -0.727 . . . . 0.0 111.284 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 47.2 m 65.8 95.79 0.05 Allowed 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 124.696 1.198 . . . . 0.0 112.008 -178.104 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . 0.418 70.5 p-90 58.27 -17.87 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 120.732 3.604 . . . . 0.0 120.732 -174.854 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 44.4 t80 -96.95 131.6 43.59 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.78 0.832 . . . . 0.0 110.153 -169.728 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -107.73 -65.89 1.08 Allowed 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.352 173.675 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.04 77.66 1.31 Allowed Glycine 0 N--CA 1.482 1.744 0 CA-C-N 118.952 0.796 . . . . 0.0 112.375 -179.713 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . 0.298 61.9 tttt 71.24 71.74 0.18 Allowed 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 124.62 1.168 . . . . 0.0 113.936 175.049 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 14.9 pt -118.95 154.74 53.22 Favored Pre-proline 0 CA--C 1.576 1.959 0 C-N-CA 124.056 0.942 . . . . 0.0 109.069 170.068 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -75.71 172.65 15.91 Favored 'Trans proline' 0 CA--C 1.564 2.015 0 C-N-CA 122.702 2.268 . . . . 0.0 114.34 178.687 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 28.6 ttm180 -61.63 -43.86 98.07 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 115.915 1.82 . . . . 0.0 115.915 175.407 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -65.3 -43.38 91.29 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 115.805 1.78 . . . . 0.0 115.805 178.349 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -67.39 -32.54 73.51 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 115.362 1.615 . . . . 0.0 115.362 169.875 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.26 -42.14 88.95 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 115.328 1.603 . . . . 0.0 115.328 169.753 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -62.81 -42.4 99.7 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 114.346 1.239 . . . . 0.0 114.346 169.585 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -53.41 -48.07 69.03 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 115.395 1.628 . . . . 0.0 115.395 170.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 37.3 mmt -62.37 -48.32 80.31 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 173.66 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 88.8 mt -76.22 -9.82 58.93 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 117.775 2.509 . . . . 0.0 117.775 178.466 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 72.4 m -57.69 -38.73 75.71 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 115.875 1.805 . . . . 0.0 115.875 170.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -60.39 -33.27 72.24 Favored 'General case' 0 CA--C 1.571 1.778 0 N-CA-C 116.061 1.875 . . . . 0.0 116.061 169.739 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -71.7 111.46 6.99 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.165 0.986 . . . . 0.0 112.122 -171.511 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 13.4 ptp180 -74.28 -17.57 60.84 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 117.86 2.541 . . . . 0.0 117.86 173.735 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 48.4 m80 -89.63 137.29 32.45 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 119.248 0.931 . . . . 0.0 111.338 -168.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -77.56 115.23 17.15 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 122.951 0.5 . . . . 0.0 110.444 176.711 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 114.63 -23.19 12.27 Favored Glycine 0 CA--C 1.551 2.321 0 CA-C-O 117.269 -1.851 . . . . 0.0 116.246 -169.291 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.4 113.47 1.99 Allowed 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 120.66 2.23 . . . . 0.0 113.238 -176.779 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 27.3 p90 -130.18 165.07 23.11 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 115.828 1.788 . . . . 0.0 115.828 -168.514 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.0 pp -142.16 125.25 16.3 Favored 'General case' 0 CA--C 1.557 1.233 0 N-CA-C 106.803 -1.555 . . . . 0.0 106.803 168.285 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 59.9 mt -87.07 114.12 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 106.584 -1.636 . . . . 0.0 106.584 173.398 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 49.3 ptt85 -99.78 159.2 15.24 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-N 114.931 -1.031 . . . . 0.0 111.042 170.028 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -86.58 135.28 33.49 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 168.368 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 84.1 p -65.32 128.45 35.9 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-O 121.275 0.559 . . . . 0.0 111.733 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -62.46 -45.46 92.94 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 116.017 1.858 . . . . 0.0 116.017 -169.725 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 68.1 m -69.72 -33.15 72.09 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 116.053 1.871 . . . . 0.0 116.053 171.405 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -119.18 101.04 50.01 Favored Pre-proline 0 CA--C 1.563 1.469 0 CA-C-N 120.018 1.281 . . . . 0.0 110.939 -175.72 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -59.46 -32.16 95.92 Favored 'Trans proline' 0 C--N 1.369 1.655 0 N-CA-C 119.934 3.013 . . . . 0.0 119.934 174.477 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -87.23 44.82 3.33 Favored Glycine 0 CA--C 1.553 2.41 0 N-CA-C 115.247 0.859 . . . . 0.0 115.247 169.374 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -160.13 130.19 5.37 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 106.187 -1.783 . . . . 0.0 106.187 -178.079 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 -103.9 174.73 5.74 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 122.106 0.955 . . . . 0.0 111.181 172.661 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 62.0 m -149.03 120.4 7.88 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 -179.633 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 36.4 tp -79.93 110.51 15.37 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.803 0.841 . . . . 0.0 109.173 170.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.6 m -96.16 103.1 14.98 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 105.696 -1.964 . . . . 0.0 105.696 174.201 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.4 p -122.21 121.12 63.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 CA-C-O 121.471 0.653 . . . . 0.0 109.809 -169.6 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 58.1 tptt -82.68 98.63 9.15 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 124.32 1.048 . . . . 0.0 109.941 177.22 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -120.08 93.31 4.01 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -175.658 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 69.28 65.18 2.68 Favored Glycine 0 CA--C 1.544 1.845 0 N-CA-C 115.658 1.023 . . . . 0.0 115.658 175.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . 0.269 26.8 t30 54.78 41.83 31.63 Favored 'General case' 0 CA--C 1.574 1.903 0 N-CA-C 116.419 2.007 . . . . 0.0 116.419 -174.207 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -160.77 129.92 4.81 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.541 -0.724 . . . . 0.0 109.738 176.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 41.1 t -94.71 106.04 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 178.328 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -98.73 119.6 37.75 Favored 'General case' 0 N--CA 1.484 1.27 0 CA-C-O 121.704 0.764 . . . . 0.0 109.37 -177.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 13.0 m-70 -99.19 109.23 21.93 Favored 'General case' 0 CA--C 1.552 1.034 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 -176.278 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -114.49 127.94 56.07 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -176.491 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -74.29 132.32 41.98 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-O 121.785 0.802 . . . . 0.0 112.751 -177.248 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 92.9 t -101.97 103.99 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 N-CA-C 104.859 -2.274 . . . . 0.0 104.859 174.77 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -104.44 132.35 50.78 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.517 0.727 . . . . 0.0 110.129 -173.5 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -84.96 161.88 19.62 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 121.895 0.855 . . . . 0.0 112.306 -179.261 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 20.7 p-10 -79.69 -39.41 31.35 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 169.685 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -178.53 -79.09 0.06 OUTLIER Glycine 0 CA--C 1.539 1.586 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 -173.361 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -74.83 -69.34 0.47 Allowed 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 177.426 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -174.18 68.78 0.1 OUTLIER Glycine 0 N--CA 1.479 1.529 0 CA-C-N 118.874 0.761 . . . . 0.0 113.294 175.636 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -120.38 102.33 8.39 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 105.38 -2.082 . . . . 0.0 105.38 171.482 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -81.4 121.39 26.17 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.439 1.095 . . . . 0.0 110.488 -169.784 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 44.0 p90 -130.03 122.0 27.54 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 121.31 0.576 . . . . 0.0 109.616 174.226 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 5.0 tt -89.36 -65.2 1.04 Allowed 'General case' 0 N--CA 1.488 1.472 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.126 169.65 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 20.2 t90 -82.32 -61.78 1.8 Allowed 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 124.446 1.098 . . . . 0.0 112.55 -172.553 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . 0.258 11.2 p -149.76 -67.36 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 CA-C-N 118.849 0.75 . . . . 0.0 110.114 -178.858 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 3.4 m -79.64 141.91 14.68 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.419 0 C-N-CA 124.291 1.036 . . . . 0.0 112.301 -171.674 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 10.0 ptpp? -96.64 156.24 16.43 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -173.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -145.14 132.12 20.27 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.248 -169.487 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 -50.61 -41.73 55.16 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 117.922 2.564 . . . . 0.0 117.922 177.145 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 90.5 p -122.65 159.33 28.11 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-O 122.688 1.233 . . . . 0.0 111.877 178.079 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 61.3 mt -62.69 -31.91 72.9 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 115.186 1.551 . . . . 0.0 115.186 169.63 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -65.36 -36.09 82.96 Favored 'General case' 0 CA--C 1.571 1.755 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 169.701 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -63.26 -47.83 80.75 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-N 119.86 1.209 . . . . 0.0 113.707 169.585 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 60.5 tp -59.53 -38.61 81.45 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 115.724 1.75 . . . . 0.0 115.724 169.685 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . 0.265 0.3 OUTLIER -67.04 -53.9 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 CA-C-N 119.743 1.156 . . . . 0.0 113.251 -179.595 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -57.97 -33.83 69.3 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 115.454 1.65 . . . . 0.0 115.454 172.282 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -57.28 -55.45 34.62 Favored 'General case' 0 CA--C 1.566 1.579 0 CA-C-N 119.353 0.979 . . . . 0.0 113.021 168.745 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . 0.265 52.7 m-70 -74.72 -9.47 58.59 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 117.944 2.572 . . . . 0.0 117.944 177.379 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 94.2 mtt-85 -62.15 -33.35 74.33 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-N 120.883 1.674 . . . . 0.0 112.962 167.168 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 70.6 m -97.03 -40.15 8.99 Favored 'General case' 0 CA--C 1.563 1.476 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 170.291 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 60.7 m -90.8 154.03 19.81 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-N 120.093 1.315 . . . . 0.0 111.527 179.617 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 33.0 t -75.75 134.66 40.41 Favored 'General case' 0 CA--C 1.559 1.323 0 CA-C-O 121.462 0.648 . . . . 0.0 112.556 177.571 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 45.5 t -70.24 -48.29 62.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 CA-C-N 115.419 -0.81 . . . . 0.0 112.202 172.258 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 57.7 m -122.62 154.71 37.64 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-O 122.262 1.03 . . . . 0.0 110.721 -177.616 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 85.2 mtt85 -77.18 -39.88 47.32 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 115.171 1.545 . . . . 0.0 115.171 -177.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 22.2 m120 -74.58 -66.45 0.74 Allowed 'General case' 0 N--CA 1.495 1.82 0 CA-C-N 119.902 1.228 . . . . 0.0 111.876 174.423 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 35.7 mm-40 -80.07 126.02 30.53 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 118.909 0.777 . . . . 0.0 109.2 170.08 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 3.2 pm0 -94.43 86.46 4.86 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 123.018 0.527 . . . . 0.0 110.477 -176.653 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 4.0 mp -85.77 122.04 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -169.526 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -121.73 117.11 25.81 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 106.428 -1.694 . . . . 0.0 106.428 176.671 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 11.2 mp -70.85 134.4 47.29 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 -168.738 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 62.7 mmt-85 -132.28 162.71 30.31 Favored 'General case' 0 CA--C 1.564 1.515 0 C-N-CA 124.963 1.305 . . . . 0.0 109.221 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -76.33 158.89 31.05 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.907 -1.12 . . . . 0.0 113.801 176.398 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.1 pp -76.65 161.73 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -177.463 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 . . . . . 0 N--CA 1.484 1.262 0 CA-C-O 124.021 1.867 . . . . 0.0 108.096 177.618 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.35 0 N-CA-C 111.261 -0.736 . . . . 0.0 111.261 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 74.3 m -83.96 105.09 14.57 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 123.099 0.56 . . . . 0.0 109.745 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 1.6 p90 -141.46 -29.81 0.62 Allowed 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 116.248 1.944 . . . . 0.0 116.248 -169.554 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 72.2 t80 -118.32 124.19 47.17 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 178.008 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -119.39 66.43 0.79 Allowed 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 121.272 0.558 . . . . 0.0 110.82 -179.052 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 53.59 -119.42 10.83 Favored Glycine 0 CA--C 1.547 2.065 0 N-CA-C 118.803 2.281 . . . . 0.0 118.803 169.433 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -141.56 96.53 3.0 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 -171.834 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.01 149.94 75.19 Favored Pre-proline 0 CA--C 1.572 1.815 0 CA-C-O 118.502 -0.761 . . . . 0.0 109.733 176.255 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -66.49 172.11 9.63 Favored 'Trans proline' 0 CA--C 1.563 1.956 0 C-N-CA 123.005 2.47 . . . . 0.0 114.556 172.342 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 59.2 ttt-85 -60.32 -41.9 94.48 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 116.08 1.882 . . . . 0.0 116.08 -177.71 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -66.08 -44.27 84.96 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 115.466 1.654 . . . . 0.0 115.466 176.077 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -63.24 -33.99 76.68 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 115.674 1.731 . . . . 0.0 115.674 170.14 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.47 -43.15 95.11 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 115.302 1.593 . . . . 0.0 115.302 169.609 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -61.22 -43.97 98.02 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 114.943 1.46 . . . . 0.0 114.943 170.261 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -57.18 -44.0 83.17 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 115.626 1.713 . . . . 0.0 115.626 173.095 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 37.9 mmt -63.04 -48.3 79.33 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 114.528 1.307 . . . . 0.0 114.528 172.456 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 95.1 mt -73.25 -12.12 60.75 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 117.518 2.414 . . . . 0.0 117.518 175.272 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 69.6 m -63.0 -37.85 88.82 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-N 120.507 1.503 . . . . 0.0 113.966 168.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt -60.59 -33.78 73.24 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 115.386 1.624 . . . . 0.0 115.386 169.206 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -71.2 117.04 12.22 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 124.478 1.111 . . . . 0.0 111.225 178.165 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -79.53 -17.39 54.15 Favored 'General case' 0 CA--C 1.569 1.677 0 N-CA-C 117.531 2.419 . . . . 0.0 117.531 172.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 45.8 m80 -89.53 133.22 34.69 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 119.198 0.908 . . . . 0.0 111.929 -168.683 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -71.63 123.31 22.22 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 122.953 0.501 . . . . 0.0 110.833 174.426 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 107.8 -20.22 31.95 Favored Glycine 0 CA--C 1.549 2.179 0 CA-C-O 117.576 -1.68 . . . . 0.0 116.51 -169.257 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.69 123.06 19.07 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-N 120.192 1.996 . . . . 0.0 111.746 -173.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 24.7 p90 -137.36 158.13 45.08 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -168.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.3 pp -137.47 127.99 26.68 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 168.458 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 74.1 mt -87.64 113.6 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 105.62 -1.993 . . . . 0.0 105.62 175.446 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 4.1 ptm180 -90.05 149.96 22.29 Favored 'General case' 0 N--CA 1.484 1.27 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.065 170.377 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -85.87 128.43 34.82 Favored 'General case' 0 CA--C 1.56 1.33 0 N-CA-C 106.795 -1.558 . . . . 0.0 106.795 168.671 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 50.3 m -65.01 132.61 49.7 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 -169.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -64.67 -50.98 64.92 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 114.666 1.358 . . . . 0.0 114.666 -174.401 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 95.9 p -65.09 -38.95 92.39 Favored 'General case' 0 CA--C 1.562 1.441 0 N-CA-C 116.083 1.883 . . . . 0.0 116.083 169.888 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -114.73 95.16 39.98 Favored Pre-proline 0 CA--C 1.563 1.474 0 CA-C-N 119.66 1.118 . . . . 0.0 109.553 -179.434 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -72.39 135.09 23.84 Favored 'Trans proline' 0 C--N 1.371 1.749 0 C-N-CA 123.068 2.512 . . . . 0.0 112.215 178.325 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 97.41 -40.49 2.52 Favored Glycine 0 CA--C 1.552 2.383 0 CA-C-O 119.308 -0.718 . . . . 0.0 113.627 -168.52 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -79.12 131.4 36.22 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 124.076 0.95 . . . . 0.0 109.168 176.384 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -100.54 168.52 9.67 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 122.102 0.953 . . . . 0.0 111.847 -170.363 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 58.8 m -147.31 123.62 10.93 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 174.106 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 26.8 tp -79.95 108.47 13.55 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.078 0.951 . . . . 0.0 109.635 175.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.2 m -91.38 107.26 19.08 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 106.12 -1.808 . . . . 0.0 106.12 172.607 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.2 p -131.06 116.11 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 -170.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.19 113.92 20.35 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.334 175.422 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -132.95 116.39 16.38 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 177.473 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 89.48 -83.33 1.41 Allowed Glycine 0 N--CA 1.481 1.654 0 CA-C-N 116.243 -0.435 . . . . 0.0 112.063 -179.306 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 10.6 p30 -138.62 -26.4 0.88 Allowed 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 115.533 1.679 . . . . 0.0 115.533 170.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -98.05 142.42 29.77 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 124.051 0.94 . . . . 0.0 110.668 -171.728 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 47.8 t -85.64 110.01 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 N-CA-C 106.533 -1.654 . . . . 0.0 106.533 172.061 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 61.9 mt-30 -104.42 113.92 27.8 Favored 'General case' 0 N--CA 1.484 1.26 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.002 -169.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 16.8 m-70 -96.26 102.49 14.28 Favored 'General case' 0 CA--C 1.553 1.071 0 CA-C-N 114.766 -1.106 . . . . 0.0 108.262 -174.192 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -106.78 123.24 47.85 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 -179.233 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 43.6 mtpt -77.2 122.95 25.76 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 121.687 0.756 . . . . 0.0 112.101 -169.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 98.7 t -92.35 96.94 6.66 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.591 0 N-CA-C 105.026 -2.213 . . . . 0.0 105.026 177.43 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 62.1 mt -90.52 135.65 33.56 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 -168.755 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 27.1 mtp-105 -87.42 144.01 26.96 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 122.014 0.912 . . . . 0.0 112.888 176.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -86.57 -53.67 4.84 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-N 114.474 -1.239 . . . . 0.0 114.304 176.593 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -165.71 -86.08 0.06 OUTLIER Glycine 0 N--CA 1.48 1.628 0 CA-C-N 119.895 1.225 . . . . 0.0 113.287 -173.08 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -68.29 -63.79 0.99 Allowed 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 114.531 1.308 . . . . 0.0 114.531 -172.394 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -161.97 13.75 0.13 Allowed Glycine 0 CA--C 1.552 2.398 0 N-CA-C 116.728 1.451 . . . . 0.0 116.728 170.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -91.96 150.58 20.93 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-N 119.204 1.502 . . . . 0.0 109.084 177.494 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -137.98 137.11 37.59 Favored 'General case' 0 N--CA 1.487 1.411 0 CA-C-N 114.944 -1.026 . . . . 0.0 109.517 -174.774 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -123.73 122.55 38.38 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 124.764 1.226 . . . . 0.0 108.693 -172.011 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 60.7 tp -100.6 -56.96 2.21 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.028 169.454 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 84.6 t90 -133.43 103.66 6.05 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 -174.456 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . 0.405 22.3 t 78.74 -82.8 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 C-N-CA 124.155 0.982 . . . . 0.0 111.982 171.713 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 16.9 m -81.37 140.72 16.16 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.399 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -169.432 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -90.14 138.45 31.51 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.49 0.662 . . . . 0.0 111.106 169.808 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -172.25 139.5 1.05 Allowed 'General case' 0 N--CA 1.488 1.454 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.623 -169.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -79.47 74.91 6.09 Favored 'General case' 0 N--CA 1.501 2.086 0 CA-C-O 123.76 1.743 . . . . 0.0 109.784 170.225 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 89.3 p -102.94 63.76 0.83 Allowed 'General case' 0 CA--C 1.554 1.122 1 N-CA-C 124.09 4.848 . . . . 0.0 124.09 -166.501 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 75.7 mt -101.52 86.62 3.0 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 104.224 -2.51 . . . . 0.0 104.224 167.592 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . 0.261 25.0 t-20 133.99 -61.05 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.045 0 C-N-CA 127.39 2.276 . . . . 0.0 105.479 -167.893 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -56.09 -45.58 79.34 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 115.367 1.617 . . . . 0.0 115.367 177.48 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 15.7 tp -66.44 -37.79 85.95 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 177.13 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 44.7 t -58.4 -65.38 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 C-N-CA 124.585 1.154 . . . . 0.0 111.548 174.318 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -66.73 -35.56 80.4 Favored 'General case' 0 CA--C 1.569 1.677 0 N-CA-C 114.826 1.417 . . . . 0.0 114.826 -173.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -58.59 -59.42 5.42 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 124.419 1.088 . . . . 0.0 113.649 169.707 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -74.83 -8.56 56.8 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 117.872 2.545 . . . . 0.0 117.872 177.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 46.1 ttm-85 -52.32 -30.83 30.23 Favored 'General case' 0 CA--C 1.577 1.992 0 N-CA-C 114.818 1.414 . . . . 0.0 114.818 168.23 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 68.0 m -105.05 -40.94 5.72 Favored 'General case' 0 CA--C 1.569 1.673 0 C-N-CA 124.995 1.318 . . . . 0.0 113.037 168.695 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 53.7 m -90.51 150.58 21.72 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-N 120.199 1.363 . . . . 0.0 111.859 -176.773 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 21.7 t -80.63 133.68 35.78 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.107 -0.995 . . . . 0.0 112.828 -178.13 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 8.3 m -66.62 -42.65 90.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 115.398 1.629 . . . . 0.0 115.398 170.649 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 14.3 t -112.65 -45.56 3.22 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 -174.432 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . 0.302 80.3 mtm180 77.15 71.98 0.06 Allowed 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 125.337 1.455 . . . . 0.0 110.64 -169.822 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . 0.269 14.4 p-10 -149.58 -65.91 0.22 Allowed 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.996 -1.112 . . . . 0.0 107.996 173.271 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 -96.29 7.42 46.5 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 115.531 1.678 . . . . 0.0 115.531 169.279 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 83.0 mm-40 56.73 70.31 0.66 Allowed 'General case' 0 N--CA 1.495 1.821 0 C-N-CA 125.196 1.399 . . . . 0.0 111.945 -169.501 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 5.0 mp -85.68 116.68 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 -169.455 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -118.64 137.87 52.99 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-N 115.125 -0.943 . . . . 0.0 108.965 -174.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 11.1 mp -83.92 115.84 22.49 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 -168.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -122.97 150.62 42.75 Favored 'General case' 0 CA--C 1.563 1.457 0 C-N-CA 125.437 1.495 . . . . 0.0 109.322 179.425 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -74.28 156.5 37.12 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.737 -1.227 . . . . 0.0 113.23 178.225 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.1 pp -72.82 164.51 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 -171.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 . . . . . 0 N--CA 1.485 1.281 0 CA-C-O 123.953 1.835 . . . . 0.0 108.394 179.029 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.358 0 N-CA-C 111.299 -0.72 . . . . 0.0 111.299 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 32.4 t -82.04 112.19 18.88 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 122.983 0.513 . . . . 0.0 109.849 178.087 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 1.2 p90 -136.86 -34.33 0.75 Allowed 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 116.167 1.914 . . . . 0.0 116.167 -169.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -80.82 117.82 21.8 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-N 121.466 1.939 . . . . 0.0 109.788 179.409 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -129.76 94.39 3.73 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 104.942 -2.244 . . . . 0.0 104.942 174.66 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -77.49 125.45 7.32 Favored Glycine 0 CA--C 1.54 1.609 0 C-N-CA 123.156 0.408 . . . . 0.0 113.577 -170.481 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.446 ' H ' ' H ' ' A' ' 87' ' ' GLU 0.376 64.5 pttt 52.9 63.48 2.22 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 115.335 1.606 . . . . 0.0 115.335 -175.378 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -107.95 127.21 28.08 Favored Pre-proline 0 CA--C 1.574 1.897 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 -173.617 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -68.88 160.91 47.85 Favored 'Trans proline' 0 CA--C 1.56 1.785 0 C-N-CA 123.156 2.571 . . . . 0.0 115.574 -172.164 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 16.1 ttm180 -73.33 -35.8 66.09 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 117.327 2.343 . . . . 0.0 117.327 -170.024 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.75 -41.6 97.98 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 115.401 1.63 . . . . 0.0 115.401 169.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -68.27 -40.99 81.7 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 114.497 1.295 . . . . 0.0 114.497 169.515 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.71 -41.36 98.12 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 115.271 1.582 . . . . 0.0 115.271 172.817 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -67.13 -44.67 79.27 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 170.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -53.01 -38.88 62.71 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 116.085 1.883 . . . . 0.0 116.085 171.767 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.51 -62.63 1.56 Allowed 'General case' 0 CA--C 1.566 1.568 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 169.915 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.1 mp -70.0 -50.71 38.82 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 117.411 2.374 . . . . 0.0 117.411 -168.674 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 60.2 p -60.3 -34.26 73.52 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 115.921 1.823 . . . . 0.0 115.921 174.631 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -72.63 -30.54 64.41 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 115.644 1.72 . . . . 0.0 115.644 170.58 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -50.72 133.23 26.14 Favored 'General case' 0 CA--C 1.556 1.19 0 N-CA-C 114.977 1.473 . . . . 0.0 114.977 176.681 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.12 -23.49 62.17 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 118.613 2.82 . . . . 0.0 118.613 174.159 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 42.9 m80 -89.43 131.51 35.45 Favored 'General case' 0 N--CA 1.484 1.225 0 CA-C-N 119.23 0.923 . . . . 0.0 110.667 -169.871 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -80.99 102.22 10.03 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 174.712 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 124.02 4.86 7.7 Favored Glycine 0 CA--C 1.552 2.405 0 CA-C-O 116.652 -2.193 . . . . 0.0 115.991 -168.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.02 116.26 6.95 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-N 121.682 2.741 . . . . 0.0 112.913 -169.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -129.8 161.41 30.8 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 118.135 2.643 . . . . 0.0 118.135 -168.046 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.8 pp -144.09 154.11 42.86 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 114.126 -1.397 . . . . 0.0 109.422 168.666 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.0 mp -112.67 124.05 68.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 178.085 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -90.36 167.49 12.61 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 124.477 1.111 . . . . 0.0 112.199 174.781 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.446 ' H ' ' H ' ' A' ' 64' ' ' LYS . 35.7 tt0 -129.15 116.11 18.71 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 106.139 -1.801 . . . . 0.0 106.139 169.183 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 64.7 m -76.85 134.73 38.94 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -170.295 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -74.62 -56.51 4.74 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-N 115.415 -0.811 . . . . 0.0 112.999 178.125 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.5 t -61.43 -39.56 91.23 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 116.068 1.877 . . . . 0.0 116.068 177.431 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -102.92 99.76 14.82 Favored Pre-proline 0 CA--C 1.565 1.523 0 CA-C-O 117.83 -1.081 . . . . 0.0 108.647 170.359 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -75.22 126.95 10.16 Favored 'Trans proline' 0 C--N 1.371 1.712 0 C-N-CA 123.016 2.477 . . . . 0.0 112.545 -175.152 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 82.2 6.62 88.63 Favored Glycine 0 CA--C 1.555 2.57 0 N-CA-C 118.189 2.036 . . . . 0.0 118.189 -169.683 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -98.12 116.54 30.56 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-N 119.813 1.806 . . . . 0.0 107.302 171.706 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -99.0 151.25 21.13 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.787 -0.819 . . . . 0.0 108.787 -178.178 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 43.2 m -132.93 112.4 11.84 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.505 -0.747 . . . . 0.0 110.175 -175.244 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 26.4 tp -79.3 105.77 10.85 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-O 121.967 0.889 . . . . 0.0 108.979 174.336 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 15.4 m -89.44 93.6 9.57 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 173.028 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.9 p -112.08 125.95 69.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 -174.342 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -77.16 129.15 35.59 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 114.813 -1.085 . . . . 0.0 111.049 173.153 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -137.75 114.65 10.68 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 87.22 -92.37 1.8 Allowed Glycine 0 N--CA 1.481 1.687 0 N-CA-C 112.056 -0.418 . . . . 0.0 112.056 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 10.8 p-10 -130.44 -22.48 2.74 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 115.434 1.642 . . . . 0.0 115.434 169.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -108.49 146.34 33.34 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 124.484 1.114 . . . . 0.0 110.251 -173.119 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 9.7 p -84.76 123.63 39.28 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.537 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.101 179.586 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -109.86 122.68 48.09 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 124.093 0.957 . . . . 0.0 108.901 -178.571 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 12.0 m-70 -103.73 96.37 6.66 Favored 'General case' 0 CA--C 1.555 1.14 0 CA-C-O 121.804 0.812 . . . . 0.0 108.864 -169.416 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -92.31 141.64 28.34 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 124.431 1.092 . . . . 0.0 110.233 -177.549 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -96.05 114.73 26.47 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.429 0.633 . . . . 0.0 110.369 -176.542 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 81.5 t -84.07 124.29 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 174.587 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 55.0 mt -102.12 136.13 42.49 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.014 -176.405 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 36.4 mtm180 -108.89 129.87 55.42 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 122.715 0.406 . . . . 0.0 110.368 176.41 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -97.31 103.32 15.24 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 123.165 0.586 . . . . 0.0 110.555 176.674 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 90.3 -110.7 3.81 Favored Glycine 0 N--CA 1.481 1.661 0 CA-C-O 120.072 -0.293 . . . . 0.0 113.325 174.491 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -79.95 -69.49 0.58 Allowed 'General case' 0 N--CA 1.487 1.419 0 CA-C-O 118.762 -0.637 . . . . 0.0 112.53 -176.127 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -159.05 75.03 0.21 Allowed Glycine 0 N--CA 1.477 1.424 0 CA-C-N 118.661 0.664 . . . . 0.0 111.581 171.203 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -117.63 91.37 3.55 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 -173.698 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -79.53 115.0 18.89 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 123.82 0.848 . . . . 0.0 111.686 -168.797 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -131.23 130.62 43.15 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.595 0.758 . . . . 0.0 109.041 177.838 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 41.8 tp -95.25 -54.76 3.3 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 118.548 -0.739 . . . . 0.0 110.38 169.113 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 45.2 m0 -74.7 -86.68 0.04 OUTLIER 'General case' 0 CA--C 1.565 1.553 0 CA-C-N 119.359 0.981 . . . . 0.0 110.537 173.388 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 10.0 m -145.06 -47.53 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 C-N-CA 124.56 1.144 . . . . 0.0 111.107 -175.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 14.0 p -79.54 130.85 35.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 CA-C-N 119.217 0.917 . . . . 0.0 110.212 -175.723 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.21 161.04 15.9 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-O 122.605 1.193 . . . . 0.0 114.205 -170.615 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -148.31 114.34 5.8 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 105.021 -2.215 . . . . 0.0 105.021 -170.629 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -57.84 -24.38 57.16 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 119.198 3.036 . . . . 0.0 119.198 -169.449 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 78.8 p -125.93 165.51 18.62 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-N 120.543 1.52 . . . . 0.0 113.096 179.506 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 33.0 mt -52.04 -47.69 64.93 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 115.23 1.567 . . . . 0.0 115.23 169.608 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 18.7 m-80 -63.12 -43.69 97.73 Favored 'General case' 0 CA--C 1.564 1.516 0 N-CA-C 114.071 1.137 . . . . 0.0 114.071 174.048 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -58.94 -50.81 72.66 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 115.388 1.625 . . . . 0.0 115.388 177.819 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 58.4 tp -61.32 -49.04 78.59 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-N 120.019 1.281 . . . . 0.0 114.237 174.566 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . 0.311 1.6 p -69.96 -37.5 72.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 -178.125 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -61.55 -34.55 75.76 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-N 119.976 1.262 . . . . 0.0 113.597 168.73 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 45.8 t80 -58.13 -54.07 51.07 Favored 'General case' 0 CA--C 1.569 1.673 0 CA-C-O 117.546 -1.216 . . . . 0.0 111.984 167.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . 0.347 21.9 m-70 -71.66 -8.99 57.54 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 118.69 2.848 . . . . 0.0 118.69 173.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 55.1 mtp85 -75.94 -22.06 56.37 Favored 'General case' 0 CA--C 1.576 1.958 0 CA-C-N 119.876 1.217 . . . . 0.0 112.926 167.299 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 70.6 m -100.73 -46.31 5.2 Favored 'General case' 0 CA--C 1.565 1.554 0 C-N-CA 125.005 1.322 . . . . 0.0 112.962 169.561 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 91.3 m -86.21 154.32 21.38 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 124.948 1.299 . . . . 0.0 110.121 173.579 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 27.4 t -80.48 148.02 30.64 Favored 'General case' 0 N--CA 1.483 1.203 0 O-C-N 121.131 -0.981 . . . . 0.0 113.238 177.376 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 77.1 t -75.17 -54.02 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 168.636 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 34.2 t -87.77 104.05 16.2 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-N 118.909 0.777 . . . . 0.0 109.071 174.29 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . 0.273 0.2 OUTLIER -59.95 -40.39 88.85 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 117.711 2.486 . . . . 0.0 117.711 -175.722 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -72.1 -63.5 1.13 Allowed 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 177.328 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -94.09 104.24 16.28 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 172.2 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 -77.45 115.28 17.09 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 -168.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -120.82 133.45 67.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 179.278 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -119.15 153.47 34.83 Favored 'General case' 0 N--CA 1.497 1.875 0 CA-C-O 121.88 0.848 . . . . 0.0 111.337 -170.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 9.5 mp -88.05 143.66 26.95 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 -169.744 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 29.1 mmm180 -132.87 142.91 49.18 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 124.929 1.292 . . . . 0.0 109.175 -179.629 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -76.1 143.37 41.31 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.379 -0.826 . . . . 0.0 111.285 176.298 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 25.0 pt -62.82 146.32 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 -176.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 . . . . . 0 N--CA 1.484 1.261 0 CA-C-O 123.91 1.814 . . . . 0.0 109.435 175.799 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.31 0 N-CA-C 111.632 -0.587 . . . . 0.0 111.632 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 26.3 t -89.34 95.28 10.22 Favored 'General case' 0 N--CA 1.486 1.331 0 CA-C-O 121.476 0.655 . . . . 0.0 110.605 -174.493 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 1.6 p90 -144.75 -46.9 0.24 Allowed 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.79 0.836 . . . . 0.0 111.976 -177.047 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -82.09 124.76 30.12 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-N 119.931 1.241 . . . . 0.0 110.101 -179.688 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -128.59 75.14 1.61 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 123.473 0.483 . . . . 0.0 110.253 -175.667 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 59.05 -114.58 6.26 Favored Glycine 0 N--CA 1.485 1.937 0 C-N-CA 123.873 0.749 . . . . 0.0 114.817 173.841 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -144.99 111.45 5.69 Favored 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 169.157 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 43.2 pt -122.99 152.2 62.6 Favored Pre-proline 0 CA--C 1.572 1.821 0 CA-C-O 118.525 -0.75 . . . . 0.0 110.476 -179.18 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -58.78 165.56 7.98 Favored 'Trans proline' 0 CA--C 1.56 1.777 0 C-N-CA 123.4 2.733 . . . . 0.0 116.745 171.367 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 25.7 ttm180 -62.92 -40.67 98.32 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 114.898 1.444 . . . . 0.0 114.898 169.679 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -62.56 -41.14 98.72 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 115.728 1.751 . . . . 0.0 115.728 170.783 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 3.1 tppp? -64.79 -37.63 88.25 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 115.201 1.556 . . . . 0.0 115.201 169.739 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.91 -41.68 91.12 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 115.682 1.734 . . . . 0.0 115.682 171.607 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -64.65 -38.78 92.16 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 114.816 1.413 . . . . 0.0 114.816 169.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -60.57 -52.83 63.49 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 114.509 1.3 . . . . 0.0 114.509 172.631 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 40.4 tpp -61.11 -44.07 97.92 Favored 'General case' 0 CA--C 1.564 1.492 0 N-CA-C 115.793 1.775 . . . . 0.0 115.793 175.386 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 92.6 mt -72.6 -20.72 61.24 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 116.616 2.08 . . . . 0.0 116.616 172.434 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 22.9 t -60.24 -37.6 80.88 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-N 121.079 1.763 . . . . 0.0 113.497 168.512 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -59.42 -37.17 77.36 Favored 'General case' 0 CA--C 1.57 1.737 0 N-CA-C 114.525 1.306 . . . . 0.0 114.525 168.7 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -69.12 114.36 7.32 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 124.322 1.049 . . . . 0.0 110.855 170.62 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 -76.24 -13.44 60.17 Favored 'General case' 0 CA--C 1.569 1.708 0 N-CA-C 117.816 2.524 . . . . 0.0 117.816 173.326 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 46.3 m80 -89.72 143.82 26.49 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 -168.402 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -71.79 130.84 42.07 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-N 114.448 -1.251 . . . . 0.0 110.818 170.44 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.92 -18.62 46.57 Favored Glycine 0 CA--C 1.552 2.377 0 N-CA-C 118.239 2.055 . . . . 0.0 118.239 -172.454 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.13 119.38 10.73 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-N 120.399 2.1 . . . . 0.0 112.345 -176.227 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 22.2 p90 -128.56 157.51 41.03 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 114.815 1.413 . . . . 0.0 114.815 -168.678 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.8 pp -138.05 139.33 39.51 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 168.239 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 70.3 mt -98.16 117.86 43.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 106.316 -1.735 . . . . 0.0 106.316 177.267 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 3.0 ptm180 -97.94 149.2 22.67 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.319 0.648 . . . . 0.0 111.481 170.547 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -96.35 137.86 34.8 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 168.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 67.4 m -69.9 138.92 52.86 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-O 121.637 0.732 . . . . 0.0 112.694 -176.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -70.69 -53.71 14.63 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 -174.075 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.0 t -62.99 -37.33 86.73 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 115.916 1.821 . . . . 0.0 115.916 172.794 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -121.01 92.9 48.75 Favored Pre-proline 0 CA--C 1.562 1.441 0 CA-C-N 119.635 1.107 . . . . 0.0 110.102 175.792 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -62.59 132.53 38.31 Favored 'Trans proline' 0 C--N 1.371 1.742 0 C-N-CA 123.361 2.707 . . . . 0.0 113.25 170.02 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 105.0 -33.73 6.34 Favored Glycine 0 CA--C 1.551 2.302 0 CA-C-O 118.697 -1.057 . . . . 0.0 114.543 -168.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -79.68 108.51 13.28 Favored 'General case' 0 N--CA 1.486 1.348 0 CA-C-N 119.427 1.614 . . . . 0.0 108.484 174.398 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 5.0 m-30 -93.93 158.65 15.54 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 121.716 0.77 . . . . 0.0 110.451 -174.826 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 74.6 m -139.81 115.48 10.1 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 176.583 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 36.4 tp -81.19 107.35 13.91 Favored 'General case' 0 CA--C 1.561 1.368 0 C-N-CA 124.907 1.283 . . . . 0.0 109.687 179.015 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.8 m -95.5 105.53 17.51 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 -174.376 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 31.9 t -117.57 123.67 72.04 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.171 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 -171.617 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 12.9 tmtt? -89.24 89.37 7.89 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 123.088 0.555 . . . . 0.0 110.203 178.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -105.49 108.22 19.62 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -177.297 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 86.95 -98.75 2.39 Favored Glycine 0 N--CA 1.479 1.556 0 N-CA-C 111.435 -0.666 . . . . 0.0 111.435 177.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 12.4 p30 -138.44 44.1 2.12 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 123.178 0.591 . . . . 0.0 112.384 169.687 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -152.84 134.62 14.63 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 -177.53 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 57.3 t -95.23 109.85 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 106.298 -1.741 . . . . 0.0 106.298 177.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 60.6 mt-30 -109.11 114.83 28.89 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-O 121.909 0.861 . . . . 0.0 109.306 -169.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 29.0 m80 -94.15 119.64 33.26 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 114.636 -1.166 . . . . 0.0 109.168 -172.82 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -118.03 119.33 34.47 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 -174.296 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -75.5 108.31 8.23 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 -169.524 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 86.6 t -84.04 117.56 29.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 -178.032 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 54.5 mt -100.78 137.82 38.66 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.139 -174.318 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 56.4 mtp180 -109.72 126.37 53.65 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 -179.522 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . 0.262 3.0 p30 -79.91 -56.94 3.9 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 114.463 1.283 . . . . 0.0 114.463 -179.031 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 179.16 137.86 3.06 Favored Glycine 0 CA--C 1.54 1.632 0 CA-C-N 119.607 1.094 . . . . 0.0 112.759 -176.49 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . 0.347 . . 80.6 -77.89 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 124.98 1.312 . . . . 0.0 112.497 -178.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -165.96 72.79 0.17 Allowed Glycine 0 N--CA 1.478 1.483 0 N-CA-C 111.696 -0.562 . . . . 0.0 111.696 171.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -126.47 162.22 26.11 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 124.169 0.988 . . . . 0.0 109.93 -178.432 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -143.99 114.97 7.84 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 -176.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -124.98 123.19 39.35 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 175.758 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -110.33 -58.79 2.03 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 123.77 0.828 . . . . 0.0 110.621 173.756 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 8.4 t90 -98.66 -62.97 1.17 Allowed 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 124.076 0.95 . . . . 0.0 112.893 -168.705 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 30.7 m -129.66 -56.38 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 CA-C-N 119.085 0.857 . . . . 0.0 112.41 -175.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 9.9 p -118.93 161.29 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 CA-C-O 122.278 1.037 . . . . 0.0 111.485 -169.541 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.52 153.04 29.84 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-O 122.025 0.917 . . . . 0.0 113.121 175.839 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -142.88 120.69 11.93 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 -175.22 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -59.45 -59.74 4.96 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -175.712 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 83.6 p -89.58 155.56 19.18 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-O 122.542 1.163 . . . . 0.0 112.378 175.372 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 10.3 tp -63.01 -33.0 74.49 Favored 'General case' 0 CA--C 1.568 1.661 0 N-CA-C 115.019 1.489 . . . . 0.0 115.019 170.05 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -63.35 -36.77 84.81 Favored 'General case' 0 CA--C 1.569 1.705 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 169.053 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.13 -42.1 94.17 Favored 'General case' 0 N--CA 1.497 1.875 0 CA-C-N 120.622 1.555 . . . . 0.0 114.17 169.758 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 16.8 tp -57.13 -46.89 82.31 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 169.101 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 45.4 t -59.17 -58.2 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 C-N-CA 124.385 1.074 . . . . 0.0 112.878 173.159 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -60.74 -32.11 71.4 Favored 'General case' 0 CA--C 1.567 1.632 0 N-CA-C 115.655 1.724 . . . . 0.0 115.655 -175.076 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -60.68 -57.8 11.18 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-N 119.665 1.12 . . . . 0.0 112.877 169.381 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 81.8 m-70 -72.85 -8.91 57.77 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 117.891 2.552 . . . . 0.0 117.891 176.688 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 50.5 ttm-85 -58.59 -31.71 68.29 Favored 'General case' 0 CA--C 1.576 1.95 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 168.046 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 69.6 m -104.16 -36.15 7.78 Favored 'General case' 0 CA--C 1.567 1.619 0 C-N-CA 124.978 1.311 . . . . 0.0 113.619 169.123 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 87.1 m -90.12 150.84 21.87 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-N 119.912 1.233 . . . . 0.0 110.826 -178.782 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 21.6 t -72.39 123.75 23.72 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.197 -0.939 . . . . 0.0 111.734 175.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.9 p -70.27 -27.78 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 N-CA-C 115.868 1.803 . . . . 0.0 115.868 175.293 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 66.3 m -135.25 136.88 42.03 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-N 119.562 1.073 . . . . 0.0 109.082 173.433 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? -80.13 93.97 5.91 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.815 0.816 . . . . 0.0 110.637 -178.413 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . 0.252 13.2 p-10 -165.9 -65.78 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 124.663 1.185 . . . . 0.0 108.044 -178.685 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -113.7 -139.03 0.38 Allowed 'General case' 0 CA--C 1.567 1.625 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 172.186 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.21 77.83 1.79 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.307 -0.871 . . . . 0.0 109.146 175.838 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 3.7 mp -86.7 108.48 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 -170.619 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 19.6 m-30 -114.72 138.4 50.77 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-N 115.331 -0.849 . . . . 0.0 109.523 -172.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 10.7 mp -85.27 108.11 17.62 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.276 -171.075 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 93.5 mtt180 -123.37 168.07 12.99 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 122.369 1.08 . . . . 0.0 109.485 -175.115 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -81.79 158.75 24.0 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 115.11 1.522 . . . . 0.0 115.11 -170.049 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 36.1 pt -81.29 162.04 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 CA-C-N 114.727 -1.124 . . . . 0.0 112.883 -179.207 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 . . . . . 0 N--CA 1.485 1.311 0 CA-C-O 122.776 1.274 . . . . 0.0 109.328 -176.765 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 1.807 0 CA-C-O 121.371 0.428 . . . . 0.0 113.323 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . 0.274 92.5 p 54.42 86.75 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 115.733 1.753 . . . . 0.0 115.733 175.856 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . 0.253 66.6 p-90 -78.27 -48.8 14.93 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 115.544 1.683 . . . . 0.0 115.544 -178.532 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -85.78 135.65 33.65 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-N 119.255 0.934 . . . . 0.0 111.403 -173.408 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -111.68 -88.0 0.53 Allowed 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 175.486 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 158.12 -150.1 20.77 Favored Glycine 0 N--CA 1.483 1.816 0 CA-C-N 119.634 1.106 . . . . 0.0 112.735 -179.163 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -83.14 89.57 6.96 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 121.566 0.698 . . . . 0.0 111.217 -178.431 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -124.42 146.62 52.71 Favored Pre-proline 0 CA--C 1.573 1.852 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 169.365 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -50.69 164.79 0.5 Allowed 'Trans proline' 0 C--N 1.37 1.681 0 C-N-CA 123.411 2.74 . . . . 0.0 117.717 175.03 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 60.1 ttt180 -59.06 -41.95 89.17 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 169.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -65.28 -45.45 84.41 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 115.193 1.553 . . . . 0.0 115.193 173.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 48.2 mmtm -61.92 -37.09 83.36 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 115.646 1.721 . . . . 0.0 115.646 171.377 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.87 -44.85 91.86 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 115.31 1.596 . . . . 0.0 115.31 169.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -61.34 -40.08 92.93 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 115.351 1.611 . . . . 0.0 115.351 170.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -61.54 -46.24 90.76 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 173.532 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 37.3 mmt -60.12 -46.57 89.17 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 114.898 1.444 . . . . 0.0 114.898 172.211 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 96.7 mt -72.59 -32.38 65.94 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 115.989 1.848 . . . . 0.0 115.989 177.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 21.1 t -56.02 -35.33 66.72 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 115.662 1.727 . . . . 0.0 115.662 169.431 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -60.15 -39.47 86.46 Favored 'General case' 0 CA--C 1.568 1.662 0 N-CA-C 115.215 1.561 . . . . 0.0 115.215 169.301 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -67.88 134.68 51.26 Favored 'General case' 0 CA--C 1.556 1.174 0 CA-C-O 123.5 1.619 . . . . 0.0 113.404 -177.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.43 -10.2 59.34 Favored 'General case' 0 CA--C 1.567 1.597 0 N-CA-C 119.12 3.007 . . . . 0.0 119.12 176.421 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 6.9 m80 -89.62 137.51 32.27 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-N 120.149 1.34 . . . . 0.0 110.836 -169.002 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -80.39 103.54 10.32 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 173.2 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 110.59 11.41 19.5 Favored Glycine 0 CA--C 1.551 2.321 0 CA-C-O 117.56 -1.689 . . . . 0.0 115.758 -168.074 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.66 120.09 14.89 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-N 120.64 2.22 . . . . 0.0 110.244 -175.339 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 14.6 p90 -132.82 157.32 45.29 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 -169.044 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.3 pp -140.8 125.58 18.08 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 168.662 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 84.6 mt -83.78 108.84 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 170.621 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 48.2 ptt85 -89.88 156.89 18.16 Favored 'General case' 0 CA--C 1.557 1.215 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.192 171.134 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -88.86 134.03 34.08 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 169.483 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 50.5 m -65.85 132.47 48.74 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 123.107 0.563 . . . . 0.0 111.133 -178.821 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -55.54 -55.01 36.87 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 116.903 2.186 . . . . 0.0 116.903 -168.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.3 t -72.39 -45.81 58.08 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 174.367 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -108.77 108.67 60.96 Favored Pre-proline 0 CA--C 1.562 1.422 0 CA-C-O 117.652 -1.166 . . . . 0.0 110.559 -174.161 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -69.48 -32.24 20.13 Favored 'Trans proline' 0 C--N 1.369 1.609 0 N-CA-C 118.724 2.548 . . . . 0.0 118.724 178.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -65.58 -19.21 66.71 Favored Glycine 0 CA--C 1.559 2.832 0 N-CA-C 117.023 1.569 . . . . 0.0 117.023 168.576 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -92.16 138.05 31.86 Favored 'General case' 0 N--CA 1.484 1.27 0 CA-C-N 118.337 1.068 . . . . 0.0 108.696 169.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -123.38 170.03 10.74 Favored 'General case' 0 CA--C 1.563 1.472 0 C-N-CA 124.23 1.012 . . . . 0.0 108.907 179.463 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 73.1 m -143.01 119.79 11.2 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.096 -1.002 . . . . 0.0 108.43 -179.299 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 43.7 tp -79.88 105.66 11.32 Favored 'General case' 0 N--CA 1.486 1.347 0 CA-C-O 121.844 0.831 . . . . 0.0 109.331 171.176 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.8 m -91.35 109.65 20.93 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 173.75 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.7 p -137.69 137.49 45.27 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 CA-C-N 119.148 0.885 . . . . 0.0 108.778 -169.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -72.88 118.86 16.34 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.009 0.433 . . . . 0.0 110.996 171.572 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 4.4 m-30 -107.71 97.69 7.39 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 169.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 81.94 -98.76 1.96 Allowed Glycine 0 CA--C 1.541 1.677 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 -169.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 70.1 m-80 -126.89 -17.6 4.88 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 115.01 1.485 . . . . 0.0 115.01 169.709 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -85.73 137.88 32.5 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 119.643 1.11 . . . . 0.0 110.081 177.863 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 64.9 t -89.28 106.43 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 -175.082 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -101.06 124.84 47.39 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-O 121.881 0.848 . . . . 0.0 109.231 -179.445 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 11.9 m-70 -97.73 131.31 44.38 Favored 'General case' 0 CA--C 1.555 1.159 0 CA-C-N 114.819 -1.082 . . . . 0.0 109.153 -175.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -128.18 125.01 38.2 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 -175.623 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -80.88 117.49 21.57 Favored 'General case' 0 N--CA 1.485 1.302 0 CA-C-O 121.596 0.712 . . . . 0.0 110.903 -170.186 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 73.1 t -85.42 102.77 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 171.764 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.4 pp -121.91 144.13 49.04 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 123.116 0.567 . . . . 0.0 111.346 -174.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -89.65 155.82 18.98 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 114.009 1.115 . . . . 0.0 114.009 -170.399 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -104.41 -64.3 1.13 Allowed 'General case' 0 N--CA 1.494 1.748 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.951 169.479 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -97.21 -121.17 4.12 Favored Glycine 0 CA--C 1.542 1.734 0 CA-C-N 119.406 1.003 . . . . 0.0 112.883 -176.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -76.2 -65.24 0.94 Allowed 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 118.786 -0.626 . . . . 0.0 112.337 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -136.08 57.99 0.67 Allowed Glycine 0 CA--C 1.542 1.78 0 CA-C-O 119.559 -0.578 . . . . 0.0 111.928 169.31 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -106.36 88.85 2.88 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 106.978 -1.489 . . . . 0.0 106.978 -174.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -81.03 122.47 27.35 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 114.852 -1.067 . . . . 0.0 111.1 -169.521 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 21.3 p90 -137.57 124.17 20.96 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 120.941 0.4 . . . . 0.0 110.044 179.259 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -106.84 -47.78 3.65 Favored 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 123.887 0.875 . . . . 0.0 112.155 169.355 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 32.2 t90 -89.92 -68.81 0.76 Allowed 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 124.834 1.254 . . . . 0.0 110.91 -171.066 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . 0.264 13.0 p -147.6 -66.89 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 C-N-CA 123.499 0.72 . . . . 0.0 109.704 174.446 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 10.8 p -79.9 138.82 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 C-N-CA 123.941 0.896 . . . . 0.0 111.455 -171.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -83.77 158.86 21.59 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 113.715 1.005 . . . . 0.0 113.715 -178.211 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -140.46 123.13 16.26 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 -171.48 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 16.9 p30 -57.84 -34.44 69.7 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 117.549 2.425 . . . . 0.0 117.549 176.345 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 74.2 m -120.88 144.92 48.15 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 119.256 0.935 . . . . 0.0 111.678 -176.744 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 14.1 tp -86.53 94.27 9.39 Favored 'General case' 0 CA--C 1.563 1.46 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 169.224 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 12.0 t30 158.19 -60.78 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 103.295 -2.854 . . . . 0.0 103.295 -168.595 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -54.16 -44.6 71.59 Favored 'General case' 0 CA--C 1.574 1.877 0 C-N-CA 124.699 1.2 . . . . 0.0 114.194 168.347 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 10.2 tt -53.93 -53.83 47.28 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 115.763 1.764 . . . . 0.0 115.763 170.049 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.2 p -68.32 -50.13 60.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 -177.803 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -56.31 -32.86 65.03 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 115.516 1.673 . . . . 0.0 115.516 172.41 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -58.36 -53.64 55.99 Favored 'General case' 0 CA--C 1.566 1.582 0 CA-C-N 119.608 1.094 . . . . 0.0 111.85 168.264 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . 0.315 40.8 m-70 -71.42 -9.54 58.34 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 118.196 2.665 . . . . 0.0 118.196 176.762 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.62 -32.03 73.38 Favored 'General case' 0 CA--C 1.581 2.142 0 CA-C-N 121.041 1.746 . . . . 0.0 112.171 166.356 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 70.6 m -95.53 -44.84 7.33 Favored 'General case' 0 CA--C 1.564 1.519 0 C-N-CA 124.604 1.162 . . . . 0.0 114.035 169.773 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 53.8 m -90.2 155.99 18.63 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-N 119.665 1.12 . . . . 0.0 111.04 -178.495 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 22.7 t -86.3 133.55 33.81 Favored 'General case' 0 CA--C 1.557 1.212 0 O-C-N 121.357 -0.84 . . . . 0.0 113.197 -175.585 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 96.4 t -69.17 -36.5 73.31 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 CA-C-O 118.534 -0.746 . . . . 0.0 111.752 169.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 22.7 t -79.2 132.86 36.66 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-N 119.639 1.109 . . . . 0.0 109.584 169.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 32.9 ttt85 -75.0 -50.15 17.51 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 -175.786 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -76.42 -55.67 5.33 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 172.644 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -80.03 158.77 26.41 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 119.028 0.831 . . . . 0.0 112.225 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 -104.04 89.79 3.39 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 4.0 mm -112.96 141.01 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 176.73 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -137.3 155.9 48.9 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-O 121.988 0.899 . . . . 0.0 112.497 -169.171 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 10.0 mp -90.28 124.78 35.17 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 124.046 0.938 . . . . 0.0 112.074 -169.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -118.98 151.73 37.66 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 124.242 1.017 . . . . 0.0 110.091 171.608 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -81.88 149.5 28.25 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 122.136 0.97 . . . . 0.0 112.656 -177.249 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.6 pp -76.01 160.32 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 CA-C-N 114.861 -1.063 . . . . 0.0 113.552 -174.484 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 . . . . . 0 N--CA 1.485 1.294 0 CA-C-O 124.052 1.882 . . . . 0.0 106.332 170.583 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.408 0 N-CA-C 111.591 -0.604 . . . . 0.0 111.591 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 89.4 p -86.73 110.59 20.0 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.131 0.573 . . . . 0.0 111.165 -178.772 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 63.6 p-90 -152.55 -36.97 0.11 Allowed 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 115.3 1.592 . . . . 0.0 115.3 -179.941 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -81.38 136.3 35.71 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-N 120.449 1.477 . . . . 0.0 112.054 -171.68 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -121.61 -74.83 0.6 Allowed 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 174.279 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 91.91 102.46 1.39 Allowed Glycine 0 CA--C 1.542 1.734 0 CA-C-N 119.376 0.989 . . . . 0.0 111.814 -178.236 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 56.9 mmtt 63.52 69.98 0.54 Allowed 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 124.808 1.243 . . . . 0.0 113.394 -177.265 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 10.6 pt -130.1 151.82 79.01 Favored Pre-proline 0 CA--C 1.574 1.886 0 CA-C-O 118.411 -0.804 . . . . 0.0 109.676 169.876 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_exo -56.45 156.42 21.87 Favored 'Trans proline' 0 C--N 1.369 1.655 0 C-N-CA 123.369 2.713 . . . . 0.0 117.348 177.344 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 61.2 ttt180 -67.52 -36.62 81.39 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 169.489 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.77 -39.84 95.24 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 115.261 1.578 . . . . 0.0 115.261 169.651 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -64.06 -35.27 80.2 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 169.159 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.79 -52.45 63.13 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-N 119.472 1.033 . . . . 0.0 113.19 169.415 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -52.92 -37.71 61.08 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 116.348 1.981 . . . . 0.0 116.348 169.537 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -59.32 -48.65 80.83 Favored 'General case' 0 CA--C 1.566 1.574 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 170.696 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -65.45 -60.46 2.93 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 172.597 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.64 -39.44 91.42 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 117.517 2.414 . . . . 0.0 117.517 -172.576 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 56.3 m -60.61 -41.0 93.92 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 115.368 1.618 . . . . 0.0 115.368 178.719 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -68.45 -26.79 65.68 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 117.024 2.231 . . . . 0.0 117.024 169.986 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -60.52 131.1 49.67 Favored 'General case' 0 CA--C 1.556 1.19 0 CA-C-N 120.248 1.385 . . . . 0.0 113.722 176.555 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 38.9 ptt85 -69.59 -20.03 63.65 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 118.65 2.833 . . . . 0.0 118.65 179.054 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 57.8 m80 -89.51 135.58 33.52 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 119.213 0.915 . . . . 0.0 111.922 -169.141 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -77.59 103.03 7.28 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 169.731 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 124.23 -0.14 8.87 Favored Glycine 0 CA--C 1.555 2.543 0 CA-C-O 117.163 -1.91 . . . . 0.0 115.768 -168.456 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.57 113.19 4.57 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 121.158 2.479 . . . . 0.0 112.173 -169.929 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 17.8 p90 -128.11 155.79 43.86 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 116.334 1.976 . . . . 0.0 116.334 -168.713 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.1 pp -148.75 133.57 17.97 Favored 'General case' 0 N--CA 1.485 1.28 0 CA-C-N 114.33 -1.305 . . . . 0.0 108.454 169.031 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 91.8 mt -91.38 110.59 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 175.897 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 3.5 ptm180 -100.98 140.18 35.64 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 114.614 -1.175 . . . . 0.0 109.329 169.98 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.54 126.57 31.05 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.704 -0.622 . . . . 0.0 109.527 177.72 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 20.5 t -63.25 125.93 25.74 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -170.201 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -63.98 -48.58 75.85 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 175.815 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 95.8 p -59.3 -39.41 82.93 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 116.75 2.13 . . . . 0.0 116.75 171.873 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -115.84 97.7 49.59 Favored Pre-proline 0 CA--C 1.563 1.46 0 CA-C-O 117.967 -1.016 . . . . 0.0 108.997 178.748 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -72.57 135.04 23.36 Favored 'Trans proline' 0 C--N 1.372 1.787 0 C-N-CA 123.157 2.571 . . . . 0.0 112.606 -178.985 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 92.05 -39.36 3.03 Favored Glycine 0 CA--C 1.556 2.622 0 CA-C-N 115.555 -0.748 . . . . 0.0 114.415 -168.595 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -79.76 146.17 32.47 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 124.275 1.03 . . . . 0.0 110.883 175.624 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -106.85 174.16 6.01 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 122.124 0.964 . . . . 0.0 111.859 -171.697 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 57.9 m -146.61 115.81 7.0 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 177.325 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 42.6 tp -79.7 115.42 19.3 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 171.049 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 20.7 m -97.98 83.77 3.19 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 175.998 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.3 p -107.4 119.74 57.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 -171.861 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 15.1 tmtt? -81.37 149.2 28.97 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.768 174.739 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -156.99 107.35 2.29 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 169.948 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 71.38 76.14 0.6 Allowed Glycine 0 N--CA 1.483 1.776 0 N-CA-C 115.186 0.834 . . . . 0.0 115.186 173.097 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . 0.348 15.0 m120 77.06 -38.7 0.31 Allowed 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 118.179 2.659 . . . . 0.0 118.179 -179.898 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -121.43 145.27 48.09 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 124.091 0.956 . . . . 0.0 110.944 -169.688 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 5.3 p -83.02 139.0 18.4 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.54 0 CA-C-N 115.373 -0.831 . . . . 0.0 111.864 178.262 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -125.27 111.53 15.32 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-O 122.103 0.954 . . . . 0.0 108.529 -176.94 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 8.0 m-70 -99.55 128.81 45.67 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-N 114.776 -1.102 . . . . 0.0 109.358 -172.268 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -133.46 133.08 41.82 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 -175.096 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 64.2 pttt -77.74 125.86 29.99 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-O 121.507 0.67 . . . . 0.0 112.05 -179.117 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 80.7 t -94.61 108.22 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 106.287 -1.746 . . . . 0.0 106.287 179.237 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 66.0 mt -95.97 149.99 20.96 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.276 -173.368 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 82.8 mtm180 -109.51 135.95 49.68 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 122.983 0.513 . . . . 0.0 110.304 -177.79 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -108.1 110.19 21.81 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 170.635 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 89.26 -113.58 4.16 Favored Glycine 0 CA--C 1.541 1.683 0 CA-C-N 116.372 -0.376 . . . . 0.0 112.343 -178.763 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -86.4 -68.99 0.7 Allowed 'General case' 0 N--CA 1.488 1.452 0 CA-C-O 118.739 -0.648 . . . . 0.0 111.687 178.792 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -156.39 70.25 0.27 Allowed Glycine 0 N--CA 1.478 1.473 0 CA-C-N 118.602 0.637 . . . . 0.0 112.33 172.58 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -103.88 99.82 9.6 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 105.089 -2.189 . . . . 0.0 105.089 171.702 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -81.19 108.25 14.67 Favored 'General case' 0 N--CA 1.484 1.255 0 CA-C-N 114.741 -1.118 . . . . 0.0 111.756 -168.58 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 33.5 p90 -117.47 121.66 41.63 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 178.788 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 4.7 tt -101.7 -63.07 1.18 Allowed 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 123.429 0.691 . . . . 0.0 109.176 170.648 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 26.9 t90 -82.43 -64.98 1.07 Allowed 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 124.337 1.055 . . . . 0.0 112.17 -169.941 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . 0.276 13.1 p -146.17 -70.33 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 CA-C-N 118.791 0.723 . . . . 0.0 109.427 177.533 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 9.4 p -79.91 143.95 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 C-N-CA 123.879 0.872 . . . . 0.0 111.621 -174.078 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.37 155.52 22.28 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -176.184 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -141.7 114.75 8.67 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 -173.764 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 23.1 t30 -54.1 -41.08 67.88 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 116.696 2.109 . . . . 0.0 116.696 -175.998 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 95.3 p -107.29 155.27 20.14 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-O 122.649 1.214 . . . . 0.0 111.904 170.612 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 60.3 mt -64.31 -29.2 70.29 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 115.282 1.586 . . . . 0.0 115.282 169.714 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -65.33 -38.73 91.05 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-N 119.682 1.128 . . . . 0.0 113.555 169.927 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -61.63 -45.06 95.68 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 169.393 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 53.1 tp -57.02 -44.14 82.55 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 115.09 1.515 . . . . 0.0 115.09 169.68 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 22.2 t -60.32 -63.26 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 C-N-CA 124.581 1.152 . . . . 0.0 112.405 173.525 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -59.56 -28.67 67.32 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 115.984 1.846 . . . . 0.0 115.984 -176.29 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 88.8 t80 -64.35 -56.07 16.92 Favored 'General case' 0 CA--C 1.566 1.586 0 CA-C-N 119.158 0.89 . . . . 0.0 111.849 168.461 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . 0.264 68.0 m-70 -68.85 -9.08 49.4 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 117.874 2.546 . . . . 0.0 117.874 177.795 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -48.48 -39.7 23.97 Favored 'General case' 0 N--CA 1.502 2.174 0 CA-C-N 120.808 1.64 . . . . 0.0 114.47 167.563 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 68.5 m -109.04 -26.38 10.2 Favored 'General case' 0 CA--C 1.565 1.527 0 N-CA-C 114.885 1.439 . . . . 0.0 114.885 169.857 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 40.2 m -90.27 152.34 21.1 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-N 120.825 1.648 . . . . 0.0 111.031 -179.788 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 29.1 t -74.31 133.24 42.57 Favored 'General case' 0 CA--C 1.559 1.31 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 -179.962 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 39.3 t -74.93 -48.09 34.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 C-N-CA 123.593 0.757 . . . . 0.0 111.583 169.861 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 70.8 m -82.85 159.36 22.42 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-O 121.858 0.837 . . . . 0.0 112.049 178.273 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 3.7 tmm_? -70.37 -61.01 1.94 Allowed 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 118.898 -0.572 . . . . 0.0 111.94 174.881 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -74.37 -56.34 4.97 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 178.787 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 51.6 mt-30 -79.86 145.32 32.79 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 118.713 0.688 . . . . 0.0 112.087 -176.81 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -79.2 122.7 26.61 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 122.958 0.503 . . . . 0.0 110.372 169.854 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 8.3 mm -127.43 102.29 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 105.565 -2.013 . . . . 0.0 105.565 179.264 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 20.8 m-30 -113.19 114.38 26.68 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 -174.398 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 10.8 mp -67.67 131.57 45.84 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 114.794 1.405 . . . . 0.0 114.794 -168.975 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 71.4 mmt-85 -127.24 140.88 51.92 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 176.874 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -75.21 141.46 43.57 Favored 'General case' 0 CA--C 1.565 1.521 0 O-C-N 121.183 -0.948 . . . . 0.0 112.209 -175.348 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 16.4 pt -62.89 146.58 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 N-CA-C 113.968 1.099 . . . . 0.0 113.968 -176.446 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 . . . . . 0 N--CA 1.482 1.142 0 CA-C-O 123.931 1.824 . . . . 0.0 109.344 -176.118 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.31 0 N-CA-C 111.32 -0.712 . . . . 0.0 111.32 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 70.5 m -146.27 112.76 5.92 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -178.882 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . 0.294 51.2 p-90 -80.84 -55.29 4.9 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 113.464 0.913 . . . . 0.0 113.464 170.458 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -94.53 133.56 38.02 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 123.63 0.772 . . . . 0.0 109.47 173.692 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -95.6 -77.17 0.48 Allowed 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 118.665 -0.683 . . . . 0.0 109.466 174.772 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -169.96 -159.07 14.92 Favored Glycine 0 CA--C 1.541 1.677 0 CA-C-N 119.077 0.853 . . . . 0.0 112.955 -179.885 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -94.31 91.85 6.91 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 172.101 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -123.71 149.7 59.82 Favored Pre-proline 0 CA--C 1.573 1.852 0 C-N-CA 123.59 0.756 . . . . 0.0 109.194 178.449 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -69.85 177.53 5.56 Favored 'Trans proline' 0 CA--C 1.565 2.029 0 C-N-CA 122.812 2.341 . . . . 0.0 114.285 175.456 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 59.6 ttt180 -61.07 -42.42 98.46 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 115.791 1.774 . . . . 0.0 115.791 179.334 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -67.23 -41.87 84.94 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 115.717 1.747 . . . . 0.0 115.717 175.526 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -64.76 -36.48 84.45 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 169.764 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.62 -40.38 96.75 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 115.799 1.777 . . . . 0.0 115.799 169.929 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -65.52 -40.83 93.43 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 114.85 1.426 . . . . 0.0 114.85 169.926 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -60.11 -48.38 81.98 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 114.957 1.465 . . . . 0.0 114.957 172.463 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 38.1 mmt -66.71 -47.31 72.76 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 176.539 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 7.1 tp -76.27 -17.94 59.22 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 117.119 2.266 . . . . 0.0 117.119 178.802 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 94.1 p -60.76 -31.32 70.66 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-N 120.616 1.553 . . . . 0.0 114.781 168.634 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -59.82 -39.63 85.74 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 169.073 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -65.04 112.83 3.52 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 124.4 1.08 . . . . 0.0 111.533 169.852 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 13.7 ptp180 -80.12 -15.46 57.07 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 117.941 2.571 . . . . 0.0 117.941 177.632 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 50.0 m80 -89.54 147.88 23.71 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 119.417 1.008 . . . . 0.0 112.367 -168.767 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -77.99 120.9 23.49 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.645 178.993 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 100.07 -21.38 44.89 Favored Glycine 0 CA--C 1.545 1.966 0 CA-C-O 117.168 -1.907 . . . . 0.0 117.119 -169.64 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.36 115.45 4.21 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 120.753 2.277 . . . . 0.0 111.128 -177.728 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 27.1 p90 -126.49 156.49 40.65 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 115.361 1.615 . . . . 0.0 115.361 -168.467 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.0 pp -132.33 125.64 31.4 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 168.382 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 71.8 mt -86.99 119.98 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 173.218 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 48.8 ptt85 -92.05 148.9 21.83 Favored 'General case' 0 CA--C 1.558 1.265 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.499 169.547 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -90.09 122.09 32.75 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 106.425 -1.695 . . . . 0.0 106.425 169.089 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 50.7 m -65.51 113.19 3.99 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.549 0.739 . . . . 0.0 111.95 -174.476 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -90.62 92.37 8.81 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-O 123.814 1.769 . . . . 0.0 108.992 178.854 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 51.7 p 163.73 -40.25 0.0 OUTLIER 'General case' 0 CA--C 1.568 1.672 0 CA-C-N 110.764 -2.925 . . . . 0.0 107.434 -168.209 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -131.87 98.61 17.46 Favored Pre-proline 0 CA--C 1.562 1.415 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 172.129 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -62.11 134.67 50.5 Favored 'Trans proline' 0 C--N 1.372 1.772 0 C-N-CA 123.383 2.722 . . . . 0.0 114.842 178.848 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 90.82 -31.7 5.45 Favored Glycine 0 CA--C 1.553 2.437 0 N-CA-C 116.398 1.319 . . . . 0.0 116.398 -169.373 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -80.63 135.5 36.06 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 118.864 1.332 . . . . 0.0 110.062 175.611 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -108.7 172.0 7.1 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 122.317 1.056 . . . . 0.0 111.127 -173.145 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 50.6 m -146.21 124.03 11.95 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 171.939 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 30.3 tp -80.09 114.42 18.98 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.665 0.786 . . . . 0.0 109.996 172.866 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.6 m -98.66 108.91 21.71 Favored 'General case' 0 CA--C 1.562 1.431 0 N-CA-C 105.336 -2.098 . . . . 0.0 105.336 172.353 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.7 p -127.63 118.67 49.89 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -170.455 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -85.19 97.09 9.71 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.236 0.615 . . . . 0.0 110.013 -179.008 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 17.2 t80 -122.0 124.98 45.26 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 -178.94 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 81.81 -111.47 3.33 Favored Glycine 0 N--CA 1.481 1.644 0 N-CA-C 110.319 -1.112 . . . . 0.0 110.319 -173.538 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -137.16 56.97 1.77 Allowed 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 169.023 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -160.04 135.09 7.94 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 -176.592 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 90.2 t -88.44 105.89 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 172.049 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 62.2 mt-30 -102.59 117.84 35.55 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.736 0.814 . . . . 0.0 109.321 -171.282 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 15.4 m-70 -96.98 113.99 25.57 Favored 'General case' 0 CA--C 1.554 1.121 0 CA-C-N 115.194 -0.912 . . . . 0.0 108.958 -173.518 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -115.2 118.52 33.55 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 177.693 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -80.71 125.77 30.46 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.753 -169.897 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 59.1 t -88.54 103.27 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 106.727 -1.582 . . . . 0.0 106.727 175.913 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -104.11 147.76 27.04 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 121.401 0.619 . . . . 0.0 110.988 -179.811 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -96.47 160.95 14.13 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -176.461 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -133.41 86.91 2.34 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.149 169.648 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 76.87 99.1 0.17 Allowed Glycine 0 N--CA 1.482 1.761 0 CA-C-O 119.197 -0.78 . . . . 0.0 114.513 172.337 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . 0.34 . . 82.09 -77.24 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 124.631 1.172 . . . . 0.0 112.72 -179.974 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -170.55 67.64 0.15 Allowed Glycine 0 N--CA 1.479 1.504 0 CA-C-O 119.662 -0.521 . . . . 0.0 113.214 174.682 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -107.6 94.19 4.95 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 105.863 -1.903 . . . . 0.0 105.863 174.078 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -79.43 126.75 31.24 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 124.204 1.002 . . . . 0.0 110.429 -169.706 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 24.0 p90 -147.92 121.22 8.99 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 -179.229 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -104.46 -42.6 5.41 Favored 'General case' 0 N--CA 1.498 1.926 0 C-N-CA 123.35 0.66 . . . . 0.0 112.508 168.853 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 43.4 t90 -89.98 -85.2 0.22 Allowed 'General case' 0 CA--C 1.56 1.336 0 C-N-CA 124.766 1.226 . . . . 0.0 109.942 -173.536 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 96.4 t -139.16 -66.52 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 -173.537 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 12.2 p -79.74 137.53 21.49 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.551 0 C-N-CA 123.772 0.829 . . . . 0.0 111.333 -175.4 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 60.9 pttt -89.36 162.35 15.84 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 -177.953 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 99.7 m-85 -145.78 120.23 9.68 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 -170.196 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 66.2 m-80 -61.12 -43.85 98.25 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 171.479 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 73.3 m -96.51 138.19 34.47 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-O 121.823 0.821 . . . . 0.0 111.272 174.305 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 13.5 tp -65.82 -31.98 73.25 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 169.661 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -59.69 -41.42 90.69 Favored 'General case' 0 CA--C 1.574 1.887 0 N-CA-C 113.92 1.082 . . . . 0.0 113.92 168.992 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -65.69 -38.32 88.93 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 115.49 1.663 . . . . 0.0 115.49 170.684 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 8.5 tt -57.12 -53.51 57.31 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-N 120.094 1.315 . . . . 0.0 114.404 170.313 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 9.9 p -64.59 -50.5 75.51 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.578 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -178.722 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -61.31 -36.79 81.09 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 115.403 1.631 . . . . 0.0 115.403 175.218 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -59.57 -53.4 58.48 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-N 119.957 1.253 . . . . 0.0 112.095 168.862 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . 0.262 69.7 m-70 -71.36 -9.09 57.6 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 118.15 2.648 . . . . 0.0 118.15 178.274 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 89.9 mtt-85 -58.17 -32.0 67.79 Favored 'General case' 0 CA--C 1.576 1.957 0 CA-C-N 120.375 1.443 . . . . 0.0 113.392 167.127 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 69.2 m -99.26 -42.77 6.87 Favored 'General case' 0 CA--C 1.569 1.678 0 C-N-CA 124.714 1.206 . . . . 0.0 112.927 168.688 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 33.7 m -87.97 155.67 19.72 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-N 119.814 1.188 . . . . 0.0 111.41 -175.373 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 25.3 t -79.56 129.13 34.19 Favored 'General case' 0 CA--C 1.56 1.336 0 O-C-N 121.187 -0.946 . . . . 0.0 113.356 -179.578 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 16.0 m -70.33 -36.85 68.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 N-CA-C 114.998 1.481 . . . . 0.0 114.998 169.748 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 22.9 t -87.25 140.1 29.88 Favored 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 123.658 0.783 . . . . 0.0 110.266 174.51 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 66.2 ttt-85 -73.18 -48.86 31.71 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 177.229 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 24.4 t30 -72.52 -57.89 3.8 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 171.962 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 63.4 mt-30 -79.88 154.4 28.38 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 118.763 0.711 . . . . 0.0 112.247 -177.223 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -94.13 104.0 16.04 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 171.928 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 17.2 mm -123.47 102.28 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 -177.802 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 22.4 m-30 -101.32 133.55 45.75 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 115.043 -0.981 . . . . 0.0 109.544 179.203 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 10.9 mp -89.3 121.44 31.58 Favored 'General case' 0 N--CA 1.486 1.338 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.266 -169.462 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 4.0 mpt_? -119.25 168.41 10.93 Favored 'General case' 0 CA--C 1.561 1.377 0 CA-C-O 123.602 1.667 . . . . 0.0 109.086 175.284 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -83.99 158.21 21.59 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-N 114.708 -1.133 . . . . 0.0 112.763 -174.264 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.1 pp -66.97 162.25 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 N-CA-C 114.565 1.321 . . . . 0.0 114.565 -177.463 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 . . . . . 0 N--CA 1.486 1.33 0 CA-C-O 122.815 1.293 . . . . 0.0 108.901 178.235 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.343 0 N-CA-C 111.664 -0.574 . . . . 0.0 111.664 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 85.5 p -87.37 99.65 12.15 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 121.265 0.555 . . . . 0.0 111.316 -174.607 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 1.2 p90 -157.6 -39.58 0.07 Allowed 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 113.55 0.945 . . . . 0.0 113.55 -174.779 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -80.81 128.39 33.6 Favored 'General case' 0 N--CA 1.484 1.263 0 CA-C-N 119.885 1.221 . . . . 0.0 110.245 177.551 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -87.49 -73.53 0.47 Allowed 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.225 178.023 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 177.81 -101.39 0.15 Allowed Glycine 0 N--CA 1.476 1.339 0 N-CA-C 109.147 -1.581 . . . . 0.0 109.147 179.618 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -139.26 82.19 1.88 Allowed 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 171.744 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 28.6 pt -107.33 149.68 39.05 Favored Pre-proline 0 CA--C 1.571 1.786 0 C-N-CA 123.564 0.746 . . . . 0.0 109.691 -178.876 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.48 168.97 22.05 Favored 'Trans proline' 0 CA--C 1.56 1.801 0 C-N-CA 122.8 2.333 . . . . 0.0 114.363 179.702 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 58.5 ttt-85 -61.99 -40.19 94.77 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 115.645 1.72 . . . . 0.0 115.645 -179.698 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -65.01 -41.09 95.68 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 115.78 1.77 . . . . 0.0 115.78 173.118 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? -64.3 -36.49 84.27 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 114.979 1.474 . . . . 0.0 114.979 169.637 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.76 -52.5 60.1 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 170.047 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -53.91 -36.15 62.41 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 116.458 2.021 . . . . 0.0 116.458 170.094 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -60.78 -50.06 74.98 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 114.433 1.271 . . . . 0.0 114.433 171.436 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -58.89 -51.32 70.53 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 114.925 1.454 . . . . 0.0 114.925 173.816 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -65.11 -33.46 76.08 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 116.16 1.911 . . . . 0.0 116.16 175.619 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 23.3 t -53.92 -35.46 61.69 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 115.725 1.75 . . . . 0.0 115.725 169.736 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -61.24 -41.12 96.34 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 114.587 1.328 . . . . 0.0 114.587 169.288 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -71.65 122.63 20.91 Favored 'General case' 0 CA--C 1.556 1.179 0 CA-C-O 122.898 1.332 . . . . 0.0 112.474 179.899 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.449 ' H ' ' HD2' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -71.09 -8.7 55.27 Favored 'General case' 0 CA--C 1.569 1.674 0 N-CA-C 119.056 2.984 . . . . 0.0 119.056 170.972 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 44.6 m80 -89.71 142.66 27.48 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 120.071 1.305 . . . . 0.0 113.104 -168.703 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -78.66 116.75 19.23 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 169.651 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 108.46 -7.0 34.13 Favored Glycine 0 CA--C 1.549 2.202 0 CA-C-O 117.06 -1.967 . . . . 0.0 117.7 -169.398 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.61 117.69 8.45 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 121.14 2.47 . . . . 0.0 112.502 -169.963 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -131.53 155.09 48.06 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 116.281 1.956 . . . . 0.0 116.281 -168.806 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.6 pp -147.48 138.85 23.81 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-N 114.647 -1.16 . . . . 0.0 108.333 168.929 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.7 mp -94.26 120.69 44.05 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.591 0 N-CA-C 106.708 -1.589 . . . . 0.0 106.708 177.229 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 3.4 ptm180 -106.05 146.4 30.17 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 124.092 0.957 . . . . 0.0 109.702 169.679 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -79.82 131.38 35.88 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 169.682 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 22.9 t -63.54 132.42 51.2 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.673 0.789 . . . . 0.0 112.559 -177.189 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -68.18 -52.23 36.79 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 -172.546 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.0 t -64.99 -35.1 80.1 Favored 'General case' 0 CA--C 1.565 1.532 0 N-CA-C 116.256 1.947 . . . . 0.0 116.256 172.059 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -115.53 98.45 50.79 Favored Pre-proline 0 CA--C 1.563 1.466 0 CA-C-N 119.49 1.041 . . . . 0.0 109.99 178.66 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -59.87 -33.46 95.92 Favored 'Trans proline' 0 C--N 1.371 1.718 0 N-CA-C 119.384 2.802 . . . . 0.0 119.384 175.303 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -87.07 47.84 3.75 Favored Glycine 0 CA--C 1.551 2.34 0 N-CA-C 114.633 0.613 . . . . 0.0 114.633 169.239 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -156.19 126.75 6.74 Favored 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 178.881 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 7.5 m-30 -92.91 169.02 10.77 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 122.042 0.925 . . . . 0.0 110.806 169.933 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 69.5 m -149.47 115.69 5.76 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 -178.812 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 33.9 tp -81.02 112.87 18.81 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.896 0.879 . . . . 0.0 109.588 176.902 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 9.7 m -94.53 83.17 4.08 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 177.996 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.7 p -107.94 115.69 49.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 -171.412 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 58.0 tttp -77.59 145.59 36.74 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 114.882 -1.054 . . . . 0.0 111.416 171.173 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -148.86 101.34 3.17 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 169.735 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 92.61 -104.12 3.14 Favored Glycine 0 N--CA 1.479 1.534 0 N-CA-C 112.002 -0.439 . . . . 0.0 112.002 179.769 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -113.2 -11.98 13.18 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 117.241 2.311 . . . . 0.0 117.241 178.55 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -116.88 142.01 47.48 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-N 119.558 1.072 . . . . 0.0 110.051 -175.909 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 39.6 t -92.94 110.86 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 175.533 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 55.1 tp60 -102.33 112.22 24.83 Favored 'General case' 0 CA--C 1.552 1.055 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 -172.165 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -94.96 108.69 20.75 Favored 'General case' 0 CA--C 1.553 1.059 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 -174.68 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -103.13 130.5 50.32 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 176.227 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -77.82 115.5 17.61 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 123.083 0.553 . . . . 0.0 112.254 -175.939 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 97.4 t -85.64 110.35 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 106.83 -1.544 . . . . 0.0 106.83 178.364 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 58.5 mt -90.53 135.63 33.57 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.102 0.561 . . . . 0.0 109.717 -173.349 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 79.1 mtp180 -116.68 119.07 34.34 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 -175.183 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . 0.29 3.9 p-10 -79.91 -66.11 0.92 Allowed 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 -175.561 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -90.85 -107.27 1.39 Allowed Glycine 0 N--CA 1.483 1.826 0 CA-C-N 119.424 1.011 . . . . 0.0 111.801 -179.56 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -79.87 -67.28 0.78 Allowed 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 118.827 -0.606 . . . . 0.0 111.236 172.426 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -149.13 70.68 0.32 Allowed Glycine 0 N--CA 1.477 1.427 0 CA-C-N 118.46 0.573 . . . . 0.0 111.884 169.807 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.17 101.16 11.82 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 105.108 -2.182 . . . . 0.0 105.108 171.664 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -83.84 106.73 15.75 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-N 115.038 -0.983 . . . . 0.0 111.141 -168.509 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -114.38 114.72 26.25 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 107.769 -1.196 . . . . 0.0 107.769 177.505 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 63.0 tp -112.01 -48.9 3.01 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 124.192 0.997 . . . . 0.0 112.191 179.749 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 33.7 t90 -92.5 -74.79 0.51 Allowed 'General case' 0 CA--C 1.557 1.22 0 C-N-CA 124.598 1.159 . . . . 0.0 110.694 -169.727 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . 0.255 10.8 p -146.28 -60.41 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 C-N-CA 123.586 0.754 . . . . 0.0 109.715 177.293 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 15.6 m -79.38 157.15 4.7 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.545 0 C-N-CA 124.251 1.02 . . . . 0.0 111.759 178.892 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -79.88 136.0 36.57 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.526 -178.38 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -124.51 99.5 6.22 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 106.222 -1.77 . . . . 0.0 106.222 177.676 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . 0.272 12.8 p30 -60.45 -41.43 94.05 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 116.874 2.175 . . . . 0.0 116.874 -172.991 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 69.3 m -94.88 152.55 18.28 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-O 122.125 0.964 . . . . 0.0 111.268 172.395 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 12.8 tp -64.77 -34.76 79.11 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 169.66 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -63.68 -35.92 82.14 Favored 'General case' 0 CA--C 1.568 1.641 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 168.81 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -60.19 -48.93 79.66 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-N 120.592 1.542 . . . . 0.0 113.858 169.533 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 53.0 tp -60.82 -50.3 74.01 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 115.355 1.613 . . . . 0.0 115.355 173.752 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 46.3 t -61.38 -60.19 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 C-N-CA 123.957 0.903 . . . . 0.0 112.111 176.445 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -59.3 -31.8 69.47 Favored 'General case' 0 CA--C 1.567 1.634 0 N-CA-C 115.607 1.706 . . . . 0.0 115.607 -176.912 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -62.96 -53.92 46.57 Favored 'General case' 0 CA--C 1.568 1.642 0 CA-C-N 119.833 1.197 . . . . 0.0 112.328 168.78 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . 0.306 76.0 m-70 -71.58 -8.5 54.43 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 118.183 2.661 . . . . 0.0 118.183 178.16 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -47.77 -40.29 20.31 Favored 'General case' 0 N--CA 1.499 2.012 0 CA-C-N 120.693 1.588 . . . . 0.0 114.945 167.916 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 70.0 m -106.38 -32.9 7.93 Favored 'General case' 0 CA--C 1.564 1.493 0 N-CA-C 114.728 1.381 . . . . 0.0 114.728 170.655 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 48.7 m -89.39 147.36 24.09 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-N 120.4 1.455 . . . . 0.0 110.172 -179.706 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.502 ' HB2' ' H ' ' A' ' 146' ' ' ILE . 54.8 p -80.47 141.32 35.33 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 120.97 -1.081 . . . . 0.0 113.346 179.214 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 46.5 t -67.37 -51.54 51.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.916 169.781 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 32.3 t -87.35 132.64 33.89 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.582 0.753 . . . . 0.0 110.715 178.796 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -88.33 70.31 9.11 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 121.629 0.728 . . . . 0.0 110.955 176.37 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . 0.297 5.8 p-10 178.77 -68.58 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 125.218 1.407 . . . . 0.0 107.665 -176.501 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -96.86 138.6 34.16 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.689 0.796 . . . . 0.0 109.413 171.943 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -73.47 117.69 15.53 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 122.696 0.398 . . . . 0.0 111.775 178.809 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.502 ' H ' ' HB2' ' A' ' 139' ' ' SER . 8.4 mm -121.21 92.34 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 176.628 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 21.4 m-30 -100.57 119.82 39.11 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-N 114.249 -1.341 . . . . 0.0 108.109 -176.893 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 10.6 mp -74.04 126.48 30.61 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 123.384 0.674 . . . . 0.0 112.321 -169.748 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 24.1 mmt85 -129.23 143.24 50.78 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 124.551 1.14 . . . . 0.0 108.154 -179.083 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -72.26 146.75 47.03 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 113.645 0.98 . . . . 0.0 113.645 -174.798 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 28.3 pt -69.37 150.15 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 C-N-CA 123.868 0.867 . . . . 0.0 112.726 178.902 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 123.848 1.785 . . . . 0.0 109.55 -177.379 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.403 0 N-CA-C 111.748 -0.541 . . . . 0.0 111.748 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 90.7 p -76.86 115.33 16.54 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 122.994 0.517 . . . . 0.0 111.601 -176.59 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . 0.38 62.1 p-90 53.11 4.77 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 121.583 3.92 . . . . 0.0 121.583 -177.431 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -139.53 129.26 24.62 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 -169.676 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -140.09 94.86 2.8 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 170.501 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -91.8 164.95 29.21 Favored Glycine 0 CA--C 1.541 1.715 0 CA-C-O 122.924 1.291 . . . . 0.0 116.082 -169.816 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . 0.259 32.3 mmmt 57.38 53.14 7.84 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-N 113.1 -1.55 . . . . 0.0 115.183 -178.364 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 42.3 pt -136.55 152.35 74.53 Favored Pre-proline 0 CA--C 1.573 1.844 0 C-N-CA 123.895 0.878 . . . . 0.0 109.941 -177.751 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -74.08 177.0 8.77 Favored 'Trans proline' 0 CA--C 1.565 2.058 0 C-N-CA 122.919 2.412 . . . . 0.0 114.124 174.847 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 56.3 ttt-85 -63.78 -42.17 97.81 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 115.303 1.594 . . . . 0.0 115.303 176.506 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -66.47 -41.36 89.14 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 115.742 1.756 . . . . 0.0 115.742 176.35 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 29.2 tptp -62.91 -36.65 84.06 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 169.595 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.28 -46.1 81.79 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 115.452 1.649 . . . . 0.0 115.452 171.432 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -62.15 -39.33 92.24 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 115.168 1.544 . . . . 0.0 115.168 170.795 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -60.34 -46.0 91.47 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 114.938 1.459 . . . . 0.0 114.938 172.872 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 34.3 mmt -59.87 -50.36 74.08 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 114.813 1.412 . . . . 0.0 114.813 171.624 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 88.1 mt -75.97 -23.88 55.36 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 117.076 2.25 . . . . 0.0 117.076 -178.985 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 91.7 p -58.8 -35.99 73.75 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 117.082 2.253 . . . . 0.0 117.082 176.574 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 37.9 mtmm -63.07 -31.84 73.08 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 115.719 1.748 . . . . 0.0 115.719 169.656 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -75.51 122.62 24.14 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.533 1.133 . . . . 0.0 111.667 -171.44 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 13.4 ptp180 -63.56 -20.58 65.75 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 119.224 3.046 . . . . 0.0 119.224 -179.826 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 39.2 m80 -89.63 136.9 32.77 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 119.8 1.182 . . . . 0.0 112.718 -168.704 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -77.23 125.31 29.12 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.38 169.674 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 107.43 -21.38 30.81 Favored Glycine 0 CA--C 1.547 2.046 0 CA-C-O 117.036 -1.98 . . . . 0.0 115.879 -168.849 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.23 111.21 2.49 Favored 'General case' 0 N--CA 1.486 1.352 0 CA-C-N 120.823 2.311 . . . . 0.0 111.821 -171.917 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.8 p90 -123.94 158.19 32.58 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 113.826 1.046 . . . . 0.0 113.826 -168.569 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.2 pp -135.67 133.0 37.69 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 168.327 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 74.1 mt -88.95 109.82 20.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 105.661 -1.978 . . . . 0.0 105.661 171.808 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 50.8 ptt85 -91.1 144.06 26.03 Favored 'General case' 0 N--CA 1.486 1.327 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.097 171.657 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -90.24 126.13 35.72 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 169.113 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 53.0 m -67.07 128.78 37.66 Favored 'General case' 0 N--CA 1.487 1.375 0 CA-C-O 121.508 0.671 . . . . 0.0 111.326 -177.937 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -68.64 -47.83 65.58 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 -172.895 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 90.8 p -61.73 -36.89 82.27 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 116.655 2.094 . . . . 0.0 116.655 169.887 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -123.01 96.74 44.51 Favored Pre-proline 0 CA--C 1.563 1.454 0 CA-C-N 119.421 1.01 . . . . 0.0 109.439 177.776 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -58.05 -33.62 97.5 Favored 'Trans proline' 0 C--N 1.371 1.712 0 N-CA-C 120.055 3.059 . . . . 0.0 120.055 178.472 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -87.26 42.65 3.15 Favored Glycine 0 CA--C 1.552 2.389 0 N-CA-C 115.565 0.986 . . . . 0.0 115.565 169.266 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -149.44 110.19 4.29 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 105.03 -2.211 . . . . 0.0 105.03 177.532 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -95.33 168.01 10.99 Favored 'General case' 0 N--CA 1.489 1.475 0 CA-C-O 121.672 0.748 . . . . 0.0 110.105 176.426 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 73.4 m -143.62 114.28 7.61 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 179.327 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 24.9 tp -79.89 107.34 12.6 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 124.442 1.097 . . . . 0.0 109.041 176.257 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 9.4 m -102.79 95.49 6.22 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 -169.956 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 20.0 t -108.62 120.22 59.6 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 CA-C-N 119.113 0.869 . . . . 0.0 109.254 -169.485 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -87.72 96.79 10.57 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.125 0.57 . . . . 0.0 109.526 173.711 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 18.3 t80 -120.53 100.16 6.98 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 179.222 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 68.35 73.0 0.74 Allowed Glycine 0 CA--C 1.542 1.759 0 N-CA-C 115.392 0.917 . . . . 0.0 115.392 175.227 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . 0.321 64.7 m-80 73.67 -22.88 0.23 Allowed 'General case' 0 N--CA 1.5 2.052 0 N-CA-C 118.564 2.802 . . . . 0.0 118.564 -179.821 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -123.91 139.09 54.31 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-N 119.538 1.063 . . . . 0.0 109.935 -169.938 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 39.4 t -100.91 112.39 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 -179.176 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -101.43 115.82 31.37 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.834 0.854 . . . . 0.0 109.208 -174.789 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 -97.12 107.54 20.09 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 115.007 -0.997 . . . . 0.0 108.587 -174.443 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -104.15 119.38 38.81 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 -176.858 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.8 tppp? -75.92 118.5 18.77 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-O 121.98 0.895 . . . . 0.0 110.646 -173.09 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 92.1 t -92.0 101.41 12.52 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.373 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 -179.51 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 68.6 mt -86.37 147.03 26.22 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 123.588 0.755 . . . . 0.0 111.072 178.396 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 73.5 mtp180 -113.0 147.23 37.6 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 123.058 0.543 . . . . 0.0 110.933 -177.776 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -135.41 132.07 37.03 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 123.276 0.63 . . . . 0.0 110.385 173.829 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 81.36 -113.3 3.61 Favored Glycine 0 CA--C 1.541 1.713 0 C-N-CA 122.957 0.313 . . . . 0.0 113.0 175.689 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -83.76 -68.09 0.74 Allowed 'General case' 0 N--CA 1.487 1.401 0 CA-C-O 118.929 -0.558 . . . . 0.0 110.979 172.465 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -162.25 73.04 0.2 Allowed Glycine 0 N--CA 1.477 1.374 0 CA-C-N 118.477 0.581 . . . . 0.0 111.69 169.93 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -99.12 100.93 12.12 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 176.561 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 79.9 m-85 -83.46 112.31 19.84 Favored 'General case' 0 CA--C 1.557 1.227 0 CA-C-N 114.503 -1.226 . . . . 0.0 109.581 -169.585 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -125.13 116.13 21.56 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 123.717 0.807 . . . . 0.0 109.155 -177.115 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -115.7 -38.29 3.75 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 178.773 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 53.2 t90 -99.91 -82.72 0.44 Allowed 'General case' 0 CA--C 1.56 1.336 0 C-N-CA 124.804 1.242 . . . . 0.0 108.679 -179.814 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 99.8 t -137.78 -66.53 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 -175.678 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 10.6 p -79.7 139.05 18.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 C-N-CA 123.69 0.796 . . . . 0.0 110.906 -177.676 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.67 168.11 19.79 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-O 122.256 1.027 . . . . 0.0 113.231 178.631 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -147.23 113.4 5.86 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 -170.104 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 23.3 t30 -59.45 -40.58 87.27 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 115.857 1.799 . . . . 0.0 115.857 -179.49 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 66.0 m -110.65 157.4 19.75 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-O 122.018 0.913 . . . . 0.0 111.203 174.089 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 90.4 mt -66.29 -30.47 70.89 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 114.457 1.28 . . . . 0.0 114.457 169.262 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -63.02 -39.74 95.67 Favored 'General case' 0 CA--C 1.573 1.858 0 CA-C-N 119.89 1.223 . . . . 0.0 113.702 169.287 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -60.8 -43.31 98.31 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 114.217 1.191 . . . . 0.0 114.217 169.282 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 9.5 tt -56.47 -49.84 73.47 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 172.568 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 13.6 m -63.89 -49.11 83.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 N-CA-C 113.831 1.049 . . . . 0.0 113.831 176.973 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -65.8 -33.02 74.89 Favored 'General case' 0 CA--C 1.569 1.68 0 N-CA-C 114.917 1.451 . . . . 0.0 114.917 -175.995 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -61.57 -59.63 4.93 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 119.852 1.205 . . . . 0.0 112.93 169.873 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . 0.261 70.1 m-70 -69.45 -9.23 52.75 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 117.67 2.47 . . . . 0.0 117.67 177.069 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 49.2 ttm-85 -59.03 -32.31 69.62 Favored 'General case' 0 CA--C 1.575 1.925 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 167.573 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 70.1 m -105.11 -35.77 7.5 Favored 'General case' 0 CA--C 1.566 1.581 0 C-N-CA 124.987 1.315 . . . . 0.0 114.045 169.368 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 57.2 m -90.9 155.32 18.83 Favored 'General case' 0 N--CA 1.498 1.959 0 CA-C-N 120.352 1.433 . . . . 0.0 111.983 179.684 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 27.8 t -75.01 135.34 41.3 Favored 'General case' 0 N--CA 1.484 1.263 0 O-C-N 121.545 -0.722 . . . . 0.0 112.73 176.953 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 11.6 t -72.88 -54.32 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 CA-C-O 118.63 -0.7 . . . . 0.0 111.179 170.878 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 39.2 t -101.86 127.57 48.62 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.07 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -62.77 -32.2 73.31 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 116.437 2.014 . . . . 0.0 116.437 -179.49 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 70.9 m-80 -76.37 -62.65 1.55 Allowed 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 119.567 1.076 . . . . 0.0 112.18 169.897 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -91.05 120.78 32.3 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 119.163 0.892 . . . . 0.0 109.258 -178.302 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 58.5 mt-30 -76.37 107.46 8.64 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.794 -0.566 . . . . 0.0 111.505 -174.252 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 14.0 mm -111.72 122.47 66.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 -173.658 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -125.81 129.16 48.88 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 -179.14 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 10.0 mp -78.72 123.09 26.8 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -169.043 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 14.5 tpt180 -111.18 150.72 29.11 Favored 'General case' 0 CA--C 1.56 1.35 0 C-N-CA 125.615 1.566 . . . . 0.0 109.164 172.442 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -76.48 157.41 32.18 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.79 -1.194 . . . . 0.0 112.249 172.262 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -64.31 152.52 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 N-CA-C 114.152 1.167 . . . . 0.0 114.152 -175.305 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 . . . . . 0 N--CA 1.488 1.431 0 CA-C-O 122.843 1.306 . . . . 0.0 108.358 171.952 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 64.5 p-90 . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 117.053 2.242 . . . . 0.0 117.053 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -81.33 121.78 26.64 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 120.696 1.589 . . . . 0.0 110.237 -173.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -124.35 106.42 10.23 Favored 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 104.543 -2.391 . . . . 0.0 104.543 173.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -39.15 -67.57 0.57 Allowed Glycine 0 N--CA 1.487 2.056 0 N-CA-C 119.765 2.666 . . . . 0.0 119.765 -169.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -151.55 91.7 1.69 Allowed 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.46 157.35 62.15 Favored Pre-proline 0 N--CA 1.5 2.066 0 CA-C-O 118.467 -0.778 . . . . 0.0 109.898 177.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -54.68 159.3 9.08 Favored 'Trans proline' 0 C--N 1.371 1.755 0 C-N-CA 123.4 2.733 . . . . 0.0 117.619 178.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 59.6 ttt180 -65.94 -40.02 90.98 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 114.503 1.297 . . . . 0.0 114.503 170.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -66.69 -44.18 82.43 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 173.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -61.02 -38.12 84.97 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 115.45 1.648 . . . . 0.0 115.45 170.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.94 -45.32 94.19 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 115.476 1.658 . . . . 0.0 115.476 169.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -60.95 -42.69 98.72 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 115.199 1.555 . . . . 0.0 115.199 171.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -59.57 -51.27 70.54 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 174.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -63.21 -45.96 89.24 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 115.024 1.491 . . . . 0.0 115.024 177.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 6.5 mp -70.05 -41.12 74.63 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 114.854 1.427 . . . . 0.0 114.854 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 69.8 m -58.76 -35.04 72.13 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 115.839 1.792 . . . . 0.0 115.839 169.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 59.4 mttm -64.29 -38.28 90.49 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 115.287 1.588 . . . . 0.0 115.287 169.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -53.54 137.07 37.39 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 179.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 36.0 ptt180 -66.97 -22.85 65.91 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 118.029 2.603 . . . . 0.0 118.029 174.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 67.0 m80 -89.33 138.03 31.8 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-N 119.186 0.903 . . . . 0.0 112.017 -169.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -77.95 124.63 28.24 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.065 169.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.61 11.95 58.75 Favored Glycine 0 CA--C 1.555 2.569 0 CA-C-O 117.839 -1.534 . . . . 0.0 116.866 -169.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -71.34 123.53 22.52 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 120.443 2.122 . . . . 0.0 112.135 -170.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.405 ' HB3' HG23 ' A' ' 99' ' ' VAL . 17.5 p90 -135.7 160.86 37.22 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 116.359 1.985 . . . . 0.0 116.359 -168.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.1 pp -144.14 141.82 30.21 Favored 'General case' 0 CA--C 1.556 1.188 0 CA-C-N 113.786 -1.552 . . . . 0.0 108.277 167.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 52.7 mt -97.62 112.46 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 172.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -105.02 150.42 24.97 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 124.4 1.08 . . . . 0.0 111.905 176.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -89.72 138.28 31.61 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 169.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 68.3 m -64.08 137.18 57.85 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.847 0.859 . . . . 0.0 112.305 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -76.15 109.6 9.96 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.241 1.016 . . . . 0.0 110.28 -169.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . 0.374 16.6 m 103.39 -34.11 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.844 0 CA-C-N 112.286 -2.233 . . . . 0.0 114.665 -172.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -93.15 112.62 57.05 Favored Pre-proline 0 CA--C 1.567 1.61 0 CA-C-N 120.628 1.558 . . . . 0.0 111.685 -176.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -81.48 134.5 8.86 Favored 'Trans proline' 0 C--N 1.371 1.732 0 C-N-CA 123.137 2.558 . . . . 0.0 112.901 -179.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 66.66 33.52 84.66 Favored Glycine 0 CA--C 1.552 2.362 0 N-CA-C 117.012 1.565 . . . . 0.0 117.012 -169.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -126.45 92.0 3.47 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 105.858 -1.904 . . . . 0.0 105.858 -178.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -93.24 163.39 13.64 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-O 122.211 1.005 . . . . 0.0 111.687 -169.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 72.8 m -147.67 120.73 8.83 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 29.9 tp -79.61 103.85 9.81 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 171.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 3.1 m -84.94 108.16 17.44 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 172.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.405 HG23 ' HB3' ' A' ' 83' ' ' PHE . 6.8 p -135.18 126.54 46.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 -173.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -75.72 112.21 11.86 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.645 174.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 12.5 m-30 -117.84 106.82 13.4 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 176.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 85.51 -95.79 2.03 Favored Glycine 0 CA--C 1.54 1.612 0 N-CA-C 111.154 -0.778 . . . . 0.0 111.154 -172.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -127.6 -24.19 3.33 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 114.956 1.465 . . . . 0.0 114.956 169.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -89.24 139.13 30.8 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 119.056 0.844 . . . . 0.0 110.558 -175.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 59.3 t -87.85 110.93 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 N-CA-C 106.66 -1.608 . . . . 0.0 106.66 178.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 69.0 mt-30 -106.95 120.56 42.39 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.177 -169.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 19.8 m-70 -99.65 97.69 8.63 Favored 'General case' 0 CA--C 1.553 1.093 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 -170.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -93.11 125.03 37.51 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 -179.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -75.6 119.84 20.19 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-O 121.32 0.581 . . . . 0.0 112.222 -170.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 90.9 t -93.79 97.86 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 N-CA-C 106.374 -1.713 . . . . 0.0 106.374 178.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 71.0 mt -85.57 154.76 21.51 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.682 0.793 . . . . 0.0 110.951 177.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 65.0 mtp180 -115.87 129.39 56.4 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.505 -0.747 . . . . 0.0 110.798 -177.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -106.23 94.12 4.98 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 123.323 0.649 . . . . 0.0 110.258 176.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 88.96 -112.84 4.01 Favored Glycine 0 CA--C 1.541 1.706 0 N-CA-C 113.918 0.327 . . . . 0.0 113.918 172.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -89.03 -94.25 0.11 Allowed 'General case' 0 N--CA 1.486 1.341 0 CA-C-O 118.228 -0.892 . . . . 0.0 111.35 -169.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -113.73 80.3 0.28 Allowed Glycine 0 N--CA 1.481 1.665 0 CA-C-N 119.335 0.971 . . . . 0.0 110.689 177.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -142.5 146.58 34.87 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -175.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -145.78 108.36 4.48 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 -169.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 21.2 p90 -126.74 117.77 23.36 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.749 0.82 . . . . 0.0 109.602 -175.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -107.95 -42.83 4.58 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 170.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 47.2 t90 -92.03 -74.07 0.53 Allowed 'General case' 0 CA--C 1.558 1.255 0 C-N-CA 124.959 1.304 . . . . 0.0 110.182 -169.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . 0.267 14.8 p -147.24 -64.98 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 C-N-CA 123.612 0.765 . . . . 0.0 109.188 174.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 9.4 m -79.56 142.21 14.29 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.426 0 C-N-CA 124.175 0.99 . . . . 0.0 111.481 -178.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.87 154.65 28.23 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -177.448 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -133.66 116.41 15.79 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 106.471 -1.677 . . . . 0.0 106.471 -171.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -55.68 -50.59 69.86 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 115.884 1.809 . . . . 0.0 115.884 -173.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 69.0 m -106.57 161.58 14.5 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-O 122.025 0.916 . . . . 0.0 111.21 173.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 84.5 mt -67.2 -29.07 68.64 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 168.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -67.07 -39.66 86.87 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-N 119.652 1.114 . . . . 0.0 113.04 169.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -60.47 -41.46 94.23 Favored 'General case' 0 CA--C 1.568 1.67 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 169.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 9.1 tt -56.99 -45.56 82.88 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 114.139 1.163 . . . . 0.0 114.139 169.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 41.3 t -60.01 -61.8 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 C-N-CA 124.308 1.043 . . . . 0.0 112.661 172.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 -63.16 -28.42 70.04 Favored 'General case' 0 CA--C 1.566 1.587 0 N-CA-C 115.879 1.807 . . . . 0.0 115.879 -174.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -63.12 -61.68 2.21 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 119.594 1.088 . . . . 0.0 112.01 169.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . 0.308 49.1 m-70 -70.11 -8.91 53.35 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 118.166 2.654 . . . . 0.0 118.166 177.414 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 59.2 ttm-85 -61.86 -28.81 69.76 Favored 'General case' 0 CA--C 1.579 2.092 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 167.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 71.0 m -110.43 -31.87 7.13 Favored 'General case' 0 CA--C 1.568 1.67 0 C-N-CA 125.199 1.4 . . . . 0.0 114.245 169.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 47.6 m -90.56 149.45 22.15 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-N 120.389 1.449 . . . . 0.0 110.445 175.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 22.8 t -80.96 137.26 36.1 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.741 -1.224 . . . . 0.0 113.242 -179.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 75.5 t -75.08 -58.82 3.99 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.834 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.126 169.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 73.4 m -89.66 114.99 26.7 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.909 0.884 . . . . 0.0 108.724 -177.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 19.3 mmm180 -89.24 81.51 6.69 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 122.33 1.062 . . . . 0.0 112.249 -169.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -160.32 -77.71 0.06 Allowed 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 103.816 -2.661 . . . . 0.0 103.816 173.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -97.08 146.57 24.89 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 169.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 65.5 mt-30 -79.35 112.27 16.42 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.665 -0.647 . . . . 0.0 111.222 -175.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -124.16 127.05 73.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 -178.023 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -119.88 168.33 11.22 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 122.545 1.164 . . . . 0.0 112.447 -169.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 11.0 mp -90.39 115.31 27.47 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 124.318 1.047 . . . . 0.0 110.251 -178.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.21 147.7 42.26 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 124.234 1.013 . . . . 0.0 109.302 178.043 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -74.11 152.17 39.95 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 122.112 0.958 . . . . 0.0 113.456 -176.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 14.3 pt -72.9 164.43 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 CA-C-N 114.903 -1.044 . . . . 0.0 113.583 -178.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 24.4 tp10 . . . . . 0 N--CA 1.485 1.315 0 CA-C-O 122.834 1.302 . . . . 0.0 109.315 172.076 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . 0.259 65.9 p-90 . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -81.82 140.79 33.97 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-N 119.596 1.089 . . . . 0.0 110.826 175.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -116.49 -87.27 0.61 Allowed 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 175.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 138.49 94.15 0.3 Allowed Glycine 0 N--CA 1.48 1.628 0 CA-C-N 119.603 1.092 . . . . 0.0 111.755 177.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . 0.259 20.5 tptm 67.14 73.42 0.34 Allowed 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 124.283 1.033 . . . . 0.0 113.56 173.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 28.4 pt -128.77 151.08 76.62 Favored Pre-proline 0 CA--C 1.576 1.95 0 C-N-CA 123.924 0.89 . . . . 0.0 109.443 176.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -75.42 172.25 16.68 Favored 'Trans proline' 0 CA--C 1.562 1.896 0 C-N-CA 122.997 2.464 . . . . 0.0 114.678 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 53.5 ttt180 -67.03 -41.3 86.8 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 115.771 1.767 . . . . 0.0 115.771 -179.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -66.9 -42.73 84.96 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 115.666 1.728 . . . . 0.0 115.666 177.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -64.94 -36.03 83.08 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 115.028 1.492 . . . . 0.0 115.028 169.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.82 -45.25 90.46 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 115.734 1.753 . . . . 0.0 115.734 170.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -62.43 -38.48 89.9 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 115.246 1.572 . . . . 0.0 115.246 170.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -61.33 -50.43 72.97 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 114.499 1.296 . . . . 0.0 114.499 173.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 39.2 tpp -57.5 -46.53 83.65 Favored 'General case' 0 CA--C 1.564 1.488 0 N-CA-C 115.604 1.705 . . . . 0.0 115.604 172.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 9.2 mp -70.65 -24.9 62.78 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 116.621 2.082 . . . . 0.0 116.621 175.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 71.6 m -57.28 -35.43 69.78 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-N 120.882 1.674 . . . . 0.0 114.908 169.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 56.8 mttp -60.45 -38.5 84.35 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 115.112 1.523 . . . . 0.0 115.112 169.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -68.49 122.29 18.14 Favored 'General case' 0 CA--C 1.556 1.183 0 C-N-CA 124.829 1.251 . . . . 0.0 112.156 178.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 16.4 ptm180 -78.24 -18.05 55.89 Favored 'General case' 0 CA--C 1.569 1.701 0 N-CA-C 118.199 2.666 . . . . 0.0 118.199 175.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 41.7 m80 -89.57 147.39 23.97 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 119.483 1.038 . . . . 0.0 113.722 -168.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -81.77 117.91 22.45 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 169.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 118.22 -32.89 5.08 Favored Glycine 0 CA--C 1.54 1.613 0 CA-C-O 117.704 -1.609 . . . . 0.0 116.35 -169.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -60.91 103.98 0.32 Allowed 'General case' 0 N--CA 1.486 1.339 0 CA-C-N 119.257 1.529 . . . . 0.0 113.9 -169.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 18.4 p90 -120.59 162.48 19.55 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 -168.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.3 pp -135.29 132.16 37.41 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 167.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 70.0 mt -91.82 114.31 28.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 105.611 -1.996 . . . . 0.0 105.611 170.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 46.8 ptt85 -100.45 156.07 17.47 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-N 114.596 -1.183 . . . . 0.0 110.484 170.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -87.67 128.03 35.29 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 168.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 16.4 t -60.36 137.83 58.07 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 113.753 1.02 . . . . 0.0 113.753 -170.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.06 119.86 17.89 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-O 122.907 1.337 . . . . 0.0 111.536 -171.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . 0.33 5.4 t 84.98 -22.21 0.21 Allowed 'General case' 0 N--CA 1.493 1.693 0 CA-C-N 111.569 -2.56 . . . . 0.0 116.075 -169.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -108.55 92.9 10.8 Favored Pre-proline 0 CA--C 1.565 1.533 0 CA-C-N 120.662 1.574 . . . . 0.0 110.213 177.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -73.52 133.15 18.51 Favored 'Trans proline' 0 C--N 1.373 1.821 0 C-N-CA 123.19 2.593 . . . . 0.0 111.429 171.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 98.69 -34.18 5.51 Favored Glycine 0 CA--C 1.553 2.456 0 CA-C-O 119.017 -0.879 . . . . 0.0 114.275 -168.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -79.64 131.84 36.09 Favored 'General case' 0 N--CA 1.484 1.257 0 CA-C-N 118.675 1.238 . . . . 0.0 108.599 169.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -116.63 164.09 15.13 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-O 122.124 0.964 . . . . 0.0 110.58 -178.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 69.0 m -143.54 115.32 8.22 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 -177.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 16.6 tp -83.8 104.93 14.29 Favored 'General case' 0 CA--C 1.561 1.386 0 C-N-CA 124.369 1.068 . . . . 0.0 108.502 174.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.8 m -93.63 108.62 20.32 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 -179.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 24.0 t -116.38 124.5 72.65 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 CA-C-N 119.762 1.164 . . . . 0.0 108.301 -169.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 58.6 tptt -84.06 120.65 26.4 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.211 0.605 . . . . 0.0 109.891 171.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 3.9 m-30 -89.23 -140.03 0.13 Allowed 'General case' 0 CA--C 1.567 1.633 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 173.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -58.13 -71.0 0.82 Allowed Glycine 0 CA--C 1.547 2.053 0 C-N-CA 123.96 0.791 . . . . 0.0 114.242 169.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 31.6 t30 -140.04 58.72 1.59 Allowed 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 117.534 0.667 . . . . 0.0 111.281 169.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -160.0 141.6 12.75 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 124.016 0.926 . . . . 0.0 108.627 176.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 57.2 t -107.35 109.83 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 177.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 18.6 mp0 -101.85 126.76 48.8 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.879 0.871 . . . . 0.0 109.777 179.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 11.9 m-70 -101.78 97.0 7.45 Favored 'General case' 0 CA--C 1.553 1.082 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 -175.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -86.41 128.81 34.99 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 172.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -91.02 118.87 30.73 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 121.208 0.528 . . . . 0.0 110.889 -169.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 91.9 t -85.91 110.21 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 107.224 -1.398 . . . . 0.0 107.224 -177.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 56.8 mt -104.31 134.41 47.58 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 -173.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 37.3 mtm180 -99.52 131.47 45.51 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 118.176 0.444 . . . . 0.0 110.929 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -85.6 -54.47 4.53 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 174.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 179.98 139.44 3.77 Favored Glycine 0 CA--C 1.542 1.732 0 CA-C-N 119.823 1.192 . . . . 0.0 113.77 -178.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . 0.344 . . 78.53 -79.15 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 125.294 1.438 . . . . 0.0 113.3 175.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -157.18 78.13 0.19 Allowed Glycine 0 N--CA 1.478 1.463 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 172.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -143.07 144.1 32.12 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -171.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -138.87 100.6 4.09 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 -172.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -99.89 105.43 17.16 Favored 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 175.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -101.63 -49.94 3.86 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-N 114.327 -1.306 . . . . 0.0 111.239 175.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 79.0 t90 -129.48 101.71 6.07 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 -172.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . 0.509 10.7 p 60.75 -90.68 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 C-N-CA 125.227 1.411 . . . . 0.0 114.188 -179.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 21.1 m -79.64 158.44 4.54 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.493 0 C-N-CA 124.449 1.1 . . . . 0.0 112.398 -175.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -79.72 152.7 29.73 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 121.876 0.846 . . . . 0.0 112.978 179.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -135.73 109.42 8.04 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 105.9 -1.889 . . . . 0.0 105.9 -171.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 15.1 t30 -57.89 -53.54 57.08 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 115.77 1.767 . . . . 0.0 115.77 -170.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 67.7 m -98.05 149.57 22.34 Favored 'General case' 0 N--CA 1.483 1.225 0 CA-C-O 123.04 1.4 . . . . 0.0 111.337 178.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 8.0 tp -65.96 -31.29 72.12 Favored 'General case' 0 CA--C 1.571 1.764 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 169.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -70.18 -37.85 75.23 Favored 'General case' 0 CA--C 1.57 1.746 0 CA-C-O 117.681 -1.152 . . . . 0.0 113.796 169.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . 0.329 9.1 pt-20 -62.16 -31.14 71.61 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-N 121.139 1.79 . . . . 0.0 115.088 169.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 59.6 tp -57.79 -44.13 86.06 Favored 'General case' 0 CA--C 1.574 1.868 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 168.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . 0.333 7.1 p -65.3 -57.61 10.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 CA-C-N 120.17 1.35 . . . . 0.0 113.918 172.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -60.32 -23.49 64.25 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 117.391 2.367 . . . . 0.0 117.391 176.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 84.8 t80 -66.25 -61.33 2.08 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-N 119.304 0.956 . . . . 0.0 112.043 169.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 71.4 m-70 -69.83 -9.54 55.13 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 117.734 2.494 . . . . 0.0 117.734 176.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 38.0 ttm180 -59.52 -29.11 67.65 Favored 'General case' 0 CA--C 1.58 2.119 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 167.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 70.7 m -110.2 -30.61 7.66 Favored 'General case' 0 CA--C 1.571 1.771 0 C-N-CA 125.483 1.513 . . . . 0.0 114.037 169.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 56.8 m -90.46 157.36 17.61 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-N 120.546 1.521 . . . . 0.0 111.266 177.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 8.2 t -75.93 129.79 37.47 Favored 'General case' 0 CA--C 1.56 1.363 0 O-C-N 121.491 -0.756 . . . . 0.0 112.8 177.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 14.1 t -69.15 -50.69 50.68 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 C-N-CA 123.807 0.843 . . . . 0.0 111.655 173.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 25.3 t -88.56 145.07 25.92 Favored 'General case' 0 CA--C 1.558 1.259 0 C-N-CA 123.341 0.656 . . . . 0.0 110.211 173.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 84.7 mtt85 -69.95 -50.39 42.43 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 177.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 21.0 m120 -72.84 -55.59 6.44 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 113.445 0.906 . . . . 0.0 113.445 174.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -83.26 146.7 28.41 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-N 118.978 0.808 . . . . 0.0 111.432 -177.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 60.5 mt-30 -86.02 94.78 9.31 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.337 0.589 . . . . 0.0 109.607 176.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 44.1 mm -114.44 133.18 61.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 -174.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -127.56 117.88 22.9 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 -169.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 14.1 tp -80.55 125.57 30.14 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 124.442 1.097 . . . . 0.0 113.952 -168.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 32.5 mmt180 -138.05 160.19 40.02 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 124.085 0.954 . . . . 0.0 110.525 -170.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -73.91 152.98 40.01 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.607 -1.308 . . . . 0.0 112.924 177.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.1 pp -66.55 159.73 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 -179.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 . . . . . 0 N--CA 1.485 1.299 0 CA-C-O 123.981 1.848 . . . . 0.0 108.584 -176.89 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . 0.253 1.6 p90 . . . . . 0 N--CA 1.488 1.448 0 CA-C-O 118.257 -0.878 . . . . 0.0 113.038 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -82.53 141.09 32.91 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 120.598 1.544 . . . . 0.0 112.345 -171.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -118.83 -71.91 0.71 Allowed 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 115.087 -0.96 . . . . 0.0 109.127 174.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 104.22 95.94 2.38 Favored Glycine 0 N--CA 1.481 1.658 0 CA-C-N 119.195 0.907 . . . . 0.0 111.655 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . 0.312 94.9 mttt 63.35 71.03 0.52 Allowed 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 124.615 1.166 . . . . 0.0 114.027 -178.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 26.1 pt -122.8 150.53 58.87 Favored Pre-proline 0 CA--C 1.576 1.948 0 C-N-CA 124.284 1.034 . . . . 0.0 108.646 170.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -72.42 163.97 37.0 Favored 'Trans proline' 0 CA--C 1.562 1.881 0 C-N-CA 122.825 2.35 . . . . 0.0 114.128 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 58.6 ttt180 -63.08 -41.78 99.5 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 115.592 1.701 . . . . 0.0 115.592 179.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.41 -46.31 83.81 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 115.305 1.594 . . . . 0.0 115.305 177.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -63.22 -35.33 79.98 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 115.346 1.61 . . . . 0.0 115.346 169.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.78 -44.72 95.45 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 115.42 1.637 . . . . 0.0 115.42 169.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -61.92 -40.73 96.5 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 115.213 1.56 . . . . 0.0 115.213 170.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -61.48 -50.34 73.12 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 114.895 1.442 . . . . 0.0 114.895 173.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -62.88 -43.98 97.34 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 115.02 1.489 . . . . 0.0 115.02 176.447 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 8.5 mp -65.19 -42.51 93.54 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 114.826 1.417 . . . . 0.0 114.826 172.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 67.5 m -54.98 -36.67 65.65 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 115.87 1.804 . . . . 0.0 115.87 169.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -63.34 -35.49 80.56 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 115.26 1.578 . . . . 0.0 115.26 169.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -63.21 126.86 28.8 Favored 'General case' 0 CA--C 1.557 1.228 0 CA-C-O 122.839 1.304 . . . . 0.0 112.61 172.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 14.5 ptp180 -67.45 -16.53 64.27 Favored 'General case' 0 CA--C 1.567 1.627 0 N-CA-C 119.026 2.973 . . . . 0.0 119.026 175.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 48.2 m80 -89.55 142.33 27.77 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 119.6 1.091 . . . . 0.0 113.281 -168.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -75.94 127.37 32.85 Favored 'General case' 0 N--CA 1.489 1.475 0 CA-C-N 115.014 -0.994 . . . . 0.0 108.632 169.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.45 4.31 66.18 Favored Glycine 0 CA--C 1.555 2.539 0 CA-C-O 117.278 -1.845 . . . . 0.0 117.621 -169.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -70.02 114.88 8.62 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 121.02 2.41 . . . . 0.0 112.73 -169.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 22.4 p90 -127.63 158.54 37.27 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 115.41 1.633 . . . . 0.0 115.41 -168.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.1 pp -134.99 158.21 44.93 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 124.169 0.988 . . . . 0.0 109.535 168.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.8 mp -114.36 113.71 44.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 104.83 -2.285 . . . . 0.0 104.83 169.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 46.6 ptt85 -101.3 140.68 35.26 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 123.783 0.833 . . . . 0.0 109.07 169.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -79.59 138.42 37.44 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.683 -0.636 . . . . 0.0 109.53 170.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 58.2 m -66.79 128.21 35.42 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 123.13 0.572 . . . . 0.0 111.511 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -64.92 -50.92 64.59 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 114.403 1.26 . . . . 0.0 114.403 -171.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.8 t -64.25 -40.31 95.74 Favored 'General case' 0 CA--C 1.564 1.514 0 N-CA-C 115.487 1.662 . . . . 0.0 115.487 170.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -111.8 95.27 27.69 Favored Pre-proline 0 CA--C 1.564 1.493 0 CA-C-N 119.32 0.964 . . . . 0.0 110.819 -177.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.43 129.19 16.49 Favored 'Trans proline' 0 C--N 1.372 1.768 0 C-N-CA 123.054 2.503 . . . . 0.0 111.014 169.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 108.27 -35.43 4.98 Favored Glycine 0 CA--C 1.553 2.434 0 CA-C-O 118.894 -0.948 . . . . 0.0 113.609 -168.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -83.79 131.91 34.87 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-N 118.63 1.215 . . . . 0.0 108.24 169.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -115.77 168.07 10.36 Favored 'General case' 0 CA--C 1.56 1.357 0 CA-C-O 122.083 0.945 . . . . 0.0 110.181 -177.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 72.8 m -145.57 112.8 6.15 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 -177.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 19.9 tp -88.54 104.34 16.74 Favored 'General case' 0 CA--C 1.561 1.393 0 C-N-CA 124.654 1.181 . . . . 0.0 109.429 177.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.8 m -82.56 119.15 23.89 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 124.879 1.272 . . . . 0.0 108.065 173.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 24.0 t -129.36 122.84 56.66 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.193 0 CA-C-N 120.805 1.638 . . . . 0.0 107.782 -175.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 59.4 tttp -80.4 138.62 36.67 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.458 169.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -150.34 105.88 3.39 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 169.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 83.76 -106.75 2.88 Favored Glycine 0 CA--C 1.54 1.61 0 N-CA-C 110.894 -0.882 . . . . 0.0 110.894 -174.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 21.3 m120 -133.9 63.74 1.62 Allowed 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 169.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -160.77 127.67 4.17 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 123.522 0.729 . . . . 0.0 109.481 175.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 99.9 t -103.57 106.39 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 177.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -107.16 131.3 54.3 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.876 0.87 . . . . 0.0 110.82 -176.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 21.8 m-70 -103.33 107.66 18.58 Favored 'General case' 0 CA--C 1.552 1.019 0 C-N-CA 123.649 0.78 . . . . 0.0 109.598 -169.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -91.33 131.55 36.75 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 115.111 -0.95 . . . . 0.0 108.6 175.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 38.3 mtmm -80.52 117.1 20.94 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.239 0.542 . . . . 0.0 109.628 178.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 95.6 t -94.48 98.33 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 N-CA-C 105.994 -1.854 . . . . 0.0 105.994 176.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -97.14 140.26 31.9 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 178.257 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 53.3 mtm180 -100.0 133.35 44.51 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 122.673 0.389 . . . . 0.0 110.88 -176.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . 0.253 4.7 p-10 -80.0 -66.53 0.86 Allowed 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 176.085 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -94.51 -116.83 2.86 Favored Glycine 0 CA--C 1.541 1.661 0 CA-C-N 119.067 0.848 . . . . 0.0 112.211 -177.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -86.62 -83.11 0.19 Allowed 'General case' 0 N--CA 1.487 1.385 0 CA-C-O 118.441 -0.79 . . . . 0.0 110.028 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -109.71 78.91 0.24 Allowed Glycine 0 N--CA 1.479 1.565 0 N-CA-C 109.971 -1.252 . . . . 0.0 109.971 169.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -131.17 78.54 1.84 Allowed 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 -174.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -80.36 119.42 23.06 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 124.114 0.966 . . . . 0.0 111.402 -169.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 10.5 p90 -139.64 123.08 17.18 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 122.49 0.316 . . . . 0.0 110.155 -178.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -112.61 -37.82 4.8 Favored 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 123.61 0.764 . . . . 0.0 112.634 168.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 51.0 t90 -84.04 -86.17 0.12 Allowed 'General case' 0 CA--C 1.56 1.344 0 C-N-CA 124.805 1.242 . . . . 0.0 109.272 -175.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . 0.258 6.1 m -139.88 -61.02 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 C-N-CA 123.833 0.853 . . . . 0.0 109.836 173.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.3 p -79.97 140.73 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 CA-C-N 119.094 0.861 . . . . 0.0 111.203 -176.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.97 156.93 24.44 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 -179.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -139.45 120.6 14.72 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 -169.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 66.7 m-80 -61.25 -39.91 92.1 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 116.566 2.062 . . . . 0.0 116.566 -173.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 66.6 m -123.75 160.38 27.42 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-O 121.882 0.849 . . . . 0.0 111.898 -176.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 98.1 mt -84.39 86.51 7.26 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 169.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 167.32 -58.56 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 104.087 -2.56 . . . . 0.0 104.087 -168.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -58.75 -44.87 90.66 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 124.379 1.071 . . . . 0.0 113.72 168.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 8.6 tt -57.25 -50.34 73.19 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 114.722 1.379 . . . . 0.0 114.722 169.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 1.7 m -66.01 -49.11 79.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -178.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -67.92 -35.18 78.01 Favored 'General case' 0 CA--C 1.566 1.594 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 -178.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 79.8 t80 -61.11 -55.18 35.52 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-N 119.894 1.225 . . . . 0.0 112.083 169.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . 0.258 76.3 m-70 -68.68 -8.85 46.25 Favored 'General case' 0 CA--C 1.566 1.577 0 N-CA-C 117.797 2.517 . . . . 0.0 117.797 175.352 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 5.9 ttm180 -58.37 -28.1 64.82 Favored 'General case' 0 CA--C 1.579 2.069 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 167.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 70.0 m -114.16 -30.82 6.52 Favored 'General case' 0 CA--C 1.57 1.745 0 C-N-CA 125.341 1.456 . . . . 0.0 113.639 169.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 32.4 m -90.32 152.33 21.07 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-N 120.753 1.615 . . . . 0.0 110.532 176.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 20.5 t -82.04 131.31 35.24 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 120.628 -1.295 . . . . 0.0 112.971 -179.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -66.2 -45.09 91.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 169.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 22.0 t -79.67 -32.2 41.46 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 115.584 1.698 . . . . 0.0 115.584 177.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . 0.336 15.9 ttt180 91.88 -66.64 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 124.926 1.29 . . . . 0.0 111.92 179.308 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -69.52 -54.7 12.9 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 172.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -79.87 140.49 36.75 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-N 118.619 0.645 . . . . 0.0 110.358 171.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 3.3 tm0? -87.41 109.41 19.55 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 123.054 0.542 . . . . 0.0 109.564 178.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 5.2 mp -133.3 121.78 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 172.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 21.6 m-30 -115.16 144.73 43.23 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.745 0.783 . . . . 0.0 109.747 173.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 10.1 mp -90.22 121.97 32.72 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 113.372 0.879 . . . . 0.0 113.372 -169.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -119.62 140.47 50.55 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 124.373 1.069 . . . . 0.0 108.388 169.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -70.39 147.21 49.8 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 -176.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 15.4 pt -67.49 154.31 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 N-CA-C 113.658 0.985 . . . . 0.0 113.658 -178.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 . . . . . 0 N--CA 1.484 1.269 0 CA-C-O 122.827 1.298 . . . . 0.0 110.013 -174.999 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 63.7 p-90 . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 115.246 1.573 . . . . 0.0 115.246 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 29.9 t80 -84.25 131.98 34.68 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-N 119.801 1.182 . . . . 0.0 110.884 -175.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -117.38 -58.92 2.0 Allowed 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 114.815 -1.084 . . . . 0.0 109.735 174.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 104.4 87.65 2.01 Favored Glycine 0 N--CA 1.479 1.543 0 CA-C-N 119.043 0.838 . . . . 0.0 111.972 172.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 68.9 tttt 66.85 69.68 0.4 Allowed 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 124.062 0.945 . . . . 0.0 113.24 178.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 25.4 pt -121.14 148.87 50.24 Favored Pre-proline 0 CA--C 1.574 1.892 0 C-N-CA 123.957 0.903 . . . . 0.0 109.024 175.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -70.9 161.48 45.95 Favored 'Trans proline' 0 CA--C 1.559 1.774 0 C-N-CA 122.933 2.422 . . . . 0.0 114.519 -177.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 56.9 ttt180 -65.16 -40.9 94.97 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 115.786 1.773 . . . . 0.0 115.786 -176.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.74 -46.47 82.08 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 115.34 1.607 . . . . 0.0 115.34 179.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 55.5 mtmt -63.55 -34.52 77.98 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 115.037 1.495 . . . . 0.0 115.037 169.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.5 -43.44 90.11 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 115.484 1.661 . . . . 0.0 115.484 170.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -63.64 -42.88 98.08 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 115.09 1.515 . . . . 0.0 115.09 172.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -63.48 -48.13 78.93 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 114.917 1.451 . . . . 0.0 114.917 175.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -65.52 -43.8 88.89 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 114.756 1.391 . . . . 0.0 114.756 176.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 85.7 mt -67.35 -40.52 85.83 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 116.228 1.936 . . . . 0.0 116.228 175.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 91.1 p -56.33 -30.47 62.62 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 116.951 2.204 . . . . 0.0 116.951 171.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -66.15 -30.66 71.19 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 116.378 1.992 . . . . 0.0 116.378 170.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -59.64 142.66 52.46 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-O 123.024 1.392 . . . . 0.0 113.577 176.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.413 ' HD3' ' H ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -70.28 -15.93 62.96 Favored 'General case' 0 CA--C 1.568 1.659 0 N-CA-C 118.129 2.64 . . . . 0.0 118.129 170.309 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 31.4 m80 -89.43 132.66 34.9 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-N 119.996 1.271 . . . . 0.0 111.137 -169.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -81.29 106.77 13.52 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 169.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 115.82 8.41 13.84 Favored Glycine 0 CA--C 1.557 2.707 0 CA-C-O 116.838 -2.09 . . . . 0.0 116.388 -168.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.44 111.23 3.97 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-N 121.639 2.719 . . . . 0.0 112.331 -170.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 28.5 p90 -118.19 155.92 29.66 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 116.509 2.041 . . . . 0.0 116.509 -168.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.4 pp -148.18 138.68 22.86 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 123.31 0.644 . . . . 0.0 109.972 169.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 81.6 mt -90.17 117.79 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 169.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 4.9 ptm180 -111.23 145.72 38.23 Favored 'General case' 0 N--CA 1.487 1.388 0 CA-C-N 114.102 -1.408 . . . . 0.0 108.708 169.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -79.38 143.93 34.64 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.342 -0.849 . . . . 0.0 109.779 172.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 7.9 t -73.72 8.38 1.95 Allowed 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 119.556 3.169 . . . . 0.0 119.556 -169.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . 0.357 5.9 mp0 74.45 -72.0 0.12 Allowed 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 125.542 1.537 . . . . 0.0 113.654 175.018 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 65.9 m -64.3 -40.71 96.49 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 115.934 1.828 . . . . 0.0 115.934 178.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -111.95 102.41 53.65 Favored Pre-proline 0 CA--C 1.563 1.471 0 CA-C-O 118.077 -0.964 . . . . 0.0 109.49 174.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -58.86 -32.09 96.6 Favored 'Trans proline' 0 C--N 1.37 1.697 0 N-CA-C 119.751 2.943 . . . . 0.0 119.751 174.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -86.76 43.17 3.21 Favored Glycine 0 CA--C 1.554 2.475 0 N-CA-C 115.359 0.903 . . . . 0.0 115.359 169.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -153.83 116.45 4.42 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 105.502 -2.036 . . . . 0.0 105.502 177.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -96.19 172.1 8.18 Favored 'General case' 0 CA--C 1.559 1.323 0 CA-C-O 122.245 1.021 . . . . 0.0 110.746 174.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 71.4 m -146.72 108.33 4.31 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 -176.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 32.5 tp -79.73 117.79 20.95 Favored 'General case' 0 CA--C 1.559 1.312 0 CA-C-O 121.834 0.826 . . . . 0.0 108.925 173.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 18.9 m -104.78 90.46 3.49 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 -172.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 10.0 t -101.09 119.24 48.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 N-CA-C 107.389 -1.338 . . . . 0.0 107.389 -170.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -79.64 134.65 36.44 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.042 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -137.9 109.64 7.1 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 -179.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 78.62 -93.19 1.24 Allowed Glycine 0 N--CA 1.487 2.075 0 N-CA-C 111.838 -0.505 . . . . 0.0 111.838 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 15.7 t30 -149.31 45.38 0.97 Allowed 'General case' 0 CA--C 1.573 1.848 0 C-N-CA 123.295 0.638 . . . . 0.0 110.616 168.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -157.6 134.49 10.04 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 178.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 24.6 t -103.91 121.88 55.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -169.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 66.3 mt-30 -94.06 120.76 34.77 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 175.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 10.2 m-70 -98.86 95.46 7.2 Favored 'General case' 0 CA--C 1.55 0.971 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 -174.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -86.66 125.0 33.56 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-N 114.862 -1.063 . . . . 0.0 108.211 177.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -81.18 125.63 30.51 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-O 121.657 0.742 . . . . 0.0 111.586 -175.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 72.5 t -86.75 106.7 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 173.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.9 pp -114.34 144.67 42.89 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 123.248 0.619 . . . . 0.0 110.903 -176.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -96.99 151.63 19.52 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -169.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . 0.252 4.4 p-10 -100.64 -65.42 0.97 Allowed 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 123.676 0.79 . . . . 0.0 111.62 169.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -94.02 -123.25 3.68 Favored Glycine 0 CA--C 1.543 1.787 0 CA-C-N 119.468 1.031 . . . . 0.0 112.874 -177.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -76.48 -65.49 0.92 Allowed 'General case' 0 N--CA 1.489 1.521 0 CA-C-O 118.833 -0.603 . . . . 0.0 112.041 177.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -135.51 61.61 0.62 Allowed Glycine 0 CA--C 1.542 1.772 0 N-CA-C 111.391 -0.683 . . . . 0.0 111.391 169.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -106.69 92.44 4.1 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 105.75 -1.944 . . . . 0.0 105.75 -179.182 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -82.41 116.7 22.0 Favored 'General case' 0 N--CA 1.484 1.228 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.61 -169.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 15.1 p90 -129.51 125.06 35.48 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-O 121.83 0.824 . . . . 0.0 109.631 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 6.0 tt -104.77 -61.63 1.44 Allowed 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 114.966 -1.016 . . . . 0.0 109.657 176.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 25.6 t90 -83.9 -82.04 0.17 Allowed 'General case' 0 CA--C 1.557 1.218 0 C-N-CA 124.36 1.064 . . . . 0.0 111.41 -169.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . 0.25 7.2 m -136.67 -58.78 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 CA-C-N 118.926 0.785 . . . . 0.0 110.378 176.21 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 13.7 m -79.82 142.02 14.52 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.382 0 C-N-CA 124.085 0.954 . . . . 0.0 111.406 -177.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -79.95 150.35 30.53 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 -176.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -131.77 113.72 13.87 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 -169.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 11.3 p30 -54.97 -42.67 72.67 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 117.297 2.332 . . . . 0.0 117.297 -177.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 98.6 p -117.53 163.61 16.16 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-O 122.266 1.031 . . . . 0.0 111.404 175.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 70.2 mt -66.18 -31.24 71.96 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 114.773 1.397 . . . . 0.0 114.773 169.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -64.14 -43.26 95.78 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-N 119.468 1.031 . . . . 0.0 113.635 169.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -58.74 -40.04 82.65 Favored 'General case' 0 CA--C 1.568 1.637 0 N-CA-C 115.125 1.528 . . . . 0.0 115.125 169.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 8.7 tt -61.24 -51.42 69.01 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 114.62 1.341 . . . . 0.0 114.62 173.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 22.7 m -64.59 -51.23 70.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 N-CA-C 113.461 0.911 . . . . 0.0 113.461 176.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -64.44 -34.34 77.97 Favored 'General case' 0 CA--C 1.564 1.508 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 -176.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -60.7 -52.15 66.35 Favored 'General case' 0 CA--C 1.567 1.61 0 CA-C-N 119.37 0.986 . . . . 0.0 111.471 168.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . 0.255 59.4 m-70 -70.12 -9.25 54.96 Favored 'General case' 0 CA--C 1.565 1.552 0 N-CA-C 118.143 2.646 . . . . 0.0 118.143 176.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 90.0 mtt180 -61.53 -30.41 70.62 Favored 'General case' 0 CA--C 1.576 1.97 0 CA-C-N 120.42 1.463 . . . . 0.0 113.025 167.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 70.3 m -102.11 -40.53 6.78 Favored 'General case' 0 CA--C 1.567 1.623 0 C-N-CA 124.934 1.294 . . . . 0.0 113.633 169.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 44.1 m -90.58 156.44 18.15 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-N 120.061 1.3 . . . . 0.0 111.533 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 33.1 t -84.6 134.55 34.39 Favored 'General case' 0 N--CA 1.485 1.312 0 O-C-N 120.654 -1.278 . . . . 0.0 113.904 -175.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -73.16 -43.73 57.17 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.751 0 C-N-CA 123.939 0.896 . . . . 0.0 112.28 168.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 22.8 t -79.48 138.2 37.48 Favored 'General case' 0 CA--C 1.559 1.309 0 CA-C-N 119.367 0.985 . . . . 0.0 111.142 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -70.63 -56.19 7.04 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 -172.014 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -73.51 -66.16 0.73 Allowed 'General case' 0 N--CA 1.489 1.518 0 CA-C-N 119.151 0.887 . . . . 0.0 112.439 -179.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -87.77 141.73 28.37 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.304 0.641 . . . . 0.0 110.73 -178.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -84.13 104.63 14.35 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 122.848 0.459 . . . . 0.0 111.458 -178.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.54 138.91 52.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 178.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -122.35 158.31 29.9 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 121.989 0.899 . . . . 0.0 113.183 -168.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 9.3 mp -87.59 133.91 33.72 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 124.129 0.972 . . . . 0.0 111.925 -175.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 59.5 mmt-85 -129.58 138.21 51.16 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 124.391 1.077 . . . . 0.0 108.517 176.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -74.8 148.42 40.35 Favored 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 121.843 0.83 . . . . 0.0 112.402 -178.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 19.4 pt -69.66 167.6 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 -169.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 . . . . . 0 N--CA 1.486 1.326 0 CA-C-O 123.902 1.811 . . . . 0.0 109.124 173.045 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 65.3 p-90 . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 116.307 1.965 . . . . 0.0 116.307 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -83.33 125.95 32.18 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-N 119.878 1.217 . . . . 0.0 110.625 -173.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -105.6 -73.88 0.67 Allowed 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 171.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 87.32 125.13 2.0 Favored Glycine 0 CA--C 1.541 1.712 0 CA-C-N 119.458 1.026 . . . . 0.0 112.778 176.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . 0.318 20.0 tptm 76.32 -13.15 0.94 Allowed 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 117.313 2.338 . . . . 0.0 117.313 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 20.3 tt -61.92 131.47 93.17 Favored Pre-proline 0 CA--C 1.575 1.93 0 CA-C-N 120.999 1.727 . . . . 0.0 112.231 174.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -53.7 166.52 1.32 Allowed 'Trans proline' 0 CA--C 1.556 1.618 0 C-N-CA 123.597 2.865 . . . . 0.0 117.394 174.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 59.8 ttt180 -64.98 -42.62 94.39 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 169.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -68.01 -42.48 80.61 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 115.673 1.731 . . . . 0.0 115.673 175.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -66.6 -36.05 81.69 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 115.257 1.577 . . . . 0.0 115.257 170.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.9 -46.14 86.19 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 115.201 1.556 . . . . 0.0 115.201 170.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -59.15 -45.28 91.4 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 114.964 1.468 . . . . 0.0 114.964 169.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -61.24 -47.54 85.57 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 115.119 1.526 . . . . 0.0 115.119 176.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -64.87 -36.36 84.1 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 115.909 1.818 . . . . 0.0 115.909 174.154 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.3 mp -90.13 -22.68 21.64 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 116.717 2.117 . . . . 0.0 116.717 -178.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 74.4 m -64.31 -44.02 92.87 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 120.946 1.703 . . . . 0.0 115.481 177.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . 0.26 0.0 OUTLIER -68.96 -21.82 64.15 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 116.763 2.135 . . . . 0.0 116.763 174.216 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -60.92 135.36 57.76 Favored 'General case' 0 N--CA 1.484 1.226 0 CA-C-N 120.268 1.395 . . . . 0.0 112.014 172.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -78.87 -19.08 52.8 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 117.872 2.545 . . . . 0.0 117.872 179.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 41.5 m80 -89.84 115.07 26.89 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 119.472 1.033 . . . . 0.0 111.607 -168.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.05 113.43 6.42 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 123.877 0.871 . . . . 0.0 110.211 179.276 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 114.6 -8.11 22.19 Favored Glycine 0 CA--C 1.546 2.0 0 CA-C-O 116.524 -2.264 . . . . 0.0 117.118 -169.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -75.76 110.88 10.56 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-N 121.789 2.794 . . . . 0.0 109.951 -173.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 16.4 p90 -120.51 163.0 18.61 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 115.164 1.542 . . . . 0.0 115.164 -168.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.2 pp -138.02 134.61 35.02 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-N 114.452 -1.249 . . . . 0.0 108.227 167.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 76.8 mt -91.4 106.79 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 170.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 51.8 ptt85 -88.25 157.39 18.79 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 123.429 0.692 . . . . 0.0 111.723 170.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -86.6 137.59 32.37 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 169.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 18.3 t -77.41 89.32 3.79 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.474 0.71 . . . . 0.0 111.984 -170.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . 0.341 45.4 mt-10 72.65 -89.78 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 125.311 1.444 . . . . 0.0 107.866 -169.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 21.5 t -152.55 61.46 0.81 Allowed 'General case' 0 CA--C 1.561 1.402 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 168.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -117.75 99.83 52.28 Favored Pre-proline 0 CA--C 1.56 1.341 0 CA-C-O 117.726 -1.131 . . . . 0.0 108.683 -179.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -71.9 128.81 14.53 Favored 'Trans proline' 0 C--N 1.371 1.736 0 C-N-CA 122.959 2.439 . . . . 0.0 111.761 179.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 104.28 -45.9 1.26 Allowed Glycine 0 CA--C 1.551 2.3 0 CA-C-N 114.964 -1.016 . . . . 0.0 112.575 -168.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -87.17 101.65 13.7 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 172.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -113.28 170.69 8.04 Favored 'General case' 0 CA--C 1.562 1.442 0 CA-C-O 121.887 0.851 . . . . 0.0 110.075 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 74.2 m -134.52 115.6 14.1 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 175.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 19.2 tp -79.87 109.35 14.2 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 124.553 1.141 . . . . 0.0 109.155 176.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 9.8 m -105.05 88.78 2.96 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 115.01 -0.995 . . . . 0.0 108.699 -169.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 13.1 t -103.57 127.59 57.46 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -170.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.14 142.38 41.63 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 173.342 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -152.81 103.98 2.82 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 174.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 84.95 -87.53 1.56 Allowed Glycine 0 CA--C 1.542 1.731 0 N-CA-C 112.043 -0.423 . . . . 0.0 112.043 -175.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -137.29 -27.78 0.95 Allowed 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 169.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -85.8 140.13 30.71 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.919 0.887 . . . . 0.0 110.387 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 51.8 t -103.84 119.3 52.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 -176.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 -97.12 118.71 34.15 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.826 0.85 . . . . 0.0 109.547 -174.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -100.43 108.65 20.7 Favored 'General case' 0 CA--C 1.553 1.067 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 -173.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -109.06 123.45 49.17 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 -173.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 19.7 tptm -78.93 124.55 28.35 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-O 121.794 0.807 . . . . 0.0 111.574 -171.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 40.0 t -97.32 106.67 18.85 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.447 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 178.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 64.7 mt -97.68 175.05 6.33 Favored 'General case' 0 CA--C 1.565 1.545 0 C-N-CA 124.163 0.985 . . . . 0.0 112.198 -175.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 15.4 mmt85 -123.68 136.45 54.48 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 123.794 0.838 . . . . 0.0 112.169 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 25.5 p-10 -136.66 123.8 21.7 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 124.067 0.947 . . . . 0.0 109.036 173.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 95.19 -125.62 8.43 Favored Glycine 0 CA--C 1.542 1.755 0 C-N-CA 123.01 0.338 . . . . 0.0 112.961 177.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -88.72 -78.98 0.32 Allowed 'General case' 0 N--CA 1.488 1.452 0 CA-C-O 118.595 -0.717 . . . . 0.0 110.683 -178.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -137.42 63.04 0.58 Allowed Glycine 0 N--CA 1.482 1.731 0 CA-C-N 118.831 0.741 . . . . 0.0 112.244 169.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -120.72 113.61 20.45 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 106.347 -1.723 . . . . 0.0 106.347 -170.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -89.78 128.35 36.12 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.666 0.786 . . . . 0.0 111.756 -169.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 23.7 p90 -124.48 128.79 49.51 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 175.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 8.3 tt -86.31 -63.96 1.23 Allowed 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 118.788 -0.625 . . . . 0.0 110.147 169.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 17.0 m0 -76.82 -71.34 0.4 Allowed 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 118.754 0.706 . . . . 0.0 111.689 178.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 11.6 p -156.47 -52.41 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 C-N-CA 124.744 1.218 . . . . 0.0 109.898 -170.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 10.9 p -79.13 138.0 20.82 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.427 0 C-N-CA 124.351 1.061 . . . . 0.0 110.431 -176.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -79.76 155.29 27.99 Favored 'General case' 0 CA--C 1.559 1.289 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 -171.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -140.97 104.64 4.71 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 103.955 -2.609 . . . . 0.0 103.955 -174.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . 0.268 8.0 p-10 -47.71 -51.33 22.34 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 118.788 2.884 . . . . 0.0 118.788 -169.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 66.5 m -101.81 163.79 12.07 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-O 122.316 1.055 . . . . 0.0 111.476 176.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 15.4 tp -66.02 -37.89 87.03 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 169.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -65.59 -33.83 76.82 Favored 'General case' 0 CA--C 1.573 1.829 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 168.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -62.15 -42.74 99.55 Favored 'General case' 0 CA--C 1.566 1.591 0 CA-C-N 120.63 1.559 . . . . 0.0 114.943 169.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 7.8 tt -60.37 -45.03 94.96 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 169.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 29.4 t -55.04 -61.33 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 C-N-CA 124.43 1.092 . . . . 0.0 112.63 169.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -58.69 -34.75 71.63 Favored 'General case' 0 CA--C 1.568 1.652 0 N-CA-C 115.701 1.741 . . . . 0.0 115.701 -177.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 90.5 t80 -57.64 -56.12 25.97 Favored 'General case' 0 CA--C 1.564 1.512 0 CA-C-O 118.119 -0.943 . . . . 0.0 112.605 169.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . 0.319 52.3 m-70 -71.81 -9.08 57.79 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 117.875 2.546 . . . . 0.0 117.875 175.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 95.8 mtt-85 -65.39 -32.97 74.88 Favored 'General case' 0 CA--C 1.576 1.951 0 CA-C-N 120.702 1.592 . . . . 0.0 112.396 166.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 68.6 m -95.15 -40.26 9.69 Favored 'General case' 0 CA--C 1.563 1.476 0 N-CA-C 114.586 1.328 . . . . 0.0 114.586 170.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 93.6 m -90.82 149.09 22.1 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 124.747 1.219 . . . . 0.0 111.069 176.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 28.7 p -78.25 134.26 37.58 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.2 -0.938 . . . . 0.0 111.929 174.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 3.4 t -65.73 -52.33 51.47 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 C-N-CA 122.928 0.491 . . . . 0.0 111.091 173.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 74.2 m -98.89 143.08 29.6 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.638 0.732 . . . . 0.0 109.36 169.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 7.9 mpt_? -73.17 -51.73 16.75 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -177.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -68.06 -59.47 3.23 Favored 'General case' 0 N--CA 1.495 1.775 0 CA-C-N 119.199 0.909 . . . . 0.0 113.229 177.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -81.72 113.86 19.98 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 170.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -80.15 101.1 8.59 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 122.753 0.421 . . . . 0.0 111.244 -171.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 11.8 mm -100.14 106.29 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -169.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -112.88 127.4 56.18 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -179.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 9.7 mp -76.24 131.28 39.19 Favored 'General case' 0 CA--C 1.561 1.402 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 -169.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 61.7 ttt-85 -136.24 148.56 48.12 Favored 'General case' 0 CA--C 1.563 1.459 0 C-N-CA 125.258 1.423 . . . . 0.0 108.443 177.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -65.33 164.8 12.87 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 120.526 -1.359 . . . . 0.0 113.211 171.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.3 pp -64.19 162.59 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 -174.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 . . . . . 0 N--CA 1.488 1.444 0 CA-C-O 122.841 1.305 . . . . 0.0 110.488 174.472 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . 0.262 1.6 p90 . . . . . 0 CA--C 1.56 1.341 0 CA-C-O 118.147 -0.93 . . . . 0.0 112.857 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -84.33 137.07 33.63 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 120.409 1.459 . . . . 0.0 111.407 -178.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -99.84 -92.5 0.28 Allowed 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 175.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 146.61 85.29 0.06 OUTLIER Glycine 0 N--CA 1.479 1.554 0 CA-C-N 119.438 1.017 . . . . 0.0 111.605 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 26.1 tptp 64.69 69.97 0.49 Allowed 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 124.168 0.987 . . . . 0.0 113.176 174.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 27.3 pt -125.0 149.29 62.83 Favored Pre-proline 0 CA--C 1.573 1.863 0 C-N-CA 123.793 0.837 . . . . 0.0 109.666 -179.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -75.07 171.34 18.5 Favored 'Trans proline' 0 CA--C 1.558 1.709 0 C-N-CA 122.93 2.42 . . . . 0.0 114.581 -178.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 57.0 ttt180 -65.26 -42.49 93.19 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 114.77 1.396 . . . . 0.0 114.77 176.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.14 -42.63 96.73 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 115.76 1.763 . . . . 0.0 115.76 176.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 14.6 tmtt? -65.37 -38.5 90.24 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 169.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.89 -46.6 84.16 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 115.314 1.598 . . . . 0.0 115.314 172.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -60.62 -40.97 93.84 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 115.16 1.541 . . . . 0.0 115.16 170.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -58.55 -56.46 21.86 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 171.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 45.7 tpp -56.71 -47.67 79.43 Favored 'General case' 0 CA--C 1.564 1.485 0 N-CA-C 115.683 1.735 . . . . 0.0 115.683 178.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 74.8 mt -68.04 -30.94 70.27 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 116.456 2.021 . . . . 0.0 116.456 175.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 21.8 t -62.96 -33.05 74.56 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 115.606 1.706 . . . . 0.0 115.606 169.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -62.46 -37.26 85.23 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 115.748 1.759 . . . . 0.0 115.748 170.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -61.05 139.44 58.07 Favored 'General case' 0 CA--C 1.556 1.18 0 N-CA-C 115.115 1.524 . . . . 0.0 115.115 -175.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 15.7 ptp180 -70.59 -21.0 62.72 Favored 'General case' 0 CA--C 1.568 1.635 0 N-CA-C 118.404 2.742 . . . . 0.0 118.404 174.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 49.5 m80 -89.21 144.97 25.72 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 119.575 1.08 . . . . 0.0 112.667 -168.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -78.09 114.99 17.48 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 123.635 0.774 . . . . 0.0 109.944 175.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 82.57 33.12 25.86 Favored Glycine 0 CA--C 1.548 2.137 0 CA-C-O 118.387 -1.23 . . . . 0.0 115.36 -168.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.99 113.64 6.56 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 118.949 1.374 . . . . 0.0 110.211 178.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 22.2 p90 -123.37 155.52 37.18 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 115.005 1.483 . . . . 0.0 115.005 -168.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.2 pp -142.02 143.84 33.35 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.895 0.878 . . . . 0.0 108.945 168.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.4 mp -94.55 119.6 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 N-CA-C 105.704 -1.962 . . . . 0.0 105.704 169.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 49.4 ptt85 -103.14 158.2 16.47 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 123.503 0.721 . . . . 0.0 111.135 169.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -90.02 126.61 35.82 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 169.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 18.0 t -65.79 139.22 58.31 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 112.878 0.695 . . . . 0.0 112.878 -173.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -70.54 -53.01 17.83 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 -171.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.6 t -62.67 -38.01 88.67 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 115.866 1.802 . . . . 0.0 115.866 172.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -118.69 97.28 50.68 Favored Pre-proline 0 CA--C 1.562 1.439 0 CA-C-N 119.195 0.907 . . . . 0.0 110.015 176.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_exo -57.4 -30.24 87.23 Favored 'Trans proline' 0 C--N 1.37 1.671 0 N-CA-C 119.617 2.891 . . . . 0.0 119.617 172.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -88.28 47.0 3.44 Favored Glycine 0 CA--C 1.552 2.395 0 N-CA-C 114.527 0.571 . . . . 0.0 114.527 168.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -160.09 125.39 4.0 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 105.906 -1.887 . . . . 0.0 105.906 -179.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 11.0 m-30 -95.93 172.26 8.12 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.823 0.821 . . . . 0.0 111.272 175.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 71.5 m -147.85 115.06 6.21 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 -179.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 28.7 tp -79.92 108.59 13.62 Favored 'General case' 0 N--CA 1.487 1.379 0 CA-C-O 122.29 1.043 . . . . 0.0 109.61 174.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 6.2 m -95.54 112.62 24.3 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 34.5 t -121.02 131.1 73.86 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.169 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 -174.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 28.7 tptp -76.98 100.59 5.67 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 123.309 0.644 . . . . 0.0 110.933 175.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -86.13 -169.16 2.51 Favored 'General case' 0 CA--C 1.572 1.817 0 CA-C-O 121.291 0.567 . . . . 0.0 109.586 173.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -68.48 106.58 1.78 Allowed Glycine 0 CA--C 1.544 1.877 0 O-C-N 120.692 -1.255 . . . . 0.0 113.497 179.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . 0.319 10.3 t30 75.23 -18.9 0.42 Allowed 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 118.192 2.664 . . . . 0.0 118.192 -175.299 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -144.33 143.36 30.94 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 120.336 1.426 . . . . 0.0 109.611 -169.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 56.2 t -90.64 113.56 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 178.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -94.76 122.97 37.92 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 121.601 0.715 . . . . 0.0 109.96 178.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 8.7 m-70 -100.19 127.1 46.53 Favored 'General case' 0 CA--C 1.552 1.046 0 CA-C-N 114.985 -1.007 . . . . 0.0 109.251 -175.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -119.21 126.72 52.2 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 -177.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 48.2 mtpt -76.27 116.4 16.93 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-O 121.182 0.515 . . . . 0.0 110.608 -177.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 75.9 t -85.09 98.9 6.63 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.374 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 172.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.8 mt -81.36 137.35 35.73 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.893 -179.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 78.1 mtp180 -113.38 120.68 41.92 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -174.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . 0.286 4.9 p-10 -85.29 -66.13 0.93 Allowed 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -88.92 -110.18 1.16 Allowed Glycine 0 N--CA 1.482 1.737 0 CA-C-N 119.331 0.968 . . . . 0.0 112.395 -176.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -84.6 -84.14 0.15 Allowed 'General case' 0 N--CA 1.487 1.413 0 CA-C-O 118.364 -0.827 . . . . 0.0 109.175 174.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -116.88 63.6 0.37 Allowed Glycine 0 N--CA 1.481 1.68 0 CA-C-N 118.896 0.771 . . . . 0.0 111.535 169.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm -101.79 87.14 3.06 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 106.017 -1.845 . . . . 0.0 106.017 -176.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 47.7 m-85 -82.78 116.85 22.3 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 114.892 -1.049 . . . . 0.0 112.64 -168.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -135.54 114.11 11.75 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.44 0.696 . . . . 0.0 110.144 177.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . 0.276 1.8 pt? -87.09 -45.45 10.7 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-O 118.758 -0.639 . . . . 0.0 112.51 168.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 45.3 m0 -83.57 -84.74 0.13 Allowed 'General case' 0 CA--C 1.564 1.495 0 CA-C-N 118.966 0.803 . . . . 0.0 109.436 173.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 61.0 t -141.02 -55.97 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 C-N-CA 124.32 1.048 . . . . 0.0 109.063 -174.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 13.6 p -79.45 128.83 38.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 C-N-CA 123.663 0.785 . . . . 0.0 110.968 -170.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.44 159.67 18.59 Favored 'General case' 0 N--CA 1.486 1.351 0 CA-C-O 122.53 1.157 . . . . 0.0 113.724 -175.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -141.84 121.5 13.41 Favored 'General case' 0 N--CA 1.484 1.242 0 CA-C-N 113.96 -1.473 . . . . 0.0 107.052 -170.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 36.0 m-80 -58.69 -41.4 86.18 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 115.585 1.698 . . . . 0.0 115.585 177.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 26.2 t -114.86 152.74 31.7 Favored 'General case' 0 N--CA 1.484 1.271 0 CA-C-O 122.069 0.937 . . . . 0.0 111.19 178.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 80.6 mt -63.95 -27.26 69.01 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 168.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -59.09 -39.23 81.54 Favored 'General case' 0 CA--C 1.575 1.935 0 CA-C-N 120.105 1.321 . . . . 0.0 113.923 168.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -70.35 -43.52 70.03 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 114.76 1.393 . . . . 0.0 114.76 171.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 9.9 tt -59.1 -46.21 88.89 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 115.361 1.615 . . . . 0.0 115.361 170.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 4.4 p -68.3 -48.41 73.43 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.538 0 N-CA-C 113.742 1.015 . . . . 0.0 113.742 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -56.25 -35.89 67.91 Favored 'General case' 0 CA--C 1.569 1.711 0 N-CA-C 115.182 1.549 . . . . 0.0 115.182 169.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 61.3 t80 -55.6 -55.86 27.12 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 117.26 -1.352 . . . . 0.0 113.102 169.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . 0.381 33.5 m-70 -73.52 -9.22 58.45 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 118.748 2.87 . . . . 0.0 118.748 175.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 91.2 mtt-85 -73.0 -27.06 61.57 Favored 'General case' 0 CA--C 1.581 2.137 0 CA-C-N 120.058 1.299 . . . . 0.0 112.42 166.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 69.6 m -97.85 -42.14 7.7 Favored 'General case' 0 CA--C 1.565 1.543 0 C-N-CA 125.012 1.325 . . . . 0.0 114.24 171.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 92.6 m -85.93 142.58 28.73 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 124.614 1.165 . . . . 0.0 109.717 171.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 33.5 t -72.35 121.09 18.9 Favored 'General case' 0 N--CA 1.485 1.303 0 O-C-N 121.449 -0.782 . . . . 0.0 111.113 173.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 11.4 p -58.33 -35.57 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 N-CA-C 115.525 1.676 . . . . 0.0 115.525 172.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 15.1 t -79.52 -28.11 41.35 Favored 'General case' 0 CA--C 1.564 1.512 0 N-CA-C 116.682 2.104 . . . . 0.0 116.682 179.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . 0.352 98.6 mtt180 86.65 -78.79 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 CA-C-N 120.274 1.397 . . . . 0.0 111.393 -177.287 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 70.1 m-80 -67.5 -52.82 34.56 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -79.7 152.19 30.04 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.166 0.586 . . . . 0.0 110.583 169.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -89.89 88.09 7.2 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 173.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 19.9 mm -113.13 141.39 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -146.63 145.69 30.15 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 121.946 0.879 . . . . 0.0 112.524 -168.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 11.2 mp -83.68 117.2 23.05 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-N 114.761 -1.109 . . . . 0.0 112.279 -169.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 27.2 mmm180 -109.29 137.49 47.09 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 124.304 1.042 . . . . 0.0 109.058 169.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -73.66 142.91 46.43 Favored 'General case' 0 CA--C 1.564 1.487 0 CA-C-O 121.742 0.782 . . . . 0.0 111.713 -178.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 17.9 pt -63.3 156.29 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 114.814 1.413 . . . . 0.0 114.814 -173.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 . . . . . 0 N--CA 1.483 1.213 0 CA-C-O 123.999 1.857 . . . . 0.0 109.11 179.531 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . 0.273 1.8 p90 . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 118.015 -0.993 . . . . 0.0 113.068 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -80.15 135.25 36.26 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-N 120.444 1.475 . . . . 0.0 110.263 172.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -121.3 -80.03 0.62 Allowed 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 179.31 -146.47 7.16 Favored Glycine 0 N--CA 1.48 1.589 0 CA-C-N 119.09 0.859 . . . . 0.0 112.012 176.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -85.03 88.43 7.46 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 121.533 0.682 . . . . 0.0 109.288 -179.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 35.8 pt -118.92 148.29 44.29 Favored Pre-proline 0 CA--C 1.573 1.832 0 C-N-CA 124.126 0.97 . . . . 0.0 109.762 -174.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -71.8 157.77 54.53 Favored 'Trans proline' 0 CA--C 1.559 1.739 0 C-N-CA 122.995 2.463 . . . . 0.0 114.325 -177.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 42.1 ttp85 -66.75 -41.1 88.35 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 115.113 1.523 . . . . 0.0 115.113 -179.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -65.75 -42.75 90.55 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 115.924 1.824 . . . . 0.0 115.924 178.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -67.39 -34.11 76.59 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 169.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.39 -43.75 96.68 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 169.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -60.44 -42.83 96.93 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 115.041 1.497 . . . . 0.0 115.041 169.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -61.7 -51.71 67.3 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 176.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -61.88 -46.51 89.08 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 115.091 1.515 . . . . 0.0 115.091 175.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 8.9 mp -66.22 -36.3 82.68 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 115.822 1.786 . . . . 0.0 115.822 175.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 20.9 t -56.24 -30.17 62.01 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 116.593 2.071 . . . . 0.0 116.593 169.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -60.67 -35.29 75.88 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 115.703 1.742 . . . . 0.0 115.703 169.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -67.93 129.41 39.83 Favored 'General case' 0 CA--C 1.555 1.15 0 CA-C-O 122.935 1.35 . . . . 0.0 112.499 -179.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 14.7 ptp180 -66.52 -17.79 65.0 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 118.912 2.93 . . . . 0.0 118.912 172.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 46.1 m80 -89.46 137.37 32.39 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 119.576 1.08 . . . . 0.0 111.818 -168.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -78.25 105.27 9.37 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 171.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 118.14 -3.65 16.33 Favored Glycine 0 CA--C 1.55 2.251 0 CA-C-O 116.198 -2.446 . . . . 0.0 116.7 -168.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.77 110.15 1.44 Allowed 'General case' 0 N--CA 1.494 1.77 0 CA-C-N 122.017 2.909 . . . . 0.0 112.231 -176.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 18.4 p90 -128.43 161.64 29.02 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 117.263 2.32 . . . . 0.0 117.263 -167.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.2 pp -143.12 151.86 41.18 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 114.233 -1.349 . . . . 0.0 108.446 168.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 3.8 mp -102.44 118.04 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 105.173 -2.158 . . . . 0.0 105.173 169.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 46.8 ptt85 -101.44 141.06 34.87 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.174 0.59 . . . . 0.0 110.083 169.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -79.89 134.96 36.33 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 169.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 53.5 m -72.33 139.21 47.81 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-O 121.491 0.662 . . . . 0.0 111.956 -177.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -69.96 -54.54 12.82 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -173.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 97.2 p -61.91 -41.95 98.52 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 115.994 1.85 . . . . 0.0 115.994 171.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -111.85 96.77 34.95 Favored Pre-proline 0 CA--C 1.562 1.405 0 CA-C-O 117.965 -1.017 . . . . 0.0 109.494 176.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -63.61 -26.59 69.2 Favored 'Trans proline' 0 CA--C 1.559 1.765 0 C-N-CA 122.959 2.439 . . . . 0.0 118.203 174.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -91.5 50.12 2.94 Favored Glycine 0 CA--C 1.553 2.422 0 CA-C-O 119.732 -0.482 . . . . 0.0 113.326 168.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -160.04 120.29 2.96 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 106.026 -1.842 . . . . 0.0 106.026 178.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 12.2 m-30 -98.63 172.2 7.64 Favored 'General case' 0 CA--C 1.565 1.55 0 CA-C-O 122.064 0.935 . . . . 0.0 111.341 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 74.3 m -148.19 112.56 5.27 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 -178.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 27.4 tp -85.21 105.08 15.64 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-O 122.308 1.051 . . . . 0.0 109.638 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.8 m -89.85 111.35 22.36 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 125.177 1.391 . . . . 0.0 107.816 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 22.0 t -127.46 121.19 56.6 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.161 0 CA-C-N 120.031 1.287 . . . . 0.0 107.795 -172.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 7.4 tmtm? -89.47 92.43 9.11 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 122.8 0.44 . . . . 0.0 110.734 177.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 25.3 t80 -125.1 111.18 15.03 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 68.12 71.05 1.01 Allowed Glycine 0 N--CA 1.482 1.739 0 N-CA-C 115.525 0.97 . . . . 0.0 115.525 173.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . 0.294 16.8 m120 70.76 -13.35 0.49 Allowed 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 118.49 2.774 . . . . 0.0 118.49 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -132.65 138.49 47.35 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 120.16 1.345 . . . . 0.0 110.159 -169.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 43.5 t -92.1 111.27 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 N-CA-C 106.045 -1.835 . . . . 0.0 106.045 171.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -104.34 114.8 29.27 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.84 0.856 . . . . 0.0 108.771 -170.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 16.7 m-70 -95.21 97.31 9.79 Favored 'General case' 0 CA--C 1.552 1.023 0 CA-C-N 114.745 -1.116 . . . . 0.0 108.417 -173.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -95.88 122.24 38.47 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 -176.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -76.37 115.85 16.5 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 121.302 0.572 . . . . 0.0 110.715 -171.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 84.7 t -91.45 104.5 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 60.7 mt -92.07 131.45 37.33 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.38 -174.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 78.0 mtp180 -106.64 148.2 28.62 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 122.865 0.466 . . . . 0.0 111.195 -173.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -137.27 129.83 29.96 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 123.029 0.531 . . . . 0.0 110.51 171.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 81.7 -113.58 3.67 Favored Glycine 0 CA--C 1.541 1.693 0 C-N-CA 122.971 0.32 . . . . 0.0 113.462 173.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -82.29 -70.37 0.55 Allowed 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 123.118 0.567 . . . . 0.0 111.102 175.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -159.28 71.76 0.23 Allowed Glycine 0 N--CA 1.477 1.431 0 N-CA-C 111.033 -0.827 . . . . 0.0 111.033 169.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -98.71 96.52 7.98 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 106.468 -1.679 . . . . 0.0 106.468 177.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -86.45 100.27 12.24 Favored 'General case' 0 CA--C 1.558 1.259 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.724 -169.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 46.3 p90 -112.87 122.51 47.86 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 123.608 0.763 . . . . 0.0 109.113 -178.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -134.67 -32.88 0.98 Allowed 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 114.44 1.274 . . . . 0.0 114.44 -171.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 46.2 t90 -114.19 -76.6 0.58 Allowed 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 124.764 1.226 . . . . 0.0 108.089 178.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 96.0 t -130.05 -73.57 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 -178.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.3 p -83.16 145.8 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 C-N-CA 123.514 0.726 . . . . 0.0 111.8 -173.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -79.72 152.51 29.84 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 121.565 0.697 . . . . 0.0 112.329 174.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -130.02 121.26 26.13 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -173.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 36.1 t30 -63.64 -50.06 70.8 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 178.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 28.4 t -94.0 148.45 22.15 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-O 122.024 0.916 . . . . 0.0 111.175 173.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 14.1 tp -68.69 -34.93 76.51 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 169.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 -61.44 -40.99 96.48 Favored 'General case' 0 CA--C 1.571 1.771 0 C-N-CA 123.881 0.873 . . . . 0.0 113.331 169.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -58.8 -43.84 90.63 Favored 'General case' 0 CA--C 1.567 1.609 0 N-CA-C 114.956 1.465 . . . . 0.0 114.956 169.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 9.3 tt -54.22 -47.66 71.92 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 114.217 1.191 . . . . 0.0 114.217 169.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 43.7 t -57.86 -60.79 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 C-N-CA 124.361 1.065 . . . . 0.0 112.78 173.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -61.02 -29.15 69.54 Favored 'General case' 0 CA--C 1.568 1.64 0 N-CA-C 116.806 2.15 . . . . 0.0 116.806 -176.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 76.4 t80 -65.4 -58.9 4.74 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-N 119.261 0.937 . . . . 0.0 112.124 169.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 74.2 m-70 -67.95 -9.27 43.9 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 117.832 2.531 . . . . 0.0 117.832 176.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 11.4 ttm180 -60.24 -30.3 69.32 Favored 'General case' 0 CA--C 1.576 1.956 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 167.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 70.5 m -108.93 -31.31 7.71 Favored 'General case' 0 CA--C 1.568 1.643 0 C-N-CA 124.982 1.313 . . . . 0.0 114.252 169.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 59.3 m -91.21 155.68 18.4 Favored 'General case' 0 N--CA 1.498 1.971 0 CA-C-N 120.664 1.575 . . . . 0.0 112.109 176.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 38.0 t -70.48 132.63 45.84 Favored 'General case' 0 N--CA 1.485 1.32 0 O-C-N 121.498 -0.751 . . . . 0.0 112.938 175.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 15.2 t -68.49 -48.16 73.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 CA-C-O 118.225 -0.893 . . . . 0.0 112.084 171.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 22.7 t -105.94 -113.25 0.26 Allowed 'General case' 0 CA--C 1.559 1.319 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 170.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 11.7 tpt180 -161.05 -41.67 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 CA-C-N 119.644 1.111 . . . . 0.0 113.275 174.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -60.12 -57.02 14.6 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 -176.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -79.76 -16.05 56.31 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 117.587 2.44 . . . . 0.0 117.587 174.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 59.51 77.9 0.29 Allowed 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 125.561 1.545 . . . . 0.0 111.71 -175.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 4.7 mp -84.28 124.23 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 -168.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -127.4 117.33 21.97 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 -176.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 10.8 mp -70.5 137.57 50.33 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 114.778 1.399 . . . . 0.0 114.778 -169.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 19.3 mmt85 -135.56 146.68 48.25 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 124.803 1.241 . . . . 0.0 107.807 179.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -72.28 147.28 46.55 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.702 -1.249 . . . . 0.0 112.924 179.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 29.6 pt -68.52 148.28 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 C-N-CA 124.133 0.973 . . . . 0.0 113.092 -178.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 . . . . . 0 N--CA 1.485 1.301 0 CA-C-O 123.872 1.796 . . . . 0.0 108.84 -174.993 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . 0.274 1.2 p90 . . . . . 0 N--CA 1.489 1.492 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -81.81 134.31 35.41 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 120.657 1.571 . . . . 0.0 111.509 -176.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -101.7 -90.11 0.35 Allowed 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 175.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 154.19 79.49 0.03 OUTLIER Glycine 0 N--CA 1.482 1.718 0 CA-C-N 119.625 1.102 . . . . 0.0 111.941 179.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . 0.384 65.4 pttt 43.16 59.37 2.96 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 117.514 2.413 . . . . 0.0 117.514 -173.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 23.1 pt -85.77 155.07 58.91 Favored Pre-proline 0 CA--C 1.576 1.954 0 CA-C-O 118.385 -0.817 . . . . 0.0 110.509 174.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -71.09 167.98 24.56 Favored 'Trans proline' 0 CA--C 1.561 1.862 0 C-N-CA 122.73 2.287 . . . . 0.0 114.107 177.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 53.9 ttt180 -63.65 -40.6 97.27 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 115.844 1.794 . . . . 0.0 115.844 177.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.4 -41.91 96.39 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 115.574 1.694 . . . . 0.0 115.574 173.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 55.7 tptt -66.86 -34.89 78.79 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 114.869 1.433 . . . . 0.0 114.869 169.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.37 -45.55 87.23 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 115.118 1.525 . . . . 0.0 115.118 171.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -65.79 -33.83 76.76 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 115.754 1.761 . . . . 0.0 115.754 169.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -57.65 -49.42 76.51 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-N 119.99 1.268 . . . . 0.0 114.24 170.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 45.3 tpp -61.36 -47.91 83.7 Favored 'General case' 0 CA--C 1.567 1.624 0 N-CA-C 115.919 1.822 . . . . 0.0 115.919 172.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 83.4 mt -89.35 -43.82 10.65 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 116.735 2.124 . . . . 0.0 116.735 -169.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 49.7 m -61.6 -32.1 72.2 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 115.598 1.703 . . . . 0.0 115.598 171.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -59.64 -43.4 93.86 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 115.706 1.743 . . . . 0.0 115.706 169.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -75.61 134.86 40.55 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-O 122.867 1.318 . . . . 0.0 111.979 177.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -58.95 -13.01 5.24 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 120.199 3.407 . . . . 0.0 120.199 177.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 50.7 m80 -89.07 127.84 35.72 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 120.008 1.276 . . . . 0.0 113.032 -168.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -73.31 130.18 39.63 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 123.932 0.893 . . . . 0.0 109.753 172.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 96.82 -6.58 64.66 Favored Glycine 0 CA--C 1.547 2.07 0 N-CA-C 118.083 1.993 . . . . 0.0 118.083 -169.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.06 114.52 5.28 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-N 120.658 2.229 . . . . 0.0 112.714 -169.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -124.25 156.04 37.54 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 115.093 1.516 . . . . 0.0 115.093 -168.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.9 pp -142.74 139.61 31.13 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-N 114.736 -1.12 . . . . 0.0 108.897 169.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.5 mp -92.84 118.78 39.26 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.436 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 173.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 40.0 ptt85 -108.51 134.73 50.88 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 169.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -79.47 139.72 37.54 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 121.581 0.705 . . . . 0.0 111.087 -177.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 49.1 m -72.2 124.15 24.42 Favored 'General case' 0 N--CA 1.486 1.369 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.719 173.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -75.25 -49.13 20.26 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 177.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 16.2 t -56.96 -35.07 68.68 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 116.369 1.988 . . . . 0.0 116.369 170.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -111.56 92.19 16.16 Favored Pre-proline 0 CA--C 1.564 1.486 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 169.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -72.13 133.05 20.6 Favored 'Trans proline' 0 C--N 1.372 1.803 0 C-N-CA 123.177 2.585 . . . . 0.0 112.324 -176.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 95.22 -35.88 4.07 Favored Glycine 0 CA--C 1.553 2.444 0 CA-C-O 119.08 -0.844 . . . . 0.0 114.297 -168.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -78.86 136.25 37.26 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-N 118.524 1.162 . . . . 0.0 109.467 178.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -106.55 172.22 6.93 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 115.254 -0.884 . . . . 0.0 111.53 -169.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 74.7 m -145.2 116.38 7.92 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 175.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 24.1 tp -79.88 122.58 26.84 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.638 0.775 . . . . 0.0 109.832 174.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 20.7 m -109.51 93.28 4.42 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 106.541 -1.651 . . . . 0.0 106.541 177.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.1 p -108.49 118.55 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 C-N-CA 123.72 0.808 . . . . 0.0 109.891 -171.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -76.71 146.6 37.92 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-N 115.285 -0.87 . . . . 0.0 112.045 172.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -155.03 107.46 2.73 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 171.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 90.61 -75.65 1.64 Allowed Glycine 0 N--CA 1.484 1.856 0 C-N-CA 122.651 0.167 . . . . 0.0 113.294 179.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -136.86 -45.35 0.58 Allowed 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 123.948 0.899 . . . . 0.0 113.147 173.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -92.94 148.29 22.13 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.37 1.068 . . . . 0.0 111.642 -169.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 20.8 t -99.01 120.98 49.06 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 -178.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 24.3 mp0 -98.29 125.01 43.22 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.935 0.894 . . . . 0.0 109.147 178.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 9.8 m-70 -107.44 114.27 28.17 Favored 'General case' 0 CA--C 1.552 1.033 0 CA-C-N 114.79 -1.096 . . . . 0.0 108.361 -169.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -122.56 125.79 46.43 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 -176.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -81.21 123.94 28.88 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-O 121.408 0.623 . . . . 0.0 110.881 -176.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 68.9 t -80.66 104.87 9.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 171.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 59.9 mt -91.13 141.11 29.16 Favored 'General case' 0 N--CA 1.484 1.256 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.826 179.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 53.3 mtp180 -108.35 146.38 33.07 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 123.533 0.733 . . . . 0.0 110.032 179.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 17.7 p-10 -79.58 -42.86 24.11 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 115.783 1.771 . . . . 0.0 115.783 -179.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 179.1 -79.3 0.06 OUTLIER Glycine 0 CA--C 1.537 1.44 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 -172.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -72.41 -64.22 1.0 Allowed 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 175.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 175.73 75.38 0.05 OUTLIER Glycine 0 N--CA 1.479 1.521 0 CA-C-N 119.039 0.836 . . . . 0.0 112.543 173.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp -128.29 111.54 13.49 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 105.018 -2.216 . . . . 0.0 105.018 174.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -91.73 131.72 36.9 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 124.026 0.93 . . . . 0.0 110.728 -169.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -144.08 137.29 27.46 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 123.646 0.778 . . . . 0.0 109.966 -178.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -132.31 -43.16 0.95 Allowed 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 172.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 39.2 t90 -85.74 -77.22 0.3 Allowed 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 124.313 1.045 . . . . 0.0 110.119 -176.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 9.4 p -149.28 -55.87 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 C-N-CA 123.727 0.811 . . . . 0.0 110.465 175.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 13.5 p -79.6 122.8 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 C-N-CA 123.827 0.851 . . . . 0.0 110.53 -175.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 6.5 ttpm? -79.88 146.45 32.17 Favored 'General case' 0 CA--C 1.559 1.299 0 CA-C-O 122.26 1.029 . . . . 0.0 112.919 -176.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -118.58 158.41 25.48 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 114.134 -1.394 . . . . 0.0 109.202 -173.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -76.99 -57.73 3.68 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 118.119 -0.943 . . . . 0.0 112.635 173.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 83.8 p -109.2 162.56 14.17 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-O 122.334 1.064 . . . . 0.0 112.575 -178.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 18.6 tp -64.99 -33.96 77.3 Favored 'General case' 0 CA--C 1.571 1.761 0 N-CA-C 115.036 1.495 . . . . 0.0 115.036 169.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 14.2 m-80 -64.45 -42.74 95.79 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 113.642 0.979 . . . . 0.0 113.642 169.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -58.78 -41.32 86.37 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 115.836 1.791 . . . . 0.0 115.836 169.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 9.7 tt -53.69 -50.25 66.27 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 115.265 1.58 . . . . 0.0 115.265 172.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 25.7 m -67.88 -45.65 83.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 176.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . 0.256 3.7 p30 -65.26 -29.52 70.31 Favored 'General case' 0 CA--C 1.569 1.711 0 N-CA-C 115.408 1.633 . . . . 0.0 115.408 -178.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 77.9 t80 -67.05 -54.2 23.8 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-N 119.256 0.934 . . . . 0.0 111.613 168.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 80.2 m-70 -67.53 -9.2 40.21 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 117.869 2.544 . . . . 0.0 117.869 176.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 52.9 ttm-85 -57.81 -31.46 66.62 Favored 'General case' 0 CA--C 1.577 2.016 0 C-N-CA 124.285 1.034 . . . . 0.0 113.726 167.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 71.0 m -107.73 -34.56 6.94 Favored 'General case' 0 CA--C 1.568 1.654 0 C-N-CA 125.151 1.38 . . . . 0.0 113.955 169.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 90.0 m -90.66 156.56 18.02 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-N 120.504 1.502 . . . . 0.0 111.913 178.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 32.4 t -74.97 121.41 21.91 Favored 'General case' 0 CA--C 1.558 1.279 0 O-C-N 121.342 -0.849 . . . . 0.0 112.034 177.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.5 p -73.14 -34.8 45.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 170.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 20.3 t -85.26 147.24 26.66 Favored 'General case' 0 CA--C 1.558 1.254 0 CA-C-N 119.098 0.863 . . . . 0.0 111.296 174.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 61.1 ttp85 -68.78 -63.37 1.07 Allowed 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 123.162 0.585 . . . . 0.0 112.297 173.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 19.6 t30 -72.42 -52.64 15.05 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 178.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 67.1 mt-30 -79.8 161.62 25.57 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.675 0.75 . . . . 0.0 112.031 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -105.61 94.56 5.27 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 175.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 28.8 mm -113.98 119.14 60.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 -172.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -121.2 126.81 50.59 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 -174.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 11.1 mp -78.5 124.2 27.88 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 -169.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 7.7 mpt_? -120.0 146.88 45.45 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 124.807 1.243 . . . . 0.0 108.242 172.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -75.4 155.56 36.27 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 121.674 0.749 . . . . 0.0 112.564 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 45.7 pt -66.08 156.61 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 N-CA-C 114.542 1.312 . . . . 0.0 114.542 -172.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 . . . . . 0 N--CA 1.483 1.221 0 CA-C-O 123.975 1.845 . . . . 0.0 109.873 -176.43 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 61.9 p-90 . . . . . 0 N--CA 1.493 1.684 0 N-CA-C 117.57 2.434 . . . . 0.0 117.57 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 33.3 t80 -83.2 124.79 30.88 Favored 'General case' 0 N--CA 1.484 1.267 0 CA-C-N 119.559 1.072 . . . . 0.0 109.616 179.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -110.33 -74.19 0.66 Allowed 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 118.483 -0.77 . . . . 0.0 109.046 179.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 177.37 -98.91 0.12 Allowed Glycine 0 N--CA 1.476 1.364 0 CA-C-N 119.263 0.938 . . . . 0.0 111.525 177.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -140.6 94.09 2.69 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 -174.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 36.5 pt -127.98 153.89 78.35 Favored Pre-proline 0 CA--C 1.575 1.922 0 C-N-CA 123.617 0.767 . . . . 0.0 110.484 -175.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -78.2 176.69 9.66 Favored 'Trans proline' 0 CA--C 1.565 2.051 0 C-N-CA 123.037 2.491 . . . . 0.0 114.458 176.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 29.3 ttm180 -61.48 -43.0 99.64 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 115.952 1.834 . . . . 0.0 115.952 172.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.74 -46.84 80.53 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 115.252 1.575 . . . . 0.0 115.252 178.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm -61.95 -35.94 79.93 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 115.559 1.688 . . . . 0.0 115.559 169.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.55 -40.9 89.3 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 115.493 1.664 . . . . 0.0 115.493 171.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -63.75 -39.76 95.06 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 115.313 1.597 . . . . 0.0 115.313 169.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -60.64 -49.2 78.46 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 174.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -62.26 -49.8 74.26 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 114.492 1.293 . . . . 0.0 114.492 173.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 9.9 mp -69.14 -27.8 65.88 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 116.42 2.007 . . . . 0.0 116.42 179.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 23.3 t -59.28 -37.98 79.02 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-N 120.508 1.503 . . . . 0.0 114.683 169.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt -63.84 -31.91 73.25 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 115.64 1.718 . . . . 0.0 115.64 169.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -64.78 120.59 12.76 Favored 'General case' 0 N--CA 1.484 1.27 0 CA-C-N 119.626 1.103 . . . . 0.0 112.196 175.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -69.12 -19.99 64.04 Favored 'General case' 0 CA--C 1.568 1.657 0 N-CA-C 117.935 2.568 . . . . 0.0 117.935 171.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 43.0 m80 -89.59 132.04 35.3 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-N 119.282 0.946 . . . . 0.0 111.136 -169.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -74.52 123.26 24.43 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.445 0.698 . . . . 0.0 109.691 176.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 99.27 2.05 56.8 Favored Glycine 0 CA--C 1.552 2.39 0 N-CA-C 117.86 1.904 . . . . 0.0 117.86 -169.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.62 109.35 4.27 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-N 120.698 2.249 . . . . 0.0 112.026 -172.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -119.52 160.03 23.18 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 116.322 1.971 . . . . 0.0 116.322 -168.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.2 pp -141.61 145.76 35.4 Favored 'General case' 0 CA--C 1.557 1.246 0 CA-C-N 113.826 -1.534 . . . . 0.0 108.989 168.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.8 mp -96.94 115.25 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 N-CA-C 104.112 -2.551 . . . . 0.0 104.112 169.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 50.7 ptt85 -102.83 152.65 21.02 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 123.819 0.847 . . . . 0.0 110.645 169.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -83.18 140.81 32.36 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 168.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 50.2 m -66.86 1.01 2.07 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 120.074 3.361 . . . . 0.0 120.074 -169.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . 0.357 24.9 tt0 79.22 -69.73 0.11 Allowed 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 125.544 1.538 . . . . 0.0 113.467 169.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 66.1 m -64.81 -39.16 93.14 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 115.579 1.696 . . . . 0.0 115.579 171.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -113.53 103.0 55.43 Favored Pre-proline 0 CA--C 1.563 1.45 0 CA-C-N 119.24 0.927 . . . . 0.0 109.875 175.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -58.77 -32.81 97.79 Favored 'Trans proline' 0 C--N 1.37 1.706 0 N-CA-C 119.742 2.939 . . . . 0.0 119.742 173.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -86.79 46.86 3.62 Favored Glycine 0 CA--C 1.552 2.347 0 N-CA-C 114.765 0.666 . . . . 0.0 114.765 169.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -160.08 132.82 6.56 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 176.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -112.43 176.25 5.1 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-O 122.161 0.981 . . . . 0.0 110.645 178.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 58.1 m -151.56 121.4 7.05 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 -179.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 25.7 tp -79.89 114.93 19.18 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 169.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 8.7 m -98.9 97.53 8.7 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 105.913 -1.884 . . . . 0.0 105.913 172.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.8 p -110.1 125.16 67.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 -175.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -76.24 139.9 41.35 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-O 121.54 0.686 . . . . 0.0 111.648 179.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -140.69 170.9 14.9 Favored 'General case' 0 CA--C 1.566 1.578 0 CA-C-O 122.184 0.992 . . . . 0.0 108.383 169.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -60.41 115.91 8.39 Favored Glycine 0 CA--C 1.546 1.978 0 O-C-N 121.108 -0.995 . . . . 0.0 114.339 178.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . 0.377 15.3 m120 83.19 -24.88 0.16 Allowed 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 117.726 2.491 . . . . 0.0 117.726 -174.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -147.74 140.37 24.66 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-N 120.264 1.393 . . . . 0.0 111.154 -173.141 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 69.1 t -94.92 115.76 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 105.196 -2.149 . . . . 0.0 105.196 169.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 62.8 mt-30 -94.3 115.45 27.68 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-O 121.73 0.776 . . . . 0.0 109.686 -175.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 8.2 m-70 -98.52 114.48 26.9 Favored 'General case' 0 CA--C 1.553 1.085 0 CA-C-N 114.844 -1.071 . . . . 0.0 108.419 -175.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -111.46 131.39 55.24 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 -179.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -85.18 119.39 25.51 Favored 'General case' 0 N--CA 1.486 1.375 0 CA-C-O 121.388 0.613 . . . . 0.0 110.283 -176.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 46.9 t -88.54 110.92 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 64.0 mt -93.67 126.11 38.66 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.084 0.554 . . . . 0.0 110.102 -175.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 71.2 mtp180 -96.27 151.89 19.09 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 123.209 0.604 . . . . 0.0 110.756 176.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 25.3 p-10 -79.68 -47.76 14.81 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 115.17 1.545 . . . . 0.0 115.17 174.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 173.57 -73.58 0.09 OUTLIER Glycine 0 CA--C 1.538 1.523 0 N-CA-C 110.841 -0.904 . . . . 0.0 110.841 -169.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -70.5 -64.69 0.85 Allowed 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 175.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 173.81 81.72 0.05 OUTLIER Glycine 0 N--CA 1.478 1.456 0 CA-C-N 118.742 0.701 . . . . 0.0 111.378 174.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -138.23 107.74 6.18 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 105.482 -2.044 . . . . 0.0 105.482 176.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -93.13 119.03 31.9 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.766 0.827 . . . . 0.0 109.383 -169.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -127.2 110.66 13.1 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 4.1 tt -97.98 -54.28 3.14 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 124.29 1.036 . . . . 0.0 111.434 172.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . 0.259 78.1 t90 -93.09 -95.09 0.15 Allowed 'General case' 0 CA--C 1.557 1.213 0 C-N-CA 124.486 1.114 . . . . 0.0 112.275 -167.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 69.7 t -133.2 -60.35 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 -172.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 24.3 m -79.36 128.56 38.47 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.397 0 CA-C-N 119.097 0.862 . . . . 0.0 109.677 178.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -80.04 131.44 35.78 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-O 121.73 0.776 . . . . 0.0 110.666 -175.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -105.15 153.32 21.69 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 114.707 -1.133 . . . . 0.0 109.747 -173.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -74.64 -54.61 7.1 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 172.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 88.0 p -120.72 168.05 11.82 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-O 122.197 0.999 . . . . 0.0 112.346 -175.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 57.5 mt -62.65 -36.47 82.92 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 114.98 1.474 . . . . 0.0 114.98 169.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . 0.281 9.8 p30 -62.22 -38.08 87.83 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 115.496 1.665 . . . . 0.0 115.496 169.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -62.28 -45.89 91.22 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 114.896 1.443 . . . . 0.0 114.896 169.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 51.5 tp -55.8 -45.58 78.21 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 115.099 1.518 . . . . 0.0 115.099 169.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 33.2 t -60.08 -61.27 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 C-N-CA 124.309 1.044 . . . . 0.0 112.215 172.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -58.47 -30.03 66.66 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 117.289 2.329 . . . . 0.0 117.289 -175.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -64.95 -55.58 18.3 Favored 'General case' 0 CA--C 1.565 1.544 0 CA-C-N 118.963 0.801 . . . . 0.0 112.619 169.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . 0.303 74.1 m-70 -71.53 -8.99 57.48 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 117.931 2.567 . . . . 0.0 117.931 178.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -48.7 -39.47 24.69 Favored 'General case' 0 N--CA 1.501 2.124 0 CA-C-N 120.59 1.541 . . . . 0.0 114.544 167.48 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 69.7 m -106.47 -29.81 9.46 Favored 'General case' 0 CA--C 1.565 1.532 0 N-CA-C 115.02 1.489 . . . . 0.0 115.02 170.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 39.5 m -89.98 147.19 23.84 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-N 120.733 1.606 . . . . 0.0 110.326 -178.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 23.1 t -77.62 122.87 25.89 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.594 -0.691 . . . . 0.0 111.586 176.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 12.4 p -68.4 -30.73 48.59 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.942 0 N-CA-C 115.3 1.593 . . . . 0.0 115.3 169.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 46.4 m -79.78 -41.26 26.88 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 116.147 1.906 . . . . 0.0 116.147 -176.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . 0.261 4.6 mmp_? 69.04 53.98 0.46 Allowed 'General case' 0 N--CA 1.5 2.027 0 C-N-CA 124.465 1.106 . . . . 0.0 113.24 -169.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -163.96 -81.26 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 177.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 -96.12 163.2 13.21 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 123.794 0.838 . . . . 0.0 109.87 169.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -79.82 98.2 6.97 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.72 -0.613 . . . . 0.0 112.145 -178.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 1.2 mp -102.37 100.74 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 103.757 -2.683 . . . . 0.0 103.757 172.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 20.4 m-30 -110.23 126.44 54.14 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 -178.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 10.8 mp -72.2 121.53 19.5 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 113.148 0.795 . . . . 0.0 113.148 -169.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 22.4 mmt85 -126.85 154.26 44.6 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 125.181 1.393 . . . . 0.0 109.18 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -75.47 147.3 39.96 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.293 -1.505 . . . . 0.0 113.367 -177.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.442 ' H ' HD13 ' A' ' 151' ' ' ILE . 0.2 OUTLIER -69.37 158.04 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 113.639 0.977 . . . . 0.0 113.639 179.721 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 . . . . . 0 N--CA 1.484 1.271 0 CA-C-O 122.851 1.31 . . . . 0.0 109.588 -178.657 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . 0.278 30.0 p-90 . . . . . 0 N--CA 1.489 1.492 0 N-CA-C 115.14 1.533 . . . . 0.0 115.14 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -83.66 134.36 34.78 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 120.771 1.623 . . . . 0.0 110.864 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -111.13 -88.28 0.52 Allowed 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 176.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 153.39 83.33 0.04 OUTLIER Glycine 0 N--CA 1.48 1.622 0 CA-C-N 119.37 0.986 . . . . 0.0 111.088 178.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . 0.257 51.6 mtpt 59.09 61.44 2.11 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 -176.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 17.4 tt -86.06 141.42 35.32 Favored Pre-proline 0 CA--C 1.572 1.811 0 CA-C-O 117.663 -1.16 . . . . 0.0 110.263 179.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -69.1 153.44 71.98 Favored 'Trans proline' 0 CA--C 1.562 1.906 0 CA-C-N 123.575 2.312 . . . . 0.0 113.578 174.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 38.6 ttt85 -58.01 -43.42 86.68 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 116.18 1.918 . . . . 0.0 116.18 -177.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.47 -46.15 84.33 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 115.007 1.484 . . . . 0.0 115.007 175.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 58.7 tttm -59.83 -36.65 77.25 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 115.248 1.573 . . . . 0.0 115.248 169.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.79 -43.29 96.76 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 115.487 1.662 . . . . 0.0 115.487 170.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -63.68 -46.06 87.27 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 114.875 1.435 . . . . 0.0 114.875 172.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -70.77 -39.22 73.35 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 115.212 1.56 . . . . 0.0 115.212 178.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 38.1 mmt -64.99 -45.2 86.61 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-N 119.922 1.237 . . . . 0.0 114.278 172.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 95.3 mt -64.89 -32.1 73.65 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 116.121 1.897 . . . . 0.0 116.121 170.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 18.9 t -57.47 -29.64 64.4 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 116.364 1.987 . . . . 0.0 116.364 169.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -63.55 -34.99 79.02 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 115.775 1.769 . . . . 0.0 115.775 169.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -70.33 131.24 43.84 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-O 122.935 1.35 . . . . 0.0 112.973 -176.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.28 -12.34 61.58 Favored 'General case' 0 CA--C 1.567 1.623 0 N-CA-C 118.947 2.943 . . . . 0.0 118.947 172.114 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 53.5 m80 -89.28 138.03 31.79 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 120.315 1.416 . . . . 0.0 111.936 -169.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -81.47 98.32 8.2 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 107.545 -1.279 . . . . 0.0 107.545 172.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 124.94 -0.1 8.33 Favored Glycine 0 CA--C 1.557 2.668 0 CA-C-O 117.089 -1.951 . . . . 0.0 115.698 -168.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.66 116.27 6.07 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-N 121.161 2.48 . . . . 0.0 112.653 -169.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 20.4 p90 -131.6 155.53 47.36 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 116.273 1.953 . . . . 0.0 116.273 -168.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.0 pp -143.37 138.13 29.21 Favored 'General case' 0 CA--C 1.558 1.25 0 CA-C-N 114.026 -1.443 . . . . 0.0 108.02 169.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.9 mp -83.57 120.09 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 N-CA-C 106.149 -1.797 . . . . 0.0 106.149 174.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 61.8 ttp85 -95.23 125.01 39.58 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-N 114.718 -1.128 . . . . 0.0 109.218 170.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -79.99 132.24 35.98 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 169.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 53.5 m -69.63 138.51 53.13 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.095 0.558 . . . . 0.0 112.32 -175.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -66.24 -59.46 3.71 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -172.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 88.2 p -62.3 -34.37 76.47 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 116.881 2.178 . . . . 0.0 116.881 174.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -121.04 97.28 48.12 Favored Pre-proline 0 CA--C 1.562 1.431 0 CA-C-N 119.112 0.869 . . . . 0.0 109.837 177.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -56.63 -30.95 85.52 Favored 'Trans proline' 0 C--N 1.369 1.641 0 N-CA-C 119.78 2.954 . . . . 0.0 119.78 172.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -88.24 46.12 3.35 Favored Glycine 0 CA--C 1.553 2.458 0 N-CA-C 114.777 0.671 . . . . 0.0 114.777 168.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -156.11 126.81 6.81 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 105.281 -2.118 . . . . 0.0 105.281 178.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -112.79 167.32 10.59 Favored 'General case' 0 CA--C 1.559 1.303 0 CA-C-O 122.416 1.103 . . . . 0.0 110.549 -174.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 71.2 m -146.32 111.89 5.55 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 -179.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 46.2 tp -79.65 107.32 12.33 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-O 122.004 0.906 . . . . 0.0 109.582 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.3 m -90.42 100.45 13.28 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 177.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.3 p -124.81 121.03 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 -172.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -76.37 142.1 41.28 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.535 170.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -150.22 107.44 3.6 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 169.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 88.9 -106.65 3.3 Favored Glycine 0 N--CA 1.481 1.645 0 N-CA-C 110.382 -1.087 . . . . 0.0 110.382 -176.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -135.68 60.1 1.7 Allowed 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 169.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -160.86 129.02 4.45 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.673 0.789 . . . . 0.0 109.386 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 55.8 t -98.91 109.01 23.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 179.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -99.77 120.39 39.66 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.872 0.869 . . . . 0.0 109.465 -176.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -100.58 105.01 16.38 Favored 'General case' 0 CA--C 1.554 1.097 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -175.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -102.34 129.12 48.7 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -177.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -77.07 126.4 30.91 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-O 121.704 0.764 . . . . 0.0 110.525 -178.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 76.9 t -108.93 100.73 11.37 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.347 0 N-CA-C 104.826 -2.287 . . . . 0.0 104.826 178.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -113.27 144.3 42.95 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.788 0.835 . . . . 0.0 110.76 -172.353 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 92.3 mtt180 -88.68 151.75 22.24 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 113.129 0.788 . . . . 0.0 113.129 -175.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -95.83 -63.82 1.12 Allowed 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 123.54 0.736 . . . . 0.0 110.882 169.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -100.01 -104.98 2.65 Favored Glycine 0 CA--C 1.541 1.707 0 CA-C-N 119.223 0.92 . . . . 0.0 111.553 177.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -139.5 122.9 17.15 Favored 'General case' 0 N--CA 1.482 1.17 0 CA-C-O 122.925 1.345 . . . . 0.0 107.566 172.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 61.74 51.71 55.57 Favored Glycine 0 CA--C 1.552 2.35 0 CA-C-N 113.192 -1.822 . . . . 0.0 115.28 -169.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -137.14 77.69 1.65 Allowed 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 105.087 -2.19 . . . . 0.0 105.087 -174.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -85.76 108.89 18.29 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -167.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 21.5 p90 -119.86 135.47 54.86 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.206 0.602 . . . . 0.0 110.571 178.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -94.48 -52.52 4.29 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 123.16 0.584 . . . . 0.0 111.624 169.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 3.2 m-90 -85.07 -76.78 0.3 Allowed 'General case' 0 CA--C 1.564 1.51 0 C-N-CA 123.775 0.83 . . . . 0.0 109.108 177.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 6.2 m -147.38 -46.14 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 C-N-CA 125.352 1.461 . . . . 0.0 110.942 -178.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 12.3 p -79.81 132.22 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 CA-C-N 119.382 0.992 . . . . 0.0 111.355 -173.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 2.2 pptp? -81.65 154.12 26.28 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 113.904 1.076 . . . . 0.0 113.904 -174.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -135.94 114.5 11.83 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 104.617 -2.364 . . . . 0.0 104.617 176.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -53.07 -38.27 62.35 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 118.933 2.938 . . . . 0.0 118.933 -169.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 91.1 p -135.41 160.36 38.68 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-O 122.522 1.153 . . . . 0.0 113.339 -171.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 11.1 mp -77.39 117.88 19.31 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 168.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . 0.356 21.3 t-20 122.88 -53.28 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.017 0 C-N-CA 126.422 1.889 . . . . 0.0 107.535 -168.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -58.84 -49.45 77.69 Favored 'General case' 0 CA--C 1.568 1.646 0 CA-C-N 119.851 1.205 . . . . 0.0 113.777 169.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 31.1 tp -60.59 -40.22 90.96 Favored 'General case' 0 CA--C 1.57 1.74 0 N-CA-C 115.413 1.634 . . . . 0.0 115.413 169.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 40.4 t -59.07 -61.99 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 C-N-CA 124.35 1.06 . . . . 0.0 112.569 173.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -61.88 -30.32 70.79 Favored 'General case' 0 CA--C 1.572 1.814 0 N-CA-C 115.086 1.513 . . . . 0.0 115.086 -178.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 94.0 t80 -59.69 -57.52 12.57 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-N 119.153 0.888 . . . . 0.0 112.245 168.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 74.4 m-70 -70.37 -9.58 56.64 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 117.913 2.56 . . . . 0.0 117.913 175.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 53.1 ttm-85 -61.1 -30.22 70.23 Favored 'General case' 0 CA--C 1.575 1.917 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 167.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 71.0 m -108.6 -30.79 8.05 Favored 'General case' 0 CA--C 1.568 1.64 0 C-N-CA 125.047 1.339 . . . . 0.0 114.081 169.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 99.1 m -90.89 156.33 18.09 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-N 120.371 1.442 . . . . 0.0 111.978 176.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 39.7 t -67.08 137.16 56.18 Favored 'General case' 0 CA--C 1.558 1.267 0 C-N-CA 123.669 0.788 . . . . 0.0 113.076 170.007 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 19.0 t -71.3 -48.91 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 CA-C-O 118.683 -0.675 . . . . 0.0 111.735 171.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 9.2 t -87.76 172.51 9.61 Favored 'General case' 0 CA--C 1.565 1.541 0 CA-C-N 118.981 0.81 . . . . 0.0 111.754 174.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 40.8 mmt180 -79.93 -57.78 3.48 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.23 -0.919 . . . . 0.0 111.724 169.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -70.1 -59.54 2.84 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 177.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 70.1 mt-30 -79.9 145.08 32.87 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-N 118.869 0.759 . . . . 0.0 111.481 -179.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -102.76 104.56 14.87 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 123.352 0.661 . . . . 0.0 109.533 -177.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 4.3 mp -112.71 127.44 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -125.5 125.38 43.18 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 10.8 mp -74.22 135.33 42.73 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 115.057 1.503 . . . . 0.0 115.057 -168.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 8.9 mmm180 -128.71 139.1 52.39 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 125.486 1.514 . . . . 0.0 108.519 174.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -71.97 146.79 47.5 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.307 -0.87 . . . . 0.0 112.451 177.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 27.1 pt -69.93 158.69 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 N-CA-C 113.564 0.949 . . . . 0.0 113.564 -174.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 . . . . . 0 N--CA 1.484 1.256 0 CA-C-O 122.803 1.287 . . . . 0.0 109.759 179.276 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 55.4 p-90 . . . . . 0 N--CA 1.479 1.017 0 CA-C-O 118.339 -0.839 . . . . 0.0 112.347 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -82.82 127.5 33.53 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-N 119.868 1.213 . . . . 0.0 112.903 -169.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -100.01 -79.67 0.49 Allowed 'General case' 0 N--CA 1.489 1.481 0 CA-C-N 114.937 -1.029 . . . . 0.0 108.765 173.005 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -175.99 -138.05 2.75 Favored Glycine 0 N--CA 1.48 1.569 0 CA-C-N 119.311 0.96 . . . . 0.0 112.28 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 20.9 tptm -103.5 87.13 2.78 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 176.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 32.6 pt -127.09 153.09 76.61 Favored Pre-proline 0 CA--C 1.573 1.828 0 C-N-CA 123.331 0.652 . . . . 0.0 111.086 -169.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -77.24 178.57 7.47 Favored 'Trans proline' 0 CA--C 1.565 2.059 0 C-N-CA 123.043 2.496 . . . . 0.0 113.944 175.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 54.3 ttt180 -65.42 -41.48 93.53 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 115.101 1.519 . . . . 0.0 115.101 175.092 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.2 -41.06 97.23 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 115.96 1.837 . . . . 0.0 115.96 179.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -64.07 -38.46 91.16 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 114.569 1.322 . . . . 0.0 114.569 169.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.59 -41.0 84.77 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 115.951 1.834 . . . . 0.0 115.951 171.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -64.17 -36.81 85.26 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 115.02 1.489 . . . . 0.0 115.02 170.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -63.77 -48.24 77.72 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 114.799 1.407 . . . . 0.0 114.799 172.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 38.8 mmt -61.54 -47.48 85.35 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 174.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 88.3 mt -75.09 -24.52 58.14 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 116.908 2.188 . . . . 0.0 116.908 177.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 97.4 p -61.83 -36.35 80.9 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-N 120.726 1.603 . . . . 0.0 114.631 168.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 59.7 mttm -60.7 -36.58 79.16 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 114.788 1.403 . . . . 0.0 114.788 169.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -64.62 120.47 12.45 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.449 1.1 . . . . 0.0 112.001 170.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 16.5 ptm180 -77.9 -15.99 58.58 Favored 'General case' 0 CA--C 1.569 1.683 0 N-CA-C 118.223 2.675 . . . . 0.0 118.223 176.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 46.0 m80 -89.57 147.85 23.71 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 119.513 1.051 . . . . 0.0 113.557 -168.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -77.6 124.4 27.88 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.789 170.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 105.6 -29.93 10.62 Favored Glycine 0 CA--C 1.546 2.002 0 CA-C-O 117.268 -1.851 . . . . 0.0 116.765 -169.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.11 112.75 1.29 Allowed 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 120.21 2.005 . . . . 0.0 113.386 -170.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.1 p90 -130.32 161.22 31.76 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 -168.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.6 pp -141.99 132.62 25.45 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.695 0.798 . . . . 0.0 108.892 168.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 87.2 mt -86.8 122.09 38.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 169.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 49.1 ptt85 -104.4 153.02 21.6 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.487 169.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -88.85 124.12 33.89 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 105.836 -1.913 . . . . 0.0 105.836 168.286 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 53.2 m -62.84 121.37 13.31 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.241 0.616 . . . . 0.0 111.871 -172.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -68.1 -47.15 68.99 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 114.496 1.295 . . . . 0.0 114.496 -170.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.1 t -65.66 -31.93 73.22 Favored 'General case' 0 CA--C 1.568 1.659 0 N-CA-C 115.832 1.79 . . . . 0.0 115.832 169.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -118.85 95.31 49.08 Favored Pre-proline 0 CA--C 1.563 1.471 0 CA-C-N 119.863 1.21 . . . . 0.0 110.158 178.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -56.05 -34.65 93.1 Favored 'Trans proline' 0 C--N 1.369 1.658 0 N-CA-C 120.111 3.081 . . . . 0.0 120.111 176.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -87.97 50.09 3.88 Favored Glycine 0 CA--C 1.55 2.281 0 N-CA-C 114.297 0.479 . . . . 0.0 114.297 169.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -159.66 142.04 13.57 Favored 'General case' 0 CA--C 1.556 1.209 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 178.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -116.68 161.19 19.61 Favored 'General case' 0 CA--C 1.564 1.501 0 CA-C-O 122.032 0.92 . . . . 0.0 109.265 171.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 67.4 m -137.4 117.33 13.27 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 178.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 43.0 tp -80.17 110.89 16.01 Favored 'General case' 0 CA--C 1.563 1.452 0 C-N-CA 124.216 1.007 . . . . 0.0 109.429 172.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 3.1 m -97.4 116.04 28.85 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 -178.28 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 41.2 t -126.21 123.2 63.19 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.194 0 CA-C-N 120.798 1.635 . . . . 0.0 108.151 -171.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 59.0 tptt -81.77 121.2 26.12 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 169.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -139.22 99.46 3.76 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 174.116 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 92.01 -98.32 2.4 Favored Glycine 0 CA--C 1.538 1.483 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.984 178.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 12.2 p30 -129.1 19.49 5.93 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 115.629 1.715 . . . . 0.0 115.629 177.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -145.3 141.37 28.5 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 120.117 1.326 . . . . 0.0 109.522 -177.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 60.6 t -96.33 108.37 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 174.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -104.02 127.68 51.58 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 123.917 0.887 . . . . 0.0 110.557 -176.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 12.7 m-70 -102.95 101.31 11.31 Favored 'General case' 0 CA--C 1.551 1.0 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -169.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -84.92 126.22 33.32 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 172.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 32.6 mmmt -82.86 119.51 24.48 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.067 0.46 . . . . 0.0 110.228 -172.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 84.3 t -86.33 103.63 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 177.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 63.3 mt -95.62 147.69 23.31 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.719 -171.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 72.7 mtp180 -116.28 122.52 45.19 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.627 -0.671 . . . . 0.0 110.355 -173.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -101.19 119.7 39.13 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 123.46 0.704 . . . . 0.0 109.75 174.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 82.02 -112.44 3.49 Favored Glycine 0 CA--C 1.541 1.701 0 C-N-CA 122.816 0.246 . . . . 0.0 113.095 177.005 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -86.43 -71.89 0.53 Allowed 'General case' 0 N--CA 1.486 1.368 0 CA-C-O 118.746 -0.645 . . . . 0.0 111.258 177.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -157.01 71.81 0.25 Allowed Glycine 0 N--CA 1.478 1.498 0 CA-C-N 118.681 0.673 . . . . 0.0 112.373 172.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.95 104.58 14.29 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 104.74 -2.318 . . . . 0.0 104.74 172.058 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -84.08 99.67 10.61 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.652 -168.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 32.8 p90 -102.49 114.36 28.5 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.71 0.804 . . . . 0.0 109.107 -178.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -105.66 -52.17 2.87 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.825 176.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 83.1 t90 -135.19 109.19 8.18 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 -169.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . 0.392 22.2 t 69.58 -91.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 C-N-CA 124.278 1.031 . . . . 0.0 111.57 169.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 8.1 p -79.97 155.3 4.55 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.609 0 C-N-CA 124.224 1.01 . . . . 0.0 111.408 177.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 25.9 pttm -79.74 148.44 31.5 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-O 121.434 0.635 . . . . 0.0 112.545 173.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -128.07 107.27 9.67 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 106.26 -1.755 . . . . 0.0 106.26 -172.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -50.63 -50.28 54.73 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 117.951 2.574 . . . . 0.0 117.951 -169.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 90.8 p -111.86 160.57 17.25 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 118.897 0.771 . . . . 0.0 111.833 176.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 79.0 mt -66.71 -34.46 77.89 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 115.38 1.622 . . . . 0.0 115.38 170.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -64.21 -45.09 89.8 Favored 'General case' 0 CA--C 1.572 1.825 0 CA-C-N 119.859 1.209 . . . . 0.0 114.002 170.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -59.08 -47.35 85.56 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 114.788 1.403 . . . . 0.0 114.788 169.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 57.4 tp -51.83 -52.48 48.98 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 115.686 1.735 . . . . 0.0 115.686 170.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 9.8 p -67.44 -50.28 63.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 -176.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -63.84 -31.0 72.03 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 114.957 1.466 . . . . 0.0 114.957 174.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -62.43 -54.55 38.55 Favored 'General case' 0 CA--C 1.567 1.618 0 CA-C-N 119.727 1.148 . . . . 0.0 111.702 168.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 36.4 m-70 -73.32 -9.7 58.98 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 118.37 2.73 . . . . 0.0 118.37 179.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 58.0 mtp85 -66.82 -21.46 66.03 Favored 'General case' 0 CA--C 1.579 2.08 0 CA-C-N 120.251 1.387 . . . . 0.0 113.347 167.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 69.3 m -104.38 -43.92 5.07 Favored 'General case' 0 CA--C 1.57 1.73 0 C-N-CA 125.453 1.501 . . . . 0.0 112.509 168.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 57.3 m -90.18 155.42 19.04 Favored 'General case' 0 N--CA 1.499 1.981 0 CA-C-N 120.051 1.296 . . . . 0.0 111.465 -179.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 21.0 t -80.18 130.74 35.44 Favored 'General case' 0 CA--C 1.56 1.352 0 O-C-N 121.293 -0.88 . . . . 0.0 113.053 -178.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 3.2 m -68.88 -42.49 82.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 169.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.8 t -83.49 135.26 34.72 Favored 'General case' 0 CA--C 1.557 1.23 0 CA-C-N 118.967 0.803 . . . . 0.0 110.259 173.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 41.4 ptt180 -69.99 -45.53 67.13 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 115.183 1.549 . . . . 0.0 115.183 174.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 70.9 m-80 -79.1 -55.53 5.04 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 123.451 0.7 . . . . 0.0 112.593 175.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -79.89 154.02 28.63 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 118.782 0.719 . . . . 0.0 111.939 179.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -92.91 96.52 10.17 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 171.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 27.7 mm -117.86 110.86 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 N-CA-C 105.146 -2.168 . . . . 0.0 105.146 -178.201 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -116.55 127.97 55.0 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.424 -174.168 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 10.7 mp -78.09 126.14 30.37 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.747 0.819 . . . . 0.0 111.905 -169.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 14.1 mmm180 -126.89 162.79 25.1 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-O 122.419 1.104 . . . . 0.0 110.432 178.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -77.36 148.67 35.46 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.984 -1.072 . . . . 0.0 112.68 -176.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 28.1 pt -70.0 159.7 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 113.993 1.108 . . . . 0.0 113.993 -179.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 . . . . . 0 N--CA 1.485 1.287 0 CA-C-O 124.002 1.858 . . . . 0.0 108.541 -177.603 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . 0.387 50.8 p-90 . . . . . 0 N--CA 1.503 2.188 0 N-CA-C 120.703 3.594 . . . . 0.0 120.703 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -128.42 132.99 48.47 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 124.319 1.048 . . . . 0.0 108.268 -169.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -99.71 -75.21 0.57 Allowed 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 118.34 -0.838 . . . . 0.0 109.316 172.204 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 97.78 113.64 3.2 Favored Glycine 0 N--CA 1.481 1.669 0 CA-C-N 119.371 0.987 . . . . 0.0 112.208 -179.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . 0.307 73.5 mmtt 65.28 25.68 12.19 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 117.425 2.38 . . . . 0.0 117.425 178.3 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 21.1 tt -90.45 129.03 46.61 Favored Pre-proline 0 CA--C 1.569 1.691 0 CA-C-O 117.139 -1.41 . . . . 0.0 107.567 169.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -67.32 170.61 13.06 Favored 'Trans proline' 0 CA--C 1.562 1.882 0 CA-C-N 123.638 2.335 . . . . 0.0 114.19 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 25.6 ttm180 -57.57 -45.59 85.0 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 116.252 1.945 . . . . 0.0 116.252 -177.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -65.98 -46.08 79.34 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 115.457 1.651 . . . . 0.0 115.457 175.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 61.5 mtpt -63.61 -34.91 78.87 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 115.426 1.639 . . . . 0.0 115.426 169.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.48 -42.4 99.46 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 115.278 1.584 . . . . 0.0 115.278 169.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -60.9 -43.45 98.49 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 169.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -64.82 -45.68 85.2 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 115.52 1.674 . . . . 0.0 115.52 175.136 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -59.83 -44.16 94.2 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 114.83 1.418 . . . . 0.0 114.83 172.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 88.6 mt -70.52 -21.75 62.7 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 116.679 2.104 . . . . 0.0 116.679 170.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 12.1 t -53.09 -37.06 61.37 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 117.223 2.305 . . . . 0.0 117.223 178.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? -64.85 -28.9 69.86 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 116.244 1.942 . . . . 0.0 116.244 170.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -71.53 114.4 9.57 Favored 'General case' 0 N--CA 1.485 1.294 0 CA-C-N 119.819 1.19 . . . . 0.0 111.259 178.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.456 ' H ' ' HD3' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -74.43 -7.35 52.68 Favored 'General case' 0 CA--C 1.57 1.721 0 N-CA-C 118.092 2.627 . . . . 0.0 118.092 172.26 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 35.5 m80 -89.81 139.94 30.08 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 119.667 1.121 . . . . 0.0 111.589 -169.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -75.98 120.12 20.87 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.183 171.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 107.78 -19.77 32.69 Favored Glycine 0 CA--C 1.546 2.022 0 CA-C-O 116.632 -2.204 . . . . 0.0 116.732 -169.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.2 108.72 0.95 Allowed 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 121.26 2.53 . . . . 0.0 112.233 -173.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 23.2 p90 -123.58 158.46 31.38 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 -168.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.9 pp -138.07 128.78 26.72 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 168.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 91.1 mt -88.54 110.76 21.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 172.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.9 ptm180 -89.42 144.61 25.92 Favored 'General case' 0 N--CA 1.484 1.226 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.192 169.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -84.8 126.9 33.84 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 169.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 20.8 t -68.11 123.11 19.76 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 122.909 0.483 . . . . 0.0 111.476 -172.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -91.11 91.17 8.14 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 123.706 1.717 . . . . 0.0 110.411 -173.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 39.7 t 162.54 -41.11 0.0 OUTLIER 'General case' 0 CA--C 1.571 1.768 0 CA-C-N 110.729 -2.941 . . . . 0.0 106.983 -168.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -150.01 113.68 3.37 Favored Pre-proline 0 CA--C 1.563 1.464 0 CA-C-O 117.57 -1.205 . . . . 0.0 108.414 178.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -68.6 -27.22 32.85 Favored 'Trans proline' 0 C--N 1.37 1.699 0 N-CA-C 119.088 2.688 . . . . 0.0 119.088 -178.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -65.3 -21.49 68.43 Favored Glycine 0 CA--C 1.561 2.938 0 N-CA-C 116.492 1.357 . . . . 0.0 116.492 168.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -88.66 137.78 32.01 Favored 'General case' 0 CA--C 1.555 1.171 0 CA-C-N 118.216 1.008 . . . . 0.0 108.839 169.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -122.69 173.16 7.9 Favored 'General case' 0 CA--C 1.567 1.61 0 CA-C-N 114.927 -1.033 . . . . 0.0 108.649 175.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 75.7 m -143.6 115.42 8.24 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 173.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 29.3 tp -79.85 114.47 18.79 Favored 'General case' 0 CA--C 1.561 1.384 0 C-N-CA 124.314 1.046 . . . . 0.0 109.167 175.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.3 m -106.16 88.51 2.81 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 -170.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 16.0 t -101.99 123.02 54.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 -169.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 51.3 tttp -88.26 96.23 10.48 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.474 171.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 20.1 t80 -105.77 112.21 25.18 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.706 -0.849 . . . . 0.0 108.706 179.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 82.78 -106.23 2.73 Favored Glycine 0 CA--C 1.539 1.589 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 -170.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -141.68 59.49 1.49 Allowed 'General case' 0 CA--C 1.565 1.543 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 169.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -155.8 128.57 7.93 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 107.046 -1.465 . . . . 0.0 107.046 177.161 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 50.0 t -95.63 110.72 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 -175.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -104.96 116.08 31.36 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.791 0.836 . . . . 0.0 109.05 -173.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -95.11 108.91 21.02 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 115.036 -0.984 . . . . 0.0 108.828 -175.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -107.07 120.79 43.04 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 -175.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -79.08 112.3 16.14 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 121.906 0.86 . . . . 0.0 110.579 -172.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 75.8 t -85.18 100.94 8.95 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 178.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.9 pp -122.86 133.84 54.41 Favored 'General case' 0 N--CA 1.491 1.575 0 CA-C-O 121.506 0.669 . . . . 0.0 111.099 -169.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -84.7 159.01 20.61 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-O 122.077 0.942 . . . . 0.0 113.042 -176.074 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -85.53 -46.63 10.66 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 114.96 -1.018 . . . . 0.0 113.106 168.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -154.93 -85.5 0.05 OUTLIER Glycine 0 CA--C 1.539 1.556 0 CA-C-N 118.958 0.799 . . . . 0.0 111.258 -177.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -72.95 -70.95 0.33 Allowed 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -175.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -168.75 54.85 0.21 Allowed Glycine 0 N--CA 1.481 1.634 0 CA-C-O 119.333 -0.704 . . . . 0.0 114.276 172.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -109.69 97.83 7.29 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 105.432 -2.062 . . . . 0.0 105.432 173.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -80.32 125.91 30.49 Favored 'General case' 0 CA--C 1.554 1.126 0 CA-C-N 113.922 -1.49 . . . . 0.0 110.775 -169.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 32.2 p90 -128.95 122.83 31.02 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 121.288 0.566 . . . . 0.0 109.884 174.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.484 ' H ' HD23 ' A' ' 120' ' ' LEU . 2.1 pt? -102.92 -53.65 2.8 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 124.291 1.036 . . . . 0.0 111.822 169.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 37.4 t90 -84.83 -74.39 0.39 Allowed 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 124.889 1.276 . . . . 0.0 110.029 -178.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 10.5 p -148.59 -56.0 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 C-N-CA 123.872 0.869 . . . . 0.0 110.668 176.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 11.1 p -79.4 135.82 24.88 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.476 0 C-N-CA 123.814 0.845 . . . . 0.0 110.858 -172.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 54.0 mttp -79.94 157.77 26.79 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 122.249 1.023 . . . . 0.0 112.366 -176.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -140.79 114.75 9.07 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 -170.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -58.73 -43.09 90.08 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 116.247 1.943 . . . . 0.0 116.247 177.115 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 94.8 p -113.37 144.74 42.27 Favored 'General case' 0 N--CA 1.484 1.27 0 CA-C-O 122.018 0.913 . . . . 0.0 111.955 -179.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 19.0 tp -84.53 62.07 7.05 Favored 'General case' 0 CA--C 1.571 1.775 0 CA-C-N 114.625 -1.17 . . . . 0.0 111.195 169.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -156.71 -51.58 0.08 Allowed 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 127.221 2.209 . . . . 0.0 105.445 172.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -61.2 -31.44 71.2 Favored 'General case' 0 CA--C 1.571 1.762 0 CA-C-N 119.537 1.062 . . . . 0.0 113.384 167.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 10.3 tt -51.7 -45.94 63.72 Favored 'General case' 0 N--CA 1.498 1.969 0 CA-C-N 120.158 1.345 . . . . 0.0 114.024 168.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 24.6 t -60.43 -59.32 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 C-N-CA 124.411 1.084 . . . . 0.0 112.162 169.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -58.7 -34.22 71.05 Favored 'General case' 0 CA--C 1.566 1.578 0 N-CA-C 116.269 1.952 . . . . 0.0 116.269 -174.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -61.63 -55.55 29.43 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 119.426 1.012 . . . . 0.0 112.279 169.258 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . 0.263 48.3 m-70 -69.6 -9.51 54.38 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 117.867 2.543 . . . . 0.0 117.867 177.301 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -62.21 -32.41 73.06 Favored 'General case' 0 CA--C 1.577 1.997 0 CA-C-N 120.266 1.393 . . . . 0.0 112.732 166.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 69.4 m -98.75 -39.64 8.54 Favored 'General case' 0 CA--C 1.565 1.529 0 N-CA-C 114.424 1.268 . . . . 0.0 114.424 169.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 52.1 m -91.07 155.61 18.54 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-N 120.175 1.352 . . . . 0.0 112.052 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 31.3 t -75.27 136.01 40.93 Favored 'General case' 0 CA--C 1.559 1.305 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 177.038 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 6.5 t -76.82 -50.03 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 CA-C-O 118.552 -0.737 . . . . 0.0 111.47 169.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 67.0 m -87.85 143.22 27.25 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 119.297 0.953 . . . . 0.0 111.338 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 19.3 ptp180 -91.12 64.47 5.31 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 121.993 0.901 . . . . 0.0 111.515 169.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . 0.271 7.2 p-10 -179.66 -70.99 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 125.624 1.57 . . . . 0.0 107.003 -172.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -86.59 149.9 24.61 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.965 0.906 . . . . 0.0 110.558 170.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 16.5 mm100 -93.32 88.45 6.0 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 122.764 0.426 . . . . 0.0 109.935 178.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 14.8 mm -90.57 117.61 34.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 -169.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -125.11 122.01 35.92 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 -177.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 10.6 mp -74.51 142.96 44.76 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 113.839 1.052 . . . . 0.0 113.839 -169.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 4.2 tmt_? -144.75 145.02 31.48 Favored 'General case' 0 CA--C 1.563 1.46 0 N-CA-C 105.798 -1.927 . . . . 0.0 105.798 -174.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -69.23 157.04 37.72 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.29 -1.507 . . . . 0.0 113.459 176.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.1 pp -72.62 159.05 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 179.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 122.88 1.324 . . . . 0.0 110.061 177.955 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . 0.256 69.0 p-90 . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 45.6 t80 -80.71 135.29 35.98 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-N 119.464 1.029 . . . . 0.0 110.967 -177.247 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -122.77 -76.91 0.59 Allowed 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 177.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 172.92 -112.89 0.45 Allowed Glycine 0 N--CA 1.479 1.542 0 N-CA-C 108.681 -1.768 . . . . 0.0 108.681 173.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 26.9 ttpp -117.83 82.99 1.92 Allowed 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 105.206 -2.146 . . . . 0.0 105.206 169.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -111.49 136.06 21.03 Favored Pre-proline 0 CA--C 1.569 1.695 0 CA-C-O 117.335 -1.317 . . . . 0.0 108.632 -168.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_exo -48.75 153.13 3.81 Favored 'Trans proline' 0 C--N 1.371 1.716 0 C-N-CA 123.736 2.957 . . . . 0.0 119.22 -177.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 59.0 ttt180 -66.5 -37.9 86.07 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 114.817 1.414 . . . . 0.0 114.817 171.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -69.04 -43.33 74.91 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 115.427 1.64 . . . . 0.0 115.427 176.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 54.6 tptt -66.55 -37.31 84.71 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 115.089 1.514 . . . . 0.0 115.089 169.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.27 -45.72 92.0 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 115.612 1.708 . . . . 0.0 115.612 169.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -64.8 -33.95 77.2 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 115.704 1.742 . . . . 0.0 115.704 171.169 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -61.9 -49.53 75.84 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 114.51 1.3 . . . . 0.0 114.51 171.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -62.71 -47.31 84.15 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 114.691 1.367 . . . . 0.0 114.691 173.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.1 mp -68.21 -25.24 65.12 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 116.302 1.964 . . . . 0.0 116.302 175.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 22.9 t -59.1 -36.3 74.9 Favored 'General case' 0 CA--C 1.571 1.759 0 CA-C-N 120.635 1.561 . . . . 0.0 114.078 168.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 27.9 mmtp -61.05 -36.29 79.19 Favored 'General case' 0 CA--C 1.57 1.746 0 N-CA-C 115.054 1.501 . . . . 0.0 115.054 169.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -67.07 119.47 12.07 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.624 1.17 . . . . 0.0 111.769 177.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 14.1 ptp180 -73.93 -17.1 61.06 Favored 'General case' 0 CA--C 1.569 1.685 0 N-CA-C 118.065 2.617 . . . . 0.0 118.065 171.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 46.5 m80 -89.74 141.87 28.21 Favored 'General case' 0 N--CA 1.487 1.418 0 CA-C-N 119.287 0.948 . . . . 0.0 113.188 -168.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.74 119.57 24.5 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 169.62 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 113.61 -28.5 8.52 Favored Glycine 0 CA--C 1.548 2.098 0 CA-C-O 117.685 -1.619 . . . . 0.0 116.347 -169.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.76 109.99 1.6 Allowed 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 120.06 1.93 . . . . 0.0 112.761 -176.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 16.4 p90 -126.63 164.19 21.8 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 115.457 1.651 . . . . 0.0 115.457 -168.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.2 pp -140.69 134.03 29.76 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 167.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 68.1 mt -88.28 117.66 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 106.568 -1.641 . . . . 0.0 106.568 169.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 5.0 ptm180 -110.66 141.9 43.28 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.447 169.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -79.89 139.04 37.28 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 121.533 0.683 . . . . 0.0 109.793 171.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 29.7 t -68.54 128.84 38.07 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.66 -178.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -68.5 -48.14 65.2 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 113.97 1.1 . . . . 0.0 113.97 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.8 t -60.84 -37.72 83.03 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 115.986 1.847 . . . . 0.0 115.986 169.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -119.67 93.11 47.18 Favored Pre-proline 0 CA--C 1.561 1.395 0 CA-C-N 119.577 1.081 . . . . 0.0 109.792 174.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -55.35 -26.36 52.49 Favored 'Trans proline' 0 CA--C 1.557 1.643 0 N-CA-C 119.761 2.947 . . . . 0.0 119.761 171.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -91.31 48.47 2.91 Favored Glycine 0 CA--C 1.552 2.393 0 CA-C-O 119.319 -0.712 . . . . 0.0 113.93 168.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -160.17 126.98 4.36 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 178.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 35.3 m-85 -92.73 165.45 12.94 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 122.213 1.006 . . . . 0.0 111.701 169.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 75.2 m -143.48 112.72 6.78 Favored 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 25.4 tp -79.98 108.65 13.73 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 124.219 1.008 . . . . 0.0 109.447 176.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 12.6 m -99.65 97.25 8.24 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 -173.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 21.7 t -107.6 126.45 63.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 -172.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 58.4 tptt -76.93 109.83 11.07 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 169.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -139.3 90.11 2.39 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -174.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 71.02 74.71 0.68 Allowed Glycine 0 N--CA 1.482 1.765 0 N-CA-C 115.654 1.021 . . . . 0.0 115.654 169.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . 0.286 66.1 m-80 68.97 -11.56 0.44 Allowed 'General case' 0 N--CA 1.501 2.121 0 N-CA-C 118.362 2.727 . . . . 0.0 118.362 -178.488 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -139.47 142.61 37.35 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 119.736 1.153 . . . . 0.0 108.992 -175.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 38.7 t -92.67 114.75 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 177.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 61.6 mt-30 -96.27 118.35 32.65 Favored 'General case' 0 N--CA 1.485 1.301 0 CA-C-O 121.666 0.746 . . . . 0.0 109.848 -178.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 13.9 m-70 -99.25 99.61 10.59 Favored 'General case' 0 CA--C 1.552 1.054 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 -175.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -96.9 121.48 38.82 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 -175.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 65.5 pttt -75.78 116.05 16.09 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.402 0.62 . . . . 0.0 112.59 -169.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 92.0 t -88.12 109.31 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 179.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 57.8 mt -91.91 145.46 24.53 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.378 -174.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 60.9 mtp180 -122.82 124.53 43.5 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.768 -0.583 . . . . 0.0 109.516 -170.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -111.16 99.45 8.29 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 123.263 0.625 . . . . 0.0 110.162 177.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 76.44 89.44 0.27 Allowed Glycine 0 N--CA 1.482 1.761 0 CA-C-O 119.452 -0.638 . . . . 0.0 113.953 174.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . 0.332 . . 75.8 -78.25 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 124.696 1.199 . . . . 0.0 112.675 -175.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -165.48 75.63 0.15 Allowed Glycine 0 CA--C 1.537 1.431 0 CA-C-O 119.782 -0.455 . . . . 0.0 112.077 173.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -105.73 98.31 8.02 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 104.44 -2.43 . . . . 0.0 104.44 169.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -80.05 100.93 8.41 Favored 'General case' 0 N--CA 1.484 1.242 0 CA-C-N 114.617 -1.174 . . . . 0.0 112.286 -167.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -108.91 113.39 26.25 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 64.2 tp -111.12 -49.5 3.01 Favored 'General case' 0 CA--C 1.564 1.504 0 CA-C-N 114.589 -1.187 . . . . 0.0 111.332 176.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 85.9 t90 -129.99 101.98 6.07 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 -175.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . 0.519 29.8 m 63.43 -88.02 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 114.895 1.443 . . . . 0.0 114.895 177.146 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 8.6 p -79.99 147.86 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 C-N-CA 124.002 0.921 . . . . 0.0 112.241 -174.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 25.6 pttm -80.04 153.29 28.9 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 121.699 0.762 . . . . 0.0 112.991 173.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -131.24 120.2 22.89 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 -175.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 56.1 m-80 -58.63 -51.66 68.97 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 114.617 1.34 . . . . 0.0 114.617 -178.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 67.2 m -97.14 148.97 22.51 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-O 122.612 1.196 . . . . 0.0 111.664 176.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 15.4 tp -65.63 -37.75 87.46 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 172.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -65.41 -32.92 74.8 Favored 'General case' 0 CA--C 1.572 1.81 0 N-CA-C 114.22 1.193 . . . . 0.0 114.22 168.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -63.19 -41.85 99.24 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-N 120.602 1.547 . . . . 0.0 114.416 169.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 63.5 tp -58.69 -43.44 89.99 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 169.086 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 25.7 t -58.62 -64.07 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 C-N-CA 124.447 1.099 . . . . 0.0 112.388 171.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -59.66 -30.91 69.08 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 116.116 1.895 . . . . 0.0 116.116 -174.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 85.4 t80 -63.61 -54.07 41.67 Favored 'General case' 0 CA--C 1.567 1.597 0 CA-C-N 118.815 0.734 . . . . 0.0 112.217 168.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . 0.27 62.2 m-70 -69.92 -9.32 54.58 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 117.891 2.552 . . . . 0.0 117.891 177.354 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -51.23 -38.87 54.89 Favored 'General case' 0 N--CA 1.501 2.087 0 CA-C-N 120.726 1.603 . . . . 0.0 113.603 167.154 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 70.0 m -102.91 -34.01 9.12 Favored 'General case' 0 CA--C 1.564 1.505 0 N-CA-C 114.668 1.358 . . . . 0.0 114.668 169.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 30.3 m -90.17 152.43 21.11 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-N 120.681 1.582 . . . . 0.0 111.178 -176.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 29.9 t -74.87 136.58 41.5 Favored 'General case' 0 CA--C 1.56 1.346 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 177.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 88.3 t -71.79 -50.91 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.903 169.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 58.5 m -91.18 154.58 19.22 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-O 122.162 0.982 . . . . 0.0 111.745 -178.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 10.4 mpt_? -71.9 -54.04 11.29 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.709 177.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 24.6 t30 -72.6 -59.56 2.66 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 173.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -79.89 150.62 30.52 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-N 118.793 0.724 . . . . 0.0 112.221 -177.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -101.45 96.97 7.49 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.383 0.673 . . . . 0.0 109.488 -179.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 5.2 mp -109.11 110.71 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 -179.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 19.3 m-30 -108.26 137.34 46.4 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 173.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 9.7 mp -85.47 128.92 34.89 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 123.36 0.664 . . . . 0.0 112.097 -169.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 4.9 mpt_? -129.07 173.77 10.15 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-O 123.409 1.576 . . . . 0.0 109.843 172.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -84.46 157.97 21.18 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-N 114.739 -1.119 . . . . 0.0 113.711 -177.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 29.2 pt -75.36 153.07 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 CA-C-O 121.704 0.764 . . . . 0.0 112.936 178.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 . . . . . 0 N--CA 1.485 1.305 0 CA-C-O 123.977 1.846 . . . . 0.0 108.847 -178.483 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 68.6 p-90 . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 116.109 1.892 . . . . 0.0 116.109 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -84.05 129.26 34.92 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-N 119.464 1.029 . . . . 0.0 110.646 -174.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -135.5 101.87 4.94 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 105.582 -2.006 . . . . 0.0 105.582 171.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -78.81 108.7 2.71 Favored Glycine 0 CA--C 1.541 1.661 0 CA-C-N 115.969 -0.56 . . . . 0.0 113.317 -173.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . 0.27 2.8 tppp? 66.36 80.27 0.22 Allowed 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 124.878 1.271 . . . . 0.0 112.178 -175.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.25 130.61 23.71 Favored Pre-proline 0 CA--C 1.572 1.792 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 -175.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -63.74 144.75 89.86 Favored 'Trans proline' 0 CA--C 1.559 1.729 0 C-N-CA 122.842 2.361 . . . . 0.0 114.532 -176.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 60.1 ttt180 -59.74 -39.32 84.36 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 116.672 2.101 . . . . 0.0 116.672 -172.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.8 -45.59 85.62 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 115.1 1.519 . . . . 0.0 115.1 174.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -62.92 -36.72 84.34 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 115.038 1.495 . . . . 0.0 115.038 169.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.46 -44.11 97.69 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 115.59 1.7 . . . . 0.0 115.59 169.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -66.07 -38.83 89.29 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 115.26 1.578 . . . . 0.0 115.26 173.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -65.39 -43.88 89.25 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 115.467 1.654 . . . . 0.0 115.467 173.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -66.38 -43.15 86.71 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 114.464 1.283 . . . . 0.0 114.464 174.501 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 94.7 mt -69.8 -31.36 69.23 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 116.179 1.918 . . . . 0.0 116.179 173.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 89.7 p -61.67 -35.78 78.94 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-N 120.245 1.384 . . . . 0.0 114.433 168.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -63.2 -35.22 79.6 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 114.664 1.357 . . . . 0.0 114.664 168.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -63.57 120.88 12.59 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-O 122.23 1.014 . . . . 0.0 111.706 169.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 17.1 ptm180 -70.65 -18.08 62.85 Favored 'General case' 0 CA--C 1.567 1.623 0 N-CA-C 119.061 2.986 . . . . 0.0 119.061 -179.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 51.7 m80 -89.5 146.54 24.55 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-N 119.651 1.114 . . . . 0.0 113.455 -168.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -80.77 110.57 16.41 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.189 -1.411 . . . . 0.0 107.189 169.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 120.1 -17.45 9.88 Favored Glycine 0 CA--C 1.552 2.357 0 CA-C-O 117.347 -1.807 . . . . 0.0 116.043 -168.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.99 113.25 3.36 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-N 120.847 2.323 . . . . 0.0 112.964 -173.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -126.8 168.59 14.22 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 115.167 1.543 . . . . 0.0 115.167 -168.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.5 pp -149.8 134.6 17.75 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 167.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 53.7 mt -85.64 113.25 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 174.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 61.7 ttp85 -95.15 138.86 32.3 Favored 'General case' 0 N--CA 1.483 1.195 0 CA-C-N 114.203 -1.362 . . . . 0.0 110.02 175.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -84.4 125.98 32.81 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 169.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 50.7 m -67.06 128.51 36.62 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.709 0.804 . . . . 0.0 112.411 -169.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -65.76 -49.66 67.57 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 -173.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.4 t -63.96 -40.36 96.25 Favored 'General case' 0 CA--C 1.564 1.51 0 N-CA-C 115.563 1.69 . . . . 0.0 115.563 170.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -112.28 93.53 22.7 Favored Pre-proline 0 CA--C 1.564 1.511 0 CA-C-O 118.02 -0.99 . . . . 0.0 109.779 178.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.58 132.87 21.2 Favored 'Trans proline' 0 C--N 1.371 1.747 0 C-N-CA 123.132 2.555 . . . . 0.0 112.076 177.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 98.91 -34.81 5.08 Favored Glycine 0 CA--C 1.554 2.512 0 CA-C-O 119.055 -0.858 . . . . 0.0 114.464 -168.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -79.24 139.25 37.96 Favored 'General case' 0 N--CA 1.485 1.325 0 CA-C-N 118.529 1.164 . . . . 0.0 109.356 171.026 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -110.0 162.64 14.34 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 122.223 1.011 . . . . 0.0 111.305 -176.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 71.0 m -136.55 117.15 13.88 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 173.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 26.6 tp -79.71 106.62 11.87 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 124.254 1.022 . . . . 0.0 108.731 176.173 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.6 m -95.75 95.69 8.47 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 -170.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 17.6 t -112.08 122.0 65.57 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 -170.196 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -83.29 102.97 12.32 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 169.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -126.14 117.19 22.62 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 107.807 -1.182 . . . . 0.0 107.807 177.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 86.43 -106.35 3.09 Favored Glycine 0 N--CA 1.48 1.621 0 N-CA-C 110.547 -1.021 . . . . 0.0 110.547 -175.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 31.6 t30 -141.88 56.51 1.49 Allowed 'General case' 0 CA--C 1.566 1.574 0 C-N-CA 122.843 0.457 . . . . 0.0 109.999 169.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -158.92 133.2 7.82 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 178.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 56.6 t -91.85 109.94 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 173.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -106.43 115.67 30.62 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.795 0.838 . . . . 0.0 108.786 -169.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 18.4 m-70 -94.88 96.73 9.52 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 114.918 -1.037 . . . . 0.0 108.375 -172.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -94.32 122.13 36.56 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 -174.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -73.79 120.05 18.85 Favored 'General case' 0 N--CA 1.487 1.379 0 CA-C-O 121.445 0.64 . . . . 0.0 111.809 -169.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 76.9 t -97.35 101.4 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 N-CA-C 105.658 -1.979 . . . . 0.0 105.658 175.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -100.13 149.51 23.44 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.284 0.634 . . . . 0.0 110.522 177.588 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 54.7 mtp180 -110.54 128.0 55.45 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 123.164 0.586 . . . . 0.0 110.316 -169.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . 0.277 4.2 p-10 -83.74 -68.64 0.7 Allowed 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 179.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -91.13 -114.56 1.83 Allowed Glycine 0 N--CA 1.482 1.734 0 CA-C-N 119.352 0.978 . . . . 0.0 112.189 -176.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -81.1 -71.65 0.46 Allowed 'General case' 0 N--CA 1.487 1.386 0 CA-C-O 118.357 -0.83 . . . . 0.0 110.607 173.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -134.7 68.1 0.54 Allowed Glycine 0 N--CA 1.48 1.607 0 CA-C-N 118.731 0.696 . . . . 0.0 112.28 169.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 2.3 mppt? -107.28 97.11 6.91 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 105.751 -1.944 . . . . 0.0 105.751 171.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -86.88 110.89 20.29 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 114.309 -1.314 . . . . 0.0 109.343 -169.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -130.56 136.2 48.67 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 121.319 0.58 . . . . 0.0 110.324 -173.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -128.27 -51.51 1.3 Allowed 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 124.067 0.947 . . . . 0.0 111.972 177.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 58.7 t90 -94.46 -79.6 0.42 Allowed 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 124.368 1.067 . . . . 0.0 110.331 -172.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 95.0 t -128.84 -77.77 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 -175.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 10.8 p -80.87 138.86 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 C-N-CA 123.508 0.723 . . . . 0.0 111.362 -172.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.77 147.71 31.74 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 121.648 0.737 . . . . 0.0 112.511 179.309 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -124.26 108.81 12.64 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 -169.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 17.7 p30 -55.79 -30.38 61.24 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 118.195 2.665 . . . . 0.0 118.195 177.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 30.9 t -124.97 146.3 49.46 Favored 'General case' 0 N--CA 1.484 1.237 0 CA-C-O 121.942 0.877 . . . . 0.0 111.436 -177.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 89.6 mt -83.77 103.56 13.16 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 105.356 -2.091 . . . . 0.0 105.356 168.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . 0.273 28.5 t-20 145.98 -57.79 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 104.53 -2.396 . . . . 0.0 104.53 -168.557 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -56.91 -42.44 79.93 Favored 'General case' 0 CA--C 1.574 1.868 0 C-N-CA 124.26 1.024 . . . . 0.0 113.597 168.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 8.4 tt -55.46 -49.44 72.48 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 114.888 1.44 . . . . 0.0 114.888 169.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . 0.276 3.6 m -63.43 -51.47 70.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 CA-C-N 119.224 0.92 . . . . 0.0 113.223 178.188 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -64.67 -33.56 76.24 Favored 'General case' 0 CA--C 1.568 1.664 0 N-CA-C 115.182 1.549 . . . . 0.0 115.182 -176.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 69.2 t80 -62.12 -59.33 5.22 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-N 119.749 1.159 . . . . 0.0 112.826 169.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 60.7 m-70 -68.94 -9.38 51.7 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 117.906 2.558 . . . . 0.0 117.906 178.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 54.5 ttm-85 -53.76 -31.42 48.55 Favored 'General case' 0 CA--C 1.574 1.868 0 N-CA-C 115.074 1.509 . . . . 0.0 115.074 168.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 70.9 m -116.49 -24.32 7.9 Favored 'General case' 0 CA--C 1.57 1.716 0 C-N-CA 125.071 1.348 . . . . 0.0 114.216 169.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 61.0 m -90.13 151.67 21.48 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-N 120.837 1.653 . . . . 0.0 110.577 177.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 32.2 t -68.35 129.09 38.88 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 178.305 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 35.1 t -71.42 -48.79 51.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 CA-C-O 118.296 -0.859 . . . . 0.0 111.95 172.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 15.7 p -91.08 168.41 11.66 Favored 'General case' 0 N--CA 1.487 1.411 0 CA-C-N 119.235 0.925 . . . . 0.0 112.122 -179.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 30.7 mmt180 -72.11 -58.42 3.44 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 177.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 23.8 t30 -75.64 -61.72 1.82 Allowed 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 65.3 mt-30 -79.95 150.35 30.53 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 118.638 0.654 . . . . 0.0 112.225 -175.006 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -83.09 121.37 26.95 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 122.843 0.457 . . . . 0.0 110.553 169.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 3.6 mp -123.64 108.82 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 104.248 -2.501 . . . . 0.0 104.248 172.107 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 18.3 m-30 -113.93 108.19 16.71 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 105.771 -1.937 . . . . 0.0 105.771 179.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . 0.35 1.0 OUTLIER -76.15 170.27 16.62 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 116.381 1.993 . . . . 0.0 116.381 -169.15 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 3.9 tmt_? -160.04 138.22 10.16 Favored 'General case' 0 CA--C 1.56 1.355 0 N-CA-C 104.621 -2.362 . . . . 0.0 104.621 -169.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -67.8 172.39 5.42 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.115 -1.616 . . . . 0.0 114.248 178.353 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 18.3 pt -70.62 156.91 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 O-C-N 120.883 -1.136 . . . . 0.0 113.184 -175.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 . . . . . 0 N--CA 1.489 1.486 0 CA-C-O 122.859 1.314 . . . . 0.0 109.869 176.554 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 62.9 p-90 . . . . . 0 N--CA 1.493 1.678 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 44.6 t80 -82.79 137.82 34.22 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 120.249 1.386 . . . . 0.0 111.799 -173.124 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -118.64 -73.2 0.65 Allowed 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.43 176.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 108.32 84.85 1.67 Allowed Glycine 0 N--CA 1.481 1.697 0 CA-C-N 118.923 0.783 . . . . 0.0 111.397 -176.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.532 ' H ' ' H ' ' A' ' 87' ' ' GLU 0.304 33.0 ttmt 64.98 79.98 0.24 Allowed 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 125.179 1.392 . . . . 0.0 114.109 178.878 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 17.8 pt -126.14 157.79 68.58 Favored Pre-proline 0 CA--C 1.579 2.083 0 C-N-CA 124.257 1.023 . . . . 0.0 109.396 171.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -75.79 165.07 30.83 Favored 'Trans proline' 0 CA--C 1.564 1.976 0 C-N-CA 122.712 2.274 . . . . 0.0 115.092 -178.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 30.0 ttm180 -63.98 -45.49 88.85 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 115.913 1.82 . . . . 0.0 115.913 176.052 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.23 -46.42 87.0 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 115.337 1.606 . . . . 0.0 115.337 -179.278 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm -62.97 -34.71 78.09 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 115.265 1.58 . . . . 0.0 115.265 169.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.88 -42.66 90.04 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 115.442 1.645 . . . . 0.0 115.442 170.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -60.54 -44.91 95.58 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 115.212 1.56 . . . . 0.0 115.212 170.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -58.66 -50.76 72.69 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 114.979 1.474 . . . . 0.0 114.979 175.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -63.96 -49.15 73.68 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 114.708 1.373 . . . . 0.0 114.708 176.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 8.8 mp -71.02 -33.12 70.04 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 116.563 2.06 . . . . 0.0 116.563 -176.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 66.7 m -60.17 -33.09 71.71 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 116.08 1.882 . . . . 0.0 116.08 169.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 57.4 mtmt -64.1 -33.64 76.22 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 115.934 1.827 . . . . 0.0 115.934 169.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -64.5 127.01 29.66 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.62 1.168 . . . . 0.0 113.009 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -62.29 -21.47 65.26 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 119.042 2.978 . . . . 0.0 119.042 177.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 43.4 m80 -89.38 132.71 34.84 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 119.264 0.938 . . . . 0.0 111.09 -169.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -75.55 105.36 6.54 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 171.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 124.78 -7.78 8.25 Favored Glycine 0 CA--C 1.553 2.448 0 CA-C-O 116.91 -2.05 . . . . 0.0 116.523 -169.029 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.12 111.92 2.77 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 121.229 2.515 . . . . 0.0 111.968 -171.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 20.1 p90 -128.24 161.96 28.11 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 115.427 1.64 . . . . 0.0 115.427 -168.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.1 pp -139.69 136.06 33.84 Favored 'General case' 0 CA--C 1.555 1.14 0 CA-C-N 113.919 -1.491 . . . . 0.0 107.884 168.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 62.7 mt -97.13 106.5 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 169.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 46.7 ptt85 -95.45 157.18 16.01 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 114.45 -1.25 . . . . 0.0 110.324 169.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.532 ' H ' ' H ' ' A' ' 64' ' ' LYS . 28.8 tt0 -85.06 135.87 33.81 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.431 -0.793 . . . . 0.0 109.163 169.484 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 93.3 p -68.67 121.9 17.41 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-O 121.026 0.441 . . . . 0.0 110.815 172.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -68.66 -39.37 80.69 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 116.684 2.105 . . . . 0.0 116.684 -175.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.5 t -63.1 -22.13 66.65 Favored 'General case' 0 CA--C 1.569 1.697 0 N-CA-C 115.864 1.802 . . . . 0.0 115.864 169.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -135.45 94.78 15.06 Favored Pre-proline 0 CA--C 1.563 1.446 0 CA-C-N 120.011 1.278 . . . . 0.0 109.027 177.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -70.33 134.06 25.93 Favored 'Trans proline' 0 C--N 1.372 1.795 0 C-N-CA 123.038 2.492 . . . . 0.0 111.933 176.042 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 101.31 -38.05 3.33 Favored Glycine 0 CA--C 1.555 2.574 0 CA-C-O 119.382 -0.676 . . . . 0.0 113.48 -168.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -79.46 130.91 35.86 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 118.182 0.991 . . . . 0.0 109.182 169.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -107.42 169.38 8.61 Favored 'General case' 0 N--CA 1.486 1.374 0 CA-C-O 122.439 1.114 . . . . 0.0 110.861 -178.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 69.4 m -141.65 117.64 10.56 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -179.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 31.2 tp -79.96 113.65 18.28 Favored 'General case' 0 CA--C 1.559 1.314 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 169.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 9.6 m -97.91 104.0 15.99 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 173.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.8 p -124.76 117.63 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 CA-C-N 118.964 0.802 . . . . 0.0 109.0 -171.047 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -74.62 140.0 44.01 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.931 169.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 15.8 t80 -157.0 95.12 1.48 Allowed 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 171.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 70.04 74.87 0.62 Allowed Glycine 0 CA--C 1.544 1.902 0 CA-C-O 119.421 -0.655 . . . . 0.0 114.64 -177.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . 0.366 9.7 t-20 78.62 -58.14 0.44 Allowed 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 116.664 2.098 . . . . 0.0 116.664 -179.026 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -91.16 142.85 27.3 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 123.898 0.879 . . . . 0.0 112.019 -169.32 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 41.6 t -102.27 113.21 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 N-CA-C 106.592 -1.632 . . . . 0.0 106.592 -178.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -96.83 117.99 32.29 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.897 0.879 . . . . 0.0 109.334 -176.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 10.5 m-70 -97.98 97.26 8.77 Favored 'General case' 0 CA--C 1.554 1.119 0 CA-C-N 114.991 -1.004 . . . . 0.0 108.443 -174.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -100.86 135.11 42.83 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 124.061 0.945 . . . . 0.0 109.11 -178.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 12.2 mmmm -79.44 125.34 29.42 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.858 -0.526 . . . . 0.0 111.957 -178.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 96.2 t -85.7 112.94 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 106.484 -1.672 . . . . 0.0 106.484 171.017 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -114.85 145.06 42.57 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.231 0.612 . . . . 0.0 110.528 -175.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -97.11 158.26 15.52 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -175.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -123.1 100.85 7.08 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 169.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 90.73 -112.72 4.14 Favored Glycine 0 CA--C 1.542 1.722 0 CA-C-O 120.082 -0.288 . . . . 0.0 113.417 176.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -84.75 -74.18 0.4 Allowed 'General case' 0 N--CA 1.488 1.462 0 CA-C-O 118.886 -0.578 . . . . 0.0 112.215 -173.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -148.22 74.36 0.28 Allowed Glycine 0 N--CA 1.479 1.518 0 N-CA-C 110.499 -1.04 . . . . 0.0 110.499 173.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -122.38 89.57 3.14 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 -177.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -80.02 115.61 19.69 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.791 -169.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 26.5 p90 -124.86 120.42 31.63 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 174.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -87.86 -59.94 2.1 Favored 'General case' 0 CA--C 1.562 1.424 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.086 169.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 39.3 t90 -80.25 -81.44 0.12 Allowed 'General case' 0 CA--C 1.56 1.343 0 C-N-CA 124.82 1.248 . . . . 0.0 110.383 -175.053 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.1 m -140.44 -53.76 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 C-N-CA 124.012 0.925 . . . . 0.0 110.937 176.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 3.4 m -79.78 140.85 16.14 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.458 0 C-N-CA 124.411 1.084 . . . . 0.0 112.096 -174.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.45 152.34 18.5 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 -171.047 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -146.22 119.91 9.2 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 -171.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -55.91 -40.46 73.09 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 116.575 2.065 . . . . 0.0 116.575 -177.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 27.1 t -102.63 153.07 20.46 Favored 'General case' 0 N--CA 1.485 1.321 0 CA-C-N 119.031 0.832 . . . . 0.0 111.483 174.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 82.9 mt -67.85 -32.64 73.31 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 169.028 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -64.26 -39.69 94.46 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 119.701 1.137 . . . . 0.0 113.803 170.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -60.56 -44.12 96.5 Favored 'General case' 0 CA--C 1.573 1.854 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 169.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 49.3 tp -55.5 -44.84 76.96 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 115.411 1.634 . . . . 0.0 115.411 169.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . 0.282 10.9 m -63.73 -51.5 69.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 CA-C-N 120.124 1.329 . . . . 0.0 113.232 175.11 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -63.34 -36.05 82.41 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 114.625 1.343 . . . . 0.0 114.625 -175.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 90.3 t80 -60.61 -52.72 63.97 Favored 'General case' 0 CA--C 1.57 1.733 0 CA-C-N 119.404 1.002 . . . . 0.0 112.03 168.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 50.7 m-70 -72.7 -9.13 58.27 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 118.728 2.862 . . . . 0.0 118.728 178.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 88.1 mtt-85 -59.84 -29.04 68.0 Favored 'General case' 0 CA--C 1.575 1.937 0 CA-C-N 120.156 1.344 . . . . 0.0 113.447 167.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 69.7 m -103.01 -39.57 6.85 Favored 'General case' 0 CA--C 1.569 1.696 0 C-N-CA 125.022 1.329 . . . . 0.0 113.094 168.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 34.3 m -90.53 156.38 18.21 Favored 'General case' 0 N--CA 1.498 1.94 0 CA-C-N 120.142 1.337 . . . . 0.0 112.031 -176.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 35.3 t -75.07 132.91 41.62 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 3.3 m -78.88 -38.39 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 114.976 1.472 . . . . 0.0 114.976 169.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 16.8 t -79.82 -40.12 29.25 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 116.61 2.078 . . . . 0.0 116.61 -169.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 15.9 tpt180 84.49 115.88 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 124.777 1.231 . . . . 0.0 108.903 -170.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . 0.351 59.2 m-80 83.62 -58.53 0.14 Allowed 'General case' 0 N--CA 1.499 2.017 0 C-N-CA 124.507 1.123 . . . . 0.0 112.604 -172.496 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 -79.57 126.63 31.13 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 170.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 76.3 mm-40 -90.1 96.03 10.48 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 -175.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 29.6 mm -111.68 109.4 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 105.787 -1.931 . . . . 0.0 105.787 -173.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -111.95 121.93 46.36 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 -173.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 10.5 mp -75.1 136.62 41.12 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 -168.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 81.7 mmt-85 -131.54 153.57 49.71 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 125.368 1.467 . . . . 0.0 108.381 178.468 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -79.31 157.39 27.71 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.822 -1.174 . . . . 0.0 112.798 -177.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 8.5 mt -69.35 146.68 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 C-N-CA 123.934 0.894 . . . . 0.0 109.886 -179.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 123.946 1.832 . . . . 0.0 108.149 178.726 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . 0.418 70.5 p-90 . . . . . 0 N--CA 1.5 2.071 0 N-CA-C 120.732 3.604 . . . . 0.0 120.732 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 44.4 t80 -96.95 131.6 43.59 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.78 0.832 . . . . 0.0 110.153 -169.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -107.73 -65.89 1.08 Allowed 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.352 173.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.04 77.66 1.31 Allowed Glycine 0 N--CA 1.482 1.744 0 CA-C-N 118.952 0.796 . . . . 0.0 112.375 -179.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . 0.298 61.9 tttt 71.24 71.74 0.18 Allowed 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 124.62 1.168 . . . . 0.0 113.936 175.049 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 14.9 pt -118.95 154.74 53.22 Favored Pre-proline 0 CA--C 1.576 1.959 0 C-N-CA 124.056 0.942 . . . . 0.0 109.069 170.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -75.71 172.65 15.91 Favored 'Trans proline' 0 CA--C 1.564 2.015 0 C-N-CA 122.702 2.268 . . . . 0.0 114.34 178.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 28.6 ttm180 -61.63 -43.86 98.07 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 115.915 1.82 . . . . 0.0 115.915 175.407 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -65.3 -43.38 91.29 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 115.805 1.78 . . . . 0.0 115.805 178.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -67.39 -32.54 73.51 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 115.362 1.615 . . . . 0.0 115.362 169.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.26 -42.14 88.95 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 115.328 1.603 . . . . 0.0 115.328 169.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -62.81 -42.4 99.7 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 114.346 1.239 . . . . 0.0 114.346 169.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -53.41 -48.07 69.03 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 115.395 1.628 . . . . 0.0 115.395 170.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 37.3 mmt -62.37 -48.32 80.31 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 173.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 88.8 mt -76.22 -9.82 58.93 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 117.775 2.509 . . . . 0.0 117.775 178.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 72.4 m -57.69 -38.73 75.71 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 115.875 1.805 . . . . 0.0 115.875 170.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -60.39 -33.27 72.24 Favored 'General case' 0 CA--C 1.571 1.778 0 N-CA-C 116.061 1.875 . . . . 0.0 116.061 169.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -71.7 111.46 6.99 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.165 0.986 . . . . 0.0 112.122 -171.511 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 13.4 ptp180 -74.28 -17.57 60.84 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 117.86 2.541 . . . . 0.0 117.86 173.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 48.4 m80 -89.63 137.29 32.45 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 119.248 0.931 . . . . 0.0 111.338 -168.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -77.56 115.23 17.15 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 122.951 0.5 . . . . 0.0 110.444 176.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 114.63 -23.19 12.27 Favored Glycine 0 CA--C 1.551 2.321 0 CA-C-O 117.269 -1.851 . . . . 0.0 116.246 -169.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.4 113.47 1.99 Allowed 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 120.66 2.23 . . . . 0.0 113.238 -176.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 27.3 p90 -130.18 165.07 23.11 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 115.828 1.788 . . . . 0.0 115.828 -168.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.0 pp -142.16 125.25 16.3 Favored 'General case' 0 CA--C 1.557 1.233 0 N-CA-C 106.803 -1.555 . . . . 0.0 106.803 168.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 59.9 mt -87.07 114.12 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 106.584 -1.636 . . . . 0.0 106.584 173.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 49.3 ptt85 -99.78 159.2 15.24 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-N 114.931 -1.031 . . . . 0.0 111.042 170.028 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -86.58 135.28 33.49 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 168.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 84.1 p -65.32 128.45 35.9 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-O 121.275 0.559 . . . . 0.0 111.733 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -62.46 -45.46 92.94 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 116.017 1.858 . . . . 0.0 116.017 -169.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 68.1 m -69.72 -33.15 72.09 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 116.053 1.871 . . . . 0.0 116.053 171.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -119.18 101.04 50.01 Favored Pre-proline 0 CA--C 1.563 1.469 0 CA-C-N 120.018 1.281 . . . . 0.0 110.939 -175.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -59.46 -32.16 95.92 Favored 'Trans proline' 0 C--N 1.369 1.655 0 N-CA-C 119.934 3.013 . . . . 0.0 119.934 174.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -87.23 44.82 3.33 Favored Glycine 0 CA--C 1.553 2.41 0 N-CA-C 115.247 0.859 . . . . 0.0 115.247 169.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -160.13 130.19 5.37 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 106.187 -1.783 . . . . 0.0 106.187 -178.079 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 -103.9 174.73 5.74 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 122.106 0.955 . . . . 0.0 111.181 172.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 62.0 m -149.03 120.4 7.88 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 -179.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 36.4 tp -79.93 110.51 15.37 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.803 0.841 . . . . 0.0 109.173 170.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.6 m -96.16 103.1 14.98 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 105.696 -1.964 . . . . 0.0 105.696 174.201 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.4 p -122.21 121.12 63.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 CA-C-O 121.471 0.653 . . . . 0.0 109.809 -169.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 58.1 tptt -82.68 98.63 9.15 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 124.32 1.048 . . . . 0.0 109.941 177.22 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -120.08 93.31 4.01 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -175.658 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 69.28 65.18 2.68 Favored Glycine 0 CA--C 1.544 1.845 0 N-CA-C 115.658 1.023 . . . . 0.0 115.658 175.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . 0.269 26.8 t30 54.78 41.83 31.63 Favored 'General case' 0 CA--C 1.574 1.903 0 N-CA-C 116.419 2.007 . . . . 0.0 116.419 -174.207 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -160.77 129.92 4.81 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.541 -0.724 . . . . 0.0 109.738 176.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 41.1 t -94.71 106.04 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 178.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -98.73 119.6 37.75 Favored 'General case' 0 N--CA 1.484 1.27 0 CA-C-O 121.704 0.764 . . . . 0.0 109.37 -177.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 13.0 m-70 -99.19 109.23 21.93 Favored 'General case' 0 CA--C 1.552 1.034 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 -176.278 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -114.49 127.94 56.07 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -176.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -74.29 132.32 41.98 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-O 121.785 0.802 . . . . 0.0 112.751 -177.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 92.9 t -101.97 103.99 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 N-CA-C 104.859 -2.274 . . . . 0.0 104.859 174.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -104.44 132.35 50.78 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.517 0.727 . . . . 0.0 110.129 -173.5 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -84.96 161.88 19.62 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 121.895 0.855 . . . . 0.0 112.306 -179.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 20.7 p-10 -79.69 -39.41 31.35 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 169.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -178.53 -79.09 0.06 OUTLIER Glycine 0 CA--C 1.539 1.586 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 -173.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -74.83 -69.34 0.47 Allowed 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 177.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -174.18 68.78 0.1 OUTLIER Glycine 0 N--CA 1.479 1.529 0 CA-C-N 118.874 0.761 . . . . 0.0 113.294 175.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -120.38 102.33 8.39 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 105.38 -2.082 . . . . 0.0 105.38 171.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -81.4 121.39 26.17 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.439 1.095 . . . . 0.0 110.488 -169.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 44.0 p90 -130.03 122.0 27.54 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 121.31 0.576 . . . . 0.0 109.616 174.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 5.0 tt -89.36 -65.2 1.04 Allowed 'General case' 0 N--CA 1.488 1.472 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.126 169.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 20.2 t90 -82.32 -61.78 1.8 Allowed 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 124.446 1.098 . . . . 0.0 112.55 -172.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . 0.258 11.2 p -149.76 -67.36 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 CA-C-N 118.849 0.75 . . . . 0.0 110.114 -178.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 3.4 m -79.64 141.91 14.68 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.419 0 C-N-CA 124.291 1.036 . . . . 0.0 112.301 -171.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 10.0 ptpp? -96.64 156.24 16.43 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -173.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -145.14 132.12 20.27 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.248 -169.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 -50.61 -41.73 55.16 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 117.922 2.564 . . . . 0.0 117.922 177.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 90.5 p -122.65 159.33 28.11 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-O 122.688 1.233 . . . . 0.0 111.877 178.079 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 61.3 mt -62.69 -31.91 72.9 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 115.186 1.551 . . . . 0.0 115.186 169.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -65.36 -36.09 82.96 Favored 'General case' 0 CA--C 1.571 1.755 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 169.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -63.26 -47.83 80.75 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-N 119.86 1.209 . . . . 0.0 113.707 169.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 60.5 tp -59.53 -38.61 81.45 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 115.724 1.75 . . . . 0.0 115.724 169.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . 0.265 0.3 OUTLIER -67.04 -53.9 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 CA-C-N 119.743 1.156 . . . . 0.0 113.251 -179.595 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -57.97 -33.83 69.3 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 115.454 1.65 . . . . 0.0 115.454 172.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -57.28 -55.45 34.62 Favored 'General case' 0 CA--C 1.566 1.579 0 CA-C-N 119.353 0.979 . . . . 0.0 113.021 168.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . 0.265 52.7 m-70 -74.72 -9.47 58.59 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 117.944 2.572 . . . . 0.0 117.944 177.379 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 94.2 mtt-85 -62.15 -33.35 74.33 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-N 120.883 1.674 . . . . 0.0 112.962 167.168 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 70.6 m -97.03 -40.15 8.99 Favored 'General case' 0 CA--C 1.563 1.476 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 170.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 60.7 m -90.8 154.03 19.81 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-N 120.093 1.315 . . . . 0.0 111.527 179.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 33.0 t -75.75 134.66 40.41 Favored 'General case' 0 CA--C 1.559 1.323 0 CA-C-O 121.462 0.648 . . . . 0.0 112.556 177.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 45.5 t -70.24 -48.29 62.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 CA-C-N 115.419 -0.81 . . . . 0.0 112.202 172.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 57.7 m -122.62 154.71 37.64 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-O 122.262 1.03 . . . . 0.0 110.721 -177.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 85.2 mtt85 -77.18 -39.88 47.32 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 115.171 1.545 . . . . 0.0 115.171 -177.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 22.2 m120 -74.58 -66.45 0.74 Allowed 'General case' 0 N--CA 1.495 1.82 0 CA-C-N 119.902 1.228 . . . . 0.0 111.876 174.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 35.7 mm-40 -80.07 126.02 30.53 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 118.909 0.777 . . . . 0.0 109.2 170.08 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 3.2 pm0 -94.43 86.46 4.86 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 123.018 0.527 . . . . 0.0 110.477 -176.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 4.0 mp -85.77 122.04 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -169.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -121.73 117.11 25.81 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 106.428 -1.694 . . . . 0.0 106.428 176.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 11.2 mp -70.85 134.4 47.29 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 -168.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 62.7 mmt-85 -132.28 162.71 30.31 Favored 'General case' 0 CA--C 1.564 1.515 0 C-N-CA 124.963 1.305 . . . . 0.0 109.221 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -76.33 158.89 31.05 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.907 -1.12 . . . . 0.0 113.801 176.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.1 pp -76.65 161.73 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -177.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 . . . . . 0 N--CA 1.484 1.262 0 CA-C-O 124.021 1.867 . . . . 0.0 108.096 177.618 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 1.6 p90 . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 116.248 1.944 . . . . 0.0 116.248 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 72.2 t80 -118.32 124.19 47.17 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 178.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -119.39 66.43 0.79 Allowed 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 121.272 0.558 . . . . 0.0 110.82 -179.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 53.59 -119.42 10.83 Favored Glycine 0 CA--C 1.547 2.065 0 N-CA-C 118.803 2.281 . . . . 0.0 118.803 169.433 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -141.56 96.53 3.0 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 -171.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.01 149.94 75.19 Favored Pre-proline 0 CA--C 1.572 1.815 0 CA-C-O 118.502 -0.761 . . . . 0.0 109.733 176.255 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -66.49 172.11 9.63 Favored 'Trans proline' 0 CA--C 1.563 1.956 0 C-N-CA 123.005 2.47 . . . . 0.0 114.556 172.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 59.2 ttt-85 -60.32 -41.9 94.48 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 116.08 1.882 . . . . 0.0 116.08 -177.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -66.08 -44.27 84.96 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 115.466 1.654 . . . . 0.0 115.466 176.077 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -63.24 -33.99 76.68 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 115.674 1.731 . . . . 0.0 115.674 170.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.47 -43.15 95.11 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 115.302 1.593 . . . . 0.0 115.302 169.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -61.22 -43.97 98.02 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 114.943 1.46 . . . . 0.0 114.943 170.261 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -57.18 -44.0 83.17 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 115.626 1.713 . . . . 0.0 115.626 173.095 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 37.9 mmt -63.04 -48.3 79.33 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 114.528 1.307 . . . . 0.0 114.528 172.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 95.1 mt -73.25 -12.12 60.75 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 117.518 2.414 . . . . 0.0 117.518 175.272 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 69.6 m -63.0 -37.85 88.82 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-N 120.507 1.503 . . . . 0.0 113.966 168.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt -60.59 -33.78 73.24 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 115.386 1.624 . . . . 0.0 115.386 169.206 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -71.2 117.04 12.22 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 124.478 1.111 . . . . 0.0 111.225 178.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -79.53 -17.39 54.15 Favored 'General case' 0 CA--C 1.569 1.677 0 N-CA-C 117.531 2.419 . . . . 0.0 117.531 172.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 45.8 m80 -89.53 133.22 34.69 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 119.198 0.908 . . . . 0.0 111.929 -168.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -71.63 123.31 22.22 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 122.953 0.501 . . . . 0.0 110.833 174.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 107.8 -20.22 31.95 Favored Glycine 0 CA--C 1.549 2.179 0 CA-C-O 117.576 -1.68 . . . . 0.0 116.51 -169.257 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.69 123.06 19.07 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-N 120.192 1.996 . . . . 0.0 111.746 -173.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 24.7 p90 -137.36 158.13 45.08 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -168.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.3 pp -137.47 127.99 26.68 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 168.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 74.1 mt -87.64 113.6 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 105.62 -1.993 . . . . 0.0 105.62 175.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 4.1 ptm180 -90.05 149.96 22.29 Favored 'General case' 0 N--CA 1.484 1.27 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.065 170.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -85.87 128.43 34.82 Favored 'General case' 0 CA--C 1.56 1.33 0 N-CA-C 106.795 -1.558 . . . . 0.0 106.795 168.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 50.3 m -65.01 132.61 49.7 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 -169.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -64.67 -50.98 64.92 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 114.666 1.358 . . . . 0.0 114.666 -174.401 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 95.9 p -65.09 -38.95 92.39 Favored 'General case' 0 CA--C 1.562 1.441 0 N-CA-C 116.083 1.883 . . . . 0.0 116.083 169.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -114.73 95.16 39.98 Favored Pre-proline 0 CA--C 1.563 1.474 0 CA-C-N 119.66 1.118 . . . . 0.0 109.553 -179.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -72.39 135.09 23.84 Favored 'Trans proline' 0 C--N 1.371 1.749 0 C-N-CA 123.068 2.512 . . . . 0.0 112.215 178.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 97.41 -40.49 2.52 Favored Glycine 0 CA--C 1.552 2.383 0 CA-C-O 119.308 -0.718 . . . . 0.0 113.627 -168.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -79.12 131.4 36.22 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 124.076 0.95 . . . . 0.0 109.168 176.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -100.54 168.52 9.67 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 122.102 0.953 . . . . 0.0 111.847 -170.363 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 58.8 m -147.31 123.62 10.93 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 174.106 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 26.8 tp -79.95 108.47 13.55 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.078 0.951 . . . . 0.0 109.635 175.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.2 m -91.38 107.26 19.08 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 106.12 -1.808 . . . . 0.0 106.12 172.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.2 p -131.06 116.11 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 -170.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.19 113.92 20.35 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.334 175.422 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -132.95 116.39 16.38 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 177.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 89.48 -83.33 1.41 Allowed Glycine 0 N--CA 1.481 1.654 0 CA-C-N 116.243 -0.435 . . . . 0.0 112.063 -179.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 10.6 p30 -138.62 -26.4 0.88 Allowed 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 115.533 1.679 . . . . 0.0 115.533 170.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -98.05 142.42 29.77 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 124.051 0.94 . . . . 0.0 110.668 -171.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 47.8 t -85.64 110.01 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 N-CA-C 106.533 -1.654 . . . . 0.0 106.533 172.061 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 61.9 mt-30 -104.42 113.92 27.8 Favored 'General case' 0 N--CA 1.484 1.26 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.002 -169.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 16.8 m-70 -96.26 102.49 14.28 Favored 'General case' 0 CA--C 1.553 1.071 0 CA-C-N 114.766 -1.106 . . . . 0.0 108.262 -174.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -106.78 123.24 47.85 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 -179.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 43.6 mtpt -77.2 122.95 25.76 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 121.687 0.756 . . . . 0.0 112.101 -169.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 98.7 t -92.35 96.94 6.66 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.591 0 N-CA-C 105.026 -2.213 . . . . 0.0 105.026 177.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 62.1 mt -90.52 135.65 33.56 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 -168.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 27.1 mtp-105 -87.42 144.01 26.96 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 122.014 0.912 . . . . 0.0 112.888 176.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -86.57 -53.67 4.84 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-N 114.474 -1.239 . . . . 0.0 114.304 176.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -165.71 -86.08 0.06 OUTLIER Glycine 0 N--CA 1.48 1.628 0 CA-C-N 119.895 1.225 . . . . 0.0 113.287 -173.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -68.29 -63.79 0.99 Allowed 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 114.531 1.308 . . . . 0.0 114.531 -172.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -161.97 13.75 0.13 Allowed Glycine 0 CA--C 1.552 2.398 0 N-CA-C 116.728 1.451 . . . . 0.0 116.728 170.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -91.96 150.58 20.93 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-N 119.204 1.502 . . . . 0.0 109.084 177.494 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -137.98 137.11 37.59 Favored 'General case' 0 N--CA 1.487 1.411 0 CA-C-N 114.944 -1.026 . . . . 0.0 109.517 -174.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -123.73 122.55 38.38 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 124.764 1.226 . . . . 0.0 108.693 -172.011 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 60.7 tp -100.6 -56.96 2.21 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.028 169.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 84.6 t90 -133.43 103.66 6.05 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 -174.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . 0.405 22.3 t 78.74 -82.8 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 C-N-CA 124.155 0.982 . . . . 0.0 111.982 171.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 16.9 m -81.37 140.72 16.16 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.399 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -169.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -90.14 138.45 31.51 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.49 0.662 . . . . 0.0 111.106 169.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -172.25 139.5 1.05 Allowed 'General case' 0 N--CA 1.488 1.454 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.623 -169.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -79.47 74.91 6.09 Favored 'General case' 0 N--CA 1.501 2.086 0 CA-C-O 123.76 1.743 . . . . 0.0 109.784 170.225 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 89.3 p -102.94 63.76 0.83 Allowed 'General case' 0 CA--C 1.554 1.122 1 N-CA-C 124.09 4.848 . . . . 0.0 124.09 -166.501 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 75.7 mt -101.52 86.62 3.0 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 104.224 -2.51 . . . . 0.0 104.224 167.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . 0.261 25.0 t-20 133.99 -61.05 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.045 0 C-N-CA 127.39 2.276 . . . . 0.0 105.479 -167.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -56.09 -45.58 79.34 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 115.367 1.617 . . . . 0.0 115.367 177.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 15.7 tp -66.44 -37.79 85.95 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 177.13 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 44.7 t -58.4 -65.38 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 C-N-CA 124.585 1.154 . . . . 0.0 111.548 174.318 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -66.73 -35.56 80.4 Favored 'General case' 0 CA--C 1.569 1.677 0 N-CA-C 114.826 1.417 . . . . 0.0 114.826 -173.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -58.59 -59.42 5.42 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 124.419 1.088 . . . . 0.0 113.649 169.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -74.83 -8.56 56.8 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 117.872 2.545 . . . . 0.0 117.872 177.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 46.1 ttm-85 -52.32 -30.83 30.23 Favored 'General case' 0 CA--C 1.577 1.992 0 N-CA-C 114.818 1.414 . . . . 0.0 114.818 168.23 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 68.0 m -105.05 -40.94 5.72 Favored 'General case' 0 CA--C 1.569 1.673 0 C-N-CA 124.995 1.318 . . . . 0.0 113.037 168.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 53.7 m -90.51 150.58 21.72 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-N 120.199 1.363 . . . . 0.0 111.859 -176.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 21.7 t -80.63 133.68 35.78 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.107 -0.995 . . . . 0.0 112.828 -178.13 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 8.3 m -66.62 -42.65 90.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 115.398 1.629 . . . . 0.0 115.398 170.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 14.3 t -112.65 -45.56 3.22 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 -174.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . 0.302 80.3 mtm180 77.15 71.98 0.06 Allowed 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 125.337 1.455 . . . . 0.0 110.64 -169.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . 0.269 14.4 p-10 -149.58 -65.91 0.22 Allowed 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.996 -1.112 . . . . 0.0 107.996 173.271 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 -96.29 7.42 46.5 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 115.531 1.678 . . . . 0.0 115.531 169.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 83.0 mm-40 56.73 70.31 0.66 Allowed 'General case' 0 N--CA 1.495 1.821 0 C-N-CA 125.196 1.399 . . . . 0.0 111.945 -169.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 5.0 mp -85.68 116.68 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 -169.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -118.64 137.87 52.99 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-N 115.125 -0.943 . . . . 0.0 108.965 -174.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 11.1 mp -83.92 115.84 22.49 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 -168.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -122.97 150.62 42.75 Favored 'General case' 0 CA--C 1.563 1.457 0 C-N-CA 125.437 1.495 . . . . 0.0 109.322 179.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -74.28 156.5 37.12 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.737 -1.227 . . . . 0.0 113.23 178.225 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.1 pp -72.82 164.51 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 -171.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 . . . . . 0 N--CA 1.485 1.281 0 CA-C-O 123.953 1.835 . . . . 0.0 108.394 179.029 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 1.2 p90 . . . . . 0 N--CA 1.488 1.438 0 N-CA-C 116.167 1.914 . . . . 0.0 116.167 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -80.82 117.82 21.8 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-N 121.466 1.939 . . . . 0.0 109.788 179.409 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -129.76 94.39 3.73 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 104.942 -2.244 . . . . 0.0 104.942 174.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -77.49 125.45 7.32 Favored Glycine 0 CA--C 1.54 1.609 0 C-N-CA 123.156 0.408 . . . . 0.0 113.577 -170.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.446 ' H ' ' H ' ' A' ' 87' ' ' GLU 0.376 64.5 pttt 52.9 63.48 2.22 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 115.335 1.606 . . . . 0.0 115.335 -175.378 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -107.95 127.21 28.08 Favored Pre-proline 0 CA--C 1.574 1.897 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 -173.617 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -68.88 160.91 47.85 Favored 'Trans proline' 0 CA--C 1.56 1.785 0 C-N-CA 123.156 2.571 . . . . 0.0 115.574 -172.164 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 16.1 ttm180 -73.33 -35.8 66.09 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 117.327 2.343 . . . . 0.0 117.327 -170.024 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.75 -41.6 97.98 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 115.401 1.63 . . . . 0.0 115.401 169.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -68.27 -40.99 81.7 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 114.497 1.295 . . . . 0.0 114.497 169.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.71 -41.36 98.12 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 115.271 1.582 . . . . 0.0 115.271 172.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -67.13 -44.67 79.27 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 170.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -53.01 -38.88 62.71 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 116.085 1.883 . . . . 0.0 116.085 171.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.51 -62.63 1.56 Allowed 'General case' 0 CA--C 1.566 1.568 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 169.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.1 mp -70.0 -50.71 38.82 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 117.411 2.374 . . . . 0.0 117.411 -168.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 60.2 p -60.3 -34.26 73.52 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 115.921 1.823 . . . . 0.0 115.921 174.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -72.63 -30.54 64.41 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 115.644 1.72 . . . . 0.0 115.644 170.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -50.72 133.23 26.14 Favored 'General case' 0 CA--C 1.556 1.19 0 N-CA-C 114.977 1.473 . . . . 0.0 114.977 176.681 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.12 -23.49 62.17 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 118.613 2.82 . . . . 0.0 118.613 174.159 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 42.9 m80 -89.43 131.51 35.45 Favored 'General case' 0 N--CA 1.484 1.225 0 CA-C-N 119.23 0.923 . . . . 0.0 110.667 -169.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -80.99 102.22 10.03 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 174.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 124.02 4.86 7.7 Favored Glycine 0 CA--C 1.552 2.405 0 CA-C-O 116.652 -2.193 . . . . 0.0 115.991 -168.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.02 116.26 6.95 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-N 121.682 2.741 . . . . 0.0 112.913 -169.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -129.8 161.41 30.8 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 118.135 2.643 . . . . 0.0 118.135 -168.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.8 pp -144.09 154.11 42.86 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 114.126 -1.397 . . . . 0.0 109.422 168.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.0 mp -112.67 124.05 68.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 178.085 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -90.36 167.49 12.61 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 124.477 1.111 . . . . 0.0 112.199 174.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.446 ' H ' ' H ' ' A' ' 64' ' ' LYS . 35.7 tt0 -129.15 116.11 18.71 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 106.139 -1.801 . . . . 0.0 106.139 169.183 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 64.7 m -76.85 134.73 38.94 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -170.295 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -74.62 -56.51 4.74 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-N 115.415 -0.811 . . . . 0.0 112.999 178.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.5 t -61.43 -39.56 91.23 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 116.068 1.877 . . . . 0.0 116.068 177.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -102.92 99.76 14.82 Favored Pre-proline 0 CA--C 1.565 1.523 0 CA-C-O 117.83 -1.081 . . . . 0.0 108.647 170.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -75.22 126.95 10.16 Favored 'Trans proline' 0 C--N 1.371 1.712 0 C-N-CA 123.016 2.477 . . . . 0.0 112.545 -175.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 82.2 6.62 88.63 Favored Glycine 0 CA--C 1.555 2.57 0 N-CA-C 118.189 2.036 . . . . 0.0 118.189 -169.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -98.12 116.54 30.56 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-N 119.813 1.806 . . . . 0.0 107.302 171.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -99.0 151.25 21.13 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.787 -0.819 . . . . 0.0 108.787 -178.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 43.2 m -132.93 112.4 11.84 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.505 -0.747 . . . . 0.0 110.175 -175.244 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 26.4 tp -79.3 105.77 10.85 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-O 121.967 0.889 . . . . 0.0 108.979 174.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 15.4 m -89.44 93.6 9.57 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 173.028 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.9 p -112.08 125.95 69.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 -174.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -77.16 129.15 35.59 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 114.813 -1.085 . . . . 0.0 111.049 173.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -137.75 114.65 10.68 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 87.22 -92.37 1.8 Allowed Glycine 0 N--CA 1.481 1.687 0 N-CA-C 112.056 -0.418 . . . . 0.0 112.056 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 10.8 p-10 -130.44 -22.48 2.74 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 115.434 1.642 . . . . 0.0 115.434 169.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -108.49 146.34 33.34 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 124.484 1.114 . . . . 0.0 110.251 -173.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 9.7 p -84.76 123.63 39.28 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.537 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.101 179.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -109.86 122.68 48.09 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 124.093 0.957 . . . . 0.0 108.901 -178.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 12.0 m-70 -103.73 96.37 6.66 Favored 'General case' 0 CA--C 1.555 1.14 0 CA-C-O 121.804 0.812 . . . . 0.0 108.864 -169.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -92.31 141.64 28.34 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 124.431 1.092 . . . . 0.0 110.233 -177.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -96.05 114.73 26.47 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.429 0.633 . . . . 0.0 110.369 -176.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 81.5 t -84.07 124.29 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 174.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 55.0 mt -102.12 136.13 42.49 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.014 -176.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 36.4 mtm180 -108.89 129.87 55.42 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 122.715 0.406 . . . . 0.0 110.368 176.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -97.31 103.32 15.24 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 123.165 0.586 . . . . 0.0 110.555 176.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 90.3 -110.7 3.81 Favored Glycine 0 N--CA 1.481 1.661 0 CA-C-O 120.072 -0.293 . . . . 0.0 113.325 174.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -79.95 -69.49 0.58 Allowed 'General case' 0 N--CA 1.487 1.419 0 CA-C-O 118.762 -0.637 . . . . 0.0 112.53 -176.127 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -159.05 75.03 0.21 Allowed Glycine 0 N--CA 1.477 1.424 0 CA-C-N 118.661 0.664 . . . . 0.0 111.581 171.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -117.63 91.37 3.55 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 -173.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -79.53 115.0 18.89 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 123.82 0.848 . . . . 0.0 111.686 -168.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -131.23 130.62 43.15 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.595 0.758 . . . . 0.0 109.041 177.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 41.8 tp -95.25 -54.76 3.3 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 118.548 -0.739 . . . . 0.0 110.38 169.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 45.2 m0 -74.7 -86.68 0.04 OUTLIER 'General case' 0 CA--C 1.565 1.553 0 CA-C-N 119.359 0.981 . . . . 0.0 110.537 173.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 10.0 m -145.06 -47.53 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 C-N-CA 124.56 1.144 . . . . 0.0 111.107 -175.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 14.0 p -79.54 130.85 35.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 CA-C-N 119.217 0.917 . . . . 0.0 110.212 -175.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.21 161.04 15.9 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-O 122.605 1.193 . . . . 0.0 114.205 -170.615 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -148.31 114.34 5.8 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 105.021 -2.215 . . . . 0.0 105.021 -170.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -57.84 -24.38 57.16 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 119.198 3.036 . . . . 0.0 119.198 -169.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 78.8 p -125.93 165.51 18.62 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-N 120.543 1.52 . . . . 0.0 113.096 179.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 33.0 mt -52.04 -47.69 64.93 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 115.23 1.567 . . . . 0.0 115.23 169.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 18.7 m-80 -63.12 -43.69 97.73 Favored 'General case' 0 CA--C 1.564 1.516 0 N-CA-C 114.071 1.137 . . . . 0.0 114.071 174.048 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -58.94 -50.81 72.66 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 115.388 1.625 . . . . 0.0 115.388 177.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 58.4 tp -61.32 -49.04 78.59 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-N 120.019 1.281 . . . . 0.0 114.237 174.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . 0.311 1.6 p -69.96 -37.5 72.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 -178.125 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -61.55 -34.55 75.76 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-N 119.976 1.262 . . . . 0.0 113.597 168.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 45.8 t80 -58.13 -54.07 51.07 Favored 'General case' 0 CA--C 1.569 1.673 0 CA-C-O 117.546 -1.216 . . . . 0.0 111.984 167.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . 0.347 21.9 m-70 -71.66 -8.99 57.54 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 118.69 2.848 . . . . 0.0 118.69 173.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 55.1 mtp85 -75.94 -22.06 56.37 Favored 'General case' 0 CA--C 1.576 1.958 0 CA-C-N 119.876 1.217 . . . . 0.0 112.926 167.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 70.6 m -100.73 -46.31 5.2 Favored 'General case' 0 CA--C 1.565 1.554 0 C-N-CA 125.005 1.322 . . . . 0.0 112.962 169.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 91.3 m -86.21 154.32 21.38 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 124.948 1.299 . . . . 0.0 110.121 173.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 27.4 t -80.48 148.02 30.64 Favored 'General case' 0 N--CA 1.483 1.203 0 O-C-N 121.131 -0.981 . . . . 0.0 113.238 177.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 77.1 t -75.17 -54.02 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 168.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 34.2 t -87.77 104.05 16.2 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-N 118.909 0.777 . . . . 0.0 109.071 174.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . 0.273 0.2 OUTLIER -59.95 -40.39 88.85 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 117.711 2.486 . . . . 0.0 117.711 -175.722 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -72.1 -63.5 1.13 Allowed 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 177.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -94.09 104.24 16.28 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 172.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 -77.45 115.28 17.09 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 -168.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -120.82 133.45 67.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 179.278 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -119.15 153.47 34.83 Favored 'General case' 0 N--CA 1.497 1.875 0 CA-C-O 121.88 0.848 . . . . 0.0 111.337 -170.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 9.5 mp -88.05 143.66 26.95 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 -169.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 29.1 mmm180 -132.87 142.91 49.18 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 124.929 1.292 . . . . 0.0 109.175 -179.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -76.1 143.37 41.31 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.379 -0.826 . . . . 0.0 111.285 176.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 25.0 pt -62.82 146.32 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 -176.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 . . . . . 0 N--CA 1.484 1.261 0 CA-C-O 123.91 1.814 . . . . 0.0 109.435 175.799 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 1.6 p90 . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 118.499 -0.762 . . . . 0.0 111.976 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -82.09 124.76 30.12 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-N 119.931 1.241 . . . . 0.0 110.101 -179.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -128.59 75.14 1.61 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 123.473 0.483 . . . . 0.0 110.253 -175.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 59.05 -114.58 6.26 Favored Glycine 0 N--CA 1.485 1.937 0 C-N-CA 123.873 0.749 . . . . 0.0 114.817 173.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -144.99 111.45 5.69 Favored 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 169.157 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 43.2 pt -122.99 152.2 62.6 Favored Pre-proline 0 CA--C 1.572 1.821 0 CA-C-O 118.525 -0.75 . . . . 0.0 110.476 -179.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -58.78 165.56 7.98 Favored 'Trans proline' 0 CA--C 1.56 1.777 0 C-N-CA 123.4 2.733 . . . . 0.0 116.745 171.367 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 25.7 ttm180 -62.92 -40.67 98.32 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 114.898 1.444 . . . . 0.0 114.898 169.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -62.56 -41.14 98.72 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 115.728 1.751 . . . . 0.0 115.728 170.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 3.1 tppp? -64.79 -37.63 88.25 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 115.201 1.556 . . . . 0.0 115.201 169.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.91 -41.68 91.12 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 115.682 1.734 . . . . 0.0 115.682 171.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -64.65 -38.78 92.16 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 114.816 1.413 . . . . 0.0 114.816 169.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -60.57 -52.83 63.49 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 114.509 1.3 . . . . 0.0 114.509 172.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 40.4 tpp -61.11 -44.07 97.92 Favored 'General case' 0 CA--C 1.564 1.492 0 N-CA-C 115.793 1.775 . . . . 0.0 115.793 175.386 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 92.6 mt -72.6 -20.72 61.24 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 116.616 2.08 . . . . 0.0 116.616 172.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 22.9 t -60.24 -37.6 80.88 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-N 121.079 1.763 . . . . 0.0 113.497 168.512 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -59.42 -37.17 77.36 Favored 'General case' 0 CA--C 1.57 1.737 0 N-CA-C 114.525 1.306 . . . . 0.0 114.525 168.7 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -69.12 114.36 7.32 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 124.322 1.049 . . . . 0.0 110.855 170.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 -76.24 -13.44 60.17 Favored 'General case' 0 CA--C 1.569 1.708 0 N-CA-C 117.816 2.524 . . . . 0.0 117.816 173.326 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 46.3 m80 -89.72 143.82 26.49 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 -168.402 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -71.79 130.84 42.07 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-N 114.448 -1.251 . . . . 0.0 110.818 170.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.92 -18.62 46.57 Favored Glycine 0 CA--C 1.552 2.377 0 N-CA-C 118.239 2.055 . . . . 0.0 118.239 -172.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.13 119.38 10.73 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-N 120.399 2.1 . . . . 0.0 112.345 -176.227 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 22.2 p90 -128.56 157.51 41.03 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 114.815 1.413 . . . . 0.0 114.815 -168.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.8 pp -138.05 139.33 39.51 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 168.239 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 70.3 mt -98.16 117.86 43.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 106.316 -1.735 . . . . 0.0 106.316 177.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 3.0 ptm180 -97.94 149.2 22.67 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.319 0.648 . . . . 0.0 111.481 170.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -96.35 137.86 34.8 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 168.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 67.4 m -69.9 138.92 52.86 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-O 121.637 0.732 . . . . 0.0 112.694 -176.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -70.69 -53.71 14.63 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 -174.075 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.0 t -62.99 -37.33 86.73 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 115.916 1.821 . . . . 0.0 115.916 172.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -121.01 92.9 48.75 Favored Pre-proline 0 CA--C 1.562 1.441 0 CA-C-N 119.635 1.107 . . . . 0.0 110.102 175.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -62.59 132.53 38.31 Favored 'Trans proline' 0 C--N 1.371 1.742 0 C-N-CA 123.361 2.707 . . . . 0.0 113.25 170.02 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 105.0 -33.73 6.34 Favored Glycine 0 CA--C 1.551 2.302 0 CA-C-O 118.697 -1.057 . . . . 0.0 114.543 -168.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -79.68 108.51 13.28 Favored 'General case' 0 N--CA 1.486 1.348 0 CA-C-N 119.427 1.614 . . . . 0.0 108.484 174.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 5.0 m-30 -93.93 158.65 15.54 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 121.716 0.77 . . . . 0.0 110.451 -174.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 74.6 m -139.81 115.48 10.1 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 176.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 36.4 tp -81.19 107.35 13.91 Favored 'General case' 0 CA--C 1.561 1.368 0 C-N-CA 124.907 1.283 . . . . 0.0 109.687 179.015 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.8 m -95.5 105.53 17.51 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 -174.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 31.9 t -117.57 123.67 72.04 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.171 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 -171.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 12.9 tmtt? -89.24 89.37 7.89 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 123.088 0.555 . . . . 0.0 110.203 178.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -105.49 108.22 19.62 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -177.297 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 86.95 -98.75 2.39 Favored Glycine 0 N--CA 1.479 1.556 0 N-CA-C 111.435 -0.666 . . . . 0.0 111.435 177.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 12.4 p30 -138.44 44.1 2.12 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 123.178 0.591 . . . . 0.0 112.384 169.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -152.84 134.62 14.63 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 -177.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 57.3 t -95.23 109.85 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 106.298 -1.741 . . . . 0.0 106.298 177.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 60.6 mt-30 -109.11 114.83 28.89 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-O 121.909 0.861 . . . . 0.0 109.306 -169.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -94.15 119.64 33.26 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 114.636 -1.166 . . . . 0.0 109.168 -172.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -118.03 119.33 34.47 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 -174.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -75.5 108.31 8.23 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 -169.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 86.6 t -84.04 117.56 29.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 -178.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 54.5 mt -100.78 137.82 38.66 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.139 -174.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 56.4 mtp180 -109.72 126.37 53.65 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 -179.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . 0.262 3.0 p30 -79.91 -56.94 3.9 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 114.463 1.283 . . . . 0.0 114.463 -179.031 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 179.16 137.86 3.06 Favored Glycine 0 CA--C 1.54 1.632 0 CA-C-N 119.607 1.094 . . . . 0.0 112.759 -176.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . 0.347 . . 80.6 -77.89 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 124.98 1.312 . . . . 0.0 112.497 -178.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -165.96 72.79 0.17 Allowed Glycine 0 N--CA 1.478 1.483 0 N-CA-C 111.696 -0.562 . . . . 0.0 111.696 171.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -126.47 162.22 26.11 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 124.169 0.988 . . . . 0.0 109.93 -178.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -143.99 114.97 7.84 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 -176.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -124.98 123.19 39.35 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 175.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -110.33 -58.79 2.03 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 123.77 0.828 . . . . 0.0 110.621 173.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 8.4 t90 -98.66 -62.97 1.17 Allowed 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 124.076 0.95 . . . . 0.0 112.893 -168.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 30.7 m -129.66 -56.38 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 CA-C-N 119.085 0.857 . . . . 0.0 112.41 -175.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 9.9 p -118.93 161.29 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 CA-C-O 122.278 1.037 . . . . 0.0 111.485 -169.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.52 153.04 29.84 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-O 122.025 0.917 . . . . 0.0 113.121 175.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -142.88 120.69 11.93 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 -175.22 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -59.45 -59.74 4.96 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -175.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 83.6 p -89.58 155.56 19.18 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-O 122.542 1.163 . . . . 0.0 112.378 175.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 10.3 tp -63.01 -33.0 74.49 Favored 'General case' 0 CA--C 1.568 1.661 0 N-CA-C 115.019 1.489 . . . . 0.0 115.019 170.05 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -63.35 -36.77 84.81 Favored 'General case' 0 CA--C 1.569 1.705 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 169.053 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.13 -42.1 94.17 Favored 'General case' 0 N--CA 1.497 1.875 0 CA-C-N 120.622 1.555 . . . . 0.0 114.17 169.758 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 16.8 tp -57.13 -46.89 82.31 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 169.101 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 45.4 t -59.17 -58.2 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 C-N-CA 124.385 1.074 . . . . 0.0 112.878 173.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -60.74 -32.11 71.4 Favored 'General case' 0 CA--C 1.567 1.632 0 N-CA-C 115.655 1.724 . . . . 0.0 115.655 -175.076 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -60.68 -57.8 11.18 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-N 119.665 1.12 . . . . 0.0 112.877 169.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 81.8 m-70 -72.85 -8.91 57.77 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 117.891 2.552 . . . . 0.0 117.891 176.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 50.5 ttm-85 -58.59 -31.71 68.29 Favored 'General case' 0 CA--C 1.576 1.95 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 168.046 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 69.6 m -104.16 -36.15 7.78 Favored 'General case' 0 CA--C 1.567 1.619 0 C-N-CA 124.978 1.311 . . . . 0.0 113.619 169.123 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 87.1 m -90.12 150.84 21.87 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-N 119.912 1.233 . . . . 0.0 110.826 -178.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 21.6 t -72.39 123.75 23.72 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.197 -0.939 . . . . 0.0 111.734 175.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.9 p -70.27 -27.78 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 N-CA-C 115.868 1.803 . . . . 0.0 115.868 175.293 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 66.3 m -135.25 136.88 42.03 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-N 119.562 1.073 . . . . 0.0 109.082 173.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? -80.13 93.97 5.91 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.815 0.816 . . . . 0.0 110.637 -178.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . 0.252 13.2 p-10 -165.9 -65.78 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 124.663 1.185 . . . . 0.0 108.044 -178.685 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -113.7 -139.03 0.38 Allowed 'General case' 0 CA--C 1.567 1.625 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 172.186 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.21 77.83 1.79 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.307 -0.871 . . . . 0.0 109.146 175.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 3.7 mp -86.7 108.48 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 -170.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 19.6 m-30 -114.72 138.4 50.77 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-N 115.331 -0.849 . . . . 0.0 109.523 -172.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 10.7 mp -85.27 108.11 17.62 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.276 -171.075 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 93.5 mtt180 -123.37 168.07 12.99 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 122.369 1.08 . . . . 0.0 109.485 -175.115 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -81.79 158.75 24.0 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 115.11 1.522 . . . . 0.0 115.11 -170.049 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 36.1 pt -81.29 162.04 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 CA-C-N 114.727 -1.124 . . . . 0.0 112.883 -179.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 . . . . . 0 N--CA 1.485 1.311 0 CA-C-O 122.776 1.274 . . . . 0.0 109.328 -176.765 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . 0.253 66.6 p-90 . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 115.544 1.683 . . . . 0.0 115.544 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -85.78 135.65 33.65 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-N 119.255 0.934 . . . . 0.0 111.403 -173.408 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -111.68 -88.0 0.53 Allowed 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 175.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 158.12 -150.1 20.77 Favored Glycine 0 N--CA 1.483 1.816 0 CA-C-N 119.634 1.106 . . . . 0.0 112.735 -179.163 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -83.14 89.57 6.96 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 121.566 0.698 . . . . 0.0 111.217 -178.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -124.42 146.62 52.71 Favored Pre-proline 0 CA--C 1.573 1.852 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 169.365 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -50.69 164.79 0.5 Allowed 'Trans proline' 0 C--N 1.37 1.681 0 C-N-CA 123.411 2.74 . . . . 0.0 117.717 175.03 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 60.1 ttt180 -59.06 -41.95 89.17 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 169.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -65.28 -45.45 84.41 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 115.193 1.553 . . . . 0.0 115.193 173.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 48.2 mmtm -61.92 -37.09 83.36 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 115.646 1.721 . . . . 0.0 115.646 171.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.87 -44.85 91.86 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 115.31 1.596 . . . . 0.0 115.31 169.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -61.34 -40.08 92.93 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 115.351 1.611 . . . . 0.0 115.351 170.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -61.54 -46.24 90.76 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 173.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 37.3 mmt -60.12 -46.57 89.17 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 114.898 1.444 . . . . 0.0 114.898 172.211 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 96.7 mt -72.59 -32.38 65.94 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 115.989 1.848 . . . . 0.0 115.989 177.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 21.1 t -56.02 -35.33 66.72 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 115.662 1.727 . . . . 0.0 115.662 169.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -60.15 -39.47 86.46 Favored 'General case' 0 CA--C 1.568 1.662 0 N-CA-C 115.215 1.561 . . . . 0.0 115.215 169.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -67.88 134.68 51.26 Favored 'General case' 0 CA--C 1.556 1.174 0 CA-C-O 123.5 1.619 . . . . 0.0 113.404 -177.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.43 -10.2 59.34 Favored 'General case' 0 CA--C 1.567 1.597 0 N-CA-C 119.12 3.007 . . . . 0.0 119.12 176.421 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 6.9 m80 -89.62 137.51 32.27 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-N 120.149 1.34 . . . . 0.0 110.836 -169.002 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -80.39 103.54 10.32 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 173.2 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 110.59 11.41 19.5 Favored Glycine 0 CA--C 1.551 2.321 0 CA-C-O 117.56 -1.689 . . . . 0.0 115.758 -168.074 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.66 120.09 14.89 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-N 120.64 2.22 . . . . 0.0 110.244 -175.339 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 14.6 p90 -132.82 157.32 45.29 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 -169.044 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.3 pp -140.8 125.58 18.08 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 168.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 84.6 mt -83.78 108.84 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 170.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 48.2 ptt85 -89.88 156.89 18.16 Favored 'General case' 0 CA--C 1.557 1.215 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.192 171.134 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -88.86 134.03 34.08 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 169.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 50.5 m -65.85 132.47 48.74 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 123.107 0.563 . . . . 0.0 111.133 -178.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -55.54 -55.01 36.87 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 116.903 2.186 . . . . 0.0 116.903 -168.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.3 t -72.39 -45.81 58.08 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 174.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -108.77 108.67 60.96 Favored Pre-proline 0 CA--C 1.562 1.422 0 CA-C-O 117.652 -1.166 . . . . 0.0 110.559 -174.161 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -69.48 -32.24 20.13 Favored 'Trans proline' 0 C--N 1.369 1.609 0 N-CA-C 118.724 2.548 . . . . 0.0 118.724 178.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -65.58 -19.21 66.71 Favored Glycine 0 CA--C 1.559 2.832 0 N-CA-C 117.023 1.569 . . . . 0.0 117.023 168.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -92.16 138.05 31.86 Favored 'General case' 0 N--CA 1.484 1.27 0 CA-C-N 118.337 1.068 . . . . 0.0 108.696 169.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -123.38 170.03 10.74 Favored 'General case' 0 CA--C 1.563 1.472 0 C-N-CA 124.23 1.012 . . . . 0.0 108.907 179.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 73.1 m -143.01 119.79 11.2 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.096 -1.002 . . . . 0.0 108.43 -179.299 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 43.7 tp -79.88 105.66 11.32 Favored 'General case' 0 N--CA 1.486 1.347 0 CA-C-O 121.844 0.831 . . . . 0.0 109.331 171.176 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.8 m -91.35 109.65 20.93 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 173.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.7 p -137.69 137.49 45.27 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 CA-C-N 119.148 0.885 . . . . 0.0 108.778 -169.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -72.88 118.86 16.34 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.009 0.433 . . . . 0.0 110.996 171.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 4.4 m-30 -107.71 97.69 7.39 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 169.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 81.94 -98.76 1.96 Allowed Glycine 0 CA--C 1.541 1.677 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 -169.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 70.1 m-80 -126.89 -17.6 4.88 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 115.01 1.485 . . . . 0.0 115.01 169.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -85.73 137.88 32.5 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 119.643 1.11 . . . . 0.0 110.081 177.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 64.9 t -89.28 106.43 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 -175.082 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -101.06 124.84 47.39 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-O 121.881 0.848 . . . . 0.0 109.231 -179.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 11.9 m-70 -97.73 131.31 44.38 Favored 'General case' 0 CA--C 1.555 1.159 0 CA-C-N 114.819 -1.082 . . . . 0.0 109.153 -175.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -128.18 125.01 38.2 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 -175.623 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -80.88 117.49 21.57 Favored 'General case' 0 N--CA 1.485 1.302 0 CA-C-O 121.596 0.712 . . . . 0.0 110.903 -170.186 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 73.1 t -85.42 102.77 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 171.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.4 pp -121.91 144.13 49.04 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 123.116 0.567 . . . . 0.0 111.346 -174.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -89.65 155.82 18.98 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 114.009 1.115 . . . . 0.0 114.009 -170.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -104.41 -64.3 1.13 Allowed 'General case' 0 N--CA 1.494 1.748 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.951 169.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -97.21 -121.17 4.12 Favored Glycine 0 CA--C 1.542 1.734 0 CA-C-N 119.406 1.003 . . . . 0.0 112.883 -176.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -76.2 -65.24 0.94 Allowed 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 118.786 -0.626 . . . . 0.0 112.337 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -136.08 57.99 0.67 Allowed Glycine 0 CA--C 1.542 1.78 0 CA-C-O 119.559 -0.578 . . . . 0.0 111.928 169.31 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -106.36 88.85 2.88 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 106.978 -1.489 . . . . 0.0 106.978 -174.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -81.03 122.47 27.35 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 114.852 -1.067 . . . . 0.0 111.1 -169.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 21.3 p90 -137.57 124.17 20.96 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 120.941 0.4 . . . . 0.0 110.044 179.259 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -106.84 -47.78 3.65 Favored 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 123.887 0.875 . . . . 0.0 112.155 169.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 32.2 t90 -89.92 -68.81 0.76 Allowed 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 124.834 1.254 . . . . 0.0 110.91 -171.066 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . 0.264 13.0 p -147.6 -66.89 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 C-N-CA 123.499 0.72 . . . . 0.0 109.704 174.446 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 10.8 p -79.9 138.82 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 C-N-CA 123.941 0.896 . . . . 0.0 111.455 -171.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -83.77 158.86 21.59 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 113.715 1.005 . . . . 0.0 113.715 -178.211 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -140.46 123.13 16.26 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 -171.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 16.9 p30 -57.84 -34.44 69.7 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 117.549 2.425 . . . . 0.0 117.549 176.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 74.2 m -120.88 144.92 48.15 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 119.256 0.935 . . . . 0.0 111.678 -176.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 14.1 tp -86.53 94.27 9.39 Favored 'General case' 0 CA--C 1.563 1.46 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 169.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 12.0 t30 158.19 -60.78 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 103.295 -2.854 . . . . 0.0 103.295 -168.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -54.16 -44.6 71.59 Favored 'General case' 0 CA--C 1.574 1.877 0 C-N-CA 124.699 1.2 . . . . 0.0 114.194 168.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 10.2 tt -53.93 -53.83 47.28 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 115.763 1.764 . . . . 0.0 115.763 170.049 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.2 p -68.32 -50.13 60.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 -177.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -56.31 -32.86 65.03 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 115.516 1.673 . . . . 0.0 115.516 172.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -58.36 -53.64 55.99 Favored 'General case' 0 CA--C 1.566 1.582 0 CA-C-N 119.608 1.094 . . . . 0.0 111.85 168.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . 0.315 40.8 m-70 -71.42 -9.54 58.34 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 118.196 2.665 . . . . 0.0 118.196 176.762 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.62 -32.03 73.38 Favored 'General case' 0 CA--C 1.581 2.142 0 CA-C-N 121.041 1.746 . . . . 0.0 112.171 166.356 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 70.6 m -95.53 -44.84 7.33 Favored 'General case' 0 CA--C 1.564 1.519 0 C-N-CA 124.604 1.162 . . . . 0.0 114.035 169.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 53.8 m -90.2 155.99 18.63 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-N 119.665 1.12 . . . . 0.0 111.04 -178.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 22.7 t -86.3 133.55 33.81 Favored 'General case' 0 CA--C 1.557 1.212 0 O-C-N 121.357 -0.84 . . . . 0.0 113.197 -175.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 96.4 t -69.17 -36.5 73.31 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 CA-C-O 118.534 -0.746 . . . . 0.0 111.752 169.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 22.7 t -79.2 132.86 36.66 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-N 119.639 1.109 . . . . 0.0 109.584 169.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 32.9 ttt85 -75.0 -50.15 17.51 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 -175.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -76.42 -55.67 5.33 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 172.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -80.03 158.77 26.41 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 119.028 0.831 . . . . 0.0 112.225 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 -104.04 89.79 3.39 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 4.0 mm -112.96 141.01 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 176.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -137.3 155.9 48.9 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-O 121.988 0.899 . . . . 0.0 112.497 -169.171 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 10.0 mp -90.28 124.78 35.17 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 124.046 0.938 . . . . 0.0 112.074 -169.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -118.98 151.73 37.66 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 124.242 1.017 . . . . 0.0 110.091 171.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -81.88 149.5 28.25 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 122.136 0.97 . . . . 0.0 112.656 -177.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.6 pp -76.01 160.32 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 CA-C-N 114.861 -1.063 . . . . 0.0 113.552 -174.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 . . . . . 0 N--CA 1.485 1.294 0 CA-C-O 124.052 1.882 . . . . 0.0 106.332 170.583 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 63.6 p-90 . . . . . 0 N--CA 1.494 1.739 0 N-CA-C 115.3 1.592 . . . . 0.0 115.3 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -81.38 136.3 35.71 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-N 120.449 1.477 . . . . 0.0 112.054 -171.68 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -121.61 -74.83 0.6 Allowed 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 174.279 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 91.91 102.46 1.39 Allowed Glycine 0 CA--C 1.542 1.734 0 CA-C-N 119.376 0.989 . . . . 0.0 111.814 -178.236 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 56.9 mmtt 63.52 69.98 0.54 Allowed 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 124.808 1.243 . . . . 0.0 113.394 -177.265 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 10.6 pt -130.1 151.82 79.01 Favored Pre-proline 0 CA--C 1.574 1.886 0 CA-C-O 118.411 -0.804 . . . . 0.0 109.676 169.876 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_exo -56.45 156.42 21.87 Favored 'Trans proline' 0 C--N 1.369 1.655 0 C-N-CA 123.369 2.713 . . . . 0.0 117.348 177.344 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 61.2 ttt180 -67.52 -36.62 81.39 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 169.489 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.77 -39.84 95.24 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 115.261 1.578 . . . . 0.0 115.261 169.651 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -64.06 -35.27 80.2 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 169.159 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.79 -52.45 63.13 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-N 119.472 1.033 . . . . 0.0 113.19 169.415 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -52.92 -37.71 61.08 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 116.348 1.981 . . . . 0.0 116.348 169.537 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -59.32 -48.65 80.83 Favored 'General case' 0 CA--C 1.566 1.574 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 170.696 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -65.45 -60.46 2.93 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 172.597 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.64 -39.44 91.42 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 117.517 2.414 . . . . 0.0 117.517 -172.576 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 56.3 m -60.61 -41.0 93.92 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 115.368 1.618 . . . . 0.0 115.368 178.719 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -68.45 -26.79 65.68 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 117.024 2.231 . . . . 0.0 117.024 169.986 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -60.52 131.1 49.67 Favored 'General case' 0 CA--C 1.556 1.19 0 CA-C-N 120.248 1.385 . . . . 0.0 113.722 176.555 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 38.9 ptt85 -69.59 -20.03 63.65 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 118.65 2.833 . . . . 0.0 118.65 179.054 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 57.8 m80 -89.51 135.58 33.52 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 119.213 0.915 . . . . 0.0 111.922 -169.141 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -77.59 103.03 7.28 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 169.731 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 124.23 -0.14 8.87 Favored Glycine 0 CA--C 1.555 2.543 0 CA-C-O 117.163 -1.91 . . . . 0.0 115.768 -168.456 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.57 113.19 4.57 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 121.158 2.479 . . . . 0.0 112.173 -169.929 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 17.8 p90 -128.11 155.79 43.86 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 116.334 1.976 . . . . 0.0 116.334 -168.713 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.1 pp -148.75 133.57 17.97 Favored 'General case' 0 N--CA 1.485 1.28 0 CA-C-N 114.33 -1.305 . . . . 0.0 108.454 169.031 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 91.8 mt -91.38 110.59 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 175.897 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 3.5 ptm180 -100.98 140.18 35.64 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 114.614 -1.175 . . . . 0.0 109.329 169.98 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.54 126.57 31.05 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.704 -0.622 . . . . 0.0 109.527 177.72 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 20.5 t -63.25 125.93 25.74 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -170.201 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -63.98 -48.58 75.85 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 175.815 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 95.8 p -59.3 -39.41 82.93 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 116.75 2.13 . . . . 0.0 116.75 171.873 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -115.84 97.7 49.59 Favored Pre-proline 0 CA--C 1.563 1.46 0 CA-C-O 117.967 -1.016 . . . . 0.0 108.997 178.748 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -72.57 135.04 23.36 Favored 'Trans proline' 0 C--N 1.372 1.787 0 C-N-CA 123.157 2.571 . . . . 0.0 112.606 -178.985 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 92.05 -39.36 3.03 Favored Glycine 0 CA--C 1.556 2.622 0 CA-C-N 115.555 -0.748 . . . . 0.0 114.415 -168.595 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -79.76 146.17 32.47 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 124.275 1.03 . . . . 0.0 110.883 175.624 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -106.85 174.16 6.01 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 122.124 0.964 . . . . 0.0 111.859 -171.697 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 57.9 m -146.61 115.81 7.0 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 177.325 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 42.6 tp -79.7 115.42 19.3 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 171.049 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 20.7 m -97.98 83.77 3.19 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 175.998 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.3 p -107.4 119.74 57.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 -171.861 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 15.1 tmtt? -81.37 149.2 28.97 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.768 174.739 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -156.99 107.35 2.29 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 169.948 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 71.38 76.14 0.6 Allowed Glycine 0 N--CA 1.483 1.776 0 N-CA-C 115.186 0.834 . . . . 0.0 115.186 173.097 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . 0.348 15.0 m120 77.06 -38.7 0.31 Allowed 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 118.179 2.659 . . . . 0.0 118.179 -179.898 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -121.43 145.27 48.09 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 124.091 0.956 . . . . 0.0 110.944 -169.688 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 5.3 p -83.02 139.0 18.4 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.54 0 CA-C-N 115.373 -0.831 . . . . 0.0 111.864 178.262 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -125.27 111.53 15.32 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-O 122.103 0.954 . . . . 0.0 108.529 -176.94 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 8.0 m-70 -99.55 128.81 45.67 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-N 114.776 -1.102 . . . . 0.0 109.358 -172.268 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -133.46 133.08 41.82 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 -175.096 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 64.2 pttt -77.74 125.86 29.99 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-O 121.507 0.67 . . . . 0.0 112.05 -179.117 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 80.7 t -94.61 108.22 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 106.287 -1.746 . . . . 0.0 106.287 179.237 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 66.0 mt -95.97 149.99 20.96 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.276 -173.368 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 82.8 mtm180 -109.51 135.95 49.68 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 122.983 0.513 . . . . 0.0 110.304 -177.79 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -108.1 110.19 21.81 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 170.635 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 89.26 -113.58 4.16 Favored Glycine 0 CA--C 1.541 1.683 0 CA-C-N 116.372 -0.376 . . . . 0.0 112.343 -178.763 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -86.4 -68.99 0.7 Allowed 'General case' 0 N--CA 1.488 1.452 0 CA-C-O 118.739 -0.648 . . . . 0.0 111.687 178.792 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -156.39 70.25 0.27 Allowed Glycine 0 N--CA 1.478 1.473 0 CA-C-N 118.602 0.637 . . . . 0.0 112.33 172.58 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -103.88 99.82 9.6 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 105.089 -2.189 . . . . 0.0 105.089 171.702 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -81.19 108.25 14.67 Favored 'General case' 0 N--CA 1.484 1.255 0 CA-C-N 114.741 -1.118 . . . . 0.0 111.756 -168.58 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 33.5 p90 -117.47 121.66 41.63 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 178.788 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 4.7 tt -101.7 -63.07 1.18 Allowed 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 123.429 0.691 . . . . 0.0 109.176 170.648 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 26.9 t90 -82.43 -64.98 1.07 Allowed 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 124.337 1.055 . . . . 0.0 112.17 -169.941 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . 0.276 13.1 p -146.17 -70.33 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 CA-C-N 118.791 0.723 . . . . 0.0 109.427 177.533 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 9.4 p -79.91 143.95 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 C-N-CA 123.879 0.872 . . . . 0.0 111.621 -174.078 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.37 155.52 22.28 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -176.184 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -141.7 114.75 8.67 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 -173.764 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 23.1 t30 -54.1 -41.08 67.88 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 116.696 2.109 . . . . 0.0 116.696 -175.998 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 95.3 p -107.29 155.27 20.14 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-O 122.649 1.214 . . . . 0.0 111.904 170.612 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 60.3 mt -64.31 -29.2 70.29 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 115.282 1.586 . . . . 0.0 115.282 169.714 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -65.33 -38.73 91.05 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-N 119.682 1.128 . . . . 0.0 113.555 169.927 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -61.63 -45.06 95.68 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 169.393 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 53.1 tp -57.02 -44.14 82.55 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 115.09 1.515 . . . . 0.0 115.09 169.68 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 22.2 t -60.32 -63.26 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 C-N-CA 124.581 1.152 . . . . 0.0 112.405 173.525 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -59.56 -28.67 67.32 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 115.984 1.846 . . . . 0.0 115.984 -176.29 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 88.8 t80 -64.35 -56.07 16.92 Favored 'General case' 0 CA--C 1.566 1.586 0 CA-C-N 119.158 0.89 . . . . 0.0 111.849 168.461 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . 0.264 68.0 m-70 -68.85 -9.08 49.4 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 117.874 2.546 . . . . 0.0 117.874 177.795 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -48.48 -39.7 23.97 Favored 'General case' 0 N--CA 1.502 2.174 0 CA-C-N 120.808 1.64 . . . . 0.0 114.47 167.563 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 68.5 m -109.04 -26.38 10.2 Favored 'General case' 0 CA--C 1.565 1.527 0 N-CA-C 114.885 1.439 . . . . 0.0 114.885 169.857 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 40.2 m -90.27 152.34 21.1 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-N 120.825 1.648 . . . . 0.0 111.031 -179.788 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 29.1 t -74.31 133.24 42.57 Favored 'General case' 0 CA--C 1.559 1.31 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 -179.962 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 39.3 t -74.93 -48.09 34.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 C-N-CA 123.593 0.757 . . . . 0.0 111.583 169.861 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 70.8 m -82.85 159.36 22.42 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-O 121.858 0.837 . . . . 0.0 112.049 178.273 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 3.7 tmm_? -70.37 -61.01 1.94 Allowed 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 118.898 -0.572 . . . . 0.0 111.94 174.881 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -74.37 -56.34 4.97 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 178.787 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 51.6 mt-30 -79.86 145.32 32.79 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 118.713 0.688 . . . . 0.0 112.087 -176.81 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -79.2 122.7 26.61 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 122.958 0.503 . . . . 0.0 110.372 169.854 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 8.3 mm -127.43 102.29 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 105.565 -2.013 . . . . 0.0 105.565 179.264 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 20.8 m-30 -113.19 114.38 26.68 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 -174.398 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 10.8 mp -67.67 131.57 45.84 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 114.794 1.405 . . . . 0.0 114.794 -168.975 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 71.4 mmt-85 -127.24 140.88 51.92 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 176.874 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -75.21 141.46 43.57 Favored 'General case' 0 CA--C 1.565 1.521 0 O-C-N 121.183 -0.948 . . . . 0.0 112.209 -175.348 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 16.4 pt -62.89 146.58 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 N-CA-C 113.968 1.099 . . . . 0.0 113.968 -176.446 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 . . . . . 0 N--CA 1.482 1.142 0 CA-C-O 123.931 1.824 . . . . 0.0 109.344 -176.118 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . 0.294 51.2 p-90 . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 113.464 0.913 . . . . 0.0 113.464 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -94.53 133.56 38.02 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 123.63 0.772 . . . . 0.0 109.47 173.692 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -95.6 -77.17 0.48 Allowed 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 118.665 -0.683 . . . . 0.0 109.466 174.772 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -169.96 -159.07 14.92 Favored Glycine 0 CA--C 1.541 1.677 0 CA-C-N 119.077 0.853 . . . . 0.0 112.955 -179.885 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -94.31 91.85 6.91 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 172.101 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -123.71 149.7 59.82 Favored Pre-proline 0 CA--C 1.573 1.852 0 C-N-CA 123.59 0.756 . . . . 0.0 109.194 178.449 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -69.85 177.53 5.56 Favored 'Trans proline' 0 CA--C 1.565 2.029 0 C-N-CA 122.812 2.341 . . . . 0.0 114.285 175.456 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 59.6 ttt180 -61.07 -42.42 98.46 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 115.791 1.774 . . . . 0.0 115.791 179.334 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -67.23 -41.87 84.94 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 115.717 1.747 . . . . 0.0 115.717 175.526 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -64.76 -36.48 84.45 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 169.764 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.62 -40.38 96.75 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 115.799 1.777 . . . . 0.0 115.799 169.929 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -65.52 -40.83 93.43 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 114.85 1.426 . . . . 0.0 114.85 169.926 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -60.11 -48.38 81.98 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 114.957 1.465 . . . . 0.0 114.957 172.463 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 38.1 mmt -66.71 -47.31 72.76 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 176.539 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 7.1 tp -76.27 -17.94 59.22 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 117.119 2.266 . . . . 0.0 117.119 178.802 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 94.1 p -60.76 -31.32 70.66 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-N 120.616 1.553 . . . . 0.0 114.781 168.634 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -59.82 -39.63 85.74 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 169.073 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -65.04 112.83 3.52 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 124.4 1.08 . . . . 0.0 111.533 169.852 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 13.7 ptp180 -80.12 -15.46 57.07 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 117.941 2.571 . . . . 0.0 117.941 177.632 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 50.0 m80 -89.54 147.88 23.71 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 119.417 1.008 . . . . 0.0 112.367 -168.767 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -77.99 120.9 23.49 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.645 178.993 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 100.07 -21.38 44.89 Favored Glycine 0 CA--C 1.545 1.966 0 CA-C-O 117.168 -1.907 . . . . 0.0 117.119 -169.64 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.36 115.45 4.21 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 120.753 2.277 . . . . 0.0 111.128 -177.728 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 27.1 p90 -126.49 156.49 40.65 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 115.361 1.615 . . . . 0.0 115.361 -168.467 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.0 pp -132.33 125.64 31.4 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 168.382 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 71.8 mt -86.99 119.98 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 173.218 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 48.8 ptt85 -92.05 148.9 21.83 Favored 'General case' 0 CA--C 1.558 1.265 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.499 169.547 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -90.09 122.09 32.75 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 106.425 -1.695 . . . . 0.0 106.425 169.089 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 50.7 m -65.51 113.19 3.99 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.549 0.739 . . . . 0.0 111.95 -174.476 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -90.62 92.37 8.81 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-O 123.814 1.769 . . . . 0.0 108.992 178.854 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 51.7 p 163.73 -40.25 0.0 OUTLIER 'General case' 0 CA--C 1.568 1.672 0 CA-C-N 110.764 -2.925 . . . . 0.0 107.434 -168.209 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -131.87 98.61 17.46 Favored Pre-proline 0 CA--C 1.562 1.415 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 172.129 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -62.11 134.67 50.5 Favored 'Trans proline' 0 C--N 1.372 1.772 0 C-N-CA 123.383 2.722 . . . . 0.0 114.842 178.848 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 90.82 -31.7 5.45 Favored Glycine 0 CA--C 1.553 2.437 0 N-CA-C 116.398 1.319 . . . . 0.0 116.398 -169.373 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -80.63 135.5 36.06 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 118.864 1.332 . . . . 0.0 110.062 175.611 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -108.7 172.0 7.1 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 122.317 1.056 . . . . 0.0 111.127 -173.145 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 50.6 m -146.21 124.03 11.95 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 171.939 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 30.3 tp -80.09 114.42 18.98 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.665 0.786 . . . . 0.0 109.996 172.866 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.6 m -98.66 108.91 21.71 Favored 'General case' 0 CA--C 1.562 1.431 0 N-CA-C 105.336 -2.098 . . . . 0.0 105.336 172.353 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.7 p -127.63 118.67 49.89 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -170.455 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -85.19 97.09 9.71 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.236 0.615 . . . . 0.0 110.013 -179.008 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 17.2 t80 -122.0 124.98 45.26 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 -178.94 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 81.81 -111.47 3.33 Favored Glycine 0 N--CA 1.481 1.644 0 N-CA-C 110.319 -1.112 . . . . 0.0 110.319 -173.538 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -137.16 56.97 1.77 Allowed 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 169.023 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -160.04 135.09 7.94 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 -176.592 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 90.2 t -88.44 105.89 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 172.049 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 62.2 mt-30 -102.59 117.84 35.55 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.736 0.814 . . . . 0.0 109.321 -171.282 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 15.4 m-70 -96.98 113.99 25.57 Favored 'General case' 0 CA--C 1.554 1.121 0 CA-C-N 115.194 -0.912 . . . . 0.0 108.958 -173.518 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -115.2 118.52 33.55 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 177.693 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -80.71 125.77 30.46 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.753 -169.897 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 59.1 t -88.54 103.27 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 106.727 -1.582 . . . . 0.0 106.727 175.913 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -104.11 147.76 27.04 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 121.401 0.619 . . . . 0.0 110.988 -179.811 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -96.47 160.95 14.13 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -176.461 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -133.41 86.91 2.34 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.149 169.648 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 76.87 99.1 0.17 Allowed Glycine 0 N--CA 1.482 1.761 0 CA-C-O 119.197 -0.78 . . . . 0.0 114.513 172.337 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . 0.34 . . 82.09 -77.24 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 124.631 1.172 . . . . 0.0 112.72 -179.974 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -170.55 67.64 0.15 Allowed Glycine 0 N--CA 1.479 1.504 0 CA-C-O 119.662 -0.521 . . . . 0.0 113.214 174.682 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -107.6 94.19 4.95 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 105.863 -1.903 . . . . 0.0 105.863 174.078 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -79.43 126.75 31.24 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 124.204 1.002 . . . . 0.0 110.429 -169.706 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 24.0 p90 -147.92 121.22 8.99 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 -179.229 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -104.46 -42.6 5.41 Favored 'General case' 0 N--CA 1.498 1.926 0 C-N-CA 123.35 0.66 . . . . 0.0 112.508 168.853 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 43.4 t90 -89.98 -85.2 0.22 Allowed 'General case' 0 CA--C 1.56 1.336 0 C-N-CA 124.766 1.226 . . . . 0.0 109.942 -173.536 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 96.4 t -139.16 -66.52 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 -173.537 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 12.2 p -79.74 137.53 21.49 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.551 0 C-N-CA 123.772 0.829 . . . . 0.0 111.333 -175.4 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 60.9 pttt -89.36 162.35 15.84 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 -177.953 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 99.7 m-85 -145.78 120.23 9.68 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 -170.196 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 66.2 m-80 -61.12 -43.85 98.25 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 171.479 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 73.3 m -96.51 138.19 34.47 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-O 121.823 0.821 . . . . 0.0 111.272 174.305 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 13.5 tp -65.82 -31.98 73.25 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 169.661 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -59.69 -41.42 90.69 Favored 'General case' 0 CA--C 1.574 1.887 0 N-CA-C 113.92 1.082 . . . . 0.0 113.92 168.992 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -65.69 -38.32 88.93 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 115.49 1.663 . . . . 0.0 115.49 170.684 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 8.5 tt -57.12 -53.51 57.31 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-N 120.094 1.315 . . . . 0.0 114.404 170.313 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 9.9 p -64.59 -50.5 75.51 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.578 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -178.722 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -61.31 -36.79 81.09 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 115.403 1.631 . . . . 0.0 115.403 175.218 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -59.57 -53.4 58.48 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-N 119.957 1.253 . . . . 0.0 112.095 168.862 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . 0.262 69.7 m-70 -71.36 -9.09 57.6 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 118.15 2.648 . . . . 0.0 118.15 178.274 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 89.9 mtt-85 -58.17 -32.0 67.79 Favored 'General case' 0 CA--C 1.576 1.957 0 CA-C-N 120.375 1.443 . . . . 0.0 113.392 167.127 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 69.2 m -99.26 -42.77 6.87 Favored 'General case' 0 CA--C 1.569 1.678 0 C-N-CA 124.714 1.206 . . . . 0.0 112.927 168.688 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 33.7 m -87.97 155.67 19.72 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-N 119.814 1.188 . . . . 0.0 111.41 -175.373 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 25.3 t -79.56 129.13 34.19 Favored 'General case' 0 CA--C 1.56 1.336 0 O-C-N 121.187 -0.946 . . . . 0.0 113.356 -179.578 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 16.0 m -70.33 -36.85 68.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 N-CA-C 114.998 1.481 . . . . 0.0 114.998 169.748 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 22.9 t -87.25 140.1 29.88 Favored 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 123.658 0.783 . . . . 0.0 110.266 174.51 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 66.2 ttt-85 -73.18 -48.86 31.71 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 177.229 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 24.4 t30 -72.52 -57.89 3.8 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 171.962 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 63.4 mt-30 -79.88 154.4 28.38 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 118.763 0.711 . . . . 0.0 112.247 -177.223 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -94.13 104.0 16.04 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 171.928 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 17.2 mm -123.47 102.28 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 -177.802 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 22.4 m-30 -101.32 133.55 45.75 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 115.043 -0.981 . . . . 0.0 109.544 179.203 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 10.9 mp -89.3 121.44 31.58 Favored 'General case' 0 N--CA 1.486 1.338 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.266 -169.462 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 4.0 mpt_? -119.25 168.41 10.93 Favored 'General case' 0 CA--C 1.561 1.377 0 CA-C-O 123.602 1.667 . . . . 0.0 109.086 175.284 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -83.99 158.21 21.59 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-N 114.708 -1.133 . . . . 0.0 112.763 -174.264 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.1 pp -66.97 162.25 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 N-CA-C 114.565 1.321 . . . . 0.0 114.565 -177.463 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 . . . . . 0 N--CA 1.486 1.33 0 CA-C-O 122.815 1.293 . . . . 0.0 108.901 178.235 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 1.2 p90 . . . . . 0 N--CA 1.491 1.622 0 N-CA-C 113.55 0.945 . . . . 0.0 113.55 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -80.81 128.39 33.6 Favored 'General case' 0 N--CA 1.484 1.263 0 CA-C-N 119.885 1.221 . . . . 0.0 110.245 177.551 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -87.49 -73.53 0.47 Allowed 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.225 178.023 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 177.81 -101.39 0.15 Allowed Glycine 0 N--CA 1.476 1.339 0 N-CA-C 109.147 -1.581 . . . . 0.0 109.147 179.618 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -139.26 82.19 1.88 Allowed 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 171.744 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 28.6 pt -107.33 149.68 39.05 Favored Pre-proline 0 CA--C 1.571 1.786 0 C-N-CA 123.564 0.746 . . . . 0.0 109.691 -178.876 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.48 168.97 22.05 Favored 'Trans proline' 0 CA--C 1.56 1.801 0 C-N-CA 122.8 2.333 . . . . 0.0 114.363 179.702 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 58.5 ttt-85 -61.99 -40.19 94.77 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 115.645 1.72 . . . . 0.0 115.645 -179.698 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -65.01 -41.09 95.68 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 115.78 1.77 . . . . 0.0 115.78 173.118 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? -64.3 -36.49 84.27 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 114.979 1.474 . . . . 0.0 114.979 169.637 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.76 -52.5 60.1 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 170.047 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -53.91 -36.15 62.41 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 116.458 2.021 . . . . 0.0 116.458 170.094 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -60.78 -50.06 74.98 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 114.433 1.271 . . . . 0.0 114.433 171.436 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -58.89 -51.32 70.53 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 114.925 1.454 . . . . 0.0 114.925 173.816 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -65.11 -33.46 76.08 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 116.16 1.911 . . . . 0.0 116.16 175.619 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 23.3 t -53.92 -35.46 61.69 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 115.725 1.75 . . . . 0.0 115.725 169.736 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -61.24 -41.12 96.34 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 114.587 1.328 . . . . 0.0 114.587 169.288 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -71.65 122.63 20.91 Favored 'General case' 0 CA--C 1.556 1.179 0 CA-C-O 122.898 1.332 . . . . 0.0 112.474 179.899 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.449 ' H ' ' HD2' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -71.09 -8.7 55.27 Favored 'General case' 0 CA--C 1.569 1.674 0 N-CA-C 119.056 2.984 . . . . 0.0 119.056 170.972 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 44.6 m80 -89.71 142.66 27.48 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 120.071 1.305 . . . . 0.0 113.104 -168.703 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -78.66 116.75 19.23 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 169.651 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 108.46 -7.0 34.13 Favored Glycine 0 CA--C 1.549 2.202 0 CA-C-O 117.06 -1.967 . . . . 0.0 117.7 -169.398 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.61 117.69 8.45 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 121.14 2.47 . . . . 0.0 112.502 -169.963 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -131.53 155.09 48.06 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 116.281 1.956 . . . . 0.0 116.281 -168.806 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.6 pp -147.48 138.85 23.81 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-N 114.647 -1.16 . . . . 0.0 108.333 168.929 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.7 mp -94.26 120.69 44.05 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.591 0 N-CA-C 106.708 -1.589 . . . . 0.0 106.708 177.229 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 3.4 ptm180 -106.05 146.4 30.17 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 124.092 0.957 . . . . 0.0 109.702 169.679 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -79.82 131.38 35.88 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 169.682 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 22.9 t -63.54 132.42 51.2 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.673 0.789 . . . . 0.0 112.559 -177.189 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -68.18 -52.23 36.79 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 -172.546 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.0 t -64.99 -35.1 80.1 Favored 'General case' 0 CA--C 1.565 1.532 0 N-CA-C 116.256 1.947 . . . . 0.0 116.256 172.059 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -115.53 98.45 50.79 Favored Pre-proline 0 CA--C 1.563 1.466 0 CA-C-N 119.49 1.041 . . . . 0.0 109.99 178.66 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -59.87 -33.46 95.92 Favored 'Trans proline' 0 C--N 1.371 1.718 0 N-CA-C 119.384 2.802 . . . . 0.0 119.384 175.303 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -87.07 47.84 3.75 Favored Glycine 0 CA--C 1.551 2.34 0 N-CA-C 114.633 0.613 . . . . 0.0 114.633 169.239 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -156.19 126.75 6.74 Favored 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 178.881 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 7.5 m-30 -92.91 169.02 10.77 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 122.042 0.925 . . . . 0.0 110.806 169.933 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 69.5 m -149.47 115.69 5.76 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 -178.812 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 33.9 tp -81.02 112.87 18.81 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.896 0.879 . . . . 0.0 109.588 176.902 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 9.7 m -94.53 83.17 4.08 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 177.996 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.7 p -107.94 115.69 49.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 -171.412 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 58.0 tttp -77.59 145.59 36.74 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 114.882 -1.054 . . . . 0.0 111.416 171.173 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -148.86 101.34 3.17 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 169.735 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 92.61 -104.12 3.14 Favored Glycine 0 N--CA 1.479 1.534 0 N-CA-C 112.002 -0.439 . . . . 0.0 112.002 179.769 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -113.2 -11.98 13.18 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 117.241 2.311 . . . . 0.0 117.241 178.55 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -116.88 142.01 47.48 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-N 119.558 1.072 . . . . 0.0 110.051 -175.909 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 39.6 t -92.94 110.86 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 175.533 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 55.1 tp60 -102.33 112.22 24.83 Favored 'General case' 0 CA--C 1.552 1.055 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 -172.165 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -94.96 108.69 20.75 Favored 'General case' 0 CA--C 1.553 1.059 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 -174.68 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -103.13 130.5 50.32 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 176.227 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -77.82 115.5 17.61 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 123.083 0.553 . . . . 0.0 112.254 -175.939 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 97.4 t -85.64 110.35 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 106.83 -1.544 . . . . 0.0 106.83 178.364 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 58.5 mt -90.53 135.63 33.57 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.102 0.561 . . . . 0.0 109.717 -173.349 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 79.1 mtp180 -116.68 119.07 34.34 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 -175.183 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . 0.29 3.9 p-10 -79.91 -66.11 0.92 Allowed 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 -175.561 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -90.85 -107.27 1.39 Allowed Glycine 0 N--CA 1.483 1.826 0 CA-C-N 119.424 1.011 . . . . 0.0 111.801 -179.56 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -79.87 -67.28 0.78 Allowed 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 118.827 -0.606 . . . . 0.0 111.236 172.426 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -149.13 70.68 0.32 Allowed Glycine 0 N--CA 1.477 1.427 0 CA-C-N 118.46 0.573 . . . . 0.0 111.884 169.807 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.17 101.16 11.82 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 105.108 -2.182 . . . . 0.0 105.108 171.664 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -83.84 106.73 15.75 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-N 115.038 -0.983 . . . . 0.0 111.141 -168.509 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -114.38 114.72 26.25 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 107.769 -1.196 . . . . 0.0 107.769 177.505 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 63.0 tp -112.01 -48.9 3.01 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 124.192 0.997 . . . . 0.0 112.191 179.749 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 33.7 t90 -92.5 -74.79 0.51 Allowed 'General case' 0 CA--C 1.557 1.22 0 C-N-CA 124.598 1.159 . . . . 0.0 110.694 -169.727 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . 0.255 10.8 p -146.28 -60.41 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 C-N-CA 123.586 0.754 . . . . 0.0 109.715 177.293 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 15.6 m -79.38 157.15 4.7 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.545 0 C-N-CA 124.251 1.02 . . . . 0.0 111.759 178.892 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -79.88 136.0 36.57 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.526 -178.38 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -124.51 99.5 6.22 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 106.222 -1.77 . . . . 0.0 106.222 177.676 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . 0.272 12.8 p30 -60.45 -41.43 94.05 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 116.874 2.175 . . . . 0.0 116.874 -172.991 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 69.3 m -94.88 152.55 18.28 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-O 122.125 0.964 . . . . 0.0 111.268 172.395 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 12.8 tp -64.77 -34.76 79.11 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 169.66 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -63.68 -35.92 82.14 Favored 'General case' 0 CA--C 1.568 1.641 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 168.81 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -60.19 -48.93 79.66 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-N 120.592 1.542 . . . . 0.0 113.858 169.533 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 53.0 tp -60.82 -50.3 74.01 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 115.355 1.613 . . . . 0.0 115.355 173.752 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 46.3 t -61.38 -60.19 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 C-N-CA 123.957 0.903 . . . . 0.0 112.111 176.445 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -59.3 -31.8 69.47 Favored 'General case' 0 CA--C 1.567 1.634 0 N-CA-C 115.607 1.706 . . . . 0.0 115.607 -176.912 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -62.96 -53.92 46.57 Favored 'General case' 0 CA--C 1.568 1.642 0 CA-C-N 119.833 1.197 . . . . 0.0 112.328 168.78 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . 0.306 76.0 m-70 -71.58 -8.5 54.43 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 118.183 2.661 . . . . 0.0 118.183 178.16 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -47.77 -40.29 20.31 Favored 'General case' 0 N--CA 1.499 2.012 0 CA-C-N 120.693 1.588 . . . . 0.0 114.945 167.916 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 70.0 m -106.38 -32.9 7.93 Favored 'General case' 0 CA--C 1.564 1.493 0 N-CA-C 114.728 1.381 . . . . 0.0 114.728 170.655 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 48.7 m -89.39 147.36 24.09 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-N 120.4 1.455 . . . . 0.0 110.172 -179.706 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.502 ' HB2' ' H ' ' A' ' 146' ' ' ILE . 54.8 p -80.47 141.32 35.33 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 120.97 -1.081 . . . . 0.0 113.346 179.214 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 46.5 t -67.37 -51.54 51.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.916 169.781 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 32.3 t -87.35 132.64 33.89 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.582 0.753 . . . . 0.0 110.715 178.796 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -88.33 70.31 9.11 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 121.629 0.728 . . . . 0.0 110.955 176.37 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . 0.297 5.8 p-10 178.77 -68.58 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 125.218 1.407 . . . . 0.0 107.665 -176.501 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -96.86 138.6 34.16 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.689 0.796 . . . . 0.0 109.413 171.943 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -73.47 117.69 15.53 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 122.696 0.398 . . . . 0.0 111.775 178.809 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.502 ' H ' ' HB2' ' A' ' 139' ' ' SER . 8.4 mm -121.21 92.34 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 176.628 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 21.4 m-30 -100.57 119.82 39.11 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-N 114.249 -1.341 . . . . 0.0 108.109 -176.893 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 10.6 mp -74.04 126.48 30.61 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 123.384 0.674 . . . . 0.0 112.321 -169.748 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 24.1 mmt85 -129.23 143.24 50.78 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 124.551 1.14 . . . . 0.0 108.154 -179.083 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -72.26 146.75 47.03 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 113.645 0.98 . . . . 0.0 113.645 -174.798 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 28.3 pt -69.37 150.15 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 C-N-CA 123.868 0.867 . . . . 0.0 112.726 178.902 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 123.848 1.785 . . . . 0.0 109.55 -177.379 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . 0.38 62.1 p-90 . . . . . 0 N--CA 1.498 1.928 0 N-CA-C 121.583 3.92 . . . . 0.0 121.583 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -139.53 129.26 24.62 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 -169.676 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -140.09 94.86 2.8 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 170.501 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -91.8 164.95 29.21 Favored Glycine 0 CA--C 1.541 1.715 0 CA-C-O 122.924 1.291 . . . . 0.0 116.082 -169.816 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . 0.259 32.3 mmmt 57.38 53.14 7.84 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-N 113.1 -1.55 . . . . 0.0 115.183 -178.364 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 42.3 pt -136.55 152.35 74.53 Favored Pre-proline 0 CA--C 1.573 1.844 0 C-N-CA 123.895 0.878 . . . . 0.0 109.941 -177.751 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -74.08 177.0 8.77 Favored 'Trans proline' 0 CA--C 1.565 2.058 0 C-N-CA 122.919 2.412 . . . . 0.0 114.124 174.847 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 56.3 ttt-85 -63.78 -42.17 97.81 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 115.303 1.594 . . . . 0.0 115.303 176.506 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -66.47 -41.36 89.14 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 115.742 1.756 . . . . 0.0 115.742 176.35 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 29.2 tptp -62.91 -36.65 84.06 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 169.595 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.28 -46.1 81.79 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 115.452 1.649 . . . . 0.0 115.452 171.432 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -62.15 -39.33 92.24 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 115.168 1.544 . . . . 0.0 115.168 170.795 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -60.34 -46.0 91.47 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 114.938 1.459 . . . . 0.0 114.938 172.872 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 34.3 mmt -59.87 -50.36 74.08 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 114.813 1.412 . . . . 0.0 114.813 171.624 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 88.1 mt -75.97 -23.88 55.36 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 117.076 2.25 . . . . 0.0 117.076 -178.985 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 91.7 p -58.8 -35.99 73.75 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 117.082 2.253 . . . . 0.0 117.082 176.574 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 37.9 mtmm -63.07 -31.84 73.08 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 115.719 1.748 . . . . 0.0 115.719 169.656 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -75.51 122.62 24.14 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.533 1.133 . . . . 0.0 111.667 -171.44 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 13.4 ptp180 -63.56 -20.58 65.75 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 119.224 3.046 . . . . 0.0 119.224 -179.826 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 39.2 m80 -89.63 136.9 32.77 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 119.8 1.182 . . . . 0.0 112.718 -168.704 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -77.23 125.31 29.12 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.38 169.674 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 107.43 -21.38 30.81 Favored Glycine 0 CA--C 1.547 2.046 0 CA-C-O 117.036 -1.98 . . . . 0.0 115.879 -168.849 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.23 111.21 2.49 Favored 'General case' 0 N--CA 1.486 1.352 0 CA-C-N 120.823 2.311 . . . . 0.0 111.821 -171.917 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.8 p90 -123.94 158.19 32.58 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 113.826 1.046 . . . . 0.0 113.826 -168.569 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.2 pp -135.67 133.0 37.69 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 168.327 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 74.1 mt -88.95 109.82 20.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 105.661 -1.978 . . . . 0.0 105.661 171.808 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 50.8 ptt85 -91.1 144.06 26.03 Favored 'General case' 0 N--CA 1.486 1.327 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.097 171.657 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -90.24 126.13 35.72 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 169.113 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 53.0 m -67.07 128.78 37.66 Favored 'General case' 0 N--CA 1.487 1.375 0 CA-C-O 121.508 0.671 . . . . 0.0 111.326 -177.937 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -68.64 -47.83 65.58 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 -172.895 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 90.8 p -61.73 -36.89 82.27 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 116.655 2.094 . . . . 0.0 116.655 169.887 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -123.01 96.74 44.51 Favored Pre-proline 0 CA--C 1.563 1.454 0 CA-C-N 119.421 1.01 . . . . 0.0 109.439 177.776 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -58.05 -33.62 97.5 Favored 'Trans proline' 0 C--N 1.371 1.712 0 N-CA-C 120.055 3.059 . . . . 0.0 120.055 178.472 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -87.26 42.65 3.15 Favored Glycine 0 CA--C 1.552 2.389 0 N-CA-C 115.565 0.986 . . . . 0.0 115.565 169.266 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -149.44 110.19 4.29 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 105.03 -2.211 . . . . 0.0 105.03 177.532 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -95.33 168.01 10.99 Favored 'General case' 0 N--CA 1.489 1.475 0 CA-C-O 121.672 0.748 . . . . 0.0 110.105 176.426 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 73.4 m -143.62 114.28 7.61 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 179.327 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 24.9 tp -79.89 107.34 12.6 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 124.442 1.097 . . . . 0.0 109.041 176.257 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 9.4 m -102.79 95.49 6.22 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 -169.956 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 20.0 t -108.62 120.22 59.6 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 CA-C-N 119.113 0.869 . . . . 0.0 109.254 -169.485 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -87.72 96.79 10.57 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.125 0.57 . . . . 0.0 109.526 173.711 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 18.3 t80 -120.53 100.16 6.98 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 179.222 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 68.35 73.0 0.74 Allowed Glycine 0 CA--C 1.542 1.759 0 N-CA-C 115.392 0.917 . . . . 0.0 115.392 175.227 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . 0.321 64.7 m-80 73.67 -22.88 0.23 Allowed 'General case' 0 N--CA 1.5 2.052 0 N-CA-C 118.564 2.802 . . . . 0.0 118.564 -179.821 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -123.91 139.09 54.31 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-N 119.538 1.063 . . . . 0.0 109.935 -169.938 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 39.4 t -100.91 112.39 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 -179.176 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -101.43 115.82 31.37 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.834 0.854 . . . . 0.0 109.208 -174.789 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 -97.12 107.54 20.09 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 115.007 -0.997 . . . . 0.0 108.587 -174.443 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -104.15 119.38 38.81 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 -176.858 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.8 tppp? -75.92 118.5 18.77 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-O 121.98 0.895 . . . . 0.0 110.646 -173.09 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 92.1 t -92.0 101.41 12.52 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.373 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 -179.51 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 68.6 mt -86.37 147.03 26.22 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 123.588 0.755 . . . . 0.0 111.072 178.396 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 73.5 mtp180 -113.0 147.23 37.6 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 123.058 0.543 . . . . 0.0 110.933 -177.776 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -135.41 132.07 37.03 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 123.276 0.63 . . . . 0.0 110.385 173.829 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 81.36 -113.3 3.61 Favored Glycine 0 CA--C 1.541 1.713 0 C-N-CA 122.957 0.313 . . . . 0.0 113.0 175.689 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -83.76 -68.09 0.74 Allowed 'General case' 0 N--CA 1.487 1.401 0 CA-C-O 118.929 -0.558 . . . . 0.0 110.979 172.465 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -162.25 73.04 0.2 Allowed Glycine 0 N--CA 1.477 1.374 0 CA-C-N 118.477 0.581 . . . . 0.0 111.69 169.93 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -99.12 100.93 12.12 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 176.561 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 79.9 m-85 -83.46 112.31 19.84 Favored 'General case' 0 CA--C 1.557 1.227 0 CA-C-N 114.503 -1.226 . . . . 0.0 109.581 -169.585 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -125.13 116.13 21.56 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 123.717 0.807 . . . . 0.0 109.155 -177.115 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -115.7 -38.29 3.75 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 178.773 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 53.2 t90 -99.91 -82.72 0.44 Allowed 'General case' 0 CA--C 1.56 1.336 0 C-N-CA 124.804 1.242 . . . . 0.0 108.679 -179.814 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 99.8 t -137.78 -66.53 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 -175.678 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 10.6 p -79.7 139.05 18.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 C-N-CA 123.69 0.796 . . . . 0.0 110.906 -177.676 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.67 168.11 19.79 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-O 122.256 1.027 . . . . 0.0 113.231 178.631 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -147.23 113.4 5.86 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 -170.104 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 23.3 t30 -59.45 -40.58 87.27 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 115.857 1.799 . . . . 0.0 115.857 -179.49 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 66.0 m -110.65 157.4 19.75 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-O 122.018 0.913 . . . . 0.0 111.203 174.089 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 90.4 mt -66.29 -30.47 70.89 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 114.457 1.28 . . . . 0.0 114.457 169.262 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -63.02 -39.74 95.67 Favored 'General case' 0 CA--C 1.573 1.858 0 CA-C-N 119.89 1.223 . . . . 0.0 113.702 169.287 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -60.8 -43.31 98.31 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 114.217 1.191 . . . . 0.0 114.217 169.282 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 9.5 tt -56.47 -49.84 73.47 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 172.568 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 13.6 m -63.89 -49.11 83.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 N-CA-C 113.831 1.049 . . . . 0.0 113.831 176.973 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -65.8 -33.02 74.89 Favored 'General case' 0 CA--C 1.569 1.68 0 N-CA-C 114.917 1.451 . . . . 0.0 114.917 -175.995 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -61.57 -59.63 4.93 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 119.852 1.205 . . . . 0.0 112.93 169.873 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . 0.261 70.1 m-70 -69.45 -9.23 52.75 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 117.67 2.47 . . . . 0.0 117.67 177.069 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 49.2 ttm-85 -59.03 -32.31 69.62 Favored 'General case' 0 CA--C 1.575 1.925 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 167.573 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 70.1 m -105.11 -35.77 7.5 Favored 'General case' 0 CA--C 1.566 1.581 0 C-N-CA 124.987 1.315 . . . . 0.0 114.045 169.368 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 57.2 m -90.9 155.32 18.83 Favored 'General case' 0 N--CA 1.498 1.959 0 CA-C-N 120.352 1.433 . . . . 0.0 111.983 179.684 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 27.8 t -75.01 135.34 41.3 Favored 'General case' 0 N--CA 1.484 1.263 0 O-C-N 121.545 -0.722 . . . . 0.0 112.73 176.953 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 11.6 t -72.88 -54.32 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 CA-C-O 118.63 -0.7 . . . . 0.0 111.179 170.878 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 39.2 t -101.86 127.57 48.62 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.07 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -62.77 -32.2 73.31 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 116.437 2.014 . . . . 0.0 116.437 -179.49 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 70.9 m-80 -76.37 -62.65 1.55 Allowed 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 119.567 1.076 . . . . 0.0 112.18 169.897 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -91.05 120.78 32.3 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 119.163 0.892 . . . . 0.0 109.258 -178.302 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 58.5 mt-30 -76.37 107.46 8.64 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.794 -0.566 . . . . 0.0 111.505 -174.252 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 14.0 mm -111.72 122.47 66.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 -173.658 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -125.81 129.16 48.88 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 -179.14 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 10.0 mp -78.72 123.09 26.8 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -169.043 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 14.5 tpt180 -111.18 150.72 29.11 Favored 'General case' 0 CA--C 1.56 1.35 0 C-N-CA 125.615 1.566 . . . . 0.0 109.164 172.442 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -76.48 157.41 32.18 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.79 -1.194 . . . . 0.0 112.249 172.262 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -64.31 152.52 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 N-CA-C 114.152 1.167 . . . . 0.0 114.152 -175.305 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 . . . . . 0 N--CA 1.488 1.431 0 CA-C-O 122.843 1.306 . . . . 0.0 108.358 171.952 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.257 0 N-CA-C 111.575 -0.61 . . . . 0.0 111.575 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 71.6 m -82.64 110.15 17.45 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.053 0.541 . . . . 0.0 110.164 -178.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 64.5 p-90 -76.0 -36.21 59.28 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 117.053 2.242 . . . . 0.0 117.053 -175.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -81.33 121.78 26.64 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 120.696 1.589 . . . . 0.0 110.237 -173.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -124.35 106.42 10.23 Favored 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 104.543 -2.391 . . . . 0.0 104.543 173.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -39.15 -67.57 0.57 Allowed Glycine 0 N--CA 1.487 2.056 0 N-CA-C 119.765 2.666 . . . . 0.0 119.765 -169.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -151.55 91.7 1.69 Allowed 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.46 157.35 62.15 Favored Pre-proline 0 N--CA 1.5 2.066 0 CA-C-O 118.467 -0.778 . . . . 0.0 109.898 177.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -54.68 159.3 9.08 Favored 'Trans proline' 0 C--N 1.371 1.755 0 C-N-CA 123.4 2.733 . . . . 0.0 117.619 178.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 59.6 ttt180 -65.94 -40.02 90.98 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 114.503 1.297 . . . . 0.0 114.503 170.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -66.69 -44.18 82.43 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 173.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -61.02 -38.12 84.97 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 115.45 1.648 . . . . 0.0 115.45 170.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.94 -45.32 94.19 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 115.476 1.658 . . . . 0.0 115.476 169.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -60.95 -42.69 98.72 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 115.199 1.555 . . . . 0.0 115.199 171.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -59.57 -51.27 70.54 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 174.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -63.21 -45.96 89.24 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 115.024 1.491 . . . . 0.0 115.024 177.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 6.5 mp -70.05 -41.12 74.63 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 114.854 1.427 . . . . 0.0 114.854 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 69.8 m -58.76 -35.04 72.13 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 115.839 1.792 . . . . 0.0 115.839 169.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 59.4 mttm -64.29 -38.28 90.49 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 115.287 1.588 . . . . 0.0 115.287 169.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -53.54 137.07 37.39 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 179.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 36.0 ptt180 -66.97 -22.85 65.91 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 118.029 2.603 . . . . 0.0 118.029 174.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 67.0 m80 -89.33 138.03 31.8 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-N 119.186 0.903 . . . . 0.0 112.017 -169.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -77.95 124.63 28.24 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.065 169.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.61 11.95 58.75 Favored Glycine 0 CA--C 1.555 2.569 0 CA-C-O 117.839 -1.534 . . . . 0.0 116.866 -169.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -71.34 123.53 22.52 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 120.443 2.122 . . . . 0.0 112.135 -170.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.405 ' HB3' HG23 ' A' ' 99' ' ' VAL . 17.5 p90 -135.7 160.86 37.22 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 116.359 1.985 . . . . 0.0 116.359 -168.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.1 pp -144.14 141.82 30.21 Favored 'General case' 0 CA--C 1.556 1.188 0 CA-C-N 113.786 -1.552 . . . . 0.0 108.277 167.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 52.7 mt -97.62 112.46 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 172.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -105.02 150.42 24.97 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 124.4 1.08 . . . . 0.0 111.905 176.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -89.72 138.28 31.61 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 169.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 68.3 m -64.08 137.18 57.85 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.847 0.859 . . . . 0.0 112.305 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -76.15 109.6 9.96 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.241 1.016 . . . . 0.0 110.28 -169.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . 0.374 16.6 m 103.39 -34.11 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.844 0 CA-C-N 112.286 -2.233 . . . . 0.0 114.665 -172.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -93.15 112.62 57.05 Favored Pre-proline 0 CA--C 1.567 1.61 0 CA-C-N 120.628 1.558 . . . . 0.0 111.685 -176.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -81.48 134.5 8.86 Favored 'Trans proline' 0 C--N 1.371 1.732 0 C-N-CA 123.137 2.558 . . . . 0.0 112.901 -179.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 66.66 33.52 84.66 Favored Glycine 0 CA--C 1.552 2.362 0 N-CA-C 117.012 1.565 . . . . 0.0 117.012 -169.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -126.45 92.0 3.47 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 105.858 -1.904 . . . . 0.0 105.858 -178.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -93.24 163.39 13.64 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-O 122.211 1.005 . . . . 0.0 111.687 -169.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 72.8 m -147.67 120.73 8.83 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 29.9 tp -79.61 103.85 9.81 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 171.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 3.1 m -84.94 108.16 17.44 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 172.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.405 HG23 ' HB3' ' A' ' 83' ' ' PHE . 6.8 p -135.18 126.54 46.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 -173.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -75.72 112.21 11.86 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.645 174.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 12.5 m-30 -117.84 106.82 13.4 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 176.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 85.51 -95.79 2.03 Favored Glycine 0 CA--C 1.54 1.612 0 N-CA-C 111.154 -0.778 . . . . 0.0 111.154 -172.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -127.6 -24.19 3.33 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 114.956 1.465 . . . . 0.0 114.956 169.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -89.24 139.13 30.8 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 119.056 0.844 . . . . 0.0 110.558 -175.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 59.3 t -87.85 110.93 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 N-CA-C 106.66 -1.608 . . . . 0.0 106.66 178.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 69.0 mt-30 -106.95 120.56 42.39 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.177 -169.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 19.8 m-70 -99.65 97.69 8.63 Favored 'General case' 0 CA--C 1.553 1.093 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 -170.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -93.11 125.03 37.51 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 -179.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -75.6 119.84 20.19 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-O 121.32 0.581 . . . . 0.0 112.222 -170.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 90.9 t -93.79 97.86 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 N-CA-C 106.374 -1.713 . . . . 0.0 106.374 178.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 71.0 mt -85.57 154.76 21.51 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.682 0.793 . . . . 0.0 110.951 177.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 65.0 mtp180 -115.87 129.39 56.4 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.505 -0.747 . . . . 0.0 110.798 -177.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -106.23 94.12 4.98 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 123.323 0.649 . . . . 0.0 110.258 176.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 88.96 -112.84 4.01 Favored Glycine 0 CA--C 1.541 1.706 0 N-CA-C 113.918 0.327 . . . . 0.0 113.918 172.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -89.03 -94.25 0.11 Allowed 'General case' 0 N--CA 1.486 1.341 0 CA-C-O 118.228 -0.892 . . . . 0.0 111.35 -169.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -113.73 80.3 0.28 Allowed Glycine 0 N--CA 1.481 1.665 0 CA-C-N 119.335 0.971 . . . . 0.0 110.689 177.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -142.5 146.58 34.87 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -175.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -145.78 108.36 4.48 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 -169.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 21.2 p90 -126.74 117.77 23.36 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.749 0.82 . . . . 0.0 109.602 -175.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -107.95 -42.83 4.58 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 170.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 47.2 t90 -92.03 -74.07 0.53 Allowed 'General case' 0 CA--C 1.558 1.255 0 C-N-CA 124.959 1.304 . . . . 0.0 110.182 -169.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . 0.267 14.8 p -147.24 -64.98 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 C-N-CA 123.612 0.765 . . . . 0.0 109.188 174.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 9.4 m -79.56 142.21 14.29 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.426 0 C-N-CA 124.175 0.99 . . . . 0.0 111.481 -178.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.87 154.65 28.23 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -177.448 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -133.66 116.41 15.79 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 106.471 -1.677 . . . . 0.0 106.471 -171.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -55.68 -50.59 69.86 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 115.884 1.809 . . . . 0.0 115.884 -173.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 69.0 m -106.57 161.58 14.5 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-O 122.025 0.916 . . . . 0.0 111.21 173.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 84.5 mt -67.2 -29.07 68.64 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 168.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -67.07 -39.66 86.87 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-N 119.652 1.114 . . . . 0.0 113.04 169.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -60.47 -41.46 94.23 Favored 'General case' 0 CA--C 1.568 1.67 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 169.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 9.1 tt -56.99 -45.56 82.88 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 114.139 1.163 . . . . 0.0 114.139 169.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 41.3 t -60.01 -61.8 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 C-N-CA 124.308 1.043 . . . . 0.0 112.661 172.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 -63.16 -28.42 70.04 Favored 'General case' 0 CA--C 1.566 1.587 0 N-CA-C 115.879 1.807 . . . . 0.0 115.879 -174.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -63.12 -61.68 2.21 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 119.594 1.088 . . . . 0.0 112.01 169.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . 0.308 49.1 m-70 -70.11 -8.91 53.35 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 118.166 2.654 . . . . 0.0 118.166 177.414 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 59.2 ttm-85 -61.86 -28.81 69.76 Favored 'General case' 0 CA--C 1.579 2.092 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 167.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 71.0 m -110.43 -31.87 7.13 Favored 'General case' 0 CA--C 1.568 1.67 0 C-N-CA 125.199 1.4 . . . . 0.0 114.245 169.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 47.6 m -90.56 149.45 22.15 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-N 120.389 1.449 . . . . 0.0 110.445 175.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 22.8 t -80.96 137.26 36.1 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.741 -1.224 . . . . 0.0 113.242 -179.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 75.5 t -75.08 -58.82 3.99 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.834 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.126 169.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 73.4 m -89.66 114.99 26.7 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.909 0.884 . . . . 0.0 108.724 -177.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 19.3 mmm180 -89.24 81.51 6.69 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 122.33 1.062 . . . . 0.0 112.249 -169.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -160.32 -77.71 0.06 Allowed 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 103.816 -2.661 . . . . 0.0 103.816 173.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -97.08 146.57 24.89 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 169.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 65.5 mt-30 -79.35 112.27 16.42 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.665 -0.647 . . . . 0.0 111.222 -175.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -124.16 127.05 73.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 -178.023 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -119.88 168.33 11.22 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 122.545 1.164 . . . . 0.0 112.447 -169.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 11.0 mp -90.39 115.31 27.47 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 124.318 1.047 . . . . 0.0 110.251 -178.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.21 147.7 42.26 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 124.234 1.013 . . . . 0.0 109.302 178.043 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -74.11 152.17 39.95 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 122.112 0.958 . . . . 0.0 113.456 -176.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 14.3 pt -72.9 164.43 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 CA-C-N 114.903 -1.044 . . . . 0.0 113.583 -178.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 24.4 tp10 . . . . . 0 N--CA 1.485 1.315 0 CA-C-O 122.834 1.302 . . . . 0.0 109.315 172.076 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.401 0 N-CA-C 111.356 -0.698 . . . . 0.0 111.356 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 89.1 p -84.23 118.05 23.91 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.059 0.544 . . . . 0.0 111.524 -179.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . 0.259 65.9 p-90 -78.82 -51.78 9.26 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 172.061 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -81.82 140.79 33.97 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-N 119.596 1.089 . . . . 0.0 110.826 175.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -116.49 -87.27 0.61 Allowed 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 175.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 138.49 94.15 0.3 Allowed Glycine 0 N--CA 1.48 1.628 0 CA-C-N 119.603 1.092 . . . . 0.0 111.755 177.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . 0.259 20.5 tptm 67.14 73.42 0.34 Allowed 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 124.283 1.033 . . . . 0.0 113.56 173.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 28.4 pt -128.77 151.08 76.62 Favored Pre-proline 0 CA--C 1.576 1.95 0 C-N-CA 123.924 0.89 . . . . 0.0 109.443 176.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -75.42 172.25 16.68 Favored 'Trans proline' 0 CA--C 1.562 1.896 0 C-N-CA 122.997 2.464 . . . . 0.0 114.678 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 53.5 ttt180 -67.03 -41.3 86.8 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 115.771 1.767 . . . . 0.0 115.771 -179.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -66.9 -42.73 84.96 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 115.666 1.728 . . . . 0.0 115.666 177.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -64.94 -36.03 83.08 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 115.028 1.492 . . . . 0.0 115.028 169.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.82 -45.25 90.46 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 115.734 1.753 . . . . 0.0 115.734 170.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -62.43 -38.48 89.9 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 115.246 1.572 . . . . 0.0 115.246 170.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -61.33 -50.43 72.97 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 114.499 1.296 . . . . 0.0 114.499 173.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 39.2 tpp -57.5 -46.53 83.65 Favored 'General case' 0 CA--C 1.564 1.488 0 N-CA-C 115.604 1.705 . . . . 0.0 115.604 172.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 9.2 mp -70.65 -24.9 62.78 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 116.621 2.082 . . . . 0.0 116.621 175.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 71.6 m -57.28 -35.43 69.78 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-N 120.882 1.674 . . . . 0.0 114.908 169.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 56.8 mttp -60.45 -38.5 84.35 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 115.112 1.523 . . . . 0.0 115.112 169.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -68.49 122.29 18.14 Favored 'General case' 0 CA--C 1.556 1.183 0 C-N-CA 124.829 1.251 . . . . 0.0 112.156 178.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 16.4 ptm180 -78.24 -18.05 55.89 Favored 'General case' 0 CA--C 1.569 1.701 0 N-CA-C 118.199 2.666 . . . . 0.0 118.199 175.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 41.7 m80 -89.57 147.39 23.97 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 119.483 1.038 . . . . 0.0 113.722 -168.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -81.77 117.91 22.45 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 169.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 118.22 -32.89 5.08 Favored Glycine 0 CA--C 1.54 1.613 0 CA-C-O 117.704 -1.609 . . . . 0.0 116.35 -169.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -60.91 103.98 0.32 Allowed 'General case' 0 N--CA 1.486 1.339 0 CA-C-N 119.257 1.529 . . . . 0.0 113.9 -169.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 18.4 p90 -120.59 162.48 19.55 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 -168.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.3 pp -135.29 132.16 37.41 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 167.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 70.0 mt -91.82 114.31 28.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 105.611 -1.996 . . . . 0.0 105.611 170.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 46.8 ptt85 -100.45 156.07 17.47 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-N 114.596 -1.183 . . . . 0.0 110.484 170.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -87.67 128.03 35.29 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 168.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 16.4 t -60.36 137.83 58.07 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 113.753 1.02 . . . . 0.0 113.753 -170.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.06 119.86 17.89 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-O 122.907 1.337 . . . . 0.0 111.536 -171.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . 0.33 5.4 t 84.98 -22.21 0.21 Allowed 'General case' 0 N--CA 1.493 1.693 0 CA-C-N 111.569 -2.56 . . . . 0.0 116.075 -169.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -108.55 92.9 10.8 Favored Pre-proline 0 CA--C 1.565 1.533 0 CA-C-N 120.662 1.574 . . . . 0.0 110.213 177.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -73.52 133.15 18.51 Favored 'Trans proline' 0 C--N 1.373 1.821 0 C-N-CA 123.19 2.593 . . . . 0.0 111.429 171.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 98.69 -34.18 5.51 Favored Glycine 0 CA--C 1.553 2.456 0 CA-C-O 119.017 -0.879 . . . . 0.0 114.275 -168.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -79.64 131.84 36.09 Favored 'General case' 0 N--CA 1.484 1.257 0 CA-C-N 118.675 1.238 . . . . 0.0 108.599 169.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -116.63 164.09 15.13 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-O 122.124 0.964 . . . . 0.0 110.58 -178.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 69.0 m -143.54 115.32 8.22 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 -177.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 16.6 tp -83.8 104.93 14.29 Favored 'General case' 0 CA--C 1.561 1.386 0 C-N-CA 124.369 1.068 . . . . 0.0 108.502 174.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.8 m -93.63 108.62 20.32 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 -179.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 24.0 t -116.38 124.5 72.65 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 CA-C-N 119.762 1.164 . . . . 0.0 108.301 -169.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 58.6 tptt -84.06 120.65 26.4 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.211 0.605 . . . . 0.0 109.891 171.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 3.9 m-30 -89.23 -140.03 0.13 Allowed 'General case' 0 CA--C 1.567 1.633 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 173.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -58.13 -71.0 0.82 Allowed Glycine 0 CA--C 1.547 2.053 0 C-N-CA 123.96 0.791 . . . . 0.0 114.242 169.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 31.6 t30 -140.04 58.72 1.59 Allowed 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 117.534 0.667 . . . . 0.0 111.281 169.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -160.0 141.6 12.75 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 124.016 0.926 . . . . 0.0 108.627 176.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 57.2 t -107.35 109.83 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 177.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 18.6 mp0 -101.85 126.76 48.8 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.879 0.871 . . . . 0.0 109.777 179.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 11.9 m-70 -101.78 97.0 7.45 Favored 'General case' 0 CA--C 1.553 1.082 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 -175.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -86.41 128.81 34.99 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 172.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -91.02 118.87 30.73 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 121.208 0.528 . . . . 0.0 110.889 -169.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 91.9 t -85.91 110.21 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 107.224 -1.398 . . . . 0.0 107.224 -177.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 56.8 mt -104.31 134.41 47.58 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 -173.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 37.3 mtm180 -99.52 131.47 45.51 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 118.176 0.444 . . . . 0.0 110.929 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -85.6 -54.47 4.53 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 174.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 179.98 139.44 3.77 Favored Glycine 0 CA--C 1.542 1.732 0 CA-C-N 119.823 1.192 . . . . 0.0 113.77 -178.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . 0.344 . . 78.53 -79.15 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 125.294 1.438 . . . . 0.0 113.3 175.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -157.18 78.13 0.19 Allowed Glycine 0 N--CA 1.478 1.463 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 172.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -143.07 144.1 32.12 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -171.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -138.87 100.6 4.09 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 -172.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -99.89 105.43 17.16 Favored 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 175.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -101.63 -49.94 3.86 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-N 114.327 -1.306 . . . . 0.0 111.239 175.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 79.0 t90 -129.48 101.71 6.07 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 -172.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . 0.509 10.7 p 60.75 -90.68 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 C-N-CA 125.227 1.411 . . . . 0.0 114.188 -179.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 21.1 m -79.64 158.44 4.54 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.493 0 C-N-CA 124.449 1.1 . . . . 0.0 112.398 -175.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -79.72 152.7 29.73 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 121.876 0.846 . . . . 0.0 112.978 179.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -135.73 109.42 8.04 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 105.9 -1.889 . . . . 0.0 105.9 -171.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 15.1 t30 -57.89 -53.54 57.08 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 115.77 1.767 . . . . 0.0 115.77 -170.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 67.7 m -98.05 149.57 22.34 Favored 'General case' 0 N--CA 1.483 1.225 0 CA-C-O 123.04 1.4 . . . . 0.0 111.337 178.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 8.0 tp -65.96 -31.29 72.12 Favored 'General case' 0 CA--C 1.571 1.764 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 169.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -70.18 -37.85 75.23 Favored 'General case' 0 CA--C 1.57 1.746 0 CA-C-O 117.681 -1.152 . . . . 0.0 113.796 169.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . 0.329 9.1 pt-20 -62.16 -31.14 71.61 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-N 121.139 1.79 . . . . 0.0 115.088 169.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 59.6 tp -57.79 -44.13 86.06 Favored 'General case' 0 CA--C 1.574 1.868 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 168.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . 0.333 7.1 p -65.3 -57.61 10.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 CA-C-N 120.17 1.35 . . . . 0.0 113.918 172.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -60.32 -23.49 64.25 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 117.391 2.367 . . . . 0.0 117.391 176.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 84.8 t80 -66.25 -61.33 2.08 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-N 119.304 0.956 . . . . 0.0 112.043 169.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 71.4 m-70 -69.83 -9.54 55.13 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 117.734 2.494 . . . . 0.0 117.734 176.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 38.0 ttm180 -59.52 -29.11 67.65 Favored 'General case' 0 CA--C 1.58 2.119 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 167.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 70.7 m -110.2 -30.61 7.66 Favored 'General case' 0 CA--C 1.571 1.771 0 C-N-CA 125.483 1.513 . . . . 0.0 114.037 169.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 56.8 m -90.46 157.36 17.61 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-N 120.546 1.521 . . . . 0.0 111.266 177.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 8.2 t -75.93 129.79 37.47 Favored 'General case' 0 CA--C 1.56 1.363 0 O-C-N 121.491 -0.756 . . . . 0.0 112.8 177.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 14.1 t -69.15 -50.69 50.68 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 C-N-CA 123.807 0.843 . . . . 0.0 111.655 173.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 25.3 t -88.56 145.07 25.92 Favored 'General case' 0 CA--C 1.558 1.259 0 C-N-CA 123.341 0.656 . . . . 0.0 110.211 173.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 84.7 mtt85 -69.95 -50.39 42.43 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 177.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 21.0 m120 -72.84 -55.59 6.44 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 113.445 0.906 . . . . 0.0 113.445 174.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -83.26 146.7 28.41 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-N 118.978 0.808 . . . . 0.0 111.432 -177.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 60.5 mt-30 -86.02 94.78 9.31 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.337 0.589 . . . . 0.0 109.607 176.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 44.1 mm -114.44 133.18 61.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 -174.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -127.56 117.88 22.9 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 -169.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 14.1 tp -80.55 125.57 30.14 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 124.442 1.097 . . . . 0.0 113.952 -168.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 32.5 mmt180 -138.05 160.19 40.02 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 124.085 0.954 . . . . 0.0 110.525 -170.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -73.91 152.98 40.01 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.607 -1.308 . . . . 0.0 112.924 177.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.1 pp -66.55 159.73 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 -179.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 . . . . . 0 N--CA 1.485 1.299 0 CA-C-O 123.981 1.848 . . . . 0.0 108.584 -176.89 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.354 0 N-CA-C 111.508 -0.637 . . . . 0.0 111.508 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 89.5 p -85.74 120.25 26.95 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 123.038 0.535 . . . . 0.0 111.924 -174.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . 0.253 1.6 p90 -156.59 -44.35 0.07 Allowed 'General case' 0 N--CA 1.488 1.448 0 CA-C-O 118.257 -0.878 . . . . 0.0 113.038 178.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -82.53 141.09 32.91 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 120.598 1.544 . . . . 0.0 112.345 -171.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -118.83 -71.91 0.71 Allowed 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 115.087 -0.96 . . . . 0.0 109.127 174.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 104.22 95.94 2.38 Favored Glycine 0 N--CA 1.481 1.658 0 CA-C-N 119.195 0.907 . . . . 0.0 111.655 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . 0.312 94.9 mttt 63.35 71.03 0.52 Allowed 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 124.615 1.166 . . . . 0.0 114.027 -178.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 26.1 pt -122.8 150.53 58.87 Favored Pre-proline 0 CA--C 1.576 1.948 0 C-N-CA 124.284 1.034 . . . . 0.0 108.646 170.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -72.42 163.97 37.0 Favored 'Trans proline' 0 CA--C 1.562 1.881 0 C-N-CA 122.825 2.35 . . . . 0.0 114.128 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 58.6 ttt180 -63.08 -41.78 99.5 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 115.592 1.701 . . . . 0.0 115.592 179.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.41 -46.31 83.81 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 115.305 1.594 . . . . 0.0 115.305 177.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -63.22 -35.33 79.98 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 115.346 1.61 . . . . 0.0 115.346 169.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.78 -44.72 95.45 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 115.42 1.637 . . . . 0.0 115.42 169.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -61.92 -40.73 96.5 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 115.213 1.56 . . . . 0.0 115.213 170.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -61.48 -50.34 73.12 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 114.895 1.442 . . . . 0.0 114.895 173.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -62.88 -43.98 97.34 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 115.02 1.489 . . . . 0.0 115.02 176.447 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 8.5 mp -65.19 -42.51 93.54 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 114.826 1.417 . . . . 0.0 114.826 172.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 67.5 m -54.98 -36.67 65.65 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 115.87 1.804 . . . . 0.0 115.87 169.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -63.34 -35.49 80.56 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 115.26 1.578 . . . . 0.0 115.26 169.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -63.21 126.86 28.8 Favored 'General case' 0 CA--C 1.557 1.228 0 CA-C-O 122.839 1.304 . . . . 0.0 112.61 172.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 14.5 ptp180 -67.45 -16.53 64.27 Favored 'General case' 0 CA--C 1.567 1.627 0 N-CA-C 119.026 2.973 . . . . 0.0 119.026 175.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 48.2 m80 -89.55 142.33 27.77 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 119.6 1.091 . . . . 0.0 113.281 -168.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -75.94 127.37 32.85 Favored 'General case' 0 N--CA 1.489 1.475 0 CA-C-N 115.014 -0.994 . . . . 0.0 108.632 169.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.45 4.31 66.18 Favored Glycine 0 CA--C 1.555 2.539 0 CA-C-O 117.278 -1.845 . . . . 0.0 117.621 -169.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -70.02 114.88 8.62 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 121.02 2.41 . . . . 0.0 112.73 -169.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 22.4 p90 -127.63 158.54 37.27 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 115.41 1.633 . . . . 0.0 115.41 -168.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.1 pp -134.99 158.21 44.93 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 124.169 0.988 . . . . 0.0 109.535 168.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.8 mp -114.36 113.71 44.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 104.83 -2.285 . . . . 0.0 104.83 169.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 46.6 ptt85 -101.3 140.68 35.26 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 123.783 0.833 . . . . 0.0 109.07 169.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -79.59 138.42 37.44 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.683 -0.636 . . . . 0.0 109.53 170.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 58.2 m -66.79 128.21 35.42 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 123.13 0.572 . . . . 0.0 111.511 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -64.92 -50.92 64.59 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 114.403 1.26 . . . . 0.0 114.403 -171.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.8 t -64.25 -40.31 95.74 Favored 'General case' 0 CA--C 1.564 1.514 0 N-CA-C 115.487 1.662 . . . . 0.0 115.487 170.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -111.8 95.27 27.69 Favored Pre-proline 0 CA--C 1.564 1.493 0 CA-C-N 119.32 0.964 . . . . 0.0 110.819 -177.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.43 129.19 16.49 Favored 'Trans proline' 0 C--N 1.372 1.768 0 C-N-CA 123.054 2.503 . . . . 0.0 111.014 169.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 108.27 -35.43 4.98 Favored Glycine 0 CA--C 1.553 2.434 0 CA-C-O 118.894 -0.948 . . . . 0.0 113.609 -168.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -83.79 131.91 34.87 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-N 118.63 1.215 . . . . 0.0 108.24 169.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -115.77 168.07 10.36 Favored 'General case' 0 CA--C 1.56 1.357 0 CA-C-O 122.083 0.945 . . . . 0.0 110.181 -177.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 72.8 m -145.57 112.8 6.15 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 -177.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 19.9 tp -88.54 104.34 16.74 Favored 'General case' 0 CA--C 1.561 1.393 0 C-N-CA 124.654 1.181 . . . . 0.0 109.429 177.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.8 m -82.56 119.15 23.89 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 124.879 1.272 . . . . 0.0 108.065 173.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 24.0 t -129.36 122.84 56.66 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.193 0 CA-C-N 120.805 1.638 . . . . 0.0 107.782 -175.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 59.4 tttp -80.4 138.62 36.67 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.458 169.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -150.34 105.88 3.39 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 169.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 83.76 -106.75 2.88 Favored Glycine 0 CA--C 1.54 1.61 0 N-CA-C 110.894 -0.882 . . . . 0.0 110.894 -174.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 21.3 m120 -133.9 63.74 1.62 Allowed 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 169.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -160.77 127.67 4.17 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 123.522 0.729 . . . . 0.0 109.481 175.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 99.9 t -103.57 106.39 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 177.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -107.16 131.3 54.3 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.876 0.87 . . . . 0.0 110.82 -176.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 21.8 m-70 -103.33 107.66 18.58 Favored 'General case' 0 CA--C 1.552 1.019 0 C-N-CA 123.649 0.78 . . . . 0.0 109.598 -169.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -91.33 131.55 36.75 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 115.111 -0.95 . . . . 0.0 108.6 175.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 38.3 mtmm -80.52 117.1 20.94 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.239 0.542 . . . . 0.0 109.628 178.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 95.6 t -94.48 98.33 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 N-CA-C 105.994 -1.854 . . . . 0.0 105.994 176.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -97.14 140.26 31.9 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 178.257 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 53.3 mtm180 -100.0 133.35 44.51 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 122.673 0.389 . . . . 0.0 110.88 -176.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . 0.253 4.7 p-10 -80.0 -66.53 0.86 Allowed 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 176.085 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -94.51 -116.83 2.86 Favored Glycine 0 CA--C 1.541 1.661 0 CA-C-N 119.067 0.848 . . . . 0.0 112.211 -177.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -86.62 -83.11 0.19 Allowed 'General case' 0 N--CA 1.487 1.385 0 CA-C-O 118.441 -0.79 . . . . 0.0 110.028 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -109.71 78.91 0.24 Allowed Glycine 0 N--CA 1.479 1.565 0 N-CA-C 109.971 -1.252 . . . . 0.0 109.971 169.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -131.17 78.54 1.84 Allowed 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 -174.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -80.36 119.42 23.06 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 124.114 0.966 . . . . 0.0 111.402 -169.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 10.5 p90 -139.64 123.08 17.18 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 122.49 0.316 . . . . 0.0 110.155 -178.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -112.61 -37.82 4.8 Favored 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 123.61 0.764 . . . . 0.0 112.634 168.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 51.0 t90 -84.04 -86.17 0.12 Allowed 'General case' 0 CA--C 1.56 1.344 0 C-N-CA 124.805 1.242 . . . . 0.0 109.272 -175.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . 0.258 6.1 m -139.88 -61.02 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 C-N-CA 123.833 0.853 . . . . 0.0 109.836 173.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.3 p -79.97 140.73 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 CA-C-N 119.094 0.861 . . . . 0.0 111.203 -176.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.97 156.93 24.44 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 -179.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -139.45 120.6 14.72 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 -169.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 66.7 m-80 -61.25 -39.91 92.1 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 116.566 2.062 . . . . 0.0 116.566 -173.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 66.6 m -123.75 160.38 27.42 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-O 121.882 0.849 . . . . 0.0 111.898 -176.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 98.1 mt -84.39 86.51 7.26 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 169.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 167.32 -58.56 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 104.087 -2.56 . . . . 0.0 104.087 -168.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -58.75 -44.87 90.66 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 124.379 1.071 . . . . 0.0 113.72 168.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 8.6 tt -57.25 -50.34 73.19 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 114.722 1.379 . . . . 0.0 114.722 169.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 1.7 m -66.01 -49.11 79.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -178.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -67.92 -35.18 78.01 Favored 'General case' 0 CA--C 1.566 1.594 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 -178.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 79.8 t80 -61.11 -55.18 35.52 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-N 119.894 1.225 . . . . 0.0 112.083 169.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . 0.258 76.3 m-70 -68.68 -8.85 46.25 Favored 'General case' 0 CA--C 1.566 1.577 0 N-CA-C 117.797 2.517 . . . . 0.0 117.797 175.352 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 5.9 ttm180 -58.37 -28.1 64.82 Favored 'General case' 0 CA--C 1.579 2.069 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 167.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 70.0 m -114.16 -30.82 6.52 Favored 'General case' 0 CA--C 1.57 1.745 0 C-N-CA 125.341 1.456 . . . . 0.0 113.639 169.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 32.4 m -90.32 152.33 21.07 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-N 120.753 1.615 . . . . 0.0 110.532 176.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 20.5 t -82.04 131.31 35.24 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 120.628 -1.295 . . . . 0.0 112.971 -179.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -66.2 -45.09 91.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 169.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 22.0 t -79.67 -32.2 41.46 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 115.584 1.698 . . . . 0.0 115.584 177.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . 0.336 15.9 ttt180 91.88 -66.64 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 124.926 1.29 . . . . 0.0 111.92 179.308 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -69.52 -54.7 12.9 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 172.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -79.87 140.49 36.75 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-N 118.619 0.645 . . . . 0.0 110.358 171.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 3.3 tm0? -87.41 109.41 19.55 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 123.054 0.542 . . . . 0.0 109.564 178.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 5.2 mp -133.3 121.78 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 172.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 21.6 m-30 -115.16 144.73 43.23 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.745 0.783 . . . . 0.0 109.747 173.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 10.1 mp -90.22 121.97 32.72 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 113.372 0.879 . . . . 0.0 113.372 -169.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -119.62 140.47 50.55 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 124.373 1.069 . . . . 0.0 108.388 169.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -70.39 147.21 49.8 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 -176.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 15.4 pt -67.49 154.31 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 N-CA-C 113.658 0.985 . . . . 0.0 113.658 -178.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 . . . . . 0 N--CA 1.484 1.269 0 CA-C-O 122.827 1.298 . . . . 0.0 110.013 -174.999 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.373 0 N-CA-C 111.489 -0.645 . . . . 0.0 111.489 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 31.3 t -82.03 105.84 13.46 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-O 121.295 0.569 . . . . 0.0 111.174 -176.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 63.7 p-90 -75.25 -45.94 36.96 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 115.246 1.573 . . . . 0.0 115.246 177.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 29.9 t80 -84.25 131.98 34.68 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-N 119.801 1.182 . . . . 0.0 110.884 -175.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -117.38 -58.92 2.0 Allowed 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 114.815 -1.084 . . . . 0.0 109.735 174.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 104.4 87.65 2.01 Favored Glycine 0 N--CA 1.479 1.543 0 CA-C-N 119.043 0.838 . . . . 0.0 111.972 172.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 68.9 tttt 66.85 69.68 0.4 Allowed 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 124.062 0.945 . . . . 0.0 113.24 178.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 25.4 pt -121.14 148.87 50.24 Favored Pre-proline 0 CA--C 1.574 1.892 0 C-N-CA 123.957 0.903 . . . . 0.0 109.024 175.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -70.9 161.48 45.95 Favored 'Trans proline' 0 CA--C 1.559 1.774 0 C-N-CA 122.933 2.422 . . . . 0.0 114.519 -177.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 56.9 ttt180 -65.16 -40.9 94.97 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 115.786 1.773 . . . . 0.0 115.786 -176.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.74 -46.47 82.08 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 115.34 1.607 . . . . 0.0 115.34 179.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 55.5 mtmt -63.55 -34.52 77.98 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 115.037 1.495 . . . . 0.0 115.037 169.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.5 -43.44 90.11 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 115.484 1.661 . . . . 0.0 115.484 170.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -63.64 -42.88 98.08 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 115.09 1.515 . . . . 0.0 115.09 172.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -63.48 -48.13 78.93 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 114.917 1.451 . . . . 0.0 114.917 175.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -65.52 -43.8 88.89 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 114.756 1.391 . . . . 0.0 114.756 176.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 85.7 mt -67.35 -40.52 85.83 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 116.228 1.936 . . . . 0.0 116.228 175.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 91.1 p -56.33 -30.47 62.62 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 116.951 2.204 . . . . 0.0 116.951 171.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -66.15 -30.66 71.19 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 116.378 1.992 . . . . 0.0 116.378 170.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -59.64 142.66 52.46 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-O 123.024 1.392 . . . . 0.0 113.577 176.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.413 ' HD3' ' H ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -70.28 -15.93 62.96 Favored 'General case' 0 CA--C 1.568 1.659 0 N-CA-C 118.129 2.64 . . . . 0.0 118.129 170.309 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 31.4 m80 -89.43 132.66 34.9 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-N 119.996 1.271 . . . . 0.0 111.137 -169.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -81.29 106.77 13.52 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 169.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 115.82 8.41 13.84 Favored Glycine 0 CA--C 1.557 2.707 0 CA-C-O 116.838 -2.09 . . . . 0.0 116.388 -168.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.44 111.23 3.97 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-N 121.639 2.719 . . . . 0.0 112.331 -170.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 28.5 p90 -118.19 155.92 29.66 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 116.509 2.041 . . . . 0.0 116.509 -168.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.4 pp -148.18 138.68 22.86 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 123.31 0.644 . . . . 0.0 109.972 169.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 81.6 mt -90.17 117.79 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 169.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 4.9 ptm180 -111.23 145.72 38.23 Favored 'General case' 0 N--CA 1.487 1.388 0 CA-C-N 114.102 -1.408 . . . . 0.0 108.708 169.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -79.38 143.93 34.64 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.342 -0.849 . . . . 0.0 109.779 172.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 7.9 t -73.72 8.38 1.95 Allowed 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 119.556 3.169 . . . . 0.0 119.556 -169.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . 0.357 5.9 mp0 74.45 -72.0 0.12 Allowed 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 125.542 1.537 . . . . 0.0 113.654 175.018 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 65.9 m -64.3 -40.71 96.49 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 115.934 1.828 . . . . 0.0 115.934 178.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -111.95 102.41 53.65 Favored Pre-proline 0 CA--C 1.563 1.471 0 CA-C-O 118.077 -0.964 . . . . 0.0 109.49 174.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -58.86 -32.09 96.6 Favored 'Trans proline' 0 C--N 1.37 1.697 0 N-CA-C 119.751 2.943 . . . . 0.0 119.751 174.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -86.76 43.17 3.21 Favored Glycine 0 CA--C 1.554 2.475 0 N-CA-C 115.359 0.903 . . . . 0.0 115.359 169.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -153.83 116.45 4.42 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 105.502 -2.036 . . . . 0.0 105.502 177.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -96.19 172.1 8.18 Favored 'General case' 0 CA--C 1.559 1.323 0 CA-C-O 122.245 1.021 . . . . 0.0 110.746 174.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 71.4 m -146.72 108.33 4.31 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 -176.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 32.5 tp -79.73 117.79 20.95 Favored 'General case' 0 CA--C 1.559 1.312 0 CA-C-O 121.834 0.826 . . . . 0.0 108.925 173.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 18.9 m -104.78 90.46 3.49 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 -172.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 10.0 t -101.09 119.24 48.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 N-CA-C 107.389 -1.338 . . . . 0.0 107.389 -170.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -79.64 134.65 36.44 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.042 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -137.9 109.64 7.1 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 -179.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 78.62 -93.19 1.24 Allowed Glycine 0 N--CA 1.487 2.075 0 N-CA-C 111.838 -0.505 . . . . 0.0 111.838 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 15.7 t30 -149.31 45.38 0.97 Allowed 'General case' 0 CA--C 1.573 1.848 0 C-N-CA 123.295 0.638 . . . . 0.0 110.616 168.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -157.6 134.49 10.04 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 178.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 24.6 t -103.91 121.88 55.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -169.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 66.3 mt-30 -94.06 120.76 34.77 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 175.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 10.2 m-70 -98.86 95.46 7.2 Favored 'General case' 0 CA--C 1.55 0.971 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 -174.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -86.66 125.0 33.56 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-N 114.862 -1.063 . . . . 0.0 108.211 177.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -81.18 125.63 30.51 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-O 121.657 0.742 . . . . 0.0 111.586 -175.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 72.5 t -86.75 106.7 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 173.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.9 pp -114.34 144.67 42.89 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 123.248 0.619 . . . . 0.0 110.903 -176.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -96.99 151.63 19.52 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -169.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . 0.252 4.4 p-10 -100.64 -65.42 0.97 Allowed 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 123.676 0.79 . . . . 0.0 111.62 169.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -94.02 -123.25 3.68 Favored Glycine 0 CA--C 1.543 1.787 0 CA-C-N 119.468 1.031 . . . . 0.0 112.874 -177.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -76.48 -65.49 0.92 Allowed 'General case' 0 N--CA 1.489 1.521 0 CA-C-O 118.833 -0.603 . . . . 0.0 112.041 177.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -135.51 61.61 0.62 Allowed Glycine 0 CA--C 1.542 1.772 0 N-CA-C 111.391 -0.683 . . . . 0.0 111.391 169.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -106.69 92.44 4.1 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 105.75 -1.944 . . . . 0.0 105.75 -179.182 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -82.41 116.7 22.0 Favored 'General case' 0 N--CA 1.484 1.228 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.61 -169.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 15.1 p90 -129.51 125.06 35.48 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-O 121.83 0.824 . . . . 0.0 109.631 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 6.0 tt -104.77 -61.63 1.44 Allowed 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 114.966 -1.016 . . . . 0.0 109.657 176.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 25.6 t90 -83.9 -82.04 0.17 Allowed 'General case' 0 CA--C 1.557 1.218 0 C-N-CA 124.36 1.064 . . . . 0.0 111.41 -169.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . 0.25 7.2 m -136.67 -58.78 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 CA-C-N 118.926 0.785 . . . . 0.0 110.378 176.21 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 13.7 m -79.82 142.02 14.52 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.382 0 C-N-CA 124.085 0.954 . . . . 0.0 111.406 -177.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -79.95 150.35 30.53 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 -176.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -131.77 113.72 13.87 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 -169.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 11.3 p30 -54.97 -42.67 72.67 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 117.297 2.332 . . . . 0.0 117.297 -177.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 98.6 p -117.53 163.61 16.16 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-O 122.266 1.031 . . . . 0.0 111.404 175.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 70.2 mt -66.18 -31.24 71.96 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 114.773 1.397 . . . . 0.0 114.773 169.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -64.14 -43.26 95.78 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-N 119.468 1.031 . . . . 0.0 113.635 169.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -58.74 -40.04 82.65 Favored 'General case' 0 CA--C 1.568 1.637 0 N-CA-C 115.125 1.528 . . . . 0.0 115.125 169.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 8.7 tt -61.24 -51.42 69.01 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 114.62 1.341 . . . . 0.0 114.62 173.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 22.7 m -64.59 -51.23 70.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 N-CA-C 113.461 0.911 . . . . 0.0 113.461 176.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -64.44 -34.34 77.97 Favored 'General case' 0 CA--C 1.564 1.508 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 -176.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -60.7 -52.15 66.35 Favored 'General case' 0 CA--C 1.567 1.61 0 CA-C-N 119.37 0.986 . . . . 0.0 111.471 168.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . 0.255 59.4 m-70 -70.12 -9.25 54.96 Favored 'General case' 0 CA--C 1.565 1.552 0 N-CA-C 118.143 2.646 . . . . 0.0 118.143 176.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 90.0 mtt180 -61.53 -30.41 70.62 Favored 'General case' 0 CA--C 1.576 1.97 0 CA-C-N 120.42 1.463 . . . . 0.0 113.025 167.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 70.3 m -102.11 -40.53 6.78 Favored 'General case' 0 CA--C 1.567 1.623 0 C-N-CA 124.934 1.294 . . . . 0.0 113.633 169.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 44.1 m -90.58 156.44 18.15 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-N 120.061 1.3 . . . . 0.0 111.533 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 33.1 t -84.6 134.55 34.39 Favored 'General case' 0 N--CA 1.485 1.312 0 O-C-N 120.654 -1.278 . . . . 0.0 113.904 -175.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -73.16 -43.73 57.17 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.751 0 C-N-CA 123.939 0.896 . . . . 0.0 112.28 168.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 22.8 t -79.48 138.2 37.48 Favored 'General case' 0 CA--C 1.559 1.309 0 CA-C-N 119.367 0.985 . . . . 0.0 111.142 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -70.63 -56.19 7.04 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 -172.014 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -73.51 -66.16 0.73 Allowed 'General case' 0 N--CA 1.489 1.518 0 CA-C-N 119.151 0.887 . . . . 0.0 112.439 -179.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -87.77 141.73 28.37 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.304 0.641 . . . . 0.0 110.73 -178.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -84.13 104.63 14.35 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 122.848 0.459 . . . . 0.0 111.458 -178.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.54 138.91 52.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 178.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -122.35 158.31 29.9 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 121.989 0.899 . . . . 0.0 113.183 -168.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 9.3 mp -87.59 133.91 33.72 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 124.129 0.972 . . . . 0.0 111.925 -175.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 59.5 mmt-85 -129.58 138.21 51.16 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 124.391 1.077 . . . . 0.0 108.517 176.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -74.8 148.42 40.35 Favored 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 121.843 0.83 . . . . 0.0 112.402 -178.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 19.4 pt -69.66 167.6 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 -169.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 . . . . . 0 N--CA 1.486 1.326 0 CA-C-O 123.902 1.811 . . . . 0.0 109.124 173.045 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.448 0 N-CA-C 111.678 -0.569 . . . . 0.0 111.678 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 23.4 m 75.39 115.27 0.06 Allowed 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 124.675 1.19 . . . . 0.0 112.628 175.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 65.3 p-90 -81.85 -39.72 23.51 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 116.307 1.965 . . . . 0.0 116.307 178.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -83.33 125.95 32.18 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-N 119.878 1.217 . . . . 0.0 110.625 -173.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -105.6 -73.88 0.67 Allowed 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 171.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 87.32 125.13 2.0 Favored Glycine 0 CA--C 1.541 1.712 0 CA-C-N 119.458 1.026 . . . . 0.0 112.778 176.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . 0.318 20.0 tptm 76.32 -13.15 0.94 Allowed 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 117.313 2.338 . . . . 0.0 117.313 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 20.3 tt -61.92 131.47 93.17 Favored Pre-proline 0 CA--C 1.575 1.93 0 CA-C-N 120.999 1.727 . . . . 0.0 112.231 174.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -53.7 166.52 1.32 Allowed 'Trans proline' 0 CA--C 1.556 1.618 0 C-N-CA 123.597 2.865 . . . . 0.0 117.394 174.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 59.8 ttt180 -64.98 -42.62 94.39 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 169.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -68.01 -42.48 80.61 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 115.673 1.731 . . . . 0.0 115.673 175.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -66.6 -36.05 81.69 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 115.257 1.577 . . . . 0.0 115.257 170.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.9 -46.14 86.19 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 115.201 1.556 . . . . 0.0 115.201 170.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -59.15 -45.28 91.4 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 114.964 1.468 . . . . 0.0 114.964 169.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -61.24 -47.54 85.57 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 115.119 1.526 . . . . 0.0 115.119 176.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -64.87 -36.36 84.1 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 115.909 1.818 . . . . 0.0 115.909 174.154 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.3 mp -90.13 -22.68 21.64 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 116.717 2.117 . . . . 0.0 116.717 -178.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 74.4 m -64.31 -44.02 92.87 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 120.946 1.703 . . . . 0.0 115.481 177.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . 0.26 0.0 OUTLIER -68.96 -21.82 64.15 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 116.763 2.135 . . . . 0.0 116.763 174.216 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -60.92 135.36 57.76 Favored 'General case' 0 N--CA 1.484 1.226 0 CA-C-N 120.268 1.395 . . . . 0.0 112.014 172.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -78.87 -19.08 52.8 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 117.872 2.545 . . . . 0.0 117.872 179.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 41.5 m80 -89.84 115.07 26.89 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 119.472 1.033 . . . . 0.0 111.607 -168.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.05 113.43 6.42 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 123.877 0.871 . . . . 0.0 110.211 179.276 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 114.6 -8.11 22.19 Favored Glycine 0 CA--C 1.546 2.0 0 CA-C-O 116.524 -2.264 . . . . 0.0 117.118 -169.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -75.76 110.88 10.56 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-N 121.789 2.794 . . . . 0.0 109.951 -173.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 16.4 p90 -120.51 163.0 18.61 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 115.164 1.542 . . . . 0.0 115.164 -168.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.2 pp -138.02 134.61 35.02 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-N 114.452 -1.249 . . . . 0.0 108.227 167.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 76.8 mt -91.4 106.79 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 170.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 51.8 ptt85 -88.25 157.39 18.79 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 123.429 0.692 . . . . 0.0 111.723 170.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -86.6 137.59 32.37 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 169.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 18.3 t -77.41 89.32 3.79 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.474 0.71 . . . . 0.0 111.984 -170.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . 0.341 45.4 mt-10 72.65 -89.78 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 125.311 1.444 . . . . 0.0 107.866 -169.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 21.5 t -152.55 61.46 0.81 Allowed 'General case' 0 CA--C 1.561 1.402 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 168.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -117.75 99.83 52.28 Favored Pre-proline 0 CA--C 1.56 1.341 0 CA-C-O 117.726 -1.131 . . . . 0.0 108.683 -179.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -71.9 128.81 14.53 Favored 'Trans proline' 0 C--N 1.371 1.736 0 C-N-CA 122.959 2.439 . . . . 0.0 111.761 179.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 104.28 -45.9 1.26 Allowed Glycine 0 CA--C 1.551 2.3 0 CA-C-N 114.964 -1.016 . . . . 0.0 112.575 -168.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -87.17 101.65 13.7 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 172.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -113.28 170.69 8.04 Favored 'General case' 0 CA--C 1.562 1.442 0 CA-C-O 121.887 0.851 . . . . 0.0 110.075 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 74.2 m -134.52 115.6 14.1 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 175.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 19.2 tp -79.87 109.35 14.2 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 124.553 1.141 . . . . 0.0 109.155 176.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 9.8 m -105.05 88.78 2.96 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 115.01 -0.995 . . . . 0.0 108.699 -169.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 13.1 t -103.57 127.59 57.46 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -170.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.14 142.38 41.63 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 173.342 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -152.81 103.98 2.82 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 174.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 84.95 -87.53 1.56 Allowed Glycine 0 CA--C 1.542 1.731 0 N-CA-C 112.043 -0.423 . . . . 0.0 112.043 -175.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -137.29 -27.78 0.95 Allowed 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 169.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -85.8 140.13 30.71 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.919 0.887 . . . . 0.0 110.387 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 51.8 t -103.84 119.3 52.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 -176.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 -97.12 118.71 34.15 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.826 0.85 . . . . 0.0 109.547 -174.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -100.43 108.65 20.7 Favored 'General case' 0 CA--C 1.553 1.067 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 -173.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -109.06 123.45 49.17 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 -173.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 19.7 tptm -78.93 124.55 28.35 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-O 121.794 0.807 . . . . 0.0 111.574 -171.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 40.0 t -97.32 106.67 18.85 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.447 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 178.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 64.7 mt -97.68 175.05 6.33 Favored 'General case' 0 CA--C 1.565 1.545 0 C-N-CA 124.163 0.985 . . . . 0.0 112.198 -175.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 15.4 mmt85 -123.68 136.45 54.48 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 123.794 0.838 . . . . 0.0 112.169 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 25.5 p-10 -136.66 123.8 21.7 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 124.067 0.947 . . . . 0.0 109.036 173.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 95.19 -125.62 8.43 Favored Glycine 0 CA--C 1.542 1.755 0 C-N-CA 123.01 0.338 . . . . 0.0 112.961 177.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -88.72 -78.98 0.32 Allowed 'General case' 0 N--CA 1.488 1.452 0 CA-C-O 118.595 -0.717 . . . . 0.0 110.683 -178.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -137.42 63.04 0.58 Allowed Glycine 0 N--CA 1.482 1.731 0 CA-C-N 118.831 0.741 . . . . 0.0 112.244 169.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -120.72 113.61 20.45 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 106.347 -1.723 . . . . 0.0 106.347 -170.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -89.78 128.35 36.12 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.666 0.786 . . . . 0.0 111.756 -169.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 23.7 p90 -124.48 128.79 49.51 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 175.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 8.3 tt -86.31 -63.96 1.23 Allowed 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 118.788 -0.625 . . . . 0.0 110.147 169.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 17.0 m0 -76.82 -71.34 0.4 Allowed 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 118.754 0.706 . . . . 0.0 111.689 178.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 11.6 p -156.47 -52.41 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 C-N-CA 124.744 1.218 . . . . 0.0 109.898 -170.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 10.9 p -79.13 138.0 20.82 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.427 0 C-N-CA 124.351 1.061 . . . . 0.0 110.431 -176.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -79.76 155.29 27.99 Favored 'General case' 0 CA--C 1.559 1.289 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 -171.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -140.97 104.64 4.71 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 103.955 -2.609 . . . . 0.0 103.955 -174.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . 0.268 8.0 p-10 -47.71 -51.33 22.34 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 118.788 2.884 . . . . 0.0 118.788 -169.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 66.5 m -101.81 163.79 12.07 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-O 122.316 1.055 . . . . 0.0 111.476 176.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 15.4 tp -66.02 -37.89 87.03 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 169.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -65.59 -33.83 76.82 Favored 'General case' 0 CA--C 1.573 1.829 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 168.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -62.15 -42.74 99.55 Favored 'General case' 0 CA--C 1.566 1.591 0 CA-C-N 120.63 1.559 . . . . 0.0 114.943 169.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 7.8 tt -60.37 -45.03 94.96 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 169.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 29.4 t -55.04 -61.33 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 C-N-CA 124.43 1.092 . . . . 0.0 112.63 169.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -58.69 -34.75 71.63 Favored 'General case' 0 CA--C 1.568 1.652 0 N-CA-C 115.701 1.741 . . . . 0.0 115.701 -177.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 90.5 t80 -57.64 -56.12 25.97 Favored 'General case' 0 CA--C 1.564 1.512 0 CA-C-O 118.119 -0.943 . . . . 0.0 112.605 169.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . 0.319 52.3 m-70 -71.81 -9.08 57.79 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 117.875 2.546 . . . . 0.0 117.875 175.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 95.8 mtt-85 -65.39 -32.97 74.88 Favored 'General case' 0 CA--C 1.576 1.951 0 CA-C-N 120.702 1.592 . . . . 0.0 112.396 166.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 68.6 m -95.15 -40.26 9.69 Favored 'General case' 0 CA--C 1.563 1.476 0 N-CA-C 114.586 1.328 . . . . 0.0 114.586 170.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 93.6 m -90.82 149.09 22.1 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 124.747 1.219 . . . . 0.0 111.069 176.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 28.7 p -78.25 134.26 37.58 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.2 -0.938 . . . . 0.0 111.929 174.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 3.4 t -65.73 -52.33 51.47 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 C-N-CA 122.928 0.491 . . . . 0.0 111.091 173.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 74.2 m -98.89 143.08 29.6 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.638 0.732 . . . . 0.0 109.36 169.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 7.9 mpt_? -73.17 -51.73 16.75 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -177.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -68.06 -59.47 3.23 Favored 'General case' 0 N--CA 1.495 1.775 0 CA-C-N 119.199 0.909 . . . . 0.0 113.229 177.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -81.72 113.86 19.98 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 170.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -80.15 101.1 8.59 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 122.753 0.421 . . . . 0.0 111.244 -171.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 11.8 mm -100.14 106.29 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -169.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -112.88 127.4 56.18 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -179.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 9.7 mp -76.24 131.28 39.19 Favored 'General case' 0 CA--C 1.561 1.402 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 -169.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 61.7 ttt-85 -136.24 148.56 48.12 Favored 'General case' 0 CA--C 1.563 1.459 0 C-N-CA 125.258 1.423 . . . . 0.0 108.443 177.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -65.33 164.8 12.87 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 120.526 -1.359 . . . . 0.0 113.211 171.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.3 pp -64.19 162.59 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 -174.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 . . . . . 0 N--CA 1.488 1.444 0 CA-C-O 122.841 1.305 . . . . 0.0 110.488 174.472 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.379 0 N-CA-C 111.352 -0.699 . . . . 0.0 111.352 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 32.1 t -88.83 116.68 27.27 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.123 0.569 . . . . 0.0 109.997 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . 0.262 1.6 p90 -130.71 -47.15 1.05 Allowed 'General case' 0 CA--C 1.56 1.341 0 CA-C-O 118.147 -0.93 . . . . 0.0 112.857 -177.046 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -84.33 137.07 33.63 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 120.409 1.459 . . . . 0.0 111.407 -178.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -99.84 -92.5 0.28 Allowed 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 175.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 146.61 85.29 0.06 OUTLIER Glycine 0 N--CA 1.479 1.554 0 CA-C-N 119.438 1.017 . . . . 0.0 111.605 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 26.1 tptp 64.69 69.97 0.49 Allowed 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 124.168 0.987 . . . . 0.0 113.176 174.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 27.3 pt -125.0 149.29 62.83 Favored Pre-proline 0 CA--C 1.573 1.863 0 C-N-CA 123.793 0.837 . . . . 0.0 109.666 -179.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -75.07 171.34 18.5 Favored 'Trans proline' 0 CA--C 1.558 1.709 0 C-N-CA 122.93 2.42 . . . . 0.0 114.581 -178.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 57.0 ttt180 -65.26 -42.49 93.19 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 114.77 1.396 . . . . 0.0 114.77 176.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.14 -42.63 96.73 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 115.76 1.763 . . . . 0.0 115.76 176.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 14.6 tmtt? -65.37 -38.5 90.24 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 169.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.89 -46.6 84.16 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 115.314 1.598 . . . . 0.0 115.314 172.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -60.62 -40.97 93.84 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 115.16 1.541 . . . . 0.0 115.16 170.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -58.55 -56.46 21.86 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 171.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 45.7 tpp -56.71 -47.67 79.43 Favored 'General case' 0 CA--C 1.564 1.485 0 N-CA-C 115.683 1.735 . . . . 0.0 115.683 178.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 74.8 mt -68.04 -30.94 70.27 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 116.456 2.021 . . . . 0.0 116.456 175.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 21.8 t -62.96 -33.05 74.56 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 115.606 1.706 . . . . 0.0 115.606 169.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -62.46 -37.26 85.23 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 115.748 1.759 . . . . 0.0 115.748 170.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -61.05 139.44 58.07 Favored 'General case' 0 CA--C 1.556 1.18 0 N-CA-C 115.115 1.524 . . . . 0.0 115.115 -175.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 15.7 ptp180 -70.59 -21.0 62.72 Favored 'General case' 0 CA--C 1.568 1.635 0 N-CA-C 118.404 2.742 . . . . 0.0 118.404 174.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 49.5 m80 -89.21 144.97 25.72 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 119.575 1.08 . . . . 0.0 112.667 -168.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -78.09 114.99 17.48 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 123.635 0.774 . . . . 0.0 109.944 175.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 82.57 33.12 25.86 Favored Glycine 0 CA--C 1.548 2.137 0 CA-C-O 118.387 -1.23 . . . . 0.0 115.36 -168.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.99 113.64 6.56 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 118.949 1.374 . . . . 0.0 110.211 178.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 22.2 p90 -123.37 155.52 37.18 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 115.005 1.483 . . . . 0.0 115.005 -168.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.2 pp -142.02 143.84 33.35 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.895 0.878 . . . . 0.0 108.945 168.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.4 mp -94.55 119.6 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 N-CA-C 105.704 -1.962 . . . . 0.0 105.704 169.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 49.4 ptt85 -103.14 158.2 16.47 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 123.503 0.721 . . . . 0.0 111.135 169.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -90.02 126.61 35.82 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 169.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 18.0 t -65.79 139.22 58.31 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 112.878 0.695 . . . . 0.0 112.878 -173.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -70.54 -53.01 17.83 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 -171.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.6 t -62.67 -38.01 88.67 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 115.866 1.802 . . . . 0.0 115.866 172.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -118.69 97.28 50.68 Favored Pre-proline 0 CA--C 1.562 1.439 0 CA-C-N 119.195 0.907 . . . . 0.0 110.015 176.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_exo -57.4 -30.24 87.23 Favored 'Trans proline' 0 C--N 1.37 1.671 0 N-CA-C 119.617 2.891 . . . . 0.0 119.617 172.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -88.28 47.0 3.44 Favored Glycine 0 CA--C 1.552 2.395 0 N-CA-C 114.527 0.571 . . . . 0.0 114.527 168.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -160.09 125.39 4.0 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 105.906 -1.887 . . . . 0.0 105.906 -179.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 11.0 m-30 -95.93 172.26 8.12 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.823 0.821 . . . . 0.0 111.272 175.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 71.5 m -147.85 115.06 6.21 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 -179.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 28.7 tp -79.92 108.59 13.62 Favored 'General case' 0 N--CA 1.487 1.379 0 CA-C-O 122.29 1.043 . . . . 0.0 109.61 174.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 6.2 m -95.54 112.62 24.3 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 34.5 t -121.02 131.1 73.86 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.169 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 -174.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 28.7 tptp -76.98 100.59 5.67 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 123.309 0.644 . . . . 0.0 110.933 175.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -86.13 -169.16 2.51 Favored 'General case' 0 CA--C 1.572 1.817 0 CA-C-O 121.291 0.567 . . . . 0.0 109.586 173.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -68.48 106.58 1.78 Allowed Glycine 0 CA--C 1.544 1.877 0 O-C-N 120.692 -1.255 . . . . 0.0 113.497 179.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . 0.319 10.3 t30 75.23 -18.9 0.42 Allowed 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 118.192 2.664 . . . . 0.0 118.192 -175.299 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -144.33 143.36 30.94 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 120.336 1.426 . . . . 0.0 109.611 -169.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 56.2 t -90.64 113.56 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 178.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -94.76 122.97 37.92 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 121.601 0.715 . . . . 0.0 109.96 178.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 8.7 m-70 -100.19 127.1 46.53 Favored 'General case' 0 CA--C 1.552 1.046 0 CA-C-N 114.985 -1.007 . . . . 0.0 109.251 -175.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -119.21 126.72 52.2 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 -177.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 48.2 mtpt -76.27 116.4 16.93 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-O 121.182 0.515 . . . . 0.0 110.608 -177.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 75.9 t -85.09 98.9 6.63 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.374 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 172.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.8 mt -81.36 137.35 35.73 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.893 -179.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 78.1 mtp180 -113.38 120.68 41.92 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -174.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . 0.286 4.9 p-10 -85.29 -66.13 0.93 Allowed 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -88.92 -110.18 1.16 Allowed Glycine 0 N--CA 1.482 1.737 0 CA-C-N 119.331 0.968 . . . . 0.0 112.395 -176.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -84.6 -84.14 0.15 Allowed 'General case' 0 N--CA 1.487 1.413 0 CA-C-O 118.364 -0.827 . . . . 0.0 109.175 174.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -116.88 63.6 0.37 Allowed Glycine 0 N--CA 1.481 1.68 0 CA-C-N 118.896 0.771 . . . . 0.0 111.535 169.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm -101.79 87.14 3.06 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 106.017 -1.845 . . . . 0.0 106.017 -176.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 47.7 m-85 -82.78 116.85 22.3 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 114.892 -1.049 . . . . 0.0 112.64 -168.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -135.54 114.11 11.75 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.44 0.696 . . . . 0.0 110.144 177.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . 0.276 1.8 pt? -87.09 -45.45 10.7 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-O 118.758 -0.639 . . . . 0.0 112.51 168.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 45.3 m0 -83.57 -84.74 0.13 Allowed 'General case' 0 CA--C 1.564 1.495 0 CA-C-N 118.966 0.803 . . . . 0.0 109.436 173.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 61.0 t -141.02 -55.97 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 C-N-CA 124.32 1.048 . . . . 0.0 109.063 -174.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 13.6 p -79.45 128.83 38.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 C-N-CA 123.663 0.785 . . . . 0.0 110.968 -170.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.44 159.67 18.59 Favored 'General case' 0 N--CA 1.486 1.351 0 CA-C-O 122.53 1.157 . . . . 0.0 113.724 -175.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -141.84 121.5 13.41 Favored 'General case' 0 N--CA 1.484 1.242 0 CA-C-N 113.96 -1.473 . . . . 0.0 107.052 -170.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 36.0 m-80 -58.69 -41.4 86.18 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 115.585 1.698 . . . . 0.0 115.585 177.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 26.2 t -114.86 152.74 31.7 Favored 'General case' 0 N--CA 1.484 1.271 0 CA-C-O 122.069 0.937 . . . . 0.0 111.19 178.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 80.6 mt -63.95 -27.26 69.01 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 168.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -59.09 -39.23 81.54 Favored 'General case' 0 CA--C 1.575 1.935 0 CA-C-N 120.105 1.321 . . . . 0.0 113.923 168.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -70.35 -43.52 70.03 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 114.76 1.393 . . . . 0.0 114.76 171.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 9.9 tt -59.1 -46.21 88.89 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 115.361 1.615 . . . . 0.0 115.361 170.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 4.4 p -68.3 -48.41 73.43 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.538 0 N-CA-C 113.742 1.015 . . . . 0.0 113.742 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -56.25 -35.89 67.91 Favored 'General case' 0 CA--C 1.569 1.711 0 N-CA-C 115.182 1.549 . . . . 0.0 115.182 169.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 61.3 t80 -55.6 -55.86 27.12 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 117.26 -1.352 . . . . 0.0 113.102 169.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . 0.381 33.5 m-70 -73.52 -9.22 58.45 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 118.748 2.87 . . . . 0.0 118.748 175.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 91.2 mtt-85 -73.0 -27.06 61.57 Favored 'General case' 0 CA--C 1.581 2.137 0 CA-C-N 120.058 1.299 . . . . 0.0 112.42 166.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 69.6 m -97.85 -42.14 7.7 Favored 'General case' 0 CA--C 1.565 1.543 0 C-N-CA 125.012 1.325 . . . . 0.0 114.24 171.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 92.6 m -85.93 142.58 28.73 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 124.614 1.165 . . . . 0.0 109.717 171.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 33.5 t -72.35 121.09 18.9 Favored 'General case' 0 N--CA 1.485 1.303 0 O-C-N 121.449 -0.782 . . . . 0.0 111.113 173.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 11.4 p -58.33 -35.57 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 N-CA-C 115.525 1.676 . . . . 0.0 115.525 172.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 15.1 t -79.52 -28.11 41.35 Favored 'General case' 0 CA--C 1.564 1.512 0 N-CA-C 116.682 2.104 . . . . 0.0 116.682 179.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . 0.352 98.6 mtt180 86.65 -78.79 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 CA-C-N 120.274 1.397 . . . . 0.0 111.393 -177.287 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 70.1 m-80 -67.5 -52.82 34.56 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -79.7 152.19 30.04 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.166 0.586 . . . . 0.0 110.583 169.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -89.89 88.09 7.2 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 173.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 19.9 mm -113.13 141.39 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -146.63 145.69 30.15 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 121.946 0.879 . . . . 0.0 112.524 -168.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 11.2 mp -83.68 117.2 23.05 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-N 114.761 -1.109 . . . . 0.0 112.279 -169.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 27.2 mmm180 -109.29 137.49 47.09 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 124.304 1.042 . . . . 0.0 109.058 169.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -73.66 142.91 46.43 Favored 'General case' 0 CA--C 1.564 1.487 0 CA-C-O 121.742 0.782 . . . . 0.0 111.713 -178.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 17.9 pt -63.3 156.29 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 114.814 1.413 . . . . 0.0 114.814 -173.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 . . . . . 0 N--CA 1.483 1.213 0 CA-C-O 123.999 1.857 . . . . 0.0 109.11 179.531 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.361 0 N-CA-C 111.488 -0.645 . . . . 0.0 111.488 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 30.6 t -88.76 108.79 19.69 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 177.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . 0.273 1.8 p90 -119.19 -47.55 2.47 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-O 118.015 -0.993 . . . . 0.0 113.068 -174.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -80.15 135.25 36.26 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-N 120.444 1.475 . . . . 0.0 110.263 172.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -121.3 -80.03 0.62 Allowed 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 179.31 -146.47 7.16 Favored Glycine 0 N--CA 1.48 1.589 0 CA-C-N 119.09 0.859 . . . . 0.0 112.012 176.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -85.03 88.43 7.46 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 121.533 0.682 . . . . 0.0 109.288 -179.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 35.8 pt -118.92 148.29 44.29 Favored Pre-proline 0 CA--C 1.573 1.832 0 C-N-CA 124.126 0.97 . . . . 0.0 109.762 -174.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -71.8 157.77 54.53 Favored 'Trans proline' 0 CA--C 1.559 1.739 0 C-N-CA 122.995 2.463 . . . . 0.0 114.325 -177.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 42.1 ttp85 -66.75 -41.1 88.35 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 115.113 1.523 . . . . 0.0 115.113 -179.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -65.75 -42.75 90.55 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 115.924 1.824 . . . . 0.0 115.924 178.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -67.39 -34.11 76.59 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 169.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.39 -43.75 96.68 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 169.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -60.44 -42.83 96.93 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 115.041 1.497 . . . . 0.0 115.041 169.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -61.7 -51.71 67.3 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 176.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -61.88 -46.51 89.08 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 115.091 1.515 . . . . 0.0 115.091 175.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 8.9 mp -66.22 -36.3 82.68 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 115.822 1.786 . . . . 0.0 115.822 175.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 20.9 t -56.24 -30.17 62.01 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 116.593 2.071 . . . . 0.0 116.593 169.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -60.67 -35.29 75.88 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 115.703 1.742 . . . . 0.0 115.703 169.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -67.93 129.41 39.83 Favored 'General case' 0 CA--C 1.555 1.15 0 CA-C-O 122.935 1.35 . . . . 0.0 112.499 -179.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 14.7 ptp180 -66.52 -17.79 65.0 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 118.912 2.93 . . . . 0.0 118.912 172.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 46.1 m80 -89.46 137.37 32.39 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 119.576 1.08 . . . . 0.0 111.818 -168.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -78.25 105.27 9.37 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 171.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 118.14 -3.65 16.33 Favored Glycine 0 CA--C 1.55 2.251 0 CA-C-O 116.198 -2.446 . . . . 0.0 116.7 -168.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.77 110.15 1.44 Allowed 'General case' 0 N--CA 1.494 1.77 0 CA-C-N 122.017 2.909 . . . . 0.0 112.231 -176.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 18.4 p90 -128.43 161.64 29.02 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 117.263 2.32 . . . . 0.0 117.263 -167.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.2 pp -143.12 151.86 41.18 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 114.233 -1.349 . . . . 0.0 108.446 168.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 3.8 mp -102.44 118.04 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 105.173 -2.158 . . . . 0.0 105.173 169.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 46.8 ptt85 -101.44 141.06 34.87 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.174 0.59 . . . . 0.0 110.083 169.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -79.89 134.96 36.33 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 169.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 53.5 m -72.33 139.21 47.81 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-O 121.491 0.662 . . . . 0.0 111.956 -177.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -69.96 -54.54 12.82 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -173.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 97.2 p -61.91 -41.95 98.52 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 115.994 1.85 . . . . 0.0 115.994 171.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -111.85 96.77 34.95 Favored Pre-proline 0 CA--C 1.562 1.405 0 CA-C-O 117.965 -1.017 . . . . 0.0 109.494 176.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -63.61 -26.59 69.2 Favored 'Trans proline' 0 CA--C 1.559 1.765 0 C-N-CA 122.959 2.439 . . . . 0.0 118.203 174.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -91.5 50.12 2.94 Favored Glycine 0 CA--C 1.553 2.422 0 CA-C-O 119.732 -0.482 . . . . 0.0 113.326 168.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -160.04 120.29 2.96 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 106.026 -1.842 . . . . 0.0 106.026 178.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 12.2 m-30 -98.63 172.2 7.64 Favored 'General case' 0 CA--C 1.565 1.55 0 CA-C-O 122.064 0.935 . . . . 0.0 111.341 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 74.3 m -148.19 112.56 5.27 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 -178.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 27.4 tp -85.21 105.08 15.64 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-O 122.308 1.051 . . . . 0.0 109.638 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.8 m -89.85 111.35 22.36 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 125.177 1.391 . . . . 0.0 107.816 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 22.0 t -127.46 121.19 56.6 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.161 0 CA-C-N 120.031 1.287 . . . . 0.0 107.795 -172.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 7.4 tmtm? -89.47 92.43 9.11 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 122.8 0.44 . . . . 0.0 110.734 177.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 25.3 t80 -125.1 111.18 15.03 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 68.12 71.05 1.01 Allowed Glycine 0 N--CA 1.482 1.739 0 N-CA-C 115.525 0.97 . . . . 0.0 115.525 173.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . 0.294 16.8 m120 70.76 -13.35 0.49 Allowed 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 118.49 2.774 . . . . 0.0 118.49 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -132.65 138.49 47.35 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 120.16 1.345 . . . . 0.0 110.159 -169.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 43.5 t -92.1 111.27 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 N-CA-C 106.045 -1.835 . . . . 0.0 106.045 171.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -104.34 114.8 29.27 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.84 0.856 . . . . 0.0 108.771 -170.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 16.7 m-70 -95.21 97.31 9.79 Favored 'General case' 0 CA--C 1.552 1.023 0 CA-C-N 114.745 -1.116 . . . . 0.0 108.417 -173.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -95.88 122.24 38.47 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 -176.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -76.37 115.85 16.5 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 121.302 0.572 . . . . 0.0 110.715 -171.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 84.7 t -91.45 104.5 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 60.7 mt -92.07 131.45 37.33 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.38 -174.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 78.0 mtp180 -106.64 148.2 28.62 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 122.865 0.466 . . . . 0.0 111.195 -173.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -137.27 129.83 29.96 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 123.029 0.531 . . . . 0.0 110.51 171.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 81.7 -113.58 3.67 Favored Glycine 0 CA--C 1.541 1.693 0 C-N-CA 122.971 0.32 . . . . 0.0 113.462 173.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -82.29 -70.37 0.55 Allowed 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 123.118 0.567 . . . . 0.0 111.102 175.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -159.28 71.76 0.23 Allowed Glycine 0 N--CA 1.477 1.431 0 N-CA-C 111.033 -0.827 . . . . 0.0 111.033 169.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -98.71 96.52 7.98 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 106.468 -1.679 . . . . 0.0 106.468 177.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -86.45 100.27 12.24 Favored 'General case' 0 CA--C 1.558 1.259 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.724 -169.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 46.3 p90 -112.87 122.51 47.86 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 123.608 0.763 . . . . 0.0 109.113 -178.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -134.67 -32.88 0.98 Allowed 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 114.44 1.274 . . . . 0.0 114.44 -171.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 46.2 t90 -114.19 -76.6 0.58 Allowed 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 124.764 1.226 . . . . 0.0 108.089 178.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 96.0 t -130.05 -73.57 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 -178.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.3 p -83.16 145.8 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 C-N-CA 123.514 0.726 . . . . 0.0 111.8 -173.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -79.72 152.51 29.84 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 121.565 0.697 . . . . 0.0 112.329 174.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -130.02 121.26 26.13 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -173.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 36.1 t30 -63.64 -50.06 70.8 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 178.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 28.4 t -94.0 148.45 22.15 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-O 122.024 0.916 . . . . 0.0 111.175 173.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 14.1 tp -68.69 -34.93 76.51 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 169.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 -61.44 -40.99 96.48 Favored 'General case' 0 CA--C 1.571 1.771 0 C-N-CA 123.881 0.873 . . . . 0.0 113.331 169.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -58.8 -43.84 90.63 Favored 'General case' 0 CA--C 1.567 1.609 0 N-CA-C 114.956 1.465 . . . . 0.0 114.956 169.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 9.3 tt -54.22 -47.66 71.92 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 114.217 1.191 . . . . 0.0 114.217 169.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 43.7 t -57.86 -60.79 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 C-N-CA 124.361 1.065 . . . . 0.0 112.78 173.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -61.02 -29.15 69.54 Favored 'General case' 0 CA--C 1.568 1.64 0 N-CA-C 116.806 2.15 . . . . 0.0 116.806 -176.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 76.4 t80 -65.4 -58.9 4.74 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-N 119.261 0.937 . . . . 0.0 112.124 169.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 74.2 m-70 -67.95 -9.27 43.9 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 117.832 2.531 . . . . 0.0 117.832 176.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 11.4 ttm180 -60.24 -30.3 69.32 Favored 'General case' 0 CA--C 1.576 1.956 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 167.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 70.5 m -108.93 -31.31 7.71 Favored 'General case' 0 CA--C 1.568 1.643 0 C-N-CA 124.982 1.313 . . . . 0.0 114.252 169.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 59.3 m -91.21 155.68 18.4 Favored 'General case' 0 N--CA 1.498 1.971 0 CA-C-N 120.664 1.575 . . . . 0.0 112.109 176.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 38.0 t -70.48 132.63 45.84 Favored 'General case' 0 N--CA 1.485 1.32 0 O-C-N 121.498 -0.751 . . . . 0.0 112.938 175.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 15.2 t -68.49 -48.16 73.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 CA-C-O 118.225 -0.893 . . . . 0.0 112.084 171.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 22.7 t -105.94 -113.25 0.26 Allowed 'General case' 0 CA--C 1.559 1.319 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 170.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 11.7 tpt180 -161.05 -41.67 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 CA-C-N 119.644 1.111 . . . . 0.0 113.275 174.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -60.12 -57.02 14.6 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 -176.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -79.76 -16.05 56.31 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 117.587 2.44 . . . . 0.0 117.587 174.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 59.51 77.9 0.29 Allowed 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 125.561 1.545 . . . . 0.0 111.71 -175.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 4.7 mp -84.28 124.23 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 -168.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -127.4 117.33 21.97 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 -176.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 10.8 mp -70.5 137.57 50.33 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 114.778 1.399 . . . . 0.0 114.778 -169.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 19.3 mmt85 -135.56 146.68 48.25 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 124.803 1.241 . . . . 0.0 107.807 179.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -72.28 147.28 46.55 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.702 -1.249 . . . . 0.0 112.924 179.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 29.6 pt -68.52 148.28 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 C-N-CA 124.133 0.973 . . . . 0.0 113.092 -178.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 . . . . . 0 N--CA 1.485 1.301 0 CA-C-O 123.872 1.796 . . . . 0.0 108.84 -174.993 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.429 0 CA-C-O 119.986 -0.341 . . . . 0.0 112.428 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 90.9 p -79.32 124.68 28.63 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 112.567 0.581 . . . . 0.0 112.567 -173.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . 0.274 1.2 p90 -149.41 -43.13 0.14 Allowed 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 -177.061 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -81.81 134.31 35.41 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 120.657 1.571 . . . . 0.0 111.509 -176.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -101.7 -90.11 0.35 Allowed 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 175.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 154.19 79.49 0.03 OUTLIER Glycine 0 N--CA 1.482 1.718 0 CA-C-N 119.625 1.102 . . . . 0.0 111.941 179.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . 0.384 65.4 pttt 43.16 59.37 2.96 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 117.514 2.413 . . . . 0.0 117.514 -173.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 23.1 pt -85.77 155.07 58.91 Favored Pre-proline 0 CA--C 1.576 1.954 0 CA-C-O 118.385 -0.817 . . . . 0.0 110.509 174.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -71.09 167.98 24.56 Favored 'Trans proline' 0 CA--C 1.561 1.862 0 C-N-CA 122.73 2.287 . . . . 0.0 114.107 177.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 53.9 ttt180 -63.65 -40.6 97.27 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 115.844 1.794 . . . . 0.0 115.844 177.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.4 -41.91 96.39 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 115.574 1.694 . . . . 0.0 115.574 173.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 55.7 tptt -66.86 -34.89 78.79 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 114.869 1.433 . . . . 0.0 114.869 169.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.37 -45.55 87.23 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 115.118 1.525 . . . . 0.0 115.118 171.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -65.79 -33.83 76.76 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 115.754 1.761 . . . . 0.0 115.754 169.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -57.65 -49.42 76.51 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-N 119.99 1.268 . . . . 0.0 114.24 170.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 45.3 tpp -61.36 -47.91 83.7 Favored 'General case' 0 CA--C 1.567 1.624 0 N-CA-C 115.919 1.822 . . . . 0.0 115.919 172.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 83.4 mt -89.35 -43.82 10.65 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 116.735 2.124 . . . . 0.0 116.735 -169.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 49.7 m -61.6 -32.1 72.2 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 115.598 1.703 . . . . 0.0 115.598 171.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -59.64 -43.4 93.86 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 115.706 1.743 . . . . 0.0 115.706 169.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -75.61 134.86 40.55 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-O 122.867 1.318 . . . . 0.0 111.979 177.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -58.95 -13.01 5.24 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 120.199 3.407 . . . . 0.0 120.199 177.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 50.7 m80 -89.07 127.84 35.72 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 120.008 1.276 . . . . 0.0 113.032 -168.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -73.31 130.18 39.63 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 123.932 0.893 . . . . 0.0 109.753 172.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 96.82 -6.58 64.66 Favored Glycine 0 CA--C 1.547 2.07 0 N-CA-C 118.083 1.993 . . . . 0.0 118.083 -169.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.06 114.52 5.28 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-N 120.658 2.229 . . . . 0.0 112.714 -169.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -124.25 156.04 37.54 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 115.093 1.516 . . . . 0.0 115.093 -168.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.9 pp -142.74 139.61 31.13 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-N 114.736 -1.12 . . . . 0.0 108.897 169.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.5 mp -92.84 118.78 39.26 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.436 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 173.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 40.0 ptt85 -108.51 134.73 50.88 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 169.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -79.47 139.72 37.54 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 121.581 0.705 . . . . 0.0 111.087 -177.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 49.1 m -72.2 124.15 24.42 Favored 'General case' 0 N--CA 1.486 1.369 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.719 173.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -75.25 -49.13 20.26 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 177.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 16.2 t -56.96 -35.07 68.68 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 116.369 1.988 . . . . 0.0 116.369 170.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -111.56 92.19 16.16 Favored Pre-proline 0 CA--C 1.564 1.486 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 169.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -72.13 133.05 20.6 Favored 'Trans proline' 0 C--N 1.372 1.803 0 C-N-CA 123.177 2.585 . . . . 0.0 112.324 -176.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 95.22 -35.88 4.07 Favored Glycine 0 CA--C 1.553 2.444 0 CA-C-O 119.08 -0.844 . . . . 0.0 114.297 -168.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -78.86 136.25 37.26 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-N 118.524 1.162 . . . . 0.0 109.467 178.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -106.55 172.22 6.93 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 115.254 -0.884 . . . . 0.0 111.53 -169.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 74.7 m -145.2 116.38 7.92 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 175.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 24.1 tp -79.88 122.58 26.84 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.638 0.775 . . . . 0.0 109.832 174.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 20.7 m -109.51 93.28 4.42 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 106.541 -1.651 . . . . 0.0 106.541 177.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.1 p -108.49 118.55 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 C-N-CA 123.72 0.808 . . . . 0.0 109.891 -171.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -76.71 146.6 37.92 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-N 115.285 -0.87 . . . . 0.0 112.045 172.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -155.03 107.46 2.73 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 171.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 90.61 -75.65 1.64 Allowed Glycine 0 N--CA 1.484 1.856 0 C-N-CA 122.651 0.167 . . . . 0.0 113.294 179.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -136.86 -45.35 0.58 Allowed 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 123.948 0.899 . . . . 0.0 113.147 173.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -92.94 148.29 22.13 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.37 1.068 . . . . 0.0 111.642 -169.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 20.8 t -99.01 120.98 49.06 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 -178.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 24.3 mp0 -98.29 125.01 43.22 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.935 0.894 . . . . 0.0 109.147 178.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 9.8 m-70 -107.44 114.27 28.17 Favored 'General case' 0 CA--C 1.552 1.033 0 CA-C-N 114.79 -1.096 . . . . 0.0 108.361 -169.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -122.56 125.79 46.43 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 -176.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -81.21 123.94 28.88 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-O 121.408 0.623 . . . . 0.0 110.881 -176.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 68.9 t -80.66 104.87 9.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 171.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 59.9 mt -91.13 141.11 29.16 Favored 'General case' 0 N--CA 1.484 1.256 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.826 179.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 53.3 mtp180 -108.35 146.38 33.07 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 123.533 0.733 . . . . 0.0 110.032 179.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 17.7 p-10 -79.58 -42.86 24.11 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 115.783 1.771 . . . . 0.0 115.783 -179.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 179.1 -79.3 0.06 OUTLIER Glycine 0 CA--C 1.537 1.44 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 -172.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -72.41 -64.22 1.0 Allowed 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 175.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 175.73 75.38 0.05 OUTLIER Glycine 0 N--CA 1.479 1.521 0 CA-C-N 119.039 0.836 . . . . 0.0 112.543 173.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp -128.29 111.54 13.49 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 105.018 -2.216 . . . . 0.0 105.018 174.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -91.73 131.72 36.9 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 124.026 0.93 . . . . 0.0 110.728 -169.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -144.08 137.29 27.46 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 123.646 0.778 . . . . 0.0 109.966 -178.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -132.31 -43.16 0.95 Allowed 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 172.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 39.2 t90 -85.74 -77.22 0.3 Allowed 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 124.313 1.045 . . . . 0.0 110.119 -176.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 9.4 p -149.28 -55.87 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 C-N-CA 123.727 0.811 . . . . 0.0 110.465 175.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 13.5 p -79.6 122.8 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 C-N-CA 123.827 0.851 . . . . 0.0 110.53 -175.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 6.5 ttpm? -79.88 146.45 32.17 Favored 'General case' 0 CA--C 1.559 1.299 0 CA-C-O 122.26 1.029 . . . . 0.0 112.919 -176.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -118.58 158.41 25.48 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 114.134 -1.394 . . . . 0.0 109.202 -173.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -76.99 -57.73 3.68 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 118.119 -0.943 . . . . 0.0 112.635 173.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 83.8 p -109.2 162.56 14.17 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-O 122.334 1.064 . . . . 0.0 112.575 -178.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 18.6 tp -64.99 -33.96 77.3 Favored 'General case' 0 CA--C 1.571 1.761 0 N-CA-C 115.036 1.495 . . . . 0.0 115.036 169.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 14.2 m-80 -64.45 -42.74 95.79 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 113.642 0.979 . . . . 0.0 113.642 169.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -58.78 -41.32 86.37 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 115.836 1.791 . . . . 0.0 115.836 169.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 9.7 tt -53.69 -50.25 66.27 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 115.265 1.58 . . . . 0.0 115.265 172.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 25.7 m -67.88 -45.65 83.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 176.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . 0.256 3.7 p30 -65.26 -29.52 70.31 Favored 'General case' 0 CA--C 1.569 1.711 0 N-CA-C 115.408 1.633 . . . . 0.0 115.408 -178.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 77.9 t80 -67.05 -54.2 23.8 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-N 119.256 0.934 . . . . 0.0 111.613 168.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 80.2 m-70 -67.53 -9.2 40.21 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 117.869 2.544 . . . . 0.0 117.869 176.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 52.9 ttm-85 -57.81 -31.46 66.62 Favored 'General case' 0 CA--C 1.577 2.016 0 C-N-CA 124.285 1.034 . . . . 0.0 113.726 167.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 71.0 m -107.73 -34.56 6.94 Favored 'General case' 0 CA--C 1.568 1.654 0 C-N-CA 125.151 1.38 . . . . 0.0 113.955 169.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 90.0 m -90.66 156.56 18.02 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-N 120.504 1.502 . . . . 0.0 111.913 178.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 32.4 t -74.97 121.41 21.91 Favored 'General case' 0 CA--C 1.558 1.279 0 O-C-N 121.342 -0.849 . . . . 0.0 112.034 177.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.5 p -73.14 -34.8 45.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 170.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 20.3 t -85.26 147.24 26.66 Favored 'General case' 0 CA--C 1.558 1.254 0 CA-C-N 119.098 0.863 . . . . 0.0 111.296 174.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 61.1 ttp85 -68.78 -63.37 1.07 Allowed 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 123.162 0.585 . . . . 0.0 112.297 173.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 19.6 t30 -72.42 -52.64 15.05 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 178.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 67.1 mt-30 -79.8 161.62 25.57 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.675 0.75 . . . . 0.0 112.031 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -105.61 94.56 5.27 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 175.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 28.8 mm -113.98 119.14 60.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 -172.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -121.2 126.81 50.59 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 -174.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 11.1 mp -78.5 124.2 27.88 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 -169.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 7.7 mpt_? -120.0 146.88 45.45 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 124.807 1.243 . . . . 0.0 108.242 172.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -75.4 155.56 36.27 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 121.674 0.749 . . . . 0.0 112.564 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 45.7 pt -66.08 156.61 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 N-CA-C 114.542 1.312 . . . . 0.0 114.542 -172.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 . . . . . 0 N--CA 1.483 1.221 0 CA-C-O 123.975 1.845 . . . . 0.0 109.873 -176.43 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.345 0 N-CA-C 111.58 -0.608 . . . . 0.0 111.58 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 32.7 t -84.36 103.88 13.91 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 122.997 0.519 . . . . 0.0 109.922 177.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 61.9 p-90 -61.53 -38.15 86.36 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 117.57 2.434 . . . . 0.0 117.57 -175.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 33.3 t80 -83.2 124.79 30.88 Favored 'General case' 0 N--CA 1.484 1.267 0 CA-C-N 119.559 1.072 . . . . 0.0 109.616 179.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -110.33 -74.19 0.66 Allowed 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 118.483 -0.77 . . . . 0.0 109.046 179.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 177.37 -98.91 0.12 Allowed Glycine 0 N--CA 1.476 1.364 0 CA-C-N 119.263 0.938 . . . . 0.0 111.525 177.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -140.6 94.09 2.69 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 -174.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 36.5 pt -127.98 153.89 78.35 Favored Pre-proline 0 CA--C 1.575 1.922 0 C-N-CA 123.617 0.767 . . . . 0.0 110.484 -175.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -78.2 176.69 9.66 Favored 'Trans proline' 0 CA--C 1.565 2.051 0 C-N-CA 123.037 2.491 . . . . 0.0 114.458 176.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 29.3 ttm180 -61.48 -43.0 99.64 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 115.952 1.834 . . . . 0.0 115.952 172.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.74 -46.84 80.53 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 115.252 1.575 . . . . 0.0 115.252 178.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm -61.95 -35.94 79.93 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 115.559 1.688 . . . . 0.0 115.559 169.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.55 -40.9 89.3 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 115.493 1.664 . . . . 0.0 115.493 171.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -63.75 -39.76 95.06 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 115.313 1.597 . . . . 0.0 115.313 169.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -60.64 -49.2 78.46 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 174.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -62.26 -49.8 74.26 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 114.492 1.293 . . . . 0.0 114.492 173.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 9.9 mp -69.14 -27.8 65.88 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 116.42 2.007 . . . . 0.0 116.42 179.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 23.3 t -59.28 -37.98 79.02 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-N 120.508 1.503 . . . . 0.0 114.683 169.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt -63.84 -31.91 73.25 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 115.64 1.718 . . . . 0.0 115.64 169.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -64.78 120.59 12.76 Favored 'General case' 0 N--CA 1.484 1.27 0 CA-C-N 119.626 1.103 . . . . 0.0 112.196 175.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -69.12 -19.99 64.04 Favored 'General case' 0 CA--C 1.568 1.657 0 N-CA-C 117.935 2.568 . . . . 0.0 117.935 171.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 43.0 m80 -89.59 132.04 35.3 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-N 119.282 0.946 . . . . 0.0 111.136 -169.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -74.52 123.26 24.43 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.445 0.698 . . . . 0.0 109.691 176.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 99.27 2.05 56.8 Favored Glycine 0 CA--C 1.552 2.39 0 N-CA-C 117.86 1.904 . . . . 0.0 117.86 -169.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.62 109.35 4.27 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-N 120.698 2.249 . . . . 0.0 112.026 -172.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -119.52 160.03 23.18 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 116.322 1.971 . . . . 0.0 116.322 -168.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.2 pp -141.61 145.76 35.4 Favored 'General case' 0 CA--C 1.557 1.246 0 CA-C-N 113.826 -1.534 . . . . 0.0 108.989 168.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.8 mp -96.94 115.25 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 N-CA-C 104.112 -2.551 . . . . 0.0 104.112 169.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 50.7 ptt85 -102.83 152.65 21.02 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 123.819 0.847 . . . . 0.0 110.645 169.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -83.18 140.81 32.36 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 168.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 50.2 m -66.86 1.01 2.07 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 120.074 3.361 . . . . 0.0 120.074 -169.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . 0.357 24.9 tt0 79.22 -69.73 0.11 Allowed 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 125.544 1.538 . . . . 0.0 113.467 169.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 66.1 m -64.81 -39.16 93.14 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 115.579 1.696 . . . . 0.0 115.579 171.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -113.53 103.0 55.43 Favored Pre-proline 0 CA--C 1.563 1.45 0 CA-C-N 119.24 0.927 . . . . 0.0 109.875 175.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -58.77 -32.81 97.79 Favored 'Trans proline' 0 C--N 1.37 1.706 0 N-CA-C 119.742 2.939 . . . . 0.0 119.742 173.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -86.79 46.86 3.62 Favored Glycine 0 CA--C 1.552 2.347 0 N-CA-C 114.765 0.666 . . . . 0.0 114.765 169.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -160.08 132.82 6.56 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 176.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -112.43 176.25 5.1 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-O 122.161 0.981 . . . . 0.0 110.645 178.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 58.1 m -151.56 121.4 7.05 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 -179.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 25.7 tp -79.89 114.93 19.18 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 169.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 8.7 m -98.9 97.53 8.7 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 105.913 -1.884 . . . . 0.0 105.913 172.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.8 p -110.1 125.16 67.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 -175.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -76.24 139.9 41.35 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-O 121.54 0.686 . . . . 0.0 111.648 179.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -140.69 170.9 14.9 Favored 'General case' 0 CA--C 1.566 1.578 0 CA-C-O 122.184 0.992 . . . . 0.0 108.383 169.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -60.41 115.91 8.39 Favored Glycine 0 CA--C 1.546 1.978 0 O-C-N 121.108 -0.995 . . . . 0.0 114.339 178.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . 0.377 15.3 m120 83.19 -24.88 0.16 Allowed 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 117.726 2.491 . . . . 0.0 117.726 -174.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -147.74 140.37 24.66 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-N 120.264 1.393 . . . . 0.0 111.154 -173.141 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 69.1 t -94.92 115.76 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 105.196 -2.149 . . . . 0.0 105.196 169.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 62.8 mt-30 -94.3 115.45 27.68 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-O 121.73 0.776 . . . . 0.0 109.686 -175.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 8.2 m-70 -98.52 114.48 26.9 Favored 'General case' 0 CA--C 1.553 1.085 0 CA-C-N 114.844 -1.071 . . . . 0.0 108.419 -175.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -111.46 131.39 55.24 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 -179.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -85.18 119.39 25.51 Favored 'General case' 0 N--CA 1.486 1.375 0 CA-C-O 121.388 0.613 . . . . 0.0 110.283 -176.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 46.9 t -88.54 110.92 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 64.0 mt -93.67 126.11 38.66 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.084 0.554 . . . . 0.0 110.102 -175.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 71.2 mtp180 -96.27 151.89 19.09 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 123.209 0.604 . . . . 0.0 110.756 176.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 25.3 p-10 -79.68 -47.76 14.81 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 115.17 1.545 . . . . 0.0 115.17 174.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 173.57 -73.58 0.09 OUTLIER Glycine 0 CA--C 1.538 1.523 0 N-CA-C 110.841 -0.904 . . . . 0.0 110.841 -169.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -70.5 -64.69 0.85 Allowed 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 175.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 173.81 81.72 0.05 OUTLIER Glycine 0 N--CA 1.478 1.456 0 CA-C-N 118.742 0.701 . . . . 0.0 111.378 174.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -138.23 107.74 6.18 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 105.482 -2.044 . . . . 0.0 105.482 176.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -93.13 119.03 31.9 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.766 0.827 . . . . 0.0 109.383 -169.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -127.2 110.66 13.1 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 4.1 tt -97.98 -54.28 3.14 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 124.29 1.036 . . . . 0.0 111.434 172.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . 0.259 78.1 t90 -93.09 -95.09 0.15 Allowed 'General case' 0 CA--C 1.557 1.213 0 C-N-CA 124.486 1.114 . . . . 0.0 112.275 -167.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 69.7 t -133.2 -60.35 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 -172.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 24.3 m -79.36 128.56 38.47 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.397 0 CA-C-N 119.097 0.862 . . . . 0.0 109.677 178.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -80.04 131.44 35.78 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-O 121.73 0.776 . . . . 0.0 110.666 -175.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -105.15 153.32 21.69 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 114.707 -1.133 . . . . 0.0 109.747 -173.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -74.64 -54.61 7.1 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 172.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 88.0 p -120.72 168.05 11.82 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-O 122.197 0.999 . . . . 0.0 112.346 -175.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 57.5 mt -62.65 -36.47 82.92 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 114.98 1.474 . . . . 0.0 114.98 169.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . 0.281 9.8 p30 -62.22 -38.08 87.83 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 115.496 1.665 . . . . 0.0 115.496 169.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -62.28 -45.89 91.22 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 114.896 1.443 . . . . 0.0 114.896 169.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 51.5 tp -55.8 -45.58 78.21 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 115.099 1.518 . . . . 0.0 115.099 169.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 33.2 t -60.08 -61.27 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 C-N-CA 124.309 1.044 . . . . 0.0 112.215 172.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -58.47 -30.03 66.66 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 117.289 2.329 . . . . 0.0 117.289 -175.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -64.95 -55.58 18.3 Favored 'General case' 0 CA--C 1.565 1.544 0 CA-C-N 118.963 0.801 . . . . 0.0 112.619 169.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . 0.303 74.1 m-70 -71.53 -8.99 57.48 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 117.931 2.567 . . . . 0.0 117.931 178.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -48.7 -39.47 24.69 Favored 'General case' 0 N--CA 1.501 2.124 0 CA-C-N 120.59 1.541 . . . . 0.0 114.544 167.48 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 69.7 m -106.47 -29.81 9.46 Favored 'General case' 0 CA--C 1.565 1.532 0 N-CA-C 115.02 1.489 . . . . 0.0 115.02 170.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 39.5 m -89.98 147.19 23.84 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-N 120.733 1.606 . . . . 0.0 110.326 -178.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 23.1 t -77.62 122.87 25.89 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.594 -0.691 . . . . 0.0 111.586 176.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 12.4 p -68.4 -30.73 48.59 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.942 0 N-CA-C 115.3 1.593 . . . . 0.0 115.3 169.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 46.4 m -79.78 -41.26 26.88 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 116.147 1.906 . . . . 0.0 116.147 -176.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . 0.261 4.6 mmp_? 69.04 53.98 0.46 Allowed 'General case' 0 N--CA 1.5 2.027 0 C-N-CA 124.465 1.106 . . . . 0.0 113.24 -169.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -163.96 -81.26 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 177.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 -96.12 163.2 13.21 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 123.794 0.838 . . . . 0.0 109.87 169.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -79.82 98.2 6.97 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.72 -0.613 . . . . 0.0 112.145 -178.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 1.2 mp -102.37 100.74 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 103.757 -2.683 . . . . 0.0 103.757 172.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 20.4 m-30 -110.23 126.44 54.14 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 -178.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 10.8 mp -72.2 121.53 19.5 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 113.148 0.795 . . . . 0.0 113.148 -169.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 22.4 mmt85 -126.85 154.26 44.6 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 125.181 1.393 . . . . 0.0 109.18 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -75.47 147.3 39.96 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.293 -1.505 . . . . 0.0 113.367 -177.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.442 ' H ' HD13 ' A' ' 151' ' ' ILE . 0.2 OUTLIER -69.37 158.04 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 113.639 0.977 . . . . 0.0 113.639 179.721 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 . . . . . 0 N--CA 1.484 1.271 0 CA-C-O 122.851 1.31 . . . . 0.0 109.588 -178.657 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.373 0 N-CA-C 111.8 -0.52 . . . . 0.0 111.8 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 88.6 p -80.25 104.17 10.62 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.19 0.596 . . . . 0.0 111.464 -178.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . 0.278 30.0 p-90 -73.48 -47.51 40.69 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 115.14 1.533 . . . . 0.0 115.14 -179.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -83.66 134.36 34.78 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 120.771 1.623 . . . . 0.0 110.864 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -111.13 -88.28 0.52 Allowed 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 176.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 153.39 83.33 0.04 OUTLIER Glycine 0 N--CA 1.48 1.622 0 CA-C-N 119.37 0.986 . . . . 0.0 111.088 178.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . 0.257 51.6 mtpt 59.09 61.44 2.11 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 -176.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 17.4 tt -86.06 141.42 35.32 Favored Pre-proline 0 CA--C 1.572 1.811 0 CA-C-O 117.663 -1.16 . . . . 0.0 110.263 179.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -69.1 153.44 71.98 Favored 'Trans proline' 0 CA--C 1.562 1.906 0 CA-C-N 123.575 2.312 . . . . 0.0 113.578 174.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 38.6 ttt85 -58.01 -43.42 86.68 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 116.18 1.918 . . . . 0.0 116.18 -177.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.47 -46.15 84.33 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 115.007 1.484 . . . . 0.0 115.007 175.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 58.7 tttm -59.83 -36.65 77.25 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 115.248 1.573 . . . . 0.0 115.248 169.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.79 -43.29 96.76 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 115.487 1.662 . . . . 0.0 115.487 170.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -63.68 -46.06 87.27 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 114.875 1.435 . . . . 0.0 114.875 172.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -70.77 -39.22 73.35 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 115.212 1.56 . . . . 0.0 115.212 178.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 38.1 mmt -64.99 -45.2 86.61 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-N 119.922 1.237 . . . . 0.0 114.278 172.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 95.3 mt -64.89 -32.1 73.65 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 116.121 1.897 . . . . 0.0 116.121 170.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 18.9 t -57.47 -29.64 64.4 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 116.364 1.987 . . . . 0.0 116.364 169.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -63.55 -34.99 79.02 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 115.775 1.769 . . . . 0.0 115.775 169.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -70.33 131.24 43.84 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-O 122.935 1.35 . . . . 0.0 112.973 -176.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.28 -12.34 61.58 Favored 'General case' 0 CA--C 1.567 1.623 0 N-CA-C 118.947 2.943 . . . . 0.0 118.947 172.114 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 53.5 m80 -89.28 138.03 31.79 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 120.315 1.416 . . . . 0.0 111.936 -169.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -81.47 98.32 8.2 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 107.545 -1.279 . . . . 0.0 107.545 172.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 124.94 -0.1 8.33 Favored Glycine 0 CA--C 1.557 2.668 0 CA-C-O 117.089 -1.951 . . . . 0.0 115.698 -168.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.66 116.27 6.07 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-N 121.161 2.48 . . . . 0.0 112.653 -169.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 20.4 p90 -131.6 155.53 47.36 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 116.273 1.953 . . . . 0.0 116.273 -168.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.0 pp -143.37 138.13 29.21 Favored 'General case' 0 CA--C 1.558 1.25 0 CA-C-N 114.026 -1.443 . . . . 0.0 108.02 169.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.9 mp -83.57 120.09 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 N-CA-C 106.149 -1.797 . . . . 0.0 106.149 174.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 61.8 ttp85 -95.23 125.01 39.58 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-N 114.718 -1.128 . . . . 0.0 109.218 170.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -79.99 132.24 35.98 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 169.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 53.5 m -69.63 138.51 53.13 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.095 0.558 . . . . 0.0 112.32 -175.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -66.24 -59.46 3.71 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -172.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 88.2 p -62.3 -34.37 76.47 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 116.881 2.178 . . . . 0.0 116.881 174.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -121.04 97.28 48.12 Favored Pre-proline 0 CA--C 1.562 1.431 0 CA-C-N 119.112 0.869 . . . . 0.0 109.837 177.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -56.63 -30.95 85.52 Favored 'Trans proline' 0 C--N 1.369 1.641 0 N-CA-C 119.78 2.954 . . . . 0.0 119.78 172.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -88.24 46.12 3.35 Favored Glycine 0 CA--C 1.553 2.458 0 N-CA-C 114.777 0.671 . . . . 0.0 114.777 168.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -156.11 126.81 6.81 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 105.281 -2.118 . . . . 0.0 105.281 178.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -112.79 167.32 10.59 Favored 'General case' 0 CA--C 1.559 1.303 0 CA-C-O 122.416 1.103 . . . . 0.0 110.549 -174.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 71.2 m -146.32 111.89 5.55 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 -179.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 46.2 tp -79.65 107.32 12.33 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-O 122.004 0.906 . . . . 0.0 109.582 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.3 m -90.42 100.45 13.28 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 177.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.3 p -124.81 121.03 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 -172.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -76.37 142.1 41.28 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.535 170.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -150.22 107.44 3.6 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 169.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 88.9 -106.65 3.3 Favored Glycine 0 N--CA 1.481 1.645 0 N-CA-C 110.382 -1.087 . . . . 0.0 110.382 -176.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -135.68 60.1 1.7 Allowed 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 169.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -160.86 129.02 4.45 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.673 0.789 . . . . 0.0 109.386 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 55.8 t -98.91 109.01 23.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 179.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -99.77 120.39 39.66 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.872 0.869 . . . . 0.0 109.465 -176.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -100.58 105.01 16.38 Favored 'General case' 0 CA--C 1.554 1.097 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -175.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -102.34 129.12 48.7 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -177.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -77.07 126.4 30.91 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-O 121.704 0.764 . . . . 0.0 110.525 -178.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 76.9 t -108.93 100.73 11.37 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.347 0 N-CA-C 104.826 -2.287 . . . . 0.0 104.826 178.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -113.27 144.3 42.95 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.788 0.835 . . . . 0.0 110.76 -172.353 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 92.3 mtt180 -88.68 151.75 22.24 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 113.129 0.788 . . . . 0.0 113.129 -175.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -95.83 -63.82 1.12 Allowed 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 123.54 0.736 . . . . 0.0 110.882 169.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -100.01 -104.98 2.65 Favored Glycine 0 CA--C 1.541 1.707 0 CA-C-N 119.223 0.92 . . . . 0.0 111.553 177.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -139.5 122.9 17.15 Favored 'General case' 0 N--CA 1.482 1.17 0 CA-C-O 122.925 1.345 . . . . 0.0 107.566 172.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 61.74 51.71 55.57 Favored Glycine 0 CA--C 1.552 2.35 0 CA-C-N 113.192 -1.822 . . . . 0.0 115.28 -169.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -137.14 77.69 1.65 Allowed 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 105.087 -2.19 . . . . 0.0 105.087 -174.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -85.76 108.89 18.29 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -167.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 21.5 p90 -119.86 135.47 54.86 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.206 0.602 . . . . 0.0 110.571 178.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -94.48 -52.52 4.29 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 123.16 0.584 . . . . 0.0 111.624 169.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 3.2 m-90 -85.07 -76.78 0.3 Allowed 'General case' 0 CA--C 1.564 1.51 0 C-N-CA 123.775 0.83 . . . . 0.0 109.108 177.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 6.2 m -147.38 -46.14 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 C-N-CA 125.352 1.461 . . . . 0.0 110.942 -178.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 12.3 p -79.81 132.22 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 CA-C-N 119.382 0.992 . . . . 0.0 111.355 -173.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 2.2 pptp? -81.65 154.12 26.28 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 113.904 1.076 . . . . 0.0 113.904 -174.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -135.94 114.5 11.83 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 104.617 -2.364 . . . . 0.0 104.617 176.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -53.07 -38.27 62.35 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 118.933 2.938 . . . . 0.0 118.933 -169.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 91.1 p -135.41 160.36 38.68 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-O 122.522 1.153 . . . . 0.0 113.339 -171.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 11.1 mp -77.39 117.88 19.31 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 168.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . 0.356 21.3 t-20 122.88 -53.28 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.017 0 C-N-CA 126.422 1.889 . . . . 0.0 107.535 -168.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -58.84 -49.45 77.69 Favored 'General case' 0 CA--C 1.568 1.646 0 CA-C-N 119.851 1.205 . . . . 0.0 113.777 169.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 31.1 tp -60.59 -40.22 90.96 Favored 'General case' 0 CA--C 1.57 1.74 0 N-CA-C 115.413 1.634 . . . . 0.0 115.413 169.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 40.4 t -59.07 -61.99 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 C-N-CA 124.35 1.06 . . . . 0.0 112.569 173.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -61.88 -30.32 70.79 Favored 'General case' 0 CA--C 1.572 1.814 0 N-CA-C 115.086 1.513 . . . . 0.0 115.086 -178.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 94.0 t80 -59.69 -57.52 12.57 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-N 119.153 0.888 . . . . 0.0 112.245 168.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 74.4 m-70 -70.37 -9.58 56.64 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 117.913 2.56 . . . . 0.0 117.913 175.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 53.1 ttm-85 -61.1 -30.22 70.23 Favored 'General case' 0 CA--C 1.575 1.917 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 167.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 71.0 m -108.6 -30.79 8.05 Favored 'General case' 0 CA--C 1.568 1.64 0 C-N-CA 125.047 1.339 . . . . 0.0 114.081 169.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 99.1 m -90.89 156.33 18.09 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-N 120.371 1.442 . . . . 0.0 111.978 176.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 39.7 t -67.08 137.16 56.18 Favored 'General case' 0 CA--C 1.558 1.267 0 C-N-CA 123.669 0.788 . . . . 0.0 113.076 170.007 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 19.0 t -71.3 -48.91 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 CA-C-O 118.683 -0.675 . . . . 0.0 111.735 171.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 9.2 t -87.76 172.51 9.61 Favored 'General case' 0 CA--C 1.565 1.541 0 CA-C-N 118.981 0.81 . . . . 0.0 111.754 174.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 40.8 mmt180 -79.93 -57.78 3.48 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.23 -0.919 . . . . 0.0 111.724 169.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -70.1 -59.54 2.84 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 177.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 70.1 mt-30 -79.9 145.08 32.87 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-N 118.869 0.759 . . . . 0.0 111.481 -179.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -102.76 104.56 14.87 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 123.352 0.661 . . . . 0.0 109.533 -177.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 4.3 mp -112.71 127.44 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -125.5 125.38 43.18 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 10.8 mp -74.22 135.33 42.73 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 115.057 1.503 . . . . 0.0 115.057 -168.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 8.9 mmm180 -128.71 139.1 52.39 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 125.486 1.514 . . . . 0.0 108.519 174.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -71.97 146.79 47.5 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.307 -0.87 . . . . 0.0 112.451 177.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 27.1 pt -69.93 158.69 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 N-CA-C 113.564 0.949 . . . . 0.0 113.564 -174.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 . . . . . 0 N--CA 1.484 1.256 0 CA-C-O 122.803 1.287 . . . . 0.0 109.759 179.276 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.362 0 N-CA-C 111.471 -0.652 . . . . 0.0 111.471 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 23.7 m 57.88 90.67 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 124.951 1.301 . . . . 0.0 112.463 -176.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 55.4 p-90 -137.65 -61.69 0.62 Allowed 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 114.849 -1.068 . . . . 0.0 112.347 -169.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -82.82 127.5 33.53 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-N 119.868 1.213 . . . . 0.0 112.903 -169.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -100.01 -79.67 0.49 Allowed 'General case' 0 N--CA 1.489 1.481 0 CA-C-N 114.937 -1.029 . . . . 0.0 108.765 173.005 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -175.99 -138.05 2.75 Favored Glycine 0 N--CA 1.48 1.569 0 CA-C-N 119.311 0.96 . . . . 0.0 112.28 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 20.9 tptm -103.5 87.13 2.78 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 176.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 32.6 pt -127.09 153.09 76.61 Favored Pre-proline 0 CA--C 1.573 1.828 0 C-N-CA 123.331 0.652 . . . . 0.0 111.086 -169.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -77.24 178.57 7.47 Favored 'Trans proline' 0 CA--C 1.565 2.059 0 C-N-CA 123.043 2.496 . . . . 0.0 113.944 175.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 54.3 ttt180 -65.42 -41.48 93.53 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 115.101 1.519 . . . . 0.0 115.101 175.092 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.2 -41.06 97.23 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 115.96 1.837 . . . . 0.0 115.96 179.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -64.07 -38.46 91.16 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 114.569 1.322 . . . . 0.0 114.569 169.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.59 -41.0 84.77 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 115.951 1.834 . . . . 0.0 115.951 171.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -64.17 -36.81 85.26 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 115.02 1.489 . . . . 0.0 115.02 170.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -63.77 -48.24 77.72 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 114.799 1.407 . . . . 0.0 114.799 172.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 38.8 mmt -61.54 -47.48 85.35 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 174.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 88.3 mt -75.09 -24.52 58.14 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 116.908 2.188 . . . . 0.0 116.908 177.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 97.4 p -61.83 -36.35 80.9 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-N 120.726 1.603 . . . . 0.0 114.631 168.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 59.7 mttm -60.7 -36.58 79.16 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 114.788 1.403 . . . . 0.0 114.788 169.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -64.62 120.47 12.45 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.449 1.1 . . . . 0.0 112.001 170.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 16.5 ptm180 -77.9 -15.99 58.58 Favored 'General case' 0 CA--C 1.569 1.683 0 N-CA-C 118.223 2.675 . . . . 0.0 118.223 176.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 46.0 m80 -89.57 147.85 23.71 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 119.513 1.051 . . . . 0.0 113.557 -168.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -77.6 124.4 27.88 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.789 170.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 105.6 -29.93 10.62 Favored Glycine 0 CA--C 1.546 2.002 0 CA-C-O 117.268 -1.851 . . . . 0.0 116.765 -169.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.11 112.75 1.29 Allowed 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 120.21 2.005 . . . . 0.0 113.386 -170.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.1 p90 -130.32 161.22 31.76 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 -168.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.6 pp -141.99 132.62 25.45 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.695 0.798 . . . . 0.0 108.892 168.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 87.2 mt -86.8 122.09 38.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 169.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 49.1 ptt85 -104.4 153.02 21.6 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.487 169.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -88.85 124.12 33.89 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 105.836 -1.913 . . . . 0.0 105.836 168.286 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 53.2 m -62.84 121.37 13.31 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.241 0.616 . . . . 0.0 111.871 -172.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -68.1 -47.15 68.99 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 114.496 1.295 . . . . 0.0 114.496 -170.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.1 t -65.66 -31.93 73.22 Favored 'General case' 0 CA--C 1.568 1.659 0 N-CA-C 115.832 1.79 . . . . 0.0 115.832 169.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -118.85 95.31 49.08 Favored Pre-proline 0 CA--C 1.563 1.471 0 CA-C-N 119.863 1.21 . . . . 0.0 110.158 178.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -56.05 -34.65 93.1 Favored 'Trans proline' 0 C--N 1.369 1.658 0 N-CA-C 120.111 3.081 . . . . 0.0 120.111 176.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -87.97 50.09 3.88 Favored Glycine 0 CA--C 1.55 2.281 0 N-CA-C 114.297 0.479 . . . . 0.0 114.297 169.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -159.66 142.04 13.57 Favored 'General case' 0 CA--C 1.556 1.209 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 178.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -116.68 161.19 19.61 Favored 'General case' 0 CA--C 1.564 1.501 0 CA-C-O 122.032 0.92 . . . . 0.0 109.265 171.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 67.4 m -137.4 117.33 13.27 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 178.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 43.0 tp -80.17 110.89 16.01 Favored 'General case' 0 CA--C 1.563 1.452 0 C-N-CA 124.216 1.007 . . . . 0.0 109.429 172.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 3.1 m -97.4 116.04 28.85 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 -178.28 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 41.2 t -126.21 123.2 63.19 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.194 0 CA-C-N 120.798 1.635 . . . . 0.0 108.151 -171.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 59.0 tptt -81.77 121.2 26.12 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 169.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -139.22 99.46 3.76 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 174.116 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 92.01 -98.32 2.4 Favored Glycine 0 CA--C 1.538 1.483 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.984 178.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 12.2 p30 -129.1 19.49 5.93 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 115.629 1.715 . . . . 0.0 115.629 177.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -145.3 141.37 28.5 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 120.117 1.326 . . . . 0.0 109.522 -177.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 60.6 t -96.33 108.37 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 174.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -104.02 127.68 51.58 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 123.917 0.887 . . . . 0.0 110.557 -176.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 12.7 m-70 -102.95 101.31 11.31 Favored 'General case' 0 CA--C 1.551 1.0 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -169.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -84.92 126.22 33.32 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 172.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 32.6 mmmt -82.86 119.51 24.48 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.067 0.46 . . . . 0.0 110.228 -172.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 84.3 t -86.33 103.63 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 177.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 63.3 mt -95.62 147.69 23.31 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.719 -171.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 72.7 mtp180 -116.28 122.52 45.19 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.627 -0.671 . . . . 0.0 110.355 -173.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -101.19 119.7 39.13 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 123.46 0.704 . . . . 0.0 109.75 174.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 82.02 -112.44 3.49 Favored Glycine 0 CA--C 1.541 1.701 0 C-N-CA 122.816 0.246 . . . . 0.0 113.095 177.005 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -86.43 -71.89 0.53 Allowed 'General case' 0 N--CA 1.486 1.368 0 CA-C-O 118.746 -0.645 . . . . 0.0 111.258 177.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -157.01 71.81 0.25 Allowed Glycine 0 N--CA 1.478 1.498 0 CA-C-N 118.681 0.673 . . . . 0.0 112.373 172.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.95 104.58 14.29 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 104.74 -2.318 . . . . 0.0 104.74 172.058 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -84.08 99.67 10.61 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.652 -168.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 32.8 p90 -102.49 114.36 28.5 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.71 0.804 . . . . 0.0 109.107 -178.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -105.66 -52.17 2.87 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.825 176.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 83.1 t90 -135.19 109.19 8.18 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 -169.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . 0.392 22.2 t 69.58 -91.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 C-N-CA 124.278 1.031 . . . . 0.0 111.57 169.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 8.1 p -79.97 155.3 4.55 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.609 0 C-N-CA 124.224 1.01 . . . . 0.0 111.408 177.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 25.9 pttm -79.74 148.44 31.5 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-O 121.434 0.635 . . . . 0.0 112.545 173.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -128.07 107.27 9.67 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 106.26 -1.755 . . . . 0.0 106.26 -172.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -50.63 -50.28 54.73 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 117.951 2.574 . . . . 0.0 117.951 -169.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 90.8 p -111.86 160.57 17.25 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 118.897 0.771 . . . . 0.0 111.833 176.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 79.0 mt -66.71 -34.46 77.89 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 115.38 1.622 . . . . 0.0 115.38 170.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -64.21 -45.09 89.8 Favored 'General case' 0 CA--C 1.572 1.825 0 CA-C-N 119.859 1.209 . . . . 0.0 114.002 170.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -59.08 -47.35 85.56 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 114.788 1.403 . . . . 0.0 114.788 169.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 57.4 tp -51.83 -52.48 48.98 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 115.686 1.735 . . . . 0.0 115.686 170.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 9.8 p -67.44 -50.28 63.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 -176.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -63.84 -31.0 72.03 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 114.957 1.466 . . . . 0.0 114.957 174.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -62.43 -54.55 38.55 Favored 'General case' 0 CA--C 1.567 1.618 0 CA-C-N 119.727 1.148 . . . . 0.0 111.702 168.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 36.4 m-70 -73.32 -9.7 58.98 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 118.37 2.73 . . . . 0.0 118.37 179.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 58.0 mtp85 -66.82 -21.46 66.03 Favored 'General case' 0 CA--C 1.579 2.08 0 CA-C-N 120.251 1.387 . . . . 0.0 113.347 167.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 69.3 m -104.38 -43.92 5.07 Favored 'General case' 0 CA--C 1.57 1.73 0 C-N-CA 125.453 1.501 . . . . 0.0 112.509 168.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 57.3 m -90.18 155.42 19.04 Favored 'General case' 0 N--CA 1.499 1.981 0 CA-C-N 120.051 1.296 . . . . 0.0 111.465 -179.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 21.0 t -80.18 130.74 35.44 Favored 'General case' 0 CA--C 1.56 1.352 0 O-C-N 121.293 -0.88 . . . . 0.0 113.053 -178.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 3.2 m -68.88 -42.49 82.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 169.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.8 t -83.49 135.26 34.72 Favored 'General case' 0 CA--C 1.557 1.23 0 CA-C-N 118.967 0.803 . . . . 0.0 110.259 173.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 41.4 ptt180 -69.99 -45.53 67.13 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 115.183 1.549 . . . . 0.0 115.183 174.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 70.9 m-80 -79.1 -55.53 5.04 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 123.451 0.7 . . . . 0.0 112.593 175.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -79.89 154.02 28.63 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 118.782 0.719 . . . . 0.0 111.939 179.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -92.91 96.52 10.17 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 171.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 27.7 mm -117.86 110.86 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 N-CA-C 105.146 -2.168 . . . . 0.0 105.146 -178.201 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -116.55 127.97 55.0 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.424 -174.168 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 10.7 mp -78.09 126.14 30.37 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.747 0.819 . . . . 0.0 111.905 -169.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 14.1 mmm180 -126.89 162.79 25.1 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-O 122.419 1.104 . . . . 0.0 110.432 178.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -77.36 148.67 35.46 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.984 -1.072 . . . . 0.0 112.68 -176.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 28.1 pt -70.0 159.7 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 113.993 1.108 . . . . 0.0 113.993 -179.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 . . . . . 0 N--CA 1.485 1.287 0 CA-C-O 124.002 1.858 . . . . 0.0 108.541 -177.603 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.348 0 N-CA-C 111.086 -0.806 . . . . 0.0 111.086 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 14.2 t 67.2 105.3 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 124.747 1.219 . . . . 0.0 111.604 -176.003 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . 0.387 50.8 p-90 51.91 11.05 0.13 Allowed 'General case' 0 N--CA 1.503 2.188 0 N-CA-C 120.703 3.594 . . . . 0.0 120.703 -177.107 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -128.42 132.99 48.47 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 124.319 1.048 . . . . 0.0 108.268 -169.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -99.71 -75.21 0.57 Allowed 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 118.34 -0.838 . . . . 0.0 109.316 172.204 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 97.78 113.64 3.2 Favored Glycine 0 N--CA 1.481 1.669 0 CA-C-N 119.371 0.987 . . . . 0.0 112.208 -179.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . 0.307 73.5 mmtt 65.28 25.68 12.19 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 117.425 2.38 . . . . 0.0 117.425 178.3 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 21.1 tt -90.45 129.03 46.61 Favored Pre-proline 0 CA--C 1.569 1.691 0 CA-C-O 117.139 -1.41 . . . . 0.0 107.567 169.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -67.32 170.61 13.06 Favored 'Trans proline' 0 CA--C 1.562 1.882 0 CA-C-N 123.638 2.335 . . . . 0.0 114.19 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 25.6 ttm180 -57.57 -45.59 85.0 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 116.252 1.945 . . . . 0.0 116.252 -177.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -65.98 -46.08 79.34 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 115.457 1.651 . . . . 0.0 115.457 175.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 61.5 mtpt -63.61 -34.91 78.87 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 115.426 1.639 . . . . 0.0 115.426 169.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.48 -42.4 99.46 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 115.278 1.584 . . . . 0.0 115.278 169.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -60.9 -43.45 98.49 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 169.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -64.82 -45.68 85.2 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 115.52 1.674 . . . . 0.0 115.52 175.136 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -59.83 -44.16 94.2 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 114.83 1.418 . . . . 0.0 114.83 172.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 88.6 mt -70.52 -21.75 62.7 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 116.679 2.104 . . . . 0.0 116.679 170.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 12.1 t -53.09 -37.06 61.37 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 117.223 2.305 . . . . 0.0 117.223 178.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? -64.85 -28.9 69.86 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 116.244 1.942 . . . . 0.0 116.244 170.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -71.53 114.4 9.57 Favored 'General case' 0 N--CA 1.485 1.294 0 CA-C-N 119.819 1.19 . . . . 0.0 111.259 178.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.456 ' H ' ' HD3' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -74.43 -7.35 52.68 Favored 'General case' 0 CA--C 1.57 1.721 0 N-CA-C 118.092 2.627 . . . . 0.0 118.092 172.26 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 35.5 m80 -89.81 139.94 30.08 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 119.667 1.121 . . . . 0.0 111.589 -169.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -75.98 120.12 20.87 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.183 171.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 107.78 -19.77 32.69 Favored Glycine 0 CA--C 1.546 2.022 0 CA-C-O 116.632 -2.204 . . . . 0.0 116.732 -169.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.2 108.72 0.95 Allowed 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 121.26 2.53 . . . . 0.0 112.233 -173.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 23.2 p90 -123.58 158.46 31.38 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 -168.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.9 pp -138.07 128.78 26.72 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 168.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 91.1 mt -88.54 110.76 21.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 172.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.9 ptm180 -89.42 144.61 25.92 Favored 'General case' 0 N--CA 1.484 1.226 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.192 169.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -84.8 126.9 33.84 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 169.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 20.8 t -68.11 123.11 19.76 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 122.909 0.483 . . . . 0.0 111.476 -172.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -91.11 91.17 8.14 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 123.706 1.717 . . . . 0.0 110.411 -173.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 39.7 t 162.54 -41.11 0.0 OUTLIER 'General case' 0 CA--C 1.571 1.768 0 CA-C-N 110.729 -2.941 . . . . 0.0 106.983 -168.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -150.01 113.68 3.37 Favored Pre-proline 0 CA--C 1.563 1.464 0 CA-C-O 117.57 -1.205 . . . . 0.0 108.414 178.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -68.6 -27.22 32.85 Favored 'Trans proline' 0 C--N 1.37 1.699 0 N-CA-C 119.088 2.688 . . . . 0.0 119.088 -178.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -65.3 -21.49 68.43 Favored Glycine 0 CA--C 1.561 2.938 0 N-CA-C 116.492 1.357 . . . . 0.0 116.492 168.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -88.66 137.78 32.01 Favored 'General case' 0 CA--C 1.555 1.171 0 CA-C-N 118.216 1.008 . . . . 0.0 108.839 169.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -122.69 173.16 7.9 Favored 'General case' 0 CA--C 1.567 1.61 0 CA-C-N 114.927 -1.033 . . . . 0.0 108.649 175.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 75.7 m -143.6 115.42 8.24 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 173.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 29.3 tp -79.85 114.47 18.79 Favored 'General case' 0 CA--C 1.561 1.384 0 C-N-CA 124.314 1.046 . . . . 0.0 109.167 175.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.3 m -106.16 88.51 2.81 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 -170.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 16.0 t -101.99 123.02 54.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 -169.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 51.3 tttp -88.26 96.23 10.48 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.474 171.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 20.1 t80 -105.77 112.21 25.18 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.706 -0.849 . . . . 0.0 108.706 179.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 82.78 -106.23 2.73 Favored Glycine 0 CA--C 1.539 1.589 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 -170.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -141.68 59.49 1.49 Allowed 'General case' 0 CA--C 1.565 1.543 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 169.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -155.8 128.57 7.93 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 107.046 -1.465 . . . . 0.0 107.046 177.161 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 50.0 t -95.63 110.72 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 -175.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -104.96 116.08 31.36 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.791 0.836 . . . . 0.0 109.05 -173.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -95.11 108.91 21.02 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 115.036 -0.984 . . . . 0.0 108.828 -175.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -107.07 120.79 43.04 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 -175.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -79.08 112.3 16.14 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 121.906 0.86 . . . . 0.0 110.579 -172.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 75.8 t -85.18 100.94 8.95 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 178.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.9 pp -122.86 133.84 54.41 Favored 'General case' 0 N--CA 1.491 1.575 0 CA-C-O 121.506 0.669 . . . . 0.0 111.099 -169.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -84.7 159.01 20.61 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-O 122.077 0.942 . . . . 0.0 113.042 -176.074 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -85.53 -46.63 10.66 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 114.96 -1.018 . . . . 0.0 113.106 168.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -154.93 -85.5 0.05 OUTLIER Glycine 0 CA--C 1.539 1.556 0 CA-C-N 118.958 0.799 . . . . 0.0 111.258 -177.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -72.95 -70.95 0.33 Allowed 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -175.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -168.75 54.85 0.21 Allowed Glycine 0 N--CA 1.481 1.634 0 CA-C-O 119.333 -0.704 . . . . 0.0 114.276 172.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -109.69 97.83 7.29 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 105.432 -2.062 . . . . 0.0 105.432 173.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -80.32 125.91 30.49 Favored 'General case' 0 CA--C 1.554 1.126 0 CA-C-N 113.922 -1.49 . . . . 0.0 110.775 -169.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 32.2 p90 -128.95 122.83 31.02 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 121.288 0.566 . . . . 0.0 109.884 174.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.484 ' H ' HD23 ' A' ' 120' ' ' LEU . 2.1 pt? -102.92 -53.65 2.8 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 124.291 1.036 . . . . 0.0 111.822 169.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 37.4 t90 -84.83 -74.39 0.39 Allowed 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 124.889 1.276 . . . . 0.0 110.029 -178.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 10.5 p -148.59 -56.0 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 C-N-CA 123.872 0.869 . . . . 0.0 110.668 176.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 11.1 p -79.4 135.82 24.88 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.476 0 C-N-CA 123.814 0.845 . . . . 0.0 110.858 -172.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 54.0 mttp -79.94 157.77 26.79 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 122.249 1.023 . . . . 0.0 112.366 -176.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -140.79 114.75 9.07 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 -170.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -58.73 -43.09 90.08 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 116.247 1.943 . . . . 0.0 116.247 177.115 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 94.8 p -113.37 144.74 42.27 Favored 'General case' 0 N--CA 1.484 1.27 0 CA-C-O 122.018 0.913 . . . . 0.0 111.955 -179.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 19.0 tp -84.53 62.07 7.05 Favored 'General case' 0 CA--C 1.571 1.775 0 CA-C-N 114.625 -1.17 . . . . 0.0 111.195 169.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -156.71 -51.58 0.08 Allowed 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 127.221 2.209 . . . . 0.0 105.445 172.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -61.2 -31.44 71.2 Favored 'General case' 0 CA--C 1.571 1.762 0 CA-C-N 119.537 1.062 . . . . 0.0 113.384 167.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 10.3 tt -51.7 -45.94 63.72 Favored 'General case' 0 N--CA 1.498 1.969 0 CA-C-N 120.158 1.345 . . . . 0.0 114.024 168.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 24.6 t -60.43 -59.32 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 C-N-CA 124.411 1.084 . . . . 0.0 112.162 169.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -58.7 -34.22 71.05 Favored 'General case' 0 CA--C 1.566 1.578 0 N-CA-C 116.269 1.952 . . . . 0.0 116.269 -174.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -61.63 -55.55 29.43 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 119.426 1.012 . . . . 0.0 112.279 169.258 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . 0.263 48.3 m-70 -69.6 -9.51 54.38 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 117.867 2.543 . . . . 0.0 117.867 177.301 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -62.21 -32.41 73.06 Favored 'General case' 0 CA--C 1.577 1.997 0 CA-C-N 120.266 1.393 . . . . 0.0 112.732 166.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 69.4 m -98.75 -39.64 8.54 Favored 'General case' 0 CA--C 1.565 1.529 0 N-CA-C 114.424 1.268 . . . . 0.0 114.424 169.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 52.1 m -91.07 155.61 18.54 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-N 120.175 1.352 . . . . 0.0 112.052 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 31.3 t -75.27 136.01 40.93 Favored 'General case' 0 CA--C 1.559 1.305 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 177.038 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 6.5 t -76.82 -50.03 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 CA-C-O 118.552 -0.737 . . . . 0.0 111.47 169.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 67.0 m -87.85 143.22 27.25 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 119.297 0.953 . . . . 0.0 111.338 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 19.3 ptp180 -91.12 64.47 5.31 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 121.993 0.901 . . . . 0.0 111.515 169.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . 0.271 7.2 p-10 -179.66 -70.99 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 125.624 1.57 . . . . 0.0 107.003 -172.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -86.59 149.9 24.61 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.965 0.906 . . . . 0.0 110.558 170.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 16.5 mm100 -93.32 88.45 6.0 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 122.764 0.426 . . . . 0.0 109.935 178.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 14.8 mm -90.57 117.61 34.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 -169.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -125.11 122.01 35.92 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 -177.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 10.6 mp -74.51 142.96 44.76 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 113.839 1.052 . . . . 0.0 113.839 -169.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 4.2 tmt_? -144.75 145.02 31.48 Favored 'General case' 0 CA--C 1.563 1.46 0 N-CA-C 105.798 -1.927 . . . . 0.0 105.798 -174.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -69.23 157.04 37.72 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.29 -1.507 . . . . 0.0 113.459 176.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.1 pp -72.62 159.05 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 179.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 122.88 1.324 . . . . 0.0 110.061 177.955 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.491 0 N-CA-C 111.772 -0.531 . . . . 0.0 111.772 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 32.7 t -92.77 120.84 33.56 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 122.948 0.499 . . . . 0.0 111.576 -171.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . 0.256 69.0 p-90 -88.16 -47.7 8.27 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 169.432 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 45.6 t80 -80.71 135.29 35.98 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-N 119.464 1.029 . . . . 0.0 110.967 -177.247 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -122.77 -76.91 0.59 Allowed 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 177.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 172.92 -112.89 0.45 Allowed Glycine 0 N--CA 1.479 1.542 0 N-CA-C 108.681 -1.768 . . . . 0.0 108.681 173.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 26.9 ttpp -117.83 82.99 1.92 Allowed 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 105.206 -2.146 . . . . 0.0 105.206 169.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -111.49 136.06 21.03 Favored Pre-proline 0 CA--C 1.569 1.695 0 CA-C-O 117.335 -1.317 . . . . 0.0 108.632 -168.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_exo -48.75 153.13 3.81 Favored 'Trans proline' 0 C--N 1.371 1.716 0 C-N-CA 123.736 2.957 . . . . 0.0 119.22 -177.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 59.0 ttt180 -66.5 -37.9 86.07 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 114.817 1.414 . . . . 0.0 114.817 171.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -69.04 -43.33 74.91 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 115.427 1.64 . . . . 0.0 115.427 176.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 54.6 tptt -66.55 -37.31 84.71 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 115.089 1.514 . . . . 0.0 115.089 169.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.27 -45.72 92.0 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 115.612 1.708 . . . . 0.0 115.612 169.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -64.8 -33.95 77.2 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 115.704 1.742 . . . . 0.0 115.704 171.169 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -61.9 -49.53 75.84 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 114.51 1.3 . . . . 0.0 114.51 171.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -62.71 -47.31 84.15 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 114.691 1.367 . . . . 0.0 114.691 173.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.1 mp -68.21 -25.24 65.12 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 116.302 1.964 . . . . 0.0 116.302 175.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 22.9 t -59.1 -36.3 74.9 Favored 'General case' 0 CA--C 1.571 1.759 0 CA-C-N 120.635 1.561 . . . . 0.0 114.078 168.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 27.9 mmtp -61.05 -36.29 79.19 Favored 'General case' 0 CA--C 1.57 1.746 0 N-CA-C 115.054 1.501 . . . . 0.0 115.054 169.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -67.07 119.47 12.07 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.624 1.17 . . . . 0.0 111.769 177.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 14.1 ptp180 -73.93 -17.1 61.06 Favored 'General case' 0 CA--C 1.569 1.685 0 N-CA-C 118.065 2.617 . . . . 0.0 118.065 171.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 46.5 m80 -89.74 141.87 28.21 Favored 'General case' 0 N--CA 1.487 1.418 0 CA-C-N 119.287 0.948 . . . . 0.0 113.188 -168.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.74 119.57 24.5 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 169.62 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 113.61 -28.5 8.52 Favored Glycine 0 CA--C 1.548 2.098 0 CA-C-O 117.685 -1.619 . . . . 0.0 116.347 -169.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.76 109.99 1.6 Allowed 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 120.06 1.93 . . . . 0.0 112.761 -176.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 16.4 p90 -126.63 164.19 21.8 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 115.457 1.651 . . . . 0.0 115.457 -168.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.2 pp -140.69 134.03 29.76 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 167.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 68.1 mt -88.28 117.66 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 106.568 -1.641 . . . . 0.0 106.568 169.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 5.0 ptm180 -110.66 141.9 43.28 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.447 169.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -79.89 139.04 37.28 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 121.533 0.683 . . . . 0.0 109.793 171.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 29.7 t -68.54 128.84 38.07 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.66 -178.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -68.5 -48.14 65.2 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 113.97 1.1 . . . . 0.0 113.97 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.8 t -60.84 -37.72 83.03 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 115.986 1.847 . . . . 0.0 115.986 169.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -119.67 93.11 47.18 Favored Pre-proline 0 CA--C 1.561 1.395 0 CA-C-N 119.577 1.081 . . . . 0.0 109.792 174.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -55.35 -26.36 52.49 Favored 'Trans proline' 0 CA--C 1.557 1.643 0 N-CA-C 119.761 2.947 . . . . 0.0 119.761 171.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -91.31 48.47 2.91 Favored Glycine 0 CA--C 1.552 2.393 0 CA-C-O 119.319 -0.712 . . . . 0.0 113.93 168.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -160.17 126.98 4.36 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 178.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 35.3 m-85 -92.73 165.45 12.94 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 122.213 1.006 . . . . 0.0 111.701 169.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 75.2 m -143.48 112.72 6.78 Favored 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 25.4 tp -79.98 108.65 13.73 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 124.219 1.008 . . . . 0.0 109.447 176.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 12.6 m -99.65 97.25 8.24 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 -173.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 21.7 t -107.6 126.45 63.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 -172.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 58.4 tptt -76.93 109.83 11.07 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 169.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -139.3 90.11 2.39 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -174.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 71.02 74.71 0.68 Allowed Glycine 0 N--CA 1.482 1.765 0 N-CA-C 115.654 1.021 . . . . 0.0 115.654 169.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . 0.286 66.1 m-80 68.97 -11.56 0.44 Allowed 'General case' 0 N--CA 1.501 2.121 0 N-CA-C 118.362 2.727 . . . . 0.0 118.362 -178.488 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -139.47 142.61 37.35 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 119.736 1.153 . . . . 0.0 108.992 -175.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 38.7 t -92.67 114.75 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 177.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 61.6 mt-30 -96.27 118.35 32.65 Favored 'General case' 0 N--CA 1.485 1.301 0 CA-C-O 121.666 0.746 . . . . 0.0 109.848 -178.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 13.9 m-70 -99.25 99.61 10.59 Favored 'General case' 0 CA--C 1.552 1.054 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 -175.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -96.9 121.48 38.82 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 -175.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 65.5 pttt -75.78 116.05 16.09 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.402 0.62 . . . . 0.0 112.59 -169.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 92.0 t -88.12 109.31 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 179.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 57.8 mt -91.91 145.46 24.53 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.378 -174.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 60.9 mtp180 -122.82 124.53 43.5 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.768 -0.583 . . . . 0.0 109.516 -170.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -111.16 99.45 8.29 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 123.263 0.625 . . . . 0.0 110.162 177.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 76.44 89.44 0.27 Allowed Glycine 0 N--CA 1.482 1.761 0 CA-C-O 119.452 -0.638 . . . . 0.0 113.953 174.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . 0.332 . . 75.8 -78.25 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 124.696 1.199 . . . . 0.0 112.675 -175.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -165.48 75.63 0.15 Allowed Glycine 0 CA--C 1.537 1.431 0 CA-C-O 119.782 -0.455 . . . . 0.0 112.077 173.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -105.73 98.31 8.02 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 104.44 -2.43 . . . . 0.0 104.44 169.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -80.05 100.93 8.41 Favored 'General case' 0 N--CA 1.484 1.242 0 CA-C-N 114.617 -1.174 . . . . 0.0 112.286 -167.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -108.91 113.39 26.25 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 64.2 tp -111.12 -49.5 3.01 Favored 'General case' 0 CA--C 1.564 1.504 0 CA-C-N 114.589 -1.187 . . . . 0.0 111.332 176.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 85.9 t90 -129.99 101.98 6.07 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 -175.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . 0.519 29.8 m 63.43 -88.02 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 114.895 1.443 . . . . 0.0 114.895 177.146 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 8.6 p -79.99 147.86 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 C-N-CA 124.002 0.921 . . . . 0.0 112.241 -174.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 25.6 pttm -80.04 153.29 28.9 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 121.699 0.762 . . . . 0.0 112.991 173.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -131.24 120.2 22.89 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 -175.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 56.1 m-80 -58.63 -51.66 68.97 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 114.617 1.34 . . . . 0.0 114.617 -178.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 67.2 m -97.14 148.97 22.51 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-O 122.612 1.196 . . . . 0.0 111.664 176.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 15.4 tp -65.63 -37.75 87.46 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 172.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -65.41 -32.92 74.8 Favored 'General case' 0 CA--C 1.572 1.81 0 N-CA-C 114.22 1.193 . . . . 0.0 114.22 168.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -63.19 -41.85 99.24 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-N 120.602 1.547 . . . . 0.0 114.416 169.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 63.5 tp -58.69 -43.44 89.99 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 169.086 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 25.7 t -58.62 -64.07 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 C-N-CA 124.447 1.099 . . . . 0.0 112.388 171.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -59.66 -30.91 69.08 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 116.116 1.895 . . . . 0.0 116.116 -174.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 85.4 t80 -63.61 -54.07 41.67 Favored 'General case' 0 CA--C 1.567 1.597 0 CA-C-N 118.815 0.734 . . . . 0.0 112.217 168.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . 0.27 62.2 m-70 -69.92 -9.32 54.58 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 117.891 2.552 . . . . 0.0 117.891 177.354 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -51.23 -38.87 54.89 Favored 'General case' 0 N--CA 1.501 2.087 0 CA-C-N 120.726 1.603 . . . . 0.0 113.603 167.154 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 70.0 m -102.91 -34.01 9.12 Favored 'General case' 0 CA--C 1.564 1.505 0 N-CA-C 114.668 1.358 . . . . 0.0 114.668 169.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 30.3 m -90.17 152.43 21.11 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-N 120.681 1.582 . . . . 0.0 111.178 -176.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 29.9 t -74.87 136.58 41.5 Favored 'General case' 0 CA--C 1.56 1.346 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 177.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 88.3 t -71.79 -50.91 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.903 169.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 58.5 m -91.18 154.58 19.22 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-O 122.162 0.982 . . . . 0.0 111.745 -178.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 10.4 mpt_? -71.9 -54.04 11.29 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.709 177.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 24.6 t30 -72.6 -59.56 2.66 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 173.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -79.89 150.62 30.52 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-N 118.793 0.724 . . . . 0.0 112.221 -177.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -101.45 96.97 7.49 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.383 0.673 . . . . 0.0 109.488 -179.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 5.2 mp -109.11 110.71 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 -179.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 19.3 m-30 -108.26 137.34 46.4 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 173.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 9.7 mp -85.47 128.92 34.89 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 123.36 0.664 . . . . 0.0 112.097 -169.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 4.9 mpt_? -129.07 173.77 10.15 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-O 123.409 1.576 . . . . 0.0 109.843 172.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -84.46 157.97 21.18 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-N 114.739 -1.119 . . . . 0.0 113.711 -177.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 29.2 pt -75.36 153.07 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 CA-C-O 121.704 0.764 . . . . 0.0 112.936 178.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 . . . . . 0 N--CA 1.485 1.305 0 CA-C-O 123.977 1.846 . . . . 0.0 108.847 -178.483 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.452 0 N-CA-C 111.617 -0.593 . . . . 0.0 111.617 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 82.5 p -93.97 100.6 12.71 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.088 0.555 . . . . 0.0 110.841 -176.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 68.6 p-90 -76.58 -39.35 52.91 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 116.109 1.892 . . . . 0.0 116.109 176.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -84.05 129.26 34.92 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-N 119.464 1.029 . . . . 0.0 110.646 -174.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -135.5 101.87 4.94 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 105.582 -2.006 . . . . 0.0 105.582 171.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -78.81 108.7 2.71 Favored Glycine 0 CA--C 1.541 1.661 0 CA-C-N 115.969 -0.56 . . . . 0.0 113.317 -173.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . 0.27 2.8 tppp? 66.36 80.27 0.22 Allowed 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 124.878 1.271 . . . . 0.0 112.178 -175.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.25 130.61 23.71 Favored Pre-proline 0 CA--C 1.572 1.792 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 -175.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -63.74 144.75 89.86 Favored 'Trans proline' 0 CA--C 1.559 1.729 0 C-N-CA 122.842 2.361 . . . . 0.0 114.532 -176.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 60.1 ttt180 -59.74 -39.32 84.36 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 116.672 2.101 . . . . 0.0 116.672 -172.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.8 -45.59 85.62 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 115.1 1.519 . . . . 0.0 115.1 174.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -62.92 -36.72 84.34 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 115.038 1.495 . . . . 0.0 115.038 169.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.46 -44.11 97.69 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 115.59 1.7 . . . . 0.0 115.59 169.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -66.07 -38.83 89.29 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 115.26 1.578 . . . . 0.0 115.26 173.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -65.39 -43.88 89.25 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 115.467 1.654 . . . . 0.0 115.467 173.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -66.38 -43.15 86.71 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 114.464 1.283 . . . . 0.0 114.464 174.501 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 94.7 mt -69.8 -31.36 69.23 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 116.179 1.918 . . . . 0.0 116.179 173.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 89.7 p -61.67 -35.78 78.94 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-N 120.245 1.384 . . . . 0.0 114.433 168.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -63.2 -35.22 79.6 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 114.664 1.357 . . . . 0.0 114.664 168.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -63.57 120.88 12.59 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-O 122.23 1.014 . . . . 0.0 111.706 169.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 17.1 ptm180 -70.65 -18.08 62.85 Favored 'General case' 0 CA--C 1.567 1.623 0 N-CA-C 119.061 2.986 . . . . 0.0 119.061 -179.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 51.7 m80 -89.5 146.54 24.55 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-N 119.651 1.114 . . . . 0.0 113.455 -168.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -80.77 110.57 16.41 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.189 -1.411 . . . . 0.0 107.189 169.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 120.1 -17.45 9.88 Favored Glycine 0 CA--C 1.552 2.357 0 CA-C-O 117.347 -1.807 . . . . 0.0 116.043 -168.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.99 113.25 3.36 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-N 120.847 2.323 . . . . 0.0 112.964 -173.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -126.8 168.59 14.22 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 115.167 1.543 . . . . 0.0 115.167 -168.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.5 pp -149.8 134.6 17.75 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 167.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 53.7 mt -85.64 113.25 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 174.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 61.7 ttp85 -95.15 138.86 32.3 Favored 'General case' 0 N--CA 1.483 1.195 0 CA-C-N 114.203 -1.362 . . . . 0.0 110.02 175.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -84.4 125.98 32.81 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 169.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 50.7 m -67.06 128.51 36.62 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.709 0.804 . . . . 0.0 112.411 -169.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -65.76 -49.66 67.57 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 -173.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.4 t -63.96 -40.36 96.25 Favored 'General case' 0 CA--C 1.564 1.51 0 N-CA-C 115.563 1.69 . . . . 0.0 115.563 170.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -112.28 93.53 22.7 Favored Pre-proline 0 CA--C 1.564 1.511 0 CA-C-O 118.02 -0.99 . . . . 0.0 109.779 178.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.58 132.87 21.2 Favored 'Trans proline' 0 C--N 1.371 1.747 0 C-N-CA 123.132 2.555 . . . . 0.0 112.076 177.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 98.91 -34.81 5.08 Favored Glycine 0 CA--C 1.554 2.512 0 CA-C-O 119.055 -0.858 . . . . 0.0 114.464 -168.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -79.24 139.25 37.96 Favored 'General case' 0 N--CA 1.485 1.325 0 CA-C-N 118.529 1.164 . . . . 0.0 109.356 171.026 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -110.0 162.64 14.34 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 122.223 1.011 . . . . 0.0 111.305 -176.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 71.0 m -136.55 117.15 13.88 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 173.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 26.6 tp -79.71 106.62 11.87 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 124.254 1.022 . . . . 0.0 108.731 176.173 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.6 m -95.75 95.69 8.47 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 -170.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 17.6 t -112.08 122.0 65.57 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 -170.196 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -83.29 102.97 12.32 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 169.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -126.14 117.19 22.62 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 107.807 -1.182 . . . . 0.0 107.807 177.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 86.43 -106.35 3.09 Favored Glycine 0 N--CA 1.48 1.621 0 N-CA-C 110.547 -1.021 . . . . 0.0 110.547 -175.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 31.6 t30 -141.88 56.51 1.49 Allowed 'General case' 0 CA--C 1.566 1.574 0 C-N-CA 122.843 0.457 . . . . 0.0 109.999 169.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -158.92 133.2 7.82 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 178.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 56.6 t -91.85 109.94 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 173.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -106.43 115.67 30.62 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.795 0.838 . . . . 0.0 108.786 -169.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 18.4 m-70 -94.88 96.73 9.52 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 114.918 -1.037 . . . . 0.0 108.375 -172.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -94.32 122.13 36.56 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 -174.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -73.79 120.05 18.85 Favored 'General case' 0 N--CA 1.487 1.379 0 CA-C-O 121.445 0.64 . . . . 0.0 111.809 -169.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 76.9 t -97.35 101.4 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 N-CA-C 105.658 -1.979 . . . . 0.0 105.658 175.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -100.13 149.51 23.44 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.284 0.634 . . . . 0.0 110.522 177.588 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 54.7 mtp180 -110.54 128.0 55.45 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 123.164 0.586 . . . . 0.0 110.316 -169.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . 0.277 4.2 p-10 -83.74 -68.64 0.7 Allowed 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 179.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -91.13 -114.56 1.83 Allowed Glycine 0 N--CA 1.482 1.734 0 CA-C-N 119.352 0.978 . . . . 0.0 112.189 -176.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -81.1 -71.65 0.46 Allowed 'General case' 0 N--CA 1.487 1.386 0 CA-C-O 118.357 -0.83 . . . . 0.0 110.607 173.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -134.7 68.1 0.54 Allowed Glycine 0 N--CA 1.48 1.607 0 CA-C-N 118.731 0.696 . . . . 0.0 112.28 169.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 2.3 mppt? -107.28 97.11 6.91 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 105.751 -1.944 . . . . 0.0 105.751 171.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -86.88 110.89 20.29 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 114.309 -1.314 . . . . 0.0 109.343 -169.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -130.56 136.2 48.67 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 121.319 0.58 . . . . 0.0 110.324 -173.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -128.27 -51.51 1.3 Allowed 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 124.067 0.947 . . . . 0.0 111.972 177.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 58.7 t90 -94.46 -79.6 0.42 Allowed 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 124.368 1.067 . . . . 0.0 110.331 -172.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 95.0 t -128.84 -77.77 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 -175.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 10.8 p -80.87 138.86 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 C-N-CA 123.508 0.723 . . . . 0.0 111.362 -172.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.77 147.71 31.74 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 121.648 0.737 . . . . 0.0 112.511 179.309 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -124.26 108.81 12.64 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 -169.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 17.7 p30 -55.79 -30.38 61.24 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 118.195 2.665 . . . . 0.0 118.195 177.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 30.9 t -124.97 146.3 49.46 Favored 'General case' 0 N--CA 1.484 1.237 0 CA-C-O 121.942 0.877 . . . . 0.0 111.436 -177.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 89.6 mt -83.77 103.56 13.16 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 105.356 -2.091 . . . . 0.0 105.356 168.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . 0.273 28.5 t-20 145.98 -57.79 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 104.53 -2.396 . . . . 0.0 104.53 -168.557 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -56.91 -42.44 79.93 Favored 'General case' 0 CA--C 1.574 1.868 0 C-N-CA 124.26 1.024 . . . . 0.0 113.597 168.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 8.4 tt -55.46 -49.44 72.48 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 114.888 1.44 . . . . 0.0 114.888 169.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . 0.276 3.6 m -63.43 -51.47 70.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 CA-C-N 119.224 0.92 . . . . 0.0 113.223 178.188 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -64.67 -33.56 76.24 Favored 'General case' 0 CA--C 1.568 1.664 0 N-CA-C 115.182 1.549 . . . . 0.0 115.182 -176.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 69.2 t80 -62.12 -59.33 5.22 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-N 119.749 1.159 . . . . 0.0 112.826 169.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 60.7 m-70 -68.94 -9.38 51.7 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 117.906 2.558 . . . . 0.0 117.906 178.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 54.5 ttm-85 -53.76 -31.42 48.55 Favored 'General case' 0 CA--C 1.574 1.868 0 N-CA-C 115.074 1.509 . . . . 0.0 115.074 168.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 70.9 m -116.49 -24.32 7.9 Favored 'General case' 0 CA--C 1.57 1.716 0 C-N-CA 125.071 1.348 . . . . 0.0 114.216 169.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 61.0 m -90.13 151.67 21.48 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-N 120.837 1.653 . . . . 0.0 110.577 177.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 32.2 t -68.35 129.09 38.88 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 178.305 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 35.1 t -71.42 -48.79 51.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 CA-C-O 118.296 -0.859 . . . . 0.0 111.95 172.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 15.7 p -91.08 168.41 11.66 Favored 'General case' 0 N--CA 1.487 1.411 0 CA-C-N 119.235 0.925 . . . . 0.0 112.122 -179.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 30.7 mmt180 -72.11 -58.42 3.44 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 177.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 23.8 t30 -75.64 -61.72 1.82 Allowed 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 65.3 mt-30 -79.95 150.35 30.53 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 118.638 0.654 . . . . 0.0 112.225 -175.006 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -83.09 121.37 26.95 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 122.843 0.457 . . . . 0.0 110.553 169.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 3.6 mp -123.64 108.82 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 104.248 -2.501 . . . . 0.0 104.248 172.107 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 18.3 m-30 -113.93 108.19 16.71 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 105.771 -1.937 . . . . 0.0 105.771 179.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . 0.35 1.0 OUTLIER -76.15 170.27 16.62 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 116.381 1.993 . . . . 0.0 116.381 -169.15 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 3.9 tmt_? -160.04 138.22 10.16 Favored 'General case' 0 CA--C 1.56 1.355 0 N-CA-C 104.621 -2.362 . . . . 0.0 104.621 -169.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -67.8 172.39 5.42 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.115 -1.616 . . . . 0.0 114.248 178.353 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 18.3 pt -70.62 156.91 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 O-C-N 120.883 -1.136 . . . . 0.0 113.184 -175.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 . . . . . 0 N--CA 1.489 1.486 0 CA-C-O 122.859 1.314 . . . . 0.0 109.869 176.554 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.454 0 N-CA-C 111.558 -0.617 . . . . 0.0 111.558 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 89.6 p -84.67 108.51 17.43 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 123.153 0.581 . . . . 0.0 111.324 -179.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 62.9 p-90 -155.46 -44.14 0.08 Allowed 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 178.066 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 44.6 t80 -82.79 137.82 34.22 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 120.249 1.386 . . . . 0.0 111.799 -173.124 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -118.64 -73.2 0.65 Allowed 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.43 176.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 108.32 84.85 1.67 Allowed Glycine 0 N--CA 1.481 1.697 0 CA-C-N 118.923 0.783 . . . . 0.0 111.397 -176.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.532 ' H ' ' H ' ' A' ' 87' ' ' GLU 0.304 33.0 ttmt 64.98 79.98 0.24 Allowed 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 125.179 1.392 . . . . 0.0 114.109 178.878 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 17.8 pt -126.14 157.79 68.58 Favored Pre-proline 0 CA--C 1.579 2.083 0 C-N-CA 124.257 1.023 . . . . 0.0 109.396 171.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -75.79 165.07 30.83 Favored 'Trans proline' 0 CA--C 1.564 1.976 0 C-N-CA 122.712 2.274 . . . . 0.0 115.092 -178.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 30.0 ttm180 -63.98 -45.49 88.85 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 115.913 1.82 . . . . 0.0 115.913 176.052 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.23 -46.42 87.0 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 115.337 1.606 . . . . 0.0 115.337 -179.278 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm -62.97 -34.71 78.09 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 115.265 1.58 . . . . 0.0 115.265 169.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.88 -42.66 90.04 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 115.442 1.645 . . . . 0.0 115.442 170.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -60.54 -44.91 95.58 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 115.212 1.56 . . . . 0.0 115.212 170.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -58.66 -50.76 72.69 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 114.979 1.474 . . . . 0.0 114.979 175.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -63.96 -49.15 73.68 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 114.708 1.373 . . . . 0.0 114.708 176.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 8.8 mp -71.02 -33.12 70.04 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 116.563 2.06 . . . . 0.0 116.563 -176.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 66.7 m -60.17 -33.09 71.71 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 116.08 1.882 . . . . 0.0 116.08 169.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 57.4 mtmt -64.1 -33.64 76.22 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 115.934 1.827 . . . . 0.0 115.934 169.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -64.5 127.01 29.66 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.62 1.168 . . . . 0.0 113.009 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -62.29 -21.47 65.26 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 119.042 2.978 . . . . 0.0 119.042 177.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 43.4 m80 -89.38 132.71 34.84 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 119.264 0.938 . . . . 0.0 111.09 -169.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -75.55 105.36 6.54 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 171.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 124.78 -7.78 8.25 Favored Glycine 0 CA--C 1.553 2.448 0 CA-C-O 116.91 -2.05 . . . . 0.0 116.523 -169.029 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.12 111.92 2.77 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 121.229 2.515 . . . . 0.0 111.968 -171.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 20.1 p90 -128.24 161.96 28.11 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 115.427 1.64 . . . . 0.0 115.427 -168.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.1 pp -139.69 136.06 33.84 Favored 'General case' 0 CA--C 1.555 1.14 0 CA-C-N 113.919 -1.491 . . . . 0.0 107.884 168.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 62.7 mt -97.13 106.5 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 169.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 46.7 ptt85 -95.45 157.18 16.01 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 114.45 -1.25 . . . . 0.0 110.324 169.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.532 ' H ' ' H ' ' A' ' 64' ' ' LYS . 28.8 tt0 -85.06 135.87 33.81 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.431 -0.793 . . . . 0.0 109.163 169.484 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 93.3 p -68.67 121.9 17.41 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-O 121.026 0.441 . . . . 0.0 110.815 172.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -68.66 -39.37 80.69 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 116.684 2.105 . . . . 0.0 116.684 -175.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.5 t -63.1 -22.13 66.65 Favored 'General case' 0 CA--C 1.569 1.697 0 N-CA-C 115.864 1.802 . . . . 0.0 115.864 169.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -135.45 94.78 15.06 Favored Pre-proline 0 CA--C 1.563 1.446 0 CA-C-N 120.011 1.278 . . . . 0.0 109.027 177.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -70.33 134.06 25.93 Favored 'Trans proline' 0 C--N 1.372 1.795 0 C-N-CA 123.038 2.492 . . . . 0.0 111.933 176.042 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 101.31 -38.05 3.33 Favored Glycine 0 CA--C 1.555 2.574 0 CA-C-O 119.382 -0.676 . . . . 0.0 113.48 -168.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -79.46 130.91 35.86 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 118.182 0.991 . . . . 0.0 109.182 169.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -107.42 169.38 8.61 Favored 'General case' 0 N--CA 1.486 1.374 0 CA-C-O 122.439 1.114 . . . . 0.0 110.861 -178.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 69.4 m -141.65 117.64 10.56 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -179.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 31.2 tp -79.96 113.65 18.28 Favored 'General case' 0 CA--C 1.559 1.314 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 169.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 9.6 m -97.91 104.0 15.99 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 173.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.8 p -124.76 117.63 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 CA-C-N 118.964 0.802 . . . . 0.0 109.0 -171.047 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -74.62 140.0 44.01 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.931 169.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 15.8 t80 -157.0 95.12 1.48 Allowed 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 171.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 70.04 74.87 0.62 Allowed Glycine 0 CA--C 1.544 1.902 0 CA-C-O 119.421 -0.655 . . . . 0.0 114.64 -177.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . 0.366 9.7 t-20 78.62 -58.14 0.44 Allowed 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 116.664 2.098 . . . . 0.0 116.664 -179.026 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -91.16 142.85 27.3 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 123.898 0.879 . . . . 0.0 112.019 -169.32 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 41.6 t -102.27 113.21 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 N-CA-C 106.592 -1.632 . . . . 0.0 106.592 -178.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -96.83 117.99 32.29 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.897 0.879 . . . . 0.0 109.334 -176.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 10.5 m-70 -97.98 97.26 8.77 Favored 'General case' 0 CA--C 1.554 1.119 0 CA-C-N 114.991 -1.004 . . . . 0.0 108.443 -174.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -100.86 135.11 42.83 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 124.061 0.945 . . . . 0.0 109.11 -178.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 12.2 mmmm -79.44 125.34 29.42 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.858 -0.526 . . . . 0.0 111.957 -178.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 96.2 t -85.7 112.94 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 106.484 -1.672 . . . . 0.0 106.484 171.017 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -114.85 145.06 42.57 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.231 0.612 . . . . 0.0 110.528 -175.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -97.11 158.26 15.52 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -175.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -123.1 100.85 7.08 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 169.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 90.73 -112.72 4.14 Favored Glycine 0 CA--C 1.542 1.722 0 CA-C-O 120.082 -0.288 . . . . 0.0 113.417 176.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -84.75 -74.18 0.4 Allowed 'General case' 0 N--CA 1.488 1.462 0 CA-C-O 118.886 -0.578 . . . . 0.0 112.215 -173.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -148.22 74.36 0.28 Allowed Glycine 0 N--CA 1.479 1.518 0 N-CA-C 110.499 -1.04 . . . . 0.0 110.499 173.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -122.38 89.57 3.14 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 -177.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -80.02 115.61 19.69 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.791 -169.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 26.5 p90 -124.86 120.42 31.63 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 174.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -87.86 -59.94 2.1 Favored 'General case' 0 CA--C 1.562 1.424 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.086 169.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 39.3 t90 -80.25 -81.44 0.12 Allowed 'General case' 0 CA--C 1.56 1.343 0 C-N-CA 124.82 1.248 . . . . 0.0 110.383 -175.053 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.1 m -140.44 -53.76 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 C-N-CA 124.012 0.925 . . . . 0.0 110.937 176.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 3.4 m -79.78 140.85 16.14 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.458 0 C-N-CA 124.411 1.084 . . . . 0.0 112.096 -174.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.45 152.34 18.5 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 -171.047 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -146.22 119.91 9.2 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 -171.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -55.91 -40.46 73.09 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 116.575 2.065 . . . . 0.0 116.575 -177.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 27.1 t -102.63 153.07 20.46 Favored 'General case' 0 N--CA 1.485 1.321 0 CA-C-N 119.031 0.832 . . . . 0.0 111.483 174.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 82.9 mt -67.85 -32.64 73.31 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 169.028 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -64.26 -39.69 94.46 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 119.701 1.137 . . . . 0.0 113.803 170.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -60.56 -44.12 96.5 Favored 'General case' 0 CA--C 1.573 1.854 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 169.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 49.3 tp -55.5 -44.84 76.96 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 115.411 1.634 . . . . 0.0 115.411 169.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . 0.282 10.9 m -63.73 -51.5 69.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 CA-C-N 120.124 1.329 . . . . 0.0 113.232 175.11 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -63.34 -36.05 82.41 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 114.625 1.343 . . . . 0.0 114.625 -175.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 90.3 t80 -60.61 -52.72 63.97 Favored 'General case' 0 CA--C 1.57 1.733 0 CA-C-N 119.404 1.002 . . . . 0.0 112.03 168.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 50.7 m-70 -72.7 -9.13 58.27 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 118.728 2.862 . . . . 0.0 118.728 178.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 88.1 mtt-85 -59.84 -29.04 68.0 Favored 'General case' 0 CA--C 1.575 1.937 0 CA-C-N 120.156 1.344 . . . . 0.0 113.447 167.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 69.7 m -103.01 -39.57 6.85 Favored 'General case' 0 CA--C 1.569 1.696 0 C-N-CA 125.022 1.329 . . . . 0.0 113.094 168.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 34.3 m -90.53 156.38 18.21 Favored 'General case' 0 N--CA 1.498 1.94 0 CA-C-N 120.142 1.337 . . . . 0.0 112.031 -176.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 35.3 t -75.07 132.91 41.62 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 3.3 m -78.88 -38.39 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 114.976 1.472 . . . . 0.0 114.976 169.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 16.8 t -79.82 -40.12 29.25 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 116.61 2.078 . . . . 0.0 116.61 -169.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 15.9 tpt180 84.49 115.88 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 124.777 1.231 . . . . 0.0 108.903 -170.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . 0.351 59.2 m-80 83.62 -58.53 0.14 Allowed 'General case' 0 N--CA 1.499 2.017 0 C-N-CA 124.507 1.123 . . . . 0.0 112.604 -172.496 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 -79.57 126.63 31.13 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 170.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 76.3 mm-40 -90.1 96.03 10.48 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 -175.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 29.6 mm -111.68 109.4 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 105.787 -1.931 . . . . 0.0 105.787 -173.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -111.95 121.93 46.36 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 -173.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 10.5 mp -75.1 136.62 41.12 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 -168.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 81.7 mmt-85 -131.54 153.57 49.71 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 125.368 1.467 . . . . 0.0 108.381 178.468 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -79.31 157.39 27.71 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.822 -1.174 . . . . 0.0 112.798 -177.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 8.5 mt -69.35 146.68 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 C-N-CA 123.934 0.894 . . . . 0.0 109.886 -179.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 123.946 1.832 . . . . 0.0 108.149 178.726 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.33 0 N-CA-C 111.284 -0.727 . . . . 0.0 111.284 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 47.2 m 65.8 95.79 0.05 Allowed 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 124.696 1.198 . . . . 0.0 112.008 -178.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . 0.418 70.5 p-90 58.27 -17.87 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 120.732 3.604 . . . . 0.0 120.732 -174.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 44.4 t80 -96.95 131.6 43.59 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.78 0.832 . . . . 0.0 110.153 -169.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -107.73 -65.89 1.08 Allowed 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.352 173.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.04 77.66 1.31 Allowed Glycine 0 N--CA 1.482 1.744 0 CA-C-N 118.952 0.796 . . . . 0.0 112.375 -179.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . 0.298 61.9 tttt 71.24 71.74 0.18 Allowed 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 124.62 1.168 . . . . 0.0 113.936 175.049 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 14.9 pt -118.95 154.74 53.22 Favored Pre-proline 0 CA--C 1.576 1.959 0 C-N-CA 124.056 0.942 . . . . 0.0 109.069 170.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -75.71 172.65 15.91 Favored 'Trans proline' 0 CA--C 1.564 2.015 0 C-N-CA 122.702 2.268 . . . . 0.0 114.34 178.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 28.6 ttm180 -61.63 -43.86 98.07 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 115.915 1.82 . . . . 0.0 115.915 175.407 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -65.3 -43.38 91.29 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 115.805 1.78 . . . . 0.0 115.805 178.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -67.39 -32.54 73.51 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 115.362 1.615 . . . . 0.0 115.362 169.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.26 -42.14 88.95 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 115.328 1.603 . . . . 0.0 115.328 169.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -62.81 -42.4 99.7 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 114.346 1.239 . . . . 0.0 114.346 169.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -53.41 -48.07 69.03 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 115.395 1.628 . . . . 0.0 115.395 170.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 37.3 mmt -62.37 -48.32 80.31 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 173.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 88.8 mt -76.22 -9.82 58.93 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 117.775 2.509 . . . . 0.0 117.775 178.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 72.4 m -57.69 -38.73 75.71 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 115.875 1.805 . . . . 0.0 115.875 170.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -60.39 -33.27 72.24 Favored 'General case' 0 CA--C 1.571 1.778 0 N-CA-C 116.061 1.875 . . . . 0.0 116.061 169.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -71.7 111.46 6.99 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.165 0.986 . . . . 0.0 112.122 -171.511 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 13.4 ptp180 -74.28 -17.57 60.84 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 117.86 2.541 . . . . 0.0 117.86 173.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 48.4 m80 -89.63 137.29 32.45 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 119.248 0.931 . . . . 0.0 111.338 -168.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -77.56 115.23 17.15 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 122.951 0.5 . . . . 0.0 110.444 176.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 114.63 -23.19 12.27 Favored Glycine 0 CA--C 1.551 2.321 0 CA-C-O 117.269 -1.851 . . . . 0.0 116.246 -169.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.4 113.47 1.99 Allowed 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 120.66 2.23 . . . . 0.0 113.238 -176.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 27.3 p90 -130.18 165.07 23.11 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 115.828 1.788 . . . . 0.0 115.828 -168.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.0 pp -142.16 125.25 16.3 Favored 'General case' 0 CA--C 1.557 1.233 0 N-CA-C 106.803 -1.555 . . . . 0.0 106.803 168.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 59.9 mt -87.07 114.12 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 106.584 -1.636 . . . . 0.0 106.584 173.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 49.3 ptt85 -99.78 159.2 15.24 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-N 114.931 -1.031 . . . . 0.0 111.042 170.028 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -86.58 135.28 33.49 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 168.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 84.1 p -65.32 128.45 35.9 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-O 121.275 0.559 . . . . 0.0 111.733 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -62.46 -45.46 92.94 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 116.017 1.858 . . . . 0.0 116.017 -169.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 68.1 m -69.72 -33.15 72.09 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 116.053 1.871 . . . . 0.0 116.053 171.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -119.18 101.04 50.01 Favored Pre-proline 0 CA--C 1.563 1.469 0 CA-C-N 120.018 1.281 . . . . 0.0 110.939 -175.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -59.46 -32.16 95.92 Favored 'Trans proline' 0 C--N 1.369 1.655 0 N-CA-C 119.934 3.013 . . . . 0.0 119.934 174.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -87.23 44.82 3.33 Favored Glycine 0 CA--C 1.553 2.41 0 N-CA-C 115.247 0.859 . . . . 0.0 115.247 169.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -160.13 130.19 5.37 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 106.187 -1.783 . . . . 0.0 106.187 -178.079 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 -103.9 174.73 5.74 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 122.106 0.955 . . . . 0.0 111.181 172.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 62.0 m -149.03 120.4 7.88 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 -179.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 36.4 tp -79.93 110.51 15.37 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.803 0.841 . . . . 0.0 109.173 170.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.6 m -96.16 103.1 14.98 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 105.696 -1.964 . . . . 0.0 105.696 174.201 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.4 p -122.21 121.12 63.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 CA-C-O 121.471 0.653 . . . . 0.0 109.809 -169.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 58.1 tptt -82.68 98.63 9.15 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 124.32 1.048 . . . . 0.0 109.941 177.22 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -120.08 93.31 4.01 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -175.658 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 69.28 65.18 2.68 Favored Glycine 0 CA--C 1.544 1.845 0 N-CA-C 115.658 1.023 . . . . 0.0 115.658 175.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . 0.269 26.8 t30 54.78 41.83 31.63 Favored 'General case' 0 CA--C 1.574 1.903 0 N-CA-C 116.419 2.007 . . . . 0.0 116.419 -174.207 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -160.77 129.92 4.81 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.541 -0.724 . . . . 0.0 109.738 176.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 41.1 t -94.71 106.04 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 178.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -98.73 119.6 37.75 Favored 'General case' 0 N--CA 1.484 1.27 0 CA-C-O 121.704 0.764 . . . . 0.0 109.37 -177.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 13.0 m-70 -99.19 109.23 21.93 Favored 'General case' 0 CA--C 1.552 1.034 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 -176.278 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -114.49 127.94 56.07 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -176.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -74.29 132.32 41.98 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-O 121.785 0.802 . . . . 0.0 112.751 -177.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 92.9 t -101.97 103.99 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 N-CA-C 104.859 -2.274 . . . . 0.0 104.859 174.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -104.44 132.35 50.78 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.517 0.727 . . . . 0.0 110.129 -173.5 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -84.96 161.88 19.62 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 121.895 0.855 . . . . 0.0 112.306 -179.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 20.7 p-10 -79.69 -39.41 31.35 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 169.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -178.53 -79.09 0.06 OUTLIER Glycine 0 CA--C 1.539 1.586 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 -173.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -74.83 -69.34 0.47 Allowed 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 177.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -174.18 68.78 0.1 OUTLIER Glycine 0 N--CA 1.479 1.529 0 CA-C-N 118.874 0.761 . . . . 0.0 113.294 175.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -120.38 102.33 8.39 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 105.38 -2.082 . . . . 0.0 105.38 171.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -81.4 121.39 26.17 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.439 1.095 . . . . 0.0 110.488 -169.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 44.0 p90 -130.03 122.0 27.54 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 121.31 0.576 . . . . 0.0 109.616 174.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 5.0 tt -89.36 -65.2 1.04 Allowed 'General case' 0 N--CA 1.488 1.472 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.126 169.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 20.2 t90 -82.32 -61.78 1.8 Allowed 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 124.446 1.098 . . . . 0.0 112.55 -172.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . 0.258 11.2 p -149.76 -67.36 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 CA-C-N 118.849 0.75 . . . . 0.0 110.114 -178.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 3.4 m -79.64 141.91 14.68 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.419 0 C-N-CA 124.291 1.036 . . . . 0.0 112.301 -171.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 10.0 ptpp? -96.64 156.24 16.43 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -173.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -145.14 132.12 20.27 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.248 -169.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 -50.61 -41.73 55.16 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 117.922 2.564 . . . . 0.0 117.922 177.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 90.5 p -122.65 159.33 28.11 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-O 122.688 1.233 . . . . 0.0 111.877 178.079 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 61.3 mt -62.69 -31.91 72.9 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 115.186 1.551 . . . . 0.0 115.186 169.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -65.36 -36.09 82.96 Favored 'General case' 0 CA--C 1.571 1.755 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 169.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -63.26 -47.83 80.75 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-N 119.86 1.209 . . . . 0.0 113.707 169.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 60.5 tp -59.53 -38.61 81.45 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 115.724 1.75 . . . . 0.0 115.724 169.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . 0.265 0.3 OUTLIER -67.04 -53.9 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 CA-C-N 119.743 1.156 . . . . 0.0 113.251 -179.595 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -57.97 -33.83 69.3 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 115.454 1.65 . . . . 0.0 115.454 172.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -57.28 -55.45 34.62 Favored 'General case' 0 CA--C 1.566 1.579 0 CA-C-N 119.353 0.979 . . . . 0.0 113.021 168.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . 0.265 52.7 m-70 -74.72 -9.47 58.59 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 117.944 2.572 . . . . 0.0 117.944 177.379 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 94.2 mtt-85 -62.15 -33.35 74.33 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-N 120.883 1.674 . . . . 0.0 112.962 167.168 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 70.6 m -97.03 -40.15 8.99 Favored 'General case' 0 CA--C 1.563 1.476 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 170.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 60.7 m -90.8 154.03 19.81 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-N 120.093 1.315 . . . . 0.0 111.527 179.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 33.0 t -75.75 134.66 40.41 Favored 'General case' 0 CA--C 1.559 1.323 0 CA-C-O 121.462 0.648 . . . . 0.0 112.556 177.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 45.5 t -70.24 -48.29 62.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 CA-C-N 115.419 -0.81 . . . . 0.0 112.202 172.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 57.7 m -122.62 154.71 37.64 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-O 122.262 1.03 . . . . 0.0 110.721 -177.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 85.2 mtt85 -77.18 -39.88 47.32 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 115.171 1.545 . . . . 0.0 115.171 -177.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 22.2 m120 -74.58 -66.45 0.74 Allowed 'General case' 0 N--CA 1.495 1.82 0 CA-C-N 119.902 1.228 . . . . 0.0 111.876 174.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 35.7 mm-40 -80.07 126.02 30.53 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 118.909 0.777 . . . . 0.0 109.2 170.08 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 3.2 pm0 -94.43 86.46 4.86 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 123.018 0.527 . . . . 0.0 110.477 -176.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 4.0 mp -85.77 122.04 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -169.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -121.73 117.11 25.81 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 106.428 -1.694 . . . . 0.0 106.428 176.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 11.2 mp -70.85 134.4 47.29 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 -168.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 62.7 mmt-85 -132.28 162.71 30.31 Favored 'General case' 0 CA--C 1.564 1.515 0 C-N-CA 124.963 1.305 . . . . 0.0 109.221 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -76.33 158.89 31.05 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.907 -1.12 . . . . 0.0 113.801 176.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.1 pp -76.65 161.73 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -177.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 . . . . . 0 N--CA 1.484 1.262 0 CA-C-O 124.021 1.867 . . . . 0.0 108.096 177.618 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.35 0 N-CA-C 111.261 -0.736 . . . . 0.0 111.261 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 74.3 m -83.96 105.09 14.57 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 123.099 0.56 . . . . 0.0 109.745 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 1.6 p90 -141.46 -29.81 0.62 Allowed 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 116.248 1.944 . . . . 0.0 116.248 -169.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 72.2 t80 -118.32 124.19 47.17 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 178.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -119.39 66.43 0.79 Allowed 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 121.272 0.558 . . . . 0.0 110.82 -179.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 53.59 -119.42 10.83 Favored Glycine 0 CA--C 1.547 2.065 0 N-CA-C 118.803 2.281 . . . . 0.0 118.803 169.433 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -141.56 96.53 3.0 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 -171.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.01 149.94 75.19 Favored Pre-proline 0 CA--C 1.572 1.815 0 CA-C-O 118.502 -0.761 . . . . 0.0 109.733 176.255 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -66.49 172.11 9.63 Favored 'Trans proline' 0 CA--C 1.563 1.956 0 C-N-CA 123.005 2.47 . . . . 0.0 114.556 172.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 59.2 ttt-85 -60.32 -41.9 94.48 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 116.08 1.882 . . . . 0.0 116.08 -177.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -66.08 -44.27 84.96 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 115.466 1.654 . . . . 0.0 115.466 176.077 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -63.24 -33.99 76.68 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 115.674 1.731 . . . . 0.0 115.674 170.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.47 -43.15 95.11 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 115.302 1.593 . . . . 0.0 115.302 169.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -61.22 -43.97 98.02 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 114.943 1.46 . . . . 0.0 114.943 170.261 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -57.18 -44.0 83.17 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 115.626 1.713 . . . . 0.0 115.626 173.095 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 37.9 mmt -63.04 -48.3 79.33 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 114.528 1.307 . . . . 0.0 114.528 172.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 95.1 mt -73.25 -12.12 60.75 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 117.518 2.414 . . . . 0.0 117.518 175.272 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 69.6 m -63.0 -37.85 88.82 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-N 120.507 1.503 . . . . 0.0 113.966 168.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt -60.59 -33.78 73.24 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 115.386 1.624 . . . . 0.0 115.386 169.206 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -71.2 117.04 12.22 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 124.478 1.111 . . . . 0.0 111.225 178.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -79.53 -17.39 54.15 Favored 'General case' 0 CA--C 1.569 1.677 0 N-CA-C 117.531 2.419 . . . . 0.0 117.531 172.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 45.8 m80 -89.53 133.22 34.69 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 119.198 0.908 . . . . 0.0 111.929 -168.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -71.63 123.31 22.22 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 122.953 0.501 . . . . 0.0 110.833 174.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 107.8 -20.22 31.95 Favored Glycine 0 CA--C 1.549 2.179 0 CA-C-O 117.576 -1.68 . . . . 0.0 116.51 -169.257 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.69 123.06 19.07 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-N 120.192 1.996 . . . . 0.0 111.746 -173.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 24.7 p90 -137.36 158.13 45.08 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -168.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.3 pp -137.47 127.99 26.68 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 168.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 74.1 mt -87.64 113.6 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 105.62 -1.993 . . . . 0.0 105.62 175.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 4.1 ptm180 -90.05 149.96 22.29 Favored 'General case' 0 N--CA 1.484 1.27 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.065 170.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -85.87 128.43 34.82 Favored 'General case' 0 CA--C 1.56 1.33 0 N-CA-C 106.795 -1.558 . . . . 0.0 106.795 168.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 50.3 m -65.01 132.61 49.7 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 -169.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -64.67 -50.98 64.92 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 114.666 1.358 . . . . 0.0 114.666 -174.401 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 95.9 p -65.09 -38.95 92.39 Favored 'General case' 0 CA--C 1.562 1.441 0 N-CA-C 116.083 1.883 . . . . 0.0 116.083 169.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -114.73 95.16 39.98 Favored Pre-proline 0 CA--C 1.563 1.474 0 CA-C-N 119.66 1.118 . . . . 0.0 109.553 -179.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -72.39 135.09 23.84 Favored 'Trans proline' 0 C--N 1.371 1.749 0 C-N-CA 123.068 2.512 . . . . 0.0 112.215 178.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 97.41 -40.49 2.52 Favored Glycine 0 CA--C 1.552 2.383 0 CA-C-O 119.308 -0.718 . . . . 0.0 113.627 -168.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -79.12 131.4 36.22 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 124.076 0.95 . . . . 0.0 109.168 176.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -100.54 168.52 9.67 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 122.102 0.953 . . . . 0.0 111.847 -170.363 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 58.8 m -147.31 123.62 10.93 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 174.106 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 26.8 tp -79.95 108.47 13.55 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.078 0.951 . . . . 0.0 109.635 175.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.2 m -91.38 107.26 19.08 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 106.12 -1.808 . . . . 0.0 106.12 172.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.2 p -131.06 116.11 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 -170.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.19 113.92 20.35 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.334 175.422 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -132.95 116.39 16.38 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 177.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 89.48 -83.33 1.41 Allowed Glycine 0 N--CA 1.481 1.654 0 CA-C-N 116.243 -0.435 . . . . 0.0 112.063 -179.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 10.6 p30 -138.62 -26.4 0.88 Allowed 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 115.533 1.679 . . . . 0.0 115.533 170.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -98.05 142.42 29.77 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 124.051 0.94 . . . . 0.0 110.668 -171.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 47.8 t -85.64 110.01 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 N-CA-C 106.533 -1.654 . . . . 0.0 106.533 172.061 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 61.9 mt-30 -104.42 113.92 27.8 Favored 'General case' 0 N--CA 1.484 1.26 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.002 -169.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 16.8 m-70 -96.26 102.49 14.28 Favored 'General case' 0 CA--C 1.553 1.071 0 CA-C-N 114.766 -1.106 . . . . 0.0 108.262 -174.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -106.78 123.24 47.85 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 -179.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 43.6 mtpt -77.2 122.95 25.76 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 121.687 0.756 . . . . 0.0 112.101 -169.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 98.7 t -92.35 96.94 6.66 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.591 0 N-CA-C 105.026 -2.213 . . . . 0.0 105.026 177.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 62.1 mt -90.52 135.65 33.56 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 -168.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 27.1 mtp-105 -87.42 144.01 26.96 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 122.014 0.912 . . . . 0.0 112.888 176.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -86.57 -53.67 4.84 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-N 114.474 -1.239 . . . . 0.0 114.304 176.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -165.71 -86.08 0.06 OUTLIER Glycine 0 N--CA 1.48 1.628 0 CA-C-N 119.895 1.225 . . . . 0.0 113.287 -173.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -68.29 -63.79 0.99 Allowed 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 114.531 1.308 . . . . 0.0 114.531 -172.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -161.97 13.75 0.13 Allowed Glycine 0 CA--C 1.552 2.398 0 N-CA-C 116.728 1.451 . . . . 0.0 116.728 170.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -91.96 150.58 20.93 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-N 119.204 1.502 . . . . 0.0 109.084 177.494 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -137.98 137.11 37.59 Favored 'General case' 0 N--CA 1.487 1.411 0 CA-C-N 114.944 -1.026 . . . . 0.0 109.517 -174.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -123.73 122.55 38.38 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 124.764 1.226 . . . . 0.0 108.693 -172.011 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 60.7 tp -100.6 -56.96 2.21 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.028 169.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 84.6 t90 -133.43 103.66 6.05 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 -174.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . 0.405 22.3 t 78.74 -82.8 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 C-N-CA 124.155 0.982 . . . . 0.0 111.982 171.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 16.9 m -81.37 140.72 16.16 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.399 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -169.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -90.14 138.45 31.51 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.49 0.662 . . . . 0.0 111.106 169.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -172.25 139.5 1.05 Allowed 'General case' 0 N--CA 1.488 1.454 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.623 -169.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -79.47 74.91 6.09 Favored 'General case' 0 N--CA 1.501 2.086 0 CA-C-O 123.76 1.743 . . . . 0.0 109.784 170.225 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 89.3 p -102.94 63.76 0.83 Allowed 'General case' 0 CA--C 1.554 1.122 1 N-CA-C 124.09 4.848 . . . . 0.0 124.09 -166.501 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 75.7 mt -101.52 86.62 3.0 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 104.224 -2.51 . . . . 0.0 104.224 167.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . 0.261 25.0 t-20 133.99 -61.05 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.045 0 C-N-CA 127.39 2.276 . . . . 0.0 105.479 -167.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -56.09 -45.58 79.34 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 115.367 1.617 . . . . 0.0 115.367 177.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 15.7 tp -66.44 -37.79 85.95 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 177.13 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 44.7 t -58.4 -65.38 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 C-N-CA 124.585 1.154 . . . . 0.0 111.548 174.318 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -66.73 -35.56 80.4 Favored 'General case' 0 CA--C 1.569 1.677 0 N-CA-C 114.826 1.417 . . . . 0.0 114.826 -173.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -58.59 -59.42 5.42 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 124.419 1.088 . . . . 0.0 113.649 169.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -74.83 -8.56 56.8 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 117.872 2.545 . . . . 0.0 117.872 177.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 46.1 ttm-85 -52.32 -30.83 30.23 Favored 'General case' 0 CA--C 1.577 1.992 0 N-CA-C 114.818 1.414 . . . . 0.0 114.818 168.23 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 68.0 m -105.05 -40.94 5.72 Favored 'General case' 0 CA--C 1.569 1.673 0 C-N-CA 124.995 1.318 . . . . 0.0 113.037 168.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 53.7 m -90.51 150.58 21.72 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-N 120.199 1.363 . . . . 0.0 111.859 -176.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 21.7 t -80.63 133.68 35.78 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.107 -0.995 . . . . 0.0 112.828 -178.13 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 8.3 m -66.62 -42.65 90.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 115.398 1.629 . . . . 0.0 115.398 170.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 14.3 t -112.65 -45.56 3.22 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 -174.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . 0.302 80.3 mtm180 77.15 71.98 0.06 Allowed 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 125.337 1.455 . . . . 0.0 110.64 -169.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . 0.269 14.4 p-10 -149.58 -65.91 0.22 Allowed 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.996 -1.112 . . . . 0.0 107.996 173.271 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 -96.29 7.42 46.5 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 115.531 1.678 . . . . 0.0 115.531 169.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 83.0 mm-40 56.73 70.31 0.66 Allowed 'General case' 0 N--CA 1.495 1.821 0 C-N-CA 125.196 1.399 . . . . 0.0 111.945 -169.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 5.0 mp -85.68 116.68 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 -169.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -118.64 137.87 52.99 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-N 115.125 -0.943 . . . . 0.0 108.965 -174.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 11.1 mp -83.92 115.84 22.49 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 -168.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -122.97 150.62 42.75 Favored 'General case' 0 CA--C 1.563 1.457 0 C-N-CA 125.437 1.495 . . . . 0.0 109.322 179.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -74.28 156.5 37.12 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.737 -1.227 . . . . 0.0 113.23 178.225 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.1 pp -72.82 164.51 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 -171.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 . . . . . 0 N--CA 1.485 1.281 0 CA-C-O 123.953 1.835 . . . . 0.0 108.394 179.029 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.358 0 N-CA-C 111.299 -0.72 . . . . 0.0 111.299 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 32.4 t -82.04 112.19 18.88 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 122.983 0.513 . . . . 0.0 109.849 178.087 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 1.2 p90 -136.86 -34.33 0.75 Allowed 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 116.167 1.914 . . . . 0.0 116.167 -169.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -80.82 117.82 21.8 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-N 121.466 1.939 . . . . 0.0 109.788 179.409 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -129.76 94.39 3.73 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 104.942 -2.244 . . . . 0.0 104.942 174.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -77.49 125.45 7.32 Favored Glycine 0 CA--C 1.54 1.609 0 C-N-CA 123.156 0.408 . . . . 0.0 113.577 -170.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.446 ' H ' ' H ' ' A' ' 87' ' ' GLU 0.376 64.5 pttt 52.9 63.48 2.22 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 115.335 1.606 . . . . 0.0 115.335 -175.378 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -107.95 127.21 28.08 Favored Pre-proline 0 CA--C 1.574 1.897 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 -173.617 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -68.88 160.91 47.85 Favored 'Trans proline' 0 CA--C 1.56 1.785 0 C-N-CA 123.156 2.571 . . . . 0.0 115.574 -172.164 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 16.1 ttm180 -73.33 -35.8 66.09 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 117.327 2.343 . . . . 0.0 117.327 -170.024 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.75 -41.6 97.98 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 115.401 1.63 . . . . 0.0 115.401 169.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -68.27 -40.99 81.7 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 114.497 1.295 . . . . 0.0 114.497 169.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.71 -41.36 98.12 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 115.271 1.582 . . . . 0.0 115.271 172.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -67.13 -44.67 79.27 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 170.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -53.01 -38.88 62.71 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 116.085 1.883 . . . . 0.0 116.085 171.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.51 -62.63 1.56 Allowed 'General case' 0 CA--C 1.566 1.568 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 169.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.1 mp -70.0 -50.71 38.82 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 117.411 2.374 . . . . 0.0 117.411 -168.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 60.2 p -60.3 -34.26 73.52 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 115.921 1.823 . . . . 0.0 115.921 174.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -72.63 -30.54 64.41 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 115.644 1.72 . . . . 0.0 115.644 170.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -50.72 133.23 26.14 Favored 'General case' 0 CA--C 1.556 1.19 0 N-CA-C 114.977 1.473 . . . . 0.0 114.977 176.681 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.12 -23.49 62.17 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 118.613 2.82 . . . . 0.0 118.613 174.159 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 42.9 m80 -89.43 131.51 35.45 Favored 'General case' 0 N--CA 1.484 1.225 0 CA-C-N 119.23 0.923 . . . . 0.0 110.667 -169.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -80.99 102.22 10.03 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 174.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 124.02 4.86 7.7 Favored Glycine 0 CA--C 1.552 2.405 0 CA-C-O 116.652 -2.193 . . . . 0.0 115.991 -168.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.02 116.26 6.95 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-N 121.682 2.741 . . . . 0.0 112.913 -169.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -129.8 161.41 30.8 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 118.135 2.643 . . . . 0.0 118.135 -168.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.8 pp -144.09 154.11 42.86 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 114.126 -1.397 . . . . 0.0 109.422 168.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.0 mp -112.67 124.05 68.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 178.085 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -90.36 167.49 12.61 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 124.477 1.111 . . . . 0.0 112.199 174.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.446 ' H ' ' H ' ' A' ' 64' ' ' LYS . 35.7 tt0 -129.15 116.11 18.71 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 106.139 -1.801 . . . . 0.0 106.139 169.183 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 64.7 m -76.85 134.73 38.94 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -170.295 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -74.62 -56.51 4.74 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-N 115.415 -0.811 . . . . 0.0 112.999 178.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.5 t -61.43 -39.56 91.23 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 116.068 1.877 . . . . 0.0 116.068 177.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -102.92 99.76 14.82 Favored Pre-proline 0 CA--C 1.565 1.523 0 CA-C-O 117.83 -1.081 . . . . 0.0 108.647 170.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -75.22 126.95 10.16 Favored 'Trans proline' 0 C--N 1.371 1.712 0 C-N-CA 123.016 2.477 . . . . 0.0 112.545 -175.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 82.2 6.62 88.63 Favored Glycine 0 CA--C 1.555 2.57 0 N-CA-C 118.189 2.036 . . . . 0.0 118.189 -169.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -98.12 116.54 30.56 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-N 119.813 1.806 . . . . 0.0 107.302 171.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -99.0 151.25 21.13 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.787 -0.819 . . . . 0.0 108.787 -178.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 43.2 m -132.93 112.4 11.84 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.505 -0.747 . . . . 0.0 110.175 -175.244 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 26.4 tp -79.3 105.77 10.85 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-O 121.967 0.889 . . . . 0.0 108.979 174.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 15.4 m -89.44 93.6 9.57 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 173.028 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.9 p -112.08 125.95 69.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 -174.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -77.16 129.15 35.59 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 114.813 -1.085 . . . . 0.0 111.049 173.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -137.75 114.65 10.68 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 87.22 -92.37 1.8 Allowed Glycine 0 N--CA 1.481 1.687 0 N-CA-C 112.056 -0.418 . . . . 0.0 112.056 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 10.8 p-10 -130.44 -22.48 2.74 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 115.434 1.642 . . . . 0.0 115.434 169.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -108.49 146.34 33.34 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 124.484 1.114 . . . . 0.0 110.251 -173.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 9.7 p -84.76 123.63 39.28 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.537 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.101 179.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -109.86 122.68 48.09 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 124.093 0.957 . . . . 0.0 108.901 -178.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 12.0 m-70 -103.73 96.37 6.66 Favored 'General case' 0 CA--C 1.555 1.14 0 CA-C-O 121.804 0.812 . . . . 0.0 108.864 -169.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -92.31 141.64 28.34 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 124.431 1.092 . . . . 0.0 110.233 -177.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -96.05 114.73 26.47 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.429 0.633 . . . . 0.0 110.369 -176.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 81.5 t -84.07 124.29 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 174.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 55.0 mt -102.12 136.13 42.49 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.014 -176.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 36.4 mtm180 -108.89 129.87 55.42 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 122.715 0.406 . . . . 0.0 110.368 176.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -97.31 103.32 15.24 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 123.165 0.586 . . . . 0.0 110.555 176.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 90.3 -110.7 3.81 Favored Glycine 0 N--CA 1.481 1.661 0 CA-C-O 120.072 -0.293 . . . . 0.0 113.325 174.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -79.95 -69.49 0.58 Allowed 'General case' 0 N--CA 1.487 1.419 0 CA-C-O 118.762 -0.637 . . . . 0.0 112.53 -176.127 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -159.05 75.03 0.21 Allowed Glycine 0 N--CA 1.477 1.424 0 CA-C-N 118.661 0.664 . . . . 0.0 111.581 171.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -117.63 91.37 3.55 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 -173.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -79.53 115.0 18.89 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 123.82 0.848 . . . . 0.0 111.686 -168.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -131.23 130.62 43.15 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.595 0.758 . . . . 0.0 109.041 177.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 41.8 tp -95.25 -54.76 3.3 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 118.548 -0.739 . . . . 0.0 110.38 169.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 45.2 m0 -74.7 -86.68 0.04 OUTLIER 'General case' 0 CA--C 1.565 1.553 0 CA-C-N 119.359 0.981 . . . . 0.0 110.537 173.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 10.0 m -145.06 -47.53 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 C-N-CA 124.56 1.144 . . . . 0.0 111.107 -175.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 14.0 p -79.54 130.85 35.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 CA-C-N 119.217 0.917 . . . . 0.0 110.212 -175.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.21 161.04 15.9 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-O 122.605 1.193 . . . . 0.0 114.205 -170.615 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -148.31 114.34 5.8 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 105.021 -2.215 . . . . 0.0 105.021 -170.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -57.84 -24.38 57.16 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 119.198 3.036 . . . . 0.0 119.198 -169.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 78.8 p -125.93 165.51 18.62 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-N 120.543 1.52 . . . . 0.0 113.096 179.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 33.0 mt -52.04 -47.69 64.93 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 115.23 1.567 . . . . 0.0 115.23 169.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 18.7 m-80 -63.12 -43.69 97.73 Favored 'General case' 0 CA--C 1.564 1.516 0 N-CA-C 114.071 1.137 . . . . 0.0 114.071 174.048 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -58.94 -50.81 72.66 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 115.388 1.625 . . . . 0.0 115.388 177.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 58.4 tp -61.32 -49.04 78.59 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-N 120.019 1.281 . . . . 0.0 114.237 174.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . 0.311 1.6 p -69.96 -37.5 72.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 -178.125 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -61.55 -34.55 75.76 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-N 119.976 1.262 . . . . 0.0 113.597 168.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 45.8 t80 -58.13 -54.07 51.07 Favored 'General case' 0 CA--C 1.569 1.673 0 CA-C-O 117.546 -1.216 . . . . 0.0 111.984 167.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . 0.347 21.9 m-70 -71.66 -8.99 57.54 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 118.69 2.848 . . . . 0.0 118.69 173.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 55.1 mtp85 -75.94 -22.06 56.37 Favored 'General case' 0 CA--C 1.576 1.958 0 CA-C-N 119.876 1.217 . . . . 0.0 112.926 167.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 70.6 m -100.73 -46.31 5.2 Favored 'General case' 0 CA--C 1.565 1.554 0 C-N-CA 125.005 1.322 . . . . 0.0 112.962 169.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 91.3 m -86.21 154.32 21.38 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 124.948 1.299 . . . . 0.0 110.121 173.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 27.4 t -80.48 148.02 30.64 Favored 'General case' 0 N--CA 1.483 1.203 0 O-C-N 121.131 -0.981 . . . . 0.0 113.238 177.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 77.1 t -75.17 -54.02 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 168.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 34.2 t -87.77 104.05 16.2 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-N 118.909 0.777 . . . . 0.0 109.071 174.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . 0.273 0.2 OUTLIER -59.95 -40.39 88.85 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 117.711 2.486 . . . . 0.0 117.711 -175.722 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -72.1 -63.5 1.13 Allowed 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 177.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -94.09 104.24 16.28 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 172.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 -77.45 115.28 17.09 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 -168.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -120.82 133.45 67.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 179.278 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -119.15 153.47 34.83 Favored 'General case' 0 N--CA 1.497 1.875 0 CA-C-O 121.88 0.848 . . . . 0.0 111.337 -170.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 9.5 mp -88.05 143.66 26.95 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 -169.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 29.1 mmm180 -132.87 142.91 49.18 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 124.929 1.292 . . . . 0.0 109.175 -179.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -76.1 143.37 41.31 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.379 -0.826 . . . . 0.0 111.285 176.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 25.0 pt -62.82 146.32 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 -176.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 . . . . . 0 N--CA 1.484 1.261 0 CA-C-O 123.91 1.814 . . . . 0.0 109.435 175.799 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.31 0 N-CA-C 111.632 -0.587 . . . . 0.0 111.632 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 26.3 t -89.34 95.28 10.22 Favored 'General case' 0 N--CA 1.486 1.331 0 CA-C-O 121.476 0.655 . . . . 0.0 110.605 -174.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 1.6 p90 -144.75 -46.9 0.24 Allowed 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.79 0.836 . . . . 0.0 111.976 -177.047 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -82.09 124.76 30.12 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-N 119.931 1.241 . . . . 0.0 110.101 -179.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -128.59 75.14 1.61 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 123.473 0.483 . . . . 0.0 110.253 -175.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 59.05 -114.58 6.26 Favored Glycine 0 N--CA 1.485 1.937 0 C-N-CA 123.873 0.749 . . . . 0.0 114.817 173.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -144.99 111.45 5.69 Favored 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 169.157 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 43.2 pt -122.99 152.2 62.6 Favored Pre-proline 0 CA--C 1.572 1.821 0 CA-C-O 118.525 -0.75 . . . . 0.0 110.476 -179.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -58.78 165.56 7.98 Favored 'Trans proline' 0 CA--C 1.56 1.777 0 C-N-CA 123.4 2.733 . . . . 0.0 116.745 171.367 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 25.7 ttm180 -62.92 -40.67 98.32 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 114.898 1.444 . . . . 0.0 114.898 169.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -62.56 -41.14 98.72 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 115.728 1.751 . . . . 0.0 115.728 170.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 3.1 tppp? -64.79 -37.63 88.25 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 115.201 1.556 . . . . 0.0 115.201 169.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.91 -41.68 91.12 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 115.682 1.734 . . . . 0.0 115.682 171.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -64.65 -38.78 92.16 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 114.816 1.413 . . . . 0.0 114.816 169.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -60.57 -52.83 63.49 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 114.509 1.3 . . . . 0.0 114.509 172.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 40.4 tpp -61.11 -44.07 97.92 Favored 'General case' 0 CA--C 1.564 1.492 0 N-CA-C 115.793 1.775 . . . . 0.0 115.793 175.386 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 92.6 mt -72.6 -20.72 61.24 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 116.616 2.08 . . . . 0.0 116.616 172.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 22.9 t -60.24 -37.6 80.88 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-N 121.079 1.763 . . . . 0.0 113.497 168.512 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -59.42 -37.17 77.36 Favored 'General case' 0 CA--C 1.57 1.737 0 N-CA-C 114.525 1.306 . . . . 0.0 114.525 168.7 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -69.12 114.36 7.32 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 124.322 1.049 . . . . 0.0 110.855 170.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 -76.24 -13.44 60.17 Favored 'General case' 0 CA--C 1.569 1.708 0 N-CA-C 117.816 2.524 . . . . 0.0 117.816 173.326 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 46.3 m80 -89.72 143.82 26.49 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 -168.402 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -71.79 130.84 42.07 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-N 114.448 -1.251 . . . . 0.0 110.818 170.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.92 -18.62 46.57 Favored Glycine 0 CA--C 1.552 2.377 0 N-CA-C 118.239 2.055 . . . . 0.0 118.239 -172.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.13 119.38 10.73 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-N 120.399 2.1 . . . . 0.0 112.345 -176.227 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 22.2 p90 -128.56 157.51 41.03 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 114.815 1.413 . . . . 0.0 114.815 -168.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.8 pp -138.05 139.33 39.51 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 168.239 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 70.3 mt -98.16 117.86 43.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 106.316 -1.735 . . . . 0.0 106.316 177.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 3.0 ptm180 -97.94 149.2 22.67 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.319 0.648 . . . . 0.0 111.481 170.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -96.35 137.86 34.8 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 168.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 67.4 m -69.9 138.92 52.86 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-O 121.637 0.732 . . . . 0.0 112.694 -176.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -70.69 -53.71 14.63 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 -174.075 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.0 t -62.99 -37.33 86.73 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 115.916 1.821 . . . . 0.0 115.916 172.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -121.01 92.9 48.75 Favored Pre-proline 0 CA--C 1.562 1.441 0 CA-C-N 119.635 1.107 . . . . 0.0 110.102 175.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -62.59 132.53 38.31 Favored 'Trans proline' 0 C--N 1.371 1.742 0 C-N-CA 123.361 2.707 . . . . 0.0 113.25 170.02 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 105.0 -33.73 6.34 Favored Glycine 0 CA--C 1.551 2.302 0 CA-C-O 118.697 -1.057 . . . . 0.0 114.543 -168.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -79.68 108.51 13.28 Favored 'General case' 0 N--CA 1.486 1.348 0 CA-C-N 119.427 1.614 . . . . 0.0 108.484 174.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 5.0 m-30 -93.93 158.65 15.54 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 121.716 0.77 . . . . 0.0 110.451 -174.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 74.6 m -139.81 115.48 10.1 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 176.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 36.4 tp -81.19 107.35 13.91 Favored 'General case' 0 CA--C 1.561 1.368 0 C-N-CA 124.907 1.283 . . . . 0.0 109.687 179.015 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.8 m -95.5 105.53 17.51 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 -174.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 31.9 t -117.57 123.67 72.04 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.171 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 -171.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 12.9 tmtt? -89.24 89.37 7.89 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 123.088 0.555 . . . . 0.0 110.203 178.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -105.49 108.22 19.62 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -177.297 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 86.95 -98.75 2.39 Favored Glycine 0 N--CA 1.479 1.556 0 N-CA-C 111.435 -0.666 . . . . 0.0 111.435 177.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 12.4 p30 -138.44 44.1 2.12 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 123.178 0.591 . . . . 0.0 112.384 169.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -152.84 134.62 14.63 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 -177.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 57.3 t -95.23 109.85 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 106.298 -1.741 . . . . 0.0 106.298 177.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 60.6 mt-30 -109.11 114.83 28.89 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-O 121.909 0.861 . . . . 0.0 109.306 -169.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -94.15 119.64 33.26 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 114.636 -1.166 . . . . 0.0 109.168 -172.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -118.03 119.33 34.47 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 -174.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -75.5 108.31 8.23 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 -169.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 86.6 t -84.04 117.56 29.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 -178.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 54.5 mt -100.78 137.82 38.66 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.139 -174.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 56.4 mtp180 -109.72 126.37 53.65 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 -179.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . 0.262 3.0 p30 -79.91 -56.94 3.9 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 114.463 1.283 . . . . 0.0 114.463 -179.031 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 179.16 137.86 3.06 Favored Glycine 0 CA--C 1.54 1.632 0 CA-C-N 119.607 1.094 . . . . 0.0 112.759 -176.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . 0.347 . . 80.6 -77.89 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 124.98 1.312 . . . . 0.0 112.497 -178.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -165.96 72.79 0.17 Allowed Glycine 0 N--CA 1.478 1.483 0 N-CA-C 111.696 -0.562 . . . . 0.0 111.696 171.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -126.47 162.22 26.11 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 124.169 0.988 . . . . 0.0 109.93 -178.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -143.99 114.97 7.84 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 -176.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -124.98 123.19 39.35 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 175.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -110.33 -58.79 2.03 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 123.77 0.828 . . . . 0.0 110.621 173.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 8.4 t90 -98.66 -62.97 1.17 Allowed 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 124.076 0.95 . . . . 0.0 112.893 -168.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 30.7 m -129.66 -56.38 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 CA-C-N 119.085 0.857 . . . . 0.0 112.41 -175.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 9.9 p -118.93 161.29 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 CA-C-O 122.278 1.037 . . . . 0.0 111.485 -169.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.52 153.04 29.84 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-O 122.025 0.917 . . . . 0.0 113.121 175.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -142.88 120.69 11.93 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 -175.22 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -59.45 -59.74 4.96 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -175.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 83.6 p -89.58 155.56 19.18 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-O 122.542 1.163 . . . . 0.0 112.378 175.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 10.3 tp -63.01 -33.0 74.49 Favored 'General case' 0 CA--C 1.568 1.661 0 N-CA-C 115.019 1.489 . . . . 0.0 115.019 170.05 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -63.35 -36.77 84.81 Favored 'General case' 0 CA--C 1.569 1.705 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 169.053 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.13 -42.1 94.17 Favored 'General case' 0 N--CA 1.497 1.875 0 CA-C-N 120.622 1.555 . . . . 0.0 114.17 169.758 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 16.8 tp -57.13 -46.89 82.31 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 169.101 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 45.4 t -59.17 -58.2 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 C-N-CA 124.385 1.074 . . . . 0.0 112.878 173.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -60.74 -32.11 71.4 Favored 'General case' 0 CA--C 1.567 1.632 0 N-CA-C 115.655 1.724 . . . . 0.0 115.655 -175.076 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -60.68 -57.8 11.18 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-N 119.665 1.12 . . . . 0.0 112.877 169.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 81.8 m-70 -72.85 -8.91 57.77 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 117.891 2.552 . . . . 0.0 117.891 176.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 50.5 ttm-85 -58.59 -31.71 68.29 Favored 'General case' 0 CA--C 1.576 1.95 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 168.046 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 69.6 m -104.16 -36.15 7.78 Favored 'General case' 0 CA--C 1.567 1.619 0 C-N-CA 124.978 1.311 . . . . 0.0 113.619 169.123 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 87.1 m -90.12 150.84 21.87 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-N 119.912 1.233 . . . . 0.0 110.826 -178.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 21.6 t -72.39 123.75 23.72 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.197 -0.939 . . . . 0.0 111.734 175.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.9 p -70.27 -27.78 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 N-CA-C 115.868 1.803 . . . . 0.0 115.868 175.293 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 66.3 m -135.25 136.88 42.03 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-N 119.562 1.073 . . . . 0.0 109.082 173.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? -80.13 93.97 5.91 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.815 0.816 . . . . 0.0 110.637 -178.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . 0.252 13.2 p-10 -165.9 -65.78 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 124.663 1.185 . . . . 0.0 108.044 -178.685 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -113.7 -139.03 0.38 Allowed 'General case' 0 CA--C 1.567 1.625 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 172.186 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.21 77.83 1.79 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.307 -0.871 . . . . 0.0 109.146 175.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 3.7 mp -86.7 108.48 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 -170.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 19.6 m-30 -114.72 138.4 50.77 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-N 115.331 -0.849 . . . . 0.0 109.523 -172.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 10.7 mp -85.27 108.11 17.62 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.276 -171.075 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 93.5 mtt180 -123.37 168.07 12.99 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 122.369 1.08 . . . . 0.0 109.485 -175.115 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -81.79 158.75 24.0 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 115.11 1.522 . . . . 0.0 115.11 -170.049 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 36.1 pt -81.29 162.04 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 CA-C-N 114.727 -1.124 . . . . 0.0 112.883 -179.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 . . . . . 0 N--CA 1.485 1.311 0 CA-C-O 122.776 1.274 . . . . 0.0 109.328 -176.765 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 1.807 0 CA-C-O 121.371 0.428 . . . . 0.0 113.323 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . 0.274 92.5 p 54.42 86.75 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 115.733 1.753 . . . . 0.0 115.733 175.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . 0.253 66.6 p-90 -78.27 -48.8 14.93 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 115.544 1.683 . . . . 0.0 115.544 -178.532 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -85.78 135.65 33.65 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-N 119.255 0.934 . . . . 0.0 111.403 -173.408 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -111.68 -88.0 0.53 Allowed 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 175.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 158.12 -150.1 20.77 Favored Glycine 0 N--CA 1.483 1.816 0 CA-C-N 119.634 1.106 . . . . 0.0 112.735 -179.163 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -83.14 89.57 6.96 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 121.566 0.698 . . . . 0.0 111.217 -178.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -124.42 146.62 52.71 Favored Pre-proline 0 CA--C 1.573 1.852 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 169.365 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -50.69 164.79 0.5 Allowed 'Trans proline' 0 C--N 1.37 1.681 0 C-N-CA 123.411 2.74 . . . . 0.0 117.717 175.03 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 60.1 ttt180 -59.06 -41.95 89.17 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 169.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -65.28 -45.45 84.41 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 115.193 1.553 . . . . 0.0 115.193 173.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 48.2 mmtm -61.92 -37.09 83.36 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 115.646 1.721 . . . . 0.0 115.646 171.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.87 -44.85 91.86 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 115.31 1.596 . . . . 0.0 115.31 169.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -61.34 -40.08 92.93 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 115.351 1.611 . . . . 0.0 115.351 170.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -61.54 -46.24 90.76 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 173.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 37.3 mmt -60.12 -46.57 89.17 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 114.898 1.444 . . . . 0.0 114.898 172.211 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 96.7 mt -72.59 -32.38 65.94 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 115.989 1.848 . . . . 0.0 115.989 177.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 21.1 t -56.02 -35.33 66.72 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 115.662 1.727 . . . . 0.0 115.662 169.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -60.15 -39.47 86.46 Favored 'General case' 0 CA--C 1.568 1.662 0 N-CA-C 115.215 1.561 . . . . 0.0 115.215 169.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -67.88 134.68 51.26 Favored 'General case' 0 CA--C 1.556 1.174 0 CA-C-O 123.5 1.619 . . . . 0.0 113.404 -177.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.43 -10.2 59.34 Favored 'General case' 0 CA--C 1.567 1.597 0 N-CA-C 119.12 3.007 . . . . 0.0 119.12 176.421 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 6.9 m80 -89.62 137.51 32.27 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-N 120.149 1.34 . . . . 0.0 110.836 -169.002 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -80.39 103.54 10.32 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 173.2 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 110.59 11.41 19.5 Favored Glycine 0 CA--C 1.551 2.321 0 CA-C-O 117.56 -1.689 . . . . 0.0 115.758 -168.074 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.66 120.09 14.89 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-N 120.64 2.22 . . . . 0.0 110.244 -175.339 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 14.6 p90 -132.82 157.32 45.29 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 -169.044 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.3 pp -140.8 125.58 18.08 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 168.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 84.6 mt -83.78 108.84 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 170.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 48.2 ptt85 -89.88 156.89 18.16 Favored 'General case' 0 CA--C 1.557 1.215 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.192 171.134 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -88.86 134.03 34.08 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 169.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 50.5 m -65.85 132.47 48.74 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 123.107 0.563 . . . . 0.0 111.133 -178.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -55.54 -55.01 36.87 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 116.903 2.186 . . . . 0.0 116.903 -168.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.3 t -72.39 -45.81 58.08 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 174.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -108.77 108.67 60.96 Favored Pre-proline 0 CA--C 1.562 1.422 0 CA-C-O 117.652 -1.166 . . . . 0.0 110.559 -174.161 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -69.48 -32.24 20.13 Favored 'Trans proline' 0 C--N 1.369 1.609 0 N-CA-C 118.724 2.548 . . . . 0.0 118.724 178.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -65.58 -19.21 66.71 Favored Glycine 0 CA--C 1.559 2.832 0 N-CA-C 117.023 1.569 . . . . 0.0 117.023 168.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -92.16 138.05 31.86 Favored 'General case' 0 N--CA 1.484 1.27 0 CA-C-N 118.337 1.068 . . . . 0.0 108.696 169.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -123.38 170.03 10.74 Favored 'General case' 0 CA--C 1.563 1.472 0 C-N-CA 124.23 1.012 . . . . 0.0 108.907 179.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 73.1 m -143.01 119.79 11.2 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.096 -1.002 . . . . 0.0 108.43 -179.299 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 43.7 tp -79.88 105.66 11.32 Favored 'General case' 0 N--CA 1.486 1.347 0 CA-C-O 121.844 0.831 . . . . 0.0 109.331 171.176 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.8 m -91.35 109.65 20.93 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 173.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.7 p -137.69 137.49 45.27 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 CA-C-N 119.148 0.885 . . . . 0.0 108.778 -169.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -72.88 118.86 16.34 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.009 0.433 . . . . 0.0 110.996 171.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 4.4 m-30 -107.71 97.69 7.39 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 169.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 81.94 -98.76 1.96 Allowed Glycine 0 CA--C 1.541 1.677 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 -169.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 70.1 m-80 -126.89 -17.6 4.88 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 115.01 1.485 . . . . 0.0 115.01 169.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -85.73 137.88 32.5 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 119.643 1.11 . . . . 0.0 110.081 177.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 64.9 t -89.28 106.43 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 -175.082 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -101.06 124.84 47.39 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-O 121.881 0.848 . . . . 0.0 109.231 -179.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 11.9 m-70 -97.73 131.31 44.38 Favored 'General case' 0 CA--C 1.555 1.159 0 CA-C-N 114.819 -1.082 . . . . 0.0 109.153 -175.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -128.18 125.01 38.2 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 -175.623 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -80.88 117.49 21.57 Favored 'General case' 0 N--CA 1.485 1.302 0 CA-C-O 121.596 0.712 . . . . 0.0 110.903 -170.186 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 73.1 t -85.42 102.77 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 171.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.4 pp -121.91 144.13 49.04 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 123.116 0.567 . . . . 0.0 111.346 -174.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -89.65 155.82 18.98 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 114.009 1.115 . . . . 0.0 114.009 -170.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -104.41 -64.3 1.13 Allowed 'General case' 0 N--CA 1.494 1.748 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.951 169.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -97.21 -121.17 4.12 Favored Glycine 0 CA--C 1.542 1.734 0 CA-C-N 119.406 1.003 . . . . 0.0 112.883 -176.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -76.2 -65.24 0.94 Allowed 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 118.786 -0.626 . . . . 0.0 112.337 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -136.08 57.99 0.67 Allowed Glycine 0 CA--C 1.542 1.78 0 CA-C-O 119.559 -0.578 . . . . 0.0 111.928 169.31 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -106.36 88.85 2.88 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 106.978 -1.489 . . . . 0.0 106.978 -174.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -81.03 122.47 27.35 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 114.852 -1.067 . . . . 0.0 111.1 -169.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 21.3 p90 -137.57 124.17 20.96 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 120.941 0.4 . . . . 0.0 110.044 179.259 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -106.84 -47.78 3.65 Favored 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 123.887 0.875 . . . . 0.0 112.155 169.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 32.2 t90 -89.92 -68.81 0.76 Allowed 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 124.834 1.254 . . . . 0.0 110.91 -171.066 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . 0.264 13.0 p -147.6 -66.89 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 C-N-CA 123.499 0.72 . . . . 0.0 109.704 174.446 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 10.8 p -79.9 138.82 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 C-N-CA 123.941 0.896 . . . . 0.0 111.455 -171.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -83.77 158.86 21.59 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 113.715 1.005 . . . . 0.0 113.715 -178.211 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -140.46 123.13 16.26 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 -171.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 16.9 p30 -57.84 -34.44 69.7 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 117.549 2.425 . . . . 0.0 117.549 176.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 74.2 m -120.88 144.92 48.15 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 119.256 0.935 . . . . 0.0 111.678 -176.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 14.1 tp -86.53 94.27 9.39 Favored 'General case' 0 CA--C 1.563 1.46 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 169.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 12.0 t30 158.19 -60.78 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 103.295 -2.854 . . . . 0.0 103.295 -168.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -54.16 -44.6 71.59 Favored 'General case' 0 CA--C 1.574 1.877 0 C-N-CA 124.699 1.2 . . . . 0.0 114.194 168.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 10.2 tt -53.93 -53.83 47.28 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 115.763 1.764 . . . . 0.0 115.763 170.049 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.2 p -68.32 -50.13 60.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 -177.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -56.31 -32.86 65.03 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 115.516 1.673 . . . . 0.0 115.516 172.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -58.36 -53.64 55.99 Favored 'General case' 0 CA--C 1.566 1.582 0 CA-C-N 119.608 1.094 . . . . 0.0 111.85 168.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . 0.315 40.8 m-70 -71.42 -9.54 58.34 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 118.196 2.665 . . . . 0.0 118.196 176.762 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.62 -32.03 73.38 Favored 'General case' 0 CA--C 1.581 2.142 0 CA-C-N 121.041 1.746 . . . . 0.0 112.171 166.356 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 70.6 m -95.53 -44.84 7.33 Favored 'General case' 0 CA--C 1.564 1.519 0 C-N-CA 124.604 1.162 . . . . 0.0 114.035 169.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 53.8 m -90.2 155.99 18.63 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-N 119.665 1.12 . . . . 0.0 111.04 -178.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 22.7 t -86.3 133.55 33.81 Favored 'General case' 0 CA--C 1.557 1.212 0 O-C-N 121.357 -0.84 . . . . 0.0 113.197 -175.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 96.4 t -69.17 -36.5 73.31 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 CA-C-O 118.534 -0.746 . . . . 0.0 111.752 169.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 22.7 t -79.2 132.86 36.66 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-N 119.639 1.109 . . . . 0.0 109.584 169.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 32.9 ttt85 -75.0 -50.15 17.51 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 -175.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -76.42 -55.67 5.33 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 172.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -80.03 158.77 26.41 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 119.028 0.831 . . . . 0.0 112.225 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 -104.04 89.79 3.39 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 4.0 mm -112.96 141.01 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 176.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -137.3 155.9 48.9 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-O 121.988 0.899 . . . . 0.0 112.497 -169.171 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 10.0 mp -90.28 124.78 35.17 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 124.046 0.938 . . . . 0.0 112.074 -169.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -118.98 151.73 37.66 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 124.242 1.017 . . . . 0.0 110.091 171.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -81.88 149.5 28.25 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 122.136 0.97 . . . . 0.0 112.656 -177.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.6 pp -76.01 160.32 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 CA-C-N 114.861 -1.063 . . . . 0.0 113.552 -174.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 . . . . . 0 N--CA 1.485 1.294 0 CA-C-O 124.052 1.882 . . . . 0.0 106.332 170.583 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.408 0 N-CA-C 111.591 -0.604 . . . . 0.0 111.591 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 89.4 p -86.73 110.59 20.0 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.131 0.573 . . . . 0.0 111.165 -178.772 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 63.6 p-90 -152.55 -36.97 0.11 Allowed 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 115.3 1.592 . . . . 0.0 115.3 -179.941 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -81.38 136.3 35.71 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-N 120.449 1.477 . . . . 0.0 112.054 -171.68 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -121.61 -74.83 0.6 Allowed 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 174.279 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 91.91 102.46 1.39 Allowed Glycine 0 CA--C 1.542 1.734 0 CA-C-N 119.376 0.989 . . . . 0.0 111.814 -178.236 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 56.9 mmtt 63.52 69.98 0.54 Allowed 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 124.808 1.243 . . . . 0.0 113.394 -177.265 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 10.6 pt -130.1 151.82 79.01 Favored Pre-proline 0 CA--C 1.574 1.886 0 CA-C-O 118.411 -0.804 . . . . 0.0 109.676 169.876 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_exo -56.45 156.42 21.87 Favored 'Trans proline' 0 C--N 1.369 1.655 0 C-N-CA 123.369 2.713 . . . . 0.0 117.348 177.344 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 61.2 ttt180 -67.52 -36.62 81.39 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 169.489 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.77 -39.84 95.24 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 115.261 1.578 . . . . 0.0 115.261 169.651 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -64.06 -35.27 80.2 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 169.159 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.79 -52.45 63.13 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-N 119.472 1.033 . . . . 0.0 113.19 169.415 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -52.92 -37.71 61.08 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 116.348 1.981 . . . . 0.0 116.348 169.537 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -59.32 -48.65 80.83 Favored 'General case' 0 CA--C 1.566 1.574 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 170.696 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -65.45 -60.46 2.93 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 172.597 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.64 -39.44 91.42 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 117.517 2.414 . . . . 0.0 117.517 -172.576 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 56.3 m -60.61 -41.0 93.92 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 115.368 1.618 . . . . 0.0 115.368 178.719 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -68.45 -26.79 65.68 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 117.024 2.231 . . . . 0.0 117.024 169.986 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -60.52 131.1 49.67 Favored 'General case' 0 CA--C 1.556 1.19 0 CA-C-N 120.248 1.385 . . . . 0.0 113.722 176.555 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 38.9 ptt85 -69.59 -20.03 63.65 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 118.65 2.833 . . . . 0.0 118.65 179.054 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 57.8 m80 -89.51 135.58 33.52 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 119.213 0.915 . . . . 0.0 111.922 -169.141 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -77.59 103.03 7.28 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 169.731 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 124.23 -0.14 8.87 Favored Glycine 0 CA--C 1.555 2.543 0 CA-C-O 117.163 -1.91 . . . . 0.0 115.768 -168.456 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.57 113.19 4.57 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 121.158 2.479 . . . . 0.0 112.173 -169.929 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 17.8 p90 -128.11 155.79 43.86 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 116.334 1.976 . . . . 0.0 116.334 -168.713 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.1 pp -148.75 133.57 17.97 Favored 'General case' 0 N--CA 1.485 1.28 0 CA-C-N 114.33 -1.305 . . . . 0.0 108.454 169.031 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 91.8 mt -91.38 110.59 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 175.897 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 3.5 ptm180 -100.98 140.18 35.64 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 114.614 -1.175 . . . . 0.0 109.329 169.98 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.54 126.57 31.05 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.704 -0.622 . . . . 0.0 109.527 177.72 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 20.5 t -63.25 125.93 25.74 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -170.201 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -63.98 -48.58 75.85 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 175.815 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 95.8 p -59.3 -39.41 82.93 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 116.75 2.13 . . . . 0.0 116.75 171.873 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -115.84 97.7 49.59 Favored Pre-proline 0 CA--C 1.563 1.46 0 CA-C-O 117.967 -1.016 . . . . 0.0 108.997 178.748 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -72.57 135.04 23.36 Favored 'Trans proline' 0 C--N 1.372 1.787 0 C-N-CA 123.157 2.571 . . . . 0.0 112.606 -178.985 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 92.05 -39.36 3.03 Favored Glycine 0 CA--C 1.556 2.622 0 CA-C-N 115.555 -0.748 . . . . 0.0 114.415 -168.595 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -79.76 146.17 32.47 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 124.275 1.03 . . . . 0.0 110.883 175.624 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -106.85 174.16 6.01 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 122.124 0.964 . . . . 0.0 111.859 -171.697 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 57.9 m -146.61 115.81 7.0 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 177.325 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 42.6 tp -79.7 115.42 19.3 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 171.049 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 20.7 m -97.98 83.77 3.19 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 175.998 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.3 p -107.4 119.74 57.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 -171.861 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 15.1 tmtt? -81.37 149.2 28.97 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.768 174.739 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -156.99 107.35 2.29 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 169.948 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 71.38 76.14 0.6 Allowed Glycine 0 N--CA 1.483 1.776 0 N-CA-C 115.186 0.834 . . . . 0.0 115.186 173.097 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . 0.348 15.0 m120 77.06 -38.7 0.31 Allowed 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 118.179 2.659 . . . . 0.0 118.179 -179.898 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -121.43 145.27 48.09 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 124.091 0.956 . . . . 0.0 110.944 -169.688 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 5.3 p -83.02 139.0 18.4 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.54 0 CA-C-N 115.373 -0.831 . . . . 0.0 111.864 178.262 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -125.27 111.53 15.32 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-O 122.103 0.954 . . . . 0.0 108.529 -176.94 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 8.0 m-70 -99.55 128.81 45.67 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-N 114.776 -1.102 . . . . 0.0 109.358 -172.268 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -133.46 133.08 41.82 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 -175.096 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 64.2 pttt -77.74 125.86 29.99 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-O 121.507 0.67 . . . . 0.0 112.05 -179.117 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 80.7 t -94.61 108.22 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 106.287 -1.746 . . . . 0.0 106.287 179.237 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 66.0 mt -95.97 149.99 20.96 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.276 -173.368 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 82.8 mtm180 -109.51 135.95 49.68 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 122.983 0.513 . . . . 0.0 110.304 -177.79 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -108.1 110.19 21.81 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 170.635 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 89.26 -113.58 4.16 Favored Glycine 0 CA--C 1.541 1.683 0 CA-C-N 116.372 -0.376 . . . . 0.0 112.343 -178.763 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -86.4 -68.99 0.7 Allowed 'General case' 0 N--CA 1.488 1.452 0 CA-C-O 118.739 -0.648 . . . . 0.0 111.687 178.792 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -156.39 70.25 0.27 Allowed Glycine 0 N--CA 1.478 1.473 0 CA-C-N 118.602 0.637 . . . . 0.0 112.33 172.58 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -103.88 99.82 9.6 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 105.089 -2.189 . . . . 0.0 105.089 171.702 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -81.19 108.25 14.67 Favored 'General case' 0 N--CA 1.484 1.255 0 CA-C-N 114.741 -1.118 . . . . 0.0 111.756 -168.58 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 33.5 p90 -117.47 121.66 41.63 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 178.788 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 4.7 tt -101.7 -63.07 1.18 Allowed 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 123.429 0.691 . . . . 0.0 109.176 170.648 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 26.9 t90 -82.43 -64.98 1.07 Allowed 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 124.337 1.055 . . . . 0.0 112.17 -169.941 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . 0.276 13.1 p -146.17 -70.33 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 CA-C-N 118.791 0.723 . . . . 0.0 109.427 177.533 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 9.4 p -79.91 143.95 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 C-N-CA 123.879 0.872 . . . . 0.0 111.621 -174.078 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.37 155.52 22.28 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -176.184 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -141.7 114.75 8.67 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 -173.764 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 23.1 t30 -54.1 -41.08 67.88 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 116.696 2.109 . . . . 0.0 116.696 -175.998 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 95.3 p -107.29 155.27 20.14 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-O 122.649 1.214 . . . . 0.0 111.904 170.612 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 60.3 mt -64.31 -29.2 70.29 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 115.282 1.586 . . . . 0.0 115.282 169.714 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -65.33 -38.73 91.05 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-N 119.682 1.128 . . . . 0.0 113.555 169.927 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -61.63 -45.06 95.68 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 169.393 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 53.1 tp -57.02 -44.14 82.55 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 115.09 1.515 . . . . 0.0 115.09 169.68 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 22.2 t -60.32 -63.26 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 C-N-CA 124.581 1.152 . . . . 0.0 112.405 173.525 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -59.56 -28.67 67.32 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 115.984 1.846 . . . . 0.0 115.984 -176.29 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 88.8 t80 -64.35 -56.07 16.92 Favored 'General case' 0 CA--C 1.566 1.586 0 CA-C-N 119.158 0.89 . . . . 0.0 111.849 168.461 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . 0.264 68.0 m-70 -68.85 -9.08 49.4 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 117.874 2.546 . . . . 0.0 117.874 177.795 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -48.48 -39.7 23.97 Favored 'General case' 0 N--CA 1.502 2.174 0 CA-C-N 120.808 1.64 . . . . 0.0 114.47 167.563 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 68.5 m -109.04 -26.38 10.2 Favored 'General case' 0 CA--C 1.565 1.527 0 N-CA-C 114.885 1.439 . . . . 0.0 114.885 169.857 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 40.2 m -90.27 152.34 21.1 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-N 120.825 1.648 . . . . 0.0 111.031 -179.788 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 29.1 t -74.31 133.24 42.57 Favored 'General case' 0 CA--C 1.559 1.31 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 -179.962 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 39.3 t -74.93 -48.09 34.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 C-N-CA 123.593 0.757 . . . . 0.0 111.583 169.861 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 70.8 m -82.85 159.36 22.42 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-O 121.858 0.837 . . . . 0.0 112.049 178.273 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 3.7 tmm_? -70.37 -61.01 1.94 Allowed 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 118.898 -0.572 . . . . 0.0 111.94 174.881 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -74.37 -56.34 4.97 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 178.787 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 51.6 mt-30 -79.86 145.32 32.79 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 118.713 0.688 . . . . 0.0 112.087 -176.81 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -79.2 122.7 26.61 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 122.958 0.503 . . . . 0.0 110.372 169.854 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 8.3 mm -127.43 102.29 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 105.565 -2.013 . . . . 0.0 105.565 179.264 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 20.8 m-30 -113.19 114.38 26.68 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 -174.398 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 10.8 mp -67.67 131.57 45.84 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 114.794 1.405 . . . . 0.0 114.794 -168.975 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 71.4 mmt-85 -127.24 140.88 51.92 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 176.874 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -75.21 141.46 43.57 Favored 'General case' 0 CA--C 1.565 1.521 0 O-C-N 121.183 -0.948 . . . . 0.0 112.209 -175.348 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 16.4 pt -62.89 146.58 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 N-CA-C 113.968 1.099 . . . . 0.0 113.968 -176.446 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 . . . . . 0 N--CA 1.482 1.142 0 CA-C-O 123.931 1.824 . . . . 0.0 109.344 -176.118 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.31 0 N-CA-C 111.32 -0.712 . . . . 0.0 111.32 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 70.5 m -146.27 112.76 5.92 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -178.882 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . 0.294 51.2 p-90 -80.84 -55.29 4.9 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 113.464 0.913 . . . . 0.0 113.464 170.458 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -94.53 133.56 38.02 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 123.63 0.772 . . . . 0.0 109.47 173.692 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -95.6 -77.17 0.48 Allowed 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 118.665 -0.683 . . . . 0.0 109.466 174.772 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -169.96 -159.07 14.92 Favored Glycine 0 CA--C 1.541 1.677 0 CA-C-N 119.077 0.853 . . . . 0.0 112.955 -179.885 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -94.31 91.85 6.91 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 172.101 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -123.71 149.7 59.82 Favored Pre-proline 0 CA--C 1.573 1.852 0 C-N-CA 123.59 0.756 . . . . 0.0 109.194 178.449 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -69.85 177.53 5.56 Favored 'Trans proline' 0 CA--C 1.565 2.029 0 C-N-CA 122.812 2.341 . . . . 0.0 114.285 175.456 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 59.6 ttt180 -61.07 -42.42 98.46 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 115.791 1.774 . . . . 0.0 115.791 179.334 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -67.23 -41.87 84.94 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 115.717 1.747 . . . . 0.0 115.717 175.526 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -64.76 -36.48 84.45 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 169.764 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.62 -40.38 96.75 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 115.799 1.777 . . . . 0.0 115.799 169.929 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -65.52 -40.83 93.43 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 114.85 1.426 . . . . 0.0 114.85 169.926 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -60.11 -48.38 81.98 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 114.957 1.465 . . . . 0.0 114.957 172.463 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 38.1 mmt -66.71 -47.31 72.76 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 176.539 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 7.1 tp -76.27 -17.94 59.22 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 117.119 2.266 . . . . 0.0 117.119 178.802 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 94.1 p -60.76 -31.32 70.66 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-N 120.616 1.553 . . . . 0.0 114.781 168.634 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -59.82 -39.63 85.74 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 169.073 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -65.04 112.83 3.52 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 124.4 1.08 . . . . 0.0 111.533 169.852 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 13.7 ptp180 -80.12 -15.46 57.07 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 117.941 2.571 . . . . 0.0 117.941 177.632 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 50.0 m80 -89.54 147.88 23.71 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 119.417 1.008 . . . . 0.0 112.367 -168.767 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -77.99 120.9 23.49 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.645 178.993 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 100.07 -21.38 44.89 Favored Glycine 0 CA--C 1.545 1.966 0 CA-C-O 117.168 -1.907 . . . . 0.0 117.119 -169.64 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.36 115.45 4.21 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 120.753 2.277 . . . . 0.0 111.128 -177.728 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 27.1 p90 -126.49 156.49 40.65 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 115.361 1.615 . . . . 0.0 115.361 -168.467 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.0 pp -132.33 125.64 31.4 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 168.382 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 71.8 mt -86.99 119.98 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 173.218 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 48.8 ptt85 -92.05 148.9 21.83 Favored 'General case' 0 CA--C 1.558 1.265 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.499 169.547 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -90.09 122.09 32.75 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 106.425 -1.695 . . . . 0.0 106.425 169.089 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 50.7 m -65.51 113.19 3.99 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.549 0.739 . . . . 0.0 111.95 -174.476 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -90.62 92.37 8.81 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-O 123.814 1.769 . . . . 0.0 108.992 178.854 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 51.7 p 163.73 -40.25 0.0 OUTLIER 'General case' 0 CA--C 1.568 1.672 0 CA-C-N 110.764 -2.925 . . . . 0.0 107.434 -168.209 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -131.87 98.61 17.46 Favored Pre-proline 0 CA--C 1.562 1.415 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 172.129 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -62.11 134.67 50.5 Favored 'Trans proline' 0 C--N 1.372 1.772 0 C-N-CA 123.383 2.722 . . . . 0.0 114.842 178.848 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 90.82 -31.7 5.45 Favored Glycine 0 CA--C 1.553 2.437 0 N-CA-C 116.398 1.319 . . . . 0.0 116.398 -169.373 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -80.63 135.5 36.06 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 118.864 1.332 . . . . 0.0 110.062 175.611 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -108.7 172.0 7.1 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 122.317 1.056 . . . . 0.0 111.127 -173.145 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 50.6 m -146.21 124.03 11.95 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 171.939 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 30.3 tp -80.09 114.42 18.98 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.665 0.786 . . . . 0.0 109.996 172.866 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.6 m -98.66 108.91 21.71 Favored 'General case' 0 CA--C 1.562 1.431 0 N-CA-C 105.336 -2.098 . . . . 0.0 105.336 172.353 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.7 p -127.63 118.67 49.89 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -170.455 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -85.19 97.09 9.71 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.236 0.615 . . . . 0.0 110.013 -179.008 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 17.2 t80 -122.0 124.98 45.26 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 -178.94 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 81.81 -111.47 3.33 Favored Glycine 0 N--CA 1.481 1.644 0 N-CA-C 110.319 -1.112 . . . . 0.0 110.319 -173.538 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -137.16 56.97 1.77 Allowed 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 169.023 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -160.04 135.09 7.94 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 -176.592 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 90.2 t -88.44 105.89 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 172.049 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 62.2 mt-30 -102.59 117.84 35.55 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.736 0.814 . . . . 0.0 109.321 -171.282 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 15.4 m-70 -96.98 113.99 25.57 Favored 'General case' 0 CA--C 1.554 1.121 0 CA-C-N 115.194 -0.912 . . . . 0.0 108.958 -173.518 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -115.2 118.52 33.55 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 177.693 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -80.71 125.77 30.46 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.753 -169.897 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 59.1 t -88.54 103.27 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 106.727 -1.582 . . . . 0.0 106.727 175.913 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -104.11 147.76 27.04 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 121.401 0.619 . . . . 0.0 110.988 -179.811 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -96.47 160.95 14.13 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -176.461 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -133.41 86.91 2.34 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.149 169.648 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 76.87 99.1 0.17 Allowed Glycine 0 N--CA 1.482 1.761 0 CA-C-O 119.197 -0.78 . . . . 0.0 114.513 172.337 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . 0.34 . . 82.09 -77.24 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 124.631 1.172 . . . . 0.0 112.72 -179.974 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -170.55 67.64 0.15 Allowed Glycine 0 N--CA 1.479 1.504 0 CA-C-O 119.662 -0.521 . . . . 0.0 113.214 174.682 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -107.6 94.19 4.95 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 105.863 -1.903 . . . . 0.0 105.863 174.078 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -79.43 126.75 31.24 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 124.204 1.002 . . . . 0.0 110.429 -169.706 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 24.0 p90 -147.92 121.22 8.99 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 -179.229 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -104.46 -42.6 5.41 Favored 'General case' 0 N--CA 1.498 1.926 0 C-N-CA 123.35 0.66 . . . . 0.0 112.508 168.853 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 43.4 t90 -89.98 -85.2 0.22 Allowed 'General case' 0 CA--C 1.56 1.336 0 C-N-CA 124.766 1.226 . . . . 0.0 109.942 -173.536 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 96.4 t -139.16 -66.52 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 -173.537 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 12.2 p -79.74 137.53 21.49 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.551 0 C-N-CA 123.772 0.829 . . . . 0.0 111.333 -175.4 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 60.9 pttt -89.36 162.35 15.84 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 -177.953 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 99.7 m-85 -145.78 120.23 9.68 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 -170.196 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 66.2 m-80 -61.12 -43.85 98.25 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 171.479 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 73.3 m -96.51 138.19 34.47 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-O 121.823 0.821 . . . . 0.0 111.272 174.305 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 13.5 tp -65.82 -31.98 73.25 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 169.661 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -59.69 -41.42 90.69 Favored 'General case' 0 CA--C 1.574 1.887 0 N-CA-C 113.92 1.082 . . . . 0.0 113.92 168.992 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -65.69 -38.32 88.93 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 115.49 1.663 . . . . 0.0 115.49 170.684 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 8.5 tt -57.12 -53.51 57.31 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-N 120.094 1.315 . . . . 0.0 114.404 170.313 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 9.9 p -64.59 -50.5 75.51 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.578 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -178.722 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -61.31 -36.79 81.09 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 115.403 1.631 . . . . 0.0 115.403 175.218 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -59.57 -53.4 58.48 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-N 119.957 1.253 . . . . 0.0 112.095 168.862 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . 0.262 69.7 m-70 -71.36 -9.09 57.6 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 118.15 2.648 . . . . 0.0 118.15 178.274 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 89.9 mtt-85 -58.17 -32.0 67.79 Favored 'General case' 0 CA--C 1.576 1.957 0 CA-C-N 120.375 1.443 . . . . 0.0 113.392 167.127 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 69.2 m -99.26 -42.77 6.87 Favored 'General case' 0 CA--C 1.569 1.678 0 C-N-CA 124.714 1.206 . . . . 0.0 112.927 168.688 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 33.7 m -87.97 155.67 19.72 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-N 119.814 1.188 . . . . 0.0 111.41 -175.373 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 25.3 t -79.56 129.13 34.19 Favored 'General case' 0 CA--C 1.56 1.336 0 O-C-N 121.187 -0.946 . . . . 0.0 113.356 -179.578 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 16.0 m -70.33 -36.85 68.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 N-CA-C 114.998 1.481 . . . . 0.0 114.998 169.748 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 22.9 t -87.25 140.1 29.88 Favored 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 123.658 0.783 . . . . 0.0 110.266 174.51 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 66.2 ttt-85 -73.18 -48.86 31.71 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 177.229 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 24.4 t30 -72.52 -57.89 3.8 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 171.962 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 63.4 mt-30 -79.88 154.4 28.38 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 118.763 0.711 . . . . 0.0 112.247 -177.223 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -94.13 104.0 16.04 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 171.928 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 17.2 mm -123.47 102.28 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 -177.802 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 22.4 m-30 -101.32 133.55 45.75 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 115.043 -0.981 . . . . 0.0 109.544 179.203 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 10.9 mp -89.3 121.44 31.58 Favored 'General case' 0 N--CA 1.486 1.338 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.266 -169.462 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 4.0 mpt_? -119.25 168.41 10.93 Favored 'General case' 0 CA--C 1.561 1.377 0 CA-C-O 123.602 1.667 . . . . 0.0 109.086 175.284 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -83.99 158.21 21.59 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-N 114.708 -1.133 . . . . 0.0 112.763 -174.264 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.1 pp -66.97 162.25 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 N-CA-C 114.565 1.321 . . . . 0.0 114.565 -177.463 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 . . . . . 0 N--CA 1.486 1.33 0 CA-C-O 122.815 1.293 . . . . 0.0 108.901 178.235 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.343 0 N-CA-C 111.664 -0.574 . . . . 0.0 111.664 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 85.5 p -87.37 99.65 12.15 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 121.265 0.555 . . . . 0.0 111.316 -174.607 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 1.2 p90 -157.6 -39.58 0.07 Allowed 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 113.55 0.945 . . . . 0.0 113.55 -174.779 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -80.81 128.39 33.6 Favored 'General case' 0 N--CA 1.484 1.263 0 CA-C-N 119.885 1.221 . . . . 0.0 110.245 177.551 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -87.49 -73.53 0.47 Allowed 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.225 178.023 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 177.81 -101.39 0.15 Allowed Glycine 0 N--CA 1.476 1.339 0 N-CA-C 109.147 -1.581 . . . . 0.0 109.147 179.618 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -139.26 82.19 1.88 Allowed 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 171.744 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 28.6 pt -107.33 149.68 39.05 Favored Pre-proline 0 CA--C 1.571 1.786 0 C-N-CA 123.564 0.746 . . . . 0.0 109.691 -178.876 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.48 168.97 22.05 Favored 'Trans proline' 0 CA--C 1.56 1.801 0 C-N-CA 122.8 2.333 . . . . 0.0 114.363 179.702 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 58.5 ttt-85 -61.99 -40.19 94.77 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 115.645 1.72 . . . . 0.0 115.645 -179.698 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -65.01 -41.09 95.68 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 115.78 1.77 . . . . 0.0 115.78 173.118 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? -64.3 -36.49 84.27 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 114.979 1.474 . . . . 0.0 114.979 169.637 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.76 -52.5 60.1 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 170.047 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -53.91 -36.15 62.41 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 116.458 2.021 . . . . 0.0 116.458 170.094 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -60.78 -50.06 74.98 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 114.433 1.271 . . . . 0.0 114.433 171.436 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -58.89 -51.32 70.53 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 114.925 1.454 . . . . 0.0 114.925 173.816 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -65.11 -33.46 76.08 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 116.16 1.911 . . . . 0.0 116.16 175.619 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 23.3 t -53.92 -35.46 61.69 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 115.725 1.75 . . . . 0.0 115.725 169.736 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -61.24 -41.12 96.34 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 114.587 1.328 . . . . 0.0 114.587 169.288 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -71.65 122.63 20.91 Favored 'General case' 0 CA--C 1.556 1.179 0 CA-C-O 122.898 1.332 . . . . 0.0 112.474 179.899 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.449 ' H ' ' HD2' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -71.09 -8.7 55.27 Favored 'General case' 0 CA--C 1.569 1.674 0 N-CA-C 119.056 2.984 . . . . 0.0 119.056 170.972 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 44.6 m80 -89.71 142.66 27.48 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 120.071 1.305 . . . . 0.0 113.104 -168.703 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -78.66 116.75 19.23 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 169.651 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 108.46 -7.0 34.13 Favored Glycine 0 CA--C 1.549 2.202 0 CA-C-O 117.06 -1.967 . . . . 0.0 117.7 -169.398 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.61 117.69 8.45 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 121.14 2.47 . . . . 0.0 112.502 -169.963 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -131.53 155.09 48.06 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 116.281 1.956 . . . . 0.0 116.281 -168.806 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.6 pp -147.48 138.85 23.81 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-N 114.647 -1.16 . . . . 0.0 108.333 168.929 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.7 mp -94.26 120.69 44.05 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.591 0 N-CA-C 106.708 -1.589 . . . . 0.0 106.708 177.229 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 3.4 ptm180 -106.05 146.4 30.17 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 124.092 0.957 . . . . 0.0 109.702 169.679 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -79.82 131.38 35.88 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 169.682 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 22.9 t -63.54 132.42 51.2 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.673 0.789 . . . . 0.0 112.559 -177.189 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -68.18 -52.23 36.79 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 -172.546 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.0 t -64.99 -35.1 80.1 Favored 'General case' 0 CA--C 1.565 1.532 0 N-CA-C 116.256 1.947 . . . . 0.0 116.256 172.059 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -115.53 98.45 50.79 Favored Pre-proline 0 CA--C 1.563 1.466 0 CA-C-N 119.49 1.041 . . . . 0.0 109.99 178.66 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -59.87 -33.46 95.92 Favored 'Trans proline' 0 C--N 1.371 1.718 0 N-CA-C 119.384 2.802 . . . . 0.0 119.384 175.303 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -87.07 47.84 3.75 Favored Glycine 0 CA--C 1.551 2.34 0 N-CA-C 114.633 0.613 . . . . 0.0 114.633 169.239 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -156.19 126.75 6.74 Favored 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 178.881 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 7.5 m-30 -92.91 169.02 10.77 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 122.042 0.925 . . . . 0.0 110.806 169.933 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 69.5 m -149.47 115.69 5.76 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 -178.812 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 33.9 tp -81.02 112.87 18.81 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.896 0.879 . . . . 0.0 109.588 176.902 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 9.7 m -94.53 83.17 4.08 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 177.996 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.7 p -107.94 115.69 49.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 -171.412 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 58.0 tttp -77.59 145.59 36.74 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 114.882 -1.054 . . . . 0.0 111.416 171.173 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -148.86 101.34 3.17 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 169.735 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 92.61 -104.12 3.14 Favored Glycine 0 N--CA 1.479 1.534 0 N-CA-C 112.002 -0.439 . . . . 0.0 112.002 179.769 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -113.2 -11.98 13.18 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 117.241 2.311 . . . . 0.0 117.241 178.55 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -116.88 142.01 47.48 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-N 119.558 1.072 . . . . 0.0 110.051 -175.909 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 39.6 t -92.94 110.86 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 175.533 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 55.1 tp60 -102.33 112.22 24.83 Favored 'General case' 0 CA--C 1.552 1.055 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 -172.165 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -94.96 108.69 20.75 Favored 'General case' 0 CA--C 1.553 1.059 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 -174.68 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -103.13 130.5 50.32 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 176.227 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -77.82 115.5 17.61 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 123.083 0.553 . . . . 0.0 112.254 -175.939 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 97.4 t -85.64 110.35 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 106.83 -1.544 . . . . 0.0 106.83 178.364 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 58.5 mt -90.53 135.63 33.57 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.102 0.561 . . . . 0.0 109.717 -173.349 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 79.1 mtp180 -116.68 119.07 34.34 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 -175.183 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . 0.29 3.9 p-10 -79.91 -66.11 0.92 Allowed 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 -175.561 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -90.85 -107.27 1.39 Allowed Glycine 0 N--CA 1.483 1.826 0 CA-C-N 119.424 1.011 . . . . 0.0 111.801 -179.56 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -79.87 -67.28 0.78 Allowed 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 118.827 -0.606 . . . . 0.0 111.236 172.426 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -149.13 70.68 0.32 Allowed Glycine 0 N--CA 1.477 1.427 0 CA-C-N 118.46 0.573 . . . . 0.0 111.884 169.807 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.17 101.16 11.82 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 105.108 -2.182 . . . . 0.0 105.108 171.664 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -83.84 106.73 15.75 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-N 115.038 -0.983 . . . . 0.0 111.141 -168.509 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -114.38 114.72 26.25 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 107.769 -1.196 . . . . 0.0 107.769 177.505 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 63.0 tp -112.01 -48.9 3.01 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 124.192 0.997 . . . . 0.0 112.191 179.749 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 33.7 t90 -92.5 -74.79 0.51 Allowed 'General case' 0 CA--C 1.557 1.22 0 C-N-CA 124.598 1.159 . . . . 0.0 110.694 -169.727 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . 0.255 10.8 p -146.28 -60.41 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 C-N-CA 123.586 0.754 . . . . 0.0 109.715 177.293 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 15.6 m -79.38 157.15 4.7 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.545 0 C-N-CA 124.251 1.02 . . . . 0.0 111.759 178.892 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -79.88 136.0 36.57 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.526 -178.38 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -124.51 99.5 6.22 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 106.222 -1.77 . . . . 0.0 106.222 177.676 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . 0.272 12.8 p30 -60.45 -41.43 94.05 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 116.874 2.175 . . . . 0.0 116.874 -172.991 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 69.3 m -94.88 152.55 18.28 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-O 122.125 0.964 . . . . 0.0 111.268 172.395 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 12.8 tp -64.77 -34.76 79.11 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 169.66 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -63.68 -35.92 82.14 Favored 'General case' 0 CA--C 1.568 1.641 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 168.81 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -60.19 -48.93 79.66 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-N 120.592 1.542 . . . . 0.0 113.858 169.533 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 53.0 tp -60.82 -50.3 74.01 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 115.355 1.613 . . . . 0.0 115.355 173.752 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 46.3 t -61.38 -60.19 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 C-N-CA 123.957 0.903 . . . . 0.0 112.111 176.445 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -59.3 -31.8 69.47 Favored 'General case' 0 CA--C 1.567 1.634 0 N-CA-C 115.607 1.706 . . . . 0.0 115.607 -176.912 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -62.96 -53.92 46.57 Favored 'General case' 0 CA--C 1.568 1.642 0 CA-C-N 119.833 1.197 . . . . 0.0 112.328 168.78 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . 0.306 76.0 m-70 -71.58 -8.5 54.43 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 118.183 2.661 . . . . 0.0 118.183 178.16 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -47.77 -40.29 20.31 Favored 'General case' 0 N--CA 1.499 2.012 0 CA-C-N 120.693 1.588 . . . . 0.0 114.945 167.916 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 70.0 m -106.38 -32.9 7.93 Favored 'General case' 0 CA--C 1.564 1.493 0 N-CA-C 114.728 1.381 . . . . 0.0 114.728 170.655 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 48.7 m -89.39 147.36 24.09 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-N 120.4 1.455 . . . . 0.0 110.172 -179.706 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.502 ' HB2' ' H ' ' A' ' 146' ' ' ILE . 54.8 p -80.47 141.32 35.33 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 120.97 -1.081 . . . . 0.0 113.346 179.214 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 46.5 t -67.37 -51.54 51.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.916 169.781 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 32.3 t -87.35 132.64 33.89 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.582 0.753 . . . . 0.0 110.715 178.796 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -88.33 70.31 9.11 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 121.629 0.728 . . . . 0.0 110.955 176.37 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . 0.297 5.8 p-10 178.77 -68.58 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 125.218 1.407 . . . . 0.0 107.665 -176.501 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -96.86 138.6 34.16 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.689 0.796 . . . . 0.0 109.413 171.943 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -73.47 117.69 15.53 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 122.696 0.398 . . . . 0.0 111.775 178.809 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.502 ' H ' ' HB2' ' A' ' 139' ' ' SER . 8.4 mm -121.21 92.34 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 176.628 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 21.4 m-30 -100.57 119.82 39.11 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-N 114.249 -1.341 . . . . 0.0 108.109 -176.893 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 10.6 mp -74.04 126.48 30.61 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 123.384 0.674 . . . . 0.0 112.321 -169.748 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 24.1 mmt85 -129.23 143.24 50.78 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 124.551 1.14 . . . . 0.0 108.154 -179.083 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -72.26 146.75 47.03 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 113.645 0.98 . . . . 0.0 113.645 -174.798 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 28.3 pt -69.37 150.15 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 C-N-CA 123.868 0.867 . . . . 0.0 112.726 178.902 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 123.848 1.785 . . . . 0.0 109.55 -177.379 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.403 0 N-CA-C 111.748 -0.541 . . . . 0.0 111.748 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 90.7 p -76.86 115.33 16.54 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 122.994 0.517 . . . . 0.0 111.601 -176.59 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . 0.38 62.1 p-90 53.11 4.77 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 121.583 3.92 . . . . 0.0 121.583 -177.431 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -139.53 129.26 24.62 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 -169.676 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -140.09 94.86 2.8 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 170.501 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -91.8 164.95 29.21 Favored Glycine 0 CA--C 1.541 1.715 0 CA-C-O 122.924 1.291 . . . . 0.0 116.082 -169.816 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . 0.259 32.3 mmmt 57.38 53.14 7.84 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-N 113.1 -1.55 . . . . 0.0 115.183 -178.364 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 42.3 pt -136.55 152.35 74.53 Favored Pre-proline 0 CA--C 1.573 1.844 0 C-N-CA 123.895 0.878 . . . . 0.0 109.941 -177.751 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -74.08 177.0 8.77 Favored 'Trans proline' 0 CA--C 1.565 2.058 0 C-N-CA 122.919 2.412 . . . . 0.0 114.124 174.847 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 56.3 ttt-85 -63.78 -42.17 97.81 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 115.303 1.594 . . . . 0.0 115.303 176.506 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -66.47 -41.36 89.14 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 115.742 1.756 . . . . 0.0 115.742 176.35 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 29.2 tptp -62.91 -36.65 84.06 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 169.595 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.28 -46.1 81.79 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 115.452 1.649 . . . . 0.0 115.452 171.432 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -62.15 -39.33 92.24 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 115.168 1.544 . . . . 0.0 115.168 170.795 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -60.34 -46.0 91.47 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 114.938 1.459 . . . . 0.0 114.938 172.872 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 34.3 mmt -59.87 -50.36 74.08 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 114.813 1.412 . . . . 0.0 114.813 171.624 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 88.1 mt -75.97 -23.88 55.36 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 117.076 2.25 . . . . 0.0 117.076 -178.985 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 91.7 p -58.8 -35.99 73.75 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 117.082 2.253 . . . . 0.0 117.082 176.574 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 37.9 mtmm -63.07 -31.84 73.08 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 115.719 1.748 . . . . 0.0 115.719 169.656 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -75.51 122.62 24.14 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.533 1.133 . . . . 0.0 111.667 -171.44 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 13.4 ptp180 -63.56 -20.58 65.75 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 119.224 3.046 . . . . 0.0 119.224 -179.826 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 39.2 m80 -89.63 136.9 32.77 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 119.8 1.182 . . . . 0.0 112.718 -168.704 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -77.23 125.31 29.12 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.38 169.674 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 107.43 -21.38 30.81 Favored Glycine 0 CA--C 1.547 2.046 0 CA-C-O 117.036 -1.98 . . . . 0.0 115.879 -168.849 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.23 111.21 2.49 Favored 'General case' 0 N--CA 1.486 1.352 0 CA-C-N 120.823 2.311 . . . . 0.0 111.821 -171.917 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.8 p90 -123.94 158.19 32.58 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 113.826 1.046 . . . . 0.0 113.826 -168.569 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.2 pp -135.67 133.0 37.69 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 168.327 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 74.1 mt -88.95 109.82 20.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 105.661 -1.978 . . . . 0.0 105.661 171.808 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 50.8 ptt85 -91.1 144.06 26.03 Favored 'General case' 0 N--CA 1.486 1.327 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.097 171.657 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -90.24 126.13 35.72 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 169.113 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 53.0 m -67.07 128.78 37.66 Favored 'General case' 0 N--CA 1.487 1.375 0 CA-C-O 121.508 0.671 . . . . 0.0 111.326 -177.937 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -68.64 -47.83 65.58 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 -172.895 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 90.8 p -61.73 -36.89 82.27 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 116.655 2.094 . . . . 0.0 116.655 169.887 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -123.01 96.74 44.51 Favored Pre-proline 0 CA--C 1.563 1.454 0 CA-C-N 119.421 1.01 . . . . 0.0 109.439 177.776 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -58.05 -33.62 97.5 Favored 'Trans proline' 0 C--N 1.371 1.712 0 N-CA-C 120.055 3.059 . . . . 0.0 120.055 178.472 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -87.26 42.65 3.15 Favored Glycine 0 CA--C 1.552 2.389 0 N-CA-C 115.565 0.986 . . . . 0.0 115.565 169.266 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -149.44 110.19 4.29 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 105.03 -2.211 . . . . 0.0 105.03 177.532 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -95.33 168.01 10.99 Favored 'General case' 0 N--CA 1.489 1.475 0 CA-C-O 121.672 0.748 . . . . 0.0 110.105 176.426 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 73.4 m -143.62 114.28 7.61 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 179.327 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 24.9 tp -79.89 107.34 12.6 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 124.442 1.097 . . . . 0.0 109.041 176.257 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 9.4 m -102.79 95.49 6.22 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 -169.956 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 20.0 t -108.62 120.22 59.6 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 CA-C-N 119.113 0.869 . . . . 0.0 109.254 -169.485 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -87.72 96.79 10.57 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.125 0.57 . . . . 0.0 109.526 173.711 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 18.3 t80 -120.53 100.16 6.98 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 179.222 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 68.35 73.0 0.74 Allowed Glycine 0 CA--C 1.542 1.759 0 N-CA-C 115.392 0.917 . . . . 0.0 115.392 175.227 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . 0.321 64.7 m-80 73.67 -22.88 0.23 Allowed 'General case' 0 N--CA 1.5 2.052 0 N-CA-C 118.564 2.802 . . . . 0.0 118.564 -179.821 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -123.91 139.09 54.31 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-N 119.538 1.063 . . . . 0.0 109.935 -169.938 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 39.4 t -100.91 112.39 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 -179.176 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -101.43 115.82 31.37 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.834 0.854 . . . . 0.0 109.208 -174.789 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 -97.12 107.54 20.09 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 115.007 -0.997 . . . . 0.0 108.587 -174.443 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -104.15 119.38 38.81 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 -176.858 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.8 tppp? -75.92 118.5 18.77 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-O 121.98 0.895 . . . . 0.0 110.646 -173.09 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 92.1 t -92.0 101.41 12.52 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.373 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 -179.51 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 68.6 mt -86.37 147.03 26.22 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 123.588 0.755 . . . . 0.0 111.072 178.396 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 73.5 mtp180 -113.0 147.23 37.6 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 123.058 0.543 . . . . 0.0 110.933 -177.776 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -135.41 132.07 37.03 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 123.276 0.63 . . . . 0.0 110.385 173.829 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 81.36 -113.3 3.61 Favored Glycine 0 CA--C 1.541 1.713 0 C-N-CA 122.957 0.313 . . . . 0.0 113.0 175.689 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -83.76 -68.09 0.74 Allowed 'General case' 0 N--CA 1.487 1.401 0 CA-C-O 118.929 -0.558 . . . . 0.0 110.979 172.465 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -162.25 73.04 0.2 Allowed Glycine 0 N--CA 1.477 1.374 0 CA-C-N 118.477 0.581 . . . . 0.0 111.69 169.93 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -99.12 100.93 12.12 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 176.561 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 79.9 m-85 -83.46 112.31 19.84 Favored 'General case' 0 CA--C 1.557 1.227 0 CA-C-N 114.503 -1.226 . . . . 0.0 109.581 -169.585 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -125.13 116.13 21.56 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 123.717 0.807 . . . . 0.0 109.155 -177.115 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -115.7 -38.29 3.75 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 178.773 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 53.2 t90 -99.91 -82.72 0.44 Allowed 'General case' 0 CA--C 1.56 1.336 0 C-N-CA 124.804 1.242 . . . . 0.0 108.679 -179.814 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 99.8 t -137.78 -66.53 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 -175.678 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 10.6 p -79.7 139.05 18.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 C-N-CA 123.69 0.796 . . . . 0.0 110.906 -177.676 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.67 168.11 19.79 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-O 122.256 1.027 . . . . 0.0 113.231 178.631 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -147.23 113.4 5.86 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 -170.104 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 23.3 t30 -59.45 -40.58 87.27 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 115.857 1.799 . . . . 0.0 115.857 -179.49 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 66.0 m -110.65 157.4 19.75 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-O 122.018 0.913 . . . . 0.0 111.203 174.089 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 90.4 mt -66.29 -30.47 70.89 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 114.457 1.28 . . . . 0.0 114.457 169.262 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -63.02 -39.74 95.67 Favored 'General case' 0 CA--C 1.573 1.858 0 CA-C-N 119.89 1.223 . . . . 0.0 113.702 169.287 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -60.8 -43.31 98.31 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 114.217 1.191 . . . . 0.0 114.217 169.282 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 9.5 tt -56.47 -49.84 73.47 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 172.568 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 13.6 m -63.89 -49.11 83.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 N-CA-C 113.831 1.049 . . . . 0.0 113.831 176.973 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -65.8 -33.02 74.89 Favored 'General case' 0 CA--C 1.569 1.68 0 N-CA-C 114.917 1.451 . . . . 0.0 114.917 -175.995 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -61.57 -59.63 4.93 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 119.852 1.205 . . . . 0.0 112.93 169.873 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . 0.261 70.1 m-70 -69.45 -9.23 52.75 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 117.67 2.47 . . . . 0.0 117.67 177.069 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 49.2 ttm-85 -59.03 -32.31 69.62 Favored 'General case' 0 CA--C 1.575 1.925 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 167.573 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 70.1 m -105.11 -35.77 7.5 Favored 'General case' 0 CA--C 1.566 1.581 0 C-N-CA 124.987 1.315 . . . . 0.0 114.045 169.368 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 57.2 m -90.9 155.32 18.83 Favored 'General case' 0 N--CA 1.498 1.959 0 CA-C-N 120.352 1.433 . . . . 0.0 111.983 179.684 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 27.8 t -75.01 135.34 41.3 Favored 'General case' 0 N--CA 1.484 1.263 0 O-C-N 121.545 -0.722 . . . . 0.0 112.73 176.953 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 11.6 t -72.88 -54.32 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 CA-C-O 118.63 -0.7 . . . . 0.0 111.179 170.878 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 39.2 t -101.86 127.57 48.62 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.07 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -62.77 -32.2 73.31 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 116.437 2.014 . . . . 0.0 116.437 -179.49 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 70.9 m-80 -76.37 -62.65 1.55 Allowed 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 119.567 1.076 . . . . 0.0 112.18 169.897 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -91.05 120.78 32.3 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 119.163 0.892 . . . . 0.0 109.258 -178.302 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 58.5 mt-30 -76.37 107.46 8.64 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.794 -0.566 . . . . 0.0 111.505 -174.252 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 14.0 mm -111.72 122.47 66.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 -173.658 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -125.81 129.16 48.88 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 -179.14 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 10.0 mp -78.72 123.09 26.8 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -169.043 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 14.5 tpt180 -111.18 150.72 29.11 Favored 'General case' 0 CA--C 1.56 1.35 0 C-N-CA 125.615 1.566 . . . . 0.0 109.164 172.442 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -76.48 157.41 32.18 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.79 -1.194 . . . . 0.0 112.249 172.262 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -64.31 152.52 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 N-CA-C 114.152 1.167 . . . . 0.0 114.152 -175.305 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 . . . . . 0 N--CA 1.488 1.431 0 CA-C-O 122.843 1.306 . . . . 0.0 108.358 171.952 . . . . . . . . 0 0 . 1 stop_ save_